<SEC-DOCUMENT>0000927653-21-000065.txt : 20210805
<SEC-HEADER>0000927653-21-000065.hdr.sgml : 20210805
<ACCEPTANCE-DATETIME>20210804174411
ACCESSION NUMBER:		0000927653-21-000065
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		76
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210805
DATE AS OF CHANGE:		20210804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MCKESSON CORP
		CENTRAL INDEX KEY:			0000927653
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				943207296
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13252
		FILM NUMBER:		211145365

	BUSINESS ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039
		BUSINESS PHONE:		972-446-4800

	MAIL ADDRESS:	
		STREET 1:		6555 STATE HIGHWAY 161
		CITY:			IRVING
		STATE:			TX
		ZIP:			75039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON HBOC INC
		DATE OF NAME CHANGE:	19990115

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MCKESSON CORP
		DATE OF NAME CHANGE:	19950209

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SP VENTURES INC
		DATE OF NAME CHANGE:	19940728
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>mck-20210630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:31dc61f2-2ef8-41d9-90f2-e8ff46606457,g:0be0b981-6200-4a1a-a19d-196bf6df3870,d:a9b664dd086f4724924e37451951b156--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:mck="http://mckesson123.com/20210630" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mck-20210630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80L2ZyYWc6ZDNiYmY0ZGY3MDU5NDhiNmI4OWNlODhlZTYzZTVkNWIvdGFibGU6MTA1YmU1NDZhNWQwNGI3ODlkZmVjZTZiNzFmODBhOTYvdGFibGVyYW5nZToxMDViZTU0NmE1ZDA0Yjc4OWRmZWNlNmI3MWY4MGE5Nl8zLTItMS0xLTA_e64509e7-83de-48f0-8e4e-9ba28101169d">0000927653</ix:nonNumeric><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80L2ZyYWc6ZDNiYmY0ZGY3MDU5NDhiNmI4OWNlODhlZTYzZTVkNWIvdGFibGU6MTA1YmU1NDZhNWQwNGI3ODlkZmVjZTZiNzFmODBhOTYvdGFibGVyYW5nZToxMDViZTU0NmE1ZDA0Yjc4OWRmZWNlNmI3MWY4MGE5Nl80LTQtMS0xLTA_220bcd1f-22bb-4cc0-a52c-6f428e15499b">03/31</ix:nonNumeric><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80L2ZyYWc6ZDNiYmY0ZGY3MDU5NDhiNmI4OWNlODhlZTYzZTVkNWIvdGFibGU6MTA1YmU1NDZhNWQwNGI3ODlkZmVjZTZiNzFmODBhOTYvdGFibGVyYW5nZToxMDViZTU0NmE1ZDA0Yjc4OWRmZWNlNmI3MWY4MGE5Nl8xMS0yLTEtMS0w_d9e0ddf0-b688-48d5-9c74-2943a9864831">2022</ix:nonNumeric><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80L2ZyYWc6ZDNiYmY0ZGY3MDU5NDhiNmI4OWNlODhlZTYzZTVkNWIvdGFibGU6MTA1YmU1NDZhNWQwNGI3ODlkZmVjZTZiNzFmODBhOTYvdGFibGVyYW5nZToxMDViZTU0NmE1ZDA0Yjc4OWRmZWNlNmI3MWY4MGE5Nl8xMi0yLTEtMS0w_122d5e3d-6d4c-4d67-b4db-bdd30ce6e3fe">Q1</ix:nonNumeric><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80L2ZyYWc6ZDNiYmY0ZGY3MDU5NDhiNmI4OWNlODhlZTYzZTVkNWIvdGFibGU6MTA1YmU1NDZhNWQwNGI3ODlkZmVjZTZiNzFmODBhOTYvdGFibGVyYW5nZToxMDViZTU0NmE1ZDA0Yjc4OWRmZWNlNmI3MWY4MGE5Nl8xMy0yLTEtMS0w_5a3de32d-14ab-41fd-bf93-a60d0ceb4336">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mck-20210630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie16ea3b369e24068be0eb517c465b38d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0444596583fc42aaa4fcca038aabea7e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1500NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia75568a432454780a30eeca181f10bb8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1625NotesDue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a9bb91a104c4960a636e6e9340aedff_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3125NotesDue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ie2dde5d2936140a6940741e305619e4e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i507f1cf3441d436a9874220e71af41c3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide611772c559475e8e24346506419cca_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie70b404c2db04f2ebe83db4787529b8e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a5a6c3bbe5e44deb764a82396a14df9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29b18210e4c94b3e9eeea079457c3440_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia04e0037336742a5862b1a73adc63e1f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedb46ad9eb03415b8c3ef478a437c8d0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31f3423fd8914bcc953eed5489c40bb9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15e4d7260c2e41f096bdffa4d471fb63_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i634d779a260d4eab96c467a9cdde3019_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c03ab80e93f47289af42a50526f49e2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22d5a4e9af084716946bdd5617413192_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ebbfc861a6b4540a93bb5855e3d39fd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26afe17b7028469f99257689fdff7dda_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a3a202be855424c8713dd4fb041ea5f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8466c6d9312243f598d0a021cf047894_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0259ca22a00146cdafb9ed748adbb334_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icedc97c57c25494bb97ac3ef916d8842_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72ec1598f96f46b4a2aa09a894edbf4e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9687fb04dbd469694095f24c00a6c23_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24796da60e81481facb6d498be5e87ed_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i755d7f41b47e492b8cb1bb239e98220c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice2df17bcd5c4d70b58287a28e594ce8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecd424d4030942d9b9c9e99c1603c4a3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f7de12727134d7896b46445549479aa_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8425fdcd51654e2788cfd296989eaf07_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ba16cd1fc7244ceb1279fd03c7f3d71_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2843b04f5ade4927b1bcf699ff9e4e7f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45bcf4e2e2d8477e8b1e8879961cbdf6_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5ddcf2818a34e28bd1e5fa9f983727c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i725d870b5d0847e5a0034ebf590b23a9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd2846306c6949939b64d3cbdef8e7c3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5039f65c2af54891b1478714de89353c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e4d9b8d9f51455cba6575dd2af5893a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5013134a08dd45ba9c62f3e98630e1ff_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i056b6f4cd57242638814e7e5ff75d938_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if98dc411e46a41db9665e0cdbbd91413_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3eb01708eee4de88a588b3642d67848_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c8196204fec46a4b86aba7adf40b724_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id548799f7ab1465c837921be5e020ed5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1aaf42c089f4e2fa8f947ce43febbf5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87c849ded324459ca97d3b31b68b0bd6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i468f96b19c9d424ab3c34d92dd9ba0f2_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b3fb15d56c74664afb9bf5941948b0f_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e51367df2e54805b65a34b535c3a768_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>mck:segment</xbrli:measure></xbrli:unit><xbrli:context id="i6a911394561149eeb8e541a9ff705e67_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d6a811e39f549ae99a6bda061e024e8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i92f41c6f9c3f4caab2c60ad954bef6af_I20210705"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i057cd4a01a544d42941664a044c0ee99_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b729438362242159879d1e5ae05f931_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84cf7e31c16f42f68495c67d9cf8d2e2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57c77c79ca8e4393a2c77738aeb14820_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c075b17e18f4530aaaaa06575761b8a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9283db20095f427da10212779ff9e45d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57a8d9571d55442c857cdee195f25036_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87ee4b68e9ad4be0b0e837451f122185_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c475719e1e54e988a2716b400ad19c8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47e37dbe4a284e4dbcd7fb304b436339_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i630193b02c1347faaf81c65e56471d75_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17d2abc247664f6daa16f853d87054b7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34e5f5eb8b104181b2273e06b8521cc7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91e0eb4c78cd4021aa5f951829fd7105_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i035aba39d89d4cbda66c1e89394e2887_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e6dc977232b4be2a968cd362119be8a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66234f14da784e5eb4675592aa380d6c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9f49c85d9c54b139a81fb46d5568528_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id94f3503c3d14315bb499f5363c098fb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4d2ba414ea445368df49de0797a4169_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a0d6267ee1a4d7780d02c0f5b857095_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i710aa73bfd1a41c98226e45589abb990_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bc550c41437490f858d0f9e149d60d0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i992084e24e76444492d6225980031942_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19168a33968540e783b28d52a160795c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if40e1d1aa4ac42c587f1b983fd883ee3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac2a35f73ee14590b8a577b32c972839_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie45718b0614548d1830f76b0122b7111_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i191304ad1c25432190397b7fa834d148_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id719933d788f420798852650db76c74f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="eurPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ied3d3ec15dce44668530b0cfc63e4725_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaf31474e16b4981835b7927ff4927eb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i487864b97fe74bb085d985d73639d6db_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63b54516555043abafd60e6f00353370_I20210412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ddf756d852f408fbd54c3f4a61f8d6a_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87be9fd9c6fb4f4785e90cb0a3b47104_I20180919"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-09-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2334ff340e7e4425bafcfaaf4f20fc95_I20210412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f923212c58c47f88ad486925df58806_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69a2a49641144b609177a6d98a66f9eb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i508c6f433af04bcd9ab04b4a8838efbd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59705e8d049944ec81dc730a85f8b9e6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i365faceb5dac4b6c8e146917134e4cd2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i412cde1488dd4d8ab371ad4c8f5faa1d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic01bba4cd87f497d8faba0d38fa0e49b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30a07bf169524e7ba24b49eb98a91985_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51575d10eabd476db89a9db186145b8a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bd869d54ffa406bb2261915a7499d39_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34ca8e4a850d48e9b2104497582378ad_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b31c456dd94434c9a3d61732463ebce_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53500c27297841a0b5752e04f4847019_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6b9935a1072411f89e91e4985e6c37a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88f5c5e2af1a4fe4952d7a38df3fb91c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42674b470461487c889c63f9ddc05423_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9a99eac4149443cb99bd6701ec37a59_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c2064f2c8eb49c3849453a95a9c86c4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82edf712cf2f4662ac55525b3410634f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i032911e077b3421889a6ddae5be68041_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e598facc678461e9c9bce2f326a6b53_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9bd1f8e3c8348ac85a0747fd5ead3c3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie633b96d5f6e4594bb149b9a781b4f7f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i340abf5713294118849a48ca0137e899_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2202b302407642afa17e3d40e4f0eba4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d12ee52b8454b869fd9946a0fa4dea8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i593296998692453094e57c17348b980f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia43438708a6949cd9cf16f70af409bba_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f7bc8f0af7b4ef4baba244ec29d1ccf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideb771110e984bc6b277c2585a3c3c6f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d856a3247a04312a0f97fa937d9eed7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32a42ebe572b4d43a291732f6cd1090f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d3366f7c074412792772c50da23b51d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i035c0f3929ab4099b0ee92a80f3a4278_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f46fc9ae83e465096134ae813e19eca_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccbdbd7b3a45463c9d5c7a2b7100baa2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0390e639fcad44a19ceb60da2c72ce2c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fbde6fe64aa486ab9d6ced83a9cd75c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie584228b8d12471fb55c1f0dfb5e49f9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f2b8389302f4c9d9c629498687890a4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17ea7a07b00745c4b4e10ece2a6d1062_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb31fe16ed0945ccb087b29dc4df346e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8407cd75013b4842b7e8b7b851404c4e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebe203936fb34a7a9344c5a6786888f7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41289baaaa434780a092e5aa64685cf3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5fef0e85ad14e5a8339aa8bf7f1f834_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9aee8ea463a843d09b2055c2c57299fd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i169a4495697f4cc6a8840fef9d567050_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a05c4c8a26643e09852e9a58afb81b1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib19d5790e42d4cf79c39f2cd0f8b3b29_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f832373d87043299bdd466eea4cdba1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae5f8b803832412fbac51e8806cb157b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e6c020b9a784d1892f9c88f64b4176e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifee3165ec08d4e9d94616eacd185bdd9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88b5e65988454c43b931f14c2f226ef5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e672708b526455fade2322b90db6797_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic881a7db34944589a71dcb5194c00876_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia66cc0f4490547d7b0e20380ae14d605_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i393368a727ec4afe826cf57617c10f72_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0509dea68b7c4cebaf62b299de6337f9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i918f3ab82fc247afa4f05e53d52b0e43_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1586326f43a34f1ea78093d8355235f0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15cf8725ddab482688388dd6b20edb40_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fb67a2ffa7344a8ac4da91deabca230_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14953d2fb5684f679ab2a851b343c97b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifffd02ac34b54a9d83eede3f64ae16e7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i755188d16c194ff880eddc359eea6d40_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52b40196e15a40109ba391d8c6419991_I20210717"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i083ed7e2edf54f4b83be55e6fa4c6f7b_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a40c09a559944b7bada0ac4b7f9ed85_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c1f8c6acdf4492e89a70c07d233052b_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cd03befc3844879a03bf8f5fa13ca89_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0edf0d51ebc4525bc018b0e3e316674_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i310b2ea151234b239e7d7b390ccb95cb_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibef52b2a142145dab5d69647024ad296_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f3accdb3da74028a9b53d7cbfada305_I20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c2de330c27f48448b2891e90290996d_D20210723-20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-23</xbrli:startDate><xbrli:endDate>2021-07-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25b1cae8ddb3438888532104a195d342_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia01f828cfc8d4b21a6b8edf6be853a2c_D20190701-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e548eee92194bd0ac6aa9274c25b1a9_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i382e8de72c834d1eac88fcfa16537bad_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4601e5b7a09c46ccb58053797c15dbc7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4398603060f24739aba2e6bf31a25415_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b2b1270b93847d1b81d237136f5a141_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacf778d3b2e94d20a54cbcb22993e5bf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id40f1c8ac21f4308bf805ca389c79975_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id62cfccb10834659abc7c6a555e79614_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbabad5c01b74ee69bce61c31d9c74ac_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87ef7e5959ad4f249be2667fc9962adc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia550dbf4b8264bfb9f5b32e88da36352_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9cfdb9a5439470287947e0237d40a46_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc80b14c5bcc4ef59c002900d86c6c35_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic94ceeda5f8d4c34920ab05d68d536f7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e80ec0a1e2d4560a4bb44c4d5f4a808_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3252989f4e9143d3a010d05024100a86_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d1c889a01024ed39200b6381c6e96e7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="iaad66d5fe7e44e1f84cb3ffe38ed1ab1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80839eede57645f39c2726f49aa8dd4f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2831786f08a4f11887081ccec157fb0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id92758a2bb7c4cff8bb23c47c0c1232f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="gbp"><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unit><xbrli:context id="ie7a08d2dbea84831a38c40ef01c2c6e7_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8814cd508cb14d7a92a7f3da4dedb9e8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i956714c5c73546d6bdd695153b63c85a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ef3d8dbb2ba449ca93f70296442ff7b_I20200427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i124c1e4e44e4428894d8a3cf36e6b1f8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A2025NotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief989ade667c4ef18be6557ba0496c47_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e159bf48d534941b449647bc4af9899_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddb83da1863c4b8384938b9fad9620c2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a3a75a3436b4b3685c3cfc786388204_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2941f5ca10940f394d4dd8bfb64ac58_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id617d1f4a3154d5ead974c1efa393746_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d7fdeabe846450cbffd7d9cb27d2e5f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b6587a427294928b598b9dd585bb983_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5eb3ee735d54234824cb44c72ee37bd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i558eb332169346989d3fd5ae0d6527e4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7c97a01f67041b391ae942c70306640_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if46eae73de4e4324a272398b73a63332_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cb0c057ebf04f36a85edd8c4c2ae13c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3de9a66fbd214a428e97ce8f78d46531_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fca76452d9740ef9b482b67b89fa4f8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2acd26c3075244feb92ff6dd6d80e75c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d2fcd1df20c4538955a00e476ec7c57_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb89381a71734f36b7d1abc0599bc5dc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0d9f4fb8711478cb44177fe5109b6be_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d0248921e62472a9c05a75192f10e2a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i057bad05c3bc428daef027fdad88ff14_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c462aabc2274d09a39e632a3b618cce_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7ab7b1f45b443cba7bfac6496401a9f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50a5c757907c4088ae0296ac7b7d7d28_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0f92fdc3cca4ab5a3cf1a1bf925cfd1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17405e4be62d40c6ab31341f02725dfc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6b3e479a7ba41eab5874e29f520ca6e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i264ad77616174b4a9fc0c900da89178a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb9b9bae1bf74a07b096fa2f28832165_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida94316064164aa9be5a8557cd06794c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f1e101a3d9e451eb8389cf243131a05_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia19dcf632c5a4f9b87ae18a87b76e38c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>mck:case</xbrli:measure></xbrli:unit><xbrli:context id="i468d5d79395f4d76980c0de14e2195fe_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i560f2387215143f39820008aab86b0e9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7967e4fff72d493bb8ebc9597e37bc19_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>mck:state</xbrli:measure></xbrli:unit><xbrli:context id="i5952f660e44f4b63bfd67ce4efa66744_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="stateattorney"><xbrli:measure>mck:stateAttorney</xbrli:measure></xbrli:unit><xbrli:unit id="distributor"><xbrli:measure>mck:distributor</xbrli:measure></xbrli:unit><xbrli:context id="icd94e17f05724bf4ba48a2eb22b0163b_I20210721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ca3354c383c4d99b989e74af58a1b0e_I20210720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfNewYorkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa1d16398d7f44208aa02d08c3991ca4_D20210721-20210721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-21</xbrli:startDate><xbrli:endDate>2021-07-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie15c86f3be0f4af2ac4c88a44e20c8ef_D20210721-20210721"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-21</xbrli:startDate><xbrli:endDate>2021-07-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47e3cbf548f448a6aac81a1abd64fb0b_D20210721-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-21</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i909c1a4a44c746a4977ccb484c3c8edf_D20210720-20210720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfNewYorkMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-20</xbrli:startDate><xbrli:endDate>2021-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadd28ed11a014305be6b12b7cad3adab_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5cbe1ba860d47aaa8b10c167bd7e101_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1f6e17a404c4e1692e1e7ec1023c177_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i570f356eb38c49d788e8a9f41b36575c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateAndLocalGovernmentalEntitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4466b2bd90eb4851915c2314922946d0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib81d4fa67aed495cbee1685f6ef28fcc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9ed7575e2c84fb79c4efda8cfe8f99c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:GovernmentalEntitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15595dc6958149c891a687ee33e881b7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:IndividualClaimantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a53a7efe6f64eb58432e009a3da7d7d_I20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:StateOpioidStatutesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7c806eed28f452681024ccfb6d0ba58_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:StateOpioidStatutesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>mck:vote</xbrli:measure></xbrli:unit><xbrli:context id="ie4f9f1cff0f944b581c9e22ae2cafe95_D20210722-20210722"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-22</xbrli:startDate><xbrli:endDate>2021-07-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bb253bd3d3a47dabfafb9011d880dc1_D20210723-20210723"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-23</xbrli:startDate><xbrli:endDate>2021-07-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i326582e2cec94f4596b88b8eac101ee1_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ee5de63e94947cf8f40df8a36d1d075_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eda871b01a9492083d9a7ace055a4bd_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaeccc89714c54493995d9661c58ae337_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i683faa57c1154143bdcceac4cfc4f4be_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5add2ae2ff484cb1a39c941a288349b2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78e5d212e61b44749ee2c344ba273205_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic34f3a349fc24b3d947bac4654010cb5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia069814e274d4623bfb7a2f2d90124b4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifeb84bdd46314ab589c286f47e9fbff3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7580c94982c04c6db55b6b8d11dd6efe_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e4d013ff96647e297facf5a8709f13e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d7a3c97158f4b2295ecfac3630c7dda_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a707105caaf4446872eecd75721360b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96cab475915a4dbcaae2796d530de73b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78d13cdfde3141419e99db6a257de4aa_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i541b64e198c948d092258fb4eb641885_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9a959a0c7b148a38c6b8331c113e2cf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76038b5bf32948138203a73d85210e1e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18ebdcc4b1e44eea804b218171e8f605_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20557e420ca347deb38e35cfe75e2f15_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf2ebdbafd554d41a758ebc6b7078157_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bbc1cd6847947c1857128d50574b91f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5e06f9d71a142728e7dd68ecedc7eb7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia79b569c95894cf8af0a2bce6c0e7a42_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6258d106eb74184a1fa0a7767f79b2f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c68e3755f574f668c6f9e3736c38803_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i207edd1ad0f24086a0af0cd0897714c5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d84fa2b48714007ba888640e7295e09_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafaf876b672949d4a457c37fb78dcc15_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09d8587e16084bb098356d7c27d734c0_D20200701-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>mck:product</xbrli:measure></xbrli:unit><xbrli:context id="ic5004bc3d244470f87a0e4366f016d4c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="country"><xbrli:measure>mck:country</xbrli:measure></xbrli:unit><xbrli:context id="i102de3e4924b431f90a2f289213c9b87_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="business_operation"><xbrli:measure>mck:business_operation</xbrli:measure></xbrli:unit><xbrli:context id="idba260eba8e74ac5a3c690150d88e82e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6affa371637042a0beed138683334e5c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcaabd55fcc24731b0b6daa24a824ce3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie40bd4cb78c741a287b7a02340752d2d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0f85e764ff74422a0b261f62ad59faa_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49c8bc60131d4dedb5a99976b761279b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927653</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ShareholderDerivativeActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ia9b664dd086f4724924e37451951b156_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;           &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTU1_f683d786-0c1b-419d-8693-d7c28fcd2aca">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YTM0NmMwYjkxMmQzNDRmZDhhMmFhYmQ5MmRmN2Q0ODAvdGFibGVyYW5nZTphMzQ2YzBiOTEyZDM0NGZkOGEyYWFiZDkyZGY3ZDQ4MF8wLTAtMS0xLTA_d7b25cb4-f01c-4b02-bce9-a823f03fc5d8">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8xMjQ_f977a8b9-444f-4729-9b33-8be5a4270634">June 30, 2021</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:93.044%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6OGEwMjVkYjRlOTczNGYyNTk4YjZiYTNlY2Y2ZGEwYmUvdGFibGVyYW5nZTo4YTAyNWRiNGU5NzM0ZjI1OThiNmJhM2VjZjZkYTBiZV8wLTAtMS0xLTA_363efe7b-b88f-4f9a-893a-0b9c27b9e22c">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTU2_7d49082e-f6e7-4d6b-834f-f593fcd6a047">1-13252</ix:nonNumeric> </span></div><div style="text-align:center"><img src="mck-20210630_g1.jpg" alt="mck-20210630_g1.jpg" style="height:29px;margin-bottom:5pt;vertical-align:text-bottom;width:196px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTQ3_31769815-511d-4683-bfe4-c67080f825d0">McKESSON CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6MmUyNWU2YTM0ZTNhNGNjYjg2ZWM3OGYzMzAyZjU2ZTkvdGFibGVyYW5nZToyZTI1ZTZhMzRlM2E0Y2NiODZlYzc4ZjMzMDJmNTZlOV8wLTAtMS0xLTA_f5b65385-36de-4e02-81be-99eb70354d40">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6MmUyNWU2YTM0ZTNhNGNjYjg2ZWM3OGYzMzAyZjU2ZTkvdGFibGVyYW5nZToyZTI1ZTZhMzRlM2E0Y2NiODZlYzc4ZjMzMDJmNTZlOV8wLTItMS0xLTA_5cd7dd29-bb08-44b3-a391-ef32cf27957b">94-3207296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTQ5_2f80c580-f9ce-434e-9d98-190c2e640a11">6555 State Hwy 161</ix:nonNumeric>, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTQ4_3f5419e0-79b2-463b-b360-e671aa75940b">Irving</ix:nonNumeric>, <ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTUw_e549d583-bc7e-4478-a3b2-048a4fcfd0d0">TX</ix:nonNumeric> <ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTQ0_90467efc-c90c-4e4d-837e-7561c2acba46">75039</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, including zip code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTUx_0f8f8440-54a1-403c-82e4-50659f0acc2a">972</ix:nonNumeric>) <ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTUy_924ae003-e16f-48a6-93dc-20e8600c0065">446-4800</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:40.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.338%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Title of each class)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Trading Symbol)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">(Name of each exchange on which registered)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie16ea3b369e24068be0eb517c465b38d_D20210401-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl8xLTAtMS0xLTA_81a4fe1a-b756-4d85-b9da-24683ae5358d">Common stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie16ea3b369e24068be0eb517c465b38d_D20210401-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl8xLTEtMS0xLTA_8ea1bbba-6c5f-474e-b476-383f11f45db3">MCK</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie16ea3b369e24068be0eb517c465b38d_D20210401-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl8xLTItMS0xLTA_afdfe537-6d22-4871-97d8-7034644443d7">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0444596583fc42aaa4fcca038aabea7e_D20210401-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl8zLTAtMS0xLTA_f3e43744-01da-4d1b-b79d-6a03cfb1924f">1.500% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0444596583fc42aaa4fcca038aabea7e_D20210401-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl8zLTEtMS0xLTA_a7301e5a-809b-44ea-b3f0-b84a48723823">MCK25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0444596583fc42aaa4fcca038aabea7e_D20210401-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl8zLTItMS0xLTA_18dbf48b-66ac-488a-8753-9c7b2de4dc6a">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia75568a432454780a30eeca181f10bb8_D20210401-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl80LTAtMS0xLTA_553856d0-4fc4-4b1a-98c8-b10c89f548e9">1.625% Notes due 2026</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia75568a432454780a30eeca181f10bb8_D20210401-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl80LTEtMS0xLTA_097adef1-4af7-4f67-8692-b7174226bf42">MCK26</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia75568a432454780a30eeca181f10bb8_D20210401-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl80LTItMS0xLTA_2288753a-a699-4c55-a985-a1dbb22e549a">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2a9bb91a104c4960a636e6e9340aedff_D20210401-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl81LTAtMS0xLTA_ad0bfce8-7c2d-4168-bbd8-f64a0dc191ea">3.125% Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2a9bb91a104c4960a636e6e9340aedff_D20210401-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl81LTEtMS0xLTA_5c5847b1-18c3-4213-9e3a-8083770bba44">MCK29</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2a9bb91a104c4960a636e6e9340aedff_D20210401-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl81LTItMS0xLTA_38e5c24d-7484-4e3b-9588-0554b35943af">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTQ1_889df83c-e1bf-453d-a12e-8a47fb2c2c47">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTUz_ff285bda-215b-49a1-9ce0-ff4483addca7">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="text-align:justify;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:28.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.727%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.745%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.749%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6NGYyYTU2ZTkzY2JhNGVmYmIzZTQ4OWI2N2QyNTUzMjQvdGFibGVyYW5nZTo0ZjJhNTZlOTNjYmE0ZWZiYjNlNDg5YjY3ZDI1NTMyNF8wLTAtMS0xLTA_7cc1d827-5afd-4b46-979b-49acacba8063">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6NGYyYTU2ZTkzY2JhNGVmYmIzZTQ4OWI2N2QyNTUzMjQvdGFibGVyYW5nZTo0ZjJhNTZlOTNjYmE0ZWZiYjNlNDg5YjY3ZDI1NTMyNF8xLTYtMS0xLTA_381dc5c6-640e-4585-949f-f51a32d98542">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6NGYyYTU2ZTkzY2JhNGVmYmIzZTQ4OWI2N2QyNTUzMjQvdGFibGVyYW5nZTo0ZjJhNTZlOTNjYmE0ZWZiYjNlNDg5YjY3ZDI1NTMyNF8yLTYtMS0xLTA_7f285827-ffeb-4d4c-9931-b2c24f30a100">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">f</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160; Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTQ2_db6d1715-5bb0-4da1-be4e-4a753a7a19e1">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9.75pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date. <ix:nonFraction unitRef="shares" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMDc3_8f88f7d1-7e1b-40d5-a1de-2e628d3f2a0e">154,674,571</ix:nonFraction> shares of the issuer&#8217;s common stock were outstanding as of June&#160;30, 2021.</span></div><div style="margin-top:11pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:24.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.018%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Item</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_10">PART I&#8212;FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_10">Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_13">Condensed Consolidated Statements of Operations for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_13">months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">June 30, 2021</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_13"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_13">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_16">Condensed Consolidated Statements of Comprehensive Income </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_16">for the three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_16">months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">June 30, 2021</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_16"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_16">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_19">Condensed Consolidated Balance Sheets as of </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">June 30, 2021</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_19"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">March 31, 2021</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_19">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_22">Condensed Consolidated Statements of Stockholders&#8217; Equity</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_22"> (</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_22">Deficit)</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_22"> for the three months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">June 30, 2021</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_22"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_22">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_25">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_25">three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_25"> months ended </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">June 30, 2021</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_25"> and </a></span><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_25">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_28">Financial Notes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_28">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_31">Note 1 - Significant Accounting Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_31">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_40">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_40">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_40"> - Held for Sale</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_40">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_43">Note</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_43"> </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_43">3</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_43"> - Restructuring, Impairment, and Related Charges</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_43">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_46">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_46">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_46"> - Income Taxes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_46">11</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_49">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_49">5</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_49"> - Redeemable Noncontrolling Interests and Noncontrolling Interests</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_49">11</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_55">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_55">6</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_55"> - Earnings (Loss) per Common Share</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_55">13</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_58">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_58">7</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_58"> - Goodwill and Intangible Assets, Net</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_58">14</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_61">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_61">8</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_61"> - Debt and Financing Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_61">16</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_64">Note </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_64">9</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_64"> - Pension Benefits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_64">17</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_67">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_67">0</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_67"> - Hedging Activities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_67">17</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_70">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_70">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_70"> - Fair Value Measurements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_70">20</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_73">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_73">2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_73"> - Commitments and Contingent Liabilities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_73">22</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_79">Note 13 - Stockholders&#8217; Equity (Deficit)</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_79">26</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_82">Note 1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_82">4</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_82"> - Segments of Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_82">29</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_88">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_88">31</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_112">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_112">48</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_115">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_115">48</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_118">PART II&#8212;OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_121">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_121">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_124">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_124">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_127">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_127">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_133">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_133">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_136">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_136">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_139">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_139">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_142">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_142">51</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_145">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_145">52</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:33.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Financial Statements.</span></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div id="ia9b664dd086f4724924e37451951b156_13"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.993%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMi01LTEtMS0w_b980b16b-76d4-45b3-b2bb-25136597a892">62,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMi03LTEtMS0w_f89ccb60-abe5-4e8d-838d-8d2938edfbf4">55,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMy01LTEtMS0w_89fded92-2190-4a90-8ce1-1c526caa7827">59,642</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMy03LTEtMS0w_7ef19ad1-1489-42c0-9d00-b12a020121e7">52,979</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfNC01LTEtMS0w_6f646fd2-74b3-459a-84dd-f89775cb0bd0">3,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfNC03LTEtMS0w_fdd2d3fe-2616-4b99-abb1-dcf36ccb2e79">2,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfNS01LTEtMS0w_86a7e808-f249-41f3-b19a-c6d22caadee6">2,232</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfNS03LTEtMS0w_1d000213-e544-4738-a80f-bda69517c442">2,097</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfNi01LTEtMS0w_0af36516-a1c2-4f86-b4f5-29b961cba49e">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfNi03LTEtMS0w_fb9f845d-14e3-47d4-aac2-e38d5f130c2b">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfOC01LTEtMS0w_0ac94e57-1374-45c7-8168-9941745e9a6d">158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="mck:RestructuringImpairmentandOtherRelatedCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfOC03LTEtMS0w_9d35ba4f-ed37-4a8b-b38b-d98a62f3369c">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTAtNS0xLTEtMA_86d535fe-46db-4437-9d59-6cff84a20e05">2,464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTAtNy0xLTEtMA_719bc19e-1274-4e37-a208-6027d8a17714">2,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTEtNS0xLTEtMA_adf828eb-7ca7-488a-816f-d492a5de8bd0">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTEtNy0xLTEtMA_33504b24-bb6d-4891-a2bd-eb39864e4ca5">678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTItNS0xLTEtMA_3574b6bc-8357-4efb-8f2a-a53d3d78ddec">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTItNy0xLTEtMA_5be30c17-0a3c-473b-bc10-8a660c679fde">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTQtNS0xLTEtMA_a68d36b4-433d-48a2-91bc-6b0c6d6f9879">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTQtNy0xLTEtMA_d73fba68-ab21-4840-90d5-4c813605be42">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTUtNS0xLTEtMA_e16b0623-8989-4ea4-81ea-d537180995f4">562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTUtNy0xLTEtMA_d32b4cc3-0961-4f51-853a-37e2b5e3d993">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTYtNS0xLTEtMA_7c2d961b-b8c8-48fa-990c-80fdfc360086">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTYtNy0xLTEtMA_0b57e646-e92f-4195-9a0f-8c2d8abd6ab0">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTctNS0xLTEtMA_fe1776d1-2c5f-4c49-b276-10212f46586a">536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTctNy0xLTEtMA_41bbb7cf-6434-4118-983f-bb23e5c95881">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTgtNS0xLTEtMA_bc49a88b-c66b-4133-aecf-2f969c16524f">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTgtNy0xLTEtMA_1dcc1199-6fe1-40d5-b122-cab2129f363a">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTktNS0xLTEtMA_e09efa75-35d2-44b5-89e5-0f233dbd2083">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTktNy0xLTEtMA_b0a6a5a4-ed82-4459-8387-59912c5f2759">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjAtNS0xLTEtMA_04ca3996-8dbf-4aa6-85d0-4d74e2b831f9">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjAtNy0xLTEtMA_e4660d64-167a-4881-8c28-b506a1628800">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjEtNS0xLTEtMA_f8c99178-374b-4642-b10c-5a40cb85de35">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjEtNy0xLTEtMA_1b20f40b-38c6-4795-8eee-7853657188e5">444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjUtNS0xLTEtMA_fe42dfc3-2a3b-482a-8434-80d90512fe5e">3.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjUtNy0xLTEtMA_2eb65c56-b363-404e-85ad-ddf7b4bfb8e4">2.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjYtNS0xLTEtMA_3e17eb44-8f86-47da-a5fe-44804e05270c">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjYtNy0xLTEtMA_1bc7802b-ca8e-47db-82da-bfbf22f6a115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjctNS0xLTEtMA_38d1a33b-d5a6-4c3c-9c85-db2d3d0bf5e6">3.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjctNy0xLTEtMA_fa7ef808-b863-4a16-98bd-1e1814397cb9">2.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjktNS0xLTEtMA_efcc517b-ecc4-4391-8959-7f7a6421cd03">3.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjktNy0xLTEtMA_5fd5f0b9-8fc6-45a6-876f-3e6927a63196">2.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzAtNS0xLTEtMA_c4e69d83-9900-41ed-8e18-8ce5a4cacc1f">0.02</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzAtNy0xLTEtMA_f127f6d9-221a-4572-b4b7-a21c218191a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzEtNS0xLTEtMA_7ef651a2-17a6-4281-ba9c-ba4f6a80a5fa">3.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzEtNy0xLTEtMA_8df360f9-512c-4960-b169-11ab0bda3d4d">2.74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzQtNS0xLTEtMA_bbab2671-e37d-4e6d-ac00-a9b12dcd5277">158.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzQtNy0xLTEtMA_aed697f2-95ec-478f-8430-dbb6c046d6a8">163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzUtNS0xLTEtMA_2c5b32d7-5df1-4ddf-a641-f630ed1e77fb">156.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzUtNy0xLTEtMA_7ab2b84b-2fba-49e0-87c5-68e8e43b0c10">162.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.993%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMi01LTEtMS0w_198ff204-c5d4-4570-b6c2-0cd815dfde82">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMi03LTEtMS0w_d49db17e-0d95-42c8-90ca-7ef72515a1c2">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfNS01LTEtMS0w_6db2bf41-d63a-4040-b76f-9d5ea59899b2">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfNS03LTEtMS0w_b185cfff-28f4-4815-92e0-0c9a0371c80c">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on cash flow hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfNi01LTEtMS0w_804df5e5-7118-4988-b1ca-137b3e272093">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfNi03LTEtMS0w_80c46e32-5f38-43ea-8940-98a1dabc0f08">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfNy01LTEtMS0w_0d2e51bf-81ad-459d-9de4-bad14faf5d20">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfNy03LTEtMS0w_dd4b91ed-05d8-43eb-9530-e883267e916a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfOC01LTEtMS0w_c08e9def-53d7-4d28-9032-4fe113e6f292">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfOC03LTEtMS0w_f5c9a55e-5036-48b2-80e1-faeba7517f20">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMTAtNS0xLTEtMA_9088d221-ba54-4e50-a1cc-7e5359b5f962">559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMTAtNy0xLTEtMA_a96dbc1c-fc35-4593-afef-d94aba0762e4">523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMTEtNS0xLTEtMA_60ea06b3-57b3-4341-9be0-7323ce12d20c">50</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMTEtNy0xLTEtMA_ae8e9626-9a7a-416b-be87-93bcdb81aa49">111</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to McKesson Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMTItNS0xLTEtMA_502307a4-17f1-4c21-889e-e3406e398944">509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMTItNy0xLTEtMA_53071544-a222-4487-97c5-dabcc88dc0eb">412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:71.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMy0xLTEtMS0w_e087cd77-8d50-44c5-b21f-bd420577a19e">2,423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMy0zLTEtMS0w_8b7d7079-d468-410e-a193-60c92769c4e1">6,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNC0xLTEtMS0w_5a154e23-1cda-47be-b13f-2dfa7d07428a">20,198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNC0zLTEtMS0w_671e5f0c-27cc-44fd-b4ad-8bfb7655d674">19,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNS0xLTEtMS0w_e2653b3d-fa3e-4751-a6ca-f05714c7ca78">20,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNS0zLTEtMS0w_32247a16-c82c-4420-9232-0d87f994d4f0">19,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNi0xLTEtMS0w_3b69f3e7-17b0-4431-ae3d-2e320a7d585f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNi0zLTEtMS0w_ec97b708-3d9b-4649-9864-c9b30c638999">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNy0xLTEtMS0w_59c23f19-fa89-4f9f-80f8-065e2cf6516d">706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNy0zLTEtMS0w_df3c5cd4-c55e-4775-ad1c-54d5aac6086a">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfOC0xLTEtMS0w_ef9147d4-0751-40d6-8885-8439b06f4302">43,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfOC0zLTEtMS0w_8bbe8481-d55f-470a-bbbc-3fa3bb08fafd">45,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant, and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfOS0xLTEtMS0w_e10c33bd-79b0-412f-b00a-54d75dcc99ea">2,549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfOS0zLTEtMS0w_811d8760-d912-46a7-bde0-88906840d907">2,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTAtMS0xLTEtMA_8ef068d5-534f-4cdb-ad77-51fecaae3618">2,071</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTAtMy0xLTEtMA_dd68240c-cc9b-410a-be28-934ad2f6c64c">2,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTEtMS0xLTEtMA_a6256960-0925-4ca5-a5c3-18dda2ba50c9">9,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTEtMy0xLTEtMA_c6e9dd2d-7bc9-4824-a056-d0aed6b47d6a">9,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTItMS0xLTEtMA_ff161f6c-360b-4289-b189-5cb4d5543c49">2,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTItMy0xLTEtMA_3396b18a-d7d2-4855-a965-f31927bc926a">2,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTQtMS0xLTEtMA_af514c4d-98a5-4c88-be4e-9030695cb264">2,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTQtMy0xLTEtMA_416d5de2-b6c0-4a64-a533-0795047d3016">2,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTUtMS0xLTEtMA_a0b8df84-b5c2-43f0-86bd-3fca80cd3a0d">62,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTUtMy0xLTEtMA_1a0b3cd1-f831-414c-ac77-a72b58b288c3">65,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY (DEFICIT)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTktMS0xLTEtMA_a20ca206-251c-406f-80a5-7e41ecd0000d">38,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTktMy0xLTEtMA_bb9bd7fc-fafc-40c4-ab3a-493e4af0e954">38,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjEtMS0xLTEtMA_c3d55c7a-cd10-4461-999b-73f4aa3d274b">752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjEtMy0xLTEtMA_aae6bc2d-6be2-45bd-9ff5-ceb8ba3599cd">742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjItMS0xLTEtMA_51797ce1-c685-4583-a585-e6dd9e6cd522">392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjItMy0xLTEtMA_8d7259fc-dcbd-4bb5-a778-7d5b6f24bb15">390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjMtMS0xLTEtMA_bbf398e2-ace4-40c0-bafa-20b2a53d9e39">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjMtMy0xLTEtMA_cb77f1c1-2bdd-4d81-9a2e-3d16b08f019d">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjQtMS0xLTEtMA_0175b607-65dd-4fb7-b07f-de9b6e834657">4,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjQtMy0xLTEtMA_fdd40058-78da-466b-99be-77de544d81a3">3,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjUtMS0xLTEtMA_0f1db60c-fb50-4df4-a2a7-2a37a796bad3">43,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjUtMy0xLTEtMA_b45f01c0-b338-4ee0-876c-22d149ffb0cd">44,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjYtMS0xLTEtMA_55577be5-0e8a-4b38-91e5-14039dafc2ec">6,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjYtMy0xLTEtMA_d609ba09-a96a-4d86-872b-7c024483ccb6">6,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjctMS0xLTEtMA_e38f434a-c3f7-441c-9793-692166737e29">1,441</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjctMy0xLTEtMA_5b47b3fd-f993-4220-893a-1138ed2568cd">1,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjgtMS0xLTEtMA_db325b72-ee53-4212-8a42-682444fa7e4b">1,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjgtMy0xLTEtMA_a159fdf6-b6a3-4c0b-8ea2-38ccf11dc47c">1,867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjktMS0xLTEtMA_e310ed96-2a03-45b5-9057-3f38a2185d22">7,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationReserveNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjktMy0xLTEtMA_d9f25fcb-8649-4cf1-b200-b1304483715b">8,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzAtMS0xLTEtMA_6b141827-48d7-4594-9a71-e1e9a1e97ba0">1,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzAtMy0xLTEtMA_236c5526-abc0-422e-b86b-a4e3b06e0e08">1,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzEtMS0xLTEtMA_0c6a764d-13ea-415e-9686-3820a0439dda">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzEtMy0xLTEtMA_d0e020be-dc36-4bb2-b823-f6b1a2733164">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McKesson Corporation stockholders&#8217; deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzIx_3209eb78-6a4f-42fb-83bf-0f18137b0a98"><ix:nonFraction unitRef="usdPerShare" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzIx_6df10fe1-2479-40c1-a23f-13033dd84b9c">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzM1_31b1ff79-2a3c-429e-af99-2ea699edbf91"><ix:nonFraction unitRef="shares" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzM1_ccdf6fbc-3040-4369-997e-e050c6313a13">100</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzU3_4ac150f0-b268-4687-917f-3cd7e1e7a5bc"><ix:nonFraction unitRef="shares" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzU3_4c29c416-ba40-47b4-9eb0-6447b989d031"><ix:nonFraction unitRef="shares" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzU3_c469fd00-0cc0-4e62-a6f8-fe2c175c1e35"><ix:nonFraction unitRef="shares" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzU3_e1821884-6fef-4567-b280-7dd7762133a0">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued or outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMS0xLTEtMA_12150b1f-ba94-4754-8e37-d2b70890a488">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMy0xLTEtMA_2d3e3a84-e5b7-48b3-a10d-a41c3f4a2b18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE3ODU1MGI3NTIzMjQyNzY4ZWRmMzg2MWFkNzMwNGZlXzE4_98abf703-b385-49b6-a93c-c7fbe4e17fbc"><ix:nonFraction unitRef="usdPerShare" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE3ODU1MGI3NTIzMjQyNzY4ZWRmMzg2MWFkNzMwNGZlXzE4_e8d8b7b6-dd4a-4156-a078-50c8e659ce94">0.01</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE3ODU1MGI3NTIzMjQyNzY4ZWRmMzg2MWFkNzMwNGZlXzMy_34c258c6-7d77-417c-939e-ae1741c78147"><ix:nonFraction unitRef="shares" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE3ODU1MGI3NTIzMjQyNzY4ZWRmMzg2MWFkNzMwNGZlXzMy_fa89546a-1c01-4492-8439-21bcdb6091ee">800</ix:nonFraction></ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE3ODU1MGI3NTIzMjQyNzY4ZWRmMzg2MWFkNzMwNGZlXzU3_e6546f37-0019-4c59-b6b6-a4cd987d2ac2">274</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE3ODU1MGI3NTIzMjQyNzY4ZWRmMzg2MWFkNzMwNGZlXzY0_edb2a67a-daec-4b80-b0c7-8da8e66d9d52">273</ix:nonFraction> shares issued at June 30, 2021 and March 31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMS0xLTEtMA_8d470b8e-37b4-4cb5-87c7-f930fb8e3f57">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMy0xLTEtMA_aff8fc5b-ed58-454f-a89c-0e9f1e7e9fa0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzUtMS0xLTEtMA_74beb754-9f08-4af9-bd7e-0a87e5d6c4cd">7,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzUtMy0xLTEtMA_d1e144b0-4d80-4cbc-a035-5b2037a84aeb">6,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzYtMS0xLTEtMA_de1476db-aef1-4f9d-b9ac-8e3cec7b475a">8,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzYtMy0xLTEtMA_88306dfa-0cda-4e3e-badf-a9cd3f533722">8,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzctMS0xLTEtMA_6838d41a-2ad8-4b5e-910e-b2b6454af753">1,627</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzctMy0xLTEtMA_834e7185-a156-44d8-9b2d-39a1cc130997">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury shares, at cost, <ix:nonFraction unitRef="shares" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzktMC0xLTEtMC90ZXh0cmVnaW9uOmQ2ODNlNjIwOWRmODQ4ZTNhZTRmNzU3MDJhODk4Yjk1XzMw_fcb47038-8822-48df-bbba-c98a2e477943">119</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzktMC0xLTEtMC90ZXh0cmVnaW9uOmQ2ODNlNjIwOWRmODQ4ZTNhZTRmNzU3MDJhODk4Yjk1XzM3_b23f6817-5871-4e1d-a07a-2cfa31da169c">115</ix:nonFraction> shares at June 30, 2021 and March 31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzktMS0xLTEtMA_588bb790-74f2-4c2d-bf9f-69712d5591e6">14,579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzktMy0xLTEtMA_7cced4ec-f3b4-4f8d-a7c9-e2b96cbaf9a2">13,670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total McKesson Corporation stockholders&#8217; deficit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDAtMS0xLTEtMA_58409ab4-9d92-4605-8d9a-8b04b8b4b687">529</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDAtMy0xLTEtMA_0a8bbdc0-7083-4aa8-ade6-d3630cafda90">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDEtMS0xLTEtMA_d963c42f-4d5e-4c6d-94b2-5bf9113ea310">484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDEtMy0xLTEtMA_03cb7a88-71e0-41a7-a925-48df297750d6">196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity (deficit)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDItMS0xLTEtMA_160aacee-f8db-4acc-9798-995d1dfb5c7d">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDItMy0xLTEtMA_c659e184-c21d-44e0-9349-8fd26d5aa81f">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, redeemable noncontrolling interests, and equity (deficit)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDMtMS0xLTEtMA_bf4586bd-d38e-4dc7-ab94-43817ff05d2f">62,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDMtMy0xLTEtMA_fde62c16-0f04-4fe4-b8cd-b3e74617ebde">65,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.642%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity (Deficit)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:19pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, March 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide611772c559475e8e24346506419cca_I20210331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0xLTEtMS0w_454ef79b-27c9-4ab0-bf08-138506b46d44">273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide611772c559475e8e24346506419cca_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0zLTEtMS0w_7d2f2e65-f8da-477d-b6e7-7b3ef17cfc75">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie70b404c2db04f2ebe83db4787529b8e_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy01LTEtMS0w_6059ea21-58d7-479a-9bcc-6cdc774eeb82">6,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a5a6c3bbe5e44deb764a82396a14df9_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy05LTEtMS0w_99362731-7840-43b1-b8f4-b623dadaaf08">8,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29b18210e4c94b3e9eeea079457c3440_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0xMS0xLTEtMA_8ebd49ce-4a96-417b-a86f-ab2293e06f22">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia04e0037336742a5862b1a73adc63e1f_I20210331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0xMy0xLTEtMA_03475dd1-3a46-4fab-8bfa-fad470f52559">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia04e0037336742a5862b1a73adc63e1f_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0xNS0xLTEtMA_917fd87a-7d6b-480e-a1e4-7f6634ecce38">13,670</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedb46ad9eb03415b8c3ef478a437c8d0_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0xNy0xLTEtMA_04a33b11-521b-441a-9437-4a9fc434112e">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0xOS0xLTEtMA_d94d273d-65f3-436c-a861-bb4e3a4b07b8">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i31f3423fd8914bcc953eed5489c40bb9_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNC0xLTEtMS0w_3dd41540-4777-43ac-b377-165a999cc347">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15e4d7260c2e41f096bdffa4d471fb63_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNC01LTEtMS0w_a77619de-bfb0-49c3-9e12-26c2efe6b70c">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i634d779a260d4eab96c467a9cdde3019_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNC0xNS0xLTEtMA_9188ea8c-b0c4-41b9-b89d-5e786d51e4c3">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNC0xOS0xLTEtMA_cd8b282b-24b1-4502-8353-2c49b4b51d6f">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15e4d7260c2e41f096bdffa4d471fb63_D20210401-20210630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNS01LTEtMS0w_e585ba3a-14e3-4647-89a0-9b8016389913">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNS0xOS0xLTEtMA_9d6168c5-308a-4f2e-8e24-8390c2b780de">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNi0xNy0xLTEtMA_177931bd-9be8-47a8-9961-a74050a86ab5">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNi0xOS0xLTEtMA_2a2dfecf-2eca-4eec-95c2-7875299bdc75">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c03ab80e93f47289af42a50526f49e2_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNy0xMS0xLTEtMA_3b7dc93d-f731-45de-a5df-5ab19368954d">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNy0xOS0xLTEtMA_782ada91-f241-4f59-9701-357996cd688e">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d5a4e9af084716946bdd5617413192_D20210401-20210630" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOC05LTEtMS0w_c7c72765-b877-4acc-b1b1-1bfcf59ccaea">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOC0xNy0xLTEtMA_e05aab43-ea36-4f1a-aee5-0944c6b9a3a1">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOC0xOS0xLTEtMA_28146496-5223-4a81-b533-464910e1252d">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15e4d7260c2e41f096bdffa4d471fb63_D20210401-20210630" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOS01LTEtMS0w_2aa0e0e6-fb43-44dc-b351-5592d65dc94a">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i634d779a260d4eab96c467a9cdde3019_D20210401-20210630" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOS0xMy0xLTEtMA_631b207e-1662-4646-b18c-74ad2f82e36c">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i634d779a260d4eab96c467a9cdde3019_D20210401-20210630" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOS0xNS0xLTEtMA_1a3bbbc5-42fd-403d-a967-e03dcd7ab876">850</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOS0xOS0xLTEtMA_63ea98dd-f0e9-4eee-904d-f437f99cac52">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15e4d7260c2e41f096bdffa4d471fb63_D20210401-20210630" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTAtNS0xLTEtMA_b6350256-77a1-4a85-9272-8912a60ec639">178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c03ab80e93f47289af42a50526f49e2_D20210401-20210630" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTAtMTEtMS0xLTA_e45a4d19-b13c-4753-b28b-2153cbedac17">170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTAtMTktMS0xLTA_0a3757a2-b9d0-409b-a84c-193844dc762b">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe AG redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTEtMTctMS0xLTM4NTg_f875cedf-f382-4c97-acf7-1a4271cda84c">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTEtMTktMS0xLTM4NTg_e38534a5-bcb7-4d74-a8f3-92a9d8f9f180">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmVlNWZhYzkzOWZkNjQwNTQ5NjUwY2NjYzI4Y2VjOTdlXzgyNDYzMzcyMDgzNzE_c5dce1f9-319c-4e72-b7a5-e6da04ae843b">0.42</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22d5a4e9af084716946bdd5617413192_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTEtOS0xLTEtMA_4214e739-38f1-4d85-ab61-4ecace389146">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTEtMTktMS0xLTA_ccfa712f-7cb7-439b-adcc-5a5fc2b2c2be">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22d5a4e9af084716946bdd5617413192_D20210401-20210630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTItOS0xLTEtMA_1b5a5fd0-660e-4b0a-be55-6f7b69ee6c37">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTItMTctMS0xLTA_f394ebbf-dcae-4cff-a117-b2d515d52fca">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTItMTktMS0xLTA_4e8bd6be-802b-4822-a342-340e238b7fc7">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, June 30, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ebbfc861a6b4540a93bb5855e3d39fd_I20210630" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMS0xLTEtMA_4bd260a0-bdfa-4900-8c62-e84ec054bf05">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ebbfc861a6b4540a93bb5855e3d39fd_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMy0xLTEtMA_8fa2e5e7-70b6-4945-85c8-2dc52498f6f3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26afe17b7028469f99257689fdff7dda_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtNS0xLTEtMA_e548f632-f920-4565-aab6-019d0364d1b9">7,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a3a202be855424c8713dd4fb041ea5f_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtOS0xLTEtMA_57e4f0a0-4a76-40c0-8fc2-266ea22bc04f">8,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8466c6d9312243f598d0a021cf047894_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMTEtMS0xLTA_33e16245-e155-4f1b-b778-5aecab1676a0">1,627</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0259ca22a00146cdafb9ed748adbb334_I20210630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMTMtMS0xLTA_ef6a5c18-7df0-4caa-90f5-016d2119291c">119</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0259ca22a00146cdafb9ed748adbb334_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMTUtMS0xLTA_fdad7145-cc7b-4dae-a3e6-b0acd9c5a111">14,579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedc97c57c25494bb97ac3ef916d8842_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMTctMS0xLTA_556c8140-d502-4989-98a1-5d9bfbefaace">484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMTktMS0xLTA_a87c78fe-078b-41f5-a688-a421f0471c89">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.454%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling<br/>Interests</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, March 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i72ec1598f96f46b4a2aa09a894edbf4e_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0xLTEtMS0w_73b83dbf-fdf3-449c-a88e-ef50d24b9270">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ec1598f96f46b4a2aa09a894edbf4e_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0zLTEtMS0w_ead5b251-acf0-40f6-bf09-107c4d66571c">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9687fb04dbd469694095f24c00a6c23_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy01LTEtMS0w_fc31ceee-9bdc-4557-804d-b135a3c70789">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24796da60e81481facb6d498be5e87ed_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy05LTEtMS0w_08b45886-bd23-4863-a4a7-7b8ef884546e">13,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i755d7f41b47e492b8cb1bb239e98220c_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0xMS0xLTEtMA_cacd71d0-0cd7-4da1-acfa-f0b981a3c3eb">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ice2df17bcd5c4d70b58287a28e594ce8_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0xMy0xLTEtMA_0c750754-76d5-40ba-8ecc-6999bf503c81">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice2df17bcd5c4d70b58287a28e594ce8_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0xNS0xLTEtMA_59f4d6c4-4425-4fc0-9c0b-bbaae741f77a">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecd424d4030942d9b9c9e99c1603c4a3_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0xNy0xLTEtMA_e7f2553a-7963-4567-af66-04256330678e">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f7de12727134d7896b46445549479aa_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0xOS0xLTEtMA_819ae5cf-e219-46b3-9f6a-f0746d4091fc">5,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Opening retained earnings adjustment: adoption of new accounting standard</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8425fdcd51654e2788cfd296989eaf07_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNC05LTEtMS0zNzc0_277354dc-111a-4a34-8d98-387f3ca11030">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ba16cd1fc7244ceb1279fd03c7f3d71_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNC0xOS0xLTEtMzc3NA_0770c747-dc47-46bd-bcd8-3ac2a61648a0">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, April 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2843b04f5ade4927b1bcf699ff9e4e7f_I20200331" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xLTEtMS0zNzc0_bfacdc75-e5ce-41ee-a477-bcf88d1134d0">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2843b04f5ade4927b1bcf699ff9e4e7f_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0zLTEtMS0zNzc0_ae42095e-f987-4c4a-93c2-05205085b3bc">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45bcf4e2e2d8477e8b1e8879961cbdf6_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS01LTEtMS0zNzc0_c31b847a-274d-4f22-b607-fe5dca62f033">6,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ddcf2818a34e28bd1e5fa9f983727c_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS05LTEtMS0zNzc0_ff32da7b-1e5e-4713-ae25-099045d03aa6">13,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i725d870b5d0847e5a0034ebf590b23a9_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xMS0xLTEtMzc3NA_6a29e4e5-c98f-420f-ba2e-d8f9f3ec50c0">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibd2846306c6949939b64d3cbdef8e7c3_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xMy0xLTEtMzc3NA_8bfdf3bc-10f6-4cea-9948-26c8b22620a2">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd2846306c6949939b64d3cbdef8e7c3_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xNS0xLTEtMzc3NA_78724e6d-88b9-4926-a650-5f71eae30623">12,892</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5039f65c2af54891b1478714de89353c_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xNy0xLTEtMzc3NA_7c6a524f-5650-45c9-b3fe-0d2d51e706d8">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e4d9b8d9f51455cba6575dd2af5893a_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xOS0xLTEtMzc3NA_b2533961-5da3-4d79-876c-86a9366eb4eb">5,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of shares under employee plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013134a08dd45ba9c62f3e98630e1ff_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNC01LTEtMS0w_85569aff-7905-4503-869a-9d07c7b25392">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i056b6f4cd57242638814e7e5ff75d938_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNC0xNS0xLTEtMA_62437a0b-02a9-4656-9e94-d3d5d7c5e885">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNC0xOS0xLTEtMA_74cc084e-64c8-49c3-9aa8-700823a949ab">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013134a08dd45ba9c62f3e98630e1ff_D20200401-20200630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS01LTEtMS0w_70e22101-893b-4dfe-a084-87db7bf80f8d">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xOS0xLTEtMA_49ce8f27-84b8-4bca-a330-bdf4adf50e90">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNi0xNy0xLTEtMA_f8c7ce06-de5b-46f4-8d4d-3b018c6cd853">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNi0xOS0xLTEtMA_7e586669-48fc-480e-be7a-308c908420f8">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if98dc411e46a41db9665e0cdbbd91413_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNy0xMS0xLTEtMA_f7273731-75ce-4027-9bfd-2203757a524d">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNy0xOS0xLTEtMA_7dff03a5-e195-4417-9419-82e19b3d3a11">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3eb01708eee4de88a588b3642d67848_D20200401-20200630" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfOC05LTEtMS0w_d66c9f5e-4e1a-4d38-8fc7-f705b0b35876">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfOC0xNy0xLTEtMA_bd069ec9-42ec-4bd3-874f-42d5db141471">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfOC0xOS0xLTEtMA_36b53d8b-a7a0-434b-b15e-5a1ca7686962">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013134a08dd45ba9c62f3e98630e1ff_D20200401-20200630" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTAtNS0xLTEtMA_d25d266a-9c66-42e4-bff0-fbaef48a087d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTAtMTktMS0xLTA_d484a516-f221-4646-bb04-795fadf3748c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared, $<ix:nonFraction unitRef="usdPerShare" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjlhMjEyMjE2MzQ5NDQ0N2VhNDJhMmNlNDgzZWFlMjQ3XzgyNDYzMzcyMDgzNjk_d6d0a8bd-24c0-40e7-af47-8fa79e900a9d">0.41</ix:nonFraction> per common share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3eb01708eee4de88a588b3642d67848_D20200401-20200630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTEtOS0xLTEtMA_aae69b5e-c05d-4837-9387-9ceaa9aa677a">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTEtMTktMS0xLTA_f9240e5e-ac6c-4b55-85b2-ba965719c8eb">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5013134a08dd45ba9c62f3e98630e1ff_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTItNS0xLTEtMA_24b3fdb7-39e7-44b8-be1f-9837fc6a52e7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3eb01708eee4de88a588b3642d67848_D20200401-20200630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTItOS0xLTEtMA_57c7b120-7725-4c02-9515-f8e83e43ea3a">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTItMTctMS0xLTA_a583d43f-3ec8-4263-8263-b4dff0850327">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTItMTktMS0xLTA_751ec993-004f-432b-a59f-607c5db540af">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balances, June 30, 2020</span></div></td><td colspan="2" style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c8196204fec46a4b86aba7adf40b724_I20200630" decimals="-6" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMS0xLTEtMA_a92406d2-4219-4e7e-aa9b-39affc4be79f">272</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c8196204fec46a4b86aba7adf40b724_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMy0xLTEtMA_e9c0a377-533b-4365-91bb-bdddbb4efb99">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id548799f7ab1465c837921be5e020ed5_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtNS0xLTEtMA_576b8adf-f541-4b7e-9305-04414962ffd1">6,711</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1aaf42c089f4e2fa8f947ce43febbf5_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtOS0xLTEtMA_9403a188-8f2e-44cb-9e03-6cadd1385543">13,384</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c849ded324459ca97d3b31b68b0bd6_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMTEtMS0xLTA_9fa6554f-e3e6-4702-ae83-f805ee4fa774">1,735</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i468f96b19c9d424ab3c34d92dd9ba0f2_I20200630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMTMtMS0xLTA_e4a111ed-2ee0-45c1-beb8-7e2447bdc2ab">110</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i468f96b19c9d424ab3c34d92dd9ba0f2_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMTUtMS0xLTA_06203651-61db-4722-ad82-b88ae18898d9">12,916</ix:nonFraction>)</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b3fb15d56c74664afb9bf5941948b0f_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMTctMS0xLTA_0f09bcde-b92c-49e7-a10d-dc0abcbe55e0">207</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e51367df2e54805b65a34b535c3a768_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMTktMS0xLTA_abef4cbb-a14a-471c-aef3-c353c9c5988b">5,653</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMy0xLTEtMS0w_dcb39c5d-572a-4cb6-bdfe-888c45d90213">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMy0zLTEtMS0w_d0ccb4af-7afb-4910-9a09-84b8f021d3cc">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNS0xLTEtMS0w_60a4d7ed-edfa-469f-a21a-ebd606f40abb">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNS0zLTEtMS0w_41b20615-13ae-4af2-bb34-c836272b22f0">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNi0xLTEtMS0w_21548671-98d0-43f4-906f-a23b12de239c">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNi0zLTEtMS0w_e484a69f-2c18-492c-825c-d1080a7e8fb4">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-lived asset impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNy0xLTEtMS0w_8ef11776-8041-4673-b4e6-40e903c64b19">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNy0zLTEtMS0w_213c483c-dbc6-40e5-96b0-a863dae79b64">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfOS0xLTEtMS0w_1919f5c6-45a5-4155-936f-592a6a1a8b33">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfOS0zLTEtMS0w_b91710b9-8c66-44fa-b5c9-72db01519b09">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Credits associated with last-in, first-out inventory method</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTAtMS0xLTEtMA_de46a8ff-2d30-48af-be95-8fe287a6652e">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTAtMy0xLTEtMA_a30d9f9c-e1ad-4c03-b921-c0bb8c4feed6">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash operating lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTEtMS0xLTEtMA_a93395f1-e48a-4110-9d2a-ebb95064dfaa">90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTEtMy0xLTEtMA_c5a7e1c3-1fa8-45de-8fdd-05f1ba8c2f96">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from sales of businesses and investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTItMS0xLTEtMA_d84bd43e-9fb8-4f2d-a6a6-a3948e09898a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:GainLossOnSaleOfOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTItMy0xLTEtMA_95ad2aad-50a3-414c-bc15-39588c837b78">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTMtMS0xLTEtMA_5e605f47-f833-4929-8a34-94660fbab6de">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTMtMy0xLTEtMA_7d6de602-73fd-4737-8f61-78a1e0da8092">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in assets and liabilities, net of acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTUtMS0xLTEtMA_ed02e954-ac90-4927-a15b-121cc5c665dd">1,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTUtMy0xLTEtMA_63b066b4-2741-490c-ad26-b00453ca4f43">2,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTYtMS0xLTEtMA_bc75aea5-a385-48a4-bacf-b5774fd3a482">901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTYtMy0xLTEtMA_039b362e-87f6-4cd5-899c-6c35ee4bb5b9">238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Drafts and accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTctMS0xLTEtMA_81b6bed2-d3d8-4ff5-bca9-f302492ab89d">609</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTctMy0xLTEtMA_45e9b4fb-37c1-48c8-b79c-04ca70ac43d9">4,214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTgtMS0xLTEtMA_2731bd91-e31c-498d-94f8-c1b31364e72b">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTgtMy0xLTEtMA_e94b1965-e63a-4617-9208-ad74df0aa3a7">89</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTktMS0xLTEtMA_309d03e4-9a74-4dc9-acea-2575737cb226">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTktMy0xLTEtMA_5c179f20-aa37-4239-96ef-05bebe812295">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjAtMS0xLTEtMA_5ce30c2c-67b7-4ea5-aafe-11ac877e60d0">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="mck:IncreaseDecreaseInLitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjAtMy0xLTEtMA_04e666f4-fd4c-495c-bb7d-1a92adac8bbe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjEtMS0xLTEtMA_efc8f577-2436-444c-b306-b0ddf2549c5a">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjEtMy0xLTEtMA_21b472f5-28da-417a-b1ef-ca20be64c6ed">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjItMS0xLTEtMA_344887ab-de7d-45c9-bb24-c7ab8f4de7ca">1,622</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjItMy0xLTEtMA_47b96b45-a48b-4c18-9c9d-6e370e01d9b2">1,062</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for property, plant, and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjUtMS0xLTEtMA_23a26243-31d8-4980-aa43-cf66a317f97b">93</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjUtMy0xLTEtMA_f5880bce-2b3d-4f6b-ab3f-46cd474c4b2e">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized software expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjYtMS0xLTEtMA_df38ca52-1c53-4ba9-b34e-bfede7f710f4">66</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:PaymentsToAcquireSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjYtMy0xLTEtMA_dd396273-f9b7-4065-ab5f-8d76e3d59421">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjctMS0xLTEtMA_3cfde963-17c1-4f37-8000-fc41b69a6445">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjctMy0xLTEtMA_02826cbc-2ea8-435b-9d58-00c99a193301">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of businesses and investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjgtMS0xLTEtMA_3e633afb-c4eb-4dfb-8efa-f147d8cf820b">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjgtMy0xLTEtMA_f37902a3-6837-48c7-9e24-d77fa7ae82bf">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjktMS0xLTEtMA_1d8ed4b0-ecb8-4a02-a86e-8e497ece4371">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjktMy0xLTEtMA_7ee5d569-b956-4d83-bf90-771702e7dc24">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzAtMS0xLTEtMA_bd5adb44-fb06-4611-bfa7-4454a9fa8c89">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzAtMy0xLTEtMA_6d19b42e-19ba-49b0-b7fb-338d1c0ae64f">130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzMtMS0xLTEtMA_2abb23cf-808f-4f8c-bce6-4a9102434247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzMtMy0xLTEtMA_e28b6824-a0ed-4d93-a24c-2badb4c9e849">5,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of short-term borrowings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzQtMS0xLTEtMA_dac74e3d-3104-45c8-a703-ecaaa289916e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzQtMy0xLTEtMA_e3accc14-0a13-482c-98fa-716d06511e67">5,303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayments of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzYtMS0xLTEtMA_3907cc70-d358-4bb3-9a52-8f17aa90aec3">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzYtMy0xLTEtMA_a0e299b0-1931-4f7b-b258-3f4ee01513cf">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock transactions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzgtMS0xLTEtMA_49920b0a-d18a-4263-a75a-f1dd293bc387">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzgtMy0xLTEtMA_b1272087-d48f-4f47-88bc-873397537693">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzktMS0xLTEtMA_8821d24c-fbd6-4b4e-b49f-4ff24b547c37">1,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzktMy0xLTEtMA_30f90197-adea-4c5c-8f7d-054b165676fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDAtMS0xLTEtMA_864a32c0-aaf0-4235-a700-9878532fa8b1">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDAtMy0xLTEtMA_2653d115-4101-492c-a92e-ac079b8185d0">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDEtMS0xLTEtOTY5OA_35ecfd49-b32b-4524-b470-6d857e1f0a87">1,031</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDEtMy0xLTEtOTcwMw_0f65e4a3-8f6d-404f-8c51-65f5290e11d7">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDEtMS0xLTEtMA_9c1cf110-65ef-441d-a399-c15ac24c88e6">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDEtMy0xLTEtMA_9e1e835d-c6a3-4145-a4cc-04b2630564ca">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDItMS0xLTEtMA_3bc3315a-2164-4bad-bad8-9ae0be3919de">2,151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDItMy0xLTEtMA_a62d84d8-0a39-430f-9d7f-b5f402f04ab2">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDMtMS0xLTEtMA_d19ca89c-fc09-4e8c-bdce-ce6c0c31756a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDMtMy0xLTEtMA_4a2ac52e-1b42-4129-9c8f-0f5667feefb4">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDQtMS0xLTEtMA_5829429e-c5da-4ff0-8417-173ff0996bfe">3,861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDQtMy0xLTEtMA_2f471cd5-f3e7-41a4-bbb5-21747550dad5">1,159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDUtMS0xLTEtMA_0d8cc6da-4381-4190-ae0e-960ef2f1cb99">6,396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f7de12727134d7896b46445549479aa_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDUtMy0xLTEtMA_41c668e3-d556-4278-bfa1-de9e34dc7cda">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of period</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDYtMS0xLTEtMA_7fe71bdb-7c29-4869-9abe-636512c2ff86">2,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e51367df2e54805b65a34b535c3a768_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDYtMy0xLTEtMA_c50efee5-966e-4f3c-aeb7-4b6e7659fe0b">2,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Restricted cash at end of period included in Prepaid expenses and other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDctMS0xLTEtMA_e7f942e1-ed3d-468e-b739-f39c069596c4">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e51367df2e54805b65a34b535c3a768_I20200630" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDctMy0xLTEtMA_d22c780b-24e5-440d-a98d-31933294cec6">251</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDktMS0xLTEtMA_e43bf605-8d67-4ba2-8434-9fda9b3f0c0f">2,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e51367df2e54805b65a34b535c3a768_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDktMy0xLTEtMA_27e88eff-e476-45f2-ad15-c0f151934f30">2,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See Financial Notes</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ia9b664dd086f4724924e37451951b156_31"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMTA3Nzg_d19233f5-1d4b-4c82-a372-8ed7848f0ae2" continuedAt="ifa9bf39a7bb94b85a950509c8f055266" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ifa9bf39a7bb94b85a950509c8f055266" continuedAt="i6eb8ea489a764d67b66efc4c75990edc"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments, and other organizations in healthcare to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. The Company reports its financial results in <ix:nonFraction unitRef="segment" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfNjIy_e4c2efc6-9ad5-48c3-a84f-8b00bfd6c4c4">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Refer to Financial Note 14, &#8220;Segments of Business,&#8221; for more information.</span></div><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMTA3NDU_5632848c-3478-4056-84de-0f59cf9016c0" escape="true"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMTA3NDE_c65ca087-612e-42ba-8be1-f0b0c4869917" escape="true">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic. As COVID-19 evolves, the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ComparabilityOfPriorYearFinancialData" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMzI5ODUzNDkwMzI2Mg_267a94b9-d6d6-40ac-a9a2-a6f0b3d5d179" escape="true">The results of operations for the three months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, previously filed with the SEC on May 12, 2021 (&#8220;2021 Annual Report&#8221;).</ix:nonNumeric> </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMTA3NjQ_341f934c-a495-489d-bbaa-2632b352c6d1" escape="true">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMTA3NTE_3819c879-ebcc-4409-a41a-e67ceaff64b0" escape="true">Certain prior year amounts have been reclassified to conform to the current year presentation.</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i6eb8ea489a764d67b66efc4c75990edc"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMTA3Njk_4c9974c7-42a4-49d4-b74b-6374dfa369a1" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures.</span></div></ix:nonNumeric></ix:continuation><div id="ia9b664dd086f4724924e37451951b156_40"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">.&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfNDkxMw_b17488dd-7fbf-4b67-bd62-8f1cf1bc50bf" continuedAt="ia7278d03021b4c7e9dc890c7ce4dbdfa" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></ix:nonNumeric></div><ix:continuation id="ia7278d03021b4c7e9dc890c7ce4dbdfa"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="mck:HeldForSalePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfMzI5ODUzNDkwMzM1Nw_a36d7861-f222-46f2-8ce0-0bde1cdc889f" escape="true">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are reclassified into &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less cost to sell is reported as an adjustment to the carrying value of the disposal group.</ix:nonNumeric> Assets and liabilities that have met the classification of held for sale were $<ix:nonFraction unitRef="usd" contextRef="i6a911394561149eeb8e541a9ff705e67_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfMTAxMA_dd42ea86-37ca-434f-bd99-6e3895050e11">7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6a911394561149eeb8e541a9ff705e67_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfMTAxNw_46059afc-961c-48c8-894b-5139d94ac292">5</ix:nonFraction> million, respectively, at June 30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i6d6a811e39f549ae99a6bda061e024e8_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfMTA0NQ_51f4dc30-3aa2-4fc2-8c4f-320293693d33">12</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i6d6a811e39f549ae99a6bda061e024e8_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfMTA1Mg_1cf627de-e5e7-4986-8726-94e8aac3be09">9</ix:nonFraction>&#160;million, respectively, at March 31, 2021. Based on its analysis, the Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations and are not considered to be significant disposals based on its quantitative and qualitative evaluation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, the Company entered into an agreement to sell certain of its European businesses (&#8220;disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;<ix:nonFraction unitRef="eur" contextRef="i92f41c6f9c3f4caab2c60ad954bef6af_I20210705" decimals="-8" format="ixt:numdotdecimal" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfNTQ5NzU1ODE1ODQ0NA_92438649-9e8a-493e-bee2-6c5459a1b153">1.2</ix:nonFraction>&#160;billion (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i92f41c6f9c3f4caab2c60ad954bef6af_I20210705" decimals="-8" format="ixt:numdotdecimal" name="mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfNTQ5NzU1ODE1ODQ3MA_0c5dddc4-bdce-4eb7-bf5b-0ffd95ea8e4e">1.5</ix:nonFraction>&#160;billion), subject to certain adjustments, including net debt adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the divestiture date. The Company concluded that the held for sale criteria were not met in the first quarter of 2022 and continued to classify the assets and liabilities of these businesses as held and used in the condensed consolidated balance sheet. Beginning in the second quarter of 2022, the disposal group will be reflected in the Company&#8217;s condensed consolidated financial statements as held for sale. The disposal group will be remeasured to the lower of its carrying amount or fair value less costs to sell, which the Company estimates will result in a charge of between $<ix:nonFraction unitRef="usd" contextRef="i057cd4a01a544d42941664a044c0ee99_D20210701-20210930" decimals="-6" format="ixt:numdotdecimal" name="mck:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfNTQ5NzU1ODE1ODQ5MA_ac92109e-b7d8-4416-acf9-1f5b1599807c">500</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i2b729438362242159879d1e5ae05f931_D20210701-20210930" decimals="-6" format="ixt:numdotdecimal" name="mck:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfNTQ5NzU1ODE1ODUwOA_20b4f091-96bb-4a16-9b1e-337e02edba8a">700</ix:nonFraction>&#160;million, primarily related to the inclusion of the accumulated other comprehensive income balances into the carrying amount of the disposal group and the impairment of internal-use software that will not be completed. While this range reflects the Company&#8217;s best estimate as of the date of this Quarterly Report on Form 10-Q, actual charges could differ based on operating results, changes in foreign exchange rates, and other factors prior to closing of the transaction. The transaction is anticipated to close during 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals, as applicable.</span></div></ix:continuation><div id="ia9b664dd086f4724924e37451951b156_43"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNzg3MQ_17ba553d-c57d-4284-8dfe-d0e464a08d8d" continuedAt="i7fa277ac5cd2425687e402cb99bef4ba" escape="true">Restructuring, Impairment, and Related Charges</ix:nonNumeric></span></div><ix:continuation id="i7fa277ac5cd2425687e402cb99bef4ba" continuedAt="i6a2f16959c1540dc9f891f0697362cdf"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges of $<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfODM_93244ae5-120f-417d-ad8a-26bf3a75c001">158</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringSettlementAndImpairmentProvisions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMTI2_7015c667-0dd0-460c-b4ed-0f4bf354823a">56</ix:nonFraction> million during the three months ended June 30, 2021 and 2020, respectively. These charges are included in &#8220;Restructuring, impairment, and related charges&#8221; in the Condensed Consolidated Statements of Operations. In addition, charges related to restructuring initiatives are included in &#8220;Cost of sales&#8221; in the Condensed Consolidated Statements of Operations and were not material for the three months ended June 30, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily includes the rationalization of the Company&#8217;s office space in North America. Where it determines to cease using office space, the Company plans to exit the portion of the facility no longer used. It also may retain and repurpose certain other office locations. The Company expects to incur total charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i84cf7e31c16f42f68495c67d9cf8d2e2_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjc0ODc3OTA4MTAxMg_d26d76c7-0a5f-4dbc-baa5-56e8013f037c">180</ix:nonFraction> million&#160;to $<ix:nonFraction unitRef="usd" contextRef="i57c77c79ca8e4393a2c77738aeb14820_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjc0ODc3OTA4MTA0MA_23c093dc-eb65-42d1-a2bc-260af3f2c07c">280</ix:nonFraction> million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i6c075b17e18f4530aaaaa06575761b8a_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjc0ODc3OTA4MTE4Mg_358cc110-af2a-4f05-9e1f-d778e060c264">95</ix:nonFraction> million in the three months ended June 30, 2021. This initiative is anticipated to be completed in 2022. Charges primarily relate to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i6a2f16959c1540dc9f891f0697362cdf" continuedAt="id297d455a9504b7c9815bd11226a5091"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which is included in the Company&#8217;s International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. The Company expects to incur total charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i9283db20095f427da10212779ff9e45d_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjkxMA_f1508871-4077-4537-b311-a1dafa76ab84">85</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i57a8d9571d55442c857cdee195f25036_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjkxNg_fecceb21-9304-41fa-89e6-d6e13ec99892">90</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i87ee4b68e9ad4be0b0e837451f122185_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjc0ODc3OTA4NTM2Ng_1519b0bb-ee39-4457-a115-bb09fa2a7b8e">63</ix:nonFraction> million of charges were recorded to date. The Company recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i2c475719e1e54e988a2716b400ad19c8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjk1Mg_ef8ae368-75a3-4e45-8aec-2f3d21108d33">6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i47e37dbe4a284e4dbcd7fb304b436339_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjc0ODc3OTA4MDk1Ng_2c40f0b9-d2e5-4f83-b6df-3e6c08f1e5a8">14</ix:nonFraction> million, respectively, in the three months ended June 30, 2021 and 2020, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. The initiative is anticipated to be substantially complete in 2022 and estimated remaining charges primarily consist of accelerated amortization of long-lived assets, facility and other exit costs, and employee-related costs.</span></div><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNzg2NQ_33803971-cf13-4306-8b27-c9d6a9a95cb0" escape="true"><div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three months ended June 30, 2021 consisted of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:20.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.271%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.091%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.249%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMi0xLTEtMS0w_bef6bcc6-2067-4369-bb9b-98ad22e670bd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMi0zLTEtMS0w_cdbf3a60-adec-4ad2-87ca-7e27ec04d735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMi01LTEtMS0w_0330d21d-fa1d-48dc-b4af-998e20462caa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMi03LTEtMS0w_79e7f816-0985-426a-bb8c-5b0f17746233">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMi05LTEtMS0w_f45f2742-d493-4484-bab3-271513c601eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMi0xMS0xLTEtMA_83d5a002-5464-4809-b81e-45f944fb4f66">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMy0xLTEtMS0w_cdcc151f-6640-4812-9645-d9ad80fe1ca5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMy0zLTEtMS0w_42c9ea8f-7f04-411a-a388-dc7ed34b27b4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMy01LTEtMS0w_a395fc65-1c73-4e4f-a055-9ecabb6f1a54">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMy03LTEtMS0w_c9bfd892-ab37-4f3b-821b-ebb5c3134663">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMy05LTEtMS0w_383085e7-03bf-4b11-bfd9-c030c9a05f12">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMy0xMS0xLTEtMA_0e868722-417a-4755-a74b-79570d7e7c45">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNC0xLTEtMS0w_f7e4b4a6-184c-45b0-bdde-59f526e5613d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNC0zLTEtMS0w_21fb9f8e-7c49-4d1e-bd5b-970b81c9557d">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNC01LTEtMS0w_d5090567-9689-444d-b8d1-79677235fbf3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNC03LTEtMS0w_a23e0868-7e17-43e4-9251-0c9980dc989b">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNC05LTEtMS0w_37dabf43-a1e6-44a3-bfcb-513496abcc21">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNC0xMS0xLTEtMA_22aed470-c376-48c6-a15b-f8b994d93a34">104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNS0xLTEtMS0w_5ac9c91e-0ef3-41e4-bf43-ed5a748e8459">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNS0zLTEtMS0w_086912ed-a5c0-47f7-8d04-93a1a690df53">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNS01LTEtMS0w_d4e65e72-2ba6-4ba6-a2bb-2969d77d0dc4">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNS03LTEtMS0w_6c2b08fa-3aea-4547-870b-2a4178795549">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNS05LTEtMS0w_22c43daa-de8f-4a57-943c-55412dc1f18a">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNS0xMS0xLTEtMA_da2b78d4-7b63-42ee-ba04-591acd8332fa">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Costs primarily relate to the transition to the partial remote work model described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs related to the transition to the partial remote work model and U.K. operating model and cost optimization efforts described above, as well as costs for optimization programs in Canada.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three months ended June 30, 2020 consisted of the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.194%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17d2abc247664f6daa16f853d87054b7_D20200401-20200630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMi0xLTEtMS0w_665eff1e-448f-4285-8219-17464c3bbdee">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e5f5eb8b104181b2273e06b8521cc7_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMi0zLTEtMS0w_6b297579-c1d3-4bab-b858-5a2158601981">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e0eb4c78cd4021aa5f951829fd7105_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMi01LTEtMS0w_acf19cc4-8808-4d0d-8748-0b480886d419">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035aba39d89d4cbda66c1e89394e2887_D20200401-20200630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMi03LTEtMS0w_85652ab4-0504-493d-bb72-15fc296fef65">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6dc977232b4be2a968cd362119be8a_D20200401-20200630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMi05LTEtMS0w_9f79736a-9abe-4641-910c-db3ea4d72e94">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMi0xMS0xLTEtMA_3c78d80d-6ccf-4e33-a48f-55e90d6fe74e">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17d2abc247664f6daa16f853d87054b7_D20200401-20200630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMy0xLTEtMS0w_f8db8846-8aa0-442e-a936-900abb201aa1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e5f5eb8b104181b2273e06b8521cc7_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMy0zLTEtMS0w_53288326-a579-48a2-aaac-5487cbbc7f8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e0eb4c78cd4021aa5f951829fd7105_D20200401-20200630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMy01LTEtMS0w_ce1ac2c4-7d59-42dd-82d9-f28fc6ccadda">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035aba39d89d4cbda66c1e89394e2887_D20200401-20200630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMy03LTEtMS0w_94c4d257-18b3-45ee-9bf2-f3ebebcd2b55">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6dc977232b4be2a968cd362119be8a_D20200401-20200630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMy05LTEtMS0w_09cc8b5f-815a-4024-9cb2-4c1f75f47121">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:BusinessExitCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMy0xMS0xLTEtMA_819df7de-ee2a-4dd3-a6c5-b0a7e0136361">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17d2abc247664f6daa16f853d87054b7_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNC0xLTEtMS0w_91c634c1-df00-469f-b044-13b36f52080c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e5f5eb8b104181b2273e06b8521cc7_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNC0zLTEtMS0w_a15d3550-2a1a-4a7b-a72d-5a0723be7fdc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e0eb4c78cd4021aa5f951829fd7105_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNC01LTEtMS0w_3292f198-a4b3-4ffd-bb26-96e947927af5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035aba39d89d4cbda66c1e89394e2887_D20200401-20200630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNC03LTEtMS0w_dfc461c1-3aed-496b-9567-44222d1b7828">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6dc977232b4be2a968cd362119be8a_D20200401-20200630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNC05LTEtMS0w_137d1157-0ebe-4787-9f2d-348b79948a78">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="mck:AssetImpairmentChargesIncludingAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNC0xMS0xLTEtMA_ad76cb34-8e56-40f7-80a7-b3cc623c8a37">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17d2abc247664f6daa16f853d87054b7_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNS0xLTEtMS0w_1706c985-fbf9-4b39-9b82-5af06fd0ebfc">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e5f5eb8b104181b2273e06b8521cc7_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNS0zLTEtMS0w_ca61ac77-35bf-4370-a816-918950ce5f0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91e0eb4c78cd4021aa5f951829fd7105_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNS01LTEtMS0w_ada67616-d058-475d-bb57-ec80ebdfe0f3">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035aba39d89d4cbda66c1e89394e2887_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNS03LTEtMS0w_75df3485-58ac-41c5-8c4f-44ee13950893">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e6dc977232b4be2a968cd362119be8a_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNS05LTEtMS0w_2b7365a2-5d39-4a8e-86b3-7ff49037fc8a">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNS0xMS0xLTEtMA_5c5a8ca0-3662-4697-9af1-f8e8b983196b">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above, and an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="id297d455a9504b7c9815bd11226a5091"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNzg2Ng_401c3929-012b-4010-8537-62082fb36554" escape="true"><div style="margin-bottom:1pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the three months ended June 30, 2021: </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.263%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66234f14da784e5eb4675592aa380d6c_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMS0xLTEtMS0w_3aba2b18-e43f-4340-a5a4-30063a92bf1a">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f49c85d9c54b139a81fb46d5568528_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMS0zLTEtMS0w_587f3ddb-2b6c-4075-8328-fb41573ed57c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id94f3503c3d14315bb499f5363c098fb_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMS01LTEtMS0w_5f33e157-e455-40c3-87b2-fc1e7df36810">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d2ba414ea445368df49de0797a4169_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMS03LTEtMS0w_7cced684-e031-4f70-9ac5-7aac03a06ea8">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a0d6267ee1a4d7780d02c0f5b857095_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMS05LTEtMS0w_06722e31-787d-4eed-a01c-f818d3a5712d">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMS0xMS0xLTEtMA_9160449c-5e61-4a4e-82cc-2af9b239e393">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMi0xLTEtMS0w_c3d5907a-f010-4514-a9a8-7b655cc537ba">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMi0zLTEtMS0w_856be6d3-cae4-4412-9e4d-01105e14e6d3">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMi01LTEtMS0w_7a1e3b57-1b9f-433f-82da-fa6b7eff1e9f">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMi03LTEtMS0w_2c39bb8d-ecb6-42b2-9e59-4133268be788">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMi05LTEtMS0w_e9de0676-173a-4aa3-a9d4-04ebb084cffe">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMi0xMS0xLTEtMA_6e97aad1-4694-49cc-aafa-b71d3259b46f">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMy0xLTEtMS0w_cf44c149-03da-490b-a580-20dd100f8cc5">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMy0zLTEtMS0w_c245b1ae-0a6d-4a8a-a70b-f54e0d1827a4">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMy01LTEtMS0w_6cbd19e9-6a9e-457b-a411-6f4d2881ff7c">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMy03LTEtMS0w_fb49b064-9fb9-45fb-9191-1629909f503c">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMy05LTEtMS0w_53be7b7f-6499-4f8c-81e8-b58c7e0d5a7f">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMy0xMS0xLTEtMA_fce74f43-a369-4aff-a208-008870e6963a">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNC0xLTEtMS0w_abc92222-944b-4016-8684-3fd023a5064b">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNC0zLTEtMS0w_b12d7697-9fce-43cf-be23-e84eee3455d4">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNC01LTEtMS0w_784ff923-a6fa-4573-9f3b-8fefc03100a3">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNC03LTEtMS0w_3bc1195f-5728-4b29-8f75-3f527f1d4e7e">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNC05LTEtMS0w_a629c7e0-013d-4204-a011-3b5fa98b7f0e">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNC0xMS0xLTEtMA_85758851-b3cb-455c-8251-3ecba0993214">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNS0xLTEtMS0w_c190f872-7bd9-4d59-8821-10072a6b58f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNS0zLTEtMS0w_f3753c4b-95f3-41ba-9a3e-b19a38ee2214">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNS01LTEtMS0w_612233c8-68e8-47e6-9c11-519c0d179f82">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNS03LTEtMS0w_efd1aa4b-67ff-4d36-9dce-e827cdb20853">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNS05LTEtMS0w_37900182-e569-4b79-b95a-4d95dfa8c8d8">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAndOtherAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNS0xMS0xLTEtMA_ad711504-0bd2-4462-9558-80bf6f80ae2b">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710aa73bfd1a41c98226e45589abb990_I20210630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNi0xLTEtMS0w_0a1bd5a0-d529-4cb8-a31f-cd784eadf6df">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bc550c41437490f858d0f9e149d60d0_I20210630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNi0zLTEtMS0w_7ae977fe-e1ff-45a4-9410-b8372fe3e034">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i992084e24e76444492d6225980031942_I20210630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNi01LTEtMS0w_1c3feba5-7ff0-491a-9485-f36fd2429cc5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19168a33968540e783b28d52a160795c_I20210630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNi03LTEtMS0w_a55373c9-bd1c-4d93-bf81-08eef10e4df1">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if40e1d1aa4ac42c587f1b983fd883ee3_I20210630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNi05LTEtMS0w_1f99abf1-9e64-4d70-abe6-5d176bc1eccf">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNi0xMS0xLTEtMA_3ede9e47-0884-4acb-aca5-4dbb908e8ade">177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2021, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNjIxMg_56fd109d-3b5c-4e65-ad6d-76892a81423d">151</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="iac2a35f73ee14590b8a577b32c972839_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNjIyNQ_5f6cb324-590c-4005-b7e8-da5176710df5">99</ix:nonFraction> million was recorded in &#8220;Other accrued liabilities&#8221; and $<ix:nonFraction unitRef="usd" contextRef="ie45718b0614548d1830f76b0122b7111_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNjI1MQ_1eb715f7-2e8a-4696-bbe1-83a0515eb0df">52</ix:nonFraction> million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of June 30, 2021, the total reserve balance was $<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNjMzMA_1a1d1513-bb05-4f33-b9e8-72ac836acb8c">177</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i191304ad1c25432190397b7fa834d148_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNjM0Mw_8ff0c632-a093-4b08-a335-7501bbe748a2">127</ix:nonFraction> million was recorded in &#8220;Other accrued liabilities&#8221; and $<ix:nonFraction unitRef="usd" contextRef="id719933d788f420798852650db76c74f_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNjM2OQ_10524adf-793b-4732-a187-0cc317d32068">50</ix:nonFraction> million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div></ix:nonNumeric></ix:continuation><div id="ia9b664dd086f4724924e37451951b156_46"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfNDM4Nw_45cbb0fe-8782-48e8-9ce4-7c4eb8ad7be0" continuedAt="ibdd048ad2db94db6b7d39ee81a71e7b5" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="ibdd048ad2db94db6b7d39ee81a71e7b5"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2021 and 2020, the Company recorded income tax expense of $<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfMTAw_9f3e9c0a-e97c-48aa-adfd-7a3913cd08cf">26</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfMTI5_44ef356c-6350-4506-b06b-5fcd233d3503">150</ix:nonFraction> million, respectively. The Company&#8217;s reported income tax rates were <ix:nonFraction unitRef="number" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfMzA3_52e4af18-e8bc-451c-a60a-1a91333e885a">4.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfMzQ0_329462e1-9818-405a-a31b-df4d2b2f9808">23.3</ix:nonFraction>% for the three months ended June 30, 2021 and 2020, respectively. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to discrete items recognized in the quarter and changes in the mix of earnings between various taxing jurisdictions. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2021, the Company had $<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfMjcxMQ_47b25dca-eb74-47da-8518-9d328f3aeb48">1.7</ix:nonFraction> billion of unrecognized tax benefits, of which $<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfMjc1Mw_47a411f3-8e23-4f21-99e7-69fa39251f29">1.3</ix:nonFraction> billion would reduce income tax expense and the effective tax rate if recognized. During the three months ended June 30, 2021, the Company recognized a net discrete tax benefit of $<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfNTQ5NzU1ODE0NzYyNg_725b80bb-0c21-4967-b8bb-6a2ab1d72a8b">97</ix:nonFraction> million primarily related to statute of limitation expirations in various taxing jurisdictions. During the next twelve months, the Company does not estimate any material reduction in its unrecognized tax benefits. However, this may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. The unrecognized tax benefit may also increase or decrease due to future developments in the Opioid related litigation and claims, as discussed in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.</span></div></ix:continuation><div id="ia9b664dd086f4724924e37451951b156_49"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMzQzMQ_97a47c76-d099-43bf-8a08-42bb980a2bfc" continuedAt="i609c30dd6fb14d4aacae73b788735c58" escape="true"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:MinorityInterestDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMzQzOA_7677261d-93f2-4db5-889f-49837702ae3d" continuedAt="i0023890d592f40ae9ab728784bb252ba" escape="true">Redeemable Noncontrolling Interests and Noncontrolling Interests</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i609c30dd6fb14d4aacae73b788735c58" continuedAt="id35da726327f4f3e998ceca491ce2e8f"><ix:continuation id="i0023890d592f40ae9ab728784bb252ba" continuedAt="if2e97b3af62a49c08970ea93bd30d684"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="ied3d3ec15dce44668530b0cfc63e4725_I20141231" decimals="INF" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfNDEw_d655c743-9ca0-44ba-a6ef-dbc3ffca7cba">0.83</ix:nonFraction> per share. As a result, during the three months ended June 30, 2021 and 2020, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $<ix:nonFraction unitRef="usd" contextRef="idaf31474e16b4981835b7927ff4927eb_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfNTQ5_5c544859-8dc0-448d-95b5-c2eb11421da7">8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i487864b97fe74bb085d985d73639d6db_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfNTky_e9066b2e-e0a5-4eca-84a8-b21481ba5fa9">11</ix:nonFraction> million, respectively. All amounts were recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="id35da726327f4f3e998ceca491ce2e8f" continuedAt="ica9926e29f3247d59a6d08709f950cbd"><ix:continuation id="if2e97b3af62a49c08970ea93bd30d684" continuedAt="i5ab26531818c44288e9ce72c6e9bf467"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i63b54516555043abafd60e6f00353370_I20210412" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfOTkx_5f4fb2e0-43f2-41c9-b6e4-46cc7bc4c452"><ix:nonFraction unitRef="eurPerShare" contextRef="i5ddf756d852f408fbd54c3f4a61f8d6a_I20141231" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfOTkx_e3951f7b-6f11-4978-9003-cc17d3b662c6">22.99</ix:nonFraction></ix:nonFraction> per share, increased annually for interest in the amount of <ix:nonFraction unitRef="number" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="mck:PutRightValueInterestRateSpread" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMTA1NA_951ec250-0e2a-482a-ad83-47fd5c1f79cb">five</ix:nonFraction> percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). Subsequent to the Domination Agreement&#8217;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#8220;Appraisal Proceedings&#8221;) with the Stuttgart Regional Court (the &#8220;Court&#8221;) to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified currently in the Domination Agreement. On September 19, 2018, the Court ruled that the Put Amount shall be increased by &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i87be9fd9c6fb4f4785e90cb0a3b47104_I20180919" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePriceIncrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3OTU0OQ_b7846977-f91d-4544-90a2-301a0fd4c077">0.51</ix:nonFraction> resulting in an adjusted Put Amount of &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i87be9fd9c6fb4f4785e90cb0a3b47104_I20180919" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3OTU1Nw_744f0d97-e6ac-41fb-a3b7-1734b4408394">23.50</ix:nonFraction>. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount shall remain &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i63b54516555043abafd60e6f00353370_I20210412" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3OTU2Ng_5f4fb2e0-43f2-41c9-b6e4-46cc7bc4c452"><ix:nonFraction unitRef="eurPerShare" contextRef="i5ddf756d852f408fbd54c3f4a61f8d6a_I20141231" decimals="INF" name="mck:NoncontrollingInterestsPutRightExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3OTU2Ng_e3951f7b-6f11-4978-9003-cc17d3b662c6">22.99</ix:nonFraction></ix:nonFraction>, thereby rejecting the lower court&#8217;s increase, and the recurring compensation remained at &#8364;<ix:nonFraction unitRef="eurPerShare" contextRef="i2334ff340e7e4425bafcfaaf4f20fc95_I20210412" decimals="INF" name="mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3OTU3NQ_a53910e4-e2bb-49cd-a5d7-5414f1e7dec8">0.83</ix:nonFraction> per share.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2021 and 2020, the Company paid $<ix:nonFraction unitRef="usd" contextRef="idaf31474e16b4981835b7927ff4927eb_D20210401-20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMTQxOQ_ebecf922-27de-40d7-b2c6-d65fdf932984">1.0</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i487864b97fe74bb085d985d73639d6db_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3NTg1Ng_e60f15dd-8eda-45b3-b0da-496192b41cc6">49</ix:nonFraction>&#160;million, respectively, to purchase <ix:nonFraction unitRef="shares" contextRef="idaf31474e16b4981835b7927ff4927eb_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMTQzNA_9f697c94-4b34-42df-ad3c-c0b2fec12fe0">34.5</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="i487864b97fe74bb085d985d73639d6db_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3NTg4NQ_88cba683-ba2a-4c07-b39c-c1d1b455dcd9">1.8</ix:nonFraction>&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $<ix:nonFraction unitRef="usd" contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3NTkxNA_00d67171-ee25-4d02-a97e-9d2bf3786a7c">983</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMTYwMw_88a39b3d-89b2-4c04-9ee6-ac645f2283f9">49</ix:nonFraction> million, respectively, for the three months ended June 30, 2021 and 2020, and the Company recorded the associated effect of the increase in the Company&#8217;s ownership interest of $<ix:nonFraction unitRef="usd" contextRef="i15e4d7260c2e41f096bdffa4d471fb63_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA4MDMzOA_b6350256-77a1-4a85-9272-8912a60ec639">178</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5013134a08dd45ba9c62f3e98630e1ff_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA4MDMyMg_d25d266a-9c66-42e4-bff0-fbaef48a087d">3</ix:nonFraction> million, respectively, as an increase to McKesson&#8217;s stockholders additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $<ix:nonFraction unitRef="usd" contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfNTQ5NzU1ODE1MTc4Ng_dfdb5bd3-389c-441c-8ac0-888eb16646ec">287</ix:nonFraction> million, were transferred from &#8220;Redeemable noncontrolling interests&#8221; to &#8220;Noncontrolling interests&#8221; on the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The redeemable noncontrolling interest was adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. Prior to expiration of the Put Right, the balance of the redeemable noncontrolling interests was reported as the greater of its carrying value or its maximum redemption value at each reporting date. At March 31, 2021, the carrying value of $<ix:nonFraction unitRef="usd" contextRef="i69a2a49641144b609177a6d98a66f9eb_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjU0Mg_049aec3d-223b-4185-a447-5621f2d8a186">1.3</ix:nonFraction>&#160;billion exceeded the maximum redemption value of $<ix:nonFraction unitRef="usd" contextRef="i69a2a49641144b609177a6d98a66f9eb_I20210331" decimals="INF" format="ixt:numdotdecimal" name="mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjU4Ng_363e0709-541c-4ca9-bc04-c1b61ed6b780">1.2</ix:nonFraction> billion and the Company owned approximately <ix:nonFraction unitRef="number" contextRef="i69a2a49641144b609177a6d98a66f9eb_I20210331" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjY0Mw_f251ef95-2ebd-4c92-84db-4115c09bcaff">78</ix:nonFraction>% of McKesson Europe&#8217;s outstanding common shares. At June 30, 2021, the Company owned approximately <ix:nonFraction unitRef="number" contextRef="i508c6f433af04bcd9ab04b4a8838efbd_I20210630" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3NzU4NQ_cb5db1ad-0e6f-40d0-a2c0-a30c1310f818">95</ix:nonFraction>%, of McKesson Europe&#8217;s outstanding common shares.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP and Vantage Oncology Holdings, LLC. As of June 30, 2021, noncontrolling interests also represent minority shareholder equity interests in McKesson Europe, as discussed above. During the three months ended June 30, 2021 and 2020, the Company allocated a total of $<ix:nonFraction unitRef="usd" contextRef="i59705e8d049944ec81dc730a85f8b9e6_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMzA4Mg_1c89016e-61e6-4d99-933a-267e271e8c13"><ix:nonFraction unitRef="usd" contextRef="i365faceb5dac4b6c8e146917134e4cd2_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMzA4Mg_ab952915-3ff5-4d11-a809-32d850e6b011">39</ix:nonFraction></ix:nonFraction> million of net income to noncontrolling interests.</span></div><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMzQ0MA_ae2c1ba2-bcef-4ed1-919c-9141ddac9a21" continuedAt="i930a9e39251e4ef88dbfe48bc523fbef" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2021 were as follows:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedb46ad9eb03415b8c3ef478a437c8d0_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfMS0yLTEtMS0w_ed787d5b-eaae-4e59-ab72-509107486ea9">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i412cde1488dd4d8ab371ad4c8f5faa1d_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfMS00LTEtMS0w_3131b7c1-1aa6-4c80-b259-2a9517c12027">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfMi0yLTEtMS0w_74f23443-c090-482d-8023-defe9f11497e">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfMi00LTEtMS0w_1d0d398c-3d98-4350-a527-519676959aba">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfMy0yLTEtMS0w_6bff1d5b-0763-4943-b804-d61addeea19a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfMy00LTEtMS0w_f61610c3-8e98-4f4c-b12f-05a1216a933e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNC00LTEtMS0w_5b22a0aa-216d-42bc-a450-025a8891586f">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNS0yLTEtMS0w_3d6e6e0a-b039-4f41-a1b8-be14d54a0878">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNS00LTEtMS0w_d7c53c5c-3f7e-4951-be08-a85f01c540f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNi00LTEtMS0w_00d67171-ee25-4d02-a97e-9d2bf3786a7c">983</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630" decimals="-6" sign="-" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNy0yLTEtMS0xMjU0_dfdb5bd3-389c-441c-8ac0-888eb16646ec">287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630" decimals="-6" name="mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNy00LTEtMS0xMjU0_7203dbe0-0937-4112-8140-9c0f48a0d01b">287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNy0yLTEtMS0w_45e8c61e-d207-4404-9ce1-6b9274e8a49a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630" decimals="-6" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNy00LTEtMS0w_d1cbae21-beaf-4adf-a4e0-25052ccd48e9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icedc97c57c25494bb97ac3ef916d8842_I20210630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfOC0yLTEtMS0w_d35afa56-d2d9-467c-b021-c415f7c80db1">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic01bba4cd87f497d8faba0d38fa0e49b_I20210630" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfOC00LTEtMS0w_8a4f4b04-6c5f-4dce-a67b-f41154704f7f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ica9926e29f3247d59a6d08709f950cbd"><ix:continuation id="i5ab26531818c44288e9ce72c6e9bf467"><ix:continuation id="i930a9e39251e4ef88dbfe48bc523fbef"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2020 were as follows:</span></div><div style="text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecd424d4030942d9b9c9e99c1603c4a3_I20200331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfMS0yLTEtMS0w_ea23ee24-a09a-4a84-bf81-e0238c4b445b">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30a07bf169524e7ba24b49eb98a91985_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfMS00LTEtMS0w_7be1af68-b940-490e-b634-1af0ae78d805">1,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfMi0yLTEtMS0w_a5f4950e-8bfa-4dd6-bffe-4efeed593c67">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfMi00LTEtMS0w_fa7cf261-fa9a-44e7-b679-955afeefee8b">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfMy0yLTEtMS0w_816bd4b7-661f-4cb0-8431-7cbd609ce91c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfMy00LTEtMS0w_3423eb4e-4235-4351-858f-e4fb4b223c27">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630" decimals="-6" name="mck:ReclassificationofTemporaryEquitytoLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfNC00LTEtMS0w_10e5f2e5-b5b9-4ff6-927f-4fca0c3ac6c9">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfNS0yLTEtMS0w_8b6c7b57-b564-4502-bfee-afa1baf05e91">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfNS00LTEtMS0w_d4fb1114-52b3-4a7a-a2d5-8feabce43111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630" decimals="-6" name="mck:NoncontrollingInterestDecreaseForExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfNi00LTEtMS0w_88a39b3d-89b2-4c04-9ee6-ac645f2283f9">49</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630" decimals="-6" sign="-" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfNy0yLTEtMS0w_96d968f2-1c92-4108-a491-58fdead74efb">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="mck:NoncontrollingInterestIncreaseDecreaseDuetoOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfNy00LTEtMS0w_254c03ed-106b-43f9-9e35-99ca3078183f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2020</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b3fb15d56c74664afb9bf5941948b0f_I20200630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfOC0yLTEtMS0w_2ad906e7-3303-47c5-b442-fe193a72c712">207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51575d10eabd476db89a9db186145b8a_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfOC00LTEtMS0w_a8ce107f-a776-4d14-ac07-ad69131281c1">1,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation></ix:continuation><div id="ia9b664dd086f4724924e37451951b156_55"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RleHRyZWdpb246NjcyOTgyMzg4YjE3NDk3YzkzY2JkNGI0ZjIyNTQyNjNfMTE3MQ_9dc6641b-f677-4591-a117-a67a4a84cd8c" continuedAt="i45abf1d1da8540cebfce6ec8995b3a5a" escape="true">Earnings (Loss) Per Common Share</ix:nonNumeric></span></div><ix:continuation id="i45abf1d1da8540cebfce6ec8995b3a5a" continuedAt="i5ed3394caea147bc8878cbd40ea0eba9"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately <ix:nonFraction unitRef="shares" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RleHRyZWdpb246NjcyOTgyMzg4YjE3NDk3YzkzY2JkNGI0ZjIyNTQyNjNfNTQ5NzU1ODE0MDg4OQ_e53f8861-2575-49a5-b99b-82b567b99a1c">1</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RleHRyZWdpb246NjcyOTgyMzg4YjE3NDk3YzkzY2JkNGI0ZjIyNTQyNjNfNTQ5NzU1ODE0MDg5Nw_7cbec23b-998b-4186-a3af-6925aa757369">3</ix:nonFraction>&#160;million of potentially dilutive securities for the three months ended June 30, 2021 and 2020 were excluded from the computation of diluted net earnings per common share as they were anti-dilutive.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i5ed3394caea147bc8878cbd40ea0eba9"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RleHRyZWdpb246NjcyOTgyMzg4YjE3NDk3YzkzY2JkNGI0ZjIyNTQyNjNfMTE4MA_0930415a-0f28-440e-a35c-2ce1d16e5ff7" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.239%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMi01LTEtMS0w_60f33560-d4f2-47e4-bea1-73858c690e04">536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMi03LTEtMS0w_6580466b-2c68-4c8a-a154-47c83853a00c">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMy01LTEtMS0w_04ca3996-8dbf-4aa6-85d0-4d74e2b831f9">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMy03LTEtMS0w_e4660d64-167a-4881-8c28-b506a1628800">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to McKesson Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfNC01LTEtMS0w_ac933a5e-c10e-4655-8d22-18258f5f9434">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfNC03LTEtMS0w_230d0e49-aef1-43a9-9d71-804e07c17b3f">445</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfNS01LTEtMS0w_7ae14a51-595c-4110-9628-d8d7c9d670cb">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfNS03LTEtMS0w_c3122786-38a3-41f7-a227-163fa4777cc0">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfNi01LTEtMS0w_2564379e-4ca7-4235-81cc-6783d0c8bbdc">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfNi03LTEtMS0w_7b3b6d28-a0a4-4e92-939a-10740eb51aec">444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfOS01LTEtMS0w_2c5b32d7-5df1-4ddf-a641-f630ed1e77fb">156.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfOS03LTEtMS0w_7ab2b84b-2fba-49e0-87c5-68e8e43b0c10">162.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bd869d54ffa406bb2261915a7499d39_D20210401-20210630" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTEtNS0xLTEtOTYzOA_877ea216-8579-4f2a-93f4-79f110676bef">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34ca8e4a850d48e9b2104497582378ad_D20200401-20200630" decimals="-5" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTEtNy0xLTEtOTY0Mw_d96ce247-46d3-48a6-8bbd-2c1271613a97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b31c456dd94434c9a3d61732463ebce_D20210401-20210630" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTEtNS0xLTEtMA_01874df9-c041-4ac4-a256-8f846e29e712">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i53500c27297841a0b5752e04f4847019_D20200401-20200630" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTEtNy0xLTEtMA_431de9f3-3edd-48db-b51c-7de5077bc3b7">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTItNS0xLTEtMA_a5d0e1e1-7eee-41b3-858c-4504f45362d4">158.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTItNy0xLTEtMA_11147a67-1e01-4ed1-a5e6-9864eed4cbbb">163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTYtNS0xLTEtMA_fe42dfc3-2a3b-482a-8434-80d90512fe5e">3.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTYtNy0xLTEtMA_2eb65c56-b363-404e-85ad-ddf7b4bfb8e4">2.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTctNS0xLTEtMA_3e17eb44-8f86-47da-a5fe-44804e05270c">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTctNy0xLTEtMA_1bc7802b-ca8e-47db-82da-bfbf22f6a115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTgtNS0xLTEtMA_ef914beb-6797-409b-9093-817c30420bc8">3.07</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTgtNy0xLTEtMA_7ad1b94b-0265-4a44-8298-55412828ec33">2.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMjAtNS0xLTEtMA_efcc517b-ecc4-4391-8959-7f7a6421cd03">3.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMjAtNy0xLTEtMA_5fd5f0b9-8fc6-45a6-876f-3e6927a63196">2.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMjEtNS0xLTEtMA_c4e69d83-9900-41ed-8e18-8ce5a4cacc1f">0.02</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="2" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMjEtNy0xLTEtMA_f127f6d9-221a-4572-b4b7-a21c218191a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMjItNS0xLTEtMA_9f63e469-8262-4c61-b1b4-4ee8339baa78">3.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMjItNy0xLTEtMA_016f4b8d-3b48-4d9b-95fe-d5a77b35de77">2.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units, performance-based restricted stock units, and performance-based stock units.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div></ix:nonNumeric></ix:continuation><div id="ia9b664dd086f4724924e37451951b156_58"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMjAyMw_a0a3de35-c69f-4c07-8cd5-776704ec3ee0" continuedAt="ie316b5c8d32742c4ba025c1297d9e140" escape="true">Goodwill and Intangible Assets, Net </ix:nonNumeric></span></div><ix:continuation id="ie316b5c8d32742c4ba025c1297d9e140" continuedAt="i48af168c67c440afa286dd605a7a953c"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMjAzMQ_83eca281-6e01-4ade-b54f-1f2dd56cb5d9" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:26.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.523%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.159%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March&#160;31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6b9935a1072411f89e91e4985e6c37a_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfMS0xLTEtMS0w_f19c3f02-d340-42b4-9bff-1130957b32ab">3,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88f5c5e2af1a4fe4952d7a38df3fb91c_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfMS0zLTEtMS0w_61d715bd-47d6-48ea-a425-ee2b4f302d42">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42674b470461487c889c63f9ddc05423_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfMS01LTEtMS0w_54f57acc-1e34-42f5-8b3e-521fc2ad6305">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9a99eac4149443cb99bd6701ec37a59_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfMS03LTEtMS0w_2aa9972d-f2f6-47c1-b015-be7617c50edc">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfMS05LTEtMS0w_067b6c4f-f243-44f4-aa61-1f4c1153bd93">9,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c2064f2c8eb49c3849453a95a9c86c4_D20210401-20210630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNi0xLTEtMS0w_b9a8aade-7993-4db6-94b9-9e14ee356b29">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82edf712cf2f4662ac55525b3410634f_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNi0zLTEtMS0w_43589d80-a0cd-4a6c-86b9-e09e5bb27dc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032911e077b3421889a6ddae5be68041_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNi01LTEtMS0w_f0d45f65-c947-4244-a4e1-6e9797b842db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c475719e1e54e988a2716b400ad19c8_D20210401-20210630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNi03LTEtMS0w_da4e4dd2-961a-4922-84f2-52e14037f72e">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNi05LTEtMS0w_e1d3c029-6f02-4fc6-ace9-395d838ce93b">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e598facc678461e9c9bce2f326a6b53_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNy0xLTEtMS0w_977a3efe-eefd-4a94-b0f0-35cf57de55d3">3,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9bd1f8e3c8348ac85a0747fd5ead3c3_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNy0zLTEtMS0w_502e91d5-fc6e-4787-8ec4-770e971f1816">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie633b96d5f6e4594bb149b9a781b4f7f_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNy01LTEtMS0w_8e9a1f56-06d2-41d2-957c-957dbd7ac4c3">2,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87ee4b68e9ad4be0b0e837451f122185_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNy03LTEtMS0w_912fbd5a-a0d4-4949-b9df-f60bedc9e97b">1,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNy05LTEtMS0w_527f632a-6635-4072-8d08-f7b0d6e9d9fa">9,520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i48af168c67c440afa286dd605a7a953c"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMjAyMA_3652b8b5-fe0b-432f-ac9f-8f6ce300e904" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i340abf5713294118849a48ca0137e899_D20210401-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi0xLTEtMS0w_b464357c-b62b-4e6f-b3da-997b4cad33a5">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2202b302407642afa17e3d40e4f0eba4_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi0zLTEtMS0w_c503e4d6-6777-4922-a19a-682a647761ea">3,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2202b302407642afa17e3d40e4f0eba4_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi01LTEtMS0w_19b7e9e8-ac4d-41da-8d2a-f21d99057181">2,329</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2202b302407642afa17e3d40e4f0eba4_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi03LTEtMS0w_b0e37e77-3877-4407-90e5-d029b6b16373">1,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d12ee52b8454b869fd9946a0fa4dea8_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi05LTEtMS0w_6b3e3b13-5d41-445d-b33b-842082f4e4cc">3,739</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d12ee52b8454b869fd9946a0fa4dea8_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi0xMS0xLTEtMA_bcf72970-5f45-4c40-8b0d-8a1de5addb8a">2,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d12ee52b8454b869fd9946a0fa4dea8_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi0xMy0xLTEtMA_20df4919-4d4a-45e1-b43d-36057343e814">1,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i593296998692453094e57c17348b980f_D20210401-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy0xLTEtMS0w_725f2c5a-f881-4158-b92c-1fe8b7aefdd3">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia43438708a6949cd9cf16f70af409bba_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy0zLTEtMS0w_bdb8b8ca-5833-4acf-a67f-ab4c7d01b189">1,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia43438708a6949cd9cf16f70af409bba_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy01LTEtMS0w_93040665-dd5d-4f53-b87d-cd66da5038df">530</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia43438708a6949cd9cf16f70af409bba_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy03LTEtMS0w_1bdbd678-4ce1-41aa-9dce-fb3e68826f8b">558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f7bc8f0af7b4ef4baba244ec29d1ccf_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy05LTEtMS0w_fe230e5e-143e-4160-9f83-1c9a740fe6b2">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f7bc8f0af7b4ef4baba244ec29d1ccf_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy0xMS0xLTEtMA_12cfe6e8-9d0c-4674-9084-e86880876ab7">513</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f7bc8f0af7b4ef4baba244ec29d1ccf_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy0xMy0xLTEtMA_60560219-a56b-4204-bdeb-92386112fb10">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ideb771110e984bc6b277c2585a3c3c6f_D20210401-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC0xLTEtMS0w_06845080-86e7-4ba0-b165-6c642581a989">23</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d856a3247a04312a0f97fa937d9eed7_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC0zLTEtMS0w_9d8cbe02-4d74-4fa6-8777-65c8e59060be">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d856a3247a04312a0f97fa937d9eed7_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC01LTEtMS0w_8ba4c2ec-9a2c-4f09-912b-8e281283e09b">252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d856a3247a04312a0f97fa937d9eed7_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC03LTEtMS0w_79aeaf09-e6f3-44a5-8b0c-dc3bc1eb357c">251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a42ebe572b4d43a291732f6cd1090f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC05LTEtMS0w_2371ef2e-2ea1-4c3f-8cfb-2dfa4d1d98f4">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32a42ebe572b4d43a291732f6cd1090f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC0xMS0xLTEtMA_da12fe70-e67e-4880-acce-af97a587558d">244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a42ebe572b4d43a291732f6cd1090f_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC0xMy0xLTEtMA_498460f1-e047-4940-b7cb-0c4877b3a646">253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3d3366f7c074412792772c50da23b51d_D20210401-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS0xLTEtMS0w_83042fe4-c174-41fc-81f8-f8d9f02690fb">12</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035c0f3929ab4099b0ee92a80f3a4278_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS0zLTEtMS0w_65958685-b95e-4329-a195-7f3c4f3aa842">934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i035c0f3929ab4099b0ee92a80f3a4278_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS01LTEtMS0w_c539da4f-77f7-48dd-9fe3-7e839978d497">412</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i035c0f3929ab4099b0ee92a80f3a4278_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS03LTEtMS0w_a96d50eb-8569-4681-8873-9eccf85f21ae">522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f46fc9ae83e465096134ae813e19eca_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS05LTEtMS0w_564d9db9-eb29-4988-b64d-f1a3ee819618">925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f46fc9ae83e465096134ae813e19eca_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS0xMS0xLTEtMA_014e46ef-4e0c-40df-8861-2aff6728566b">394</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f46fc9ae83e465096134ae813e19eca_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS0xMy0xLTEtMA_a236331c-acf7-4631-a940-a99db2bbc92e">531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iccbdbd7b3a45463c9d5c7a2b7100baa2_D20210401-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi0xLTEtMS0w_70c8696c-8e52-41ab-b515-933ded48ec48">4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0390e639fcad44a19ceb60da2c72ce2c_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi0zLTEtMS0w_729af322-d93a-4d2d-bdfe-c4afabff4f43">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0390e639fcad44a19ceb60da2c72ce2c_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi01LTEtMS0w_1301da3a-7e7b-4787-8309-8d7894541f75">127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0390e639fcad44a19ceb60da2c72ce2c_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi03LTEtMS0w_60c22e22-51d4-4187-925b-3d94e083817b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fbde6fe64aa486ab9d6ced83a9cd75c_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi05LTEtMS0w_4919dcc5-b437-425f-bbeb-2a532b0f61ef">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fbde6fe64aa486ab9d6ced83a9cd75c_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi0xMS0xLTEtMA_dad07931-a5a2-43ae-b152-55a955dba662">122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fbde6fe64aa486ab9d6ced83a9cd75c_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi0xMy0xLTEtMA_4f81e866-a4ca-4af6-a779-e8391b0a59fc">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie584228b8d12471fb55c1f0dfb5e49f9_D20210401-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy0xLTEtMS0w_830db249-fff6-4050-a000-434334152cef">6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f2b8389302f4c9d9c629498687890a4_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy0zLTEtMS0w_3b03c4da-1ee1-4fdc-ac83-969d6f195df9">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f2b8389302f4c9d9c629498687890a4_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy01LTEtMS0w_98f8adff-4521-4891-b128-8044e9f2b057">230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f2b8389302f4c9d9c629498687890a4_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy03LTEtMS0w_dd2b6e8c-492c-42be-8874-61bcb9624a12">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ea7a07b00745c4b4e10ece2a6d1062_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy05LTEtMS0w_3a28cd0a-378d-4ea8-9df8-6beded1856fb">254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ea7a07b00745c4b4e10ece2a6d1062_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy0xMS0xLTEtMA_b0b69d23-9224-422f-8497-1304a4bfa306">226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ea7a07b00745c4b4e10ece2a6d1062_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy0xMy0xLTEtMA_8acbdba3-e938-4974-9122-c01a377c82ed">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfOC0zLTEtMS0w_c879ffae-1abb-456a-9e87-2ea6a5237888">6,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfOC01LTEtMS0w_ccbcfef2-53d0-4b05-af18-ad2fd3b33822">3,880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfOC03LTEtMS0w_7e40b803-a341-43c3-aa60-e2716279d8fc">2,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfOC05LTEtMS0w_46b1cfea-66cc-4d45-bcd3-00a9b5e07959">6,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfOC0xMS0xLTEtMA_640990ed-90bf-4c51-ac0e-ff0d81a69ab4">3,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfOC0xMy0xLTEtMA_1ec90775-4411-420d-a564-ed840be9f4ed">2,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets was $<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTY5NQ_f6a0711f-2601-4b6c-86b0-a94232f684ad">98</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTczOA_0a07d9c7-090d-4e4a-b10d-f006a7fa1386">106</ix:nonFraction> million for the three months ended June 30, 2021 and 2020, respectively. Estimated amortization expense of these assets is as follows: $<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTgzOQ_774548f0-d309-42cf-b124-03090d049228">279</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTg0Mw_90283535-1148-4934-b062-3d868ad3a6f7">273</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTg0Nw_502d9889-3d66-4cc3-a039-257c7232c632">261</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTg1MQ_f2cd4cf8-2560-4d7a-a137-7b010849acff">255</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTg1OQ_d4a98522-8a9c-4298-9160-ba2e5d0e5ab8">223</ix:nonFraction> million for the remainder of 2022 and each of the succeeding years through 2026 and $<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-8" format="ixt:numdotdecimal" name="mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTkzNA_41b977a6-bd26-4dd4-b903-e78d7277a27e">1.5</ix:nonFraction> billion thereafter. All intangible assets were subject to amortization as of June 30, 2021 and March 31, 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_61"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNTIxOA_be952569-b553-4754-aa61-8ea5c2e07165" continuedAt="i34130527e9d64783a80ce0f4f583dd8c" escape="true">Debt and Financing Activities</ix:nonNumeric></span></div><ix:continuation id="i34130527e9d64783a80ce0f4f583dd8c" continuedAt="i0084550df3e242b8aca3458a4af201d1"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNTIwNg_edafe4ca-2267-47d5-b72d-c0046a4a1eb9" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibb31fe16ed0945ccb087b29dc4df346e_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNC0wLTEtMS0wL3RleHRyZWdpb246MzM0Y2I3NGI3Mjg2NGEzODkzMjUyNGUyMGU5NGE2MGNfNA_74ae5e8c-ad04-4cdb-91a8-90e3363b745a">2.70</ix:nonFraction>% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb31fe16ed0945ccb087b29dc4df346e_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNC0xLTEtMS0w_d979501c-4db6-491a-a7bb-b12d367fc2f8">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8407cd75013b4842b7e8b7b851404c4e_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNC0zLTEtMS0w_a5552860-1e7f-420c-876a-329fde368d92">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebe203936fb34a7a9344c5a6786888f7_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNS0wLTEtMS0wL3RleHRyZWdpb246YTIwNGFkNzExYmY1NDZhZmE3MWRlNjBhMmQwNjE4NmVfNA_ef5deaae-3880-4ef9-b550-79e36dfcc1a5">2.85</ix:nonFraction>% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebe203936fb34a7a9344c5a6786888f7_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNS0xLTEtMS0w_0d2e8a2d-3185-42c0-b86c-4154039fbdf2">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41289baaaa434780a092e5aa64685cf3_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNS0zLTEtMS0w_b992577f-7e05-4481-9c2a-23bb52390f6b">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5fef0e85ad14e5a8339aa8bf7f1f834_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNi0wLTEtMS0wL3RleHRyZWdpb246ZTNjNmFhM2JmMGFkNDg1MzhkOGQwZGY5YjVjZWQyYWFfNA_a868f6b5-e8ce-402d-88e9-7680400dcd3e">3.80</ix:nonFraction>% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5fef0e85ad14e5a8339aa8bf7f1f834_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNi0xLTEtMS0w_e84bcdec-980c-4cac-9f02-e46972058d92">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aee8ea463a843d09b2055c2c57299fd_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNi0zLTEtMS0w_6d5fcd13-5784-475e-a5ba-40017098d6f3">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i169a4495697f4cc6a8840fef9d567050_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNy0wLTEtMS0wL3RleHRyZWdpb246NzY3NzViYTdiNWI5NDdiYzhjNjY4N2VkMDRhOTJlODNfNA_513f7f2c-3cf9-4991-9939-7022cde725c3">0.90</ix:nonFraction>% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169a4495697f4cc6a8840fef9d567050_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNy0xLTEtMS0w_37b0c644-4b4c-4ae3-81b2-3236d0ab118b">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a05c4c8a26643e09852e9a58afb81b1_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNy0zLTEtMS0w_b62d5ab8-e98d-4f86-bc24-fac76ee4f6d1">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib19d5790e42d4cf79c39f2cd0f8b3b29_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfOC0wLTEtMS0wL3RleHRyZWdpb246M2IyNzZlZjUyMmM5NDU5ZDljMTgyZWY3ZmZiODdmMWJfNA_240fd751-3f31-4a83-8560-7551ae67f4c1">7.65</ix:nonFraction>% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib19d5790e42d4cf79c39f2cd0f8b3b29_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfOC0xLTEtMS0w_c98af1ba-7d34-4bf9-9ebb-3598c8be6216">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f832373d87043299bdd466eea4cdba1_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfOC0zLTEtMS0w_3bec897c-ef5d-4cc5-8203-4add327d3f75">167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iae5f8b803832412fbac51e8806cb157b_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfOS0wLTEtMS0wL3RleHRyZWdpb246OTQxZmI4OTk2YzVmNDFiZjg5ZGY2ZjIwM2QzNDg1YzFfNA_3d870748-3135-4f8d-8380-a2cd63561ab3">3.95</ix:nonFraction>% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae5f8b803832412fbac51e8806cb157b_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfOS0xLTEtMS0w_f191fcdc-1ff1-4c0c-81b5-e167a6f4d294">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e6c020b9a784d1892f9c88f64b4176e_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfOS0zLTEtMS0w_63146fa3-984f-402d-a0b2-d0d57a51f6b6">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifee3165ec08d4e9d94616eacd185bdd9_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjdiNTFjMTMzMzQyZDRmMGE5ZDM5MzhjMDMyZjQyNTFhXzQ_fda62bca-962a-48da-8484-e4bcdd9df7b2">4.75</ix:nonFraction>% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifee3165ec08d4e9d94616eacd185bdd9_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTAtMS0xLTEtMA_3b92e267-a743-4e41-a9fa-0dea55508a51">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88b5e65988454c43b931f14c2f226ef5_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTAtMy0xLTEtMA_d099c789-cf8e-4792-a559-3d36055f812c">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7e672708b526455fade2322b90db6797_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmYxY2YxMTE0M2ZiMjQ3ODBhMWQ5MjFiZjk1ZWUwMWQ1XzQ_8ba124a6-b621-4f6d-99a3-35f2e1bb5e2d">6.00</ix:nonFraction>% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e672708b526455fade2322b90db6797_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTEtMS0xLTEtMA_c9b3e883-2817-4654-8f4c-025471b3a641">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic881a7db34944589a71dcb5194c00876_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTEtMy0xLTEtMA_3335c15c-3b5b-4918-9c98-65894ec8b7a1">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia66cc0f4490547d7b0e20380ae14d605_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjU3NWM2OTAwZWFkODQ4N2FhZTE0NWFmMmM3MzliMjgwXzQ_85d2dc74-60bf-4550-b42a-f33683e1e4c5">4.88</ix:nonFraction>% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66cc0f4490547d7b0e20380ae14d605_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTItMS0xLTEtMA_43cfe9d3-ae60-4124-a201-d3c0017c54b6">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i393368a727ec4afe826cf57617c10f72_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTItMy0xLTEtMA_13a8bed4-36ca-4da3-802e-01361352b343">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0509dea68b7c4cebaf62b299de6337f9_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjE4ZTRlNDlkZTg3YjQ5NDZhYjJiOTMzZTUyZGQ5YThjXzQ_4b1205bb-e5dd-440e-ad31-c6c736f7adf7">0.63</ix:nonFraction>% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0509dea68b7c4cebaf62b299de6337f9_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTQtMS0xLTEtMA_81275a9a-3379-484b-a96f-fcd16826cdec">711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i918f3ab82fc247afa4f05e53d52b0e43_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTQtMy0xLTEtMA_7bd57c76-8de2-4d38-a929-70cc95b6c773">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1586326f43a34f1ea78093d8355235f0_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOmIxM2U1ZDFlZWFiNTQwZmE5YzMzZjllZGQzMTcxM2I1XzQ_fb987dc9-ca2b-475c-84dc-3edb9697a629">1.50</ix:nonFraction>% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1586326f43a34f1ea78093d8355235f0_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTUtMS0xLTEtMA_f43d41ed-54a4-4e26-8951-c61ae954af27">708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15cf8725ddab482688388dd6b20edb40_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTUtMy0xLTEtMA_4fd869da-58e2-43ef-8ed8-320b1e1b30fe">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1fb67a2ffa7344a8ac4da91deabca230_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NzNmODExNDZjMzQ3NjlhNWMwOGZjNWQzM2Q0MmNjXzQ_fbfb49f0-2994-4b22-8d7d-8db2d4bc5eab">1.63</ix:nonFraction>% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb67a2ffa7344a8ac4da91deabca230_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTYtMS0xLTEtMA_ba946efa-5498-433b-8497-a69ff00b4244">592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14953d2fb5684f679ab2a851b343c97b_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTYtMy0xLTEtMA_a3b37d49-5cd4-4857-98f1-6eba041f8766">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifffd02ac34b54a9d83eede3f64ae16e7_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmVmZjdmY2FjODRlOTQ5YjA5NDMzODMyMzlkNGQ0MjFiXzQ_ec36a2c4-33e0-4eab-9250-5e8aea7628fe">3.13</ix:nonFraction>% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifffd02ac34b54a9d83eede3f64ae16e7_I20210630" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTctMS0xLTEtMA_89c45a31-b4f0-41de-a91f-df629a89f8a9">635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i755188d16c194ff880eddc359eea6d40_I20210331" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTctMy0xLTEtMA_c78fa87d-9141-40b4-8e46-10e832f3d8f3">627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTktMS0xLTEtMA_e7774703-fd36-40f0-8880-3c7fa89bbbc0">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:FinanceLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTktMy0xLTEtMA_e837330b-ea58-4ef4-9f60-ec1a834055f1">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMjAtMS0xLTEtMA_d0e8e8f7-5283-43f2-a996-98caa9770da9">7,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMjAtMy0xLTEtMA_c4eaf777-f2c3-4a86-b6f7-2584a7a2c94d">7,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMjEtMS0xLTEtMA_5cb57bc0-6ef3-4f15-902a-5d1ae248e779">752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMjEtMy0xLTEtMA_fcc58642-7128-4b13-9df0-e70d55d6e5a2">742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMjItMS0xLTEtMA_31ab5d8b-f314-46eb-8fb8-816a8b0e2396">6,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMjItMy0xLTEtMA_d048f283-4b63-4376-891f-e9337619ccb1">6,406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzg0_90ceab7c-dde2-4374-bbb1-c99a551f32c6">7.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtAndCapitalLeaseObligations" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzkx_2dfcb4e2-a25c-4c90-9121-b12115e15432">7.1</ix:nonFraction> billion at June 30, 2021 and March 31, 2021, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNDMx_85d0aebd-8a0b-4801-acbb-20ebafd427c2">752</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNDM4_2b2b4de9-aec0-4a0b-b4a3-10d79d65411f">742</ix:nonFraction> million, respectively, was included under the caption &#8220;Current portion of long-term debt&#8221; within the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 17, 2021, the Company redeemed its <ix:nonFraction unitRef="number" contextRef="i52b40196e15a40109ba391d8c6419991_I20210717" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk2NzE4MA_cf89bcdb-d92f-4f9c-a704-0ee3f60a6950">0.63</ix:nonFraction>% &#8364;<ix:nonFraction unitRef="eur" contextRef="i52b40196e15a40109ba391d8c6419991_I20210717" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MDc0NQ_b1eece72-423a-4bc9-99a2-b59ee1f38878">600</ix:nonFraction> million (or, approximately $<ix:nonFraction unitRef="usd" contextRef="i52b40196e15a40109ba391d8c6419991_I20210717" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MDczOQ_0ba780ac-37c3-40cc-a7e3-4203f427752f">709</ix:nonFraction> million) total principal Euro-denominated notes, originally due on August 17, 2021, prior to maturity. The notes were redeemed at par value using cash on hand.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tender Offer</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) <ix:nonFraction unitRef="number" contextRef="i083ed7e2edf54f4b83be55e6fa4c6f7b_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzAzMA_4e73f42e-6fee-411e-8248-9576f5647dc9">2.85</ix:nonFraction>% Notes due 2023, (ii) <ix:nonFraction unitRef="number" contextRef="i5a40c09a559944b7bada0ac4b7f9ed85_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzAzNw_c028ac05-5f90-4169-93ea-fb136b3b7da1">3.80</ix:nonFraction>% Notes due 2024, (iii) <ix:nonFraction unitRef="number" contextRef="i2c1f8c6acdf4492e89a70c07d233052b_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzA0NA_ec34ec02-08b6-4f22-a8b6-b86269169bf6">7.65</ix:nonFraction>% Debentures due 2027, (iv) <ix:nonFraction unitRef="number" contextRef="i8cd03befc3844879a03bf8f5fa13ca89_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzA1MQ_23484198-e5f7-409d-95b6-f31eac66566a">3.95</ix:nonFraction>% Notes due 2028, (v) <ix:nonFraction unitRef="number" contextRef="if0edf0d51ebc4525bc018b0e3e316674_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzA1OA_77d6ea81-e08c-4480-88b8-b8071f290bce">4.75</ix:nonFraction>% Notes due 2029, (vi) <ix:nonFraction unitRef="number" contextRef="i310b2ea151234b239e7d7b390ccb95cb_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzA2NQ_6fb228d4-04a7-43de-b251-9862c452db19">6.00</ix:nonFraction>% Notes due 2041, and (vii) <ix:nonFraction unitRef="number" contextRef="ibef52b2a142145dab5d69647024ad296_I20210723" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzA3Mg_c3117060-7236-47a7-89cd-a55e8b600101">4.88</ix:nonFraction>% Notes due 2044 (collectively referred to herein as the &#8220;Tender Offer Notes&#8221;). In connection with the tender offer, the Company paid an aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="i5f3accdb3da74028a9b53d7cbfada305_I20210723" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentRepurchaseAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MjQwNg_f82a56be-6477-45c8-bea1-5e431d90852a">1.1</ix:nonFraction>&#160;billion to redeem $<ix:nonFraction unitRef="usd" contextRef="i5f3accdb3da74028a9b53d7cbfada305_I20210723" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MjQyOQ_7e20c257-e487-4607-b5f2-2414481fd66e">922</ix:nonFraction>&#160;million principal amount of the notes at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i9c2de330c27f48448b2891e90290996d_D20210723-20210723" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzA3OQ_3ecca617-4c9c-4fd8-be79-4f7285161f99">100</ix:nonFraction>% of the principal amount and premiums of $<ix:nonFraction unitRef="usd" contextRef="i9c2de330c27f48448b2891e90290996d_D20210723-20210723" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MjQ1MQ_bbac30a4-fea1-4df6-b08f-28c37e755e1c">182</ix:nonFraction>&#160;million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment and in the second quarter of 2022 the Company will record a loss on debt extinguishment, consisting of the premiums paid and a portion of the unamortized discounts and debt issuance costs proportional to the principal amount of debt retired.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i0084550df3e242b8aca3458a4af201d1"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Credit Agreement, dated as of September 25, 2019 (the &#8220;2020 Credit Facility&#8221;), that provides a syndicated $<ix:nonFraction unitRef="usd" contextRef="i25b1cae8ddb3438888532104a195d342_I20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMjgxOQ_b025cb03-544d-45eb-bbb9-90b62cd97543">4.0</ix:nonFraction> billion <ix:nonNumeric contextRef="ia01f828cfc8d4b21a6b8edf6be853a2c_D20190701-20190930" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNTIwNw_67522d2a-f148-4dab-ad86-177bee1ae4f9">five-year</ix:nonNumeric> senior unsecured credit facility with a $<ix:nonFraction unitRef="usd" contextRef="i6e548eee92194bd0ac6aa9274c25b1a9_I20190930" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMjk0OQ_64ef72f9-16ef-4b28-b098-99bec1df6f1e">3.6</ix:nonFraction> billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had <ix:nonFraction unitRef="usd" contextRef="i382e8de72c834d1eac88fcfa16537bad_D20210401-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromLinesOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzEwMA_b346caeb-b66e-4f4b-8735-6b6980ac85e6"><ix:nonFraction unitRef="usd" contextRef="i4601e5b7a09c46ccb58053797c15dbc7_D20200401-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromLinesOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzEwMA_ceaaf7a4-a528-42b2-87b4-17a06867f03c">no</ix:nonFraction></ix:nonFraction>&#160;borrowings during the three months ended June 30, 2021 and 2020 and <ix:nonFraction unitRef="usd" contextRef="i4398603060f24739aba2e6bf31a25415_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzE1OA_198a1f09-154b-4c11-bed4-b818d17ec538"><ix:nonFraction unitRef="usd" contextRef="i3b2b1270b93847d1b81d237136f5a141_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzE1OA_91f6d472-a333-4ec2-88c9-cd17829044ce">no</ix:nonFraction></ix:nonFraction> amounts outstanding as of June 30, 2021 and March 31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2021, the Company entered into Amendment No. 2 to the 2020 Credit Facility, which superseded Amendment No. 1, dated as of February 1, 2021. The 2020 Credit Facility, as amended, contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At June 30, 2021, the Company was in compliance with all covenants. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euro with a committed amount of $<ix:nonFraction unitRef="usd" contextRef="iacf778d3b2e94d20a54cbcb22993e5bf_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNDQ0MQ_90c0e5d2-48ae-4633-90bb-8f9cf68abf65">8</ix:nonFraction> million and an uncommitted amount of $<ix:nonFraction unitRef="usd" contextRef="iacf778d3b2e94d20a54cbcb22993e5bf_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNDQ3Mw_bad49bf9-63ee-4115-a5c6-90210bc459e3">118</ix:nonFraction> million as of June 30, 2021. Borrowings and repayments were not material during the three months ended June 30, 2021 and 2020, and amounts outstanding under these credit lines were not material as of June 30, 2021 and March 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $<ix:nonFraction unitRef="usd" contextRef="id40f1c8ac21f4308bf805ca389c79975_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNDg2Mg_6c509fc1-9432-4290-984d-80492e98d7cf">4.0</ix:nonFraction> billion in outstanding commercial paper notes. There were <ix:nonFraction unitRef="usd" contextRef="id62cfccb10834659abc7c6a555e79614_D20210401-20210630" decimals="-8" format="ixt-sec:numwordsen" name="us-gaap:RepaymentsOfCommercialPaper" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MTIyNw_a3e32221-8793-4b20-9a57-a9992172c4af"><ix:nonFraction unitRef="usd" contextRef="id62cfccb10834659abc7c6a555e79614_D20210401-20210630" decimals="-8" format="ixt-sec:numwordsen" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MTIyNw_da787528-72e2-461b-a7df-10af4649d458">no</ix:nonFraction></ix:nonFraction> borrowings or repayments during the three months ended June 30, 2021. During the three months ended June 30, 2020, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="ibbabad5c01b74ee69bce61c31d9c74ac_D20200401-20200630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNDk3MA_85d32092-a0e5-40db-b1aa-d7a64dfa78da">5.3</ix:nonFraction> billion and repaid $<ix:nonFraction unitRef="usd" contextRef="ibbabad5c01b74ee69bce61c31d9c74ac_D20200401-20200630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfCommercialPaper" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNTAwNg_b834d3fb-cfd1-4478-9a10-ce443114b2b6">5.3</ix:nonFraction> billion under the program. At June 30, 2021 and March 31, 2021, there were <ix:nonFraction unitRef="usd" contextRef="i87ef7e5959ad4f249be2667fc9962adc_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LongTermCommercialPaperCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNTE2NA_10a48458-9f84-4d45-bee3-f868a2e03136"><ix:nonFraction unitRef="usd" contextRef="id40f1c8ac21f4308bf805ca389c79975_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LongTermCommercialPaperCurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNTE2NA_8052c964-24e8-4039-8efe-5cf10c01f3fe">no</ix:nonFraction></ix:nonFraction> commercial paper notes outstanding.</span></div></ix:continuation><div id="ia9b664dd086f4724924e37451951b156_64"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82NC9mcmFnOmRlNDcyNTI0NDE3NzQ3NjY5M2NhNjBkYTQzM2NiODE0L3RleHRyZWdpb246ZGU0NzI1MjQ0MTc3NDc2NjkzY2E2MGRhNDMzY2I4MTRfMjQ2NQ_7b3a1f6f-24cd-4bc7-8a6a-489f25385d67" continuedAt="i2ffcaefd204a46ccb838d77bba58f79e" escape="true">Pension Benefits</ix:nonNumeric></span></div><ix:continuation id="i2ffcaefd204a46ccb838d77bba58f79e"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic expense for defined benefit pension plans was approximately <ix:nonFraction unitRef="usd" contextRef="ia550dbf4b8264bfb9f5b32e88da36352_D20210401-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82NC9mcmFnOmRlNDcyNTI0NDE3NzQ3NjY5M2NhNjBkYTQzM2NiODE0L3RleHRyZWdpb246ZGU0NzI1MjQ0MTc3NDc2NjkzY2E2MGRhNDMzY2I4MTRfNzU_ed54a695-dac0-4d61-b9ff-0e1b588fc087">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie9cfdb9a5439470287947e0237d40a46_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82NC9mcmFnOmRlNDcyNTI0NDE3NzQ3NjY5M2NhNjBkYTQzM2NiODE0L3RleHRyZWdpb246ZGU0NzI1MjQ0MTc3NDc2NjkzY2E2MGRhNDMzY2I4MTRfMTE1_78a5e9ad-943e-4b76-bdab-4d6e89809fe2">7</ix:nonFraction> million for the three months ended June 30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash contributions to these plans were $<ix:nonFraction unitRef="usd" contextRef="ia550dbf4b8264bfb9f5b32e88da36352_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82NC9mcmFnOmRlNDcyNTI0NDE3NzQ3NjY5M2NhNjBkYTQzM2NiODE0L3RleHRyZWdpb246ZGU0NzI1MjQ0MTc3NDc2NjkzY2E2MGRhNDMzY2I4MTRfMTkx_3c5c9928-1a46-4860-bb9e-dc48e5c80cc9">14</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie9cfdb9a5439470287947e0237d40a46_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82NC9mcmFnOmRlNDcyNTI0NDE3NzQ3NjY5M2NhNjBkYTQzM2NiODE0L3RleHRyZWdpb246ZGU0NzI1MjQ0MTc3NDc2NjkzY2E2MGRhNDMzY2I4MTRfMjMx_cc7c2c3c-9ff1-4b51-8786-1ac97113909c">7</ix:nonFraction> million for the three months ended June 30, 2021 and 2020, respectively. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding <ix:nonFraction unitRef="number" contextRef="icc80b14c5bcc4ef59c002900d86c6c35_I20210630" decimals="INF" name="us-gaap:DefinedBenefitPlanFundedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82NC9mcmFnOmRlNDcyNTI0NDE3NzQ3NjY5M2NhNjBkYTQzM2NiODE0L3RleHRyZWdpb246ZGU0NzI1MjQ0MTc3NDc2NjkzY2E2MGRhNDMzY2I4MTRfNTc0_ab359394-c402-4f4c-bbd5-8aca90965ce8">10</ix:nonFraction>% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.</span></div></ix:continuation><div id="ia9b664dd086f4724924e37451951b156_67"></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMTEyMjE_2558807d-4b1e-40ad-91c1-096b0017e01a" continuedAt="i3fe46f3a16c146dc96eacf7ba35a3cad" escape="true">Hedging Activities </ix:nonNumeric></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3fe46f3a16c146dc96eacf7ba35a3cad" continuedAt="if96d8dd222f74ce5989878da86e3c904">In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="if96d8dd222f74ce5989878da86e3c904" continuedAt="ibedaa890172f4aee930768dfcf993859"><div style="margin-bottom:6pt;padding-left:2.25pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2021 and March 31, 2021, the Company had &#8364;<ix:nonFraction unitRef="eur" contextRef="ic94ceeda5f8d4c34920ab05d68d536f7_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMTUwMg_407a223c-78fc-42d0-bbab-a8e24de97d19"><ix:nonFraction unitRef="eur" contextRef="i7e80ec0a1e2d4560a4bb44c4d5f4a808_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMTUwMg_780d4e36-0865-4d10-a8f1-88bd4bed7928">1.7</ix:nonFraction></ix:nonFraction> billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Losses from net investment hedges recorded within Other comprehensive income were $<ix:nonFraction unitRef="usd" contextRef="i3252989f4e9143d3a010d05024100a86_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMjcxMQ_25f7c989-fcad-4b32-a385-13e3a71a4cbb">22</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0d1c889a01024ed39200b6381c6e96e7_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMjc2NA_fe567143-2c50-4387-8af8-f6a3f51841c2">34</ix:nonFraction> million during the three months ended June 30, 2021 and 2020, respectively. There was no ineffectiveness in non-derivative net investment hedges during the three months ended June 30, 2021 and 2020.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2021 and March 31, 2021, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $<ix:nonFraction unitRef="cad" contextRef="iaad66d5fe7e44e1f84cb3ffe38ed1ab1_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMzI4OQ_8ef8f095-a4cf-4d90-b310-6fc9dbc722d2"><ix:nonFraction unitRef="cad" contextRef="i80839eede57645f39c2726f49aa8dd4f_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMzI4OQ_f19cfcbc-cd5b-4daa-b1bd-db2932e686b9">500</ix:nonFraction></ix:nonFraction> million Canadian dollars. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in &#8220;Accumulated other comprehensive loss&#8221; in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#8217;s net investment hedges for the three months ended June 30, 2021 and 2020. The remaining cross-currency swaps will mature November 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from the Company&#8217;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $<ix:nonFraction unitRef="usd" contextRef="ie2831786f08a4f11887081ccec157fb0_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfNTQ2OA_43cac93b-262d-4d34-974d-edb381976e3d">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id92758a2bb7c4cff8bb23c47c0c1232f_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfNTUyMQ_d8da1535-7c9f-4873-b747-a70b3af20449">51</ix:nonFraction> million during the three months ended June 30, 2021 and 2020, respectively. There was no ineffectiveness in the Company&#8217;s cross-currency swap hedges for the three months ended June 30, 2021 and 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#163;<ix:nonFraction unitRef="gbp" contextRef="ie7a08d2dbea84831a38c40ef01c2c6e7_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfNTgyMw_de8ce093-e40a-4374-82a8-1a5fea4d6b15">450</ix:nonFraction> million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#163;<ix:nonFraction unitRef="gbp" contextRef="ie7a08d2dbea84831a38c40ef01c2c6e7_I20190930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfNjE3NQ_de8ce093-e40a-4374-82a8-1a5fea4d6b15">450</ix:nonFraction> million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ibedaa890172f4aee930768dfcf993859" continuedAt="ia6692c88106543a794b80b1e9018eb7a"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At June 30, 2021 and March 31, 2021, the Company had cross-currency swaps with total gross notional amounts of approximately $<ix:nonFraction unitRef="usd" contextRef="i8814cd508cb14d7a92a7f3da4dedb9e8_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfNzQzNg_62a6558e-a152-497c-8bcc-ab45d3d47191"><ix:nonFraction unitRef="usd" contextRef="i956714c5c73546d6bdd695153b63c85a_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfNzQzNg_6591078b-2e3d-4d92-886b-2df1798e0e10">2.6</ix:nonFraction></ix:nonFraction> billion, which are designated as cash flow hedges. These swaps will mature between August 2021 and January 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i9ef3d8dbb2ba449ca93f70296442ff7b_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODA4MQ_25042617-c77b-44f0-ad3b-619b59f6ba9f">500</ix:nonFraction> million and &#8364;<ix:nonFraction unitRef="eur" contextRef="i9ef3d8dbb2ba449ca93f70296442ff7b_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODA4OA_b0b8fc63-9cdb-4155-90e4-c2bc8ef36ed9">600</ix:nonFraction> million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $<ix:nonFraction unitRef="usd" contextRef="i9ef3d8dbb2ba449ca93f70296442ff7b_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODMxNw_25042617-c77b-44f0-ad3b-619b59f6ba9f">500</ix:nonFraction> million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#8220;EURIBOR&#8221;) for the &#8364;<ix:nonFraction unitRef="eur" contextRef="i9ef3d8dbb2ba449ca93f70296442ff7b_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODU0Mg_b0b8fc63-9cdb-4155-90e4-c2bc8ef36ed9">600</ix:nonFraction> million swaps. The $<ix:nonFraction unitRef="usd" contextRef="i9ef3d8dbb2ba449ca93f70296442ff7b_I20200427" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODU1Ng_25042617-c77b-44f0-ad3b-619b59f6ba9f">500</ix:nonFraction> million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the <ix:nonNumeric contextRef="i124c1e4e44e4428894d8a3cf36e6b1f8_D20210401-20210630" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMTEyMjM_d30903c9-ab2e-4de6-b8de-43ebfb8db8b7">five-year</ix:nonNumeric> life of the 2025 Notes. Refer to Financial Note 8, &#8220;Debt and Financing Activities,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from cash flow hedges recorded in Other comprehensive income were <ix:nonFraction unitRef="usd" contextRef="ief989ade667c4ef18be6557ba0496c47_D20210401-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODkzOA_2de0f948-eaaa-47de-bcac-673ce90d783d">zero</ix:nonFraction> and a loss of $<ix:nonFraction unitRef="usd" contextRef="i7e159bf48d534941b449647bc4af9899_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODk5NQ_c8af7c7b-5b90-4b07-92a0-d2dee7a2b576">5</ix:nonFraction> million during the three months ended June 30, 2021 and 2020, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations were not material in the three months ended June 30, 2021 and 2020. There was no ineffectiveness in the Company&#8217;s cash flow hedges for the three months ended June 30, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At June 30, 2021 and March 31, 2021, the total gross notional amounts of these contracts were $<ix:nonFraction unitRef="usd" contextRef="iddb83da1863c4b8384938b9fad9620c2_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfOTcwMw_758f3c00-f663-45b1-a3b1-fb772823332c">54</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1a3a75a3436b4b3685c3cfc786388204_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfOTcxMA_6feee010-20ff-479d-8d29-3fe738f7d1db">39</ix:nonFraction> million, respectively. These contracts will predominantly mature between July 2021 and December 2021 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. Changes in the fair values were not material in the three months ended June 30, 2021 and 2020. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ia6692c88106543a794b80b1e9018eb7a" continuedAt="i8f5861f92b4941438251462b67777c8a"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMTEyMTg_7900f410-44fd-41fa-bf63-a8312fa3e316" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.033%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.672%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.817%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.206%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2941f5ca10940f394d4dd8bfb64ac58_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNS0yLTEtMS0w_3a25398a-69b1-45b2-9d15-6466c285ee2d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id617d1f4a3154d5ead974c1efa393746_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNS00LTEtMS0w_de6f6b39-ae07-4e1b-96e7-034e943201bb">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d7fdeabe846450cbffd7d9cb27d2e5f_I20210630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNS01LTEtMS0w_f4150ec9-5ac9-44b6-8aca-fb198f333b71">895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b6587a427294928b598b9dd585bb983_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNS03LTEtMS0w_53cd49d1-eb78-4982-827f-f7537f4fd252">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5eb3ee735d54234824cb44c72ee37bd_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNS05LTEtMS0w_011b680b-6fcf-4610-b3cb-4da390d4bfce">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i558eb332169346989d3fd5ae0d6527e4_I20210331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNS0xMC0xLTEtMA_6b1f1ea2-efc3-4340-b523-4225220702cc">826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7c97a01f67041b391ae942c70306640_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNi0yLTEtMS0w_4f6abb76-ed31-404f-b5e5-b8284f887b56">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if46eae73de4e4324a272398b73a63332_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNi00LTEtMS0w_f8599d97-bcb5-473e-a84e-3b60cce47f60">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cb0c057ebf04f36a85edd8c4c2ae13c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNi01LTEtMS0w_dcd9c31d-9303-42ed-878e-bddd575800cc">2,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de9a66fbd214a428e97ce8f78d46531_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNi03LTEtMS0w_3d0f47ca-7791-495f-b7d4-d377c171a4a0">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fca76452d9740ef9b482b67b89fa4f8_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNi05LTEtMS0w_18cf76ea-f31a-4ae4-b8f2-fdbd9560b678">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2acd26c3075244feb92ff6dd6d80e75c_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNi0xMC0xLTEtMA_65fae290-2a78-45b2-9f19-30d9b9a581d7">2,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d2fcd1df20c4538955a00e476ec7c57_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNy0yLTEtMS0w_743a44f8-1f1a-46e3-b9e0-52ac30b6446c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d2fcd1df20c4538955a00e476ec7c57_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNy00LTEtMS0w_b9225112-5faa-4061-a71a-8596d6816891">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d2fcd1df20c4538955a00e476ec7c57_I20210630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNy01LTEtMS0w_459fe097-bfcf-4965-ad70-d09d4f3c3832">711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb89381a71734f36b7d1abc0599bc5dc_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNy03LTEtMS0w_280a0106-ee93-41bc-a3e4-9c52521e5eb4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb89381a71734f36b7d1abc0599bc5dc_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNy05LTEtMS0w_5c8659cd-994b-4d34-92d5-1e064bc01f16">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb89381a71734f36b7d1abc0599bc5dc_I20210331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNy0xMC0xLTEtMA_ddab9e96-d147-4645-8533-20f85d0065c2">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0d9f4fb8711478cb44177fe5109b6be_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfOS0yLTEtMS0w_8b56d704-b5a4-4aaa-a716-b0209c68900b">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0d9f4fb8711478cb44177fe5109b6be_I20210630" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfOS00LTEtMS0w_a4e02095-a74f-4345-8ba0-90c22cec5c47">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d0248921e62472a9c05a75192f10e2a_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfOS03LTEtMS0w_76f28175-d2e1-4a26-8743-8ce09baa818c">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d0248921e62472a9c05a75192f10e2a_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfOS05LTEtMS0w_ffaf538b-331e-492f-a4dc-1eec7ebb7fc6">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057bad05c3bc428daef027fdad88ff14_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTEtMi0xLTEtMA_53d945ce-c283-4dce-861a-e04f4a318ac2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057bad05c3bc428daef027fdad88ff14_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTEtNC0xLTEtMA_cfc3d45a-4711-4f1f-a92c-6cc137957d2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057bad05c3bc428daef027fdad88ff14_I20210630" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTEtNS0xLTEtMA_627d2b1d-b66f-4c3a-a638-d53864f7d6c4">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c462aabc2274d09a39e632a3b618cce_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTEtNy0xLTEtMA_eabc7dae-b1a0-4bac-afb2-eab55370d427">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c462aabc2274d09a39e632a3b618cce_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTEtOS0xLTEtMA_d7f59c9f-f04a-45e6-9907-966c611b99b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c462aabc2274d09a39e632a3b618cce_I20210331" decimals="-6" name="us-gaap:DerivativeAssetNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTEtMTAtMS0xLTA_2d524bb1-ee49-4ebc-8c08-fa6bcffc8318">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ab7b1f45b443cba7bfac6496401a9f_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTItMi0xLTEtMA_017be7f0-2beb-425e-8cb5-5d9e51448c56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ab7b1f45b443cba7bfac6496401a9f_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTItNC0xLTEtMA_eb9f9f6b-269a-483d-b253-213a65830402">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7ab7b1f45b443cba7bfac6496401a9f_I20210630" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTItNS0xLTEtMA_2f3ed6e0-95dc-495c-9b60-1e5dc80ad438">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50a5c757907c4088ae0296ac7b7d7d28_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTItNy0xLTEtMA_91748879-0afb-4efe-aa5a-4741e9b406ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50a5c757907c4088ae0296ac7b7d7d28_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTItOS0xLTEtMA_bf75039e-80b2-4a5b-9d6f-acb4626ee1fe">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50a5c757907c4088ae0296ac7b7d7d28_I20210331" decimals="-6" name="us-gaap:DerivativeLiabilityNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTItMTAtMS0xLTA_b987e842-35ce-460c-bb30-e2e47753ca43">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0f92fdc3cca4ab5a3cf1a1bf925cfd1_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTMtMi0xLTEtMA_3bd1b7b5-4919-4df1-98e8-1f2de6321441">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0f92fdc3cca4ab5a3cf1a1bf925cfd1_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTMtNC0xLTEtMA_b43dbc36-f3b1-42d2-ae1a-d407beda1612">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17405e4be62d40c6ab31341f02725dfc_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTMtNy0xLTEtMA_9fef164b-9663-4f2c-92ee-194e7b27f0f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17405e4be62d40c6ab31341f02725dfc_I20210331" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTMtOS0xLTEtMA_a0a50455-a812-4d71-914c-ade9daea01f1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8f5861f92b4941438251462b67777c8a">Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.</ix:continuation> </span></div><div id="ia9b664dd086f4724924e37451951b156_70"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RleHRyZWdpb246MmEzOThhZjdhMjg4NGU1ZmI1OTczNWNjZTZhZDZhM2VfNjkxNw_09a4e881-c165-48a5-bccf-8cde1155d988" continuedAt="i47af7e793694498bb9edb8b1092b36ee" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i47af7e793694498bb9edb8b1092b36ee" continuedAt="i3a6252a3bfb541129c318fea53e1642f"><div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at June 30, 2021 and March 31, 2021 included investments in money market funds of $<ix:nonFraction unitRef="usd" contextRef="ie6b3e479a7ba41eab5874e29f520ca6e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RleHRyZWdpb246MmEzOThhZjdhMjg4NGU1ZmI1OTczNWNjZTZhZDZhM2VfMTIzNg_5c138f3d-2ed6-45c1-b816-1396fc21fd21">521</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i264ad77616174b4a9fc0c900da89178a_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RleHRyZWdpb246MmEzOThhZjdhMjg4NGU1ZmI1OTczNWNjZTZhZDZhM2VfMTI0Mw_fa04cd3e-0f47-4adc-96e0-78e1ae07cea8">1.6</ix:nonFraction> billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#8217;s marketable securities were not material at June 30, 2021 and March 31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps, foreign currency forward contracts, and cross-currency swaps were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s derivatives including interest rate swaps, forward foreign currency contracts, and cross-currency swaps.</span></div></ix:continuation><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i3a6252a3bfb541129c318fea53e1642f" continuedAt="ifb518f50c37e46a689432a0cdc3db936"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets associated with the Company&#8217;s restructuring initiatives as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges.&#8221; At March 31, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s International segment and goodwill of the Company&#8217;s Europe Retail Pharmacy reporting unit within the International segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="ieb9b9bae1bf74a07b096fa2f28832165_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RleHRyZWdpb246MmEzOThhZjdhMjg4NGU1ZmI1OTczNWNjZTZhZDZhM2VfNTAwNw_659878f7-bb84-408c-9635-b03826d439c6"><ix:nonFraction unitRef="usd" contextRef="ida94316064164aa9be5a8557cd06794c_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LiabilitiesFairValueDisclosure" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RleHRyZWdpb246MmEzOThhZjdhMjg4NGU1ZmI1OTczNWNjZTZhZDZhM2VfNTAwNw_ad888619-3727-4ea0-ab48-0f338f6e25cd">no</ix:nonFraction></ix:nonFraction> liabilities measured at fair value on a nonrecurring basis at June 30, 2021 and March 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2021 and March 31, 2021, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RleHRyZWdpb246MmEzOThhZjdhMjg4NGU1ZmI1OTczNWNjZTZhZDZhM2VfMzI5ODUzNDkxMzU1NQ_d1abff47-037a-4638-9868-adac1413985d" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:55.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.752%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.903%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f1e101a3d9e451eb8389cf243131a05_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RhYmxlOjllZTUyYWRlZWI5OTQ4MjliYTg2NDhmYTQ1MzEyNTU4L3RhYmxlcmFuZ2U6OWVlNTJhZGVlYjk5NDgyOWJhODY0OGZhNDUzMTI1NThfMi0xLTEtMS02NjA_218d99a3-719a-4439-bf0a-632457096dcb">7,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f1e101a3d9e451eb8389cf243131a05_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RhYmxlOjllZTUyYWRlZWI5OTQ4MjliYTg2NDhmYTQ1MzEyNTU4L3RhYmxlcmFuZ2U6OWVlNTJhZGVlYjk5NDgyOWJhODY0OGZhNDUzMTI1NThfMi0zLTEtMS02NjM_d1da27ce-e638-42c9-965e-b1148133bb79">7,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia19dcf632c5a4f9b87ae18a87b76e38c_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RhYmxlOjllZTUyYWRlZWI5OTQ4MjliYTg2NDhmYTQ1MzEyNTU4L3RhYmxlcmFuZ2U6OWVlNTJhZGVlYjk5NDgyOWJhODY0OGZhNDUzMTI1NThfMi01LTEtMS02NTA_c8e54c83-e7e4-49fe-b334-c8792a41c7a5">7,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia19dcf632c5a4f9b87ae18a87b76e38c_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RhYmxlOjllZTUyYWRlZWI5OTQ4MjliYTg2NDhmYTQ1MzEyNTU4L3RhYmxlcmFuZ2U6OWVlNTJhZGVlYjk5NDgyOWJhODY0OGZhNDUzMTI1NThfMi03LTEtMS02NTM_1b424d62-612f-4db9-95f5-88dc05c523b2">7,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, included within &#8220;Prepaid expenses and other&#8221; on the Company&#8217;s Condensed Consolidated Balance Sheets as of June 30, 2021 and March 31, 2021, primarily consists of funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. The amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within &#8220;Other accrued liabilities&#8221; on the Company&#8217;s Condensed Consolidated Balance Sheets as of June 30, 2021 and March 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a discounted cash flow (&#8220;DCF&#8221;) model to determine the fair value of the reporting unit. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifb518f50c37e46a689432a0cdc3db936">The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</ix:continuation></span></div><div id="ia9b664dd086f4724924e37451951b156_73"></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMTkzMzE_4a11691f-67e8-4261-accc-56457d888144" continuedAt="ie9eb5c9b8f094239b64e32c455348a08" escape="true">Commitments and Contingent Liabilities </ix:nonNumeric></span></div><ix:continuation id="ie9eb5c9b8f094239b64e32c455348a08" continuedAt="i5124be7ba9a74307868a8f4328d56253"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMTkzMzA_7df1dbef-5808-48dd-aacb-5924ad6fbe7b" continuedAt="i7cf47959e181400dbc196d43b8bba487" escape="true"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765321000039/mck-20210331.htm#i08f9baf810c0412e93ea6effc6d22995_214">Financial Note 19 to the Company&#8217;s 2021 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></ix:nonNumeric></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7cf47959e181400dbc196d43b8bba487">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.</ix:continuation> </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#8220;MDL&#8221;) in the United States District Court for the Northern District of Ohio captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: National Prescription Opiate Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 17-md-2804. At present, there are approximately <ix:nonFraction unitRef="case" contextRef="i468d5d79395f4d76980c0de14e2195fe_I20210630" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMzgxMA_69694646-a29b-40a8-b49e-7f9e49bf9298">2,900</ix:nonFraction> cases under the jurisdiction of the MDL court. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="case" contextRef="i560f2387215143f39820008aab86b0e9_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMzg2Mg_279bc8a7-5b5e-41d5-89e9-449d9b55ff1c">Three</ix:nonFraction> cases involving McKesson that were previously part of the federal MDL have been remanded to other federal courts for discovery and trial. On January 14, 2020, the Judicial Panel on Multidistrict Litigation finalized its Conditional Remand Order, ordering that the cases brought by Cabell County, West Virginia and the City of Huntington, West Virginia be remanded to the U.S. District Court for the Southern District of West Virginia. Trial in that case ended on July 28, 2021 and the outcome is pending. On February 5, 2020, the case brought by the City and County of San Francisco was remanded to the U.S. District Court for the Northern District of California; trial has been set for April 25, 2022. Also on February 5, 2020, the case brought by the Cherokee Nation was remanded by the MDL court to the U.S. District Court for the Eastern District of Oklahoma; trial has been set for September 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i5124be7ba9a74307868a8f4328d56253" continuedAt="id188a3e585844b3ebdee0b496e0162a7"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also named in approximately <ix:nonFraction unitRef="case" contextRef="i7967e4fff72d493bb8ebc9597e37bc19_I20210630" decimals="-2" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNDc5Nw_42ad3c71-6e8b-457e-997c-fb1ba94c057b">300</ix:nonFraction> similar state court cases pending in <ix:nonFraction unitRef="state" contextRef="i7967e4fff72d493bb8ebc9597e37bc19_I20210630" decimals="INF" name="mck:LossContingencyNumberofStates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNDgzNw_323aa495-93c7-4f8c-8bad-54824ff745bb">38</ix:nonFraction> states plus Puerto Rico, along with <ix:nonFraction unitRef="case" contextRef="i5952f660e44f4b63bfd67ce4efa66744_I20210630" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNDg3Ng_c9009ede-00a4-4c3c-becc-10e536027278">3</ix:nonFraction> cases in Canada. These include actions filed by <ix:nonFraction unitRef="stateattorney" contextRef="i7967e4fff72d493bb8ebc9597e37bc19_I20210630" decimals="INF" name="mck:LossContingencyNumberofStateAttorneyGenerals" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNDkyNw_abe8bc4b-d67f-4b76-80c7-9fcc210c9d0f">26</ix:nonFraction> state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state court cases. For example, trials in the cases brought by the Ohio and Washington attorneys general are scheduled for September 2021; the case brought by the Alabama attorney general is scheduled to go to trial in November 2021; the case brought by the Rhode Island attorney general is scheduled for January 2022; and the case brought by Dallas County, Texas, is scheduled for trial in January 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2021, the Company and the <ix:nonFraction unitRef="distributor" contextRef="icd94e17f05724bf4ba48a2eb22b0163b_I20210721" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberOfOtherDefendants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyMDM4Mw_5b9ee651-5a11-475e-8fcf-629cfb5e81b2"><ix:nonFraction unitRef="distributor" contextRef="i8ca3354c383c4d99b989e74af58a1b0e_I20210720" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberOfOtherDefendants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyMDM4Mw_9487d9df-5bcf-4c86-9b4f-11cad846dcfd">two</ix:nonFraction></ix:nonFraction> other national pharmaceutical distributors announced that they had negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. If the proposed settlement agreement and settlement process leads to final settlement, the <ix:nonFraction unitRef="distributor" contextRef="ifa1d16398d7f44208aa02d08c3991ca4_D20210721-20210721" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNumberOfDefendants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyMDM3NA_af9c2b8b-9689-4894-b87b-9ae47e583db1">three</ix:nonFraction> distributors would pay up to approximately $<ix:nonFraction unitRef="usd" contextRef="ie15c86f3be0f4af2ac4c88a44e20c8ef_D20210721-20210721" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNjA5NQ_31cc8254-16ba-497b-bdd0-bf49f96ad33f">21</ix:nonFraction> billion over <ix:nonNumeric contextRef="ie15c86f3be0f4af2ac4c88a44e20c8ef_D20210721-20210721" format="ixt-sec:duryear" name="mck:LossContingencySettlementAgreementAwardPaymentPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNjExNQ_8c94d338-c2ff-4f44-94c6-4e6fd67326ce">18</ix:nonNumeric> years, with up to $<ix:nonFraction unitRef="usd" contextRef="ifa1d16398d7f44208aa02d08c3991ca4_D20210721-20210721" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNjE0NA_81a017d4-cbdc-4e09-b99e-d87cd61d83a0">7.9</ix:nonFraction> billion to be paid by the Company for its <ix:nonFraction unitRef="number" contextRef="i8ca3354c383c4d99b989e74af58a1b0e_I20210720" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMTczNw_1424e6a1-76eb-4f57-b160-6d52f05dc32b"><ix:nonFraction unitRef="number" contextRef="icd94e17f05724bf4ba48a2eb22b0163b_I20210721" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMTczNw_37b1f8e0-79f6-46f7-92e9-6595dcbb8a37">38.1</ix:nonFraction></ix:nonFraction>% portion; a minimum of <ix:nonFraction unitRef="number" contextRef="icd94e17f05724bf4ba48a2eb22b0163b_I20210721" decimals="2" name="mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyMDQ4Ng_a9f19a80-20e9-47a4-9890-32e20ba91736">85</ix:nonFraction>% of such payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposed agreement would also establish a clearinghouse that would consolidate controlled-substance distribution data from the <ix:nonFraction unitRef="distributor" contextRef="ifa1d16398d7f44208aa02d08c3991ca4_D20210721-20210721" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNumberOfDefendants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyMTc2NA_af9c2b8b-9689-4894-b87b-9ae47e583db1">three</ix:nonFraction> largest U.S. distributors, which will be available to the settling states to use as part of their anti-diversion efforts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Agreement is subject to contingencies and will not become effective unless the Company determines that (1) following a sign-on period of 30 days, a sufficient number of states have agreed to be bound by the proposed agreement; and, subsequently, (2) following a sign-on period of 120 days, that a sufficient number of states and political subdivisions, including those that have not sued, have agreed to be bound by the agreement (or otherwise had their claims foreclosed).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exact amount that would be due under the proposed agreement depends on several factors, including the participation rate of states and political subdivisions, the extent to which states take action to foreclose opioid lawsuits by political subdivisions, and the extent to which political subdivisions in settling states file additional opioid lawsuits against the Company after the proposed agreement becomes effective. The proposed agreement contemplates that if certain governmental entities do not agree to a settlement under the framework, but the distributors nonetheless conclude that there is sufficient participation to warrant the settlement, there would be a corresponding reduction in the amount due from the Company to account for the unresolved claims of the governmental entities that do not participate. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This settlement process only addresses the claims of U.S. state attorneys general and political subdivisions in participating states. The West Virginia subdivisions and Native American tribes are not part of this settlement process. The proposed agreement provides that the Company will place its first annual payment, estimated to be approximately $<ix:nonFraction unitRef="usd" contextRef="i47e3cbf548f448a6aac81a1abd64fb0b_D20210721-20210930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMzAwMQ_ae0f6f08-5490-4bf0-8485-fbfc588fab30">482</ix:nonFraction>&#160;million, into escrow on or before September 30, 2021, to be disbursed when and if the proposed agreement becomes effective. Subsequent payments would be due on July 15 of each year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 20, 2021, the Company announced that it and the <ix:nonFraction unitRef="distributor" contextRef="icd94e17f05724bf4ba48a2eb22b0163b_I20210721" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberOfOtherDefendants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyNzA3MQ_5b9ee651-5a11-475e-8fcf-629cfb5e81b2"><ix:nonFraction unitRef="distributor" contextRef="i8ca3354c383c4d99b989e74af58a1b0e_I20210720" decimals="INF" format="ixt-sec:numwordsen" name="mck:LossContingencyNumberOfOtherDefendants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyNzA3MQ_9487d9df-5bcf-4c86-9b4f-11cad846dcfd">two</ix:nonFraction></ix:nonFraction> other national pharmaceutical distributors had agreed to pay up to $<ix:nonFraction unitRef="usd" contextRef="i909c1a4a44c746a4977ccb484c3c8edf_D20210720-20210720" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyNzA3NQ_e2bd209d-b4fb-427a-9e22-098fd2b2cb7e">1.2</ix:nonFraction>&#160;billion, of which the Company&#8217;s portion would be <ix:nonFraction unitRef="number" contextRef="i8ca3354c383c4d99b989e74af58a1b0e_I20210720" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMTgxNQ_1424e6a1-76eb-4f57-b160-6d52f05dc32b"><ix:nonFraction unitRef="number" contextRef="icd94e17f05724bf4ba48a2eb22b0163b_I20210721" decimals="3" name="mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMTgxNQ_37b1f8e0-79f6-46f7-92e9-6595dcbb8a37">38.1</ix:nonFraction></ix:nonFraction>%, in a settlement with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that New York and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework, as well as certain attorneys&#8217; fees and costs. If the broad settlement is finalized, New York and its participating subdivisions will become part of that broader agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that a broad settlement of opioid claims by governmental entities is probable, and that the loss related thereto can be reasonably estimated. The Company recorded a charge of $<ix:nonFraction unitRef="usd" contextRef="iadd28ed11a014305be6b12b7cad3adab_D20200401-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNzc1MA_492b00af-04ad-4e61-bed9-954f48bda804">8.1</ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="iadd28ed11a014305be6b12b7cad3adab_D20200401-20210331" decimals="-5" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNzc1NA_e43492cc-b78e-455f-a690-c7a44c5171c5">6.8</ix:nonFraction> billion after-tax) in the fiscal year ended March 31, 2021 related to its share of the global settlement as well as claims of West Virginia municipalities and the Native American tribes. In connection with the matters described above, the Company recorded additional charges of $<ix:nonFraction unitRef="usd" contextRef="id5cbe1ba860d47aaa8b10c167bd7e101_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyOTg2OQ_3a4706c5-c219-42f9-98ec-848a062369ce">74</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="id5cbe1ba860d47aaa8b10c167bd7e101_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyOTg4Mg_22444da2-35c3-4939-b71e-863819a21bec">61</ix:nonFraction>&#160;million after-tax) in the quarter ended June 30, 2021 within &#8220;Claims and litigation charges, net&#8221; in the Condensed Consolidated Statements of Operations, including a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="ia1f6e17a404c4e1692e1e7ec1023c177_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMTg2Mw_2fc60270-86cb-4ce3-9071-38b4dfab6650">27</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="ia1f6e17a404c4e1692e1e7ec1023c177_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMTkwMA_c18f9341-549a-4dd9-b45f-f2335d9dfd7c">22</ix:nonFraction>&#160;million after-tax) related to the settlement with New York and its participating subdivisions, and a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i570f356eb38c49d788e8a9f41b36575c_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMjA2MA_f7421756-3d78-4bd0-84c0-d93c429f5db2">47</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="i570f356eb38c49d788e8a9f41b36575c_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMjA3Mw_f8720c55-0924-4113-9d61-ff274d7a29ed">39</ix:nonFraction>&#160;million after-tax) related to the proposed settlement agreement with state and local governmental entities.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="id188a3e585844b3ebdee0b496e0162a7" continuedAt="ie55a1d85846e462a9c72e98803ef87ac"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMzI5ODUzNDk3NzU2NQ_b8ddf9ea-5bf2-41da-93f9-0d3a2a2d0d5d" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s estimated accrued liability for opioid-related claims of governmental entities, including the $<ix:nonFraction unitRef="usd" contextRef="i47e3cbf548f448a6aac81a1abd64fb0b_D20210721-20210930" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMzQxMQ_ae0f6f08-5490-4bf0-8485-fbfc588fab30">482</ix:nonFraction>&#160;million initial payment under the proposed settlement agreement, is as follows as of June 30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4466b2bd90eb4851915c2314922946d0_I20210630" decimals="-6" name="us-gaap:LossContingencyAccrualCarryingValueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RhYmxlOmUwYTU4MmE3NGJiMzQxNmI5NWViMjc5NTMwODg4OGMyL3RhYmxlcmFuZ2U6ZTBhNTgyYTc0YmIzNDE2Yjk1ZWIyNzk1MzA4ODg4YzJfMS0xLTEtMS0xMjkyMA_8eae0f26-b138-40fb-b626-55107d3a287d">545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4466b2bd90eb4851915c2314922946d0_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualCarryingValueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RhYmxlOmUwYTU4MmE3NGJiMzQxNmI5NWViMjc5NTMwODg4OGMyL3RhYmxlcmFuZ2U6ZTBhNTgyYTc0YmIzNDE2Yjk1ZWIyNzk1MzA4ODg4YzJfMi0xLTEtMS0xMjkyMA_824cfaa2-71d3-4ded-ba56-7bbc2a1e8375">7,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4466b2bd90eb4851915c2314922946d0_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RhYmxlOmUwYTU4MmE3NGJiMzQxNmI5NWViMjc5NTMwODg4OGMyL3RhYmxlcmFuZ2U6ZTBhNTgyYTc0YmIzNDE2Yjk1ZWIyNzk1MzA4ODg4YzJfNC0xLTEtMS0xMjkyMA_af1b9d96-fd59-4c2b-abe8-558e990bec94">8,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This amount, recorded in &#8220;Other accrued liabilities&#8221; on the Condensed Consolidated Balance Sheet, is the amount estimated to be paid prior to June 30, 2022.</span></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a broad settlement is not reached under the proposed agreement, litigation will continue. The Company continues to prepare for trial in these pending matters, and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as <ix:nonFraction unitRef="case" contextRef="ib81d4fa67aed495cbee1685f6ef28fcc_I20210630" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMzI5ODUzNDk3NzU2Nw_bf226e2d-cdc2-4542-9d07-c48cb7b4247d">3</ix:nonFraction> cases brought in Canada (<ix:nonFraction unitRef="case" contextRef="if9ed7575e2c84fb79c4efda8cfe8f99c_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMzI5ODUzNDk3NzU4Mg_53f8edda-9bf0-4699-9771-dcc50039767e">two</ix:nonFraction> by governmental entities and <ix:nonFraction unitRef="case" contextRef="i15595dc6958149c891a687ee33e881b7_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMzI5ODUzNDk3NzU3NA_f19558b0-a042-4744-8814-3519033c0b0a">one</ix:nonFraction> by an individual). These claims, and those of private entities generally, are not included in the settlement framework for governmental entities, or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. One such case brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court seeks to recover for damages allegedly arising from their family members&#8217; abuse of prescription opioids; trial in that case is scheduled to begin in October 2021. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poppell v. Cardinal Health, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CE19-00472. The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with any potential settlement arrangement or other resolution of all of these opioid-related litigation matters, including the uncertain scope of participation by governmental entities in any potential settlement under the framework described above, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company was served with two qui tam complaints filed by the same two relators alleging violations of the federal False Claims Act, the California False Claims Act, and the California Unfair Business Practices statute based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19-cv-2233, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State of California ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CGC-19-576931. The complaints seek relief including treble damages, civil penalties, attorney fees, and costs in unspecified amounts. On February 16, 2021, the court in the federal action dismissed the second amended complaint with prejudice, and the relators appealed the dismissal to the U.S. Court of Appeals for the Ninth Circuit. On June 28, 2021, the court in the state action dismissed the complaint with prejudice.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ie55a1d85846e462a9c72e98803ef87ac"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 5, 2018, the Company&#8217;s subsidiary, RxC Acquisition Company (d/b/a RxCrossroads), was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in July 2017 in the United States District Court for the Southern District of Illinois by a relator against RxC Acquisition Company, among others, alleging that UCB, Inc. provided illegal &#8220;kickbacks&#8221; to providers, including nurse educator services and reimbursement assistance services provided through RxC Acquisition Company, in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. CIMZNHCA, LLC v. UCB, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 17-cv-00765. The complaint sought treble damages, civil penalties, and further relief. The United States and the states named in the complaint declined to intervene in the suit. On December 17, 2018, the United States filed a motion to dismiss the complaint in its entirety; this motion was denied on April 15, 2019. On June 7, 2019, the court denied the United States&#8217; motion for reconsideration. On July 8, 2019, the United States appealed to the United States Court of Appeals for the Seventh Circuit seeking interlocutory review of the denial of its motion for reconsideration of the denial of the motion to dismiss the complaint. On September 3, 2019, the United States District Court for the Southern District of Illinois stayed the district court proceedings pending the appeal. On August 17, 2020, the Seventh Circuit reversed the district court&#8217;s decision on the United States&#8217; motion to dismiss and remanded the case with instructions that the district court enter judgment for the defendants on the relator&#8217;s claims under the False Claims Act. The relator sought a re-hearing en banc at the Seventh Circuit, which was denied. The relator&#8217;s False Claims Act case was dismissed, with judgment entered in favor of the defendants on September 30, 2020. On February 10, 2021, the relator filed a Petition for Writ of Certiorari at the United States Supreme Court seeking review of the Seventh Circuit&#8217;s ruling; that petition was denied on June 28, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2021, the Norwegian Competition Authority carried out an inspection of Norsk Medisinaldepot AS regarding alleged sharing of competitively sensitive information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the United States Department of Justice served a Civil Investigative Demand on the Company seeking documents related to distribution arrangements for ophthalmology products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV. State Opioid Statutes</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory or industry measures to address the misuse of prescription opioid medications could affect the Company&#8217;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#8220;OSA&#8221;) which required the creation of an aggregate $<ix:nonFraction unitRef="usd" contextRef="i2a53a7efe6f64eb58432e009a3da7d7d_I20180430" decimals="INF" format="ixt:numdotdecimal" name="mck:OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMTc3MTI_be84a43c-c08b-4816-8911-d734196679b4">100</ix:nonFraction>&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Company has accrued a $<ix:nonFraction unitRef="usd" contextRef="ia7c806eed28f452681024ccfb6d0ba58_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMTg1MTg_8f7ac982-38a1-4cee-8f5a-4d8735fabfb2">50</ix:nonFraction>&#160;million pre-tax charge ($<ix:nonFraction unitRef="usd" contextRef="ia7c806eed28f452681024ccfb6d0ba58_I20210630" decimals="-6" format="ixt:numdotdecimal" name="mck:LossContingencyAccrualAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMTg1Mzc_58e20590-1d2a-46d7-8081-73145b87fa7b">37</ix:nonFraction>&#160;million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2021 and in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheet as of March 31, 2021. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing en banc with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. The petition was filed on May 17, 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_79"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNTM1Mw_f0fc0953-dd63-469b-8a4b-38baac22acfa" continuedAt="i6823ed0b82b443a69269e618d688e900" escape="true">Stockholders' Equity (Deficit) </ix:nonNumeric></span></div><ix:continuation id="i6823ed0b82b443a69269e618d688e900" continuedAt="i7287026d6b5a4ce38adc84b8f0a34d42"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted <ix:nonFraction unitRef="vote" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="mck:CommonStockVotingRightsNumberofVotesPerCommonShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNzk_0c767056-668f-45e7-88af-5276f1806ea6">one</ix:nonFraction> vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company raised its quarterly dividend from $<ix:nonFraction unitRef="usdPerShare" contextRef="ie4f9f1cff0f944b581c9e22ae2cafe95_D20210722-20210722" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzAy_34e2c435-b44e-4492-9981-1ab75496adf0">0.42</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="i0bb253bd3d3a47dabfafb9011d880dc1_D20210723-20210723" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzA4_f11d1d95-1fb0-4453-8ea8-a3c1851bd661">0.47</ix:nonFraction> per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $<ix:nonFraction unitRef="usd" contextRef="i326582e2cec94f4596b88b8eac101ee1_D20210501-20210531" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMTA0NDUzNjA0Nzg5MTU_246d0b12-3864-4553-be06-d4171caefb78">1.0</ix:nonFraction>&#160;billion of the Company&#8217;s common stock. Pursuant to the ASR agreement, the Company paid $<ix:nonFraction unitRef="usd" contextRef="i326582e2cec94f4596b88b8eac101ee1_D20210501-20210531" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMTA0NDUzNjA0Nzg5ODk_246d0b12-3864-4553-be06-d4171caefb78">1.0</ix:nonFraction>&#160;billion to the financial institution and received an initial delivery of <ix:nonFraction unitRef="shares" contextRef="i7ee5de63e94947cf8f40df8a36d1d075_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMTA0NDUzNjA0NzkwNTg_036f0c46-6266-4ede-a8df-3df8d18bc947">4.3</ix:nonFraction> million shares in May 2021. The transaction will be completed during the second quarter of 2022, at which point the Company expects to receive additional shares. There were <ix:nonFraction unitRef="shares" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNzY5NjU4MTQxMDI4Mw_fd919c41-d545-4722-aef8-fa030c6af557">no</ix:nonFraction> share repurchases during the three months ended June 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Board approved an increase of $<ix:nonFraction unitRef="usd" contextRef="i4eda871b01a9492083d9a7ace055a4bd_I20210131" decimals="INF" format="ixt:numdotdecimal" name="mck:StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMTA0NDUzNjA0NzgzMjk_75ffe220-f29c-43a7-a284-e07ae00a38e6">2.0</ix:nonFraction> billion for the authorized share repurchase of McKesson&#8217;s common stock. The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock at June 30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMTA0NDUzNjA0Nzg0MTI_73f0aff2-cdde-47f0-bfc1-01a3d2925547">1.8</ix:nonFraction> billion.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="i7287026d6b5a4ce38adc84b8f0a34d42" continuedAt="ia6403969a2e640818e50df4620888416"><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Comprehensive Income (Loss)</span></div><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNTM1OQ_65da3b62-1ea6-4f14-ac9d-e1038efd38ff" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.163%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.258%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments arising during period, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMy0wLTEtMS0wL3RleHRyZWdpb246ZDk3MDYxNWQzZGQ3NGUyZjk1MDEyM2E1MDJjYzY5ZjdfOTc_0e61fa54-1c8a-4073-a3d1-d8f01728b409">zero</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMy0wLTEtMS0wL3RleHRyZWdpb246ZDk3MDYxNWQzZGQ3NGUyZjk1MDEyM2E1MDJjYzY5ZjdfMTAx_fa3f08fe-aacf-46ce-8246-f44f0d3ad5f1">zero</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMy01LTEtMS0w_c66a428b-bc51-4222-8887-48058e451fd6">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMy03LTEtMS0w_6c8278f5-9f7e-45f0-a626-4305ef5db83f">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNC0wLTEtMS0wL3RleHRyZWdpb246MDUzZWFiMGRiYzM5NDU2ZmI3OGI1NzMyMzJmZjNkZWZfNjc_35058cbb-6d8f-4b12-9b90-bb62d0457eb9">zero</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNC0wLTEtMS0wL3RleHRyZWdpb246MDUzZWFiMGRiYzM5NDU2ZmI3OGI1NzMyMzJmZjNkZWZfNzE_9fc7905b-670a-479a-95c0-081acedc2f08">zero</ix:nonFraction></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNC01LTEtMS0w_738974cb-3e8d-4ed2-800f-c78370e3fa69">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNC03LTEtMS0w_2f366f34-79e5-4496-b84e-37b6cfead65f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNS01LTEtMS0w_3caaf5ce-2244-49aa-ada9-8993ce29f088">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNS03LTEtMS0w_251668a2-ac31-457d-afc7-f94d61d965e4">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on net investment hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on net investment hedges arising during period, net of income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNy0wLTEtMS0wL3RleHRyZWdpb246ZWIxYjlmYWY0OThmNDBlNDhkMjEzZTcxNWI4ZGFmZDFfOTk_8bfcf0da-1ae9-4cff-ae6c-21d87dd12f39">6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNy0wLTEtMS0wL3RleHRyZWdpb246ZWIxYjlmYWY0OThmNDBlNDhkMjEzZTcxNWI4ZGFmZDFfMTAz_86c7a0bc-7b2d-4faa-9872-49509e90a5c3">22</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNy01LTEtMS0w_a1a800db-c088-4edc-804d-22f77ab31f1f">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNy03LTEtMS0w_c229bde4-9bf2-4cb8-8a70-d911a6cbaf71">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfOC0wLTEtMS0wL3RleHRyZWdpb246ZmYxZTE3ODMzN2VlNDIzYmIxMjdmY2FhMzg4MTQyMjJfNjc_d2d8677c-d9ff-4044-a8a4-ba449c727c81">zero</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfOC0wLTEtMS0wL3RleHRyZWdpb246ZmYxZTE3ODMzN2VlNDIzYmIxMjdmY2FhMzg4MTQyMjJfNzE_e24b5eaf-8fa2-4e7b-85bf-6ed35537261a">zero</ix:nonFraction></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfOC01LTEtMS0w_9d44c605-82bc-47f8-bbae-3c49c6c28047">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfOC03LTEtMS0w_48810358-e55a-442f-9c53-9f66a6dd75cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfOS01LTEtMS0w_75289773-4486-4717-b487-591feeef6686">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfOS03LTEtMS0w_6b8628b3-3b2d-4f5b-8bb8-aff5f919e118">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on cash flow hedges</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on cash flow hedges arising during period, net of income tax benefit of <ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmQzMWMzMTQ3ZGVkYjQ5YWJhZDRjOWUzNjg3YjYzNjE3XzExMg_7068d8c7-e46c-464c-9154-fe525d301507">zero</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmQzMWMzMTQ3ZGVkYjQ5YWJhZDRjOWUzNjg3YjYzNjE3XzExNg_4f19f6c0-216e-4129-ae71-647b53f552e2">zero</ix:nonFraction></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTEtNS0xLTEtMA_d6c0b4d6-29f9-4faf-b16d-f7b50c290cb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTEtNy0xLTEtMA_60944f49-1904-4d78-93ad-43dc3e8918c5">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmY2NTcxNzBiYTAyMzRkMWVhNmNiOTk3NTJmODhlMWY0XzY3_b2a1e38d-3b34-41ee-b6ca-b2eb856015b4">zero</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmY2NTcxNzBiYTAyMzRkMWVhNmNiOTk3NTJmODhlMWY0Xzcy_16acfe77-f92e-4c10-9ef8-207bd97e8867">zero</ix:nonFraction></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTItNS0xLTEtMA_7594d702-ae83-4c19-8e28-1b9a0e5e84e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTItNy0xLTEtMA_6e156fce-94f6-4750-8106-4abf1cd98644">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTMtNS0xLTEtMA_1825dfdb-a4f9-4e43-96b2-fc975590a073">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTMtNy0xLTEtMA_38000b67-0d45-4851-ba46-367f9c8074b8">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain and prior service cost arising during the period, net of income tax expense of <ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjkzMTQ1YWQwNzgxYzQ3NWQ4ZTdmZDMzZTgzNTEyMGJiXzEwMg_5574ae9f-1e76-4470-b158-6f3192c7672b">zero</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjkzMTQ1YWQwNzgxYzQ3NWQ4ZTdmZDMzZTgzNTEyMGJiXzEwNg_5767e066-5b5d-4efa-8dc8-9153e44af620">zero</ix:nonFraction></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i683faa57c1154143bdcceac4cfc4f4be_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTUtNS0xLTEtMA_cdeeaed3-a626-4214-8f71-ba5aa890049a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5add2ae2ff484cb1a39c941a288349b2_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTUtNy0xLTEtMA_fb033b33-4d00-46d3-8d8e-cdc0557f5901">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain (loss), prior service cost and transition obligation, net of income tax benefit expense of <ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOmNhNjhjMGE2YzBlMjRkMjY4ODMzYzcxYWUxNGE0NzNlXzExMQ_5f7f7ae0-a3f5-4ca6-92f9-53d2c13ff727">zero</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOmNhNjhjMGE2YzBlMjRkMjY4ODMzYzcxYWUxNGE0NzNlXzExNQ_d52bd485-cda1-4b79-9387-8b9432c7feff">zero</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78e5d212e61b44749ee2c344ba273205_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTYtNS0xLTEtMA_6ab0a528-7cc5-41b5-988e-3137565f729e">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic34f3a349fc24b3d947bac4654010cb5_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTYtNy0xLTEtMA_ae9ee35a-220f-4483-b41c-34f753e85a2f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other, net of income tax benefit of <ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjRiZGU5Yjk1NTE3NTQxMTNiMjliYTEzZWFiMTgxYjQ1Xzg1_b54a12cf-b0db-4768-ac0d-e692844efec9">zero</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjRiZGU5Yjk1NTE3NTQxMTNiMjliYTEzZWFiMTgxYjQ1Xzg5_18b62431-d85f-44e6-89d5-6b0679f5a062">zero</ix:nonFraction></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia069814e274d4623bfb7a2f2d90124b4_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTctNS0xLTEtMA_bb66c669-cc3b-43f0-998e-c04a6808ca44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifeb84bdd46314ab589c286f47e9fbff3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTctNy0xLTEtMA_fe7f4a53-5eae-4e30-9a49-80d936b4ad3c">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax benefit of $<ix:nonFraction unitRef="usd" contextRef="i7580c94982c04c6db55b6b8d11dd6efe_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjU2NTQxZDkxZDMwZjRjY2Q4NzBlODZiMDEyMmM5YTY4XzY3_d073e2c4-221e-455a-9d49-cec70b52f2bb">1</ix:nonFraction> and <ix:nonFraction unitRef="usd" contextRef="i0e4d013ff96647e297facf5a8709f13e_D20200401-20200630" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjU2NTQxZDkxZDMwZjRjY2Q4NzBlODZiMDEyMmM5YTY4Xzcx_284b1dda-2ea8-47aa-a6bb-d1a26bdf64a1">zero</ix:nonFraction></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7580c94982c04c6db55b6b8d11dd6efe_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTgtNS0xLTEtMA_a7bd7011-7b6f-449b-b9d3-6e205266cf2c">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e4d013ff96647e297facf5a8709f13e_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTgtNy0xLTEtMA_4f382d37-4564-4ea6-8cbc-856de169ece9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7580c94982c04c6db55b6b8d11dd6efe_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTktNS0xLTEtMA_c419eadb-9a4a-4388-be62-7af9dd19164f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e4d013ff96647e297facf5a8709f13e_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTktNy0xLTEtMA_276c05eb-0e26-43f6-bfa2-91a5e2718939">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMjEtNS0xLTEtMA_e8834b00-946d-4d13-8214-4c92acc0d794">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMjEtNy0xLTEtMA_0c494576-fcdc-4213-9713-dcc5cc2a0dc1">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three months ended June 30, 2021 and 2020 includes net foreign currency translation adjustments of $<ix:nonFraction unitRef="usd" contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMjk5Mw_7d1d26cd-7429-46c7-ad96-d9649fdaa29b">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzA4Ng_f78ff415-8b7f-40e9-9418-361ff87f2e83">58</ix:nonFraction> million, respectively, attributable to redeemable noncontrolling interests. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three months ended June 30, 2021 includes foreign currency losses of $<ix:nonFraction unitRef="usd" contextRef="i3252989f4e9143d3a010d05024100a86_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzcyNA_25f7c989-fcad-4b32-a385-13e3a71a4cbb">22</ix:nonFraction> million on the net investment hedges from the &#8364;<ix:nonFraction unitRef="eur" contextRef="ic94ceeda5f8d4c34920ab05d68d536f7_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzc4Nw_407a223c-78fc-42d0-bbab-a8e24de97d19"><ix:nonFraction unitRef="eur" contextRef="i7e80ec0a1e2d4560a4bb44c4d5f4a808_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzc4Nw_780d4e36-0865-4d10-a8f1-88bd4bed7928">1.7</ix:nonFraction></ix:nonFraction> billion&#160;Euro-denominated notes, losses of $<ix:nonFraction unitRef="usd" contextRef="ie2831786f08a4f11887081ccec157fb0_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzg3Mg_43cac93b-262d-4d34-974d-edb381976e3d">5</ix:nonFraction> million on the net investment hedges from cross-currency swaps, and losses on net investment hedges of $<ix:nonFraction unitRef="usd" contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzk5Mg_026c46e6-d6b3-4531-9ee1-f5618123a437">6</ix:nonFraction> million attributable to redeemable noncontrolling interests. The three months ended June 30, 2020 include foreign currency losses of $<ix:nonFraction unitRef="usd" contextRef="i0d1c889a01024ed39200b6381c6e96e7_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNDExMg_fe567143-2c50-4387-8af8-f6a3f51841c2">34</ix:nonFraction> million on the net investment hedges from the &#8364;<ix:nonFraction unitRef="eur" contextRef="i7d7a3c97158f4b2295ecfac3630c7dda_I20200630" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNDE4NA_ac546bc5-5f2a-4290-a3e8-312fa3ecc7c4">1.7</ix:nonFraction> billion Euro-denominated notes and losses of $<ix:nonFraction unitRef="usd" contextRef="id92758a2bb7c4cff8bb23c47c0c1232f_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNDI3Mg_d8da1535-7c9f-4873-b747-a70b3af20449">51</ix:nonFraction> million on the net investment hedges from cross-currency swaps. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three months ended June 30, 2021 and 2020 include net actuarial gains of <ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt-sec:numwordsen" name="mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNDM5Mg_e31f9d11-7a2b-4be0-a617-d86350a9387a">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNTQ5NzU1ODE1NDQ2NQ_b5164b36-09b3-4197-ad5c-b79d0bb929be">3</ix:nonFraction> million, respectively, which are attributable to redeemable noncontrolling interests.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Pre-tax amount was reclassified into &#8220;Cost of sales&#8221; and &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into &#8220;Income tax expense&#8221; in the Condensed Consolidated Statements of Operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ia6403969a2e640818e50df4620888416"><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income (Loss) </span></div><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNTM1Mg_9ad8d806-647a-4c5e-a44c-bf67969fc650" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three months ended June 30, 2021 are as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Losses on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a707105caaf4446872eecd75721360b_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMi0xLTEtMS0w_1b7b32dd-c1f7-4ae7-9ea8-7417db727833">1,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96cab475915a4dbcaae2796d530de73b_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMi0zLTEtMS0w_49a847ee-1c3d-46d8-9b62-4631ef5ff19d">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78d13cdfde3141419e99db6a257de4aa_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMi01LTEtMS0w_bd6d96f0-b355-4f94-966f-306fdcec48de">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i541b64e198c948d092258fb4eb641885_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMi03LTEtMS0w_e565d99b-0df4-467b-9842-40e936b4be41">96</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i29b18210e4c94b3e9eeea079457c3440_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMi05LTEtMS0w_c5f5514d-8415-4a18-9bdd-6ae90b990e9d">1,480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMy0xLTEtMS0w_d9d70446-4047-4917-a5be-945774604032">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMy0zLTEtMS0w_4ebc2a3e-a512-4b9d-9d6c-6c4a61ebd1a0">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMy01LTEtMS0w_764ecf38-9a43-4167-bb44-30e431540edf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMy03LTEtMS0w_e4d8d199-e58e-48a2-8bd3-0349681770d0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMy05LTEtMS0w_c4693b25-251c-454b-b1c8-7706f1e08386">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNC0xLTEtMS0w_b2937426-ad8d-456c-b88d-ece077c34b6f">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNC0zLTEtMS0w_db1cc371-5d08-46ce-879b-83a4015b4436">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNC01LTEtMS0w_2ba15a13-b338-4cbe-a4d2-fb546604e1fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNC03LTEtMS0w_0fdccbf9-0086-449d-bbe3-e73daa47b907">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNC05LTEtMS0w_a72d9672-4695-4dce-8a7b-f894f573f163">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNS0xLTEtMS0w_f36cfab7-f888-4432-806c-e26468252b1c">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNS0zLTEtMS0w_d60d1813-c2e4-4e66-bd66-aed4022ba448">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNS01LTEtMS0w_32490bb6-0cab-49a7-9263-c20419bb0e68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNS03LTEtMS0w_97c7f5ee-a455-4865-98c6-a5e6e2d40eab">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNS05LTEtMS0w_3ed239d9-6de1-4cf9-be2c-ad911a6212e5">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNi0xLTEtMS0w_5ac354bd-80fb-4fd2-88c9-648417725868">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNi0zLTEtMS0w_7e12559a-d985-4a2c-ad7c-b18aabc45ad5">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNi01LTEtMS0w_d283ee41-b247-43c5-939a-1d488faa8542">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNi03LTEtMS0w_63812d1e-7509-4dfc-99ee-46df700bad16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNi05LTEtMS0w_4e26f1e5-149f-4019-83b1-3005c9c5334e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNy0xLTEtMS0w_13ca6ec7-d06f-477d-bcee-5a2514586bdd">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNy0zLTEtMS0w_c2ca58ee-b3d9-47c6-a1ba-3e9caf7c140c">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNy01LTEtMS0w_9bc8c1d8-7f5c-4592-af8d-c373b5ff916d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNy03LTEtMS0w_7278cbb9-f37e-4c31-b7cd-7c2ed13c5e04">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNy05LTEtMS0w_ed8f6d1b-4f84-4675-97db-bb7aa85295cb">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC0xLTEtMS0xMDg5Mg_e29bfadc-53b8-4371-9512-f2995e00bc5e">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC0zLTEtMS0xMDg5NQ_545a8be7-1f23-44d9-a9db-49e09eff6928">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC01LTEtMS0xMDg5OA_d1256b91-270f-48ac-90ed-f45a5090e754">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC03LTEtMS0xMDkwOA_e8841d27-5411-485a-99a4-cf48bcb16c14">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c03ab80e93f47289af42a50526f49e2_D20210401-20210630" decimals="-6" sign="-" name="mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC05LTEtMS0xMDkxMA_f264acae-f056-4f31-99a2-2a27c5262a96">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9a959a0c7b148a38c6b8331c113e2cf_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC0xLTEtMS0w_8951256d-96e6-46b1-85ea-26faf44ee96d">1,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76038b5bf32948138203a73d85210e1e_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC0zLTEtMS0w_c482c1a5-eb17-4aa4-a9a5-53ca2c230085">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18ebdcc4b1e44eea804b218171e8f605_I20210630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC01LTEtMS0w_c44b9f3e-452f-4f09-9a98-f9f1d594df82">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20557e420ca347deb38e35cfe75e2f15_I20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC03LTEtMS0w_dd90959b-b4d5-4761-a3f5-24b17e8482d5">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8466c6d9312243f598d0a021cf047894_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC05LTEtMS0w_e4558b42-bf05-4ffa-a5de-ecb280b817db">1,627</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three months ended June 30, 2020 are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf2ebdbafd554d41a758ebc6b7078157_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMi0xLTEtMS0w_e7a22dc2-aa83-4994-a5fe-2073cfc6340c">1,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bbc1cd6847947c1857128d50574b91f_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMi0zLTEtMS0w_426acfbd-1d94-42ea-af25-46053e05c214">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5e06f9d71a142728e7dd68ecedc7eb7_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMi01LTEtMS0w_aa75eb3e-4048-461b-a2b1-1b93e193d932">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia79b569c95894cf8af0a2bce6c0e7a42_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMi03LTEtMS0w_c5c59a7b-6ca4-4ea7-b4e0-dd12515fa656">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i755d7f41b47e492b8cb1bb239e98220c_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMi05LTEtMS0w_522d69ac-5782-49b7-9480-06b8898fa65a">1,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMy0xLTEtMS0w_ede8f8b3-601c-4d7f-8173-30e606f58411">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMy0zLTEtMS0w_a8ce6aab-e899-4c5c-859a-9b8b9a5eb38a">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMy01LTEtMS0w_46273a19-4ade-48e4-853c-de84ab3dc3b0">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6258d106eb74184a1fa0a7767f79b2f_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMy03LTEtMS0w_94422eff-c573-4589-9530-493b0f52f35e">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMy05LTEtMS0w_9e8cfde9-9900-4c6b-9945-91997b5160df">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNC0xLTEtMS0w_ffd17850-0bd3-4b16-b3eb-dab0ccfbfd5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNC0zLTEtMS0w_17579710-1c66-4cbf-b756-d873fab1fd87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNC01LTEtMS0w_76a4f8c1-8e6c-4374-81e5-3e2b032a4820">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6258d106eb74184a1fa0a7767f79b2f_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNC03LTEtMS0w_23ebcb65-7c64-4e92-8afe-a6c7c43f1bdb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNC05LTEtMS0w_659f6f4f-2d27-4863-a481-e1d5d327e4f4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNS0xLTEtMS0w_c01470d9-08cf-4ccd-a807-aba9c66031a7">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNS0zLTEtMS0w_ab56f417-c4f5-4046-ad43-7d49f6004657">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNS01LTEtMS0w_97be3ec3-2f95-41b8-adc3-7140823477ff">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6258d106eb74184a1fa0a7767f79b2f_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNS03LTEtMS0w_5a888a23-4b55-4d34-b59e-c10f7064d8b9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNS05LTEtMS0w_3381c8e1-4d3a-4ba7-992b-ce47910b9ca7">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNi0xLTEtMS0w_3bb24f2b-c108-419f-a2cd-e41323776e28">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNi0zLTEtMS0w_a8505aeb-2202-430b-89dc-d285a5d96539">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNi01LTEtMS0w_b9c6fd58-e57c-4db6-b330-ae6cf97f2cc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6258d106eb74184a1fa0a7767f79b2f_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNi03LTEtMS0w_7762746e-9d28-4381-89f3-a4fccd86fa9a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNi05LTEtMS0w_b48643c6-f38c-4650-a1e6-80c7a29e5169">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNy0xLTEtMS0w_cf4055bc-a1e1-46f4-a0b6-03757ba2d8a1">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNy0zLTEtMS0w_423ebc36-90db-4ff8-a61a-ce5a2e38ef53">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNy01LTEtMS0w_a5476ea7-7933-461a-8947-59ca917b3232">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6258d106eb74184a1fa0a7767f79b2f_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNy03LTEtMS0w_27981dce-fb35-4c15-b78d-8b5dadc4f6a1">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNy05LTEtMS0w_276ae825-1555-42d2-92dc-b0e33f16e139">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c68e3755f574f668c6f9e3736c38803_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfOC0xLTEtMS0w_5d194d0a-78d9-402c-ba17-e7354e8bfc32">1,742</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edd1ad0f24086a0af0cd0897714c5_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfOC0zLTEtMS0w_6943764b-7d2b-409f-8db2-2dc0d934077c">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d84fa2b48714007ba888640e7295e09_I20200630" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfOC01LTEtMS0w_a82015b0-8bd8-41ae-944e-7133d027e0da">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafaf876b672949d4a457c37fb78dcc15_I20200630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfOC03LTEtMS0w_14403d3b-1a66-48ae-967a-a5a3ba618e76">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c849ded324459ca97d3b31b68b0bd6_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfOC05LTEtMS0w_6d41cf9b-0ff9-40e8-97a7-ab3699f43f0b">1,735</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_82"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfODAwMw_309f7dc7-f48a-4839-9f27-09d1802b467f" continuedAt="iee8e5b710d3f4acc88743637d2fe7d03" escape="true">Segments of Business</ix:nonNumeric></span></div><ix:continuation id="iee8e5b710d3f4acc88743637d2fe7d03" continuedAt="ic8f4ceb844664199b9dca31c23dafa15"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing with the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in <ix:nonFraction unitRef="segment" contextRef="i09d8587e16084bb098356d7c27d734c0_D20200701-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1MTc2Ng_318febcf-bcb7-43f9-a5cb-6b6118ef182a">four</ix:nonFraction> reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment unifies the solutions and services of CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation to serve biopharma and life sciences partners and patients. By combining automation and expert navigation of the healthcare ecosystem, RxTS connects pharmacies, providers, payers, and biopharma to address patients&#8217; medication access, adherence, and affordability challenges to help people get the medicine they need to live healthier lives. RxCrossroads was previously included in the former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and McKesson Prescription Automation were previously included in Other.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than <ix:nonFraction unitRef="product" contextRef="ic5004bc3d244470f87a0e4366f016d4c_I20210630" decimals="-3" format="ixt:numdotdecimal" name="mck:NumberOfNationalBrandMedicalSurgicalProducts" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMzI5ODUzNDkwMjkxMQ_d845094b-ecea-40dc-8f30-1c572f3d8863">275,000</ix:nonFraction> national brand medical-surgical products as well as McKesson&#8217;s own line of products through a network of distribution centers within the United States.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in <ix:nonFraction unitRef="country" contextRef="i102de3e4924b431f90a2f289213c9b87_I20210630" decimals="INF" name="us-gaap:NumberOfCountriesInWhichEntityOperates" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1MTc2Mg_2a994c98-0117-4162-a9ba-d8a6eeeb04cd">12</ix:nonFraction> European countries where it owns, partners, or franchises with retail pharmacies and operates through <ix:nonFraction unitRef="business_operation" contextRef="i102de3e4924b431f90a2f289213c9b87_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="mck:NumberOfBusinessOperations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMzI5ODUzNDkwMjkwNw_ccad910e-e54c-426b-9397-418ca3333f17">two</ix:nonFraction> businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology services throughout Canada and includes Rexall Health retail pharmacies. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other. In the second quarter of 2022, the Company entered into an agreement to sell certain of its Europe businesses, primarily located in France, Italy, Ireland, Portugal, Belgium, and Slovenia. The sale also includes the Company&#8217;s German headquarters and wound-care business, business center in Lithuania, and an ownership stake in its joint venture in the Netherlands. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for more information.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL NOTES (CONCLUDED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><ix:continuation id="ic8f4ceb844664199b9dca31c23dafa15" continuedAt="i097636a5eb8c464a928e0739bb8e7f9d"><ix:nonNumeric contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfODAwNQ_d814627c-fffd-434e-99c7-18655b371cea" continuedAt="i84fdd4f2e76a466a9f10426c01cab497" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:77.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.843%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c2064f2c8eb49c3849453a95a9c86c4_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMy0xLTEtMS0w_03d9030d-5b64-4997-b52a-e10c538bd696">50,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba260eba8e74ac5a3c690150d88e82e_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMy0zLTEtMS0w_ac8fd5d8-e472-4d29-8e55-aa751ad9dadc">44,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82edf712cf2f4662ac55525b3410634f_D20210401-20210630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfNC0xLTEtMS0yNTE2_f44be8a8-f2a5-4b17-a920-96be1eb60a41">881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6affa371637042a0beed138683334e5c_D20200401-20200630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfNC0zLTEtMS0yNTE2_78a77e35-358a-4660-ac36-6f0b12cd689e">656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032911e077b3421889a6ddae5be68041_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfNS0xLTEtMS0w_8bb28e8d-24cc-4f6a-ba3d-56b4c0828727">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcaabd55fcc24731b0b6daa24a824ce3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfNS0zLTEtMS0w_cc4fcdef-63d0-4888-a73f-519b86215672">1,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c475719e1e54e988a2716b400ad19c8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfNi0xLTEtMS0w_1562028f-0fe6-479e-bc94-8f356f348691">9,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47e37dbe4a284e4dbcd7fb304b436339_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfNi0zLTEtMS0w_7f2b6d56-935e-4f02-866e-fd0a6fb190c5">8,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfOC0xLTEtMS0w_0652d326-146b-4129-939e-df5fcaeb98a0">62,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfOC0zLTEtMS0w_c75a18ff-a2b9-42c1-a4f8-ddae9a68ec95">55,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c2064f2c8eb49c3849453a95a9c86c4_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTEtMS0xLTEtMA_b3bf2db3-17ff-4024-bbe0-7d5d0ddd2c58">682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idba260eba8e74ac5a3c690150d88e82e_D20200401-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTEtMy0xLTEtMA_26ccfdbe-c056-42fe-b42f-3225fdfc8ecc">613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82edf712cf2f4662ac55525b3410634f_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTItMS0xLTEtMjUyOQ_a3e03b23-4dea-44d4-b7bb-bc93d658e380">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6affa371637042a0beed138683334e5c_D20200401-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTItMy0xLTEtMjUyOQ_6cd1c295-2963-4aa4-9c64-890431152aeb">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032911e077b3421889a6ddae5be68041_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTMtMS0xLTEtMA_544352d5-7c03-4173-9780-e53a6e17b387">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcaabd55fcc24731b0b6daa24a824ce3_D20200401-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTMtMy0xLTEtMA_4b68cd29-e7ea-4f87-97b0-e567b431f25d">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c475719e1e54e988a2716b400ad19c8_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTQtMS0xLTEtMA_700b5bfe-0b54-45fb-9ce4-a14f82bea29a">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47e37dbe4a284e4dbcd7fb304b436339_D20200401-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTQtMy0xLTEtMA_b6433cc1-dd77-453c-8472-83f2fa28896d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie40bd4cb78c741a287b7a02340752d2d_D20210401-20210630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTYtMS0xLTEtMA_d557dbc7-756f-4281-9156-e4e0dbf577bf">914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f85e764ff74422a0b261f62ad59faa_D20200401-20200630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTYtMy0xLTEtMA_c81b951b-dcfe-4c93-adeb-55099fecff30">773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTctMS0xLTEtMA_4bacd687-6f28-42a0-8e86-15f1d907f7fc">303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="mck:CorporateOperatingExpenseandOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTctMy0xLTEtMA_cfa629e1-ef64-4113-944e-00e54a8785f4">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTgtMS0xLTEtMA_75d4b7a5-15f1-40d3-a869-6a62d369e714">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:InterestAndDebtExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTgtMy0xLTEtMA_3d04b349-9c35-4b8b-81cd-2c5316e5ff23">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTktMS0xLTEtMA_d7276f3c-fd6e-4196-9ceb-5c7e71a3fa28">562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTktMy0xLTEtMA_3a87d50e-7900-446b-af2b-e8ebdf649635">645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than <ix:nonFraction unitRef="number" contextRef="i1c2064f2c8eb49c3849453a95a9c86c4_D20210401-20210630" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1MzI3Ng_91e34103-9912-4352-a2d1-c59738aa9c94">1</ix:nonFraction>% of the U.S. Pharmaceutical segment&#8217;s total revenues, approximately <ix:nonFraction unitRef="number" contextRef="i82edf712cf2f4662ac55525b3410634f_D20210401-20210630" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1MzMwNQ_8c93786a-8a59-4ff0-a795-6e786e41dd5f">35</ix:nonFraction>% of the RxTS segment&#8217;s total revenues, less than <ix:nonFraction unitRef="number" contextRef="i032911e077b3421889a6ddae5be68041_D20210401-20210630" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1MzI4NA_11855d46-e39e-4dfb-9fba-d5ce77d00180">2</ix:nonFraction>% of the Medical-Surgical Solutions segment&#8217;s total revenues, and approximately <ix:nonFraction unitRef="number" contextRef="i2c475719e1e54e988a2716b400ad19c8_D20210401-20210630" decimals="2" name="mck:RevenueDerivedFromServicesPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1MzQwOQ_18512bc7-bbae-4d08-bf36-e65de27415b9">7</ix:nonFraction>% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#8217;s reportable segments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three months ended June 30, 2021 and 2020 includes $<ix:nonFraction unitRef="usd" contextRef="i1c2064f2c8eb49c3849453a95a9c86c4_D20210401-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1Mzg0NQ_2e818a88-ad57-4fc9-9e20-f669c196563f">23</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idba260eba8e74ac5a3c690150d88e82e_D20200401-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:InventoryLIFOReservePeriodCharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1Mzg0OQ_6f3d34d3-f955-4843-ae64-ec17b707d02a">52</ix:nonFraction> million, respectively, of credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the three months ended June 30, 2021 includes inventory charges totaling $<ix:nonFraction unitRef="usd" contextRef="i032911e077b3421889a6ddae5be68041_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1NDA2OQ_49d82941-cebc-4691-86e9-3489a8613567">164</ix:nonFraction> million on certain personal protective equipment and other related products.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:continuation id="i097636a5eb8c464a928e0739bb8e7f9d" continuedAt="i860ac0f35a514867a11e1695ee544b71"><ix:continuation id="i84fdd4f2e76a466a9f10426c01cab497" continuedAt="icd14441366f04234ba453f8d11360f59"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the three months ended June 30, 2021 includes charges of $<ix:nonFraction unitRef="usd" contextRef="id5cbe1ba860d47aaa8b10c167bd7e101_D20210401-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMzI5ODUzNDkyNDkzNA_4f66f5b6-7574-45c5-b2ad-8f801cd0b689">74</ix:nonFraction>&#160;million related to the Company&#8217;s estimated liability for opioid-related claims, as discussed in more detail in Financial </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i860ac0f35a514867a11e1695ee544b71"><ix:continuation id="icd14441366f04234ba453f8d11360f59">, &#8220;Commitments and Contingent Liabilities." Corporate expenses, net for the three months ended June 30, 2020 includes a net gain of $<ix:nonFraction unitRef="usd" contextRef="i49c8bc60131d4dedb5a99976b761279b_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1NjcwNQ_6d42b095-f9c3-4370-988f-9c7056784134">131</ix:nonFraction> million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program.</ix:continuation></ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_85"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="ia9b664dd086f4724924e37451951b156_88"></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GENERAL</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of financial condition and results of operations, referred to as the &#8220;Financial Review,&#8221; is intended to assist the reader in the understanding and assessment of significant changes and trends related to the results of operations and financial position of McKesson Corporation together with its subsidiaries (collectively, the &#8220;Company,&#8221; &#8220;McKesson,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; or &#8220;us&#8221; and other similar pronouns). This discussion and analysis should be read in conjunction with the condensed consolidated financial statements and accompanying financial notes in Item 1 of Part I of this Quarterly Report on Form 10-Q and in Item 8 of Part II of our Annual Report on Form 10-K for the fiscal year ended March 31, 2021 previously filed with the Securities and Exchange Commission on May&#160;12, 2021 (&#8220;2021 Annual Report&#8221;).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean our fiscal year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements in this report constitute forward-looking statements. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Cautionary Notice About Forward-Looking Statements&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> included in this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Our Business:</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. We partner with pharmaceutical manufacturers, providers, pharmacies, governments, and other organizations in healthcare to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We implemented a new segment reporting structure commencing with the second quarter of 2021, which resulted in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. All prior segment information has been recast to reflect our new segment structure and current period presentation. Our organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments include the manner in which management evaluates the performance of the Company combined with the nature of individual business activities. We evaluate the performance of our operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes our four reportable segments and the changes made to our reporting structure commencing in the second quarter of 2021. Refer to Financial Note 14, &#8220;Segments of Business,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for further information regarding our reportable segments. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">U.S. Pharmaceutical</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, previously the U.S. Pharmaceutical and Specialty Solutions reportable segment, continues to distribute branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">RxTS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that unifies the solutions and services of CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation to serve our biopharma and life sciences partners and patients. By combining automation and expert navigation of the healthcare ecosystem, RxTS connects pharmacies, providers, payers, and biopharma to address patients&#8217; medication access, adherence, and affordability challenges to help people get the medicine they need to live healthier lives. RxCrossroads was previously included in the former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and McKesson Prescription Automation were previously included in Other.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provides medical-surgical supply distribution, logistics, and other services to healthcare providers in the United States (&#8220;U.S.&#8221;) and was unaffected by the segment realignment.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a reportable segment that includes our operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Summary: </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary provides highlights and key factors that impacted our business, operating results, financial condition, and liquidity for the three months ended June 30, 2021. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Coronavirus disease 2019 (&#8220;COVID-19&#8221;) continues to impact our year over year results. As previously disclosed in our 2021 Annual Report, pharmaceutical distribution volumes decreased across the enterprise during the first quarter of 2021 as a result of the weakened and uncertain global economic environment and COVID-19 restrictions following the onset of the pandemic. We remain in a dynamic environment and volume trends continue to be non-linear. However, the recovery from the pandemic is favorably reflected in our results when comparing 2022 versus 2021. We also had favorable contributions from our COVID-19 vaccine and related ancillary supply kit distribution programs during the first quarter of 2022 and a year over year increase in sales of COVID-19 tests; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In response to the global pandemic, McKesson plans to donate certain personal protective equipment (&#8220;PPE&#8221;) to charitable organizations to assist with COVID-19 recovery efforts. During the first quarter of 2022, we recorded inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment. The majority of these charges are driven by the intent of management not to sell certain excess PPE inventory and instead direct it to charitable organizations. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section included below for further information on COVID-19 and related impacts;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues of $62.7 billion for the three months ended June 30, 2021 increased 13% from the prior year primarily driven by market growth in our U.S. Pharmaceutical segment;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Gross profit increased 12% for the three months ended June 30, 2021 compared to the prior year primarily in our International segment driven by favorable effects of foreign currency exchange fluctuations, and in our U.S. Pharmaceutical segment driven by the contribution from our COVID-19 vaccine distribution program; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total operating expenses for the three months ended June 30, 2021 includes charges of $74 million related to our estimated liability for opioid-related claims as further described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section included below;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Diluted earnings per common share from continuing operations attributable to McKesson Corporation for the three months ended June 30, 2021 of $3.09 reflects the aforementioned items, net of any respective tax impacts, discrete tax items recognized in the quarter, and a lower share count compared to the prior year due to the cumulative effect of share repurchases; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We paid $1.0 billion to purchase 34.5&#160;million shares of McKesson Europe AG (&#8220;McKesson Europe&#8221;) during the three months ended June 30, 2021 through exercises of a put right by the noncontrolling shareholders pursuant to the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;);</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We returned $1.1 billion of cash to shareholders during the three months ended June 30, 2021 through $1.0 billion of share repurchases under an accelerated share repurchase (&#8220;ASR&#8221;) program entered into in May 2021, and $69 million of dividend payments. On July 23, 2021, we raised our quarterly dividend from $0.42 to $0.47 per common share;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 5, 2021, we entered into an agreement to sell certain of our European businesses to the PHOENIX Group for a purchase price of &#8364;1.2&#160;billion (or, approximately $1.5&#160;billion), subject to certain adjustments under the agreement. Beginning in the second quarter of 2022, the disposal group will be reflected in our condensed consolidated financial statements as held for sale and will be remeasured to the lower of its carrying amount or fair value less costs to sell, which we estimate will result in a charge between $500&#160;million and $700&#160;million, primarily related to the inclusion of the accumulated other comprehensive income balances into the carrying amount of the disposal group and the impairment of internal-use software that will not be completed. The transaction is anticipated to close in 2023, pursuant to customary closing conditions, including receipt of required regulatory approvals. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 17, 2021, we redeemed our 0.63% Euro-denominated notes with a principal amount of &#8364;600 million (or, approximately $709&#160;million) prior to the maturity date of August 17, 2021. The notes were redeemed using cash on hand; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 23, 2021, we completed a cash tender offer and paid an aggregate consideration of $1.1&#160;billion to redeem certain notes with a principal amount of $922&#160;million. As a result of the redemption, we incurred a loss on debt extinguishment in the second quarter of 2022, consisting of the premiums paid and a portion of the write-off of unamortized discounts and debt issuance costs in an amount proportional to the principal amount of debt retired. Refer to Financial Note 8, &#8220;Debt and Financing Activities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information.</span></div><div id="ia9b664dd086f4724924e37451951b156_1364"></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trends and Uncertainties:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The novel strain of coronavirus, which causes the infectious disease known as COVID-19, continues to evolve since it was declared a global pandemic on March 11, 2020 by the World Health Organization. We continue to evaluate the nature and extent of the ongoing impacts COVID-19 has on our business, operations, and financial results. Refer to Item 7 - Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations in Part II of our 2021 Annual Report for a full disclosure of trends and uncertainties due to COVID-19 since the onset of the pandemic. The disclosures below include significant updates that occurred during the first quarter of 2022. The full extent to which COVID-19 will impact us depends on many factors and future developments, which are described at the end of this COVID-19 section. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Response to COVID-19 in the Workplace</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During this unprecedented time, we are committed in continuing to supply our customers and protect the safety of our employees. The various responses we put in place initially at the onset of the pandemic to mitigate the impact of COVID-19 on our business operations include telecommuting and work-from-home policies, restricted travel, employee support programs, and enhanced safety measures. During the first quarter of 2022, we approved changes to our real estate strategy to increase efficiencies and support flexibility for our employees, including a transition to a partial remote work model for certain employees on a go-forward basis as further discussed in this Financial Review and in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. In July 2021, we also lifted certain travel restrictions across the enterprise. We continue to enforce the safety measures in the workplace as recommended by the Centers for Disease Control and Prevention (&#8220;CDC&#8221;).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Role in the Distribution of COVID-19 Vaccines and Ancillary Supply Kits</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions, we remain well positioned to respond to the COVID-19 pandemic in the U.S., Canada, and Europe. We have worked and continue to work closely with national and local governments, agencies, and industry partners to ensure that available supplies, including PPE, and medicine reach our customers and patients. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to support the U.S. government as a centralized distributor of COVID-19 vaccines and ancillary supplies needed to administer vaccines through a contract with the CDC. We have been distributing COVID-19 vaccines since December 2020, when the first Emergency Use Authorization was issued by the U.S. Food and Drug Administration. In the first quarter of 2022, McKesson began supporting the U.S. government&#8217;s commitment to donate COVID-19 vaccines worldwide. For this initiative, we are responsible for picking and packing the COVID-19 vaccines into temperature-controlled coolers and preparing them for pickup by an international partner. We will not manage the actual shipments of the vaccines to other countries. The results of operations related to our vaccine distribution are reflected in our U.S. Pharmaceutical segment. We also continue to manage the assembly and distribution of ancillary supply kits needed to administer COVID-19 vaccines, including sourcing some of those supplies, through agreements with both the Department of Health and Human Services (&#8220;HHS&#8221;) and Pfizer, Inc. The results of operations for the kitting and distribution of ancillary supplies are reflected in our Medical-Surgical Solutions segment. The future financial impact of the arrangements with the CDC and HHS depend on numerous uncertainties, which are described at the end of this COVID-19 section. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">McKesson Canada and McKesson Europe are also playing a role in helping support governments and public health entities in not only distributing COVID-19 vaccines, but administering them in pharmacies as well.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trends in our Business </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the onset of the COVID-19 pandemic late in our fourth quarter of 2020, we experienced higher pharmaceutical distribution volumes and increased retail pharmacy foot traffic as our customers increased supplies on hand in March. Subsequently, during the first quarter of 2021, pharmaceutical distribution volumes decreased as a result of the weakened and uncertain global economic environment and COVID-19 restrictions, including government shutdowns and shelter-in-place orders. We also experienced decreased demand for primary care medical-surgical supplies due to deferrals in elective procedures in hospitals and surgery centers as well as decreased traffic and closures of doctors&#8217; offices, which was partially offset by demand for PPE and COVID-19 tests. Additionally, the decreased traffic in doctors&#8217; offices and general shelter-in-place guidance by governmental authorities negatively impacted retail pharmacy foot traffic in both Europe and Canada. This drove favorability in our results when comparing the first quarter of 2022 versus 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced significant improvements in prescription volumes and primary care patient visits during our first quarter of 2022 compared to the same prior year period, however, the recovery of COVID-19 continues to be non-linear and tracked with patient mobility. During the first quarter of 2022, the COVID-19 vaccine and related ancillary kit distribution in the U.S. favorably impacted our results. While demand for PPE remained relatively flat year over year, we saw higher sales for COVID-19 tests primarily due to limited product availability in the first quarter of 2021. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impact to our Results of Operations, Financial Condition, and Liquidity</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June 30, 2021, COVID-19 tests as well as the kitting and distribution of ancillary supplies for COVID-19 vaccines in our Medical-Surgical Solutions segment contributed approximately $323 million, or 13%, in segment revenues, and including total inventory charges which is further described below, reduced our segment operating profit by approximately $90 million, or 120%. Additionally, the distribution of COVID-19 vaccines in our U.S. Pharmaceutical segment contributed less than 10% in segment operating profit for the three months ended June 30, 2021. The financial impact from the COVID-19 vaccine efforts in our International segment during the three months ended June 30, 2021 was not material to our consolidated results, but contributed to year over year favorability in segment operating profit. During the three months ended June 30, 2020, we had lower pharmaceutical volumes, specialty drug volumes, and patient care visits that negatively impacted our consolidated revenues and income from continuing operations before income taxes. The recovery of prescription volume trends and patient care visits, which are also described in more detail above in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trends in our Business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section, resulted in favorability year over year across our businesses when comparing 2022 versus 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain PPE items held for resale were valued in our inventory at costs that were inflated by earlier COVID-19 pandemic demand levels. That inventory valuation, if not supported by market resale prices, may be written down to net realizable value. We may also write-off inventory due to decreased customer demand and excess inventory. During the three months ended June 30, 2021, we recorded inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment. Of this amount, we recorded $147 million in cost of sales driven by the intent of management not to sell certain excess PPE inventory, which required an inventory write-down to zero, and instead direct it to charitable organizations. We recorded $8 million in total operating expenses for excess inventory which has already been committed for donation during our first quarter of 2022. In addition, $9 million of inventory charges were recorded in cost of sales for PPE and other related products that management intends to sell. Although market price volatility and changes to anticipated customer demand may require additional write-downs in future periods of other PPE and related product categories, we are taking measures to mitigate such risk.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall, these COVID-19 related items had a net favorable impact on consolidated income from continuing operations before income taxes for the three months ended June 30, 2021 compared to the same prior year period. Impacts to future periods due to COVID-19 may differ based on future developments, which is described at the end of this COVID-19 section.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2021, we maintained appropriate labor and overall vendor supply levels and experienced no material impacts to our liquidity or net working capital due to the COVID-19 pandemic. We continue to monitor the COVID-19 situation closely and engage with manufacturers, industry partners, and government agencies to anticipate shortages and respond to demand for certain medications and therapies. We are monitoring our customers closely for changes to their timing of payments or ability to pay amounts owed to us as a result of COVID-19 pandemic impacts to their businesses. We remain well-capitalized with access to liquidity from our revolving credit facility. Long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, have remained open and accessible to us during the COVID-19 pandemic. At June 30, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks and Forward-Looking Information</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has disrupted the global economy and exacerbated uncertainties inherent in estimates, judgments, and assumptions used in our forecasts. We still face numerous uncertainties in estimating the direct and indirect effects of COVID-19 on our future business operations, financial condition, results of operations, and liquidity. The full extent to which COVID-19 will impact us depends on many factors and future developments, including: the duration and spread of the virus; governmental actions to limit the spread of the virus; potential seasonality of viral outbreaks; potential new variants of the original virus; the amount of COVID-19 vaccines authorized, manufactured, distributed, and administered; the amount of ancillary supply kits assembled and distributed; the effectiveness of COVID-19 vaccines and governmental measures in controlling the spread of the virus; and the effectiveness of treatments of infected individuals. Due to several rapidly changing variables related to the COVID-19 pandemic, estimations of future economic trends and the timing of when stability will return remains challenging. Additionally, we periodically review our intangible and other long-lived assets for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Key assumptions and estimates about future values in our impairment assessments can be affected by a variety of factors, including the impacts of the global pandemic on industry and economic trends as well as on our business strategy and internal forecasts. Material changes to key assumptions and estimates can decrease the projected cash flows or increase the discount rates and have resulted in impairment charges of certain long-lived assets and could potentially result in future impairment charges. Refer to Item 1A - Risk Factors in Part I of our 2021 Annual Report for a disclosure of risk factors related to COVID-19.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opioid-Related Litigation and Claims </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a defendant in approximately 3,200 legal proceedings asserting claims related to the distribution of controlled substances (opioids) in federal and state courts throughout the U.S., and in Puerto Rico and Canada. Those proceedings include approximately 2,900 federal cases and approximately 300 state court cases throughout the U.S., and cases in Puerto Rico and Canada. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2021, we and the two other national pharmaceutical distributors announced that we had negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. Under the proposed agreement, the three distributors would pay up to approximately $21 billion over a period of 18 years, with up to approximately $7.9 billion to be paid by us for our 38.1% portion if all eligible entities participate. In addition, the proposed agreement would require the three distributors, including the Company, to establish a clearinghouse for controlled substances distribution data and adopt changes to anti-diversion programs. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 20, 2021, we announced that we and the two other national pharmaceutical distributors had agreed to pay up to $1.2 billion, of which our portion would be 38.1%, in a settlement with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that New York and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework, as well as certain attorneys&#8217; fees and costs. If the broad settlement is finalized, New York and its participating subdivisions will become part of that broader agreement. We previously recorded a charge of $8.1 billion for the year ended March 31, 2021 within &#8220;Claims and litigation charges, net&#8221; in our Consolidated Statement of Operations, related to our share of the settlement framework described above, as well as other opioid-related claims. We have increased that by $74 million this quarter, including a charge</span><span style="background-color:#fefefe;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of $27 million related to the settlement with New York and its participating subdivisions and a charge of $47 million related to the proposed settlement agreement with state and local governmental entities. We also</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> reclassified $545 million to &#8220;Other accrued liabilities&#8221; for the estimated payment due within one year, and the remaining liability is recorded in &#8220;Long-term litigation liabilities&#8221; in our Condensed Consolidated Balance Sheet as of June 30, 2021. Because of the many uncertainties associated with any potential settlement arrangement or other resolution of opioid-related litigation, including the uncertainty of the scope of participation by plaintiffs in any potential settlement, we are not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. In light of the uncertainty, the amount of any ultimate loss may differ materially from the amount accrued. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the progress toward a broad settlement, we also continue to prepare for trial in these pending matters. We believe that we have valid defenses to the claims pending against us and, absent an acceptable settlement, intend to vigorously defend against all such claims. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on our financial position, cash flows or liquidity, or results of operations. Refer to Financial Note 12, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10&#8209;Q for more information. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Opioid Statutes </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory, or industry measures to address the misuse of prescription opioid medications could affect our business in ways that we may not be able to predict. In April 2018, the State of New York adopted the Opioid Stewardship Act (&#8220;OSA&#8221;) which required the imposition of an annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State of New York appealed to the U.S. Court of Appeals for the Second Circuit. The State of New York has subsequently adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA would apply only to opioid sales on or before December 31, 2018. The excise tax applies only to the first sale occurring in New York, and thus may not apply to sales from our distribution centers in New York to New York customers. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision striking down the OSA on procedural grounds. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing en banc with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the U.S. Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. A petition for certiorari was filed with the Supreme Court on May 17, 2021. Unless the appellate court&#8217;s decision is overturned, the OSA will be reinstated for calendar years 2017 and 2018 (but not beyond those years), and, subject to any further legal challenge, we will have to pay our ratable share of the annual surcharge for those two years. During the second quarter of 2021, we reflected an estimated liability of $50&#160;million for the OSA surcharge in our consolidated financial statements on the assumption that the appellate court&#8217;s decision will stand. Refer to Note 12, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10&#8209;Q for more information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_8246337209696"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Consolidated Results:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share data)</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,032&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">4.85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,022)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Total operating expenses as a percentage of revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per common share attributable to McKesson Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.07&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average diluted common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent.</span></div><div style="margin-bottom:12pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues increased for the three months ended June 30, 2021 compared to the same prior year period primarily due to market growth in our U.S. Pharmaceutical segment. Revenues were also favorable year over year due to the recovery of pharmaceutical distribution volumes from the prior year impact of COVID-19 across our businesses. Market growth includes growing drug utilization, price increases, and newly launched products, partially offset by price deflation associated with branded to generic drug conversion. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit increased for the three months ended June 30, 2021 largely due to the pandemic, including the recovery of the prior year impacts from COVID-19, such as disruptions of doctors&#8217; office operations, deferred or cancelled elective procedures, lower demand for pharmaceuticals, and overall reduction of foot traffic in pharmacies, and the favorable contributions from our COVID-19 vaccine and related ancillary supply kit distribution programs. This was partially offset by inventory charges on certain PPE and other related products. Gross profit was also favorably impacted by foreign currency exchange fluctuations for the three months ended June 30, 2021 and unfavorably impacted by the contribution of our German pharmaceutical wholesale business to a joint venture with Walgreens Boots Alliance (&#8220;WBA&#8221;) on November 1, 2020.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Last-in, first-out (&#8220;LIFO&#8221;) inventory credits were $23 million and $52 million for the three months ended June 30, 2021 and 2020, respectively. LIFO credits are lower in the first quarter of 2022 compared to the same prior year period primarily due to a decrease in the volume of branded off-patent to generic drug launches and higher brand inflation. Our U.S. Pharmaceutical business uses the LIFO method of accounting for the majority of its inventories, which results in cost of sales that more closely reflects replacement cost than under other accounting methods. The business&#8217; practice is to pass on to customers published price changes from suppliers. Manufacturers generally provide us with price protection, which limits price related inventory losses. A LIFO expense is recognized when the net effect of price increases on pharmaceutical and non-pharmaceutical products held in inventory exceeds the impact of price declines, including the effect of branded pharmaceutical products that have lost market exclusivity. A LIFO credit is recognized when the net effect of price declines exceeds the impact of price increases on pharmaceutical and non-pharmaceutical products held in inventory. Our quarterly LIFO credit is based on our estimates of the annual LIFO credit which is impacted by expected changes in year-end inventory quantities, product mix, and manufacturer pricing practices, which may be influenced by market and other external factors. Changes to any of the above factors could have a material impact to our annual LIFO credit. The actual valuation of inventory under the LIFO method is calculated at the end of the fiscal year. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Operating Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the components of our total operating expenses for the three months ended June 30, 2021 and 2020 is as follows: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Selling, distribution, general, and administrative expenses (&#8220;SDG&amp;A&#8221;):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SDG&amp;A consists of personnel costs, transportation costs, depreciation and amortization, lease costs, professional fee expenses, and administrative expenses.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Claims and litigation charges, net:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These charges include adjustments for estimated probable settlements related to our controlled substance monitoring and reporting, and opioid-related claims, as well as any applicable income items or credit adjustments due to subsequent changes in estimates. Legal fees to defend claims, which are expensed as incurred, are included within SDG&amp;A. We have reclassified prior period amounts to conform to the current period presentation.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline">Restructuring, impairment, and related charges:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Restructuring charges are incurred for programs in which we change our operations, the scope of a business undertaken by our business units, or the manner in which that business is conducted as well as long-lived asset impairments.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, distribution, general, and administrative expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,232&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims and litigation charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(156)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Percent of revenues</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3.93&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">3.63&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June 30, 2021, total operating expenses and total operating expenses as a percentage of revenues increased compared to the same prior year period. Total operating expenses were impacted by the following significant items:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">SDG&amp;A for the three months ended June 30, 2021 and 2020 includes opioid-related costs of $35&#160;million and $43&#160;million, respectively, primarily related to litigation expenses;</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">SDG&amp;A for the three months ended June 30, 2021 when compared to the same prior year period also includes increased costs primarily to support growth across our businesses, partially offset by lower operating expenses due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Claims and litigation charges, net for the three months ended June 30, 2021 includes charges of $74 million related to our estimated liability for opioid-related claims as previously discussed in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Claims and litigation charges, net for the three months ended June 30, 2020 includes a net gain of $131&#160;million reflecting insurance proceeds received, net of attorneys' fees and expenses awarded to plaintiffs' counsel, in connection with the previously reported $175 million settlement of the shareholder derivative action related to our controlled substances monitoring program;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Restructuring, impairment, and related charges for three months ended June 30, 2021 and 2020 primarily includes charges related to our European and Canadian businesses in our International segment and Corporate expenses, net. The year over year increase in restructuring, impairment, and related charges of $102 million is primarily due to our transition to a partial remote work model approved during the first quarter of 2022 and costs for optimization programs in Canada. In addition, certain charges related to restructuring initiatives are included under the caption &#8220;Cost of sales&#8221; in our Condensed Consolidated Statements of Operations and were not material for the three months ended June 30, 2020. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Restructuring Initiatives and Long-Lived Asset Impairments&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Operating Profit and Corporate Expenses, Net&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sections below as well as Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information; and </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.85pt">Total operating expenses were unfavorably impacted by foreign currency exchange fluctuations for the three months ended June 30, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill for impairment on an annual basis as of October 1, and at an interim date, if indicators of potential impairment exist. The annual impairment testing performed in 2021 did not indicate any impairment of goodwill and no goodwill impairment charges were recorded during the three months ended June 30, 2021 nor 2020. However, other risks, expenses, and future developments, such as additional government actions, increased regulatory uncertainty, and material changes in key market assumptions limit our ability to estimate projected cash flows, which could adversely affect the fair value of various reporting units in future periods, including our McKesson Canada reporting unit within our International segment and our RxCrossroads reporting unit within our RxTS segment, where the risk of a material goodwill impairment is higher than other reporting units. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives and Long-Lived Asset Impairments</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, we approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily includes the rationalization of our office space in North America. Where we determine to cease using office space, we plan to exit the portion of the facility no longer used. We also may retain and repurpose certain other office locations. We expect to incur total charges of approximately $180 million&#160;to $280 million for this initiative, of which $95 million of charges were recorded to date. This initiative is anticipated to be complete in 2022 and estimated remaining charges consist primarily of lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we committed to an initiative within the United Kingdom, which is included in our International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. We expect to incur total charges of approximately $85 million to $90 million for this initiative, of which $63 million of charges were recorded to date. The initiative is anticipated to be substantially complete in 2022 and estimated remaining charges consist primarily of accelerated amortization of long-lived assets, facility and other exit costs, and employee-related costs.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for further information on our restructuring initiatives and long-lived asset impairments.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in other income, net for the three months ended June 30, 2021 compared to the same prior year period was primarily due to higher net equity in earnings and a pension settlement gain in our International segment recognized during the first quarter of 2022. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense decreased for the three months ended June 30, 2021 compared to the same prior year period primarily due to the repayment of $1.0 billion of long-term debt in the third quarter of 2021. Interest expense may also fluctuate based on timing, amounts, and interest rates of term debt repaid and new term debt issued, as well as amounts incurred associated with financing fees. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2021 and 2020, we recorded income tax expense of $26 million and $150 million, respectively. We reported income tax rates of 4.6% and 23.3% for the three months ended June 30, 2021 and 2020, respectively. Fluctuations in our reported income tax rates are primarily due to discrete items recognized in the quarter and changes in our business mix of income between various taxing jurisdictions. Refer to Financial Note 4, &#8220;Income Taxes,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests for the three months ended June 30, 2021 and 2020 primarily represents ClarusONE Sourcing Services LLP, Vantage Oncology Holdings, LLC, and the accrual of the annual recurring compensation amount of &#8364;0.83 per McKesson Europe share that McKesson is obligated to pay to the noncontrolling shareholders of McKesson Europe under the Domination Agreement. Noncontrolling interests with redemption features, such as put rights, that are not solely within our control are considered redeemable noncontrolling interests.&#160;Redeemable noncontrolling interests are presented outside of McKesson Corporation stockholders&#8217; deficit on our condensed consolidated balance sheets. Refer to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Selected Measures of Liquidity and Capital Resources&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section of this Financial Review and Financial Note 5, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for more information on changes to our redeemable and noncontrolling interests that occurred during the first quarter of 2022. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Attributable to McKesson Corporation</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to McKesson Corporation was $486 million and $444 million for the three months ended June 30, 2021 and 2020, respectively. Diluted earnings per common share attributable to McKesson Corporation was $3.07 and $2.72 for the three months ended June 30, 2021 and 2020, respectively. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Weighted-Average Diluted Common Shares Outstanding</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per common share was calculated based on a weighted-average number of shares outstanding of</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">158.1 million and 163.2 million for the three months ended June 30, 2021 and 2020, respectively. Weighted-average diluted shares outstanding for the three months ended June 30, 2021 decreased from the same prior year period primarily due to the cumulative effect of shares repurchases.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_91"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview of Segment Results:</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Revenues:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,674&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in revenues for each of our segments for the three months ended June 30, 2021 compared to the same prior year period consisted of the following:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in billions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Increase (decrease)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales to pharmacies and institutional healthcare providers</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales to specialty practices and other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in U.S. Pharmaceutical revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in Prescription Technology Solutions revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales to primary care customers</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales to extended care customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in Medical-Surgical Solutions revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales in Europe, excluding FX impact</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales in Canada, excluding FX impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact from FX</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in International revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total change in revenues</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">FX - foreign currency exchange fluctuations. We calculate the impact from FX by converting current year period results of our operations in foreign countries, which are recorded in local currencies, into U.S. dollars by applying the average foreign currency exchange rates of the comparable prior year period.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes the results for the distribution of COVID-19 vaccines.</span></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes the results for the kitting and distribution of ancillary supply kits needed to administer COVID-19 vaccines.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Pharmaceutical revenues for the three months ended June 30, 2021 increased</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12% compared to the same prior year period primarily due to market growth, including higher volumes from retail national account customers, branded pharmaceutical price increases, and growth in specialty pharmaceuticals, partially offset by branded to generic drug conversions. Revenues for this segment were also favorable year over year due to the recovery of prescription volumes from the prior year impact of COVID-19, including increased customer demand for pharmaceuticals in retail pharmacies and institutional healthcare providers. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RxTS revenues for the three months ended June 30, 2021 increased 34% compared to the same prior year period primarily due to increased volume with new and existing customers and the recovery of prescription volumes from the prior year impact of COVID-19.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical-Surgical Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical-Surgical Solutions revenues for the three months ended June 30, 2021 increased 40% compared to the same prior year period largely in our primary care business due to improvements in patient care visits as a result of prior year customer closures due to COVID-19 and higher sales of COVID-19 tests in the first quarter of 2022. Revenues for this segment were also favorably impacted by the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues for the three months ended June 30, 2021 increased 8% compared to the same prior year period. Excluding the favorable effects of foreign currency exchange fluctuations, revenues for this segment decreased 3% largely due to the contribution of our German pharmaceutical wholesale business to a joint venture with WBA. This was partially offset by favorability year over year due to the recovery of volumes from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses across the segment as well as sales to a new customer in our Canadian business.</span></div><div id="ia9b664dd086f4724924e37451951b156_94"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Operating Profit and Corporate Expenses, Net:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bp</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.57&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.04&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All percentage changes displayed above which are not meaningful are displayed as zero percent.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">bp - basis points</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit includes gross profit, net of total operating expenses, as well as other income, net, for our reportable segments. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Operating profit for our Medical-Surgical Solutions segment for the three months ended June 30, 2021 includes inventory charges totaling $164 million on certain PPE and other related products primarily driven by the intent of management not to sell certain excess PPE inventory and instead direct it to charitable organizations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net includes charges of $74 million for the three months ended June 30, 2021 related to our estimated liability for opioid-related claims and a net gain of $131 million for the three months ended June 30, 2020 recorded in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program. </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Pharmaceutical</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit increased for this segment for the three months ended June 30, 2021 compared to the same prior year period primarily due to the contribution from our COVID-19 vaccine distribution program and growth in specialty pharmaceuticals, partially offset by a decrease in LIFO credits of $29 million and increased costs for strategic growth initiatives. Operating profit for this segment was also favorable year over year due to the recovery of prescription volumes from the prior year impact of COVID-19. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prescription Technology Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment increased for the three months ended June 30, 2021 compared to the same prior year period primarily due to increased volumes with new and existing customers and the recovery of prescription volumes from the prior year impact of COVID-19.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Medical-Surgical Solutions</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment decreased for the three months ended June 30, 2021 compared to the same prior year period primarily due to inventory charges on certain PPE and other related products. This was partially offset by favorability in our primary care business from improvements in patient care visits as a result of prior year customer closures due to COVID-19, as well as the contribution from kitting and distribution of ancillary supplies for COVID-19 vaccines and higher sales of COVID-19 tests in the first quarter of 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Three Months Ended June 30, 2021 vs. 2020</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit for this segment increased for the three months ended June 30, 2021 compared to the same prior year period largely due to favorability year over year due to the volume recovery from COVID-19 in our pharmaceutical distribution and retail pharmacy businesses across the segment and to a lesser extent, the distribution of COVID-19 vaccines, COVID-19 tests, and PPE. This was partially offset by higher restructuring charges for optimization programs in Canada.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Expenses, Net</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate expenses, net increased for the three months ended June 30, 2021 compared to the same prior year period primarily due to a net gain of $131 million recognized during the first quarter of 2021 in connection with insurance proceeds received from the settlement of the shareholder derivative action related to our controlled substances monitoring program. We also recorded charges of $74 million related to our estimated liability for opioid-related claims during the first quarter of 2022 and higher restructuring charges for the transition to a partial remote work model for certain employees.</span></div><div id="ia9b664dd086f4724924e37451951b156_100"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New accounting pronouncements that we have recently adopted as well as those that have been recently issued but not yet adopted by us are included in Financial Note 1, &#8220;Significant Accounting Policies,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.</span></div><div id="ia9b664dd086f4724924e37451951b156_103"></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our available cash generated from operations and our short-term investment portfolio, together with our existing sources of liquidity from our credit facilities and commercial paper program, will be sufficient to fund our short-term and long-term capital expenditures, working capital, and other cash requirements. We remain well-capitalized with access to liquidity from our $4.0 billion revolving credit facility. At June 30, 2021, we were in compliance with all debt covenants, and believe we have the ability to continue to meet our debt covenants in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the net change in cash, cash equivalents, and restricted cash for the periods shown: </span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,622)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,062)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(560)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,212)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,861)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,159)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,702)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating activities used cash of $1.6 billion and $1.1 billion during the three months ended June 30, 2021 and 2020, respectively.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from operations can be significantly impacted by factors such as timing of receipts from customers, inventory receipts, and payments to vendors. Additionally, working capital is primarily a function of sales and purchase volumes, inventory requirements, and vendor payment terms. Operating activities for the three months ended June 30, 2021 were affected by an increase in receivables of $1.0 billion and an increase in inventory of $0.9 billion, both primarily due to timing and higher revenues. Operating activities for the three months ended June 30, 2020 were affected by a decrease in drafts and accounts payable of $4.2 billion primarily associated with timing and management of inventory levels as well as a decrease in receivables of $2.3 billion primarily due to lower revenues. Other non-cash items for the three months ended June 30, 2021 includes non-cash inventory charges totaling $164 million on certain PPE and other related products in our Medical-Surgical Solutions segment.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities used cash of $99 million and $130 million during the three months ended June 30, 2021 and 2020, respectively. Investing activities for the three months ended June 30, 2021 and 2020 includes $159 million and $117 million, respectively, in capital expenditures for property, plant, and equipment, and capitalized software. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities used cash of $2.2 billion during the three months ended June 30, 2021 and provided cash of $61 million during the three months ended June 30, 2020. Financing activities for the three months ended June 30, 2021 includes $1.0 billion of cash paid for share repurchases under an ASR program entered into in May 2021. Financing activities for the three months ended June 30, 2021 and 2020 includes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$69 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $74 million of cash paid for dividends, respectively. Additionally, financing activities for the three months ended June 30, 2021 and 2020 includes payments of $1.0 billion and $49&#160;million, respectively, to purchase shares of McKesson Europe through exercises of a put right option by noncontrolling shareholders. The put right option expired on June 15, 2021 as further described below. Financing activities for the three months ended June 30, 2020 includes cash receipts and payments of $5.3 billion for short-term borrowings, primarily commercial paper. Cash used for other financing activities generally includes shares surrendered for tax withholding and payments to noncontrolling interests. Other financing activities for the three months ended June 30, 2020 also includes restricted cash inflow related to funds temporarily held on behalf of unaffiliated medical practice groups.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors (the &#8220;Board&#8221;) has authorized the repurchase of McKesson&#8217;s common stock from time to time in open market transactions, privately negotiated transactions, ASR programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, restrictions under our debt obligations, and other market and economic conditions. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONTINUED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. Pursuant to the ASR agreement, we paid $1.0&#160;billion to the financial institution and received an initial delivery of 4.3 million shares in May 2021. The transaction will be completed during the second quarter of 2022, at which point we expect to receive additional shares. There were no share repurchases during the three months ended June 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock was $1.8 billion at June 30, 2021. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future operating cash flow, financial assets, and current access to capital and credit markets, including our existing credit facilities, will give us the ability to meet our financing needs for the foreseeable future. However, there can be no assurance that an increase in volatility or disruption in the global capital and credit markets will not impair our liquidity or increase our costs of borrowing. </span></div><div id="ia9b664dd086f4724924e37451951b156_106"></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selected Measures of Liquidity and Capital Resources</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:55.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.974%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.978%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,396&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(485)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt to capital ratio </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on McKesson stockholders&#8217; deficit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(218.2)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142.5)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This ratio describes the relationship and changes within our capital resources, and is computed as total debt divided by the sum of total debt and McKesson stockholders&#8217; deficit, which excludes noncontrolling and redeemable noncontrolling interests and accumulated other comprehensive loss.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Ratio is computed as net income (loss) attributable to McKesson Corporation for the last four quarters, divided by a five-quarter average of McKesson stockholders&#8217; equity (deficit), which excludes noncontrolling and redeemable noncontrolling interests.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents, which are readily convertible to known amounts of cash, are carried at fair value. Cash equivalents are primarily invested in AAA-rated U.S. government money market funds and overnight deposits with financial institutions. Deposits with financial institutions are primarily denominated in U.S. dollars and the functional currencies of our foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. We mitigate the risk of our short-term investment portfolio by depositing funds with reputable financial institutions and monitoring risk profiles and investment strategies of money market funds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents balance as of June 30, 2021 and March 31, 2021 included approximately</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.2 billion and $2.3 billion of cash held by our subsidiaries outside of the U.S., respectively. Our primary intent is to utilize this cash for foreign operations for an indefinite period of time. Although the vast majority of cash held outside the U.S. is available for repatriation, doing so could subject us to foreign withholding taxes and state income taxes.&#160;Following enactment of the 2017 Tax Cuts and Jobs Act, the repatriation of cash to the U.S. is generally no longer taxable for federal income tax purposes. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Working capital primarily includes cash and cash equivalents, receivables, and inventories, net of drafts and accounts payable, short-term borrowings, current portion of long-term debt, and other accrued liabilities. Our businesses require substantial investments in working capital that are susceptible to large variations during the year as a result of inventory purchase patterns and seasonal demands. Inventory purchase activity is a function of sales activity and other requirements. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated working capital decreased at June 30, 2021 compared to March 31, 2021 primarily due to a decrease in cash and cash equivalents and an increase in other accrued liabilities, partially offset by an increase in receivables and inventory as well as a decrease in drafts and accounts payable. The increase in other accrued liabilities is primarily due to the reclassification of $545 million from long-term to short-term for the amount we expect to pay for opioid-related claims within one year as of June 30, 2021. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Financial Review and Financial Note 12, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10&#8209;Q for further information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL REVIEW (CONCLUDED)</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt to capital ratio increased for the three months ended June 30, 2021 primarily due to an increase in McKesson stockholders&#8217; deficit driven by share repurchases under an ASR program entered into in May 2021, partially offset by net income for the quarter. Our unfavorable return on McKesson&#8217;s stockholders&#8217; deficit as of June 30, 2021 and March 31, 2021 was primarily driven by net loss for the year ended March 31, 2021, which includes an after-tax non-cash charge of $6.8 billion related to our estimated liability for opioid-related claims, as discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Trends and Uncertainties&#8221;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Financial Review and Financial Note 12, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10&#8209;Q.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, we raised our quarterly dividend from $0.42 to $0.47 per common share for dividends declared on or after such date by the Board. We anticipate that we will continue to pay quarterly cash dividends in the future. However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our redeemable noncontrolling interests primarily related to our consolidated subsidiary, McKesson Europe. At March 31, 2021, the carrying value was $1.3&#160;billion and we owned approximately 78% of McKesson Europe&#8217;s outstanding common shares. Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published semi-annually by the German Bundesbank, less any compensation amount or guaranteed dividend already paid by McKesson (&#8220;Put Amount&#8221;). During the three months ended June 30, 2021 and 2020, we paid $1.0 billion and $49&#160;million, respectively, to purchase 34.5&#160;million and 1.8&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders, which reduced the balance of our redeemable noncontrolling interests.  </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, valued at $287&#160;million, were transferred from redeemable noncontrolling interests to noncontrolling interests. At June 30, 2021, we owned approximately 95% of McKesson Europe&#8217;s outstanding common shares.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we are obligated to pay an annual recurring compensation of &#8364;0.83 per McKesson Europe share (the &#8220;Compensation Amount&#8221;) to the noncontrolling shareholders of McKesson Europe under the Domination Agreement. The Compensation Amount is recognized ratably during the applicable annual period. The Domination Agreement does not expire, but it may be terminated at the end of any fiscal year by giving at least six months&#8217; advance notice. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Financial Note 5, &#8220;Redeemable Noncontrolling Interests and Noncontrolling Interests,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for additional information on redeemable noncontrolling interests. </span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Resources</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We fund our working capital requirements primarily with cash and cash equivalents as well as short-term borrowings from our credit facilities and commercial paper issuances. Funds necessary for future debt maturities and our other cash requirements, including any future payments that may be made related to our estimated litigation liability of $8.1 billion for opioid-related claims, are expected to be met by existing cash balances, cash flow from operations, existing credit sources, and other capital market transactions. Long-term debt markets and commercial paper markets, our primary sources of capital after cash flow from operations, are open and accessible to us should we decide to access those markets. Detailed information regarding our debt and financing activities is included in Financial Note 8, &#8220;Debt and Financing Activities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_109"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTICE ABOUT FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q, including &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Item 2 of Part I of this report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Some of these statements can be identified by the use of terminology such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;seeks,&#8221; &#8220;approximately,&#8221; &#8220;intends,&#8221; &#8220;projects,&#8221; &#8220;plans,&#8221; &#8220;estimates,&#8221; or the negative of these words and other comparable terminology. The discussion of financial trends, strategy, plans, assumptions, or intentions may also include forward-looking statements. Readers should not place undue reliance on forward-looking statements, which speak only as of the date such statements were first made. Except to the extent required by law, we undertake no obligation to update or revise our forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, anticipated, or implied. Although it is not possible to predict or identify all such risks and uncertainties, they include, but are not limited to, factors described in the Risk Factors discussion in Item 1A of Part I of our most recently filed Annual Report on Form 10-K. </span></div><div id="ia9b664dd086f4724924e37451951b156_112"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-align:justify;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Quantitative and Qualitative Disclosures about Market Risk.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe there has been no material change in our exposure to risks associated with fluctuations in interest and foreign currency exchange rates as disclosed in our 2021 Annual Report. </span></div><div id="ia9b664dd086f4724924e37451951b156_115"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Controls and Procedures. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Chief Executive Officer and our Chief Financial Officer, with the participation of other members of the Company&#8217;s management, have evaluated the effectiveness of the Company&#8217;s &#8220;disclosure controls and procedures&#8221; (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (&#8220;Exchange Act&#8221;)) as of the end of the period covered by this quarterly report, and our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective based on their evaluation of these controls and procedures as required by paragraph (b) of Exchange Act Rules 13a-15 or 15d-15. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our &#8220;internal control over financial reporting&#8221; (as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that occurred during the three months ended June 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="ia9b664dd086f4724924e37451951b156_118"></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div id="ia9b664dd086f4724924e37451951b156_121"></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Legal Proceedings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth in Financial Note 12, &#8220;Commitments and Contingent Liabilities,&#8221; to the accompanying condensed consolidated financial statements included in this Quarterly Report on Form 10-Q, and in Financial Note 19, &#8220;Commitments and Contingent Liabilities,&#8221; to the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, is incorporated herein by reference. Disclosure of an environmental proceeding with a governmental agency generally is included only if we expect monetary sanctions in the proceeding to exceed $1 million, unless otherwise material.</span></div><div id="ia9b664dd086f4724924e37451951b156_124"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:16.8pt">Risk Factors.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than factual updates discussed in this Quarterly Report on Form 10-Q, there have been no material changes for the period covered by this Quarterly Report on Form 10-Q to the risk factors disclosed in Part I, Item 1A, of our 2021 Annual Report on Form 10-K.</span></div><div id="ia9b664dd086f4724924e37451951b156_127"></div><div><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. Pursuant to the ASR agreement, we paid $1.0&#160;billion to the financial institution and received an initial delivery of 4.3 million shares in May 2021. The transaction will be completed during the second quarter of 2022, at which point the Company expects to receive additional shares. There were no share repurchases during the three months ended June 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock was $1.8 billion at June 30, 2021. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information on the Company&#8217;s share repurchases during the three months ended June 30, 2021.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.570%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.165%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.165%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.168%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share Repurchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except price per share)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number<br/>of Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Paid&#160;Per&#160;Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares Purchased<br/>As Part of Publicly<br/>Announced<br/>Program</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate<br/>Dollar&#160;Value&#160;of<br/>Shares&#160;that&#160;May<br/>Yet Be Purchased Under the Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2021 &#8211; April 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,785</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1, 2021 &#8211; May 31, 2021 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.07</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2021 &#8211; June 30, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This table does not include the value of equity awards surrendered to satisfy tax withholding obligations.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The average price paid per share in the above table is an estimate based on the initial share purchase price under an ASR agreement and may differ from the total average price paid for share repurchases under the ASR program upon its final settlement during the second quarter of 2022. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_133"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Defaults Upon Senior Securities.</span></div><div style="margin-bottom:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ia9b664dd086f4724924e37451951b156_136"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Mine Safety Disclosures.</span></div><div style="margin-bottom:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ia9b664dd086f4724924e37451951b156_139"></div><div style="padding-left:18pt;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Other Information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:12pt;text-indent:24.75pt"><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_142"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.02pt">Exhibits. </span></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits identified in parentheses below are on file with the SEC and are incorporated by reference as exhibits hereto. </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit311x06302021.htm">Certification of the Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit312x06302021.htm">Certification of the Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#8224;&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="mck_exhibit32x06302021.htm">Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from the McKesson Corporation Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, formatted in Inline Extensible Business Reporting Language (iXBRL): (i) Condensed Consolidated Statements of Operations, (ii) Condensed Consolidated Statements of Comprehensive Income, (iii) Condensed Consolidated Balance Sheets, (iv) Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit), (v) Condensed Consolidated Statements of Cash Flows, and (vi) related Financial Notes.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#8224;&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-align:justify;text-indent:-20.25pt"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="ia9b664dd086f4724924e37451951b156_145"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#ia9b664dd086f4724924e37451951b156_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">McKESSON CORPORATION</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.217%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESSON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ORPORATION</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Britt J. Vitalone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.217%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESSON</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ORPORATION</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/  Sundeep G. Reddy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sundeep G. Reddy</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Controller</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>mck_exhibit311x06302021.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id2f95581f699403589d18358d25c8521_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Brian S. Tyler, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:7pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>mck_exhibit312x06302021.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie646052cdc5c4038bc227f3e592dd898_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) AND RULE 15d-14(a) OF THE SECURITIES EXCHANGE ACT, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Britt J. Vitalone, certify that&#58; </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of McKesson Corporation&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and </font></div><div style="margin-bottom:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:7pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.049%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.834%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>mck_exhibit32x06302021.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i76902e13733a45aa899e0c32b201453d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:6.75pt;text-align:right;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the quarterly report of McKesson Corporation (the &#8220;Company&#8221;) on Form 10-Q for the quarterly period ended June 30, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), the undersigned, in the capacities and on the dates indicated below, each hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge&#58;</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:24pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160; Brian S. Tyler</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Brian S. Tyler</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:36pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-6.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.728%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;  Britt J. Vitalone</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Britt J. Vitalone</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 4, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:27pt;text-indent:-9pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Report pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to McKesson Corporation and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>mck-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:31dc61f2-2ef8-41d9-90f2-e8ff46606457,g:0be0b981-6200-4a1a-a19d-196bf6df3870-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mck="http://mckesson123.com/20210630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://mckesson123.com/20210630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mck-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://mckesson123.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSale" roleURI="http://mckesson123.com/role/HeldforSale">
        <link:definition>2104102 - Disclosure - Held for Sale</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldforSaleNarrativeDetails" roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails">
        <link:definition>2405402 - Disclosure - Held for Sale - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedCharges" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges">
        <link:definition>2106103 - Disclosure - Restructuring, Impairment, and Related Charges</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesTables" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables">
        <link:definition>2307301 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesNarrativeDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails">
        <link:definition>2408403 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails">
        <link:definition>2409404 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails">
        <link:definition>2410405 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://mckesson123.com/role/IncomeTaxes">
        <link:definition>2111104 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://mckesson123.com/role/IncomeTaxesDetails">
        <link:definition>2412406 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterests" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests">
        <link:definition>2113105 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables">
        <link:definition>2314302 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
        <link:definition>2415407 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails">
        <link:definition>2416408 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShare" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare">
        <link:definition>2117106 - Disclosure - Earnings (Loss) Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareTables" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables">
        <link:definition>2318303 - Disclosure - Earnings (Loss) Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerCommonShareDetails" roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareDetails">
        <link:definition>2419409 - Disclosure - Earnings (Loss) Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNet" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet">
        <link:definition>2120107 - Disclosure - Goodwill and Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetTables" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables">
        <link:definition>2321304 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
        <link:definition>2422410 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
        <link:definition>2423411 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails">
        <link:definition>2424412 - Disclosure - Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivities" roleURI="http://mckesson123.com/role/DebtandFinancingActivities">
        <link:definition>2125108 - Disclosure - Debt and Financing Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesTables" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables">
        <link:definition>2326305 - Disclosure - Debt and Financing Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
        <link:definition>2427413 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1">
        <link:definition>2427413 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesLongTermDebtNarrativeDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails">
        <link:definition>2428414 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
        <link:definition>2429415 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandFinancingActivitiesCommercialPaperDetails" roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails">
        <link:definition>2430416 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefits" roleURI="http://mckesson123.com/role/PensionBenefits">
        <link:definition>2131109 - Disclosure - Pension Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionBenefitsNarrativeDetails" roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails">
        <link:definition>2432417 - Disclosure - Pension Benefits - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivities" roleURI="http://mckesson123.com/role/HedgingActivities">
        <link:definition>2133110 - Disclosure - Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesTables" roleURI="http://mckesson123.com/role/HedgingActivitiesTables">
        <link:definition>2334306 - Disclosure - Hedging Activities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesNarrativeDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails">
        <link:definition>2435418 - Disclosure - Hedging Activities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HedgingActivitiesDerivativeInstrumentsFairValueDetails" roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails">
        <link:definition>2436419 - Disclosure - Hedging Activities - Derivative Instruments Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://mckesson123.com/role/FairValueMeasurements">
        <link:definition>2137111 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://mckesson123.com/role/FairValueMeasurementsTables">
        <link:definition>2338307 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://mckesson123.com/role/FairValueMeasurementsDetails">
        <link:definition>2439420 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilities" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities">
        <link:definition>2140112 - Disclosure - Commitments and Contingent Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesTables" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables">
        <link:definition>2341308 - Disclosure - Commitments and Contingent Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesNarrativeDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails">
        <link:definition>2442421 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails">
        <link:definition>2443422 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficit" roleURI="http://mckesson123.com/role/StockholdersEquityDeficit">
        <link:definition>2144113 - Disclosure - Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitTables" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables">
        <link:definition>2345309 - Disclosure - Stockholders' Equity (Deficit) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitNarrativeDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails">
        <link:definition>2446423 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails">
        <link:definition>2447424 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails">
        <link:definition>2448425 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusiness" roleURI="http://mckesson123.com/role/SegmentsofBusiness">
        <link:definition>2149114 - Disclosure - Segments of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessTables" roleURI="http://mckesson123.com/role/SegmentsofBusinessTables">
        <link:definition>2350310 - Disclosure - Segments of Business (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessDetails" roleURI="http://mckesson123.com/role/SegmentsofBusinessDetails">
        <link:definition>2451426 - Disclosure - Segments of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mck_ShareholderDerivativeActionMember" abstract="true" name="ShareholderDerivativeActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofStateAttorneyGenerals" abstract="false" name="LossContingencyNumberofStateAttorneyGenerals" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_A270NotesDueDecember152022Member" abstract="true" name="A270NotesDueDecember152022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A090NotesDueDecember32025Member" abstract="true" name="A090NotesDueDecember32025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EuropeanBusinessesDisposalGroupMember" abstract="true" name="EuropeanBusinessesDisposalGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" abstract="false" name="StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_BritishPoundSterlingDenominatedNotesMember" abstract="true" name="BritishPoundSterlingDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A163EuroNotesDueOctober302026Member" abstract="true" name="A163EuroNotesDueOctober302026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" abstract="false" name="RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mck_MedicalSurgicalSolutionsSegmentMember" abstract="true" name="MedicalSurgicalSolutionsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CorporateOperatingExpenseandOtherIncomeNet" abstract="false" name="CorporateOperatingExpenseandOtherIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" abstract="false" name="OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" abstract="false" name="OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_LossContingencyAccrualAfterTax" abstract="false" name="LossContingencyAccrualAfterTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_TenderOfferNotesMember" abstract="true" name="TenderOfferNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePriceIncrease" abstract="false" name="NoncontrollingInterestsPutRightExercisePriceIncrease" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_LossContingencyNumberofStates" abstract="false" name="LossContingencyNumberofStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" abstract="false" name="OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_CurrentAssetLiabilityMember" abstract="true" name="CurrentAssetLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" abstract="true" name="ThreeLargestU.S.PharmaceuticalDistributorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_HeldForSalePolicyTextBlock" abstract="false" name="HeldForSalePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mck_A1625NotesDue2026Member" abstract="true" name="A1625NotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_CommonStockVotingRightsNumberofVotesPerCommonShare" abstract="false" name="CommonStockVotingRightsNumberofVotesPerCommonShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" abstract="false" name="ReclassificationOfTemporaryEquityToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_StateAndLocalGovernmentalEntitiesMember" abstract="true" name="StateAndLocalGovernmentalEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_PharmacyLicensesMember" abstract="true" name="PharmacyLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NationalPrescriptionOpiateLitigationMember" abstract="true" name="NationalPrescriptionOpiateLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" abstract="false" name="AnnualRecurringCompensationPerSharetoNoncontrollingInterests" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_IndividualClaimantMember" abstract="true" name="IndividualClaimantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RevenueDerivedFromServicesPercentage" abstract="false" name="RevenueDerivedFromServicesPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_A1500NotesDue2025Member" abstract="true" name="A1500NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A765DebenturesDueMarch12027Member" abstract="true" name="A765DebenturesDueMarch12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencySettlementAgreementAwardPaymentPeriod" abstract="false" name="LossContingencySettlementAgreementAwardPaymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mck_November2018CrossCurrencySwapsMember" abstract="true" name="November2018CrossCurrencySwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" abstract="false" name="AssetImpairmentChargesIncludingAcceleratedDepreciation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_PutRightValueInterestRateSpread" abstract="false" name="PutRightValueInterestRateSpread" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_RestructuringPlanRemoteWorkTransitioningMember" abstract="true" name="RestructuringPlanRemoteWorkTransitioningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" abstract="false" name="OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A3125NotesDue2029Member" abstract="true" name="A3125NotesDue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" abstract="true" name="AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" abstract="true" name="AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_EuroDenominatedNotesMember" abstract="true" name="EuroDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" abstract="true" name="ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestMember" abstract="true" name="RedeemableNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A488NotesDueMarch152044Member" abstract="true" name="A488NotesDueMarch152044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A063EuroNotesDueAugust172021Member" abstract="true" name="A063EuroNotesDueAugust172021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StateOfNewYorkMember" abstract="true" name="StateOfNewYorkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_GovernmentalEntitiesMember" abstract="true" name="GovernmentalEntitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" abstract="true" name="RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" abstract="false" name="RedeemableNoncontrollingInterestsMaximumRedemptionValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" abstract="true" name="SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" abstract="false" name="LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" abstract="false" name="LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mck_MckessonEuropeSubsidiaryMember" abstract="true" name="MckessonEuropeSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A380NotesDueMarch152024Member" abstract="true" name="A380NotesDueMarch152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A2025NotesMember" abstract="true" name="A2025NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncurrentAssetLiabilityMember" abstract="true" name="NoncurrentAssetLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A150EuroNotesDueNovember172025Member" abstract="true" name="A150EuroNotesDueNovember172025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_IncreaseDecreaseInLitigationReserve" abstract="false" name="IncreaseDecreaseInLitigationReserve" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NumberOfBusinessOperations" abstract="false" name="NumberOfBusinessOperations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_InternationalSegmentMember" abstract="true" name="InternationalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" abstract="false" name="LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_A313SterlingNotesDueFebruary172029Member" abstract="true" name="A313SterlingNotesDueFebruary172029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_RestructuringImpairmentandOtherRelatedCharges" abstract="false" name="RestructuringImpairmentandOtherRelatedCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_USPharmaceuticalSegmentMember" abstract="true" name="USPharmaceuticalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A600NotesDueMarch12041Member" abstract="true" name="A600NotesDueMarch12041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_StateOpioidStatutesMember" abstract="true" name="StateOpioidStatutesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NoncontrollingInterestsPutRightExercisePrice" abstract="false" name="NoncontrollingInterestsPutRightExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mck_LossContingencyNumberOfOtherDefendants" abstract="false" name="LossContingencyNumberOfOtherDefendants" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" abstract="false" name="NoncontrollingInterestIncreaseDecreaseDuetoOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected" abstract="false" name="DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" abstract="true" name="AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_NumberOfNationalBrandMedicalSurgicalProducts" abstract="false" name="NumberOfNationalBrandMedicalSurgicalProducts" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mck_ReclassificationofTemporaryEquitytoLiability" abstract="false" name="ReclassificationofTemporaryEquitytoLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_A285NotesDueMarch152023Member" abstract="true" name="A285NotesDueMarch152023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_PrescriptionTechnologySolutionsMember" abstract="true" name="PrescriptionTechnologySolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A475NotesDueMay302029Member" abstract="true" name="A475NotesDueMay302029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_VantageandClarusOneSourcingServicesLLCMember" abstract="true" name="VantageandClarusOneSourcingServicesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_A395NotesDueFebruary162028Member" abstract="true" name="A395NotesDueFebruary162028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_AcceleratedShareRepurchaseMember" abstract="true" name="AcceleratedShareRepurchaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" abstract="false" name="LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" abstract="false" name="NoncontrollingInterestDecreaseForExerciseOfPutRight" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>mck-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:31dc61f2-2ef8-41d9-90f2-e8ff46606457,g:0be0b981-6200-4a1a-a19d-196bf6df3870-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_94d1da1b-1546-4375-8126-f013bfa788ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_87d6a055-83d7-49d3-9d0b-2cfedbab24d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_94d1da1b-1546-4375-8126-f013bfa788ec" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_87d6a055-83d7-49d3-9d0b-2cfedbab24d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_4df52f05-60b0-41a9-8ef9-205a19c20a63" xlink:href="mck-20210630.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_94d1da1b-1546-4375-8126-f013bfa788ec" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_4df52f05-60b0-41a9-8ef9-205a19c20a63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_721563bb-cdaa-4611-8804-ed2ee1cb7727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_94d1da1b-1546-4375-8126-f013bfa788ec" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_721563bb-cdaa-4611-8804-ed2ee1cb7727" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_621c1d53-3db6-4da1-8cc5-f8e4ced8be61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b3631955-4fd4-4118-9365-9a09ac8c0b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_621c1d53-3db6-4da1-8cc5-f8e4ced8be61" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b3631955-4fd4-4118-9365-9a09ac8c0b62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_49bc1e46-9280-4613-88a1-1e70c32f6d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_621c1d53-3db6-4da1-8cc5-f8e4ced8be61" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_49bc1e46-9280-4613-88a1-1e70c32f6d36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c98df9d0-2a27-48f0-aa6a-78980dc17923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1b61796c-fcee-42fd-ab4e-efc341058b81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c98df9d0-2a27-48f0-aa6a-78980dc17923" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1b61796c-fcee-42fd-ab4e-efc341058b81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d0e141a6-7da2-47c7-8db8-d168f23b6cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c98df9d0-2a27-48f0-aa6a-78980dc17923" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d0e141a6-7da2-47c7-8db8-d168f23b6cc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_97912a5b-e066-4fd8-9222-81b406aaafdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_15ff1b64-39fe-4435-bfa4-f3e511cd3523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_97912a5b-e066-4fd8-9222-81b406aaafdf" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_15ff1b64-39fe-4435-bfa4-f3e511cd3523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_9be2e8c3-01c8-4c9d-acdc-f32718221b55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareDiluted_97912a5b-e066-4fd8-9222-81b406aaafdf" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_9be2e8c3-01c8-4c9d-acdc-f32718221b55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1a21f471-f0d2-40e9-ae96-a5a97a9926f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a80b176a-ed48-4f70-b4ab-fe6aae3d6ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1a21f471-f0d2-40e9-ae96-a5a97a9926f7" xlink:to="loc_us-gaap_ProfitLoss_a80b176a-ed48-4f70-b4ab-fe6aae3d6ce9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_490073b6-b7d4-4d85-9a48-561f7502141f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1a21f471-f0d2-40e9-ae96-a5a97a9926f7" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_490073b6-b7d4-4d85-9a48-561f7502141f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4b425a75-ec06-4a9e-8b2e-8b88a57af991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1245177c-fd38-4a73-ab25-a4d0d761bf8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_4b425a75-ec06-4a9e-8b2e-8b88a57af991" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_1245177c-fd38-4a73-ab25-a4d0d761bf8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_6587611a-638c-4a2d-91ce-79f9dc48ea16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_4b425a75-ec06-4a9e-8b2e-8b88a57af991" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_6587611a-638c-4a2d-91ce-79f9dc48ea16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c14b8473-bae1-4f2a-a898-3aa729e1e115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_48da1c28-8081-45a4-83ab-cd31b65718fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c14b8473-bae1-4f2a-a898-3aa729e1e115" xlink:to="loc_us-gaap_OperatingExpenses_48da1c28-8081-45a4-83ab-cd31b65718fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_5702bff2-aa1b-467b-9e15-d09fd2f027b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c14b8473-bae1-4f2a-a898-3aa729e1e115" xlink:to="loc_us-gaap_GrossProfit_5702bff2-aa1b-467b-9e15-d09fd2f027b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_cc0dfbd3-a2fb-4634-9342-926a96e29388" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_68f3f791-ea47-40e6-9bdc-c8778b73609d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_cc0dfbd3-a2fb-4634-9342-926a96e29388" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_68f3f791-ea47-40e6-9bdc-c8778b73609d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_2c7eb958-2a0b-4f50-882d-13e17b9c5b14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasic_cc0dfbd3-a2fb-4634-9342-926a96e29388" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_2c7eb958-2a0b-4f50-882d-13e17b9c5b14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3ae39349-ee36-410b-ab06-05313b3d06e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_484ff165-a548-4619-b681-e19e4b0ad355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3ae39349-ee36-410b-ab06-05313b3d06e1" xlink:to="loc_us-gaap_OperatingIncomeLoss_484ff165-a548-4619-b681-e19e4b0ad355" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_d6a62eaf-5b86-490c-9943-91079266e2de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3ae39349-ee36-410b-ab06-05313b3d06e1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_d6a62eaf-5b86-490c-9943-91079266e2de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_9616f8a3-a086-42e7-bd3a-01ca321bf273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3ae39349-ee36-410b-ab06-05313b3d06e1" xlink:to="loc_us-gaap_InterestAndDebtExpense_9616f8a3-a086-42e7-bd3a-01ca321bf273" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="mck-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0dde3033-6d3d-487c-9620-fefbae2f9fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cec58c6f-31f9-47fb-8d6b-2cbc31a372b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_0dde3033-6d3d-487c-9620-fefbae2f9fb4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_cec58c6f-31f9-47fb-8d6b-2cbc31a372b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_c72e72f9-14d9-4dd8-8d9a-75b026a40bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_0dde3033-6d3d-487c-9620-fefbae2f9fb4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_c72e72f9-14d9-4dd8-8d9a-75b026a40bb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_26eba6a1-cea6-46b8-9cfc-53b5c9474f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f751a510-fb05-4687-b833-e3ff7cfe1ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_26eba6a1-cea6-46b8-9cfc-53b5c9474f02" xlink:to="loc_us-gaap_ProfitLoss_f751a510-fb05-4687-b833-e3ff7cfe1ac8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_040b840d-71db-418d-aef8-9484e9447c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_26eba6a1-cea6-46b8-9cfc-53b5c9474f02" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_040b840d-71db-418d-aef8-9484e9447c8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7f32ddff-ce24-4b18-a5cc-1e633a6e6748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4bb0b103-133f-4109-bf9d-1c013c76f392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7f32ddff-ce24-4b18-a5cc-1e633a6e6748" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4bb0b103-133f-4109-bf9d-1c013c76f392" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_6e28098b-8f90-4435-b8de-bc7c3e123366" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7f32ddff-ce24-4b18-a5cc-1e633a6e6748" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_6e28098b-8f90-4435-b8de-bc7c3e123366" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_63bebc1a-21bb-4d47-857e-4eb23787e2df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7f32ddff-ce24-4b18-a5cc-1e633a6e6748" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_63bebc1a-21bb-4d47-857e-4eb23787e2df" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20210630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_88b7c82d-912e-4a14-9fa0-bfb5a2f163ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_a20441b6-45a4-413a-8d68-9f9ef961630f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_88b7c82d-912e-4a14-9fa0-bfb5a2f163ce" xlink:to="loc_us-gaap_PreferredStockValue_a20441b6-45a4-413a-8d68-9f9ef961630f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_aa39b0a1-79c4-4f71-a077-52a22f8f2a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_88b7c82d-912e-4a14-9fa0-bfb5a2f163ce" xlink:to="loc_us-gaap_CommonStockValue_aa39b0a1-79c4-4f71-a077-52a22f8f2a4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a30135d3-4249-45c3-9197-ca5c791ceb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_88b7c82d-912e-4a14-9fa0-bfb5a2f163ce" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a30135d3-4249-45c3-9197-ca5c791ceb6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9240e7dd-417e-474d-b14b-7778138cfa25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_88b7c82d-912e-4a14-9fa0-bfb5a2f163ce" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9240e7dd-417e-474d-b14b-7778138cfa25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d62819c0-6f21-425e-862e-12c5be2333e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_88b7c82d-912e-4a14-9fa0-bfb5a2f163ce" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d62819c0-6f21-425e-862e-12c5be2333e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_cc231179-3f38-4f4f-a154-80a6a6b5debf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_88b7c82d-912e-4a14-9fa0-bfb5a2f163ce" xlink:to="loc_us-gaap_TreasuryStockValue_cc231179-3f38-4f4f-a154-80a6a6b5debf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddd23c57-556e-4656-a80e-04091b7fd1df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0dac3c4e-8c72-4153-9c55-34365601ab5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddd23c57-556e-4656-a80e-04091b7fd1df" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0dac3c4e-8c72-4153-9c55-34365601ab5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_76f6c8ba-08c2-4662-a1c9-a143781a2d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddd23c57-556e-4656-a80e-04091b7fd1df" xlink:to="loc_us-gaap_LiabilitiesCurrent_76f6c8ba-08c2-4662-a1c9-a143781a2d31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_50595175-0532-4a36-b78a-3bf58dc2aa82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddd23c57-556e-4656-a80e-04091b7fd1df" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_50595175-0532-4a36-b78a-3bf58dc2aa82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_7a5893c1-8014-4763-b909-3d3501507fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddd23c57-556e-4656-a80e-04091b7fd1df" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_7a5893c1-8014-4763-b909-3d3501507fb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_676ffbb9-9d28-4bd5-ba3c-63171b764fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddd23c57-556e-4656-a80e-04091b7fd1df" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_676ffbb9-9d28-4bd5-ba3c-63171b764fd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_65ec65a9-cd57-4290-bf57-462838dae8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddd23c57-556e-4656-a80e-04091b7fd1df" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_65ec65a9-cd57-4290-bf57-462838dae8ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e0138610-7ab2-4cdb-865a-352a1151ef5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddd23c57-556e-4656-a80e-04091b7fd1df" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e0138610-7ab2-4cdb-865a-352a1151ef5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3aabae5d-5043-49e3-a4bf-48aae3e007f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ddd23c57-556e-4656-a80e-04091b7fd1df" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3aabae5d-5043-49e3-a4bf-48aae3e007f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5391dd88-0f9f-43af-84f7-8bd12efea85c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_76dc94c2-d786-4efd-b205-d9e10d60ae73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5391dd88-0f9f-43af-84f7-8bd12efea85c" xlink:to="loc_us-gaap_AssetsCurrent_76dc94c2-d786-4efd-b205-d9e10d60ae73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2b7c532c-6def-4902-9adb-d518656db839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5391dd88-0f9f-43af-84f7-8bd12efea85c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2b7c532c-6def-4902-9adb-d518656db839" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_861ddc80-b898-466c-8109-7e62a2165bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5391dd88-0f9f-43af-84f7-8bd12efea85c" xlink:to="loc_us-gaap_Goodwill_861ddc80-b898-466c-8109-7e62a2165bf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c8f026a3-b342-4627-9735-1d94c9461c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5391dd88-0f9f-43af-84f7-8bd12efea85c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c8f026a3-b342-4627-9735-1d94c9461c3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1e02a2fb-a544-466a-9dbd-fbf573878dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5391dd88-0f9f-43af-84f7-8bd12efea85c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1e02a2fb-a544-466a-9dbd-fbf573878dc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c15fc412-656e-477a-ac66-d4dcc77c9d06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_5391dd88-0f9f-43af-84f7-8bd12efea85c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c15fc412-656e-477a-ac66-d4dcc77c9d06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_02b2df87-a6b6-4db2-a277-a6da7feece2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_cbc05285-614e-445d-8413-ddea7aa824c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_02b2df87-a6b6-4db2-a277-a6da7feece2d" xlink:to="loc_us-gaap_AccountsPayableCurrent_cbc05285-614e-445d-8413-ddea7aa824c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_af846354-eaef-446a-9b98-6d217deafd14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_02b2df87-a6b6-4db2-a277-a6da7feece2d" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_af846354-eaef-446a-9b98-6d217deafd14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_aeff8899-6d0b-448f-8b64-e3f3d189ac2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_02b2df87-a6b6-4db2-a277-a6da7feece2d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_aeff8899-6d0b-448f-8b64-e3f3d189ac2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d69cfa1f-364f-41bc-adb4-116e7f9e7a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_02b2df87-a6b6-4db2-a277-a6da7feece2d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d69cfa1f-364f-41bc-adb4-116e7f9e7a6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_43ddda9b-f782-4165-a7a2-71fc61af6170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_02b2df87-a6b6-4db2-a277-a6da7feece2d" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_43ddda9b-f782-4165-a7a2-71fc61af6170" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d3c5cba1-c518-4115-9198-3c499933b637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9e97116d-9719-484b-ae36-0b1c3d618504" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d3c5cba1-c518-4115-9198-3c499933b637" xlink:to="loc_us-gaap_StockholdersEquity_9e97116d-9719-484b-ae36-0b1c3d618504" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_8052a4d6-85b0-4f7d-89c6-961b9329a3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d3c5cba1-c518-4115-9198-3c499933b637" xlink:to="loc_us-gaap_MinorityInterest_8052a4d6-85b0-4f7d-89c6-961b9329a3c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a7c12971-273d-451e-85ef-126a9d3d1e00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_783f3ba1-ae58-41f4-a7a3-6688bea3d5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a7c12971-273d-451e-85ef-126a9d3d1e00" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_783f3ba1-ae58-41f4-a7a3-6688bea3d5d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_fba1a1b7-f005-4382-933f-d266caacc6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a7c12971-273d-451e-85ef-126a9d3d1e00" xlink:to="loc_us-gaap_ReceivablesNetCurrent_fba1a1b7-f005-4382-933f-d266caacc6f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ff05d935-d606-4104-80ac-d1af5ff7772e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a7c12971-273d-451e-85ef-126a9d3d1e00" xlink:to="loc_us-gaap_InventoryNet_ff05d935-d606-4104-80ac-d1af5ff7772e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9956b484-5ec7-4b84-993c-497b790b4ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a7c12971-273d-451e-85ef-126a9d3d1e00" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9956b484-5ec7-4b84-993c-497b790b4ad7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_f788e982-488c-4510-9409-8882f1685a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a7c12971-273d-451e-85ef-126a9d3d1e00" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_f788e982-488c-4510-9409-8882f1685a53" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2785014f-39d5-4ce2-96ad-12d212d15318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9e38e76c-e0ac-4fc7-8c11-97ae619a989d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2785014f-39d5-4ce2-96ad-12d212d15318" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9e38e76c-e0ac-4fc7-8c11-97ae619a989d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_f47277fb-5d3d-4392-b26f-b4dc25eb8e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2785014f-39d5-4ce2-96ad-12d212d15318" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_f47277fb-5d3d-4392-b26f-b4dc25eb8e21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_3833aef0-3e45-4eae-b0a3-af3412ec8aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2785014f-39d5-4ce2-96ad-12d212d15318" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_3833aef0-3e45-4eae-b0a3-af3412ec8aa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_6a8af95a-1404-4897-b10e-b34bcea2080b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2785014f-39d5-4ce2-96ad-12d212d15318" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_6a8af95a-1404-4897-b10e-b34bcea2080b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_533c41bc-1eee-4d5d-b90d-67a39ed72428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2785014f-39d5-4ce2-96ad-12d212d15318" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_533c41bc-1eee-4d5d-b90d-67a39ed72428" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_81633cdc-d3aa-4b98-bac1-1316ebd6ae78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2785014f-39d5-4ce2-96ad-12d212d15318" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_81633cdc-d3aa-4b98-bac1-1316ebd6ae78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2d940020-1f7f-472d-a2c9-59cdfe668ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2785014f-39d5-4ce2-96ad-12d212d15318" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2d940020-1f7f-472d-a2c9-59cdfe668ef5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_08f28175-b52d-4f37-b982-c3aab546fcc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2785014f-39d5-4ce2-96ad-12d212d15318" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_08f28175-b52d-4f37-b982-c3aab546fcc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_da5af433-5a93-48db-b2ad-1fededce76ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4e8813d4-222e-4b35-89e2-5e76288d15d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_da5af433-5a93-48db-b2ad-1fededce76ce" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4e8813d4-222e-4b35-89e2-5e76288d15d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_6abd1af2-7bec-4a0d-becf-f727b6ec524e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_da5af433-5a93-48db-b2ad-1fededce76ce" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_6abd1af2-7bec-4a0d-becf-f727b6ec524e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b16fced3-e71f-423e-b219-a08c1dc47921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_da5af433-5a93-48db-b2ad-1fededce76ce" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b16fced3-e71f-423e-b219-a08c1dc47921" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_aaf0674e-bc79-45cd-bffe-37322afdd55d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_da5af433-5a93-48db-b2ad-1fededce76ce" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_aaf0674e-bc79-45cd-bffe-37322afdd55d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2a032af8-33c6-43a1-821d-d858e760c121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_da5af433-5a93-48db-b2ad-1fededce76ce" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2a032af8-33c6-43a1-821d-d858e760c121" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f2a445d2-7196-4427-bf8e-8a5a4ef6227c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_4440ac30-93b9-40eb-8dc0-443812904273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f2a445d2-7196-4427-bf8e-8a5a4ef6227c" xlink:to="loc_us-gaap_RestrictedCashCurrent_4440ac30-93b9-40eb-8dc0-443812904273" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fac819b1-e90e-49d1-8b36-e35d65a04aca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f2a445d2-7196-4427-bf8e-8a5a4ef6227c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fac819b1-e90e-49d1-8b36-e35d65a04aca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_cb8e7e04-bc27-4c93-90de-bcd4f9d1001e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_cb8e7e04-bc27-4c93-90de-bcd4f9d1001e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_d27c19e3-f686-4744-8ea2-9d769a1e2412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_d27c19e3-f686-4744-8ea2-9d769a1e2412" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_dc939506-f474-4e9c-b685-7a9433963c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_dc939506-f474-4e9c-b685-7a9433963c73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_13b41e4e-fb71-4e87-8806-23a7e566e88a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_AdjustmentForAmortization_13b41e4e-fb71-4e87-8806-23a7e566e88a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d8948d83-53ce-4bfe-979f-2ff275b9aa20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_ProfitLoss_d8948d83-53ce-4bfe-979f-2ff275b9aa20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_6e3d93a7-c312-49db-a2f6-e29c81b5123f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_6e3d93a7-c312-49db-a2f6-e29c81b5123f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ff0ea4f2-98bb-4602-b921-da8a84164369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_Depreciation_ff0ea4f2-98bb-4602-b921-da8a84164369" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_7b2bbe4a-9dab-4431-bbbd-d09ce71c5ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_7b2bbe4a-9dab-4431-bbbd-d09ce71c5ca2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_e65cdb5e-ab6a-4ae9-9d6a-0a5daca7bed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_e65cdb5e-ab6a-4ae9-9d6a-0a5daca7bed6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_6bff944d-89de-4106-a8f2-667c1cfd1afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_6bff944d-89de-4106-a8f2-667c1cfd1afa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_38cee978-3c84-475b-9d9c-39513bc15dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_38cee978-3c84-475b-9d9c-39513bc15dd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_fc3035f1-4d91-418b-b2aa-2d8e7498009d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_AssetImpairmentCharges_fc3035f1-4d91-418b-b2aa-2d8e7498009d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_f7707cd6-c231-43e8-aa06-6c38e8274f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_OperatingLeaseExpense_f7707cd6-c231-43e8-aa06-6c38e8274f3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_40c45657-738a-4a52-97d9-5e12e83f12e2" xlink:href="mck-20210630.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_40c45657-738a-4a52-97d9-5e12e83f12e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1613d329-9d7a-48d8-9e66-dd7c373f989a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1613d329-9d7a-48d8-9e66-dd7c373f989a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_14dac2c4-9f29-48cc-82f8-ddf48283e954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_08210249-a034-49b7-9084-c5a7b803e55a" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_14dac2c4-9f29-48cc-82f8-ddf48283e954" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6790a380-d100-47bc-b1cb-f79abdcf5a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bcf58bff-a180-4b5d-b07b-732fdb4a5133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6790a380-d100-47bc-b1cb-f79abdcf5a04" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bcf58bff-a180-4b5d-b07b-732fdb4a5133" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_42e20f39-e9cb-4ca3-a48f-e8a1a6ddaf4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6790a380-d100-47bc-b1cb-f79abdcf5a04" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_42e20f39-e9cb-4ca3-a48f-e8a1a6ddaf4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a97fc1c4-614c-4a29-8ee3-fba166d0d14f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6790a380-d100-47bc-b1cb-f79abdcf5a04" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a97fc1c4-614c-4a29-8ee3-fba166d0d14f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_259f796d-9e99-4210-bbf8-dba6374dbad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6790a380-d100-47bc-b1cb-f79abdcf5a04" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_259f796d-9e99-4210-bbf8-dba6374dbad6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b535ab8d-36e8-4fd4-97b3-4b0cf7e757b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_7788b2c1-c1c9-4fea-8586-7a9dca28cb32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_b535ab8d-36e8-4fd4-97b3-4b0cf7e757b6" xlink:to="loc_us-gaap_SeveranceCosts1_7788b2c1-c1c9-4fea-8586-7a9dca28cb32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_430e58e4-f0d7-403c-8d16-4b8b74baed9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_b535ab8d-36e8-4fd4-97b3-4b0cf7e757b6" xlink:to="loc_us-gaap_BusinessExitCosts1_430e58e4-f0d7-403c-8d16-4b8b74baed9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_61823868-7a9b-4f4b-a80d-1624cbc786a6" xlink:href="mck-20210630.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_b535ab8d-36e8-4fd4-97b3-4b0cf7e757b6" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_61823868-7a9b-4f4b-a80d-1624cbc786a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#EarningsLossPerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_3215cdb8-072f-4a8e-b319-314a5cd34b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4521e207-febb-4a96-bd98-194067440066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_3215cdb8-072f-4a8e-b319-314a5cd34b20" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_4521e207-febb-4a96-bd98-194067440066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7b06b030-b009-486f-8fe7-14f26f2ed936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_3215cdb8-072f-4a8e-b319-314a5cd34b20" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7b06b030-b009-486f-8fe7-14f26f2ed936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f9d3e6d7-f827-468a-b59d-05532b8b03e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_41b39ebb-d35d-4ca3-a17b-68fd61cb3a18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f9d3e6d7-f827-468a-b59d-05532b8b03e6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_41b39ebb-d35d-4ca3-a17b-68fd61cb3a18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_feabc3fb-b472-4f1c-a837-7fdb4cf50879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f9d3e6d7-f827-468a-b59d-05532b8b03e6" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_feabc3fb-b472-4f1c-a837-7fdb4cf50879" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a147b006-9fa8-4679-9e4d-c149c4da32a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_fa7384f3-bbe3-4806-8df8-636ff3e6a991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a147b006-9fa8-4679-9e4d-c149c4da32a6" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_fa7384f3-bbe3-4806-8df8-636ff3e6a991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_22124eb4-960d-4b11-86da-b71bc14dacc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a147b006-9fa8-4679-9e4d-c149c4da32a6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_22124eb4-960d-4b11-86da-b71bc14dacc4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_02f6347a-58ac-437d-bd6b-552765922b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4ec1ba4f-31cb-464a-a43b-1537ec8e2802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_02f6347a-58ac-437d-bd6b-552765922b86" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4ec1ba4f-31cb-464a-a43b-1537ec8e2802" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_265938b7-36c0-4970-a12e-0f77301fdbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_02f6347a-58ac-437d-bd6b-552765922b86" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_265938b7-36c0-4970-a12e-0f77301fdbb7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_8074feb6-691a-46de-a41c-aedca1a72c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_fbf5ea90-a951-454f-915b-327ff80eb98d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_8074feb6-691a-46de-a41c-aedca1a72c47" xlink:to="loc_us-gaap_FinanceLeaseLiability_fbf5ea90-a951-454f-915b-327ff80eb98d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c530128b-7c02-46c7-bf3a-f52da87418e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_8074feb6-691a-46de-a41c-aedca1a72c47" xlink:to="loc_us-gaap_LongTermDebt_c530128b-7c02-46c7-bf3a-f52da87418e4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="simple" xlink:href="mck-20210630.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_90a1db07-0bfd-4e6b-924f-928fcdda7c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ec15a0ff-d3d2-4c59-b715-6ddf0510aa30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_90a1db07-0bfd-4e6b-924f-928fcdda7c50" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ec15a0ff-d3d2-4c59-b715-6ddf0510aa30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2db2db10-803a-423d-bd2b-8f4a24a0dd7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations_90a1db07-0bfd-4e6b-924f-928fcdda7c50" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_2db2db10-803a-423d-bd2b-8f4a24a0dd7a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_1de9d882-3579-4f0c-a560-62484fdbf630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_fccde6f2-2b2b-49b3-bc30-cdfe54923ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_1de9d882-3579-4f0c-a560-62484fdbf630" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_fccde6f2-2b2b-49b3-bc30-cdfe54923ba2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_b2e8113d-1ad3-4429-a03e-d69ef0f8ee28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue_1de9d882-3579-4f0c-a560-62484fdbf630" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_b2e8113d-1ad3-4429-a03e-d69ef0f8ee28" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4702f653-56e7-4d86-b04b-46bbd11a6098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a869cf16-0324-4620-a72c-30fa683ab9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4702f653-56e7-4d86-b04b-46bbd11a6098" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_a869cf16-0324-4620-a72c-30fa683ab9bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_f8d0876a-d0bd-45f4-b276-5ec4a1f64946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4702f653-56e7-4d86-b04b-46bbd11a6098" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_f8d0876a-d0bd-45f4-b276-5ec4a1f64946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0296ded7-29c4-4b99-9420-3600bf11ea34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_91de84f0-10e4-4045-8412-0ef25babbbfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0296ded7-29c4-4b99-9420-3600bf11ea34" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_91de84f0-10e4-4045-8412-0ef25babbbfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5078b4d0-db22-4f52-b45b-239b9f56337a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0296ded7-29c4-4b99-9420-3600bf11ea34" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5078b4d0-db22-4f52-b45b-239b9f56337a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#SegmentsofBusinessDetails"/>
  <link:calculationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3f47d0d6-5c9c-4cf0-99b7-bc690a83c11e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b2e8f5f8-d976-48df-9026-d1c4fcc09b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3f47d0d6-5c9c-4cf0-99b7-bc690a83c11e" xlink:to="loc_us-gaap_OperatingIncomeLoss_b2e8f5f8-d976-48df-9026-d1c4fcc09b5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_fb878473-d172-413b-bf6b-6fdd1ae4bfc4" xlink:href="mck-20210630.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3f47d0d6-5c9c-4cf0-99b7-bc690a83c11e" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_fb878473-d172-413b-bf6b-6fdd1ae4bfc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_4290f55b-8839-46c7-8266-6ce9673eb0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3f47d0d6-5c9c-4cf0-99b7-bc690a83c11e" xlink:to="loc_us-gaap_InterestAndDebtExpense_4290f55b-8839-46c7-8266-6ce9673eb0b6" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>mck-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:31dc61f2-2ef8-41d9-90f2-e8ff46606457,g:0be0b981-6200-4a1a-a19d-196bf6df3870-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20210630.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended" id="i43c014ea745946c9818ff20318399f90_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_63a72252-8cd0-4fd3-b754-22b41b403a19" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_DocumentType_63a72252-8cd0-4fd3-b754-22b41b403a19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_74ebd5c6-4024-43ae-a053-9be195e519d4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_DocumentQuarterlyReport_74ebd5c6-4024-43ae-a053-9be195e519d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4cf1353a-be34-4fc5-b762-b9c12f96b9f3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_DocumentPeriodEndDate_4cf1353a-be34-4fc5-b762-b9c12f96b9f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_706ad803-c7fc-4964-9ea8-11289e8a1c51" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_DocumentTransitionReport_706ad803-c7fc-4964-9ea8-11289e8a1c51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_507a7f73-ae54-4324-bed7-c381655d2bfd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityFileNumber_507a7f73-ae54-4324-bed7-c381655d2bfd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5c8cdacf-929a-4ed7-a831-def4f4dd607b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityRegistrantName_5c8cdacf-929a-4ed7-a831-def4f4dd607b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d1387bc0-9f05-457c-afa8-0fb0a4175428" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d1387bc0-9f05-457c-afa8-0fb0a4175428" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b07dfdb7-59ed-4a24-a0a7-b3fc8db87564" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityTaxIdentificationNumber_b07dfdb7-59ed-4a24-a0a7-b3fc8db87564" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f5703fbf-ca57-480f-9fc3-a9d950aa9d2b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityAddressAddressLine1_f5703fbf-ca57-480f-9fc3-a9d950aa9d2b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2f9d22c1-ddfc-40e9-99a1-a9a58acf0f71" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityAddressCityOrTown_2f9d22c1-ddfc-40e9-99a1-a9a58acf0f71" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5158ee04-b847-4070-bb97-93eb791b2632" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityAddressStateOrProvince_5158ee04-b847-4070-bb97-93eb791b2632" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_aca8d6b9-4330-43a2-9322-b3695da6851a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityAddressPostalZipCode_aca8d6b9-4330-43a2-9322-b3695da6851a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e503d7f9-10e4-41ad-9adb-dfb7955def15" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_CityAreaCode_e503d7f9-10e4-41ad-9adb-dfb7955def15" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4ab9f3ca-fed3-4e30-abc9-1cc7c4ffdb27" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_LocalPhoneNumber_4ab9f3ca-fed3-4e30-abc9-1cc7c4ffdb27" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ca5d0579-fbae-4a5b-9ae2-cdee0b799d9f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_Security12bTitle_ca5d0579-fbae-4a5b-9ae2-cdee0b799d9f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d0614eb0-4164-4845-a6ec-f6113bd2847d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_TradingSymbol_d0614eb0-4164-4845-a6ec-f6113bd2847d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b72d587d-d2c5-4f2b-b7a8-4a3f700dd2b3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_SecurityExchangeName_b72d587d-d2c5-4f2b-b7a8-4a3f700dd2b3" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8b3d2d79-047a-4bfe-b87a-25668bb2d2fa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityCurrentReportingStatus_8b3d2d79-047a-4bfe-b87a-25668bb2d2fa" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_12130e24-bac2-44a5-9b4d-48a9c76eedd8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityInteractiveDataCurrent_12130e24-bac2-44a5-9b4d-48a9c76eedd8" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6b35f74f-2917-4466-b893-660714a9aeef" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityFilerCategory_6b35f74f-2917-4466-b893-660714a9aeef" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_59426d4f-071f-4c79-ad15-e8d8366edda0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntitySmallBusiness_59426d4f-071f-4c79-ad15-e8d8366edda0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_50be5d07-7322-40b7-bb31-78a4b80e96e4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityEmergingGrowthCompany_50be5d07-7322-40b7-bb31-78a4b80e96e4" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ad33df09-83a6-4fe9-bc2d-db9b9b6444ff" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityShellCompany_ad33df09-83a6-4fe9-bc2d-db9b9b6444ff" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_f90b437e-aec6-4d7b-b5a2-020edb1d228e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_f90b437e-aec6-4d7b-b5a2-020edb1d228e" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cf3351a3-f766-4fcf-ae5c-fcc8391ec605" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityCentralIndexKey_cf3351a3-f766-4fcf-ae5c-fcc8391ec605" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_939e0ecd-b8c4-455b-a967-ab8308298a1a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_DocumentFiscalYearFocus_939e0ecd-b8c4-455b-a967-ab8308298a1a" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_93b78203-595b-46c9-a885-a50982f420ce" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_DocumentFiscalPeriodFocus_93b78203-595b-46c9-a885-a50982f420ce" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_187424b3-7b30-4883-af33-631983eeffcf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_AmendmentFlag_187424b3-7b30-4883-af33-631983eeffcf" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e1bbd3b4-bb3b-4881-bb28-8f82e5f3fb4e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_CurrentFiscalYearEndDate_e1bbd3b4-bb3b-4881-bb28-8f82e5f3fb4e" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_f5b9596b-c3b9-4010-a3d4-a043f6ccdf78" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntitiesTable_f5b9596b-c3b9-4010-a3d4-a043f6ccdf78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6bcc9536-b7d3-4928-9197-1af7a46ad925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_f5b9596b-c3b9-4010-a3d4-a043f6ccdf78" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6bcc9536-b7d3-4928-9197-1af7a46ad925" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6bcc9536-b7d3-4928-9197-1af7a46ad925_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6bcc9536-b7d3-4928-9197-1af7a46ad925" xlink:to="loc_us-gaap_ClassOfStockDomain_6bcc9536-b7d3-4928-9197-1af7a46ad925_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_621620fa-3774-4468-b4cf-e1f40975ddf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6bcc9536-b7d3-4928-9197-1af7a46ad925" xlink:to="loc_us-gaap_ClassOfStockDomain_621620fa-3774-4468-b4cf-e1f40975ddf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a515a3fb-acfb-48c4-92b0-08808547c67c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_621620fa-3774-4468-b4cf-e1f40975ddf7" xlink:to="loc_us-gaap_CommonStockMember_a515a3fb-acfb-48c4-92b0-08808547c67c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member_ff97b079-4ccd-4a75-bd92-3a4fdfe4ce54" xlink:href="mck-20210630.xsd#mck_A1500NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_621620fa-3774-4468-b4cf-e1f40975ddf7" xlink:to="loc_mck_A1500NotesDue2025Member_ff97b079-4ccd-4a75-bd92-3a4fdfe4ce54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member_44d63db3-797a-478d-8008-5dc81b1b435b" xlink:href="mck-20210630.xsd#mck_A1625NotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_621620fa-3774-4468-b4cf-e1f40975ddf7" xlink:to="loc_mck_A1625NotesDue2026Member_44d63db3-797a-478d-8008-5dc81b1b435b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member_2eef3c4e-716b-41f8-99fa-091236764a41" xlink:href="mck-20210630.xsd#mck_A3125NotesDue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_621620fa-3774-4468-b4cf-e1f40975ddf7" xlink:to="loc_mck_A3125NotesDue2029Member_2eef3c4e-716b-41f8-99fa-091236764a41" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="mck-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended" id="i2f611458f1d24782a1036140aca2537e_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4bb75948-bb30-410a-a052-0b9cf82419f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4bb75948-bb30-410a-a052-0b9cf82419f7" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_8026f9c5-65cd-4f21-8f49-3da1b631b833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_SharesOutstanding_8026f9c5-65cd-4f21-8f49-3da1b631b833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_6a520d56-9ae0-4f90-a6da-b26be9fc6d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_TreasuryStockShares_6a520d56-9ae0-4f90-a6da-b26be9fc6d5f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f7f04cbe-97e3-4544-9a56-73e1a4854cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f7f04cbe-97e3-4544-9a56-73e1a4854cd7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0d6e611c-5d87-421a-97b2-3ee32bc1b1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0d6e611c-5d87-421a-97b2-3ee32bc1b1b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_55e83667-f3d4-4918-97fa-633d2241c86f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_55e83667-f3d4-4918-97fa-633d2241c86f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f6049eca-f6b2-4d1b-8724-5461c0d56b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f6049eca-f6b2-4d1b-8724-5461c0d56b40" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_a74e375d-8085-45f8-8c56-13fa3e2ea00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_a74e375d-8085-45f8-8c56-13fa3e2ea00f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6a6158b7-d97a-486a-9fa8-06bdae522b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6a6158b7-d97a-486a-9fa8-06bdae522b2a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_b43db364-6b07-471a-ba36-6bc08b446332" xlink:href="mck-20210630.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_b43db364-6b07-471a-ba36-6bc08b446332" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_5ba081b6-262e-47ee-af78-46d5b0c0b5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_5ba081b6-262e-47ee-af78-46d5b0c0b5c7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_f5ef7c60-319b-4dca-b5e2-895af6924ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_f5ef7c60-319b-4dca-b5e2-895af6924ee2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_48dacedf-0274-47c2-8413-faa319a16c1b" xlink:href="mck-20210630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_48dacedf-0274-47c2-8413-faa319a16c1b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_dfbe71f1-40c2-4b32-86ac-ccd2d2e89284" xlink:href="mck-20210630.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_dfbe71f1-40c2-4b32-86ac-ccd2d2e89284" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_97f01bbd-b796-405d-9eec-fd1cb5ff37d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_DividendsCommonStockCash_97f01bbd-b796-405d-9eec-fd1cb5ff37d6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_a66e115c-1a48-48f8-9543-0bd567cdbe87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_StockholdersEquityOther_a66e115c-1a48-48f8-9543-0bd567cdbe87" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_772ce395-118e-4db1-ac52-792c0314d740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_68e55a7a-1c26-472a-b8d6-4063033634fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_76b4eae3-bdd9-46f7-bb82-25e1940ddea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5e11e785-725f-4f3b-8bb8-63ac98588b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4bb75948-bb30-410a-a052-0b9cf82419f7" xlink:to="loc_us-gaap_StatementTable_5e11e785-725f-4f3b-8bb8-63ac98588b51" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_79a20978-22d0-41cc-965e-ca0ea8365be4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5e11e785-725f-4f3b-8bb8-63ac98588b51" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_79a20978-22d0-41cc-965e-ca0ea8365be4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_79a20978-22d0-41cc-965e-ca0ea8365be4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_79a20978-22d0-41cc-965e-ca0ea8365be4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_79a20978-22d0-41cc-965e-ca0ea8365be4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b136cb5a-e5a3-4a93-b8aa-c040b8914704" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_79a20978-22d0-41cc-965e-ca0ea8365be4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b136cb5a-e5a3-4a93-b8aa-c040b8914704" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_8462d780-57e8-4235-a0f5-c0b3c4ebfb78" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b136cb5a-e5a3-4a93-b8aa-c040b8914704" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_8462d780-57e8-4235-a0f5-c0b3c4ebfb78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_f4c531a5-489e-4f14-9716-c9a53d87fcc7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b136cb5a-e5a3-4a93-b8aa-c040b8914704" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_f4c531a5-489e-4f14-9716-c9a53d87fcc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_604eb520-e36c-42d0-8586-c9f9ca5743e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5e11e785-725f-4f3b-8bb8-63ac98588b51" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_604eb520-e36c-42d0-8586-c9f9ca5743e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_604eb520-e36c-42d0-8586-c9f9ca5743e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_604eb520-e36c-42d0-8586-c9f9ca5743e1" xlink:to="loc_us-gaap_EquityComponentDomain_604eb520-e36c-42d0-8586-c9f9ca5743e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_604eb520-e36c-42d0-8586-c9f9ca5743e1" xlink:to="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_724f0286-c529-45ba-88ae-16df28781d32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:to="loc_us-gaap_CommonStockMember_724f0286-c529-45ba-88ae-16df28781d32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_fd5ee204-a77c-4767-a958-28688d1edf43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_fd5ee204-a77c-4767-a958-28688d1edf43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_74969889-f254-46ff-9e0f-087c6b8f386e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:to="loc_us-gaap_RetainedEarningsMember_74969889-f254-46ff-9e0f-087c6b8f386e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d221c7d1-4e6d-4462-a1bf-efabd22c3451" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d221c7d1-4e6d-4462-a1bf-efabd22c3451" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_50d6008d-67e4-4fc0-8dae-8aee079a6691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:to="loc_us-gaap_TreasuryStockMember_50d6008d-67e4-4fc0-8dae-8aee079a6691" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_39c24ba0-511e-4025-9780-06c59e5588c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:to="loc_us-gaap_NoncontrollingInterestMember_39c24ba0-511e-4025-9780-06c59e5588c4" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#HeldforSaleNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended" id="ie3a2ec33d701441e987b2744ba57a711_HeldforSaleNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_111afe13-89c5-41c5-a98b-e50f5ee7fd59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_ea480451-ccf1-40c6-bddd-655aecbfaaff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_111afe13-89c5-41c5-a98b-e50f5ee7fd59" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_ea480451-ccf1-40c6-bddd-655aecbfaaff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_361cd265-3ff7-437a-9f8e-a4af6bf6582e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_111afe13-89c5-41c5-a98b-e50f5ee7fd59" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_361cd265-3ff7-437a-9f8e-a4af6bf6582e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_f6a98236-232e-4931-ab7c-065a5d82fc6e" xlink:href="mck-20210630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_111afe13-89c5-41c5-a98b-e50f5ee7fd59" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_f6a98236-232e-4931-ab7c-065a5d82fc6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected_4e54e888-5ddb-46cc-9cb8-0c167ee3d510" xlink:href="mck-20210630.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_111afe13-89c5-41c5-a98b-e50f5ee7fd59" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected_4e54e888-5ddb-46cc-9cb8-0c167ee3d510" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_111afe13-89c5-41c5-a98b-e50f5ee7fd59" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7bd2097e-eeb8-4093-bc0a-10433da3f5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7bd2097e-eeb8-4093-bc0a-10433da3f5cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7bd2097e-eeb8-4093-bc0a-10433da3f5cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7bd2097e-eeb8-4093-bc0a-10433da3f5cb" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7bd2097e-eeb8-4093-bc0a-10433da3f5cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9f0805ed-f896-426b-9aff-765e013c960d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7bd2097e-eeb8-4093-bc0a-10433da3f5cb" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9f0805ed-f896-426b-9aff-765e013c960d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_4dcd7e8e-9583-4195-884c-a7b8a8ff0ceb" xlink:href="mck-20210630.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9f0805ed-f896-426b-9aff-765e013c960d" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_4dcd7e8e-9583-4195-884c-a7b8a8ff0ceb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_0650d8a7-f022-4542-914c-5e4fe2b076e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_0650d8a7-f022-4542-914c-5e4fe2b076e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0650d8a7-f022-4542-914c-5e4fe2b076e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_0650d8a7-f022-4542-914c-5e4fe2b076e1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0650d8a7-f022-4542-914c-5e4fe2b076e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c9d54ef2-a588-4277-9637-1d4f57bcf649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_0650d8a7-f022-4542-914c-5e4fe2b076e1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c9d54ef2-a588-4277-9637-1d4f57bcf649" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a9d5bb17-8e3c-4166-bb5e-42ed7cfcc65b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c9d54ef2-a588-4277-9637-1d4f57bcf649" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a9d5bb17-8e3c-4166-bb5e-42ed7cfcc65b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b6c9ccd6-b239-4283-ae96-93d75db544fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b6c9ccd6-b239-4283-ae96-93d75db544fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b6c9ccd6-b239-4283-ae96-93d75db544fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b6c9ccd6-b239-4283-ae96-93d75db544fc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b6c9ccd6-b239-4283-ae96-93d75db544fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bd91d7e9-64e8-4dcf-b178-810e780597b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b6c9ccd6-b239-4283-ae96-93d75db544fc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bd91d7e9-64e8-4dcf-b178-810e780597b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ad43c5b1-c8ac-446e-a795-355d22a87636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_bd91d7e9-64e8-4dcf-b178-810e780597b3" xlink:to="loc_us-gaap_SubsequentEventMember_ad43c5b1-c8ac-446e-a795-355d22a87636" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0b15d000-72ea-4e5c-bbb0-2b4c4f5577e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:to="loc_srt_StatementScenarioAxis_0b15d000-72ea-4e5c-bbb0-2b4c4f5577e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0b15d000-72ea-4e5c-bbb0-2b4c4f5577e5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_0b15d000-72ea-4e5c-bbb0-2b4c4f5577e5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0b15d000-72ea-4e5c-bbb0-2b4c4f5577e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4d135e39-22c4-4ff8-aeb7-1a054c8d8d49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_0b15d000-72ea-4e5c-bbb0-2b4c4f5577e5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4d135e39-22c4-4ff8-aeb7-1a054c8d8d49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_9f15a187-9a80-4648-9a78-25da343e54dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_4d135e39-22c4-4ff8-aeb7-1a054c8d8d49" xlink:to="loc_srt_ScenarioForecastMember_9f15a187-9a80-4648-9a78-25da343e54dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ffd2a8ae-b688-4da2-ab6e-04f5c1a91de3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:to="loc_srt_RangeAxis_ffd2a8ae-b688-4da2-ab6e-04f5c1a91de3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ffd2a8ae-b688-4da2-ab6e-04f5c1a91de3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_ffd2a8ae-b688-4da2-ab6e-04f5c1a91de3" xlink:to="loc_srt_RangeMember_ffd2a8ae-b688-4da2-ab6e-04f5c1a91de3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b6cbc9ea-eb23-427e-82da-de4222e68f7b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_ffd2a8ae-b688-4da2-ab6e-04f5c1a91de3" xlink:to="loc_srt_RangeMember_b6cbc9ea-eb23-427e-82da-de4222e68f7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4aa1ad23-ed1d-4456-85f6-5ae5121f4fdf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b6cbc9ea-eb23-427e-82da-de4222e68f7b" xlink:to="loc_srt_MinimumMember_4aa1ad23-ed1d-4456-85f6-5ae5121f4fdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c081c888-db08-43ee-8f87-5601c1dc4d45" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b6cbc9ea-eb23-427e-82da-de4222e68f7b" xlink:to="loc_srt_MaximumMember_c081c888-db08-43ee-8f87-5601c1dc4d45" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended" id="ib1cc7048b01a43eab639ef53c82cf217_RestructuringImpairmentandRelatedChargesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_fe4b943f-ac76-4556-8e16-8f2d16ef2656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_5ff47113-a881-457a-a221-383952d4f029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fe4b943f-ac76-4556-8e16-8f2d16ef2656" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_5ff47113-a881-457a-a221-383952d4f029" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_15b6f376-8c56-4e1c-a4eb-a41388dde7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fe4b943f-ac76-4556-8e16-8f2d16ef2656" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_15b6f376-8c56-4e1c-a4eb-a41388dde7d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a58a1af5-659e-458a-9ec0-1df123af9993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fe4b943f-ac76-4556-8e16-8f2d16ef2656" xlink:to="loc_us-gaap_RestructuringCharges_a58a1af5-659e-458a-9ec0-1df123af9993" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_ace64231-22bf-4338-b1ee-8df787fd3cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fe4b943f-ac76-4556-8e16-8f2d16ef2656" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_ace64231-22bf-4338-b1ee-8df787fd3cbb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039b1a5c-0d2d-4647-9606-4297df69882c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fe4b943f-ac76-4556-8e16-8f2d16ef2656" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039b1a5c-0d2d-4647-9606-4297df69882c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_b70a1f5c-cd7a-4917-b55c-d37d6fdcc698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039b1a5c-0d2d-4647-9606-4297df69882c" xlink:to="loc_us-gaap_RestructuringPlanAxis_b70a1f5c-cd7a-4917-b55c-d37d6fdcc698" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_b70a1f5c-cd7a-4917-b55c-d37d6fdcc698_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_b70a1f5c-cd7a-4917-b55c-d37d6fdcc698" xlink:to="loc_us-gaap_RestructuringPlanDomain_b70a1f5c-cd7a-4917-b55c-d37d6fdcc698_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_b7ea7013-1e32-4502-8cc0-c597f19a3648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_b70a1f5c-cd7a-4917-b55c-d37d6fdcc698" xlink:to="loc_us-gaap_RestructuringPlanDomain_b7ea7013-1e32-4502-8cc0-c597f19a3648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_c29e2556-cf5f-4591-bedc-656b1b97970c" xlink:href="mck-20210630.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_b7ea7013-1e32-4502-8cc0-c597f19a3648" xlink:to="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_c29e2556-cf5f-4591-bedc-656b1b97970c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d79eaf9c-448a-4b8a-b2d0-e57fc3f4784d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039b1a5c-0d2d-4647-9606-4297df69882c" xlink:to="loc_srt_RangeAxis_d79eaf9c-448a-4b8a-b2d0-e57fc3f4784d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d79eaf9c-448a-4b8a-b2d0-e57fc3f4784d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d79eaf9c-448a-4b8a-b2d0-e57fc3f4784d" xlink:to="loc_srt_RangeMember_d79eaf9c-448a-4b8a-b2d0-e57fc3f4784d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_161f6081-b9fc-42f2-af7c-96b07fc8085e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d79eaf9c-448a-4b8a-b2d0-e57fc3f4784d" xlink:to="loc_srt_RangeMember_161f6081-b9fc-42f2-af7c-96b07fc8085e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ea19f379-7ca3-4ab7-aae9-c2b3f8b81bf4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_161f6081-b9fc-42f2-af7c-96b07fc8085e" xlink:to="loc_srt_MinimumMember_ea19f379-7ca3-4ab7-aae9-c2b3f8b81bf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_db5175e6-1346-4739-a199-1f82e68a651a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_161f6081-b9fc-42f2-af7c-96b07fc8085e" xlink:to="loc_srt_MaximumMember_db5175e6-1346-4739-a199-1f82e68a651a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b0f4c450-d971-4c7d-a899-c9cda0ecacf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039b1a5c-0d2d-4647-9606-4297df69882c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b0f4c450-d971-4c7d-a899-c9cda0ecacf1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b0f4c450-d971-4c7d-a899-c9cda0ecacf1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b0f4c450-d971-4c7d-a899-c9cda0ecacf1" xlink:to="loc_us-gaap_SegmentDomain_b0f4c450-d971-4c7d-a899-c9cda0ecacf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_287e4c0a-c70a-4427-9d9a-22ed720b5a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b0f4c450-d971-4c7d-a899-c9cda0ecacf1" xlink:to="loc_us-gaap_SegmentDomain_287e4c0a-c70a-4427-9d9a-22ed720b5a68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_e25764d1-a73d-4a84-a9de-608cd9098ad1" xlink:href="mck-20210630.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_287e4c0a-c70a-4427-9d9a-22ed720b5a68" xlink:to="loc_mck_InternationalSegmentMember_e25764d1-a73d-4a84-a9de-608cd9098ad1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_6fa3a6f9-9775-4b19-8b05-6f46b61e3eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039b1a5c-0d2d-4647-9606-4297df69882c" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_6fa3a6f9-9775-4b19-8b05-6f46b61e3eed" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6fa3a6f9-9775-4b19-8b05-6f46b61e3eed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6fa3a6f9-9775-4b19-8b05-6f46b61e3eed" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6fa3a6f9-9775-4b19-8b05-6f46b61e3eed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_650e0c32-e597-4115-bfca-c1a9049407b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6fa3a6f9-9775-4b19-8b05-6f46b61e3eed" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_650e0c32-e597-4115-bfca-c1a9049407b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_9ee19f9d-294b-418b-b8d6-83db9fa66dcb" xlink:href="mck-20210630.xsd#mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_650e0c32-e597-4115-bfca-c1a9049407b3" xlink:to="loc_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_9ee19f9d-294b-418b-b8d6-83db9fa66dcb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended" id="i4af5bb0898cd4aa0997272339d716275_RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_3e51caab-5351-4098-913d-270a93cee298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_47f7f226-a69a-4997-a36e-8056a2a0a8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3e51caab-5351-4098-913d-270a93cee298" xlink:to="loc_us-gaap_SeveranceCosts1_47f7f226-a69a-4997-a36e-8056a2a0a8a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_7bb84e35-7a20-40b0-978e-0194dde9fd21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3e51caab-5351-4098-913d-270a93cee298" xlink:to="loc_us-gaap_BusinessExitCosts1_7bb84e35-7a20-40b0-978e-0194dde9fd21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_f9c27c43-e8fa-4d03-81ed-d73d4600c67b" xlink:href="mck-20210630.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3e51caab-5351-4098-913d-270a93cee298" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_f9c27c43-e8fa-4d03-81ed-d73d4600c67b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_468342c2-130d-442f-8e22-0a1ee5631880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3e51caab-5351-4098-913d-270a93cee298" xlink:to="loc_us-gaap_RestructuringCharges_468342c2-130d-442f-8e22-0a1ee5631880" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cbd0421a-819d-4a6e-97bd-c6eb170ca146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3e51caab-5351-4098-913d-270a93cee298" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cbd0421a-819d-4a6e-97bd-c6eb170ca146" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_269a2014-fa79-4c6f-b46d-803371dfc561" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cbd0421a-819d-4a6e-97bd-c6eb170ca146" xlink:to="loc_srt_ConsolidationItemsAxis_269a2014-fa79-4c6f-b46d-803371dfc561" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_269a2014-fa79-4c6f-b46d-803371dfc561_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_269a2014-fa79-4c6f-b46d-803371dfc561" xlink:to="loc_srt_ConsolidationItemsDomain_269a2014-fa79-4c6f-b46d-803371dfc561_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ca04e6ce-6b30-4a16-961d-451d3f647cf9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_269a2014-fa79-4c6f-b46d-803371dfc561" xlink:to="loc_srt_ConsolidationItemsDomain_ca04e6ce-6b30-4a16-961d-451d3f647cf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9000d320-2c11-43ea-aa66-b67ff68090b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ca04e6ce-6b30-4a16-961d-451d3f647cf9" xlink:to="loc_us-gaap_OperatingSegmentsMember_9000d320-2c11-43ea-aa66-b67ff68090b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_98b8d851-9abb-4b20-8c5b-6d6e6c054472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_ca04e6ce-6b30-4a16-961d-451d3f647cf9" xlink:to="loc_us-gaap_CorporateNonSegmentMember_98b8d851-9abb-4b20-8c5b-6d6e6c054472" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_49b8dd07-e1a5-405f-86de-905e07dd3f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cbd0421a-819d-4a6e-97bd-c6eb170ca146" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_49b8dd07-e1a5-405f-86de-905e07dd3f7b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_49b8dd07-e1a5-405f-86de-905e07dd3f7b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_49b8dd07-e1a5-405f-86de-905e07dd3f7b" xlink:to="loc_us-gaap_SegmentDomain_49b8dd07-e1a5-405f-86de-905e07dd3f7b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9148ef7a-702f-4aa3-bf76-5b9dbc010c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_49b8dd07-e1a5-405f-86de-905e07dd3f7b" xlink:to="loc_us-gaap_SegmentDomain_9148ef7a-702f-4aa3-bf76-5b9dbc010c31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_8df6beab-0fe0-40e1-87dd-786c8afa3df7" xlink:href="mck-20210630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9148ef7a-702f-4aa3-bf76-5b9dbc010c31" xlink:to="loc_mck_USPharmaceuticalSegmentMember_8df6beab-0fe0-40e1-87dd-786c8afa3df7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_c1ff6c28-4fe7-40d6-94fe-109ab1b68422" xlink:href="mck-20210630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9148ef7a-702f-4aa3-bf76-5b9dbc010c31" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_c1ff6c28-4fe7-40d6-94fe-109ab1b68422" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_18426ee1-6445-4048-b452-766ed7c01900" xlink:href="mck-20210630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9148ef7a-702f-4aa3-bf76-5b9dbc010c31" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_18426ee1-6445-4048-b452-766ed7c01900" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_2e4a83d0-ca38-40bc-80a1-0b80b99a5b9c" xlink:href="mck-20210630.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9148ef7a-702f-4aa3-bf76-5b9dbc010c31" xlink:to="loc_mck_InternationalSegmentMember_2e4a83d0-ca38-40bc-80a1-0b80b99a5b9c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="extended" id="i0607f1be21b34f1b8f7bc25057b17e5a_RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0f1b9af7-77e2-4681-8319-f40a9bdd379a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0f1b9af7-77e2-4681-8319-f40a9bdd379a" xlink:to="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_6fbf23ac-0e7f-4c59-97b7-f7b1f0c705b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:to="loc_us-gaap_RestructuringReserve_6fbf23ac-0e7f-4c59-97b7-f7b1f0c705b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_921a7ec7-4823-4280-bfbd-eb81e46dd407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:to="loc_us-gaap_RestructuringCharges_921a7ec7-4823-4280-bfbd-eb81e46dd407" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_dc061506-3518-4f4b-b333-85848d7f8cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_dc061506-3518-4f4b-b333-85848d7f8cc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_ddd25081-07ea-40bb-91c3-bfc31a1d263e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:to="loc_us-gaap_PaymentsForRestructuring_ddd25081-07ea-40bb-91c3-bfc31a1d263e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_c3e716c1-a3b5-4b02-8740-33cd5804012d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_c3e716c1-a3b5-4b02-8740-33cd5804012d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_5390815d-373b-4788-8955-97e3a0e0d201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f86fccb-3ab7-4dce-ada4-cbd77a950f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0f1b9af7-77e2-4681-8319-f40a9bdd379a" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f86fccb-3ab7-4dce-ada4-cbd77a950f6f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_76a2e22e-d487-4cab-aa1b-86143addffd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f86fccb-3ab7-4dce-ada4-cbd77a950f6f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_76a2e22e-d487-4cab-aa1b-86143addffd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_76a2e22e-d487-4cab-aa1b-86143addffd8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_76a2e22e-d487-4cab-aa1b-86143addffd8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_76a2e22e-d487-4cab-aa1b-86143addffd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7cfb9c19-c132-40aa-8c33-ea6c0d33b0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_76a2e22e-d487-4cab-aa1b-86143addffd8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7cfb9c19-c132-40aa-8c33-ea6c0d33b0b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_77460fcc-df02-4558-9557-8b26c130ea21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7cfb9c19-c132-40aa-8c33-ea6c0d33b0b4" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_77460fcc-df02-4558-9557-8b26c130ea21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_2174c9d9-0342-4a48-b200-368e92148937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7cfb9c19-c132-40aa-8c33-ea6c0d33b0b4" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_2174c9d9-0342-4a48-b200-368e92148937" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8bacbac5-2f03-4705-b212-6533b945472b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f86fccb-3ab7-4dce-ada4-cbd77a950f6f" xlink:to="loc_srt_ConsolidationItemsAxis_8bacbac5-2f03-4705-b212-6533b945472b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8bacbac5-2f03-4705-b212-6533b945472b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_8bacbac5-2f03-4705-b212-6533b945472b" xlink:to="loc_srt_ConsolidationItemsDomain_8bacbac5-2f03-4705-b212-6533b945472b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d2163ee0-d930-49a0-b2be-f7c1199c057f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_8bacbac5-2f03-4705-b212-6533b945472b" xlink:to="loc_srt_ConsolidationItemsDomain_d2163ee0-d930-49a0-b2be-f7c1199c057f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1bc4ba45-697e-491b-9574-23d79194ce8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d2163ee0-d930-49a0-b2be-f7c1199c057f" xlink:to="loc_us-gaap_OperatingSegmentsMember_1bc4ba45-697e-491b-9574-23d79194ce8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_515365e8-f11a-47c2-86e2-cc25df452c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d2163ee0-d930-49a0-b2be-f7c1199c057f" xlink:to="loc_us-gaap_CorporateNonSegmentMember_515365e8-f11a-47c2-86e2-cc25df452c47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d0f64969-e47d-4dd8-9701-b3dd6b2e2508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f86fccb-3ab7-4dce-ada4-cbd77a950f6f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d0f64969-e47d-4dd8-9701-b3dd6b2e2508" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d0f64969-e47d-4dd8-9701-b3dd6b2e2508_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d0f64969-e47d-4dd8-9701-b3dd6b2e2508" xlink:to="loc_us-gaap_SegmentDomain_d0f64969-e47d-4dd8-9701-b3dd6b2e2508_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_43937a96-fde3-447e-9668-057034918580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d0f64969-e47d-4dd8-9701-b3dd6b2e2508" xlink:to="loc_us-gaap_SegmentDomain_43937a96-fde3-447e-9668-057034918580" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_342ec597-57c9-4c95-84a0-a45ee1be6e13" xlink:href="mck-20210630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_43937a96-fde3-447e-9668-057034918580" xlink:to="loc_mck_USPharmaceuticalSegmentMember_342ec597-57c9-4c95-84a0-a45ee1be6e13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_776a8f93-61f7-46dd-a3fc-ac3356508848" xlink:href="mck-20210630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_43937a96-fde3-447e-9668-057034918580" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_776a8f93-61f7-46dd-a3fc-ac3356508848" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_b6a09417-a60e-4c9b-bd74-db9869da6472" xlink:href="mck-20210630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_43937a96-fde3-447e-9668-057034918580" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_b6a09417-a60e-4c9b-bd74-db9869da6472" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_686b0abd-8284-45a3-af53-6c94247155a1" xlink:href="mck-20210630.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_43937a96-fde3-447e-9668-057034918580" xlink:to="loc_mck_InternationalSegmentMember_686b0abd-8284-45a3-af53-6c94247155a1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended" id="idd077777121746e4a9d683559481f40d_RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_8cc78358-2b1b-4b81-89be-39c476ae1c93" xlink:href="mck-20210630.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_8cc78358-2b1b-4b81-89be-39c476ae1c93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_32803e48-a451-47f9-9470-ee5c7d859fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_32803e48-a451-47f9-9470-ee5c7d859fb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_e8c88808-6f7e-48d4-afda-ee5ca97b07bf" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_e8c88808-6f7e-48d4-afda-ee5ca97b07bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_10bd6ae1-9e86-4cee-a36f-aa51bd6e2750" xlink:href="mck-20210630.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_PutRightValueInterestRateSpread_10bd6ae1-9e86-4cee-a36f-aa51bd6e2750" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_6340a67e-91dd-4fbe-bee1-e1d4ed6e1bf0" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_6340a67e-91dd-4fbe-bee1-e1d4ed6e1bf0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_ffcd6226-cc14-4545-80a6-08f9af78b2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_ffcd6226-cc14-4545-80a6-08f9af78b2f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_40df4a01-4cc4-49e6-81a0-7cbeb75147f5" xlink:href="mck-20210630.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_40df4a01-4cc4-49e6-81a0-7cbeb75147f5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_f03d04be-9cb8-4d00-9195-722a456d4ffe" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_f03d04be-9cb8-4d00-9195-722a456d4ffe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_389940a4-e5c2-43f4-a52c-f5b58edbd5bc" xlink:href="mck-20210630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_389940a4-e5c2-43f4-a52c-f5b58edbd5bc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_1f2185dd-f89d-427a-a66d-d3d6cf9d03ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_1f2185dd-f89d-427a-a66d-d3d6cf9d03ed" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_57578eef-a2a8-4f5f-aaef-a57e5243ae66" xlink:href="mck-20210630.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_57578eef-a2a8-4f5f-aaef-a57e5243ae66" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_27487cd5-9e03-4e2a-bfe8-a38507f4e786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_27487cd5-9e03-4e2a-bfe8-a38507f4e786" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_40768d13-af36-4ff8-bce4-313a68c5d1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_40768d13-af36-4ff8-bce4-313a68c5d1b9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_9be63dcb-b9ca-4193-aa25-c0601afb8067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_us-gaap_MinorityInterestTable_9be63dcb-b9ca-4193-aa25-c0601afb8067" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_14fba01b-0815-4233-b3d3-0b3301f2192d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_9be63dcb-b9ca-4193-aa25-c0601afb8067" xlink:to="loc_srt_OwnershipAxis_14fba01b-0815-4233-b3d3-0b3301f2192d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_14fba01b-0815-4233-b3d3-0b3301f2192d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_14fba01b-0815-4233-b3d3-0b3301f2192d" xlink:to="loc_srt_OwnershipDomain_14fba01b-0815-4233-b3d3-0b3301f2192d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_3cc28eb0-ac19-4445-a790-63b55284cbf7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_14fba01b-0815-4233-b3d3-0b3301f2192d" xlink:to="loc_srt_OwnershipDomain_3cc28eb0-ac19-4445-a790-63b55284cbf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_f10d958b-74ee-4eda-9c29-1acb57c404dc" xlink:href="mck-20210630.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_3cc28eb0-ac19-4445-a790-63b55284cbf7" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_f10d958b-74ee-4eda-9c29-1acb57c404dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_c2381915-91de-4ea2-bdfb-d2d9607a5a3d" xlink:href="mck-20210630.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_3cc28eb0-ac19-4445-a790-63b55284cbf7" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_c2381915-91de-4ea2-bdfb-d2d9607a5a3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d4763e08-245e-4ef7-99fe-12d424848f99" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_9be63dcb-b9ca-4193-aa25-c0601afb8067" xlink:to="loc_dei_LegalEntityAxis_d4763e08-245e-4ef7-99fe-12d424848f99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d4763e08-245e-4ef7-99fe-12d424848f99_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_d4763e08-245e-4ef7-99fe-12d424848f99" xlink:to="loc_dei_EntityDomain_d4763e08-245e-4ef7-99fe-12d424848f99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_89fb4597-916f-481f-b22f-7b897af7f528" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_d4763e08-245e-4ef7-99fe-12d424848f99" xlink:to="loc_dei_EntityDomain_89fb4597-916f-481f-b22f-7b897af7f528" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_7267da98-f5e8-4104-9958-714d7eced7fe" xlink:href="mck-20210630.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_89fb4597-916f-481f-b22f-7b897af7f528" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_7267da98-f5e8-4104-9958-714d7eced7fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c9e1daf3-7842-49d6-8ec6-c4df507124b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_9be63dcb-b9ca-4193-aa25-c0601afb8067" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c9e1daf3-7842-49d6-8ec6-c4df507124b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c9e1daf3-7842-49d6-8ec6-c4df507124b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c9e1daf3-7842-49d6-8ec6-c4df507124b4" xlink:to="loc_us-gaap_EquityComponentDomain_c9e1daf3-7842-49d6-8ec6-c4df507124b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4247ff8c-8648-4a34-bdcf-ce2565a8586c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c9e1daf3-7842-49d6-8ec6-c4df507124b4" xlink:to="loc_us-gaap_EquityComponentDomain_4247ff8c-8648-4a34-bdcf-ce2565a8586c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_e1f16adb-c72f-4268-bf71-2270c485df61" xlink:href="mck-20210630.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4247ff8c-8648-4a34-bdcf-ce2565a8586c" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_e1f16adb-c72f-4268-bf71-2270c485df61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_53fe1856-8afe-4b2f-b4d5-82836387e021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4247ff8c-8648-4a34-bdcf-ce2565a8586c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_53fe1856-8afe-4b2f-b4d5-82836387e021" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended" id="i20a1c705e40643bfbc6e7edb5b86821b_RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_3d41b341-ac42-4540-964c-25a66f31387a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3d41b341-ac42-4540-964c-25a66f31387a" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_4e7e8552-0d50-4914-945e-dc34098da07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:to="loc_us-gaap_MinorityInterest_4e7e8552-0d50-4914-945e-dc34098da07b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0f82f224-2948-4a92-b6af-4b15e50ccb76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0f82f224-2948-4a92-b6af-4b15e50ccb76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2062d99e-5b25-4a00-bc47-a2142e6f95c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2062d99e-5b25-4a00-bc47-a2142e6f95c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c440392a-12ed-4259-91e5-c3537518b038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c440392a-12ed-4259-91e5-c3537518b038" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_f0cb7401-9fd9-46b6-b883-773c525bce71" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_f0cb7401-9fd9-46b6-b883-773c525bce71" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f1db2cac-4e64-4ecd-9b9e-12bc5b27d7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestLineItems_3d41b341-ac42-4540-964c-25a66f31387a" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_afc1e25e-6190-4be3-9843-2b4eb4e57df3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_afc1e25e-6190-4be3-9843-2b4eb4e57df3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_8d65a123-c095-453f-bb0c-6d5697bd73a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_8d65a123-c095-453f-bb0c-6d5697bd73a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_275cd3b7-50ad-4821-9564-77bab3be275c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_06a02cf3-d8ea-4b1a-827d-151160315cc7" xlink:href="mck-20210630.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_06a02cf3-d8ea-4b1a-827d-151160315cc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_22d34efc-9af0-4136-a5c4-0e6826f27841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_9cf387d9-a5eb-425e-a421-1bb63719d8c4" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_9cf387d9-a5eb-425e-a421-1bb63719d8c4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_9456cd45-2e01-40ee-8a11-bbcb3bfeec43" xlink:href="mck-20210630.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_9456cd45-2e01-40ee-8a11-bbcb3bfeec43" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_153f1b1d-3ebf-4cca-b749-43725ae1d125" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_d1fad93e-3102-49d4-9a04-0c0ace517534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_7c36a2ed-deea-45b3-b774-8674d801d254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MinorityInterestLineItems_3d41b341-ac42-4540-964c-25a66f31387a" xlink:to="loc_us-gaap_MinorityInterestTable_7c36a2ed-deea-45b3-b774-8674d801d254" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_05d88dda-6517-413b-a1f1-0f8c438ff65d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MinorityInterestTable_7c36a2ed-deea-45b3-b774-8674d801d254" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_05d88dda-6517-413b-a1f1-0f8c438ff65d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_05d88dda-6517-413b-a1f1-0f8c438ff65d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_05d88dda-6517-413b-a1f1-0f8c438ff65d" xlink:to="loc_us-gaap_EquityComponentDomain_05d88dda-6517-413b-a1f1-0f8c438ff65d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2c52b40c-d66b-4fed-bb1f-f1f703c7262a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_05d88dda-6517-413b-a1f1-0f8c438ff65d" xlink:to="loc_us-gaap_EquityComponentDomain_2c52b40c-d66b-4fed-bb1f-f1f703c7262a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_872131ee-cc75-4235-9ec4-c924a159241f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2c52b40c-d66b-4fed-bb1f-f1f703c7262a" xlink:to="loc_us-gaap_NoncontrollingInterestMember_872131ee-cc75-4235-9ec4-c924a159241f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_8f57d551-c8ab-40ac-9535-48a7b1f7c885" xlink:href="mck-20210630.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2c52b40c-d66b-4fed-bb1f-f1f703c7262a" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_8f57d551-c8ab-40ac-9535-48a7b1f7c885" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#EarningsLossPerCommonShareDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="extended" id="idb10570ab35e43ff908065647ca1ea97_EarningsLossPerCommonShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_734779fe-f5fe-441c-a918-c6cc776bdcd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_734779fe-f5fe-441c-a918-c6cc776bdcd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_34e4dfb9-db4e-4963-b58e-6dc103549332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_34e4dfb9-db4e-4963-b58e-6dc103549332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_d9d31281-89ce-4494-b8d6-34aec8185cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_d9d31281-89ce-4494-b8d6-34aec8185cf9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_988aaa76-9923-47c7-9455-960fea523989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_988aaa76-9923-47c7-9455-960fea523989" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_254edab6-9353-475a-8ccc-5bce8fe0c27a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_NetIncomeLoss_254edab6-9353-475a-8ccc-5bce8fe0c27a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9a972f1d-9124-4abe-991e-0dc29aed9390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9a972f1d-9124-4abe-991e-0dc29aed9390" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_60eb258f-3d9a-451a-88da-550940fc2cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9a972f1d-9124-4abe-991e-0dc29aed9390" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_60eb258f-3d9a-451a-88da-550940fc2cda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_fc19b5e0-0df9-4e72-bf2d-1f42742d66c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9a972f1d-9124-4abe-991e-0dc29aed9390" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_fc19b5e0-0df9-4e72-bf2d-1f42742d66c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_49d2dc3b-2342-4477-811e-4854cef5be65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_fc19b5e0-0df9-4e72-bf2d-1f42742d66c2" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_49d2dc3b-2342-4477-811e-4854cef5be65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06652fa9-8115-4a39-b65b-54ac314ec274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9a972f1d-9124-4abe-991e-0dc29aed9390" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06652fa9-8115-4a39-b65b-54ac314ec274" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cc527933-1649-4f94-8ebd-dae83d701e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cc527933-1649-4f94-8ebd-dae83d701e8b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_cec4dca7-3083-4c6c-9298-8ceadc9a314c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cc527933-1649-4f94-8ebd-dae83d701e8b" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_cec4dca7-3083-4c6c-9298-8ceadc9a314c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_ba68639a-14ec-4680-9d57-7041d2fd336d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_cec4dca7-3083-4c6c-9298-8ceadc9a314c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_ba68639a-14ec-4680-9d57-7041d2fd336d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_291016de-78bc-4deb-89dd-2b68c5c87639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_cec4dca7-3083-4c6c-9298-8ceadc9a314c" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_291016de-78bc-4deb-89dd-2b68c5c87639" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_714faaf0-50d5-496d-bdbc-53d01411e305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_cec4dca7-3083-4c6c-9298-8ceadc9a314c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_714faaf0-50d5-496d-bdbc-53d01411e305" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_b262568c-937a-4e9f-a24c-84cbd632d1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cc527933-1649-4f94-8ebd-dae83d701e8b" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_b262568c-937a-4e9f-a24c-84cbd632d1dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_28bf1d31-ccad-4f04-888f-e510ce4a299e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b262568c-937a-4e9f-a24c-84cbd632d1dc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_28bf1d31-ccad-4f04-888f-e510ce4a299e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_b53322dd-63d4-4e2c-96c8-abec189f8aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b262568c-937a-4e9f-a24c-84cbd632d1dc" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_b53322dd-63d4-4e2c-96c8-abec189f8aa4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6610cb2d-c9d8-497f-b9cc-2b335436f5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b262568c-937a-4e9f-a24c-84cbd632d1dc" xlink:to="loc_us-gaap_EarningsPerShareBasic_6610cb2d-c9d8-497f-b9cc-2b335436f5b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_83faa119-c023-4ad0-9952-e601bbaa3e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_83faa119-c023-4ad0-9952-e601bbaa3e04" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_953a5382-32d9-4967-a42b-2d3847f73622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_953a5382-32d9-4967-a42b-2d3847f73622" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_82993dda-ddc2-4584-9439-d7e0727f462e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_953a5382-32d9-4967-a42b-2d3847f73622" xlink:to="loc_us-gaap_AwardTypeAxis_82993dda-ddc2-4584-9439-d7e0727f462e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82993dda-ddc2-4584-9439-d7e0727f462e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_82993dda-ddc2-4584-9439-d7e0727f462e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_82993dda-ddc2-4584-9439-d7e0727f462e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d48ce2d5-861e-41f6-ad78-192e68254a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_82993dda-ddc2-4584-9439-d7e0727f462e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d48ce2d5-861e-41f6-ad78-192e68254a63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_19a28b23-024e-407e-acd7-b408d4cb2ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d48ce2d5-861e-41f6-ad78-192e68254a63" xlink:to="loc_us-gaap_EmployeeStockOptionMember_19a28b23-024e-407e-acd7-b408d4cb2ce2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d6f15929-12f7-4b67-b12f-7c29fb118710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d48ce2d5-861e-41f6-ad78-192e68254a63" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d6f15929-12f7-4b67-b12f-7c29fb118710" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended" id="ifb64dac7125b48308f3678d621b79c92_GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_9b376b93-ce9e-4176-ab5b-fc31b28f68ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_f598e516-616a-4ffa-a133-a69c17403579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9b376b93-ce9e-4176-ab5b-fc31b28f68ba" xlink:to="loc_us-gaap_GoodwillRollForward_f598e516-616a-4ffa-a133-a69c17403579" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_960d9407-cea6-4540-8c86-1146e7ae42b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_f598e516-616a-4ffa-a133-a69c17403579" xlink:to="loc_us-gaap_Goodwill_960d9407-cea6-4540-8c86-1146e7ae42b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0b1b162d-a1f5-48a3-8be8-f293063736bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_f598e516-616a-4ffa-a133-a69c17403579" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0b1b162d-a1f5-48a3-8be8-f293063736bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8e5a500c-3ca1-42c2-8167-57beda6b5561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_691b26f3-1c85-4853-ad1d-b5be58108778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_9b376b93-ce9e-4176-ab5b-fc31b28f68ba" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_691b26f3-1c85-4853-ad1d-b5be58108778" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_65d9a69a-76f9-4a25-bc99-db9ba4aa9fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_691b26f3-1c85-4853-ad1d-b5be58108778" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_65d9a69a-76f9-4a25-bc99-db9ba4aa9fc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_65d9a69a-76f9-4a25-bc99-db9ba4aa9fc9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_65d9a69a-76f9-4a25-bc99-db9ba4aa9fc9" xlink:to="loc_us-gaap_SegmentDomain_65d9a69a-76f9-4a25-bc99-db9ba4aa9fc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d25be56-d967-4e4b-bb46-ee1b7cef364d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_65d9a69a-76f9-4a25-bc99-db9ba4aa9fc9" xlink:to="loc_us-gaap_SegmentDomain_0d25be56-d967-4e4b-bb46-ee1b7cef364d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_e78c4c1b-a145-47ef-a6a6-043dad9940f9" xlink:href="mck-20210630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d25be56-d967-4e4b-bb46-ee1b7cef364d" xlink:to="loc_mck_USPharmaceuticalSegmentMember_e78c4c1b-a145-47ef-a6a6-043dad9940f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_1dcd3e04-563c-4ec3-a69b-ea2480fca258" xlink:href="mck-20210630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d25be56-d967-4e4b-bb46-ee1b7cef364d" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_1dcd3e04-563c-4ec3-a69b-ea2480fca258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_5062777c-def5-45a3-be15-1dcdd0fe5cdc" xlink:href="mck-20210630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d25be56-d967-4e4b-bb46-ee1b7cef364d" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_5062777c-def5-45a3-be15-1dcdd0fe5cdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_bc4525c9-af18-4bf9-8cb0-52dcd980a832" xlink:href="mck-20210630.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d25be56-d967-4e4b-bb46-ee1b7cef364d" xlink:to="loc_mck_InternationalSegmentMember_bc4525c9-af18-4bf9-8cb0-52dcd980a832" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended" id="i57b172c0e0d145dda5c9af59a9e072ac_GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_044a5243-4a8c-4205-8627-15e68f292427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_ed693d3f-ae27-4790-9644-48feee340c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_044a5243-4a8c-4205-8627-15e68f292427" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_ed693d3f-ae27-4790-9644-48feee340c21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e000e730-04d2-4579-b9ea-07b3db2bcd02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_044a5243-4a8c-4205-8627-15e68f292427" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e000e730-04d2-4579-b9ea-07b3db2bcd02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_59e22248-70cb-46a3-9a97-b6a7c20e7a77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_044a5243-4a8c-4205-8627-15e68f292427" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_59e22248-70cb-46a3-9a97-b6a7c20e7a77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0c01c9ec-2e93-43fb-98b5-6c0ce81c4ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_044a5243-4a8c-4205-8627-15e68f292427" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0c01c9ec-2e93-43fb-98b5-6c0ce81c4ba5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_47f51b06-6c60-4439-a737-88e4f489cb39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_044a5243-4a8c-4205-8627-15e68f292427" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_47f51b06-6c60-4439-a737-88e4f489cb39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82dbb9eb-f3bb-4e6b-9f77-804dae300ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_47f51b06-6c60-4439-a737-88e4f489cb39" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82dbb9eb-f3bb-4e6b-9f77-804dae300ce2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_82dbb9eb-f3bb-4e6b-9f77-804dae300ce2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82dbb9eb-f3bb-4e6b-9f77-804dae300ce2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_82dbb9eb-f3bb-4e6b-9f77-804dae300ce2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82dbb9eb-f3bb-4e6b-9f77-804dae300ce2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_124ecb48-84b5-4879-ac4b-1ab093b80dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_124ecb48-84b5-4879-ac4b-1ab093b80dcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_d6a42d7b-4a49-45a6-a9f4-765bba9fb2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:to="loc_us-gaap_ServiceAgreementsMember_d6a42d7b-4a49-45a6-a9f4-765bba9fb2b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember_ae7e09d1-5dfc-46f9-89d7-908b9fecb062" xlink:href="mck-20210630.xsd#mck_PharmacyLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:to="loc_mck_PharmacyLicensesMember_ae7e09d1-5dfc-46f9-89d7-908b9fecb062" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_4d9214d5-6584-459a-9441-7cb777c816aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_4d9214d5-6584-459a-9441-7cb777c816aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_97c5059a-b021-41a3-81a0-4dbded0663d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_97c5059a-b021-41a3-81a0-4dbded0663d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_352d4235-6ffa-4a8e-856a-4f74cbc160e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_352d4235-6ffa-4a8e-856a-4f74cbc160e7" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended" id="i8b63789c60644e5ab2164c1288c904db_DebtandFinancingActivitiesScheduleofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_595657b8-48ca-4e91-9e64-93022b60defb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_595657b8-48ca-4e91-9e64-93022b60defb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6adb5bd0-4165-4fb6-b01e-491a8ff7208b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:to="loc_us-gaap_LongTermDebt_6adb5bd0-4165-4fb6-b01e-491a8ff7208b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_72b432af-787a-424b-a23c-b97a6c896dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:to="loc_us-gaap_FinanceLeaseLiability_72b432af-787a-424b-a23c-b97a6c896dce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_baf33193-697e-43ca-827b-c7e3735753a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_baf33193-697e-43ca-827b-c7e3735753a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a9b0c0db-2f3e-4e2f-b703-2622c9958453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a9b0c0db-2f3e-4e2f-b703-2622c9958453" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e642f06a-3493-41cd-a967-ba2c4d130faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e642f06a-3493-41cd-a967-ba2c4d130faa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2ad55648-d973-435e-8c71-29b1fe1711d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:to="loc_us-gaap_DebtInstrumentTable_2ad55648-d973-435e-8c71-29b1fe1711d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c8055835-448f-4641-8ccc-d658db8076e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2ad55648-d973-435e-8c71-29b1fe1711d0" xlink:to="loc_us-gaap_DebtInstrumentAxis_c8055835-448f-4641-8ccc-d658db8076e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c8055835-448f-4641-8ccc-d658db8076e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_c8055835-448f-4641-8ccc-d658db8076e6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c8055835-448f-4641-8ccc-d658db8076e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_c8055835-448f-4641-8ccc-d658db8076e6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_d898f7dc-2ab9-4cee-b8c3-2ff100552d2a" xlink:href="mck-20210630.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A270NotesDueDecember152022Member_d898f7dc-2ab9-4cee-b8c3-2ff100552d2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_f5778396-bbc1-4b02-b3f9-6081c9d91fb9" xlink:href="mck-20210630.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A285NotesDueMarch152023Member_f5778396-bbc1-4b02-b3f9-6081c9d91fb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_7e2a59f6-9ca1-4d98-9473-168fee6323d6" xlink:href="mck-20210630.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A380NotesDueMarch152024Member_7e2a59f6-9ca1-4d98-9473-168fee6323d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_220c3959-2261-45b7-a4bf-323431aa8efa" xlink:href="mck-20210630.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A090NotesDueDecember32025Member_220c3959-2261-45b7-a4bf-323431aa8efa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_79e6f206-617b-428c-b584-1c40c9235638" xlink:href="mck-20210630.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_79e6f206-617b-428c-b584-1c40c9235638" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_dc7785f1-7990-4714-b456-9fc7e81dcd67" xlink:href="mck-20210630.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A395NotesDueFebruary162028Member_dc7785f1-7990-4714-b456-9fc7e81dcd67" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_e86980cf-d11e-4cd0-9ccc-976130c38447" xlink:href="mck-20210630.xsd#mck_A475NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A475NotesDueMay302029Member_e86980cf-d11e-4cd0-9ccc-976130c38447" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_64eeff6e-d142-4951-8517-bb65da68f4a5" xlink:href="mck-20210630.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A600NotesDueMarch12041Member_64eeff6e-d142-4951-8517-bb65da68f4a5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_b9a6340c-4019-4dfa-b6bc-d10de502a37c" xlink:href="mck-20210630.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A488NotesDueMarch152044Member_b9a6340c-4019-4dfa-b6bc-d10de502a37c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_8ffb2bc9-a09d-4af6-8e5b-a5ddce254daa" xlink:href="mck-20210630.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_8ffb2bc9-a09d-4af6-8e5b-a5ddce254daa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_ac9c26ee-1829-4051-819a-0b95a2c32451" xlink:href="mck-20210630.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_ac9c26ee-1829-4051-819a-0b95a2c32451" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_1740f91c-bbe8-4888-8056-bc622813e64b" xlink:href="mck-20210630.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_1740f91c-bbe8-4888-8056-bc622813e64b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_816ef6f2-40be-429f-96fe-4db2ea683517" xlink:href="mck-20210630.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_816ef6f2-40be-429f-96fe-4db2ea683517" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0b779fd2-4926-4f27-8e0e-048ae59b0172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2ad55648-d973-435e-8c71-29b1fe1711d0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0b779fd2-4926-4f27-8e0e-048ae59b0172" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0b779fd2-4926-4f27-8e0e-048ae59b0172_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0b779fd2-4926-4f27-8e0e-048ae59b0172" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0b779fd2-4926-4f27-8e0e-048ae59b0172_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_75b6fd3c-3327-42ca-9818-8442d5c45cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0b779fd2-4926-4f27-8e0e-048ae59b0172" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_75b6fd3c-3327-42ca-9818-8442d5c45cfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_85e1c0c5-c438-42b6-8445-f5b33eef8f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_75b6fd3c-3327-42ca-9818-8442d5c45cfc" xlink:to="loc_us-gaap_LoansPayableMember_85e1c0c5-c438-42b6-8445-f5b33eef8f56" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="extended" id="iaeac0196168345f5a94f30668d053a49_DebtandFinancingActivitiesLongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_c285d8f5-0e88-4fde-adee-1deda9e28cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_c285d8f5-0e88-4fde-adee-1deda9e28cd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_da0c4ec6-a75b-4714-a778-3376dbeee293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_da0c4ec6-a75b-4714-a778-3376dbeee293" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c249bc91-c87b-4338-8c1c-112f6529ba74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c249bc91-c87b-4338-8c1c-112f6529ba74" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_d61b0662-92ba-4aad-bc61-d1a78dfa3f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_d61b0662-92ba-4aad-bc61-d1a78dfa3f5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_dbf6f45d-4413-4b95-ac43-35fb9616d61b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_dbf6f45d-4413-4b95-ac43-35fb9616d61b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_740d9017-4d64-4470-a73e-83885b3d67dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_740d9017-4d64-4470-a73e-83885b3d67dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_dbf17d07-4be2-4769-9126-afa6a6240cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_dbf17d07-4be2-4769-9126-afa6a6240cde" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e6b84143-34c6-4711-9c5a-eb0c3ee693c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_DebtInstrumentTable_e6b84143-34c6-4711-9c5a-eb0c3ee693c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4a1fb2de-0d7d-4dc7-a424-9e3f0548d34f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6b84143-34c6-4711-9c5a-eb0c3ee693c7" xlink:to="loc_us-gaap_DebtInstrumentAxis_4a1fb2de-0d7d-4dc7-a424-9e3f0548d34f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4a1fb2de-0d7d-4dc7-a424-9e3f0548d34f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4a1fb2de-0d7d-4dc7-a424-9e3f0548d34f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4a1fb2de-0d7d-4dc7-a424-9e3f0548d34f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4a1fb2de-0d7d-4dc7-a424-9e3f0548d34f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_6ef7ba6e-3a27-4e8b-9d27-b06520b2ac83" xlink:href="mck-20210630.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_6ef7ba6e-3a27-4e8b-9d27-b06520b2ac83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_4260711a-c9a2-4618-9693-18704ba143b0" xlink:href="mck-20210630.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A285NotesDueMarch152023Member_4260711a-c9a2-4618-9693-18704ba143b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_eb198cb1-c42e-44c7-83a2-2e8381e168c6" xlink:href="mck-20210630.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A380NotesDueMarch152024Member_eb198cb1-c42e-44c7-83a2-2e8381e168c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_8396730f-4f77-4568-a3ef-8e347b2688a2" xlink:href="mck-20210630.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_8396730f-4f77-4568-a3ef-8e347b2688a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_dc308933-74f5-444f-9da7-0aa58f79e43e" xlink:href="mck-20210630.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A395NotesDueFebruary162028Member_dc308933-74f5-444f-9da7-0aa58f79e43e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_119c6f56-da41-480d-8859-ad6bb9078b8e" xlink:href="mck-20210630.xsd#mck_A475NotesDueMay302029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A475NotesDueMay302029Member_119c6f56-da41-480d-8859-ad6bb9078b8e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_9854de8a-2eb2-4943-9964-68557bace7fa" xlink:href="mck-20210630.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A600NotesDueMarch12041Member_9854de8a-2eb2-4943-9964-68557bace7fa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_56b259da-1b1e-4cc6-a11f-b2c1bc7887a1" xlink:href="mck-20210630.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A488NotesDueMarch152044Member_56b259da-1b1e-4cc6-a11f-b2c1bc7887a1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember_bbdd11a3-c867-4ba4-9f6a-86747850528b" xlink:href="mck-20210630.xsd#mck_TenderOfferNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_TenderOfferNotesMember_bbdd11a3-c867-4ba4-9f6a-86747850528b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_84dad953-3b06-4f08-b462-95f907603876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6b84143-34c6-4711-9c5a-eb0c3ee693c7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_84dad953-3b06-4f08-b462-95f907603876" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_84dad953-3b06-4f08-b462-95f907603876_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_84dad953-3b06-4f08-b462-95f907603876" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_84dad953-3b06-4f08-b462-95f907603876_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f50e4efb-68fc-4a3a-97a6-acbe4a96d156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_84dad953-3b06-4f08-b462-95f907603876" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f50e4efb-68fc-4a3a-97a6-acbe4a96d156" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_eda00a71-080f-499e-b0da-1458ff27722a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f50e4efb-68fc-4a3a-97a6-acbe4a96d156" xlink:to="loc_us-gaap_LoansPayableMember_eda00a71-080f-499e-b0da-1458ff27722a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5400bf10-838a-4423-b49a-590474cfcb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e6b84143-34c6-4711-9c5a-eb0c3ee693c7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5400bf10-838a-4423-b49a-590474cfcb5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_5400bf10-838a-4423-b49a-590474cfcb5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5400bf10-838a-4423-b49a-590474cfcb5a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_5400bf10-838a-4423-b49a-590474cfcb5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_aab5f57a-c06c-4b48-8a2f-a7b62ad06483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5400bf10-838a-4423-b49a-590474cfcb5a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_aab5f57a-c06c-4b48-8a2f-a7b62ad06483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_233080d1-7b0f-4ca4-9c05-33a4aca0e3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_aab5f57a-c06c-4b48-8a2f-a7b62ad06483" xlink:to="loc_us-gaap_SubsequentEventMember_233080d1-7b0f-4ca4-9c05-33a4aca0e3df" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended" id="i97093216c5fa48ea84948aaa2749aba9_DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bcfbf509-f163-4df1-98bc-59fb75957849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bcfbf509-f163-4df1-98bc-59fb75957849" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_fcda6a90-7d08-4276-8fdf-76843356d455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:to="loc_us-gaap_DebtInstrumentTerm_fcda6a90-7d08-4276-8fdf-76843356d455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_9997bdc3-6c5e-42c8-bc8e-a4c809084e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_9997bdc3-6c5e-42c8-bc8e-a4c809084e82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_abe12a66-04e8-446c-9ec1-8fd08c5bd39a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:to="loc_us-gaap_LineOfCredit_abe12a66-04e8-446c-9ec1-8fd08c5bd39a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_0ff60159-7a8a-4a29-96fd-9c17cc84c494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_0ff60159-7a8a-4a29-96fd-9c17cc84c494" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_53f7427b-7150-4c2e-a9d0-6201ef9f1615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_53f7427b-7150-4c2e-a9d0-6201ef9f1615" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_ecd5364d-0cad-455b-8e6d-338d8c0a4980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_ecd5364d-0cad-455b-8e6d-338d8c0a4980" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3ce5e35b-7021-4b2b-9cae-59a21eaa7257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ecd5364d-0cad-455b-8e6d-338d8c0a4980" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3ce5e35b-7021-4b2b-9cae-59a21eaa7257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3ce5e35b-7021-4b2b-9cae-59a21eaa7257_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3ce5e35b-7021-4b2b-9cae-59a21eaa7257" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3ce5e35b-7021-4b2b-9cae-59a21eaa7257_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_60ebc12a-c9a3-44b2-99f7-96c7f9c78e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3ce5e35b-7021-4b2b-9cae-59a21eaa7257" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_60ebc12a-c9a3-44b2-99f7-96c7f9c78e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_a4a927aa-9721-40d7-9d22-82c92d001f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_60ebc12a-c9a3-44b2-99f7-96c7f9c78e47" xlink:to="loc_us-gaap_UnsecuredDebtMember_a4a927aa-9721-40d7-9d22-82c92d001f02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_013884f7-7d7e-4146-9cc8-ab470272152d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ecd5364d-0cad-455b-8e6d-338d8c0a4980" xlink:to="loc_us-gaap_CreditFacilityAxis_013884f7-7d7e-4146-9cc8-ab470272152d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_013884f7-7d7e-4146-9cc8-ab470272152d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_013884f7-7d7e-4146-9cc8-ab470272152d" xlink:to="loc_us-gaap_CreditFacilityDomain_013884f7-7d7e-4146-9cc8-ab470272152d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_002edac8-6b69-4994-887b-79dd56f33280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_013884f7-7d7e-4146-9cc8-ab470272152d" xlink:to="loc_us-gaap_CreditFacilityDomain_002edac8-6b69-4994-887b-79dd56f33280" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_66bdfbc2-a998-4145-a027-5a485cdc973f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_002edac8-6b69-4994-887b-79dd56f33280" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_66bdfbc2-a998-4145-a027-5a485cdc973f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_c0c4f439-795f-489d-89b2-c86037619e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_002edac8-6b69-4994-887b-79dd56f33280" xlink:to="loc_us-gaap_LineOfCreditMember_c0c4f439-795f-489d-89b2-c86037619e92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6e1f8ff7-980a-4828-b02d-7356f0ddaaac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ecd5364d-0cad-455b-8e6d-338d8c0a4980" xlink:to="loc_us-gaap_DebtInstrumentAxis_6e1f8ff7-980a-4828-b02d-7356f0ddaaac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6e1f8ff7-980a-4828-b02d-7356f0ddaaac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6e1f8ff7-980a-4828-b02d-7356f0ddaaac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6e1f8ff7-980a-4828-b02d-7356f0ddaaac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cd2fda2d-0f2d-464c-9464-629ef36bd665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6e1f8ff7-980a-4828-b02d-7356f0ddaaac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cd2fda2d-0f2d-464c-9464-629ef36bd665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_d5e14c44-4494-46c9-bfe5-bcbfd5f84800" xlink:href="mck-20210630.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd2fda2d-0f2d-464c-9464-629ef36bd665" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_d5e14c44-4494-46c9-bfe5-bcbfd5f84800" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_a017425d-13a8-4a74-896a-9477d93888aa" xlink:href="mck-20210630.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd2fda2d-0f2d-464c-9464-629ef36bd665" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_a017425d-13a8-4a74-896a-9477d93888aa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended" id="i42d61ec8e7d945989b3727f4171016a8_DebtandFinancingActivitiesCommercialPaperDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0c60871b-d80e-47ed-9820-23e781c0b5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f1c0b30d-56b3-44bd-90c8-6e9588dba777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c60871b-d80e-47ed-9820-23e781c0b5f1" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f1c0b30d-56b3-44bd-90c8-6e9588dba777" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_5f335308-4b7a-4f65-83a7-2be402cf2de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c60871b-d80e-47ed-9820-23e781c0b5f1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_5f335308-4b7a-4f65-83a7-2be402cf2de9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_8365bcfd-632a-4d98-8b16-efdad94951c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c60871b-d80e-47ed-9820-23e781c0b5f1" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_8365bcfd-632a-4d98-8b16-efdad94951c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent_0a4329f3-9c5b-4b78-96aa-b4cabcf50f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c60871b-d80e-47ed-9820-23e781c0b5f1" xlink:to="loc_us-gaap_LongTermCommercialPaperCurrent_0a4329f3-9c5b-4b78-96aa-b4cabcf50f67" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_05017f30-224a-46c0-90ad-bb6782cfd849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c60871b-d80e-47ed-9820-23e781c0b5f1" xlink:to="loc_us-gaap_DebtInstrumentTable_05017f30-224a-46c0-90ad-bb6782cfd849" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8c78986e-0816-4383-8bde-f2bbb99b437f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_05017f30-224a-46c0-90ad-bb6782cfd849" xlink:to="loc_us-gaap_CreditFacilityAxis_8c78986e-0816-4383-8bde-f2bbb99b437f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8c78986e-0816-4383-8bde-f2bbb99b437f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_8c78986e-0816-4383-8bde-f2bbb99b437f" xlink:to="loc_us-gaap_CreditFacilityDomain_8c78986e-0816-4383-8bde-f2bbb99b437f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1c9b9f62-1981-4ddc-8fb2-e2a31d35e0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_8c78986e-0816-4383-8bde-f2bbb99b437f" xlink:to="loc_us-gaap_CreditFacilityDomain_1c9b9f62-1981-4ddc-8fb2-e2a31d35e0f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_8d096cc5-0320-49b6-88fd-23eda09c638f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_1c9b9f62-1981-4ddc-8fb2-e2a31d35e0f1" xlink:to="loc_us-gaap_CommercialPaperMember_8d096cc5-0320-49b6-88fd-23eda09c638f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#PensionBenefitsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended" id="i0dfe5e30953645cab0bd31131240cb86_PensionBenefitsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b0a59e6b-07fa-4066-a459-d1d8e1394047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ad8ae12c-7e4e-49fd-9035-0a05fba19075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b0a59e6b-07fa-4066-a459-d1d8e1394047" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ad8ae12c-7e4e-49fd-9035-0a05fba19075" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_576df35a-d1d9-4233-ba5e-6a01c4f9a75e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b0a59e6b-07fa-4066-a459-d1d8e1394047" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_576df35a-d1d9-4233-ba5e-6a01c4f9a75e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage_bf84c66b-444c-49e8-a8e5-b18e1ab580e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b0a59e6b-07fa-4066-a459-d1d8e1394047" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedPercentage_bf84c66b-444c-49e8-a8e5-b18e1ab580e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_072b6fcb-6684-4bcb-9456-7326ddc36b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b0a59e6b-07fa-4066-a459-d1d8e1394047" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_072b6fcb-6684-4bcb-9456-7326ddc36b21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b2ac993a-370c-4fa1-aa18-260da7f68959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_072b6fcb-6684-4bcb-9456-7326ddc36b21" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b2ac993a-370c-4fa1-aa18-260da7f68959" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b2ac993a-370c-4fa1-aa18-260da7f68959_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b2ac993a-370c-4fa1-aa18-260da7f68959" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b2ac993a-370c-4fa1-aa18-260da7f68959_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_971af3cd-de17-4284-8a55-d15bb9a3e08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b2ac993a-370c-4fa1-aa18-260da7f68959" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_971af3cd-de17-4284-8a55-d15bb9a3e08b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9f47a247-578d-463f-a970-721fd5a7025c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_971af3cd-de17-4284-8a55-d15bb9a3e08b" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9f47a247-578d-463f-a970-721fd5a7025c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended" id="i76bec494d96949eca0f58326105f17a7_HedgingActivitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_24b50d7d-3a4d-488c-a2d6-66caeb806eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:to="loc_us-gaap_LongTermDebt_24b50d7d-3a4d-488c-a2d6-66caeb806eee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_4210d8ca-52ce-4e74-a43b-8ab86e50b568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_4210d8ca-52ce-4e74-a43b-8ab86e50b568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_23306c6a-56a5-463f-9480-5e95d67fac5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_23306c6a-56a5-463f-9480-5e95d67fac5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_9f01f30a-2b80-4f18-8e5e-bfe6a1538192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_9f01f30a-2b80-4f18-8e5e-bfe6a1538192" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_92cc0732-3613-4825-8b38-7cd612871fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:to="loc_us-gaap_DebtInstrumentTerm_92cc0732-3613-4825-8b38-7cd612871fdd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3ceb0fd6-6017-4724-b64a-f31b5d3563cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3ceb0fd6-6017-4724-b64a-f31b5d3563cf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:to="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_28c2709d-6f37-46dc-8af9-f6d820131088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:to="loc_us-gaap_DebtInstrumentAxis_28c2709d-6f37-46dc-8af9-f6d820131088" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_28c2709d-6f37-46dc-8af9-f6d820131088_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_28c2709d-6f37-46dc-8af9-f6d820131088" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_28c2709d-6f37-46dc-8af9-f6d820131088_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_576ff542-0e9e-44ba-9006-406dab3a0467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_28c2709d-6f37-46dc-8af9-f6d820131088" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_576ff542-0e9e-44ba-9006-406dab3a0467" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_943a89f8-882d-4d79-bc96-765c44e519c6" xlink:href="mck-20210630.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_576ff542-0e9e-44ba-9006-406dab3a0467" xlink:to="loc_mck_EuroDenominatedNotesMember_943a89f8-882d-4d79-bc96-765c44e519c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_993b8e72-e8a2-403f-b785-dcba3b1c4c4d" xlink:href="mck-20210630.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_576ff542-0e9e-44ba-9006-406dab3a0467" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_993b8e72-e8a2-403f-b785-dcba3b1c4c4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2025NotesMember_931a6585-1673-4e4d-9e99-1f2455a03521" xlink:href="mck-20210630.xsd#mck_A2025NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_576ff542-0e9e-44ba-9006-406dab3a0467" xlink:to="loc_mck_A2025NotesMember_931a6585-1673-4e4d-9e99-1f2455a03521" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6f2e8e49-eeb8-4e70-8c3f-87cf00f52ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6f2e8e49-eeb8-4e70-8c3f-87cf00f52ec1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6f2e8e49-eeb8-4e70-8c3f-87cf00f52ec1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6f2e8e49-eeb8-4e70-8c3f-87cf00f52ec1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6f2e8e49-eeb8-4e70-8c3f-87cf00f52ec1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c9b99cae-5d5b-447c-930a-d9725685b723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6f2e8e49-eeb8-4e70-8c3f-87cf00f52ec1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c9b99cae-5d5b-447c-930a-d9725685b723" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_c89e3db2-8f1f-4bbf-90a4-11711541caf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9b99cae-5d5b-447c-930a-d9725685b723" xlink:to="loc_us-gaap_LoansPayableMember_c89e3db2-8f1f-4bbf-90a4-11711541caf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1083de15-96f9-4821-8bdb-e5c9850e5c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1083de15-96f9-4821-8bdb-e5c9850e5c3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1083de15-96f9-4821-8bdb-e5c9850e5c3d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1083de15-96f9-4821-8bdb-e5c9850e5c3d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1083de15-96f9-4821-8bdb-e5c9850e5c3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f6c20d24-38a7-4ed5-8a1a-2234043bfc2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1083de15-96f9-4821-8bdb-e5c9850e5c3d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f6c20d24-38a7-4ed5-8a1a-2234043bfc2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_8e54dbae-db2b-442a-850e-d131b9e576ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f6c20d24-38a7-4ed5-8a1a-2234043bfc2d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_8e54dbae-db2b-442a-850e-d131b9e576ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_39f90b8f-e98e-4729-8235-5748c8155bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f6c20d24-38a7-4ed5-8a1a-2234043bfc2d" xlink:to="loc_us-gaap_CashFlowHedgingMember_39f90b8f-e98e-4729-8235-5748c8155bf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_31b7e858-a1f9-4402-8b28-f1df1aa3260e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_31b7e858-a1f9-4402-8b28-f1df1aa3260e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_31b7e858-a1f9-4402-8b28-f1df1aa3260e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_31b7e858-a1f9-4402-8b28-f1df1aa3260e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_31b7e858-a1f9-4402-8b28-f1df1aa3260e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2767b2c0-9f59-442a-9bbf-2892c31fa56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_31b7e858-a1f9-4402-8b28-f1df1aa3260e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2767b2c0-9f59-442a-9bbf-2892c31fa56f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember_f3f57189-46a0-421a-b51d-e02647922536" xlink:href="mck-20210630.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2767b2c0-9f59-442a-9bbf-2892c31fa56f" xlink:to="loc_mck_November2018CrossCurrencySwapsMember_f3f57189-46a0-421a-b51d-e02647922536" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_7a9739f1-3021-4308-96e5-909504d76f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2767b2c0-9f59-442a-9bbf-2892c31fa56f" xlink:to="loc_us-gaap_CurrencySwapMember_7a9739f1-3021-4308-96e5-909504d76f7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7cf20104-45d1-4677-b94d-cede6d20d9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2767b2c0-9f59-442a-9bbf-2892c31fa56f" xlink:to="loc_us-gaap_InterestRateSwapMember_7cf20104-45d1-4677-b94d-cede6d20d9c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_79f786f3-326e-4f0b-9c45-1a5b972756e7" xlink:href="mck-20210630.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2767b2c0-9f59-442a-9bbf-2892c31fa56f" xlink:to="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_79f786f3-326e-4f0b-9c45-1a5b972756e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0685bb35-d7ba-4835-b268-6926e4ebd71e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:to="loc_us-gaap_HedgingDesignationAxis_0685bb35-d7ba-4835-b268-6926e4ebd71e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0685bb35-d7ba-4835-b268-6926e4ebd71e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_0685bb35-d7ba-4835-b268-6926e4ebd71e" xlink:to="loc_us-gaap_HedgingDesignationDomain_0685bb35-d7ba-4835-b268-6926e4ebd71e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e0c0bdb8-be4c-4537-8f19-3f8f87c65b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_0685bb35-d7ba-4835-b268-6926e4ebd71e" xlink:to="loc_us-gaap_HedgingDesignationDomain_e0c0bdb8-be4c-4537-8f19-3f8f87c65b1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_eba05f4b-eff3-4557-becc-1a9f786fde38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_e0c0bdb8-be4c-4537-8f19-3f8f87c65b1d" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_eba05f4b-eff3-4557-becc-1a9f786fde38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_1ab7b0a7-b8ef-43cb-9c20-fa953344bc13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_e0c0bdb8-be4c-4537-8f19-3f8f87c65b1d" xlink:to="loc_us-gaap_NondesignatedMember_1ab7b0a7-b8ef-43cb-9c20-fa953344bc13" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#HedgingActivitiesDerivativeInstrumentsFairValueDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="extended" id="iebf03da8159f4cd297a5540b97e91a4c_HedgingActivitiesDerivativeInstrumentsFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_6e7f5686-53b9-4495-8d1a-4a99f654618a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_96d3ad8a-3c33-4246-a729-332ca629844c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_6e7f5686-53b9-4495-8d1a-4a99f654618a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_96d3ad8a-3c33-4246-a729-332ca629844c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_2e03eb74-18fe-4ec2-b164-b11c547f71e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_6e7f5686-53b9-4495-8d1a-4a99f654618a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_2e03eb74-18fe-4ec2-b164-b11c547f71e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_b5927e69-9011-4306-89ea-23695a517efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_6e7f5686-53b9-4495-8d1a-4a99f654618a" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_b5927e69-9011-4306-89ea-23695a517efc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_24d20da1-1262-4a2d-9d29-bd238a7c5fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_6e7f5686-53b9-4495-8d1a-4a99f654618a" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_24d20da1-1262-4a2d-9d29-bd238a7c5fdf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_001161b4-ac1e-428d-bfc0-3bfb6bb3972c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_6e7f5686-53b9-4495-8d1a-4a99f654618a" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_001161b4-ac1e-428d-bfc0-3bfb6bb3972c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a533e9a6-f135-4c18-a253-f13bdc4bbed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_001161b4-ac1e-428d-bfc0-3bfb6bb3972c" xlink:to="loc_us-gaap_HedgingDesignationAxis_a533e9a6-f135-4c18-a253-f13bdc4bbed8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_a533e9a6-f135-4c18-a253-f13bdc4bbed8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_a533e9a6-f135-4c18-a253-f13bdc4bbed8" xlink:to="loc_us-gaap_HedgingDesignationDomain_a533e9a6-f135-4c18-a253-f13bdc4bbed8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f0d4b603-d779-44ce-b99f-0a0bb892cf3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_a533e9a6-f135-4c18-a253-f13bdc4bbed8" xlink:to="loc_us-gaap_HedgingDesignationDomain_f0d4b603-d779-44ce-b99f-0a0bb892cf3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5258322b-32f9-44f2-8a13-b867e44b897c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f0d4b603-d779-44ce-b99f-0a0bb892cf3f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5258322b-32f9-44f2-8a13-b867e44b897c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_5a448f36-924f-4145-acb7-50585fbe8c16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_f0d4b603-d779-44ce-b99f-0a0bb892cf3f" xlink:to="loc_us-gaap_NondesignatedMember_5a448f36-924f-4145-acb7-50585fbe8c16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_432e61f5-cc5d-4666-9336-5048e6655b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_001161b4-ac1e-428d-bfc0-3bfb6bb3972c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_432e61f5-cc5d-4666-9336-5048e6655b42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_432e61f5-cc5d-4666-9336-5048e6655b42_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_432e61f5-cc5d-4666-9336-5048e6655b42" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_432e61f5-cc5d-4666-9336-5048e6655b42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1c82f79b-14af-4fa0-bf02-21be0ec0d18d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_432e61f5-cc5d-4666-9336-5048e6655b42" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1c82f79b-14af-4fa0-bf02-21be0ec0d18d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_5d619a9d-1f51-49c3-86ab-c928d80d485f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c82f79b-14af-4fa0-bf02-21be0ec0d18d" xlink:to="loc_us-gaap_CurrencySwapMember_5d619a9d-1f51-49c3-86ab-c928d80d485f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ae5c0c65-f1b8-4d4e-b448-cdd074561b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c82f79b-14af-4fa0-bf02-21be0ec0d18d" xlink:to="loc_us-gaap_InterestRateSwapMember_ae5c0c65-f1b8-4d4e-b448-cdd074561b6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e3150c09-1a1f-49e4-ac74-39a359221e14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c82f79b-14af-4fa0-bf02-21be0ec0d18d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e3150c09-1a1f-49e4-ac74-39a359221e14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8f4e5a79-1075-4aee-83b1-c197210536b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_001161b4-ac1e-428d-bfc0-3bfb6bb3972c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8f4e5a79-1075-4aee-83b1-c197210536b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8f4e5a79-1075-4aee-83b1-c197210536b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8f4e5a79-1075-4aee-83b1-c197210536b5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8f4e5a79-1075-4aee-83b1-c197210536b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8f4e5a79-1075-4aee-83b1-c197210536b5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_85fe1d92-b573-467a-ad46-d8661189f536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_85fe1d92-b573-467a-ad46-d8661189f536" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_9622be7b-3805-488d-b43d-7ad16807058a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_9622be7b-3805-488d-b43d-7ad16807058a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_0e659369-347e-4d16-9de3-dc95f99eb208" xlink:href="mck-20210630.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:to="loc_mck_CurrentAssetLiabilityMember_0e659369-347e-4d16-9de3-dc95f99eb208" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_2bcf59f5-02c3-4567-a968-89aaccdd37ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_2bcf59f5-02c3-4567-a968-89aaccdd37ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_bc488615-3b76-49d6-aa93-e8157478f5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_bc488615-3b76-49d6-aa93-e8157478f5da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncurrentAssetLiabilityMember_f60e39fb-14bb-44cf-8d7c-164ffa59a7da" xlink:href="mck-20210630.xsd#mck_NoncurrentAssetLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:to="loc_mck_NoncurrentAssetLiabilityMember_f60e39fb-14bb-44cf-8d7c-164ffa59a7da" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="ie06765b60991463dbccb67be4011b401_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d91462b1-8efc-4b36-8a1c-9b4f7a435c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7b138cbe-6310-4ecc-88ae-fa1a9cc8f1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d91462b1-8efc-4b36-8a1c-9b4f7a435c46" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7b138cbe-6310-4ecc-88ae-fa1a9cc8f1d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_11849ecd-4fd2-42f7-8ff2-484b422a434b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d91462b1-8efc-4b36-8a1c-9b4f7a435c46" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_11849ecd-4fd2-42f7-8ff2-484b422a434b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4727305c-a603-462c-ac56-ec013fdeca9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d91462b1-8efc-4b36-8a1c-9b4f7a435c46" xlink:to="loc_us-gaap_LongTermDebt_4727305c-a603-462c-ac56-ec013fdeca9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_5c9bb0fe-85fc-4ac6-be49-358243b77745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d91462b1-8efc-4b36-8a1c-9b4f7a435c46" xlink:to="loc_us-gaap_DebtInstrumentFairValue_5c9bb0fe-85fc-4ac6-be49-358243b77745" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_327d5992-b987-490f-aba4-46959e0455ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d91462b1-8efc-4b36-8a1c-9b4f7a435c46" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_327d5992-b987-490f-aba4-46959e0455ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_133e1d5d-f98d-453a-bb08-814193841f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_327d5992-b987-490f-aba4-46959e0455ad" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_133e1d5d-f98d-453a-bb08-814193841f96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_133e1d5d-f98d-453a-bb08-814193841f96_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_133e1d5d-f98d-453a-bb08-814193841f96" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_133e1d5d-f98d-453a-bb08-814193841f96_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_542d9ae8-66d6-4409-ae3a-db1520e102b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_133e1d5d-f98d-453a-bb08-814193841f96" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_542d9ae8-66d6-4409-ae3a-db1520e102b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_71631aba-1d0b-4522-a0ef-b54cd20424b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_542d9ae8-66d6-4409-ae3a-db1520e102b6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_71631aba-1d0b-4522-a0ef-b54cd20424b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_f358b8a3-0bd5-4a97-9440-a31dd561c0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_542d9ae8-66d6-4409-ae3a-db1520e102b6" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_f358b8a3-0bd5-4a97-9440-a31dd561c0f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_29f887ce-a564-4e37-904e-a5e6c2c98e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_327d5992-b987-490f-aba4-46959e0455ad" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_29f887ce-a564-4e37-904e-a5e6c2c98e66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_29f887ce-a564-4e37-904e-a5e6c2c98e66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_29f887ce-a564-4e37-904e-a5e6c2c98e66" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_29f887ce-a564-4e37-904e-a5e6c2c98e66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5de3f82c-2344-4e4f-8f6c-404de7d3f5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_29f887ce-a564-4e37-904e-a5e6c2c98e66" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5de3f82c-2344-4e4f-8f6c-404de7d3f5c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fafe064d-fe5e-4f62-9e01-38abcbfac4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5de3f82c-2344-4e4f-8f6c-404de7d3f5c9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fafe064d-fe5e-4f62-9e01-38abcbfac4a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_73df711c-08c3-4008-a425-b76886e35721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5de3f82c-2344-4e4f-8f6c-404de7d3f5c9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_73df711c-08c3-4008-a425-b76886e35721" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended" id="i95df1c7e458f4849a32d09b81d9ad4e7_CommitmentsandContingentLiabilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_8ee13c43-4092-4122-af36-02faca0de473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_8ee13c43-4092-4122-af36-02faca0de473" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_5e9b00ab-b9e5-4bd9-ae93-3433b9e2c193" xlink:href="mck-20210630.xsd#mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_5e9b00ab-b9e5-4bd9-ae93-3433b9e2c193" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_211f8d4e-461d-470c-9001-77f07fdea37e" xlink:href="mck-20210630.xsd#mck_LossContingencyNumberofStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencyNumberofStates_211f8d4e-461d-470c-9001-77f07fdea37e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStateAttorneyGenerals_a69a9aba-1b0e-48a0-83fa-0d77de6405cd" xlink:href="mck-20210630.xsd#mck_LossContingencyNumberofStateAttorneyGenerals"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencyNumberofStateAttorneyGenerals_a69a9aba-1b0e-48a0-83fa-0d77de6405cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants_1717f187-e476-4ac3-a093-9bebd9a85d44" xlink:href="mck-20210630.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencyNumberOfOtherDefendants_1717f187-e476-4ac3-a093-9bebd9a85d44" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_9591720d-f248-400a-8ab9-2c5fa784f85f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_9591720d-f248-400a-8ab9-2c5fa784f85f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_cd52e2f3-0a42-4b2b-9fa3-7590ff9947cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_cd52e2f3-0a42-4b2b-9fa3-7590ff9947cc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_b9bfe451-7150-492a-a5cb-e0a85003edad" xlink:href="mck-20210630.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_b9bfe451-7150-492a-a5cb-e0a85003edad" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_790cf2ee-d043-4ec4-82ee-f0a7bfc65795" xlink:href="mck-20210630.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_790cf2ee-d043-4ec4-82ee-f0a7bfc65795" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_4c18711b-ed1f-400d-9a6c-2e38896af06d" xlink:href="mck-20210630.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_4c18711b-ed1f-400d-9a6c-2e38896af06d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_0642ae68-19b0-4e21-9e6e-9dbb19a79910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_0642ae68-19b0-4e21-9e6e-9dbb19a79910" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a725b7b4-7a14-4dda-87ab-7b57e73637ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a725b7b4-7a14-4dda-87ab-7b57e73637ed" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_c77362a4-0b59-4233-9604-e338075e1acc" xlink:href="mck-20210630.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_c77362a4-0b59-4233-9604-e338075e1acc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_21b42503-0152-4252-9d6c-9b7c598afa55" xlink:href="mck-20210630.xsd#mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_21b42503-0152-4252-9d6c-9b7c598afa55" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_c39fcc8b-a124-4547-8473-28112541f06e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_c39fcc8b-a124-4547-8473-28112541f06e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualAfterTax_ebb3f4b9-053f-4fc1-8cef-798223194465" xlink:href="mck-20210630.xsd#mck_LossContingencyAccrualAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencyAccrualAfterTax_ebb3f4b9-053f-4fc1-8cef-798223194465" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_8b7fd866-20da-420e-a6f7-424dc562d7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_us-gaap_LitigationStatusAxis_8b7fd866-20da-420e-a6f7-424dc562d7dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_8b7fd866-20da-420e-a6f7-424dc562d7dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_8b7fd866-20da-420e-a6f7-424dc562d7dd" xlink:to="loc_us-gaap_LitigationStatusDomain_8b7fd866-20da-420e-a6f7-424dc562d7dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_49e7cd73-8ff4-4a1a-ac5a-d3c98a20394b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_8b7fd866-20da-420e-a6f7-424dc562d7dd" xlink:to="loc_us-gaap_LitigationStatusDomain_49e7cd73-8ff4-4a1a-ac5a-d3c98a20394b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_ea04b0f7-9c3a-4f67-b339-90bfe45b98bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_49e7cd73-8ff4-4a1a-ac5a-d3c98a20394b" xlink:to="loc_us-gaap_PendingLitigationMember_ea04b0f7-9c3a-4f67-b339-90bfe45b98bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_410b18bc-6bec-428b-8a97-b35cbb43b7eb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_dei_LegalEntityAxis_410b18bc-6bec-428b-8a97-b35cbb43b7eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_410b18bc-6bec-428b-8a97-b35cbb43b7eb_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_410b18bc-6bec-428b-8a97-b35cbb43b7eb" xlink:to="loc_dei_EntityDomain_410b18bc-6bec-428b-8a97-b35cbb43b7eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_15991861-1ad3-46e7-b98e-461564fb7af3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_410b18bc-6bec-428b-8a97-b35cbb43b7eb" xlink:to="loc_dei_EntityDomain_15991861-1ad3-46e7-b98e-461564fb7af3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_a6ff4312-d9ff-488f-9082-a1732e604d99" xlink:href="mck-20210630.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_15991861-1ad3-46e7-b98e-461564fb7af3" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_a6ff4312-d9ff-488f-9082-a1732e604d99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_54364607-60ff-4b6a-bb59-3e1a66d3f233" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_srt_StatementGeographicalAxis_54364607-60ff-4b6a-bb59-3e1a66d3f233" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_54364607-60ff-4b6a-bb59-3e1a66d3f233_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_54364607-60ff-4b6a-bb59-3e1a66d3f233" xlink:to="loc_srt_SegmentGeographicalDomain_54364607-60ff-4b6a-bb59-3e1a66d3f233_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1c73ba94-e65e-44a2-94bc-237712b7a27f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_54364607-60ff-4b6a-bb59-3e1a66d3f233" xlink:to="loc_srt_SegmentGeographicalDomain_1c73ba94-e65e-44a2-94bc-237712b7a27f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_8a518a2c-c2a6-4ce5-b8ee-aeef32cc8039" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1c73ba94-e65e-44a2-94bc-237712b7a27f" xlink:to="loc_country_CA_8a518a2c-c2a6-4ce5-b8ee-aeef32cc8039" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6d45c966-b9e7-498c-b4aa-e8ce94828531" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_srt_LitigationCaseAxis_6d45c966-b9e7-498c-b4aa-e8ce94828531" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6d45c966-b9e7-498c-b4aa-e8ce94828531_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_6d45c966-b9e7-498c-b4aa-e8ce94828531" xlink:to="loc_srt_LitigationCaseTypeDomain_6d45c966-b9e7-498c-b4aa-e8ce94828531_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2e146726-ba46-445c-b09d-75e57975ba2d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_6d45c966-b9e7-498c-b4aa-e8ce94828531" xlink:to="loc_srt_LitigationCaseTypeDomain_2e146726-ba46-445c-b09d-75e57975ba2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_c530b742-ab4e-459b-a42a-813a730c33ce" xlink:href="mck-20210630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_2e146726-ba46-445c-b09d-75e57975ba2d" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_c530b742-ab4e-459b-a42a-813a730c33ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2cbe9821-ae62-4d58-8080-30879ce6e1f7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_srt_RangeAxis_2cbe9821-ae62-4d58-8080-30879ce6e1f7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2cbe9821-ae62-4d58-8080-30879ce6e1f7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2cbe9821-ae62-4d58-8080-30879ce6e1f7" xlink:to="loc_srt_RangeMember_2cbe9821-ae62-4d58-8080-30879ce6e1f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_11e99f83-b458-4c26-ade2-3b0201b7eafc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2cbe9821-ae62-4d58-8080-30879ce6e1f7" xlink:to="loc_srt_RangeMember_11e99f83-b458-4c26-ade2-3b0201b7eafc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9d2a92f8-f1bc-4dee-b378-924919b4cb73" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_11e99f83-b458-4c26-ade2-3b0201b7eafc" xlink:to="loc_srt_MinimumMember_9d2a92f8-f1bc-4dee-b378-924919b4cb73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_71d3f1d7-0b55-415b-b7a1-12c4187fd0c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_11e99f83-b458-4c26-ade2-3b0201b7eafc" xlink:to="loc_srt_MaximumMember_71d3f1d7-0b55-415b-b7a1-12c4187fd0c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a1765a6f-4566-4aae-aaa6-46a2a0098fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a1765a6f-4566-4aae-aaa6-46a2a0098fe7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_a1765a6f-4566-4aae-aaa6-46a2a0098fe7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a1765a6f-4566-4aae-aaa6-46a2a0098fe7" xlink:to="loc_us-gaap_LossContingencyNatureDomain_a1765a6f-4566-4aae-aaa6-46a2a0098fe7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_d30b52a3-9eeb-4db2-b583-177b7304d3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a1765a6f-4566-4aae-aaa6-46a2a0098fe7" xlink:to="loc_us-gaap_LossContingencyNatureDomain_d30b52a3-9eeb-4db2-b583-177b7304d3c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_bd78cba3-e388-4466-8a2e-747513037f36" xlink:href="mck-20210630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_d30b52a3-9eeb-4db2-b583-177b7304d3c4" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_bd78cba3-e388-4466-8a2e-747513037f36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOpioidStatutesMember_b78fae6b-16ab-4c4a-ac27-16ebd4e4f6e3" xlink:href="mck-20210630.xsd#mck_StateOpioidStatutesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_d30b52a3-9eeb-4db2-b583-177b7304d3c4" xlink:to="loc_mck_StateOpioidStatutesMember_b78fae6b-16ab-4c4a-ac27-16ebd4e4f6e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_afcc5592-421c-4a37-be87-fed7441a4f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_afcc5592-421c-4a37-be87-fed7441a4f8c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_afcc5592-421c-4a37-be87-fed7441a4f8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_afcc5592-421c-4a37-be87-fed7441a4f8c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_afcc5592-421c-4a37-be87-fed7441a4f8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8662acd4-0630-4f50-8d86-2a63a4bf8265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_afcc5592-421c-4a37-be87-fed7441a4f8c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8662acd4-0630-4f50-8d86-2a63a4bf8265" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8aae1a68-b358-4d7b-9d47-f2ea2b9746a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8662acd4-0630-4f50-8d86-2a63a4bf8265" xlink:to="loc_us-gaap_SubsequentEventMember_8aae1a68-b358-4d7b-9d47-f2ea2b9746a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_99a468a6-89ed-4a34-9fab-512ce8cdd859" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_srt_StatementScenarioAxis_99a468a6-89ed-4a34-9fab-512ce8cdd859" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_99a468a6-89ed-4a34-9fab-512ce8cdd859_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_99a468a6-89ed-4a34-9fab-512ce8cdd859" xlink:to="loc_srt_ScenarioUnspecifiedDomain_99a468a6-89ed-4a34-9fab-512ce8cdd859_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f3dd82c7-d1b7-4437-95e8-599d575cbce8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_99a468a6-89ed-4a34-9fab-512ce8cdd859" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f3dd82c7-d1b7-4437-95e8-599d575cbce8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_31db5c61-9a6b-4e5b-b819-8e43806debac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f3dd82c7-d1b7-4437-95e8-599d575cbce8" xlink:to="loc_srt_ScenarioForecastMember_31db5c61-9a6b-4e5b-b819-8e43806debac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_40d719b0-5a0b-47bd-850c-caa9cba9df91" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_srt_CounterpartyNameAxis_40d719b0-5a0b-47bd-850c-caa9cba9df91" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_40d719b0-5a0b-47bd-850c-caa9cba9df91_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_40d719b0-5a0b-47bd-850c-caa9cba9df91" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_40d719b0-5a0b-47bd-850c-caa9cba9df91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5e422b9-6512-48c5-9d13-a4ae304a8db0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_40d719b0-5a0b-47bd-850c-caa9cba9df91" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5e422b9-6512-48c5-9d13-a4ae304a8db0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfNewYorkMember_80d45c5e-48ac-465f-a3a3-d198fe7b092c" xlink:href="mck-20210630.xsd#mck_StateOfNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5e422b9-6512-48c5-9d13-a4ae304a8db0" xlink:to="loc_mck_StateOfNewYorkMember_80d45c5e-48ac-465f-a3a3-d198fe7b092c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateAndLocalGovernmentalEntitiesMember_d5230492-aef8-4ec7-89b7-30396036ac13" xlink:href="mck-20210630.xsd#mck_StateAndLocalGovernmentalEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5e422b9-6512-48c5-9d13-a4ae304a8db0" xlink:to="loc_mck_StateAndLocalGovernmentalEntitiesMember_d5230492-aef8-4ec7-89b7-30396036ac13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember_8e0e9872-2950-4778-8078-6d13aa8f9f23" xlink:href="mck-20210630.xsd#mck_GovernmentalEntitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5e422b9-6512-48c5-9d13-a4ae304a8db0" xlink:to="loc_mck_GovernmentalEntitiesMember_8e0e9872-2950-4778-8078-6d13aa8f9f23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember_8babffba-b191-4417-9f2a-5bcec3b895ad" xlink:href="mck-20210630.xsd#mck_IndividualClaimantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5e422b9-6512-48c5-9d13-a4ae304a8db0" xlink:to="loc_mck_IndividualClaimantMember_8babffba-b191-4417-9f2a-5bcec3b895ad" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended" id="ic225c50c277b49189cbd7bf321a0f203_CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_361f572e-99d3-4c87-8f17-e9094be948f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_d6600a9a-96db-490c-9b2e-dc4e24df13b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_361f572e-99d3-4c87-8f17-e9094be948f4" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_d6600a9a-96db-490c-9b2e-dc4e24df13b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_c9b843ee-0bfc-4342-b1a5-012049d26ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_361f572e-99d3-4c87-8f17-e9094be948f4" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_c9b843ee-0bfc-4342-b1a5-012049d26ccf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7c234973-75c0-4758-a4a3-8c6e02889af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_361f572e-99d3-4c87-8f17-e9094be948f4" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7c234973-75c0-4758-a4a3-8c6e02889af7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d767c119-791b-41a2-9821-8e586696f2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_361f572e-99d3-4c87-8f17-e9094be948f4" xlink:to="loc_us-gaap_LossContingenciesTable_d767c119-791b-41a2-9821-8e586696f2fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d557f325-1345-4b33-b7ce-31c0ef34fa85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_d767c119-791b-41a2-9821-8e586696f2fa" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d557f325-1345-4b33-b7ce-31c0ef34fa85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_d557f325-1345-4b33-b7ce-31c0ef34fa85_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d557f325-1345-4b33-b7ce-31c0ef34fa85" xlink:to="loc_us-gaap_LossContingencyNatureDomain_d557f325-1345-4b33-b7ce-31c0ef34fa85_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_faefb52a-9188-49b8-a636-445512fb882c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d557f325-1345-4b33-b7ce-31c0ef34fa85" xlink:to="loc_us-gaap_LossContingencyNatureDomain_faefb52a-9188-49b8-a636-445512fb882c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_e7ecd868-bcec-4073-b8d2-82abb2e9e24e" xlink:href="mck-20210630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_faefb52a-9188-49b8-a636-445512fb882c" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_e7ecd868-bcec-4073-b8d2-82abb2e9e24e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended" id="if9607ca5d820430797bed0d0436c6ad0_StockholdersEquityDeficitNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_158aee70-c617-450d-83c6-bf1dc72aee7e" xlink:href="mck-20210630.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_158aee70-c617-450d-83c6-bf1dc72aee7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_f41682a0-3a5f-4600-9883-e693daab8ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_f41682a0-3a5f-4600-9883-e693daab8ba2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_dc049e77-870e-4f77-bb36-eadf6a797068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_dc049e77-870e-4f77-bb36-eadf6a797068" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_e1b1cc31-de2d-4588-9a51-b4559b429c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_e1b1cc31-de2d-4588-9a51-b4559b429c7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_d87eed42-c13a-491f-9b02-f080615f9d10" xlink:href="mck-20210630.xsd#mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:to="loc_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_d87eed42-c13a-491f-9b02-f080615f9d10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f3e94d1c-f201-4833-85ff-12d6efff7afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f3e94d1c-f201-4833-85ff-12d6efff7afe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_23a1e721-937e-4b0c-9851-f49654b4a4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_23a1e721-937e-4b0c-9851-f49654b4a4f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_89df3a0a-4132-4fa7-9306-df9c6e608622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_23a1e721-937e-4b0c-9851-f49654b4a4f4" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_89df3a0a-4132-4fa7-9306-df9c6e608622" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_89df3a0a-4132-4fa7-9306-df9c6e608622_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_89df3a0a-4132-4fa7-9306-df9c6e608622" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_89df3a0a-4132-4fa7-9306-df9c6e608622_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_9a0d8585-51e6-4c6e-b8f4-0bc1655cfd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_89df3a0a-4132-4fa7-9306-df9c6e608622" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_9a0d8585-51e6-4c6e-b8f4-0bc1655cfd5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_58339447-9fde-4c0d-87ea-d7878c32f2ea" xlink:href="mck-20210630.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_9a0d8585-51e6-4c6e-b8f4-0bc1655cfd5d" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_58339447-9fde-4c0d-87ea-d7878c32f2ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c1a17678-cac9-430e-9419-1bf1a48fab86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_23a1e721-937e-4b0c-9851-f49654b4a4f4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c1a17678-cac9-430e-9419-1bf1a48fab86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c1a17678-cac9-430e-9419-1bf1a48fab86_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c1a17678-cac9-430e-9419-1bf1a48fab86" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c1a17678-cac9-430e-9419-1bf1a48fab86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_31582dda-a0c8-46a1-a463-b85fcad55776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c1a17678-cac9-430e-9419-1bf1a48fab86" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_31582dda-a0c8-46a1-a463-b85fcad55776" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d59a0a54-0bd3-4d0e-8cdd-0828dfed5296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_31582dda-a0c8-46a1-a463-b85fcad55776" xlink:to="loc_us-gaap_SubsequentEventMember_d59a0a54-0bd3-4d0e-8cdd-0828dfed5296" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e270142d-8abd-4126-b2ab-754b20716811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_23a1e721-937e-4b0c-9851-f49654b4a4f4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e270142d-8abd-4126-b2ab-754b20716811" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e270142d-8abd-4126-b2ab-754b20716811_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e270142d-8abd-4126-b2ab-754b20716811" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e270142d-8abd-4126-b2ab-754b20716811_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_91b4bd71-4a71-47cb-8c09-6975dcba4371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e270142d-8abd-4126-b2ab-754b20716811" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_91b4bd71-4a71-47cb-8c09-6975dcba4371" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_24c59413-d3ba-4106-ae8e-2e1222775d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_91b4bd71-4a71-47cb-8c09-6975dcba4371" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_24c59413-d3ba-4106-ae8e-2e1222775d74" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="extended" id="i3783f83669564feb94c6f1d01c162107_StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_01f1e237-6901-4190-9fb3-94b8a211e480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_01f1e237-6901-4190-9fb3-94b8a211e480" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c629843c-4162-4208-a1da-ad8c6a7c25d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c629843c-4162-4208-a1da-ad8c6a7c25d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4198ef88-df40-4630-99ec-ec382bd081d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4198ef88-df40-4630-99ec-ec382bd081d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_6d8985d7-30aa-4568-987c-d626812c0e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_6d8985d7-30aa-4568-987c-d626812c0e33" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_0a94b1d0-76d6-421d-afa2-a5fcfa8d5cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_0a94b1d0-76d6-421d-afa2-a5fcfa8d5cf5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_8b89e7b0-ba75-4cef-aa74-744972fd4fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_8b89e7b0-ba75-4cef-aa74-744972fd4fe9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3a9841dd-2652-4ee2-a14b-c9d4028b564c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3a9841dd-2652-4ee2-a14b-c9d4028b564c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_f6787aed-cfff-40fc-9d2f-2247e6954d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_f6787aed-cfff-40fc-9d2f-2247e6954d18" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_987958c7-de45-408b-b893-a99ada1d46ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_987958c7-de45-408b-b893-a99ada1d46ae" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_bf8fef28-6722-404d-b84b-c8fbde4a8ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_bf8fef28-6722-404d-b84b-c8fbde4a8ab3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_43814884-afb5-436e-b1c6-63753e047c1d" xlink:href="mck-20210630.xsd#mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_43814884-afb5-436e-b1c6-63753e047c1d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_fefba11b-7387-4141-ae64-f03246612465" xlink:href="mck-20210630.xsd#mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_fefba11b-7387-4141-ae64-f03246612465" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_57cec226-7baf-4ebb-adaa-a57cead8b592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_57cec226-7baf-4ebb-adaa-a57cead8b592" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_155233ea-4726-4068-9bce-fb3808929926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_LongTermDebt_155233ea-4726-4068-9bce-fb3808929926" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_feba933f-921c-41d7-a524-a64a76368bad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_feba933f-921c-41d7-a524-a64a76368bad" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_055b4e91-5bfc-4d85-ac81-2c441a1be561" xlink:href="mck-20210630.xsd#mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_055b4e91-5bfc-4d85-ac81-2c441a1be561" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5f74d00c-b5cf-4fd4-98c3-40bab1f77be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:to="loc_us-gaap_HedgingDesignationAxis_5f74d00c-b5cf-4fd4-98c3-40bab1f77be6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5f74d00c-b5cf-4fd4-98c3-40bab1f77be6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_5f74d00c-b5cf-4fd4-98c3-40bab1f77be6" xlink:to="loc_us-gaap_HedgingDesignationDomain_5f74d00c-b5cf-4fd4-98c3-40bab1f77be6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3a11e8f6-5870-421f-a0c0-e613fff4d7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_5f74d00c-b5cf-4fd4-98c3-40bab1f77be6" xlink:to="loc_us-gaap_HedgingDesignationDomain_3a11e8f6-5870-421f-a0c0-e613fff4d7d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_dca5f903-38d3-42e5-aaa7-069e79a01e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_3a11e8f6-5870-421f-a0c0-e613fff4d7d5" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_dca5f903-38d3-42e5-aaa7-069e79a01e40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b4707f5-c0af-4751-ac93-b76a476c4f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b4707f5-c0af-4751-ac93-b76a476c4f38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_4b4707f5-c0af-4751-ac93-b76a476c4f38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b4707f5-c0af-4751-ac93-b76a476c4f38" xlink:to="loc_us-gaap_HedgingRelationshipDomain_4b4707f5-c0af-4751-ac93-b76a476c4f38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1455d6f4-a628-4825-8e6a-2481b5a809af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b4707f5-c0af-4751-ac93-b76a476c4f38" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1455d6f4-a628-4825-8e6a-2481b5a809af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_49486a4d-9a15-4f81-8d0a-7785baa0e333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1455d6f4-a628-4825-8e6a-2481b5a809af" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_49486a4d-9a15-4f81-8d0a-7785baa0e333" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d54b7fd7-7ac3-4d84-9373-367675607978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:to="loc_us-gaap_DebtInstrumentAxis_d54b7fd7-7ac3-4d84-9373-367675607978" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d54b7fd7-7ac3-4d84-9373-367675607978_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d54b7fd7-7ac3-4d84-9373-367675607978" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d54b7fd7-7ac3-4d84-9373-367675607978_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1bca2921-e6a2-413a-912c-634dd7426bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d54b7fd7-7ac3-4d84-9373-367675607978" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1bca2921-e6a2-413a-912c-634dd7426bed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_a57d9ad5-bfab-4821-b70a-e157ee7b004b" xlink:href="mck-20210630.xsd#mck_EuroDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1bca2921-e6a2-413a-912c-634dd7426bed" xlink:to="loc_mck_EuroDenominatedNotesMember_a57d9ad5-bfab-4821-b70a-e157ee7b004b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_cb9de779-aff8-46d8-9a06-c18275367503" xlink:href="mck-20210630.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1bca2921-e6a2-413a-912c-634dd7426bed" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_cb9de779-aff8-46d8-9a06-c18275367503" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d1f36a44-c4c2-4b9c-872c-96e0e35b5359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d1f36a44-c4c2-4b9c-872c-96e0e35b5359" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d1f36a44-c4c2-4b9c-872c-96e0e35b5359_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d1f36a44-c4c2-4b9c-872c-96e0e35b5359" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d1f36a44-c4c2-4b9c-872c-96e0e35b5359_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_728814ad-a069-4983-9000-2bf08951d269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d1f36a44-c4c2-4b9c-872c-96e0e35b5359" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_728814ad-a069-4983-9000-2bf08951d269" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_99fc91b1-5604-404e-9430-0c191c068508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_728814ad-a069-4983-9000-2bf08951d269" xlink:to="loc_us-gaap_LoansPayableMember_99fc91b1-5604-404e-9430-0c191c068508" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a3863f17-2a97-4206-abc7-ee3c2b6fcbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a3863f17-2a97-4206-abc7-ee3c2b6fcbb8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a3863f17-2a97-4206-abc7-ee3c2b6fcbb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a3863f17-2a97-4206-abc7-ee3c2b6fcbb8" xlink:to="loc_us-gaap_EquityComponentDomain_a3863f17-2a97-4206-abc7-ee3c2b6fcbb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a3863f17-2a97-4206-abc7-ee3c2b6fcbb8" xlink:to="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_188861a0-027f-4240-823c-7f15d7a38506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_188861a0-027f-4240-823c-7f15d7a38506" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_2a845d35-ddc8-49b5-a74c-6d6302d1e4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_2a845d35-ddc8-49b5-a74c-6d6302d1e4ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_17226b75-43a2-4406-9f37-0cdc91f6f77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_17226b75-43a2-4406-9f37-0cdc91f6f77f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_d643a7f3-282c-40ea-a201-ffdcdd9d3f7f" xlink:href="mck-20210630.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_d643a7f3-282c-40ea-a201-ffdcdd9d3f7f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_d9604c55-6334-4e10-8a43-0a42f579a9a8" xlink:href="mck-20210630.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_d9604c55-6334-4e10-8a43-0a42f579a9a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_49b0737f-1be4-49d6-bf7f-e58fc855ce4a" xlink:href="mck-20210630.xsd#mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_49b0737f-1be4-49d6-bf7f-e58fc855ce4a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_cac95cac-6ef0-41ad-8503-2fff2c800819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_cac95cac-6ef0-41ad-8503-2fff2c800819" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended" id="i72eda70386f94cfda3d47fb8cdeeb83c_StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02d76650-5ba1-41a6-89c4-6f1e064cd569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02d76650-5ba1-41a6-89c4-6f1e064cd569" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b7f902ce-adae-4845-94cc-cf7bcaaa1ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b7f902ce-adae-4845-94cc-cf7bcaaa1ddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9733a5c3-2c0e-4459-a585-dab10174b07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9733a5c3-2c0e-4459-a585-dab10174b07d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1b7ed7e6-450c-4ab7-aa32-a16e6305949a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1b7ed7e6-450c-4ab7-aa32-a16e6305949a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0fcc514e-8930-427b-940d-49308792df8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0fcc514e-8930-427b-940d-49308792df8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c9e3e768-094d-4446-adcb-80ea9bbae75d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c9e3e768-094d-4446-adcb-80ea9bbae75d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a1f24c8d-3350-4a63-a79a-56b5dc96e67c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a1f24c8d-3350-4a63-a79a-56b5dc96e67c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_76a81dcb-9130-49fb-ad3b-f4d7dbc5eebb" xlink:href="mck-20210630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_76a81dcb-9130-49fb-ad3b-f4d7dbc5eebb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_84979dad-f6a3-4a08-9983-136854024f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e0447bc6-1910-48a9-a944-f1002abb617e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02d76650-5ba1-41a6-89c4-6f1e064cd569" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e0447bc6-1910-48a9-a944-f1002abb617e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e4cc906d-b022-47d1-8f99-c7709a72e1ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e0447bc6-1910-48a9-a944-f1002abb617e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e4cc906d-b022-47d1-8f99-c7709a72e1ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e4cc906d-b022-47d1-8f99-c7709a72e1ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e4cc906d-b022-47d1-8f99-c7709a72e1ec" xlink:to="loc_us-gaap_EquityComponentDomain_e4cc906d-b022-47d1-8f99-c7709a72e1ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b7af4b24-3601-4670-960a-35f03ef3e9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e4cc906d-b022-47d1-8f99-c7709a72e1ec" xlink:to="loc_us-gaap_EquityComponentDomain_b7af4b24-3601-4670-960a-35f03ef3e9fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_86e3f4f5-f0bc-4367-8e1d-7d0084114ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b7af4b24-3601-4670-960a-35f03ef3e9fb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_86e3f4f5-f0bc-4367-8e1d-7d0084114ad0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_3b49eb1a-271c-4638-b1d4-9443794dcade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_86e3f4f5-f0bc-4367-8e1d-7d0084114ad0" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_3b49eb1a-271c-4638-b1d4-9443794dcade" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_555721fa-6792-4742-9d26-24e0443ada23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_86e3f4f5-f0bc-4367-8e1d-7d0084114ad0" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_555721fa-6792-4742-9d26-24e0443ada23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_dd9ac87c-24f6-40b3-834e-a583e1f7ceac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_86e3f4f5-f0bc-4367-8e1d-7d0084114ad0" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_dd9ac87c-24f6-40b3-834e-a583e1f7ceac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_51e5a906-e337-4b6c-b11e-015b15a22075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_86e3f4f5-f0bc-4367-8e1d-7d0084114ad0" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_51e5a906-e337-4b6c-b11e-015b15a22075" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#SegmentsofBusinessDetails"/>
  <link:definitionLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="extended" id="ib7f61b9556054b3bb0bea16a275cbbb5_SegmentsofBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_4b32f6ad-fb65-4879-98fa-be087373baa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_NumberOfReportableSegments_4b32f6ad-fb65-4879-98fa-be087373baa7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_984c4860-cfa8-4c41-8d58-a5e63dcf9289" xlink:href="mck-20210630.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_984c4860-cfa8-4c41-8d58-a5e63dcf9289" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_3ac7b2a0-7023-4ca1-9a46-77df96633f31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_3ac7b2a0-7023-4ca1-9a46-77df96633f31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations_d18d9652-2e0a-407d-ad3b-9b0e9a14b46f" xlink:href="mck-20210630.xsd#mck_NumberOfBusinessOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_mck_NumberOfBusinessOperations_d18d9652-2e0a-407d-ad3b-9b0e9a14b46f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_b26dbea1-77ea-4124-98a2-0120260fd351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:to="loc_us-gaap_RevenuesAbstract_b26dbea1-77ea-4124-98a2-0120260fd351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_33555836-bdc8-427a-a755-347f98759e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_b26dbea1-77ea-4124-98a2-0120260fd351" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_33555836-bdc8-427a-a755-347f98759e19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_62706c61-d66a-42af-9cc3-31b4508dfdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_62706c61-d66a-42af-9cc3-31b4508dfdfe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_61f015cf-3590-473c-8471-91d22d039e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_62706c61-d66a-42af-9cc3-31b4508dfdfe" xlink:to="loc_us-gaap_OperatingIncomeLoss_61f015cf-3590-473c-8471-91d22d039e74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_356d1244-7257-4d3b-87b0-0cad90a6d2ab" xlink:href="mck-20210630.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_356d1244-7257-4d3b-87b0-0cad90a6d2ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_5acfa984-4a4e-455a-988c-13ff0d5248d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:to="loc_us-gaap_InterestAndDebtExpense_5acfa984-4a4e-455a-988c-13ff0d5248d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8baf576c-0bb4-4e88-9fb6-2e58bbe06330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8baf576c-0bb4-4e88-9fb6-2e58bbe06330" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_c17b5061-8bb0-4a27-8916-19539fb94300" xlink:href="mck-20210630.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_c17b5061-8bb0-4a27-8916-19539fb94300" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_74143e0a-4363-47ee-a0a3-db6d85eb4142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_74143e0a-4363-47ee-a0a3-db6d85eb4142" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_9df3dfc7-458e-4fba-b7da-802be7ad2ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_InventoryWriteDown_9df3dfc7-458e-4fba-b7da-802be7ad2ea1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_5ecc3715-f9e8-44c8-9c0e-636074e4fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_5ecc3715-f9e8-44c8-9c0e-636074e4fa39" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_4af2753e-a77f-425c-9da0-2c381f21422f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_4af2753e-a77f-425c-9da0-2c381f21422f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_81000136-dbae-407c-b9b0-a255acbd5be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_81000136-dbae-407c-b9b0-a255acbd5be5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_81000136-dbae-407c-b9b0-a255acbd5be5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_81000136-dbae-407c-b9b0-a255acbd5be5" xlink:to="loc_us-gaap_SegmentDomain_81000136-dbae-407c-b9b0-a255acbd5be5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f7585d06-0802-4f87-a9f1-6dfec2d3b6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_81000136-dbae-407c-b9b0-a255acbd5be5" xlink:to="loc_us-gaap_SegmentDomain_f7585d06-0802-4f87-a9f1-6dfec2d3b6d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_0da38026-a3d0-4103-8bbb-c8c1e35b61fb" xlink:href="mck-20210630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f7585d06-0802-4f87-a9f1-6dfec2d3b6d8" xlink:to="loc_mck_USPharmaceuticalSegmentMember_0da38026-a3d0-4103-8bbb-c8c1e35b61fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_7c6d9cca-485b-467c-87dc-7b882f4e7c25" xlink:href="mck-20210630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f7585d06-0802-4f87-a9f1-6dfec2d3b6d8" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_7c6d9cca-485b-467c-87dc-7b882f4e7c25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_89ebf3ba-41b3-4588-8d50-20699916289a" xlink:href="mck-20210630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f7585d06-0802-4f87-a9f1-6dfec2d3b6d8" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_89ebf3ba-41b3-4588-8d50-20699916289a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_6212a641-f332-448d-8be6-cdf8c86c2488" xlink:href="mck-20210630.xsd#mck_InternationalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f7585d06-0802-4f87-a9f1-6dfec2d3b6d8" xlink:to="loc_mck_InternationalSegmentMember_6212a641-f332-448d-8be6-cdf8c86c2488" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_07454d27-fce1-4b1d-8fa9-cec74db36aae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:to="loc_srt_StatementGeographicalAxis_07454d27-fce1-4b1d-8fa9-cec74db36aae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_07454d27-fce1-4b1d-8fa9-cec74db36aae_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_07454d27-fce1-4b1d-8fa9-cec74db36aae" xlink:to="loc_srt_SegmentGeographicalDomain_07454d27-fce1-4b1d-8fa9-cec74db36aae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6a97d9be-9fa4-40cd-b205-0706010cccd1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_07454d27-fce1-4b1d-8fa9-cec74db36aae" xlink:to="loc_srt_SegmentGeographicalDomain_6a97d9be-9fa4-40cd-b205-0706010cccd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ca753f91-dcb3-47a2-a8cb-d6e8082e14f9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6a97d9be-9fa4-40cd-b205-0706010cccd1" xlink:to="loc_country_US_ca753f91-dcb3-47a2-a8cb-d6e8082e14f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_4cd20610-0c39-4dca-b967-fbed76ef76d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6a97d9be-9fa4-40cd-b205-0706010cccd1" xlink:to="loc_srt_EuropeMember_4cd20610-0c39-4dca-b967-fbed76ef76d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_69917e10-580a-4504-a29b-a9cb5064d240" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:to="loc_srt_LitigationCaseAxis_69917e10-580a-4504-a29b-a9cb5064d240" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_69917e10-580a-4504-a29b-a9cb5064d240_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_69917e10-580a-4504-a29b-a9cb5064d240" xlink:to="loc_srt_LitigationCaseTypeDomain_69917e10-580a-4504-a29b-a9cb5064d240_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f7cf72d0-1909-4368-b96d-c3f22d333328" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_69917e10-580a-4504-a29b-a9cb5064d240" xlink:to="loc_srt_LitigationCaseTypeDomain_f7cf72d0-1909-4368-b96d-c3f22d333328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionMember_bacdcffa-8c68-4c65-abfd-48b922e8cbf6" xlink:href="mck-20210630.xsd#mck_ShareholderDerivativeActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_f7cf72d0-1909-4368-b96d-c3f22d333328" xlink:to="loc_mck_ShareholderDerivativeActionMember_bacdcffa-8c68-4c65-abfd-48b922e8cbf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0542fdeb-9680-4e9b-9fab-4eab4035fa4a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:to="loc_srt_ConsolidationItemsAxis_0542fdeb-9680-4e9b-9fab-4eab4035fa4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_0542fdeb-9680-4e9b-9fab-4eab4035fa4a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_0542fdeb-9680-4e9b-9fab-4eab4035fa4a" xlink:to="loc_srt_ConsolidationItemsDomain_0542fdeb-9680-4e9b-9fab-4eab4035fa4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_bbec2d78-3bee-4bd0-8f70-48a5c51d68b1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_0542fdeb-9680-4e9b-9fab-4eab4035fa4a" xlink:to="loc_srt_ConsolidationItemsDomain_bbec2d78-3bee-4bd0-8f70-48a5c51d68b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_8cd4a408-2551-4536-9af8-21c95e4d0cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_bbec2d78-3bee-4bd0-8f70-48a5c51d68b1" xlink:to="loc_us-gaap_OperatingSegmentsMember_8cd4a408-2551-4536-9af8-21c95e4d0cb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8c7b3ec9-d59f-426e-ad38-d21edb3e15dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8c7b3ec9-d59f-426e-ad38-d21edb3e15dd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_8c7b3ec9-d59f-426e-ad38-d21edb3e15dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8c7b3ec9-d59f-426e-ad38-d21edb3e15dd" xlink:to="loc_us-gaap_LossContingencyNatureDomain_8c7b3ec9-d59f-426e-ad38-d21edb3e15dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_c7c8f954-d32b-4b2a-9f77-772a699bdafb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8c7b3ec9-d59f-426e-ad38-d21edb3e15dd" xlink:to="loc_us-gaap_LossContingencyNatureDomain_c7c8f954-d32b-4b2a-9f77-772a699bdafb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_ceecd7f4-8375-4cad-b623-03c9f223a7bc" xlink:href="mck-20210630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_c7c8f954-d32b-4b2a-9f77-772a699bdafb" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_ceecd7f4-8375-4cad-b623-03c9f223a7bc" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>mck-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:31dc61f2-2ef8-41d9-90f2-e8ff46606457,g:0be0b981-6200-4a1a-a19d-196bf6df3870-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_HedgingDesignationDomain_9d5bc534-7d22-4e79-870b-adb0ab1ce20a_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_c3f6f8d7-a096-41c7-a421-d74cd8c1956f_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and trade names</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a4e2a6f1-cb59-4788-88f5-2718aa54aca3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_bd08eff6-000b-405a-88ba-30736420a905_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_821cda08-04dc-42e0-b8be-d25140158053_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_22442eb4-47f8-457a-bf47-11cfa0cc8cdc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_890ea240-3aad-478a-9a00-c60e2e1020b2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_58513d8a-f3a7-4671-a250-02bf7353c2cb_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_178a0857-5afb-44c8-b839-83a3eac2bc68_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_5a2ed931-e802-4c42-af77-f879146024dc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_d5a0a55a-5ee7-4f73-8748-b110410cc42e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_86eb1535-8501-4313-ae2a-d41a0fb5bdec_terseLabel_en-US" xlink:label="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax expenses related to estimated litigation liability</link:label>
    <link:label id="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_label_en-US" xlink:label="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease), Net of Tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_documentation_en-US" xlink:label="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:href="mck-20210630.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:to="lab_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_c119521c-6267-455d-b169-45b2f084be70_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncurrentAssetLiabilityMember_5534d829-9388-4d49-8a31-be28bcc819e2_terseLabel_en-US" xlink:label="lab_mck_NoncurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Asset / Liability</link:label>
    <link:label id="lab_mck_NoncurrentAssetLiabilityMember_label_en-US" xlink:label="lab_mck_NoncurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Asset / Liability [Member]</link:label>
    <link:label id="lab_mck_NoncurrentAssetLiabilityMember_documentation_en-US" xlink:label="lab_mck_NoncurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current Asset / Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncurrentAssetLiabilityMember" xlink:href="mck-20210630.xsd#mck_NoncurrentAssetLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncurrentAssetLiabilityMember" xlink:to="lab_mck_NoncurrentAssetLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_cf914c24-3227-4216-8716-8de03b60befc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:to="lab_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d00b876d-7ef4-4f01-9c76-e76fcd4f60e6_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_d2fcf20a-9b39-4631-a2f2-79620368c4c6_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_dc1f5709-93dd-4e82-9388-b9edd3a8f53d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_7ef68c9c-af58-4867-b106-d38040284906_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_82471628-ee8c-4991-bc3d-46091ab12277_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7ec0f510-db21-40a4-b517-427425d44085_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_d68dec09-56a8-485e-83c1-935389029c33_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price percentage of principal (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a32d3ecd-0f91-440d-9088-47bc32770b41_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_5fde49db-7c8a-417e-b5f2-96bfb53e332f_terseLabel_en-US" xlink:label="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate annual surcharge on licensed manufacturers and distributors of opioids</link:label>
    <link:label id="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_label_en-US" xlink:label="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids</link:label>
    <link:label id="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_documentation_en-US" xlink:label="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:href="mck-20210630.xsd#mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:to="lab_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessExitCosts1_a698e315-290d-45ba-9f3c-ca9ade54d256_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exit and other-related costs</link:label>
    <link:label id="lab_us-gaap_BusinessExitCosts1_label_en-US" xlink:label="lab_us-gaap_BusinessExitCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Exit Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessExitCosts1" xlink:to="lab_us-gaap_BusinessExitCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_44e04ca1-f0fa-419f-810c-11f0976e9c1b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireSoftware" xlink:to="lab_us-gaap_PaymentsToAcquireSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_6148d1c3-7b6f-4301-8d57-901a0917fdb6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_ffb4c76a-7491-4a18-9830-4bf490e2bf1c_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_edf78a14-cf32-4634-9cee-f8c1f5402b0b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustments, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_f264deb0-a293-4850-b45d-21223d835967_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_83dfc38f-e02a-4b63-85dc-20b17153c9b5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract" xlink:to="lab_us-gaap_OperatingIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_d13dc0ed-4688-4e9e-9a68-33ee4bf69325_terseLabel_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased (shares)</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_label_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:label id="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_documentation_en-US" xlink:label="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:href="mck-20210630.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:to="lab_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStateAttorneyGenerals_5d1c0845-91f5-4fae-889d-d7f64a502d38_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of attorney generals that have filed claims</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStateAttorneyGenerals_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of State Attorney Generals</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStateAttorneyGenerals_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of State Attorney Generals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:href="mck-20210630.xsd#mck_LossContingencyNumberofStateAttorneyGenerals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:to="lab_mck_LossContingencyNumberofStateAttorneyGenerals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_0a9bd048-72f8-45a8-8282-4cfc39b5cb1f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_9f9a09e0-cb47-4868-b8cd-3a800fed9f12_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Asset Impairment Charges</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0b195522-d831-4f28-999f-6c03761bfabf_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized amount available for future repurchases</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_062b53e9-c6ab-4f2e-ad78-d9eb662c7b97_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_c822dfb1-2925-4197-b565-26ca5934fba7_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_785f49d7-d266-41d0-9d27-8378c03fb58e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities (shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_13153337-0a4a-4ee0-a160-eee6e91b625f_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_d3cc58c8-27f9-410f-9cff-e805a9e9bba6_terseLabel_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes due March 15, 2024</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_label_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024 [Member]</link:label>
    <link:label id="lab_mck_A380NotesDueMarch152024Member_documentation_en-US" xlink:label="lab_mck_A380NotesDueMarch152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.80% Notes Due March 15, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member" xlink:href="mck-20210630.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A380NotesDueMarch152024Member" xlink:to="lab_mck_A380NotesDueMarch152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_f16485dd-c9c3-4a6b-9e90-47b821b9eac1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected_0aadf9b4-dd9e-4642-8582-7c56ba6998bc_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge to remeasure to lower of carrying amount or fair value less costs to sell</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected_label_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down, Expected</link:label>
    <link:label id="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected_documentation_en-US" xlink:label="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down, Expected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected" xlink:href="mck-20210630.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected" xlink:to="lab_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_619fcec9-14ef-43d1-97fb-36405b142847_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_2462daec-5bcc-486a-95e5-90c686040a82_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_5e871624-6227-4f92-b914-217f4ecac7d4_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_01c48566-dba6-48bb-be19-bf30b034c3b9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_a51c0b51-b174-46f8-a186-1ba33fa55048_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsNonrecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Nonrecurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsNonrecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_e9d0c4b1-0f91-4c15-a14f-3aecd09222c0_terseLabel_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes per share of common stock permitted on proposals presented to stockholders (vote)</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_label_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:label id="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_documentation_en-US" xlink:label="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number of Votes Per Common Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:href="mck-20210630.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:to="lab_mck_CommonStockVotingRightsNumberofVotesPerCommonShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_087454aa-927c-4d9c-9657-d40c55ce90ad_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Activities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_39c5cd8d-0e20-49be-a76d-de6ad948b732_terseLabel_en-US" xlink:label="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approved increase to the authorized share repurchase amount</link:label>
    <link:label id="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized to be Repurchased</link:label>
    <link:label id="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_documentation_en-US" xlink:label="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized to be Repurchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" xlink:href="mck-20210630.xsd#mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" xlink:to="lab_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_053fc8f3-6ca1-4f9e-a598-b5d73c270564_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_5b0e5f93-402f-4a3d-a46a-cd24a3cd30e9_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2f097007-c88d-410f-8f29-b3270484e2ae_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_aba031d1-2f38-4e1d-a523-1ff108a3fa6d_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of commercial paper</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_RepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d4d4b987-b317-4b0d-bdab-13069e14bc97_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_935bfd9f-a27d-4e81-b76d-aa61af726c1c_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_605550d1-5f3f-4188-bccb-f5d6f150290a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_85ecf172-b762-45b5-b111-17295a4ec2ec_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of businesses and investments, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses and Interests in Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_03ebb134-8149-46ea-b51b-b34ea0794419_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_9ead196c-623e-4dd6-8f09-16346ad9dcf2_terseLabel_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward contracts to hedge Euro against British Pound cash flows</link:label>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_label_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]</link:label>
    <link:label id="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_documentation_en-US" xlink:label="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:href="mck-20210630.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:to="lab_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_5fbb2f6d-c802-4641-8d72-2094cc7cdcd8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_606c6613-5b6e-46d2-83b5-e1cfb108a0dc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair values of liabilities</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A475NotesDueMay302029Member_45b7e4f9-558f-4ed4-b8db-d56e3b6b4b74_terseLabel_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes due May 30, 2029</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_label_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029 [Member]</link:label>
    <link:label id="lab_mck_A475NotesDueMay302029Member_documentation_en-US" xlink:label="lab_mck_A475NotesDueMay302029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.75% Notes Due May 30, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member" xlink:href="mck-20210630.xsd#mck_A475NotesDueMay302029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A475NotesDueMay302029Member" xlink:to="lab_mck_A475NotesDueMay302029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_f7d8423c-066f-4a71-bacb-61dbf29b1489_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage (as a percent)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c478c9c6-2748-4daf-9eac-5f8b694c9ef6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingent Liabilities</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_7b773baf-9ca5-4d08-9393-3080e2765f2e_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_93edc2c1-ffd1-44ef-a8b6-3ab0533b6f07_verboseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value of redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_f8d6f4b9-b0a0-4fd8-89dc-d64f21c1abab_periodStartLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_d709b7d6-e7bc-4d3c-851e-f55107ffca8c_periodEndLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_e0f85d19-536c-407e-9079-de36f94205ba_terseLabel_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual recurring dividend (in euro per share)</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_label_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:label id="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_documentation_en-US" xlink:label="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Recurring Compensation Per Share to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:href="mck-20210630.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:to="lab_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IndividualClaimantMember_4e0d357a-2574-41c5-a9be-d832760f61de_terseLabel_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">An individual</link:label>
    <link:label id="lab_mck_IndividualClaimantMember_label_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant [Member]</link:label>
    <link:label id="lab_mck_IndividualClaimantMember_documentation_en-US" xlink:label="lab_mck_IndividualClaimantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Claimant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember" xlink:href="mck-20210630.xsd#mck_IndividualClaimantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IndividualClaimantMember" xlink:to="lab_mck_IndividualClaimantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_f230dd25-544f-48d4-beee-617b35b869be_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt principal redeemed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e1099be6-cd2d-400e-9acd-3228dbc35cb3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_ea383ec7-6ad9-4030-ab10-8b975e6a1d64_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of settlement award to be used by state and local government for remediation (percent)</link:label>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_label_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Award Amount To Be Used by State and Local Government</link:label>
    <link:label id="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Award Amount To Be Used by State and Local Government</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:href="mck-20210630.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:to="lab_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0bccca01-f543-4962-b152-3ea3ae19d2e2_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_d4a6b634-da90-4d49-997c-843858745779_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_114794b4-0707-4740-a4cd-f64b355ce8fb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_afdb1a38-3973-4661-bc86-ef9644a05f6f_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_485a255e-b5c7-4262-b0e8-cd016f5d4420_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LitigationReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveNoncurrent" xlink:to="lab_us-gaap_LitigationReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuropeanBusinessesDisposalGroupMember_7b4ad782-4386-409c-9683-f75b4c0de6d5_terseLabel_en-US" xlink:label="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Businesses (Disposal Group)</link:label>
    <link:label id="lab_mck_EuropeanBusinessesDisposalGroupMember_label_en-US" xlink:label="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Businesses (Disposal Group) [Member]</link:label>
    <link:label id="lab_mck_EuropeanBusinessesDisposalGroupMember_documentation_en-US" xlink:label="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">European Businesses (Disposal Group)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember" xlink:href="mck-20210630.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuropeanBusinessesDisposalGroupMember" xlink:to="lab_mck_EuropeanBusinessesDisposalGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_4bc9af77-6907-40fb-85bf-7a8b4fd4a21f_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_c115f220-812b-454b-9043-f98ed5811769_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_f1931d9a-a7b6-474c-ac21-08ac2e91c78a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complaints filed against the entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_dbe63b9e-7823-475b-8d3e-9560b1cf9a76_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_7e24d4a0-9b4e-4cb7-ae00-d6aa2236dc51_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in retirement-related benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_94c35c2a-6dba-4461-ad27-7d85ec724cda_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service agreements</link:label>
    <link:label id="lab_us-gaap_ServiceAgreementsMember_label_en-US" xlink:label="lab_us-gaap_ServiceAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceAgreementsMember" xlink:to="lab_us-gaap_ServiceAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_e6d70303-87ad-41e6-a619-17ff76e0d554_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_edbf8234-bbf4-4ecd-bd29-aa40c1f0dfb7_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_59ebb487-9d66-4cc3-b017-c83599023582_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_987c5485-6175-4c54-8d02-d64a4fcd6ed7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_6212e8c0-8048-4311-8e41-60f87fb70ad1_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_531d552d-fc3a-482d-8a12-19c45f244368_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opening retained earnings adjustment: adoption of new accounting standard</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_81226597-a0dc-4f70-bb6c-3e5df89d6006_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_0fe1ad81-657d-423c-9c63-1e291364755e_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_ae24a51a-61d0-4513-afc0-aee9f5578e06_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_408d0e97-eeca-4886-8a90-f2d77a8ae465_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_32dd67a4-6c48-4896-b452-8b5430299d90_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_840ff79a-fb91-4350-b2e3-ce4ea37d1ca2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_f512aa26-ac69-4622-83a2-3e45671596fe_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_78fca045-53f3-499b-ae93-265b787f843e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_ac50f891-77c7-4554-ab14-1526b742ca02_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_285157c7-7307-4751-84fa-2f5bb4a92f4a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_42bc3873-8e37-4162-893e-d0becc24bf93_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt outstanding</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_f26bb4d4-9aa6-4d71-bf89-670d3e6ed95f_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of liabilities</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_e41d2b9e-afc7-4568-a1b1-d595f3db4001_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The 2020 Credit Facility</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:href="mck-20210630.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_6106ddd2-04aa-45e5-aadd-6502c1bcd01d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, inputs, level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fd668ece-cebf-4d37-bac2-969f950dacdf_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_c7565233-541c-4953-95e6-7e20dd061d78_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_1f26e520-e478-4a3f-9d29-36973338ae75_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_11d386a2-0c83-4582-a6d0-072a8a14568a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_e4b4c621-721f-4ca6-a4df-62089c6ada21_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, redeemable noncontrolling interests, and equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_61663ce7-b681-424f-8ddd-9e655b8c71ae_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_abe84294-45cf-4470-aa08-dfe81b3ace5f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses on cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_bda86f0f-603e-44f8-9939-45b244aff0a2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (losses) from cash flow hedges recorded within other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_7671562b-441f-4d91-b9e3-af8cca6efeeb_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_91f9293e-16ab-4e57-a65a-fdd2c2873920_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_03b52da7-fb07-4ea7-9e81-7fd5f69fbf85_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_554a6d27-6f26-4da6-9418-d77624289510_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of commercial paper</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_94dd6d80-e06b-4cad-9159-725ef7094e73_terseLabel_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Translation gain (loss) attributable to redeemable noncontrolling interest</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:href="mck-20210630.xsd#mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_5ead899e-9695-43c8-a1c1-54b425fecc87_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_bc500a2e-623f-4360-a003-5a111e10d353_terseLabel_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_label_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prescription Technology Solutions [Member]</link:label>
    <link:label id="lab_mck_PrescriptionTechnologySolutionsMember_documentation_en-US" xlink:label="lab_mck_PrescriptionTechnologySolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember" xlink:href="mck-20210630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PrescriptionTechnologySolutionsMember" xlink:to="lab_mck_PrescriptionTechnologySolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_748d8a1c-3e5b-4f47-8c5a-535e07ee1ddc_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY (DEFICIT)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_df6836a5-e18c-425e-a870-b2938ecf671d_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would reduce income tax expense and the effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_73942907-4cfd-4a75-8cf6-18355b891fcf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_87dff02f-7022-4ccd-a0a0-eea78d1a7d32_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_18cd35c6-610b-4929-af23-670d5aef6e03_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward starting interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_bf30ac1d-fc13-4759-97cb-61af70e27bf4_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_b14431e3-7934-40ca-9f74-625824a162a9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_2eea72a9-030a-473b-b845-57770d953a47_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to income statement, tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_386674a3-61cd-4814-852a-f7eee74218a6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_f89e67ca-3830-4630-8382-0c2cc2898f6b_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_cf325a7a-6dea-4f7e-9408-1d85c57ef3e8_verboseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_label_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:label id="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) Due to Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:to="lab_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_46af3380-c4fe-4f27-baf2-48640794c422_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_dadef7b6-8928-4453-a4a0-637547607b62_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationProfitLossAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Profit (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_be2db389-f56d-49ba-8905-ddcd2bea9e57_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_a681cbd5-3986-4f7d-83f2-fbd51ff53af7_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4e537fb5-f20c-4414-b53b-a335cb0b146e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_6a5ec3a8-1f99-4498-be6e-4b8f1c448c31_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_c1cc49ba-b171-4287-ba57-c59510ea6940_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_fbf5c97a-5f0b-4ed0-a580-52b62b048252_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts outstanding under facility</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_2f04e325-f31e-416d-88a2-1228adec9b31_terseLabel_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Europe Subsidiary</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_label_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:label id="lab_mck_MckessonEuropeSubsidiaryMember_documentation_en-US" xlink:label="lab_mck_MckessonEuropeSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mckesson Europe Subsidiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember" xlink:href="mck-20210630.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MckessonEuropeSubsidiaryMember" xlink:to="lab_mck_MckessonEuropeSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aea606ef-ab50-4e3e-9342-6eccbac7d199_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_1780c892-5c07-4e5f-a7e6-d1cc3615097d_terseLabel_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments and other, net of income tax expense</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:href="mck-20210630.xsd#mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:to="lab_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_9a6307b5-17ce-4212-bbf1-0854a2c45649_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_58854902-54db-454a-bd9b-4d8a793cfd46_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_be5d5c99-0562-4f66-a51c-c72f3c524090_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_e8bfb8dd-2480-45db-a680-a1af34e5cce5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, distribution, general, and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_8ca2cddc-58e6-4eb8-87ec-f0471b482159_terseLabel_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_label_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_BritishPoundSterlingDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Pound Sterling Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:href="mck-20210630.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_BritishPoundSterlingDenominatedNotesMember" xlink:to="lab_mck_BritishPoundSterlingDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_45b3b410-7104-43a1-b8dd-abe201e08edf_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_90ecacf9-c3e0-4950-9a85-297011bca58f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_6800a004-228c-435e-833a-e7422afff2a0_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_361868cf-ab3d-48d8-9192-e5174aa791c9_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_TenderOfferNotesMember_43ee4d11-852e-4b27-bd6d-e891a0863682_terseLabel_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes</link:label>
    <link:label id="lab_mck_TenderOfferNotesMember_label_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes [Member]</link:label>
    <link:label id="lab_mck_TenderOfferNotesMember_documentation_en-US" xlink:label="lab_mck_TenderOfferNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tender Offer Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember" xlink:href="mck-20210630.xsd#mck_TenderOfferNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_TenderOfferNotesMember" xlink:to="lab_mck_TenderOfferNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_eb069b21-46b9-4bec-a199-b075b0bc9146_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_95f841fa-cf73-417f-baa6-8d174970aabb_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_c675c560-ac4a-446e-a4d9-2c774f1ed875_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_6da3ac7a-2572-4fe7-b8eb-1b52feca981b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Translation and Other Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAndOtherAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_08efc60c-92cf-493d-857f-bdd7f43742c6_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_63aab3b8-225d-4978-bc38-37dae0a21723_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:to="lab_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_d0117821-fc0d-4e4f-8b78-4175b1ecff93_terseLabel_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes due December 3, 2025</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_label_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025 [Member]</link:label>
    <link:label id="lab_mck_A090NotesDueDecember32025Member_documentation_en-US" xlink:label="lab_mck_A090NotesDueDecember32025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.90% Notes Due December 3, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member" xlink:href="mck-20210630.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A090NotesDueDecember32025Member" xlink:to="lab_mck_A090NotesDueDecember32025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_96749515-3f04-4172-85ae-3d106c2d7477_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_6cac1e29-ef7e-4ae9-a797-7b81cddbd0b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_5c9a9f4c-4826-4b46-b25f-8fdfe9cc7c17_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_85d7f09b-5c1b-4553-b77c-14e233611d1f_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Financing Activities</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_27e29673-540e-43f2-80b4-0a3475378f28_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_c6bb2426-9282-4671-bdd8-9cf0727e7dec_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_ac4540aa-945f-47e8-8457-9d76bf96ea7b_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_e12bc954-d4b9-4886-92c8-f584ed1d8bea_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_6cc31dea-aa39-4723-af45-5fa8238d8b08_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_f42d667e-c9a3-465e-9485-b706b26d6dc0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash charges</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_8e16ef70-4cdb-4f58-bd48-9680992f218d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_a6f1e3fd-a124-4f5d-9de2-9e77d8d8d999_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum redemption value of redeemable noncontrolling interest</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests, Maximum Redemption Value</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests, Maximum Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:href="mck-20210630.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:to="lab_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_9579367e-7235-47b8-88ae-a660d3919033_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, by Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_d5690df2-19c8-4839-b00d-59cf8a03ffa7_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_4843455d-4c82-454d-a01d-2e5626d21a53_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_249e0e94-cc79-4814-956e-ff15e9e29938_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value, 800 shares authorized and 274 and 273 shares issued at June 30, 2021 and March 31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedPercentage_f4156508-8dcd-4b90-82d0-d992cd48f2a4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage threshold of greater of projected benefit obligation or market value of assets (percent)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8ef17c56-eee5-4a39-89c7-f07989b38bbe_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_071223af-ff4a-46d7-99d2-16a29926c9e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding the fair value of derivatives on a gross basis</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_906286c7-ebba-49fb-8beb-ca1f4b56c951_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory impairments and excess inventory</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_0fd4c518-d4e0-413a-ad2e-ddcd80d02358_terseLabel_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_label_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:label id="lab_mck_AcceleratedShareRepurchaseMember_documentation_en-US" xlink:label="lab_mck_AcceleratedShareRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember" xlink:href="mck-20210630.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AcceleratedShareRepurchaseMember" xlink:to="lab_mck_AcceleratedShareRepurchaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_c1856e25-2c29-4c21-9c22-3909d38ad5cd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (loss) on cash flow hedges arising during period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_9fa202a2-1a2f-45a2-b094-49370d9c93f2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_b92802d0-0453-49b2-ac29-e8e5d71fed89_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5344f2df-b86a-4855-b7ab-c8aa99494b97_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e59f931f-ce0d-4038-8b86-fec1ef2e366d_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_d1891368-a94d-4def-ac49-4b413e177467_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_fc97deef-5e57-4200-852e-59369b069558_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_7666d4bb-99f6-49db-beaf-ac144513c088_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_129d0867-87ca-4e99-8c36-98f1102e9780_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted balance, April 1</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_2340eba7-3784-4100-a050-21285ec952dc_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_69a38cd1-8b00-44a9-8591-b0a65e584997_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_8eac4523-12bc-4d33-aafc-194905d3cd03_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_d0c93def-25a1-40dc-a6ac-4b17207ecfb0_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_2fa6b170-4dbb-4a1b-a2cd-d61779aba13e_terseLabel_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_label_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:label id="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_documentation_en-US" xlink:label="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Largest U.S. Pharmaceutical Distributors [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:href="mck-20210630.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:to="lab_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_9f9536a8-7a2e-4486-ae94-a58b7dd9f3ad_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_b9a8b446-6d3a-403c-b017-e570d9beb4fd_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for purchase shares of McKesson Europe</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_70f00b20-bb6a-4678-9be6-1be72a7455f5_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on net investment hedges arising during period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_bf6a4d8c-003e-4496-9989-beccd9d7a73f_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestLineItems_label_en-US" xlink:label="lab_us-gaap_MinorityInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestLineItems" xlink:to="lab_us-gaap_MinorityInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_245a6e8e-136f-431e-a54c-86d591bc10bf_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_af5f3aa5-0ff6-4486-9f63-003ac863d2cf_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_0a8535bc-d8f8-45f3-b5d0-1d865021b9d9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_c4648080-61cf-4d95-a674-73af4b90b2c4_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f39cad8d-c601-406f-ad72-6cc46dec2143_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5a8f9862-472d-4a14-9320-90efaeca39ca_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOpioidStatutesMember_eaf6f4bb-8b4e-4bb2-9239-64e1ace01896_terseLabel_en-US" xlink:label="lab_mck_StateOpioidStatutesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State Opioid Statutes</link:label>
    <link:label id="lab_mck_StateOpioidStatutesMember_label_en-US" xlink:label="lab_mck_StateOpioidStatutesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State Opioid Statutes [Member]</link:label>
    <link:label id="lab_mck_StateOpioidStatutesMember_documentation_en-US" xlink:label="lab_mck_StateOpioidStatutesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State Opioid Statutes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOpioidStatutesMember" xlink:href="mck-20210630.xsd#mck_StateOpioidStatutesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOpioidStatutesMember" xlink:to="lab_mck_StateOpioidStatutesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_071ee57d-6421-4e46-bf3b-6c4227c1f198_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_5bad8bc6-c7e5-47b4-9a10-2ad358c7f392_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_0a316088-4f41-42b0-81ec-9c1f9c204b6a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_e0018778-370c-44c3-a324-8a7bfd7ca329_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_e2d9aa1c-7de6-4c76-a559-334134422899_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_2630bf4c-a9c8-485f-8977-10e7a552ece8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_ea3ef59d-7c8a-4992-9573-cd0327e8745e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) from net investment hedges recorded within other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_feb432e6-0fe4-426a-a604-90311f7b83a4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_ddd34495-7bd4-4896-b024-01c64721db66_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments of Business</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_39b49935-670f-4309-8d4e-69571534be0f_terseLabel_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss and prior servicecost arising during the period, net of income tax benefit</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:href="mck-20210630.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:to="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_47a704da-70c9-44ab-a463-7c9e38ab0622_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_3fc589a3-617d-4ace-add4-b18d0358468c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating profit</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_ce2606cd-2d55-41f3-9d0e-0d5a2e436ffb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c9c6c325-6bef-4d3e-a8aa-c9cc84d33400_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_3ed51783-54e2-4101-bdef-5abec934d4ba_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0169ffec-1730-4871-be7f-94551285c18a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_5cb5b142-e85f-4647-b92f-9489f23c1af0_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1df24048-71a3-41a4-9705-fc5b786d40db_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_0b968fbf-75be-4a2f-9b7a-63313cc73d8a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment, and Related Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_1b332522-ca59-4c5b-bbcc-04493693004e_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_3fbdbb83-0e84-4b7b-ab49-e4ff9c0b711e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_705f5b4e-387c-4111-ace2-25469e9bee50_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_c52a3507-03de-4c0e-85af-55fa1d83ae28_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_dcb07362-3223-482a-8f67-1a06abf56813_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_fd83bfcc-f92c-4172-8d2a-e964e71d7f79_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_88ae3e11-3789-465d-84cc-bfffbd23c6b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_a01c3e74-fffb-4828-8dd1-703b783f109d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_33312357-1951-4e26-9c93-38cdb0110e1b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_1d8333c5-30e7-4102-914a-d4839db71049_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_c5ff6ba3-b752-46db-ab6c-27d3a24ba2da_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings under facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_941c3791-593d-4812-a436-227173a02aa2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived asset impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_332dde86-f1d9-4736-82b6-14734ecde8b5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional values of financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_68d3eaf8-2255-45da-b40b-18caed2f76b5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ab5c19f4-c23d-4fc1-bb21-8101eaa4b16a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5c55ba83-1637-470d-8a4a-39c36cb91c22_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for property, plant, and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_ce4ade4a-8ddb-406e-88d0-e637c8ddbc09_terseLabel_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes due March 1, 2041</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_label_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041 [Member]</link:label>
    <link:label id="lab_mck_A600NotesDueMarch12041Member_documentation_en-US" xlink:label="lab_mck_A600NotesDueMarch12041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.00% Notes Due March 1, 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member" xlink:href="mck-20210630.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A600NotesDueMarch12041Member" xlink:to="lab_mck_A600NotesDueMarch12041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_2dd84812-0062-4f88-ad74-79021768f8f9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash contributions to the plans</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_13bf2cd5-5b9e-48d7-b443-009270afa144_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_1418bcbe-515c-4d98-9e27-97675cd82045_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ShareholderDerivativeActionMember_80a7ae79-16de-4aaf-ae74-fbd66b8878c0_terseLabel_en-US" xlink:label="lab_mck_ShareholderDerivativeActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder derivative action</link:label>
    <link:label id="lab_mck_ShareholderDerivativeActionMember_label_en-US" xlink:label="lab_mck_ShareholderDerivativeActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action [Member]</link:label>
    <link:label id="lab_mck_ShareholderDerivativeActionMember_documentation_en-US" xlink:label="lab_mck_ShareholderDerivativeActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholder Derivative Action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionMember" xlink:href="mck-20210630.xsd#mck_ShareholderDerivativeActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ShareholderDerivativeActionMember" xlink:to="lab_mck_ShareholderDerivativeActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_7c21f1c8-7f05-432c-800b-8ecbdf0f7753_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_1f0df44f-de6f-4203-98d2-8543ee31e903_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of recurring compensation to other accrued liabilities</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_label_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:label id="lab_mck_ReclassificationofTemporaryEquitytoLiability_documentation_en-US" xlink:label="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:href="mck-20210630.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationofTemporaryEquitytoLiability" xlink:to="lab_mck_ReclassificationofTemporaryEquitytoLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_466b4796-e998-4859-9ba4-5b9aa3a99b5a_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_ac0c014e-982d-4e84-abe7-b677794c00eb_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_1def5903-f479-4d16-8eb7-b2a3003c60d4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f448463b-cad6-4503-a00b-a5f511f52c39_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_d39fad8b-70b7-4f71-ac1b-fbd27c957917_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7f08184d-be53-45cf-9f42-c2c91997d112_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_6b0f9018-f315-443e-99eb-465a2814fd4d_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_c7a2728f-1448-423e-8a43-b6d2e2aeebb6_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total McKesson Corporation stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_a482ad45-1f8c-40de-bbd1-16c93fb24d16_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_4ec6d48e-ac71-4c1d-a2c7-475b64e39b28_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_2748db5c-f794-490b-962e-7697882e01fe_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_68c578dd-ef57-4da9-8d23-bfeecfe6bf02_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_48339796-25e1-423c-8421-b61a4d6075f8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_a905d2ca-69d2-42f4-8bbe-991a446fd9b5_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McKesson Corporation stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_150a736c-8737-4500-807d-46328ae5b90e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_9ba0ccdb-55d2-4fd3-ae9f-13fc6ea95199_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_193608e0-f81f-4f4d-8859-d17cf010b998_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate consideration of debt redeemed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_173f290d-da79-4cbd-ae89-e25520873e97_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_11845a19-3580-4ff5-ada6-0f51683f32df_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_251a7eed-cc6b-4669-950e-75fa7590cbd2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1500NotesDue2025Member_b6f8f125-a581-4911-9f5f-fd15906af0ba_terseLabel_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025</link:label>
    <link:label id="lab_mck_A1500NotesDue2025Member_label_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mck_A1500NotesDue2025Member_documentation_en-US" xlink:label="lab_mck_A1500NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.500% Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member" xlink:href="mck-20210630.xsd#mck_A1500NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1500NotesDue2025Member" xlink:to="lab_mck_A1500NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_83402719-cbdf-4cd2-898c-1aa3e2d7b128_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases selected for remand to other federal courts</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_label_en-US" xlink:label="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts</link:label>
    <link:label id="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:href="mck-20210630.xsd#mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:to="lab_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_1b04c589-7a21-4727-85b8-38b98042642e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic pension expense</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_7e110277-b0db-47e1-ac33-7fbf2de38189_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_5e536c1a-a269-4af7-8d50-8111903ea415_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_1506f38f-c5e7-4297-9593-c83355b392a1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_9fcf0351-e994-4a7d-946c-be38eadaf1d5_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_af87c95e-cdb9-4762-8459-fd214297d2bd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_984ef6a8-ecee-4ad8-8bb1-ebc5ad33b349_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_64dda9c7-739c-45df-af42-4e88f45a4cfd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_a34a2065-20ef-4546-b676-d68b1b6b9dc7_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right redemption price per share (in euros per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePrice_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_fa5973a1-c46e-405d-a9cf-24534607f855_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_fb07810c-a1a0-421c-a8ee-d74f15d07b7d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_e7822eb7-fc28-4897-9f7d-646ae4d8cf5c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_570639d2-6d84-413d-92c7-1053807cb962_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_22e38c96-2058-4ddc-815b-57d1240f7c57_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_4a53414e-b49f-4b46-af24-503f6c93cadb_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease and other obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_3da25c94-2353-4afd-b468-b6261b62777f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateAndLocalGovernmentalEntitiesMember_51f4410d-93f8-4dbe-92be-9fb2a396bd8a_terseLabel_en-US" xlink:label="lab_mck_StateAndLocalGovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local governmental entities</link:label>
    <link:label id="lab_mck_StateAndLocalGovernmentalEntitiesMember_label_en-US" xlink:label="lab_mck_StateAndLocalGovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Governmental Entities [Member]</link:label>
    <link:label id="lab_mck_StateAndLocalGovernmentalEntitiesMember_documentation_en-US" xlink:label="lab_mck_StateAndLocalGovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Governmental Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateAndLocalGovernmentalEntitiesMember" xlink:href="mck-20210630.xsd#mck_StateAndLocalGovernmentalEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateAndLocalGovernmentalEntitiesMember" xlink:to="lab_mck_StateAndLocalGovernmentalEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_a76fc7c0-de58-43c5-886d-7cb7ab19fc0a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b990ca5f-7bed-4a06-ae17-4f68a6b17a03_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_8be6ebae-17ed-41c2-9100-44eb1671fefd_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesLineItems_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_d79a6b07-b8d1-4682-8756-940320d296f0_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of countries in which entity segment operates</link:label>
    <link:label id="lab_us-gaap_NumberOfCountriesInWhichEntityOperates_label_en-US" xlink:label="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Countries in which Entity Operates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:to="lab_us-gaap_NumberOfCountriesInWhichEntityOperates" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_a77f2ebc-844d-47f3-92d2-48baea3d96c7_negatedTerseLabel_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate income (expenses), net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_label_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:label id="lab_mck_CorporateOperatingExpenseandOtherIncomeNet_documentation_en-US" xlink:label="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Operating Expense and Other Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:href="mck-20210630.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:to="lab_mck_CorporateOperatingExpenseandOtherIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_afa66fab-bafa-4963-9463-79427bfeacc8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_78c2a6f5-c8a7-41df-a4c3-002c6a5e9908_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ccdc4a44-8892-41cc-beaa-532f7ede4ab6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e9db6b18-c389-4c52-9934-47b3b7b0832a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0f20d900-72b7-4b1e-8f1f-21127919e511_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ab42ac4a-9eca-490f-9f48-b6971caaec9d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_dec3aa83-9347-4b86-8a69-c1d19fc9f59c_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_e39f4fda-36a7-4151-9857-2208daceb6ea_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit) related to continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_db29b175-3504-4e09-95f7-bba53b0fe3a5_terseLabel_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_label_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:label id="lab_mck_MedicalSurgicalSolutionsSegmentMember_documentation_en-US" xlink:label="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical-Surgical Solutions Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:href="mck-20210630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_MedicalSurgicalSolutionsSegmentMember" xlink:to="lab_mck_MedicalSurgicalSolutionsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_50166c34-73b1-4540-951a-30e33008db77_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_13774c29-fb43-461f-90d4-5f34cab5b6b9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72d29138-54bf-4d09-9add-03b0eedf267e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_d7c4097c-43cc-4a6f-86db-baaa1f6a5371_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_StateOfNewYorkMember_5fe56f4f-3bff-4c3a-bdb8-eaace72af1aa_terseLabel_en-US" xlink:label="lab_mck_StateOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of New York</link:label>
    <link:label id="lab_mck_StateOfNewYorkMember_label_en-US" xlink:label="lab_mck_StateOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of New York [Member]</link:label>
    <link:label id="lab_mck_StateOfNewYorkMember_documentation_en-US" xlink:label="lab_mck_StateOfNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State of New York</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfNewYorkMember" xlink:href="mck-20210630.xsd#mck_StateOfNewYorkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_StateOfNewYorkMember" xlink:to="lab_mck_StateOfNewYorkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_cd7d766b-05fd-412f-a925-4f8ea348de3d_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_a7f9ac0e-1520-4fa6-b24f-e24557f0ebd8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_16c6228b-d04d-46ed-8a78-c8ce55d67434_terseLabel_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures due March 1, 2027</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_label_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027 [Member]</link:label>
    <link:label id="lab_mck_A765DebenturesDueMarch12027Member_documentation_en-US" xlink:label="lab_mck_A765DebenturesDueMarch12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">7.65% Debentures Due March 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member" xlink:href="mck-20210630.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A765DebenturesDueMarch12027Member" xlink:to="lab_mck_A765DebenturesDueMarch12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_dfdb5230-673f-493f-a673-c0612dae85f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_bfb0f570-2977-405e-99b1-8c7f0a08049d_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in noncontrolling interest</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_e3156534-5f27-42e6-8e7c-d33e7f778e13_negatedTerseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercises of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_label_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:label id="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease for Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:to="lab_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberofStates_73d9aa9d-7fbc-4a2e-89fb-44db3582800f_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states in which court cases are pending</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_label_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:label id="lab_mck_LossContingencyNumberofStates_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberofStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates" xlink:href="mck-20210630.xsd#mck_LossContingencyNumberofStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberofStates" xlink:to="lab_mck_LossContingencyNumberofStates" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_9ad99b2a-16bf-4774-afc9-27091127d3d7_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_9e1fe129-7a0b-40e1-93b1-61e15fc7ee37_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_7882d3de-eceb-4a7e-ae3d-e4d354de0284_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0a6cca7c-70bb-4948-aef2-f78688e85ea7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_f1ef3eea-2ffa-4259-a339-5baa315a1314_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_e47d0fd2-959d-4cd4-8d0e-5d672ef72348_terseLabel_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_label_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Expected</link:label>
    <link:label id="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_documentation_en-US" xlink:label="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Expected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:href="mck-20210630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:to="lab_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_e721d6d1-5bc4-4040-befe-51b7171be32d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_de33b157-50f9-4efd-8993-eecb8972f535_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_7c729c42-7365-457d-8bed-f75ae1c80c2e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_5ac88bdd-e04d-4892-b3a6-7b351474b999_terseLabel_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments and other, tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_label_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Translation Impact On Pension Plans, Tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_documentation_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income Translation Impact On Pension Plans, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:href="mck-20210630.xsd#mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:to="lab_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_06f6401b-526b-4351-9eab-1b78d12ed697_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_c157fff9-b5a1-4e2b-a488-71392122febb_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_75056258-3e87-4427-ae0c-c8eedd065068_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_f83a68df-12de-408f-ac46-c998b57429aa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_6ce26a77-db0f-4c65-a32c-7039349dbfb4_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases (shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_26a29cad-c367-481b-85b7-3428bd611afe_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_d790fbe3-4ac7-4e9c-b2f2-9e7dbabdbee8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_14cbfd8b-3838-4f4f-a98d-6ea27bd73a5b_terseLabel_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opioid Litigation</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_label_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">National Prescription Opiate Litigation [Member]</link:label>
    <link:label id="lab_mck_NationalPrescriptionOpiateLitigationMember_documentation_en-US" xlink:label="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In re: National Prescription Opiate Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:href="mck-20210630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NationalPrescriptionOpiateLitigationMember" xlink:to="lab_mck_NationalPrescriptionOpiateLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_8ec46ee0-00a1-4a2c-8b33-17cc75855a49_terseLabel_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Dollar, British Pound Sterling, and Euros Sublimit</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_label_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:label id="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_documentation_en-US" xlink:label="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:href="mck-20210630.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:to="lab_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_44b566cd-3dfc-4e56-b754-7226b1fa4263_terseLabel_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of national brand medical-surgical products offered (more than)</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_label_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical-Surgical Products</link:label>
    <link:label id="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts_documentation_en-US" xlink:label="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of National Brand Medical-Surgical Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:href="mck-20210630.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:to="lab_mck_NumberOfNationalBrandMedicalSurgicalProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PharmacyLicensesMember_499458f5-e212-40cb-9fb2-0143b8599673_terseLabel_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy licenses</link:label>
    <link:label id="lab_mck_PharmacyLicensesMember_label_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy Licenses [Member]</link:label>
    <link:label id="lab_mck_PharmacyLicensesMember_documentation_en-US" xlink:label="lab_mck_PharmacyLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy licenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember" xlink:href="mck-20210630.xsd#mck_PharmacyLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PharmacyLicensesMember" xlink:to="lab_mck_PharmacyLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_e29c33b0-ac3e-426d-8a97-0641ec53f9df_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_f3fd7d79-342a-405e-adfa-abd56cefa5b5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_14ea16ea-8479-41b0-a1b3-0db7f2580163_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_728ebbd7-41e0-4948-82b5-8daf4e4cbb07_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award payable under proposed framework</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_GovernmentalEntitiesMember_36d942d3-1926-4eda-b829-7a37db7350ce_terseLabel_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental entities</link:label>
    <link:label id="lab_mck_GovernmentalEntitiesMember_label_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Entities [Member]</link:label>
    <link:label id="lab_mck_GovernmentalEntitiesMember_documentation_en-US" xlink:label="lab_mck_GovernmentalEntitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Governmental Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember" xlink:href="mck-20210630.xsd#mck_GovernmentalEntitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_GovernmentalEntitiesMember" xlink:to="lab_mck_GovernmentalEntitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_b82b26b6-c084-47a6-9c54-bd3aae71eb9a_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermCommercialPaperCurrent_16adf9a0-4830-4dcd-8e59-ff0128a37320_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_LongTermCommercialPaperCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Commercial Paper, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermCommercialPaperCurrent" xlink:to="lab_us-gaap_LongTermCommercialPaperCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_fef63d84-9c57-4892-a096-1e8f487c10fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A3125NotesDue2029Member_67f49075-ab05-46eb-8451-b3461fb2396c_terseLabel_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029</link:label>
    <link:label id="lab_mck_A3125NotesDue2029Member_label_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029 [Member]</link:label>
    <link:label id="lab_mck_A3125NotesDue2029Member_documentation_en-US" xlink:label="lab_mck_A3125NotesDue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes Due 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member" xlink:href="mck-20210630.xsd#mck_A3125NotesDue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A3125NotesDue2029Member" xlink:to="lab_mck_A3125NotesDue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_d9a3257e-cbba-4bb3-a6c6-38eb67efae3d_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_ebb1a561-ae35-43e9-b2b0-30616d1f132f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_fc65af17-8874-47f3-833d-87e2b3c5f85a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ff9e8ca-8fe6-49a4-a55c-b202a649c06b_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_e52e4012-2ee4-4149-a26a-72b6d261bf40_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value, inputs, level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_5c35c357-780f-4b6c-9fd1-f20f13410f64_terseLabel_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan - Remote Work Transitioning</link:label>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_label_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning [Member]</link:label>
    <link:label id="lab_mck_RestructuringPlanRemoteWorkTransitioningMember_documentation_en-US" xlink:label="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan, Remote Work Transitioning</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:href="mck-20210630.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:to="lab_mck_RestructuringPlanRemoteWorkTransitioningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_651647cf-d546-4ce6-bc0a-b56a1ae64147_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_6f65a197-403b-4a14-86be-92c043e8f8f8_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_41fee364-8b47-4efc-8daa-b498b847ac69_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_65370db8-7e96-4ece-9b66-74667f0145f3_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_4867c8f8-082d-481f-94fe-448486a7284a_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_bb6ca13f-2ae9-4b22-baaf-461f86562a21_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_05f2250c-eca8-4d5f-adb8-7a62f065b31c_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Benefits</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_18dd9abe-baa1-4949-ba89-7bc606d74d92_terseLabel_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_label_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:label id="lab_mck_VantageandClarusOneSourcingServicesLLCMember_documentation_en-US" xlink:label="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vantage and ClarusOne Sourcing Services LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:href="mck-20210630.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:to="lab_mck_VantageandClarusOneSourcingServicesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_9d2d2e29-49e8-4a50-9d6b-dc2edbf0c239_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c37f49f0-1c69-44c4-b67d-8339640b1ced_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of computations for basic and diluted earnings per common share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_f449be8f-a5e5-4319-ad8a-8e6d7ca8d3bb_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_accc3e83-dd12-4ca7-8f52-54e4815e83f5_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_8f703780-68a5-4ecd-9870-b5131082fa9a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges recognized</link:label>
    <link:label id="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions_label_en-US" xlink:label="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Settlement and Impairment Provisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:to="lab_us-gaap_RestructuringSettlementAndImpairmentProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8aa41544-c9e6-4c11-bcce-c5a1688b0781_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_0b2ab0a7-8977-4fb6-88c8-753827b018d4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) attributable to McKesson</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_e2cc63b7-33b9-4e7d-bd4a-0bce5196febb_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_401ce20c-6a73-4b92-a16d-2b1ad680bd38_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses on Net Investment Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_323287d8-26b3-4de8-9f71-787fb6bb6b61_terseLabel_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes due October 30, 2026</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_label_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026 [Member]</link:label>
    <link:label id="lab_mck_A163EuroNotesDueOctober302026Member_documentation_en-US" xlink:label="lab_mck_A163EuroNotesDueOctober302026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.63% Euro Notes Due October 30, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member" xlink:href="mck-20210630.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A163EuroNotesDueOctober302026Member" xlink:to="lab_mck_A163EuroNotesDueOctober302026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_98afb17e-9e9a-4863-b452-1b393c242858_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_0bebe840-21ab-4074-b537-b99e909aefc1_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims and litigation charges, net</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_15e61b7c-ac43-43c3-b76e-e3a855fcf470_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain on settlement proceeds</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_aa438510-f687-4c90-8d73-60594cf60394_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_e12a11a7-22b6-4db1-a702-a3b4bcebd501_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_b8d97d0b-bfc8-45a1-9e46-859c8bf1bc32_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected total pre-tax charges</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_167d55b2-8ca2-48cd-bde0-aff71a283712_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in retirement-related benefit plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_5fc95a98-3eff-4276-83a6-a3fe88a6e0f5_terseLabel_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes due March 15, 2044</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_label_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044 [Member]</link:label>
    <link:label id="lab_mck_A488NotesDueMarch152044Member_documentation_en-US" xlink:label="lab_mck_A488NotesDueMarch152044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88% Notes Due March 15, 2044</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member" xlink:href="mck-20210630.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A488NotesDueMarch152044Member" xlink:to="lab_mck_A488NotesDueMarch152044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_898da376-d9a5-4199-9b79-c9abc83cf6ec_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_6adfc36a-5bc1-433f-8d2d-04c143877265_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on debt instrument (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_0c8923a1-1ac8-4f08-80ed-d5388f021394_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_24a4458c-4ebc-4aaf-8e6e-a7ac1ef2fbdf_terseLabel_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes due February 16, 2028</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_label_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028 [Member]</link:label>
    <link:label id="lab_mck_A395NotesDueFebruary162028Member_documentation_en-US" xlink:label="lab_mck_A395NotesDueFebruary162028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95% Notes Due February 16, 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member" xlink:href="mck-20210630.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A395NotesDueFebruary162028Member" xlink:to="lab_mck_A395NotesDueFebruary162028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_HeldForSalePolicyTextBlock_bb3c5a5c-189b-45ef-b3e5-f60d4436db52_terseLabel_en-US" xlink:label="lab_mck_HeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:label id="lab_mck_HeldForSalePolicyTextBlock_label_en-US" xlink:label="lab_mck_HeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale [Policy Text Block]</link:label>
    <link:label id="lab_mck_HeldForSalePolicyTextBlock_documentation_en-US" xlink:label="lab_mck_HeldForSalePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldForSalePolicyTextBlock" xlink:href="mck-20210630.xsd#mck_HeldForSalePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_HeldForSalePolicyTextBlock" xlink:to="lab_mck_HeldForSalePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b962b42b-4ab7-4e09-8169-7143bab62d79_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_68ff10a1-8636-4670-bfb0-274401057e4b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9a21e3c0-3079-43a2-85d6-57274fbde0fc_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_00ffc767-37ae-4645-a8b4-d7005d226470_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_d6b9fce1-395a-4071-a34d-ca33ebe1efe5_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests and Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="lab_us-gaap_MinorityInterestDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_72471ef5-7807-410b-91ae-f7f8456e899f_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesTable_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_6db92377-4d2f-456d-889e-665af7510035_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_02970c46-2a0b-491c-a2f4-1f0a121b1676_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_4dae8b3d-583f-4d1c-a137-bfe72d9b4f34_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_7814dca9-3ad0-4bf9-87ee-ac3954ed9c73_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_81738d95-4965-4ce8-ba90-5d95393bf83b_terseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_0845138d-4989-4224-af63-0db2412f7ba4_verboseLabel_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Associated increase in Company's ownership interest on its equity</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_label_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:label id="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_documentation_en-US" xlink:label="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Exercise of Put Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:href="mck-20210630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:to="lab_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_455d8bbe-752d-4d10-bcd9-fe152cdb1ac2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_e88fdbfe-1ad2-49a6-829e-b307a9c95697_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_beaedd57-3212-48df-9f1f-ece9b4cf2826_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7b45e43-aa8f-48f2-99c8-cec7ae65acc2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_54706195-3a89-4aa9-ba04-638818cfff49_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar, notional amount, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityNotionalAmount" xlink:to="lab_us-gaap_DerivativeLiabilityNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_f98eda6a-b5a5-4aaf-b2ce-e60ee3278883_terseLabel_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes due November 17, 2025</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_label_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025 [Member]</link:label>
    <link:label id="lab_mck_A150EuroNotesDueNovember172025Member_documentation_en-US" xlink:label="lab_mck_A150EuroNotesDueNovember172025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.50% Euro Notes Due November 17, 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member" xlink:href="mck-20210630.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A150EuroNotesDueNovember172025Member" xlink:to="lab_mck_A150EuroNotesDueNovember172025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_a84f01c9-a4e0-44ff-a78c-23b1aea25a92_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f20ac8ad-3d21-497e-af85-c5943838aaf4_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_20d1b493-3496-4b84-af14-4501dcb3ce70_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_1f34644c-ddbc-4fc6-a4a5-14117424f487_terseLabel_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial gain (losses) attributable to redeemable noncontrolling interest</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax</link:label>
    <link:label id="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_documentation_en-US" xlink:label="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:href="mck-20210630.xsd#mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:to="lab_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_2d27db9b-fd63-47c4-a918-a61e405749a1_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_ce6d9ffc-5b47-4bd5-ba79-e56a87e6e4a4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_079c8cf4-e934-4a15-914f-064953d9942f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b6947dde-46f1-4890-9dd1-770a58cf3421_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_db8b06aa-e052-4b92-8473-2e3f907f3498_totalLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_2cfb9e78-fd1b-481b-ae76-8246cd5b00a8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_4f1baa69-fc7f-4aef-8378-fff36bf8eb53_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_fdaea322-2f14-4a61-9d8e-af0134be6311_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_0825a3de-d123-4767-a3dc-f7606e6e958e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_2b9a76a2-3289-4dee-816c-515c10332bb6_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_22bb66e2-0fe9-462d-9748-61b78ef58bbf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_2149b3a9-d601-4cf4-bb7c-7036bec0339e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_19bc9d58-8c0b-4d48-9d82-f05e42e41910_terseLabel_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period over which award would be payable under proposed framework</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_label_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:label id="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod_documentation_en-US" xlink:label="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Settlement Agreement, Award Payment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:href="mck-20210630.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:to="lab_mck_LossContingencySettlementAgreementAwardPaymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_76450850-ebc7-47c5-8c5c-f0cc233e0964_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_a2378840-1ebe-4d32-8671-b83a4fb13d3f_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares, at cost, 119 and 115 shares at June 30, 2021 and March 31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3a12d38b-faf6-44a3-8556-76946c84c2e8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_5e5fe196-21e1-4490-839b-a3b557600b2a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_84a73492-29a4-4a93-b497-02353079eb7d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_b6393025-ec6b-479b-ae51-9bd93481b4ab_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_db7b8032-f8df-49f5-93bd-5e74d6e6e871_verboseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_1981d3cb-7519-4c2a-93d1-3a4244f6a954_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_55ed09f4-9c8b-4856-8a31-b16469712a4d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_757f6ff6-bf1d-403c-a470-b8c9c5f4e9d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding other comprehensive income (loss) including noncontrolling and redeemable noncontrolling interests, net of tax, by component</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_cdeb5575-4c3b-4164-9bd3-a4d3cc976f7d_terseLabel_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_RedeemableNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_RedeemableNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember" xlink:href="mck-20210630.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RedeemableNoncontrollingInterestMember" xlink:to="lab_mck_RedeemableNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_ca9eb2c2-9669-4780-956f-3682fb7f7d98_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_baffb2d7-2add-46a8-9e47-c8258467308d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_d0cd48b4-fa09-4583-8066-2052d6be69b5_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_7a8e00b8-cd98-4f0d-8149-4d778ab9a31c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of tax</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_66beaa3c-a31e-4da5-b6ac-c6c9e7d81cbf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from sales of businesses and investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfOtherAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="lab_us-gaap_GainLossOnSaleOfOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_bec8da21-6695-4848-bdb3-da2cbe19d46b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_7adc6eb9-0935-47a9-b693-8e17dfd7226d_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net restructuring, impairment, and related charges recognized</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_ede889cf-747c-4240-8487-4c6fc3c60d68_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_f85f0faa-644b-4ef0-a6f0-ca98eaf8ebc8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_90743998-fe7c-49ae-bd4c-4f1493a6cfc0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Drafts and accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_cb1bded5-90e3-4b62-afb9-f51ccd6589b5_terseLabel_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:href="mck-20210630.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:to="lab_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_962882fa-91b1-4a7c-9fac-95f542ffdc40_terseLabel_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of other national distributors named in suit</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_label_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Other Defendants</link:label>
    <link:label id="lab_mck_LossContingencyNumberOfOtherDefendants_documentation_en-US" xlink:label="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Other Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants" xlink:href="mck-20210630.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyNumberOfOtherDefendants" xlink:to="lab_mck_LossContingencyNumberOfOtherDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_2afb48e8-1496-46d0-a535-2a5021f20b6e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_df814bce-d72a-476a-a926-6f2664042ec3_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_40752b28-1a12-40fa-b367-7587fd515994_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_891ba7b7-865f-49bc-883e-000b908f866d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_a1ca768d-df72-4fc2-b0a7-231c4c587f31_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, remainder of 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_634822db-22dd-49ab-9aa1-0ae8b482fedc_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_f76bd4d8-0f25-4837-a235-52625a097fa1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment, and Related Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_6e1dec79-f0f1-4335-812b-c0c8ecb05e1d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_cc36e918-d134-45a8-a01a-054bfc453859_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_ff6a3ce0-7a22-4977-a9fe-ee3ba704c653_terseLabel_en-US" xlink:label="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments</link:label>
    <link:label id="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_label_en-US" xlink:label="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments [Member]</link:label>
    <link:label id="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_documentation_en-US" xlink:label="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" xlink:href="mck-20210630.xsd#mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" xlink:to="lab_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_bf4ca73c-fbbf-464b-bde1-8d6a1bf2aa13_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_0787930e-c855-4129-af61-f2b3528ef2f9_negatedLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComparabilityOfPriorYearFinancialData_11b23991-34ce-460d-84a5-e003fbf594a4_terseLabel_en-US" xlink:label="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Results of Operations</link:label>
    <link:label id="lab_us-gaap_ComparabilityOfPriorYearFinancialData_label_en-US" xlink:label="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comparability of Prior Year Financial Data, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComparabilityOfPriorYearFinancialData"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:to="lab_us-gaap_ComparabilityOfPriorYearFinancialData" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_3c64db1a-6d40-42e6-aaa0-e489af6e22eb_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_a047f4cc-e073-42e8-9c8a-5d516131cedb_terseLabel_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments and accelerated depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_label_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:label id="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_documentation_en-US" xlink:label="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges, Including Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:href="mck-20210630.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:to="lab_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_2cefae2e-e864-4c7f-b2c5-b44496dbacf8_terseLabel_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_label_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_documentation_en-US" xlink:label="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:href="mck-20210630.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:to="lab_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_fe903d4d-c95b-4e02-becb-c0b7b5b4f0cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Accrual Liability</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss Contingencies by Contingency [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:to="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_20c50904-635c-487c-93b8-30961eaa8d3c_terseLabel_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other/Other accrued liabilities</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_label_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:label id="lab_mck_CurrentAssetLiabilityMember_documentation_en-US" xlink:label="lab_mck_CurrentAssetLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Asset / Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember" xlink:href="mck-20210630.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_CurrentAssetLiabilityMember" xlink:to="lab_mck_CurrentAssetLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_68d49af3-b2bb-4d2b-982c-2248afc746f9_terseLabel_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue derived from services, percentage (less than)</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_label_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:label id="lab_mck_RevenueDerivedFromServicesPercentage_documentation_en-US" xlink:label="lab_mck_RevenueDerivedFromServicesPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Derived From Services, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage" xlink:href="mck-20210630.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RevenueDerivedFromServicesPercentage" xlink:to="lab_mck_RevenueDerivedFromServicesPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_f02a99e2-e4b2-41d7-8ce0-36d626005986_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_62e02f8a-0cd1-47c6-88de-2263e170bf49_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_label_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Debt Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDebtExpense" xlink:to="lab_us-gaap_InterestAndDebtExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_497fb3fb-9019-4c95-b848-6b6e28a06257_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_cc85922a-0302-442a-869e-f7004d362fbf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_b4ba2ae7-2204-4563-af1d-6fb61a1823d5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated senior unsecured revolving credit facility term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_49f23985-a31f-4701-aeb9-3c0720dad6f1_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_b20111d3-5dc2-4436-a78a-0cd5f693dfb9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of actuarial (gain) loss and prior service costs, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e2b68174-f42f-4369-8c96-a9c10a6683e8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_03602852-2259-4d07-a8a7-6e4b381efded_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_a42f4eef-1328-4af9-8f8e-87f852e387da_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_6179db38-2129-4643-ab44-bc04b71c36a7_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_MovementInMinorityInterestRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward" xlink:to="lab_us-gaap_MovementInMinorityInterestRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_f70f68ce-f5cf-47b6-8204-004f7e6d73e2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant, and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_cb94cf9e-9cc4-4c0f-a4d8-f96c867b7e68_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_f8fedc90-3e0c-4f98-98e9-41ea98a5ec2a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A1625NotesDue2026Member_bee3a0f5-5756-43b5-bc19-5caa48c90960_terseLabel_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026</link:label>
    <link:label id="lab_mck_A1625NotesDue2026Member_label_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026 [Member]</link:label>
    <link:label id="lab_mck_A1625NotesDue2026Member_documentation_en-US" xlink:label="lab_mck_A1625NotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Notes Due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member" xlink:href="mck-20210630.xsd#mck_A1625NotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A1625NotesDue2026Member" xlink:to="lab_mck_A1625NotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_3814e096-b5ab-4d96-b462-5eee6ad10d50_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_351602b2-7cee-4591-99ca-6da0d07b8d2f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_a2e959cc-2b36-43ea-b31f-45b95967a63d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_86ea2f5a-6b13-4f43-bc9c-945479d99acc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson Corporation</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_ee6092da-8bf8-452e-8f9c-fc7c5525dfae_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock transactions:</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestTable_897597fe-2c45-4fb9-afa0-0e7d7511c05b_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_us-gaap_MinorityInterestTable_label_en-US" xlink:label="lab_us-gaap_MinorityInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestTable" xlink:to="lab_us-gaap_MinorityInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_a71ef86f-c450-480c-aeeb-d0170d8b0ce7_terseLabel_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 cross currency swaps</link:label>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_label_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps [Member]</link:label>
    <link:label id="lab_mck_November2018CrossCurrencySwapsMember_documentation_en-US" xlink:label="lab_mck_November2018CrossCurrencySwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2018 Cross Currency Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember" xlink:href="mck-20210630.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_November2018CrossCurrencySwapsMember" xlink:to="lab_mck_November2018CrossCurrencySwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_6a8b6e5b-1e37-4b1c-b830-60f069fb4446_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_262e7fa2-e4b0-4fb1-a7b8-52e939e86042_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_5a208dd7-be18-40c9-91f5-cf69c6f099ac_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to income statement, net of income tax expense</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8cfd95d5-0faf-4098-bd6f-0ac3687ca63b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to earnings and other</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_f9e6a6a6-77fd-487b-9663-0bb2f712c54b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Current Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_8cefc3e0-c00f-48da-9fcb-cc78316925f4_negatedTerseLabel_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of McKesson Europe redeemable noncontrolling interests</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_492e96ed-7261-43c5-8bc5-5debfe1ec56b_negatedLabel_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of McKesson Europe redeemable noncontrolling interests</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_label_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Noncontrolling Interest</link:label>
    <link:label id="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_documentation_en-US" xlink:label="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Temporary Equity to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:href="mck-20210630.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:to="lab_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_58b4e65f-23c8-48fa-809a-48c6c258bb8a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_8d9bd125-ed6d-49a3-82c4-1ba1c06cd0dc_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance and employee-related costs, net</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_4cdd07bc-a17c-4f59-a0c7-f3f61a66011a_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_a82e24ea-a661-44c6-9385-f1353deb8cad_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_06dc7961-172e-4d76-ad36-fff401fd336b_negatedTerseLabel_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, impairment, and related charges</link:label>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_label_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Other Related Charges</link:label>
    <link:label id="lab_mck_RestructuringImpairmentandOtherRelatedCharges_documentation_en-US" xlink:label="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring, Impairment and Other Related Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:href="mck-20210630.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:to="lab_mck_RestructuringImpairmentandOtherRelatedCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_ef39d822-2af0-4672-ab38-78315a8361ba_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_2f40b28f-32de-4315-bd35-0512e17c43da_totalLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total litigation liabilities</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_ca990051-70f9-4ac0-88ea-a23965f30b4e_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_6971b0aa-223b-40e7-938e-bfca269db903_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_cc3d22c8-9c04-4dab-b964-e39131db5d03_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_183a4770-3f8a-402b-a27d-87dea05daf11_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_f28e87be-d4cd-4fec-88ea-874e40606ed5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_DebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_4ca08fac-bcdd-465e-89dd-abee043fe56a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_bf67280d-1ea8-4f51-a9cf-788442273e9c_terseLabel_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated annual amortization expense, thereafter</link:label>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_label_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:label id="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_documentation_en-US" xlink:label="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:href="mck-20210630.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="lab_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_1acc8523-7628-4b95-8221-2b79bdeeda32_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_13467da3-de19-4656-9cd9-48cca3ba95e2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) per common share attributable to McKesson:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_aae05cf1-0436-476c-a329-eecd73b957da_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_a681c881-caa3-4c43-9273-15a2d8b93b31_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial loss and prior service cost arising during the period, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_27b2e01a-d6ae-488f-a86e-c5291a9301d4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported income tax expense (benefit) rates (percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LossContingencyAccrualAfterTax_f45e65f2-4650-40f2-b355-5fcdcb3541fb_terseLabel_en-US" xlink:label="lab_mck_LossContingencyAccrualAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After-tax accrual</link:label>
    <link:label id="lab_mck_LossContingencyAccrualAfterTax_label_en-US" xlink:label="lab_mck_LossContingencyAccrualAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, After Tax</link:label>
    <link:label id="lab_mck_LossContingencyAccrualAfterTax_documentation_en-US" xlink:label="lab_mck_LossContingencyAccrualAfterTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, After Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualAfterTax" xlink:href="mck-20210630.xsd#mck_LossContingencyAccrualAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LossContingencyAccrualAfterTax" xlink:to="lab_mck_LossContingencyAccrualAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_312fe567-b5e8-4088-862b-ab05a9c87f8f_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_9f892c18-8ff0-4854-a171-08cf8ee1e34b_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_3f66d176-eb19-49fc-810a-7ab4abc676b6_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_133c72cb-98af-4511-ad7f-3584a1fb0eb7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Restricted cash at end of period included in Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_bf61bf7c-321a-43b1-af4e-05027f2f629d_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5fc857ad-458e-40d6-af49-669d9ce693cb_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4034d2be-377b-445c-a4be-0f31c02a9730_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_c4507590-bbf8-4938-81fa-19d3480f544f_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_d6a8dfd4-6eb4-4bc3-b15b-3681a1b56f7b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_741788f7-282d-4d59-86c5-7c942493b7f6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_f6846a7e-d99d-402d-92a3-b3946ac3e413_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_efd83cc0-371f-4700-af2b-5c6063ecd373_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4fed3e29-e10b-4f0c-a16a-525564665e0a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_465c35c2-eee4-4510-899a-9b18d611e83a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_ee4bc383-db10-49a6-81ee-4c5ee35e6f31_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_85edd8a8-976e-4b30-a904-307631422791_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_a4d8d306-8d4e-445a-a448-4a02d591209f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of information regarding intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_7986f854-b487-438e-9b08-91c283874804_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Remaining Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_569f3192-1f49-4f27-85d7-6b0b1e2bc9b9_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_7a5fcca7-de13-46d5-a44d-05777c5a2727_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f02cf2b8-0bb1-48ac-878a-fde427a9545d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_9aa6801e-60f8-40ec-abd3-018e6f8ed3a4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_InternationalSegmentMember_a2c6e9ca-6e58-40d4-bfc9-a677b78b3139_terseLabel_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_label_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment [Member]</link:label>
    <link:label id="lab_mck_InternationalSegmentMember_documentation_en-US" xlink:label="lab_mck_InternationalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember" xlink:href="mck-20210630.xsd#mck_InternationalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_InternationalSegmentMember" xlink:to="lab_mck_InternationalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4d5ab58d-7310-4989-b19e-c45d7b60ed42_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ceeaf772-fb4e-4250-8daf-00b5ee0cf12e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_c7dc6b74-0bef-42ee-93e3-12e1b6d833cf_terseLabel_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of settlement to be paid by the Company</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_label_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</link:label>
    <link:label id="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_documentation_en-US" xlink:label="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:href="mck-20210630.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:to="lab_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_945ec564-e4ab-4de6-ba5f-a13390a0ee33_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_a7550d56-311d-42f0-9e93-b47c0a1a6281_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_85f6cc9e-4db5-46a6-8800-3b5469396b11_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_acfd8456-3577-4e1b-8fc1-3f9f96fea7c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_f676d03a-ec5b-41f9-9ccf-90787f2ae528_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_ab29672d-067f-4340-a093-12a72d0668fc_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_c9886871-84d4-423a-8a21-d51bedf935c4_terseLabel_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_label_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:label id="lab_mck_USPharmaceuticalSegmentMember_documentation_en-US" xlink:label="lab_mck_USPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Pharmaceutical Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember" xlink:href="mck-20210630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_USPharmaceuticalSegmentMember" xlink:to="lab_mck_USPharmaceuticalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_ba87eb1c-7f4b-4e98-aeac-7d70a9e4cbaf_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NumberOfBusinessOperations_b55f6f3f-86d3-41cd-a90d-a1d68d45a3ec_terseLabel_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business operations</link:label>
    <link:label id="lab_mck_NumberOfBusinessOperations_label_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Business Operations</link:label>
    <link:label id="lab_mck_NumberOfBusinessOperations_documentation_en-US" xlink:label="lab_mck_NumberOfBusinessOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Business Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations" xlink:href="mck-20210630.xsd#mck_NumberOfBusinessOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NumberOfBusinessOperations" xlink:to="lab_mck_NumberOfBusinessOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_07d2a8a4-da22-4e4e-9161-42f955d9ee4c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discrete tax benefit recognized</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_cad4d65d-99bd-42e3-9549-2fc1d6093a8a_terseLabel_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes due February 17, 2029</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_label_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029 [Member]</link:label>
    <link:label id="lab_mck_A313SterlingNotesDueFebruary172029Member_documentation_en-US" xlink:label="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13% Sterling Notes Due February 17, 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:href="mck-20210630.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A313SterlingNotesDueFebruary172029Member" xlink:to="lab_mck_A313SterlingNotesDueFebruary172029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_cc6160de-7670-4994-97be-ce59c4cc384a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrencySwapMember_22468c1f-73b1-4838-8eca-66228f045ffb_terseLabel_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency swap</link:label>
    <link:label id="lab_us-gaap_CurrencySwapMember_label_en-US" xlink:label="lab_us-gaap_CurrencySwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrencySwapMember" xlink:to="lab_us-gaap_CurrencySwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_ae38d8d2-9871-4768-9585-cd49d1da4be4_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated for hedge accounting</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_1db82347-65ac-4536-ada5-1be337db0bd0_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4639ad13-2c42-4a8a-ad71-20e3c7d0083a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_d17b8580-4c11-4e92-88fe-9a3e49418e1f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_630c3090-af14-4bdd-91ee-764ae038a304_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of shares under employee plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_92ba7ad6-0c58-4846-aece-8f6042063088_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Dollar notional amount, asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A2025NotesMember_83aefae9-1617-4ec2-a11b-5ebcf8ffe315_terseLabel_en-US" xlink:label="lab_mck_A2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Notes</link:label>
    <link:label id="lab_mck_A2025NotesMember_label_en-US" xlink:label="lab_mck_A2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Notes [Member]</link:label>
    <link:label id="lab_mck_A2025NotesMember_documentation_en-US" xlink:label="lab_mck_A2025NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2025NotesMember" xlink:href="mck-20210630.xsd#mck_A2025NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A2025NotesMember" xlink:to="lab_mck_A2025NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_66e7910d-7968-4c1a-8fa6-0a556a1e241d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_a91c0bae-99a9-48f9-ab81-3f60ebb8d17d_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_a38b09e9-3443-4bb7-a4a1-e45054648c73_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_0274fe3c-eb71-4023-9c91-0289129f52c3_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_8816ea00-962c-4c68-b6a3-e15ffb864fe7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified to income statement, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_6c3f9ef5-1748-4304-b057-016a74bb7c29_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6edcdb2e-2cf0-4b5e-bcff-003db0b8dd27_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Syndicated senior unsecured revolving credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_cbcd7844-bad1-4567-87e6-f25e867e4280_netLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding notes (up to)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_43f85d6f-03ab-4399-bb3d-ef514b250fab_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments, net</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_f15432e7-82c4-4dc2-b9bc-e94c8498d75e_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_c06bdc89-84ef-438d-a0e8-253ec39aeb99_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_800133ba-47ea-4c94-b0b9-a610abec124c_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_cda671ce-7c52-4a5a-8bce-488a55440160_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfDefendants_907bbd37-e8c6-4c11-83bd-7b1a433e2d03_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of distributors</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfDefendants_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfDefendants" xlink:to="lab_us-gaap_LossContingencyNumberOfDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_b061c24c-cbcc-4de7-a56b-577ec35e6162_terseLabel_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes due December 15, 2022</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_label_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022 [Member]</link:label>
    <link:label id="lab_mck_A270NotesDueDecember152022Member_documentation_en-US" xlink:label="lab_mck_A270NotesDueDecember152022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.70% Notes Due December 15, 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member" xlink:href="mck-20210630.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A270NotesDueDecember152022Member" xlink:to="lab_mck_A270NotesDueDecember152022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_40450cdd-6877-4cdc-864e-5f98c7dbab2b_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected settlement payment</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_65cecea0-0795-4189-94ed-d417850fd686_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_33198058-72d2-4fe0-8555-e9897f7a0c91_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_a55c39d4-ffa8-4baa-b35b-b833fbf5f192_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_0e1ad151-9690-4a5b-8372-bded3e544233_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_64e903c8-112c-4c26-b372-364fbae74899_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_96ef06bb-ed07-42bc-9223-4100da6a1908_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b41e1dcb-e374-418f-b9a1-50d49e26bb9d_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_af57284f-9ad8-4feb-8d8e-e0e9e9798be4_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax charges recorded to-date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_71a995aa-41c3-4cd1-a19d-a1b3f505e5f3_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_73bbb019-e341-490b-ad28-7d497715ff70_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of derivative, liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_668172b3-9257-44ba-8ad2-2cc899e39348_terseLabel_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes due August 17, 2021</link:label>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_label_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes Due August 17, 2021 [Member]</link:label>
    <link:label id="lab_mck_A063EuroNotesDueAugust172021Member_documentation_en-US" xlink:label="lab_mck_A063EuroNotesDueAugust172021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.63% Euro Notes Due August 17, 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member" xlink:href="mck-20210630.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A063EuroNotesDueAugust172021Member" xlink:to="lab_mck_A063EuroNotesDueAugust172021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_70c83925-3330-4a27-8bf1-148341dd8049_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_af48077f-28f5-4d12-a7cc-980674f71190_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_02caae2e-a65c-4a20-bf20-7b1578c7c9ff_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_ea54efbe-ee0c-4ba6-8d73-a95ed032bf35_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_33982672-eb03-4599-9b52-73e42ad33274_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_c8734949-d1a2-4fb2-b914-e3429d44aa6a_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_8446f651-e6f0-41f1-9d69-57fc306e6456_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_cfd41981-f659-490a-a406-f03ff27aebfb_verboseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in net investment hedge, gains (losses) gross</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_ce8108a4-a6d3-4f4e-a184-68c7455b34a1_terseLabel_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes due March 15, 2023</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_label_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023 [Member]</link:label>
    <link:label id="lab_mck_A285NotesDueMarch152023Member_documentation_en-US" xlink:label="lab_mck_A285NotesDueMarch152023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.85% Notes Due March 15, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member" xlink:href="mck-20210630.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_A285NotesDueMarch152023Member" xlink:to="lab_mck_A285NotesDueMarch152023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_ae21bc43-b0b2-4a88-8718-c2c5dafa1d80_terseLabel_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation liabilities</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_label_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:label id="lab_mck_IncreaseDecreaseInLitigationReserve_documentation_en-US" xlink:label="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Litigation Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:href="mck-20210630.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_IncreaseDecreaseInLitigationReserve" xlink:to="lab_mck_IncreaseDecreaseInLitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_254e0369-be8d-4f03-a453-61ae116bb910_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_f3dc97d4-c7de-453a-9f06-2387fb29c184_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_aaec272b-5f7d-467b-9df6-c9b179e76fc4_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_a6e50411-4b20-4038-82cf-e4b2bb8352b2_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_cc758b0e-a1aa-4458-affd-62387553b888_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_b1df5d64-93bd-432b-b1fa-579173199f5f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of changes in the carrying amount of goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_70fe2408-c7c2-4833-bc0c-df94babb27e2_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_eff92dfe-3d29-4572-94dd-208e07f2c55e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_965eb70c-affa-4490-8b52-27ec4314dc14_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_d076f086-ed89-4c17-8f1f-38236de898ab_terseLabel_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put right value, interest rate spread (as a percent)</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_label_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:label id="lab_mck_PutRightValueInterestRateSpread_documentation_en-US" xlink:label="lab_mck_PutRightValueInterestRateSpread" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Right Value, Interest Rate Spread</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread" xlink:href="mck-20210630.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_PutRightValueInterestRateSpread" xlink:to="lab_mck_PutRightValueInterestRateSpread" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_d4c53b0f-976d-4147-8f60-23e720425479_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_84513d0e-3ef8-46a7-8d19-4891aaedd664_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax expenses related to estimated litigation liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:to="lab_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_EuroDenominatedNotesMember_d9d41e29-5e14-4626-bf65-18401b02a45d_terseLabel_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_label_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:label id="lab_mck_EuroDenominatedNotesMember_documentation_en-US" xlink:label="lab_mck_EuroDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember" xlink:href="mck-20210630.xsd#mck_EuroDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_EuroDenominatedNotesMember" xlink:to="lab_mck_EuroDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_2cb5dbc1-6b7b-487f-ad8c-cf0c1c25aaf3_terseLabel_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in Put Amount (in Euros per share)</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_label_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price Increase</link:label>
    <link:label id="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_documentation_en-US" xlink:label="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests, Put Right, Exercise Price Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:to="lab_mck_NoncontrollingInterestsPutRightExercisePriceIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_2abaeb1b-7c90-444a-9972-5c4daaed7e1c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credits associated with last-in, first-out inventory method</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_d7039f59-9e47-4c83-ae80-dd5c6e6e5cb7_negatedLabel_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax credits related to LIFO accounting</link:label>
    <link:label id="lab_us-gaap_InventoryLIFOReservePeriodCharge_label_en-US" xlink:label="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, LIFO Reserve, Period Charge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLIFOReservePeriodCharge" xlink:to="lab_us-gaap_InventoryLIFOReservePeriodCharge" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>mck-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:31dc61f2-2ef8-41d9-90f2-e8ff46606457,g:0be0b981-6200-4a1a-a19d-196bf6df3870-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://mckesson123.com/role/CoverPage" xlink:type="simple" xlink:href="mck-20210630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_679031ee-7fcc-4e2e-859f-b970ca67f112" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_f5b9596b-c3b9-4010-a3d4-a043f6ccdf78" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_679031ee-7fcc-4e2e-859f-b970ca67f112" xlink:to="loc_dei_EntitiesTable_f5b9596b-c3b9-4010-a3d4-a043f6ccdf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6bcc9536-b7d3-4928-9197-1af7a46ad925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_f5b9596b-c3b9-4010-a3d4-a043f6ccdf78" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6bcc9536-b7d3-4928-9197-1af7a46ad925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_621620fa-3774-4468-b4cf-e1f40975ddf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6bcc9536-b7d3-4928-9197-1af7a46ad925" xlink:to="loc_us-gaap_ClassOfStockDomain_621620fa-3774-4468-b4cf-e1f40975ddf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a515a3fb-acfb-48c4-92b0-08808547c67c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_621620fa-3774-4468-b4cf-e1f40975ddf7" xlink:to="loc_us-gaap_CommonStockMember_a515a3fb-acfb-48c4-92b0-08808547c67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1500NotesDue2025Member_ff97b079-4ccd-4a75-bd92-3a4fdfe4ce54" xlink:href="mck-20210630.xsd#mck_A1500NotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_621620fa-3774-4468-b4cf-e1f40975ddf7" xlink:to="loc_mck_A1500NotesDue2025Member_ff97b079-4ccd-4a75-bd92-3a4fdfe4ce54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A1625NotesDue2026Member_44d63db3-797a-478d-8008-5dc81b1b435b" xlink:href="mck-20210630.xsd#mck_A1625NotesDue2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_621620fa-3774-4468-b4cf-e1f40975ddf7" xlink:to="loc_mck_A1625NotesDue2026Member_44d63db3-797a-478d-8008-5dc81b1b435b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A3125NotesDue2029Member_2eef3c4e-716b-41f8-99fa-091236764a41" xlink:href="mck-20210630.xsd#mck_A3125NotesDue2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_621620fa-3774-4468-b4cf-e1f40975ddf7" xlink:to="loc_mck_A3125NotesDue2029Member_2eef3c4e-716b-41f8-99fa-091236764a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_f5b9596b-c3b9-4010-a3d4-a043f6ccdf78" xlink:to="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_63a72252-8cd0-4fd3-b754-22b41b403a19" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_DocumentType_63a72252-8cd0-4fd3-b754-22b41b403a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_74ebd5c6-4024-43ae-a053-9be195e519d4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_DocumentQuarterlyReport_74ebd5c6-4024-43ae-a053-9be195e519d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4cf1353a-be34-4fc5-b762-b9c12f96b9f3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_DocumentPeriodEndDate_4cf1353a-be34-4fc5-b762-b9c12f96b9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_706ad803-c7fc-4964-9ea8-11289e8a1c51" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_DocumentTransitionReport_706ad803-c7fc-4964-9ea8-11289e8a1c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_507a7f73-ae54-4324-bed7-c381655d2bfd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityFileNumber_507a7f73-ae54-4324-bed7-c381655d2bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5c8cdacf-929a-4ed7-a831-def4f4dd607b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityRegistrantName_5c8cdacf-929a-4ed7-a831-def4f4dd607b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d1387bc0-9f05-457c-afa8-0fb0a4175428" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d1387bc0-9f05-457c-afa8-0fb0a4175428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b07dfdb7-59ed-4a24-a0a7-b3fc8db87564" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityTaxIdentificationNumber_b07dfdb7-59ed-4a24-a0a7-b3fc8db87564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f5703fbf-ca57-480f-9fc3-a9d950aa9d2b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityAddressAddressLine1_f5703fbf-ca57-480f-9fc3-a9d950aa9d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2f9d22c1-ddfc-40e9-99a1-a9a58acf0f71" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityAddressCityOrTown_2f9d22c1-ddfc-40e9-99a1-a9a58acf0f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5158ee04-b847-4070-bb97-93eb791b2632" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityAddressStateOrProvince_5158ee04-b847-4070-bb97-93eb791b2632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_aca8d6b9-4330-43a2-9322-b3695da6851a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityAddressPostalZipCode_aca8d6b9-4330-43a2-9322-b3695da6851a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e503d7f9-10e4-41ad-9adb-dfb7955def15" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_CityAreaCode_e503d7f9-10e4-41ad-9adb-dfb7955def15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4ab9f3ca-fed3-4e30-abc9-1cc7c4ffdb27" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_LocalPhoneNumber_4ab9f3ca-fed3-4e30-abc9-1cc7c4ffdb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ca5d0579-fbae-4a5b-9ae2-cdee0b799d9f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_Security12bTitle_ca5d0579-fbae-4a5b-9ae2-cdee0b799d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d0614eb0-4164-4845-a6ec-f6113bd2847d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_TradingSymbol_d0614eb0-4164-4845-a6ec-f6113bd2847d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b72d587d-d2c5-4f2b-b7a8-4a3f700dd2b3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_SecurityExchangeName_b72d587d-d2c5-4f2b-b7a8-4a3f700dd2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8b3d2d79-047a-4bfe-b87a-25668bb2d2fa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityCurrentReportingStatus_8b3d2d79-047a-4bfe-b87a-25668bb2d2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_12130e24-bac2-44a5-9b4d-48a9c76eedd8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityInteractiveDataCurrent_12130e24-bac2-44a5-9b4d-48a9c76eedd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6b35f74f-2917-4466-b893-660714a9aeef" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityFilerCategory_6b35f74f-2917-4466-b893-660714a9aeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_59426d4f-071f-4c79-ad15-e8d8366edda0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntitySmallBusiness_59426d4f-071f-4c79-ad15-e8d8366edda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_50be5d07-7322-40b7-bb31-78a4b80e96e4" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityEmergingGrowthCompany_50be5d07-7322-40b7-bb31-78a4b80e96e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ad33df09-83a6-4fe9-bc2d-db9b9b6444ff" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityShellCompany_ad33df09-83a6-4fe9-bc2d-db9b9b6444ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_f90b437e-aec6-4d7b-b5a2-020edb1d228e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_f90b437e-aec6-4d7b-b5a2-020edb1d228e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_cf3351a3-f766-4fcf-ae5c-fcc8391ec605" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_EntityCentralIndexKey_cf3351a3-f766-4fcf-ae5c-fcc8391ec605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_939e0ecd-b8c4-455b-a967-ab8308298a1a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_DocumentFiscalYearFocus_939e0ecd-b8c4-455b-a967-ab8308298a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_93b78203-595b-46c9-a885-a50982f420ce" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_DocumentFiscalPeriodFocus_93b78203-595b-46c9-a885-a50982f420ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_187424b3-7b30-4883-af33-631983eeffcf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_AmendmentFlag_187424b3-7b30-4883-af33-631983eeffcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_e1bbd3b4-bb3b-4881-bb28-8f82e5f3fb4e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_1fc931ab-7fdf-4596-bbbb-1e9ac177d7ff" xlink:to="loc_dei_CurrentFiscalYearEndDate_e1bbd3b4-bb3b-4881-bb28-8f82e5f3fb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mck-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b14c23f3-e44b-4f37-ae6b-5b632b63a98a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b14c23f3-e44b-4f37-ae6b-5b632b63a98a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_64afb2c2-6da7-4009-8960-c04c10eaaa89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_64afb2c2-6da7-4009-8960-c04c10eaaa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_cf01b178-810e-473e-a44e-3fb3f75508de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_GrossProfit_cf01b178-810e-473e-a44e-3fb3f75508de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2092b5c2-83fd-4ace-8cdb-7e3b745e1f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2092b5c2-83fd-4ace-8cdb-7e3b745e1f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_d8a6c223-71cc-44f2-a5ca-07cd6ec81f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_d8a6c223-71cc-44f2-a5ca-07cd6ec81f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringImpairmentandOtherRelatedCharges_ed2d24f0-f137-45c7-9611-31e8e607d88b" xlink:href="mck-20210630.xsd#mck_RestructuringImpairmentandOtherRelatedCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_mck_RestructuringImpairmentandOtherRelatedCharges_ed2d24f0-f137-45c7-9611-31e8e607d88b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a55cd678-9dad-44e5-be7e-f9ae6902f67d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_OperatingExpenses_a55cd678-9dad-44e5-be7e-f9ae6902f67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_35fb84a9-8e51-4664-89f5-b4dcb4e5f511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_OperatingIncomeLoss_35fb84a9-8e51-4664-89f5-b4dcb4e5f511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_386054d7-5c74-407b-805a-afe5bc65e091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_386054d7-5c74-407b-805a-afe5bc65e091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_94e2b0bf-acdf-4795-b3b8-243b93af5e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_InterestAndDebtExpense_94e2b0bf-acdf-4795-b3b8-243b93af5e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ba6c451f-f858-48aa-99c3-e8a10707fc01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ba6c451f-f858-48aa-99c3-e8a10707fc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e1dacde8-fb5d-4d2f-b72c-9cffcc096907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e1dacde8-fb5d-4d2f-b72c-9cffcc096907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_11d018e6-83f5-422e-9f2e-b58d94ad601a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_11d018e6-83f5-422e-9f2e-b58d94ad601a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1de182c0-c214-4cff-b725-82f353a51f98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_1de182c0-c214-4cff-b725-82f353a51f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_9beaf52f-31ef-487f-92f0-3d7c9d38faff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_ProfitLoss_9beaf52f-31ef-487f-92f0-3d7c9d38faff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0ca6855f-2c05-4093-98f6-e89365db494f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0ca6855f-2c05-4093-98f6-e89365db494f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_461dd55f-78b3-4f38-81b1-cacd54c192a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_NetIncomeLoss_461dd55f-78b3-4f38-81b1-cacd54c192a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6d3fe032-4632-4dbc-8827-894a5022571d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_EarningsPerShareAbstract_6d3fe032-4632-4dbc-8827-894a5022571d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_70ce57c0-6758-48dd-84ca-30ad8aeb0632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6d3fe032-4632-4dbc-8827-894a5022571d" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_70ce57c0-6758-48dd-84ca-30ad8aeb0632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_de51c3cb-da3f-44ce-85ca-36b591cd30dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_70ce57c0-6758-48dd-84ca-30ad8aeb0632" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_de51c3cb-da3f-44ce-85ca-36b591cd30dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_de88651a-80c4-46c0-a317-eaf9477de45b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_70ce57c0-6758-48dd-84ca-30ad8aeb0632" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_de88651a-80c4-46c0-a317-eaf9477de45b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bf1f5c46-a145-4bf5-9326-09e84b030494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_70ce57c0-6758-48dd-84ca-30ad8aeb0632" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bf1f5c46-a145-4bf5-9326-09e84b030494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_3a34fd2d-c404-493c-bb1a-75cbf5e3d495" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6d3fe032-4632-4dbc-8827-894a5022571d" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_3a34fd2d-c404-493c-bb1a-75cbf5e3d495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_c19639b9-af52-476f-8436-57920cf59a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_3a34fd2d-c404-493c-bb1a-75cbf5e3d495" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_c19639b9-af52-476f-8436-57920cf59a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_c30a969f-3b0d-46bf-8d62-18b8b08d1c67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_3a34fd2d-c404-493c-bb1a-75cbf5e3d495" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_c30a969f-3b0d-46bf-8d62-18b8b08d1c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3001fd15-ee51-4ca5-bb19-3ee5bcabb5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_3a34fd2d-c404-493c-bb1a-75cbf5e3d495" xlink:to="loc_us-gaap_EarningsPerShareBasic_3001fd15-ee51-4ca5-bb19-3ee5bcabb5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1d1c0dfc-9b2a-469e-b597-185d1fe260a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef2db4d6-787e-4616-b7e3-a7530163dd07" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1d1c0dfc-9b2a-469e-b597-185d1fe260a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e7b139d6-cb14-4089-a709-d7d659631be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1d1c0dfc-9b2a-469e-b597-185d1fe260a6" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e7b139d6-cb14-4089-a709-d7d659631be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fb02c623-b09f-4c26-a015-2abe1ae807ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1d1c0dfc-9b2a-469e-b597-185d1fe260a6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_fb02c623-b09f-4c26-a015-2abe1ae807ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="mck-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bb2cb812-3f3f-4f3a-ad8e-cf3eb2926ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_89f39f3a-c827-40b2-9674-0ee0d99b01cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bb2cb812-3f3f-4f3a-ad8e-cf3eb2926ea3" xlink:to="loc_us-gaap_ProfitLoss_89f39f3a-c827-40b2-9674-0ee0d99b01cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_194daa72-0d67-46c1-a5d9-340647b3f6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bb2cb812-3f3f-4f3a-ad8e-cf3eb2926ea3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_194daa72-0d67-46c1-a5d9-340647b3f6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b5391beb-d491-4558-811b-fccee606ff89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_194daa72-0d67-46c1-a5d9-340647b3f6fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b5391beb-d491-4558-811b-fccee606ff89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_76ab3334-3ce4-448c-9e60-4f593043e506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_194daa72-0d67-46c1-a5d9-340647b3f6fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_76ab3334-3ce4-448c-9e60-4f593043e506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_93830b18-702b-4d02-b585-63af25beb6ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_194daa72-0d67-46c1-a5d9-340647b3f6fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_93830b18-702b-4d02-b585-63af25beb6ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e891e88e-4416-41d3-8f92-37ac76e4074d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_194daa72-0d67-46c1-a5d9-340647b3f6fc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e891e88e-4416-41d3-8f92-37ac76e4074d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4c18aad4-2330-4acb-a765-1ad0290be4bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bb2cb812-3f3f-4f3a-ad8e-cf3eb2926ea3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4c18aad4-2330-4acb-a765-1ad0290be4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_bb33b107-47f4-4b54-9754-c11761e8cba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bb2cb812-3f3f-4f3a-ad8e-cf3eb2926ea3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_bb33b107-47f4-4b54-9754-c11761e8cba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_1c346f30-2533-44e2-9d29-a8767777cf77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_bb2cb812-3f3f-4f3a-ad8e-cf3eb2926ea3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_1c346f30-2533-44e2-9d29-a8767777cf77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mck-20210630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0dce29e0-66f5-4895-a4d9-8503eddd4cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c11f7def-54ab-41aa-a239-796be920e330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0dce29e0-66f5-4895-a4d9-8503eddd4cc8" xlink:to="loc_us-gaap_AssetsAbstract_c11f7def-54ab-41aa-a239-796be920e330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_8027c7ad-7a42-4e98-a313-5363db0f014f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c11f7def-54ab-41aa-a239-796be920e330" xlink:to="loc_us-gaap_AssetsCurrentAbstract_8027c7ad-7a42-4e98-a313-5363db0f014f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_990e7b2f-8435-4f6b-9612-2b1aa67cd1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8027c7ad-7a42-4e98-a313-5363db0f014f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_990e7b2f-8435-4f6b-9612-2b1aa67cd1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_049c241f-d394-4066-8b0e-63722c88c311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8027c7ad-7a42-4e98-a313-5363db0f014f" xlink:to="loc_us-gaap_ReceivablesNetCurrent_049c241f-d394-4066-8b0e-63722c88c311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e92bf643-4605-4103-8825-ac27e97498cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8027c7ad-7a42-4e98-a313-5363db0f014f" xlink:to="loc_us-gaap_InventoryNet_e92bf643-4605-4103-8825-ac27e97498cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c35e6328-fdc0-4f7a-a8cc-bda826e5d053" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8027c7ad-7a42-4e98-a313-5363db0f014f" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_c35e6328-fdc0-4f7a-a8cc-bda826e5d053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_604108f2-13f6-47ec-83a2-cd8ca9f1d31d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8027c7ad-7a42-4e98-a313-5363db0f014f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_604108f2-13f6-47ec-83a2-cd8ca9f1d31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3ee0cf4d-02e9-46cf-912e-3aed1e0a3859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8027c7ad-7a42-4e98-a313-5363db0f014f" xlink:to="loc_us-gaap_AssetsCurrent_3ee0cf4d-02e9-46cf-912e-3aed1e0a3859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_748b91f0-f4c6-450c-b066-3a8ecf90901c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c11f7def-54ab-41aa-a239-796be920e330" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_748b91f0-f4c6-450c-b066-3a8ecf90901c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_649ace0c-56af-44e7-a6b3-8542719ba8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c11f7def-54ab-41aa-a239-796be920e330" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_649ace0c-56af-44e7-a6b3-8542719ba8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2ecd602a-a672-4753-873c-bbb7a73d859a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c11f7def-54ab-41aa-a239-796be920e330" xlink:to="loc_us-gaap_Goodwill_2ecd602a-a672-4753-873c-bbb7a73d859a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_865bd953-db5e-4fbb-9fcb-c908eb49b47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c11f7def-54ab-41aa-a239-796be920e330" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_865bd953-db5e-4fbb-9fcb-c908eb49b47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a2110479-39a1-428e-bffe-698e4e8fd54f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c11f7def-54ab-41aa-a239-796be920e330" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a2110479-39a1-428e-bffe-698e4e8fd54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d66e1a41-010d-4cb4-b983-79a4796a54cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c11f7def-54ab-41aa-a239-796be920e330" xlink:to="loc_us-gaap_Assets_d66e1a41-010d-4cb4-b983-79a4796a54cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_92d9e717-f1cb-46df-96b3-d10b5902d012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0dce29e0-66f5-4895-a4d9-8503eddd4cc8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_92d9e717-f1cb-46df-96b3-d10b5902d012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_d6777ad0-538b-4251-b27e-179f7d3a0b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_92d9e717-f1cb-46df-96b3-d10b5902d012" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_d6777ad0-538b-4251-b27e-179f7d3a0b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f37e42fb-ef37-490d-be0e-709eb298c0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d6777ad0-538b-4251-b27e-179f7d3a0b02" xlink:to="loc_us-gaap_AccountsPayableCurrent_f37e42fb-ef37-490d-be0e-709eb298c0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_17fa47c8-26a0-4acc-b197-a71a48cdc8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d6777ad0-538b-4251-b27e-179f7d3a0b02" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_17fa47c8-26a0-4acc-b197-a71a48cdc8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_44aedd1b-1407-4c1f-9775-2641f769cd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d6777ad0-538b-4251-b27e-179f7d3a0b02" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_44aedd1b-1407-4c1f-9775-2641f769cd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_520765c4-13dd-4a37-a7e2-d44219760a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d6777ad0-538b-4251-b27e-179f7d3a0b02" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_520765c4-13dd-4a37-a7e2-d44219760a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a5e7aaa5-21f1-4ef5-b3e5-d57b55c76659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d6777ad0-538b-4251-b27e-179f7d3a0b02" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a5e7aaa5-21f1-4ef5-b3e5-d57b55c76659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d00eddcb-0132-4a64-a78b-1a41538aa311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_d6777ad0-538b-4251-b27e-179f7d3a0b02" xlink:to="loc_us-gaap_LiabilitiesCurrent_d00eddcb-0132-4a64-a78b-1a41538aa311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0c0abcd8-7b12-40c0-8568-6af358345a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_92d9e717-f1cb-46df-96b3-d10b5902d012" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_0c0abcd8-7b12-40c0-8568-6af358345a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4afdc685-eb1b-46dd-a351-94a372857d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_92d9e717-f1cb-46df-96b3-d10b5902d012" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_4afdc685-eb1b-46dd-a351-94a372857d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_373080b0-e9e7-4e7c-ab27-cb3326955c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_92d9e717-f1cb-46df-96b3-d10b5902d012" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_373080b0-e9e7-4e7c-ab27-cb3326955c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveNoncurrent_260a8961-6324-4a30-a548-0654b56b7627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationReserveNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_92d9e717-f1cb-46df-96b3-d10b5902d012" xlink:to="loc_us-gaap_LitigationReserveNoncurrent_260a8961-6324-4a30-a548-0654b56b7627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3731d787-463f-49ec-bc73-0801df0243a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_92d9e717-f1cb-46df-96b3-d10b5902d012" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3731d787-463f-49ec-bc73-0801df0243a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_fde4f103-c3ce-4329-82f0-8d4cdd01d82e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_92d9e717-f1cb-46df-96b3-d10b5902d012" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_fde4f103-c3ce-4329-82f0-8d4cdd01d82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_759574c3-cc2e-4265-9490-802589cd63f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_92d9e717-f1cb-46df-96b3-d10b5902d012" xlink:to="loc_us-gaap_StockholdersEquityAbstract_759574c3-cc2e-4265-9490-802589cd63f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_b7565231-07ae-40ce-8976-0a19c511bd8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_759574c3-cc2e-4265-9490-802589cd63f5" xlink:to="loc_us-gaap_PreferredStockValue_b7565231-07ae-40ce-8976-0a19c511bd8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ab8e9963-03f2-478e-b291-36d582ac0e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_759574c3-cc2e-4265-9490-802589cd63f5" xlink:to="loc_us-gaap_CommonStockValue_ab8e9963-03f2-478e-b291-36d582ac0e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b5cc52df-72c2-488a-b858-86e5b7ef301d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_759574c3-cc2e-4265-9490-802589cd63f5" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b5cc52df-72c2-488a-b858-86e5b7ef301d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a023955a-f789-4e22-852f-e7980136eee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_759574c3-cc2e-4265-9490-802589cd63f5" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a023955a-f789-4e22-852f-e7980136eee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e8aad269-5f06-4986-8414-3e646edd6b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_759574c3-cc2e-4265-9490-802589cd63f5" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e8aad269-5f06-4986-8414-3e646edd6b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_e8efbe71-ac45-4cf2-8ffe-9878595b0cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_759574c3-cc2e-4265-9490-802589cd63f5" xlink:to="loc_us-gaap_TreasuryStockValue_e8efbe71-ac45-4cf2-8ffe-9878595b0cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9461ad85-192b-4e07-8068-506853c3a790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_759574c3-cc2e-4265-9490-802589cd63f5" xlink:to="loc_us-gaap_StockholdersEquity_9461ad85-192b-4e07-8068-506853c3a790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_dd351a29-a3fd-4139-950d-1109b2d67059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_759574c3-cc2e-4265-9490-802589cd63f5" xlink:to="loc_us-gaap_MinorityInterest_dd351a29-a3fd-4139-950d-1109b2d67059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d1e0bd5-10e7-4068-9915-f592ff0d3edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_759574c3-cc2e-4265-9490-802589cd63f5" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0d1e0bd5-10e7-4068-9915-f592ff0d3edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b2587ab2-c301-4adf-aa8e-e924c62c35d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_92d9e717-f1cb-46df-96b3-d10b5902d012" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_b2587ab2-c301-4adf-aa8e-e924c62c35d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="mck-20210630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_85128866-f8fb-49f6-a0e7-411be27f7c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_fe25e501-b641-4a41-8966-c45f0bab6c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_85128866-f8fb-49f6-a0e7-411be27f7c12" xlink:to="loc_us-gaap_StockholdersEquityAbstract_fe25e501-b641-4a41-8966-c45f0bab6c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_234f7cab-6c86-44bd-b02b-64daf6d57ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe25e501-b641-4a41-8966-c45f0bab6c40" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_234f7cab-6c86-44bd-b02b-64daf6d57ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_c40d049d-2deb-408c-8ba1-2914af27f8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe25e501-b641-4a41-8966-c45f0bab6c40" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_c40d049d-2deb-408c-8ba1-2914af27f8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_8c0726d1-d799-4aa6-9cf4-fb9cb70eca76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe25e501-b641-4a41-8966-c45f0bab6c40" xlink:to="loc_us-gaap_PreferredStockSharesIssued_8c0726d1-d799-4aa6-9cf4-fb9cb70eca76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_e4c0429d-5335-45c2-82ab-c348f8b9273d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe25e501-b641-4a41-8966-c45f0bab6c40" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_e4c0429d-5335-45c2-82ab-c348f8b9273d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8abac33e-6d4f-403b-b575-6e6338fab7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe25e501-b641-4a41-8966-c45f0bab6c40" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8abac33e-6d4f-403b-b575-6e6338fab7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2c848dae-83bd-4397-a700-5300045e2caf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe25e501-b641-4a41-8966-c45f0bab6c40" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2c848dae-83bd-4397-a700-5300045e2caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_fb4e45d6-103e-4cba-b86f-9d3b01411d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe25e501-b641-4a41-8966-c45f0bab6c40" xlink:to="loc_us-gaap_CommonStockSharesIssued_fb4e45d6-103e-4cba-b86f-9d3b01411d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_8aee21c3-74ad-458d-9450-89de29222a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_fe25e501-b641-4a41-8966-c45f0bab6c40" xlink:to="loc_us-gaap_TreasuryStockShares_8aee21c3-74ad-458d-9450-89de29222a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="mck-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_4840bfe2-4999-4861-a38c-5960e9fdc51c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5e11e785-725f-4f3b-8bb8-63ac98588b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_4840bfe2-4999-4861-a38c-5960e9fdc51c" xlink:to="loc_us-gaap_StatementTable_5e11e785-725f-4f3b-8bb8-63ac98588b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_79a20978-22d0-41cc-965e-ca0ea8365be4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5e11e785-725f-4f3b-8bb8-63ac98588b51" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_79a20978-22d0-41cc-965e-ca0ea8365be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b136cb5a-e5a3-4a93-b8aa-c040b8914704" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_79a20978-22d0-41cc-965e-ca0ea8365be4" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b136cb5a-e5a3-4a93-b8aa-c040b8914704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_8462d780-57e8-4235-a0f5-c0b3c4ebfb78" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b136cb5a-e5a3-4a93-b8aa-c040b8914704" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_8462d780-57e8-4235-a0f5-c0b3c4ebfb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_f4c531a5-489e-4f14-9716-c9a53d87fcc7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b136cb5a-e5a3-4a93-b8aa-c040b8914704" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_f4c531a5-489e-4f14-9716-c9a53d87fcc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_604eb520-e36c-42d0-8586-c9f9ca5743e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5e11e785-725f-4f3b-8bb8-63ac98588b51" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_604eb520-e36c-42d0-8586-c9f9ca5743e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_604eb520-e36c-42d0-8586-c9f9ca5743e1" xlink:to="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_724f0286-c529-45ba-88ae-16df28781d32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:to="loc_us-gaap_CommonStockMember_724f0286-c529-45ba-88ae-16df28781d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_fd5ee204-a77c-4767-a958-28688d1edf43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_fd5ee204-a77c-4767-a958-28688d1edf43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_74969889-f254-46ff-9e0f-087c6b8f386e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:to="loc_us-gaap_RetainedEarningsMember_74969889-f254-46ff-9e0f-087c6b8f386e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d221c7d1-4e6d-4462-a1bf-efabd22c3451" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d221c7d1-4e6d-4462-a1bf-efabd22c3451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_50d6008d-67e4-4fc0-8dae-8aee079a6691" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:to="loc_us-gaap_TreasuryStockMember_50d6008d-67e4-4fc0-8dae-8aee079a6691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_39c24ba0-511e-4025-9780-06c59e5588c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6950925c-7caa-41e3-811c-5ce9e939e446" xlink:to="loc_us-gaap_NoncontrollingInterestMember_39c24ba0-511e-4025-9780-06c59e5588c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4bb75948-bb30-410a-a052-0b9cf82419f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5e11e785-725f-4f3b-8bb8-63ac98588b51" xlink:to="loc_us-gaap_StatementLineItems_4bb75948-bb30-410a-a052-0b9cf82419f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4bb75948-bb30-410a-a052-0b9cf82419f7" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_8026f9c5-65cd-4f21-8f49-3da1b631b833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_SharesOutstanding_8026f9c5-65cd-4f21-8f49-3da1b631b833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_6a520d56-9ae0-4f90-a6da-b26be9fc6d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_TreasuryStockShares_6a520d56-9ae0-4f90-a6da-b26be9fc6d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f7f04cbe-97e3-4544-9a56-73e1a4854cd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f7f04cbe-97e3-4544-9a56-73e1a4854cd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0d6e611c-5d87-421a-97b2-3ee32bc1b1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0d6e611c-5d87-421a-97b2-3ee32bc1b1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_55e83667-f3d4-4918-97fa-633d2241c86f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_55e83667-f3d4-4918-97fa-633d2241c86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f6049eca-f6b2-4d1b-8724-5461c0d56b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f6049eca-f6b2-4d1b-8724-5461c0d56b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_a74e375d-8085-45f8-8c56-13fa3e2ea00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_a74e375d-8085-45f8-8c56-13fa3e2ea00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6a6158b7-d97a-486a-9fa8-06bdae522b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6a6158b7-d97a-486a-9fa8-06bdae522b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_b43db364-6b07-471a-ba36-6bc08b446332" xlink:href="mck-20210630.xsd#mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest_b43db364-6b07-471a-ba36-6bc08b446332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_5ba081b6-262e-47ee-af78-46d5b0c0b5c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_5ba081b6-262e-47ee-af78-46d5b0c0b5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_f5ef7c60-319b-4dca-b5e2-895af6924ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_f5ef7c60-319b-4dca-b5e2-895af6924ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_48dacedf-0274-47c2-8413-faa319a16c1b" xlink:href="mck-20210630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_48dacedf-0274-47c2-8413-faa319a16c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_dfbe71f1-40c2-4b32-86ac-ccd2d2e89284" xlink:href="mck-20210630.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_dfbe71f1-40c2-4b32-86ac-ccd2d2e89284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_97f01bbd-b796-405d-9eec-fd1cb5ff37d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_DividendsCommonStockCash_97f01bbd-b796-405d-9eec-fd1cb5ff37d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_a66e115c-1a48-48f8-9543-0bd567cdbe87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_StockholdersEquityOther_a66e115c-1a48-48f8-9543-0bd567cdbe87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_772ce395-118e-4db1-ac52-792c0314d740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_SharesOutstanding_772ce395-118e-4db1-ac52-792c0314d740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_68e55a7a-1c26-472a-b8d6-4063033634fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_TreasuryStockShares_68e55a7a-1c26-472a-b8d6-4063033634fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_76b4eae3-bdd9-46f7-bb82-25e1940ddea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6c933445-f97d-4664-a2a0-6b3731a2102a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_76b4eae3-bdd9-46f7-bb82-25e1940ddea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="simple" xlink:href="mck-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d620d18c-c230-4b0f-9f42-c68098fcc847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_b8026abe-e904-46dc-96fc-02f201ed174d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d620d18c-c230-4b0f-9f42-c68098fcc847" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_b8026abe-e904-46dc-96fc-02f201ed174d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mck-20210630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_991d1947-b483-4389-a305-85641a0c9fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cd51ff49-4109-4c08-a9e0-da98f33eb418" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_991d1947-b483-4389-a305-85641a0c9fb5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cd51ff49-4109-4c08-a9e0-da98f33eb418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_52bddb83-653a-4af5-95e8-ebae9a82b6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cd51ff49-4109-4c08-a9e0-da98f33eb418" xlink:to="loc_us-gaap_ProfitLoss_52bddb83-653a-4af5-95e8-ebae9a82b6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e16a2044-1050-46fb-a68d-9b7a0d60e61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cd51ff49-4109-4c08-a9e0-da98f33eb418" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e16a2044-1050-46fb-a68d-9b7a0d60e61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_0a4e02c2-f201-4e70-a61f-0af64f28ffdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e16a2044-1050-46fb-a68d-9b7a0d60e61c" xlink:to="loc_us-gaap_Depreciation_0a4e02c2-f201-4e70-a61f-0af64f28ffdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_5a3deeac-a730-4633-8a5d-aa533fb5f11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e16a2044-1050-46fb-a68d-9b7a0d60e61c" xlink:to="loc_us-gaap_AdjustmentForAmortization_5a3deeac-a730-4633-8a5d-aa533fb5f11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_3ebecf7a-3972-43d9-9daa-756e43916778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e16a2044-1050-46fb-a68d-9b7a0d60e61c" xlink:to="loc_us-gaap_AssetImpairmentCharges_3ebecf7a-3972-43d9-9daa-756e43916778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_bcdc49b4-d4ef-4cf5-b083-6fe6efa06d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e16a2044-1050-46fb-a68d-9b7a0d60e61c" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_bcdc49b4-d4ef-4cf5-b083-6fe6efa06d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_bc5af18e-a2ff-4884-af40-bfd30e32a061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e16a2044-1050-46fb-a68d-9b7a0d60e61c" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_bc5af18e-a2ff-4884-af40-bfd30e32a061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_df590b43-1bf6-44f6-b8ae-12d490663786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e16a2044-1050-46fb-a68d-9b7a0d60e61c" xlink:to="loc_us-gaap_OperatingLeaseExpense_df590b43-1bf6-44f6-b8ae-12d490663786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfOtherAssets_e1828054-2039-4007-bdca-f98a46c8b9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e16a2044-1050-46fb-a68d-9b7a0d60e61c" xlink:to="loc_us-gaap_GainLossOnSaleOfOtherAssets_e1828054-2039-4007-bdca-f98a46c8b9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_f4601bcb-3a2b-4a1a-8f03-a1bd5fb062d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e16a2044-1050-46fb-a68d-9b7a0d60e61c" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_f4601bcb-3a2b-4a1a-8f03-a1bd5fb062d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_7895314b-8f00-449b-90a5-e0c414a519f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e16a2044-1050-46fb-a68d-9b7a0d60e61c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_7895314b-8f00-449b-90a5-e0c414a519f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_d0959241-eb3d-4704-9137-90880bcd3195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_7895314b-8f00-449b-90a5-e0c414a519f1" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_d0959241-eb3d-4704-9137-90880bcd3195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_303cff5e-2a5c-4eda-ab86-1f40f3c05838" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_7895314b-8f00-449b-90a5-e0c414a519f1" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_303cff5e-2a5c-4eda-ab86-1f40f3c05838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a861514c-ae54-41c3-a45e-c83c10f8d8b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_7895314b-8f00-449b-90a5-e0c414a519f1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a861514c-ae54-41c3-a45e-c83c10f8d8b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2590f6c0-e307-4bc7-91be-cad7008a9427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_7895314b-8f00-449b-90a5-e0c414a519f1" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_2590f6c0-e307-4bc7-91be-cad7008a9427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_1a60bc8e-b81a-43dc-8127-6e10bdbac390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedTaxesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_7895314b-8f00-449b-90a5-e0c414a519f1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedTaxesPayable_1a60bc8e-b81a-43dc-8127-6e10bdbac390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IncreaseDecreaseInLitigationReserve_56554dc4-3351-4a4d-8b07-8278d50fa623" xlink:href="mck-20210630.xsd#mck_IncreaseDecreaseInLitigationReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_7895314b-8f00-449b-90a5-e0c414a519f1" xlink:to="loc_mck_IncreaseDecreaseInLitigationReserve_56554dc4-3351-4a4d-8b07-8278d50fa623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0a9f1c32-58e0-4ee3-b0ed-78251c73503b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_7895314b-8f00-449b-90a5-e0c414a519f1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_0a9f1c32-58e0-4ee3-b0ed-78251c73503b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3fc2eac8-5169-41d2-888a-b794d63b6afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cd51ff49-4109-4c08-a9e0-da98f33eb418" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3fc2eac8-5169-41d2-888a-b794d63b6afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15a141ed-5bcd-4a7f-b2a8-22267ab7e162" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_991d1947-b483-4389-a305-85641a0c9fb5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15a141ed-5bcd-4a7f-b2a8-22267ab7e162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5195c96d-5853-42df-b823-a0ed3504647a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15a141ed-5bcd-4a7f-b2a8-22267ab7e162" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5195c96d-5853-42df-b823-a0ed3504647a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireSoftware_c9e04af8-b757-437b-95aa-2fe45a248866" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireSoftware"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15a141ed-5bcd-4a7f-b2a8-22267ab7e162" xlink:to="loc_us-gaap_PaymentsToAcquireSoftware_c9e04af8-b757-437b-95aa-2fe45a248866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_837a67d9-5596-4c01-b0b2-ee3126c660f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15a141ed-5bcd-4a7f-b2a8-22267ab7e162" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_837a67d9-5596-4c01-b0b2-ee3126c660f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_852d6400-5dc7-419c-8690-cb6b1fc2bf3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15a141ed-5bcd-4a7f-b2a8-22267ab7e162" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates_852d6400-5dc7-419c-8690-cb6b1fc2bf3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_21d277a1-6b75-431e-a93e-0b976b769dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15a141ed-5bcd-4a7f-b2a8-22267ab7e162" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_21d277a1-6b75-431e-a93e-0b976b769dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_44c8feaa-2c7c-4e8c-820f-a75019d3027b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_15a141ed-5bcd-4a7f-b2a8-22267ab7e162" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_44c8feaa-2c7c-4e8c-820f-a75019d3027b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2377a487-65dd-4e9a-a6c8-6bcb8b8ac8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_991d1947-b483-4389-a305-85641a0c9fb5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2377a487-65dd-4e9a-a6c8-6bcb8b8ac8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_09a2869f-cae1-4f50-bbad-32c68242bc10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2377a487-65dd-4e9a-a6c8-6bcb8b8ac8c8" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_09a2869f-cae1-4f50-bbad-32c68242bc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_24273eb0-ad6a-4941-9e01-7043d1947e87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2377a487-65dd-4e9a-a6c8-6bcb8b8ac8c8" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_24273eb0-ad6a-4941-9e01-7043d1947e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_318b66ff-8daf-4a1f-9072-ffbd3bee81dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2377a487-65dd-4e9a-a6c8-6bcb8b8ac8c8" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_318b66ff-8daf-4a1f-9072-ffbd3bee81dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_f770bc74-f055-4e84-8a23-897bc5ae6028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2377a487-65dd-4e9a-a6c8-6bcb8b8ac8c8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_f770bc74-f055-4e84-8a23-897bc5ae6028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e621220f-5dbd-4d88-be2c-22a15283beb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_f770bc74-f055-4e84-8a23-897bc5ae6028" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_e621220f-5dbd-4d88-be2c-22a15283beb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6476478b-6de7-4a15-b26c-ce83a8e71601" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract_f770bc74-f055-4e84-8a23-897bc5ae6028" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_6476478b-6de7-4a15-b26c-ce83a8e71601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_b2fcd0ea-d222-48e9-be8c-2465a0449ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2377a487-65dd-4e9a-a6c8-6bcb8b8ac8c8" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_b2fcd0ea-d222-48e9-be8c-2465a0449ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_87b3e9c8-918d-41d9-b21a-89dea95b48ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2377a487-65dd-4e9a-a6c8-6bcb8b8ac8c8" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_87b3e9c8-918d-41d9-b21a-89dea95b48ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7fd00745-50e5-4e65-9f0d-ecbd33851fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2377a487-65dd-4e9a-a6c8-6bcb8b8ac8c8" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7fd00745-50e5-4e65-9f0d-ecbd33851fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c086c794-5b40-4cd2-82f2-e316d13cbed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2377a487-65dd-4e9a-a6c8-6bcb8b8ac8c8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c086c794-5b40-4cd2-82f2-e316d13cbed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f77676f3-11de-4651-8ded-53ecf3c16d8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_991d1947-b483-4389-a305-85641a0c9fb5" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f77676f3-11de-4651-8ded-53ecf3c16d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ce4c7b57-e8d9-44b8-801f-31e6e3641496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_991d1947-b483-4389-a305-85641a0c9fb5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ce4c7b57-e8d9-44b8-801f-31e6e3641496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_acc93b4a-f86a-4b27-9362-5605534191e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_991d1947-b483-4389-a305-85641a0c9fb5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_acc93b4a-f86a-4b27-9362-5605534191e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3ff5b712-e28f-4805-963a-8568d264aaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_991d1947-b483-4389-a305-85641a0c9fb5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3ff5b712-e28f-4805-963a-8568d264aaa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_ea1ff723-f116-4a89-bb35-a19fa7b0c732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_991d1947-b483-4389-a305-85641a0c9fb5" xlink:to="loc_us-gaap_RestrictedCashCurrent_ea1ff723-f116-4a89-bb35-a19fa7b0c732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e3732aaa-38fa-44ea-b40f-67399b8843ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_991d1947-b483-4389-a305-85641a0c9fb5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e3732aaa-38fa-44ea-b40f-67399b8843ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="mck-20210630.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ed97e9e7-1210-4193-9397-8503d38a1882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_47bc7923-d435-4501-ae64-efbb678087c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed97e9e7-1210-4193-9397-8503d38a1882" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_47bc7923-d435-4501-ae64-efbb678087c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="mck-20210630.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_78b390c9-4f50-497b-8a8a-7a749cb6b78f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_2757ee9f-f286-400b-9c72-e48099ba92ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78b390c9-4f50-497b-8a8a-7a749cb6b78f" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_2757ee9f-f286-400b-9c72-e48099ba92ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_91304e9a-239f-48e3-89f8-074aaa256598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78b390c9-4f50-497b-8a8a-7a749cb6b78f" xlink:to="loc_us-gaap_UseOfEstimates_91304e9a-239f-48e3-89f8-074aaa256598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComparabilityOfPriorYearFinancialData_c9c5980d-773f-4fed-a72f-80c42da8237f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComparabilityOfPriorYearFinancialData"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78b390c9-4f50-497b-8a8a-7a749cb6b78f" xlink:to="loc_us-gaap_ComparabilityOfPriorYearFinancialData_c9c5980d-773f-4fed-a72f-80c42da8237f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_21f9d77f-3364-4ab9-a014-f86d9aa76109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78b390c9-4f50-497b-8a8a-7a749cb6b78f" xlink:to="loc_us-gaap_FiscalPeriod_21f9d77f-3364-4ab9-a014-f86d9aa76109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_395cc5fd-9489-453d-8619-db58e783f039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78b390c9-4f50-497b-8a8a-7a749cb6b78f" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_395cc5fd-9489-453d-8619-db58e783f039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_057da4fc-0fa2-4ecd-b2fd-5c7e0d021510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78b390c9-4f50-497b-8a8a-7a749cb6b78f" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_057da4fc-0fa2-4ecd-b2fd-5c7e0d021510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_HeldForSalePolicyTextBlock_874af104-56cd-408a-8ffb-dccfd78ddc13" xlink:href="mck-20210630.xsd#mck_HeldForSalePolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78b390c9-4f50-497b-8a8a-7a749cb6b78f" xlink:to="loc_mck_HeldForSalePolicyTextBlock_874af104-56cd-408a-8ffb-dccfd78ddc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_6df83a34-27a1-417f-8607-c74c77f8ac18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_78b390c9-4f50-497b-8a8a-7a749cb6b78f" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_6df83a34-27a1-417f-8607-c74c77f8ac18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_44fdfa5a-47c5-4932-b011-c10ec8cc1775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_6e83a7d3-36c8-4ea6-bb76-043522fa7f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44fdfa5a-47c5-4932-b011-c10ec8cc1775" xlink:to="loc_us-gaap_NumberOfReportableSegments_6e83a7d3-36c8-4ea6-bb76-043522fa7f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSale" xlink:type="simple" xlink:href="mck-20210630.xsd#HeldforSale"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSale" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3feba795-3cbc-4266-8fb0-7968f55df19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_c838ad88-0960-4bb6-b722-42840df892b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_3feba795-3cbc-4266-8fb0-7968f55df19d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_c838ad88-0960-4bb6-b722-42840df892b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#HeldforSaleNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HeldforSaleNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_498fc589-ac2e-4c43-9f0f-e898628dd649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_498fc589-ac2e-4c43-9f0f-e898628dd649" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7bd2097e-eeb8-4093-bc0a-10433da3f5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7bd2097e-eeb8-4093-bc0a-10433da3f5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9f0805ed-f896-426b-9aff-765e013c960d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_7bd2097e-eeb8-4093-bc0a-10433da3f5cb" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9f0805ed-f896-426b-9aff-765e013c960d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuropeanBusinessesDisposalGroupMember_4dcd7e8e-9583-4195-884c-a7b8a8ff0ceb" xlink:href="mck-20210630.xsd#mck_EuropeanBusinessesDisposalGroupMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9f0805ed-f896-426b-9aff-765e013c960d" xlink:to="loc_mck_EuropeanBusinessesDisposalGroupMember_4dcd7e8e-9583-4195-884c-a7b8a8ff0ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_0650d8a7-f022-4542-914c-5e4fe2b076e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_0650d8a7-f022-4542-914c-5e4fe2b076e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c9d54ef2-a588-4277-9637-1d4f57bcf649" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_0650d8a7-f022-4542-914c-5e4fe2b076e1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c9d54ef2-a588-4277-9637-1d4f57bcf649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a9d5bb17-8e3c-4166-bb5e-42ed7cfcc65b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_c9d54ef2-a588-4277-9637-1d4f57bcf649" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_a9d5bb17-8e3c-4166-bb5e-42ed7cfcc65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b6c9ccd6-b239-4283-ae96-93d75db544fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b6c9ccd6-b239-4283-ae96-93d75db544fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bd91d7e9-64e8-4dcf-b178-810e780597b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b6c9ccd6-b239-4283-ae96-93d75db544fc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bd91d7e9-64e8-4dcf-b178-810e780597b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ad43c5b1-c8ac-446e-a795-355d22a87636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_bd91d7e9-64e8-4dcf-b178-810e780597b3" xlink:to="loc_us-gaap_SubsequentEventMember_ad43c5b1-c8ac-446e-a795-355d22a87636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0b15d000-72ea-4e5c-bbb0-2b4c4f5577e5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:to="loc_srt_StatementScenarioAxis_0b15d000-72ea-4e5c-bbb0-2b4c4f5577e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_4d135e39-22c4-4ff8-aeb7-1a054c8d8d49" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_0b15d000-72ea-4e5c-bbb0-2b4c4f5577e5" xlink:to="loc_srt_ScenarioUnspecifiedDomain_4d135e39-22c4-4ff8-aeb7-1a054c8d8d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_9f15a187-9a80-4648-9a78-25da343e54dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_4d135e39-22c4-4ff8-aeb7-1a054c8d8d49" xlink:to="loc_srt_ScenarioForecastMember_9f15a187-9a80-4648-9a78-25da343e54dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_ffd2a8ae-b688-4da2-ab6e-04f5c1a91de3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:to="loc_srt_RangeAxis_ffd2a8ae-b688-4da2-ab6e-04f5c1a91de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b6cbc9ea-eb23-427e-82da-de4222e68f7b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_ffd2a8ae-b688-4da2-ab6e-04f5c1a91de3" xlink:to="loc_srt_RangeMember_b6cbc9ea-eb23-427e-82da-de4222e68f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4aa1ad23-ed1d-4456-85f6-5ae5121f4fdf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b6cbc9ea-eb23-427e-82da-de4222e68f7b" xlink:to="loc_srt_MinimumMember_4aa1ad23-ed1d-4456-85f6-5ae5121f4fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c081c888-db08-43ee-8f87-5601c1dc4d45" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b6cbc9ea-eb23-427e-82da-de4222e68f7b" xlink:to="loc_srt_MaximumMember_c081c888-db08-43ee-8f87-5601c1dc4d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_111afe13-89c5-41c5-a98b-e50f5ee7fd59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c90a0815-8173-4d7b-b7c0-a4832ac30d5b" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_111afe13-89c5-41c5-a98b-e50f5ee7fd59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_ea480451-ccf1-40c6-bddd-655aecbfaaff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_111afe13-89c5-41c5-a98b-e50f5ee7fd59" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent_ea480451-ccf1-40c6-bddd-655aecbfaaff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_361cd265-3ff7-437a-9f8e-a4af6bf6582e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_111afe13-89c5-41c5-a98b-e50f5ee7fd59" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_361cd265-3ff7-437a-9f8e-a4af6bf6582e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_f6a98236-232e-4931-ab7c-065a5d82fc6e" xlink:href="mck-20210630.xsd#mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_111afe13-89c5-41c5-a98b-e50f5ee7fd59" xlink:to="loc_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected_f6a98236-232e-4931-ab7c-065a5d82fc6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected_4e54e888-5ddb-46cc-9cb8-0c167ee3d510" xlink:href="mck-20210630.xsd#mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_111afe13-89c5-41c5-a98b-e50f5ee7fd59" xlink:to="loc_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected_4e54e888-5ddb-46cc-9cb8-0c167ee3d510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="simple" xlink:href="mck-20210630.xsd#RestructuringImpairmentandRelatedCharges"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9a27a570-dd1b-43a7-aaa4-8817a2dd7256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_01b2248b-0557-45fb-a4af-de28cefc1b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_9a27a570-dd1b-43a7-aaa4-8817a2dd7256" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_01b2248b-0557-45fb-a4af-de28cefc1b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="simple" xlink:href="mck-20210630.xsd#RestructuringImpairmentandRelatedChargesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_01793c59-1c5e-4508-bbd1-3f7a36eff8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_50ceb998-c20a-4eee-a145-ddd172d1be56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_01793c59-1c5e-4508-bbd1-3f7a36eff8c7" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_50ceb998-c20a-4eee-a145-ddd172d1be56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_62aacff5-f709-4177-8d00-a1f858c59ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_01793c59-1c5e-4508-bbd1-3f7a36eff8c7" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_62aacff5-f709-4177-8d00-a1f858c59ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#RestructuringImpairmentandRelatedChargesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_cde0d849-aab9-4721-90cd-9c27cfb13703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039b1a5c-0d2d-4647-9606-4297df69882c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_cde0d849-aab9-4721-90cd-9c27cfb13703" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039b1a5c-0d2d-4647-9606-4297df69882c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_b70a1f5c-cd7a-4917-b55c-d37d6fdcc698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039b1a5c-0d2d-4647-9606-4297df69882c" xlink:to="loc_us-gaap_RestructuringPlanAxis_b70a1f5c-cd7a-4917-b55c-d37d6fdcc698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_b7ea7013-1e32-4502-8cc0-c597f19a3648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_b70a1f5c-cd7a-4917-b55c-d37d6fdcc698" xlink:to="loc_us-gaap_RestructuringPlanDomain_b7ea7013-1e32-4502-8cc0-c597f19a3648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_c29e2556-cf5f-4591-bedc-656b1b97970c" xlink:href="mck-20210630.xsd#mck_RestructuringPlanRemoteWorkTransitioningMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_b7ea7013-1e32-4502-8cc0-c597f19a3648" xlink:to="loc_mck_RestructuringPlanRemoteWorkTransitioningMember_c29e2556-cf5f-4591-bedc-656b1b97970c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d79eaf9c-448a-4b8a-b2d0-e57fc3f4784d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039b1a5c-0d2d-4647-9606-4297df69882c" xlink:to="loc_srt_RangeAxis_d79eaf9c-448a-4b8a-b2d0-e57fc3f4784d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_161f6081-b9fc-42f2-af7c-96b07fc8085e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d79eaf9c-448a-4b8a-b2d0-e57fc3f4784d" xlink:to="loc_srt_RangeMember_161f6081-b9fc-42f2-af7c-96b07fc8085e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ea19f379-7ca3-4ab7-aae9-c2b3f8b81bf4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_161f6081-b9fc-42f2-af7c-96b07fc8085e" xlink:to="loc_srt_MinimumMember_ea19f379-7ca3-4ab7-aae9-c2b3f8b81bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_db5175e6-1346-4739-a199-1f82e68a651a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_161f6081-b9fc-42f2-af7c-96b07fc8085e" xlink:to="loc_srt_MaximumMember_db5175e6-1346-4739-a199-1f82e68a651a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b0f4c450-d971-4c7d-a899-c9cda0ecacf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039b1a5c-0d2d-4647-9606-4297df69882c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b0f4c450-d971-4c7d-a899-c9cda0ecacf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_287e4c0a-c70a-4427-9d9a-22ed720b5a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b0f4c450-d971-4c7d-a899-c9cda0ecacf1" xlink:to="loc_us-gaap_SegmentDomain_287e4c0a-c70a-4427-9d9a-22ed720b5a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_e25764d1-a73d-4a84-a9de-608cd9098ad1" xlink:href="mck-20210630.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_287e4c0a-c70a-4427-9d9a-22ed720b5a68" xlink:to="loc_mck_InternationalSegmentMember_e25764d1-a73d-4a84-a9de-608cd9098ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_6fa3a6f9-9775-4b19-8b05-6f46b61e3eed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039b1a5c-0d2d-4647-9606-4297df69882c" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_6fa3a6f9-9775-4b19-8b05-6f46b61e3eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_650e0c32-e597-4115-bfca-c1a9049407b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6fa3a6f9-9775-4b19-8b05-6f46b61e3eed" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_650e0c32-e597-4115-bfca-c1a9049407b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_9ee19f9d-294b-418b-b8d6-83db9fa66dcb" xlink:href="mck-20210630.xsd#mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_650e0c32-e597-4115-bfca-c1a9049407b3" xlink:to="loc_mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember_9ee19f9d-294b-418b-b8d6-83db9fa66dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_fe4b943f-ac76-4556-8e16-8f2d16ef2656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_039b1a5c-0d2d-4647-9606-4297df69882c" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_fe4b943f-ac76-4556-8e16-8f2d16ef2656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_5ff47113-a881-457a-a221-383952d4f029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringSettlementAndImpairmentProvisions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fe4b943f-ac76-4556-8e16-8f2d16ef2656" xlink:to="loc_us-gaap_RestructuringSettlementAndImpairmentProvisions_5ff47113-a881-457a-a221-383952d4f029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_15b6f376-8c56-4e1c-a4eb-a41388dde7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fe4b943f-ac76-4556-8e16-8f2d16ef2656" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_15b6f376-8c56-4e1c-a4eb-a41388dde7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_a58a1af5-659e-458a-9ec0-1df123af9993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fe4b943f-ac76-4556-8e16-8f2d16ef2656" xlink:to="loc_us-gaap_RestructuringCharges_a58a1af5-659e-458a-9ec0-1df123af9993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_ace64231-22bf-4338-b1ee-8df787fd3cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_fe4b943f-ac76-4556-8e16-8f2d16ef2656" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_ace64231-22bf-4338-b1ee-8df787fd3cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6f711f65-978f-4c3f-8734-8b222d151956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cbd0421a-819d-4a6e-97bd-c6eb170ca146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6f711f65-978f-4c3f-8734-8b222d151956" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cbd0421a-819d-4a6e-97bd-c6eb170ca146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_269a2014-fa79-4c6f-b46d-803371dfc561" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cbd0421a-819d-4a6e-97bd-c6eb170ca146" xlink:to="loc_srt_ConsolidationItemsAxis_269a2014-fa79-4c6f-b46d-803371dfc561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_ca04e6ce-6b30-4a16-961d-451d3f647cf9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_269a2014-fa79-4c6f-b46d-803371dfc561" xlink:to="loc_srt_ConsolidationItemsDomain_ca04e6ce-6b30-4a16-961d-451d3f647cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9000d320-2c11-43ea-aa66-b67ff68090b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ca04e6ce-6b30-4a16-961d-451d3f647cf9" xlink:to="loc_us-gaap_OperatingSegmentsMember_9000d320-2c11-43ea-aa66-b67ff68090b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_98b8d851-9abb-4b20-8c5b-6d6e6c054472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_ca04e6ce-6b30-4a16-961d-451d3f647cf9" xlink:to="loc_us-gaap_CorporateNonSegmentMember_98b8d851-9abb-4b20-8c5b-6d6e6c054472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_49b8dd07-e1a5-405f-86de-905e07dd3f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cbd0421a-819d-4a6e-97bd-c6eb170ca146" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_49b8dd07-e1a5-405f-86de-905e07dd3f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9148ef7a-702f-4aa3-bf76-5b9dbc010c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_49b8dd07-e1a5-405f-86de-905e07dd3f7b" xlink:to="loc_us-gaap_SegmentDomain_9148ef7a-702f-4aa3-bf76-5b9dbc010c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_8df6beab-0fe0-40e1-87dd-786c8afa3df7" xlink:href="mck-20210630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9148ef7a-702f-4aa3-bf76-5b9dbc010c31" xlink:to="loc_mck_USPharmaceuticalSegmentMember_8df6beab-0fe0-40e1-87dd-786c8afa3df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_c1ff6c28-4fe7-40d6-94fe-109ab1b68422" xlink:href="mck-20210630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9148ef7a-702f-4aa3-bf76-5b9dbc010c31" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_c1ff6c28-4fe7-40d6-94fe-109ab1b68422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_18426ee1-6445-4048-b452-766ed7c01900" xlink:href="mck-20210630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9148ef7a-702f-4aa3-bf76-5b9dbc010c31" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_18426ee1-6445-4048-b452-766ed7c01900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_2e4a83d0-ca38-40bc-80a1-0b80b99a5b9c" xlink:href="mck-20210630.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9148ef7a-702f-4aa3-bf76-5b9dbc010c31" xlink:to="loc_mck_InternationalSegmentMember_2e4a83d0-ca38-40bc-80a1-0b80b99a5b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_3e51caab-5351-4098-913d-270a93cee298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_cbd0421a-819d-4a6e-97bd-c6eb170ca146" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_3e51caab-5351-4098-913d-270a93cee298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_47f7f226-a69a-4997-a36e-8056a2a0a8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3e51caab-5351-4098-913d-270a93cee298" xlink:to="loc_us-gaap_SeveranceCosts1_47f7f226-a69a-4997-a36e-8056a2a0a8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessExitCosts1_7bb84e35-7a20-40b0-978e-0194dde9fd21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessExitCosts1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3e51caab-5351-4098-913d-270a93cee298" xlink:to="loc_us-gaap_BusinessExitCosts1_7bb84e35-7a20-40b0-978e-0194dde9fd21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_f9c27c43-e8fa-4d03-81ed-d73d4600c67b" xlink:href="mck-20210630.xsd#mck_AssetImpairmentChargesIncludingAcceleratedDepreciation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3e51caab-5351-4098-913d-270a93cee298" xlink:to="loc_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation_f9c27c43-e8fa-4d03-81ed-d73d4600c67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_468342c2-130d-442f-8e22-0a1ee5631880" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_3e51caab-5351-4098-913d-270a93cee298" xlink:to="loc_us-gaap_RestructuringCharges_468342c2-130d-442f-8e22-0a1ee5631880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5bbb4e01-42d4-4308-ba14-1b1d711bdfed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f86fccb-3ab7-4dce-ada4-cbd77a950f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_5bbb4e01-42d4-4308-ba14-1b1d711bdfed" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f86fccb-3ab7-4dce-ada4-cbd77a950f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_76a2e22e-d487-4cab-aa1b-86143addffd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f86fccb-3ab7-4dce-ada4-cbd77a950f6f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_76a2e22e-d487-4cab-aa1b-86143addffd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7cfb9c19-c132-40aa-8c33-ea6c0d33b0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_76a2e22e-d487-4cab-aa1b-86143addffd8" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7cfb9c19-c132-40aa-8c33-ea6c0d33b0b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_77460fcc-df02-4558-9557-8b26c130ea21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7cfb9c19-c132-40aa-8c33-ea6c0d33b0b4" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_77460fcc-df02-4558-9557-8b26c130ea21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_2174c9d9-0342-4a48-b200-368e92148937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7cfb9c19-c132-40aa-8c33-ea6c0d33b0b4" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_2174c9d9-0342-4a48-b200-368e92148937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8bacbac5-2f03-4705-b212-6533b945472b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f86fccb-3ab7-4dce-ada4-cbd77a950f6f" xlink:to="loc_srt_ConsolidationItemsAxis_8bacbac5-2f03-4705-b212-6533b945472b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d2163ee0-d930-49a0-b2be-f7c1199c057f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_8bacbac5-2f03-4705-b212-6533b945472b" xlink:to="loc_srt_ConsolidationItemsDomain_d2163ee0-d930-49a0-b2be-f7c1199c057f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_1bc4ba45-697e-491b-9574-23d79194ce8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d2163ee0-d930-49a0-b2be-f7c1199c057f" xlink:to="loc_us-gaap_OperatingSegmentsMember_1bc4ba45-697e-491b-9574-23d79194ce8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_515365e8-f11a-47c2-86e2-cc25df452c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d2163ee0-d930-49a0-b2be-f7c1199c057f" xlink:to="loc_us-gaap_CorporateNonSegmentMember_515365e8-f11a-47c2-86e2-cc25df452c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d0f64969-e47d-4dd8-9701-b3dd6b2e2508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f86fccb-3ab7-4dce-ada4-cbd77a950f6f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d0f64969-e47d-4dd8-9701-b3dd6b2e2508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_43937a96-fde3-447e-9668-057034918580" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d0f64969-e47d-4dd8-9701-b3dd6b2e2508" xlink:to="loc_us-gaap_SegmentDomain_43937a96-fde3-447e-9668-057034918580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_342ec597-57c9-4c95-84a0-a45ee1be6e13" xlink:href="mck-20210630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_43937a96-fde3-447e-9668-057034918580" xlink:to="loc_mck_USPharmaceuticalSegmentMember_342ec597-57c9-4c95-84a0-a45ee1be6e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_776a8f93-61f7-46dd-a3fc-ac3356508848" xlink:href="mck-20210630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_43937a96-fde3-447e-9668-057034918580" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_776a8f93-61f7-46dd-a3fc-ac3356508848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_b6a09417-a60e-4c9b-bd74-db9869da6472" xlink:href="mck-20210630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_43937a96-fde3-447e-9668-057034918580" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_b6a09417-a60e-4c9b-bd74-db9869da6472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_686b0abd-8284-45a3-af53-6c94247155a1" xlink:href="mck-20210630.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_43937a96-fde3-447e-9668-057034918580" xlink:to="loc_mck_InternationalSegmentMember_686b0abd-8284-45a3-af53-6c94247155a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_0f1b9af7-77e2-4681-8319-f40a9bdd379a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1f86fccb-3ab7-4dce-ada4-cbd77a950f6f" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_0f1b9af7-77e2-4681-8319-f40a9bdd379a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_0f1b9af7-77e2-4681-8319-f40a9bdd379a" xlink:to="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_6fbf23ac-0e7f-4c59-97b7-f7b1f0c705b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:to="loc_us-gaap_RestructuringReserve_6fbf23ac-0e7f-4c59-97b7-f7b1f0c705b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_921a7ec7-4823-4280-bfbd-eb81e46dd407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:to="loc_us-gaap_RestructuringCharges_921a7ec7-4823-4280-bfbd-eb81e46dd407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_dc061506-3518-4f4b-b333-85848d7f8cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_dc061506-3518-4f4b-b333-85848d7f8cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_ddd25081-07ea-40bb-91c3-bfc31a1d263e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:to="loc_us-gaap_PaymentsForRestructuring_ddd25081-07ea-40bb-91c3-bfc31a1d263e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_c3e716c1-a3b5-4b02-8740-33cd5804012d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAndOtherAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:to="loc_us-gaap_RestructuringReserveTranslationAndOtherAdjustment_c3e716c1-a3b5-4b02-8740-33cd5804012d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_5390815d-373b-4788-8955-97e3a0e0d201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_0dedcdfd-5751-491e-b35f-a6160b94c365" xlink:to="loc_us-gaap_RestructuringReserve_5390815d-373b-4788-8955-97e3a0e0d201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mck-20210630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9976b63b-80c7-4c7d-b776-d74be4b9bbb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_6b699b17-f69d-4981-9663-1f903f84d3b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9976b63b-80c7-4c7d-b776-d74be4b9bbb6" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_6b699b17-f69d-4981-9663-1f903f84d3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_eb8a5a50-7209-4312-b554-9f68f07866e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0c282bde-1f98-4b85-abb7-751f8abf3733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb8a5a50-7209-4312-b554-9f68f07866e3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0c282bde-1f98-4b85-abb7-751f8abf3733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4327dcba-763f-49fa-89bd-8381d3d0c57e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb8a5a50-7209-4312-b554-9f68f07866e3" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4327dcba-763f-49fa-89bd-8381d3d0c57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_da30d0f4-df1b-4c71-ac89-a9ee2fbeac2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb8a5a50-7209-4312-b554-9f68f07866e3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_da30d0f4-df1b-4c71-ac89-a9ee2fbeac2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_69532eea-044c-4b7d-b178-de8ad28acb86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb8a5a50-7209-4312-b554-9f68f07866e3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_69532eea-044c-4b7d-b178-de8ad28acb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_12d66764-e510-4bef-9d57-303cf8570e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb8a5a50-7209-4312-b554-9f68f07866e3" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_12d66764-e510-4bef-9d57-303cf8570e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="simple" xlink:href="mck-20210630.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterests"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_80cbaedb-db6a-47f0-9f84-76c13dd1a340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDisclosureTextBlock_694ac198-8f81-418b-bd79-2896fdf2033d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_80cbaedb-db6a-47f0-9f84-76c13dd1a340" xlink:to="loc_us-gaap_MinorityInterestDisclosureTextBlock_694ac198-8f81-418b-bd79-2896fdf2033d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="simple" xlink:href="mck-20210630.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_95d8c5c7-a45e-482e-8977-9252907e1572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_aa5888d5-012b-40ab-b8a9-fce8656ea792" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_95d8c5c7-a45e-482e-8977-9252907e1572" xlink:to="loc_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock_aa5888d5-012b-40ab-b8a9-fce8656ea792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_955996f1-e6b4-406e-8fe3-8e934b05e6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_9be63dcb-b9ca-4193-aa25-c0601afb8067" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_955996f1-e6b4-406e-8fe3-8e934b05e6a7" xlink:to="loc_us-gaap_MinorityInterestTable_9be63dcb-b9ca-4193-aa25-c0601afb8067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_14fba01b-0815-4233-b3d3-0b3301f2192d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_9be63dcb-b9ca-4193-aa25-c0601afb8067" xlink:to="loc_srt_OwnershipAxis_14fba01b-0815-4233-b3d3-0b3301f2192d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_3cc28eb0-ac19-4445-a790-63b55284cbf7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_14fba01b-0815-4233-b3d3-0b3301f2192d" xlink:to="loc_srt_OwnershipDomain_3cc28eb0-ac19-4445-a790-63b55284cbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_f10d958b-74ee-4eda-9c29-1acb57c404dc" xlink:href="mck-20210630.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_3cc28eb0-ac19-4445-a790-63b55284cbf7" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_f10d958b-74ee-4eda-9c29-1acb57c404dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_VantageandClarusOneSourcingServicesLLCMember_c2381915-91de-4ea2-bdfb-d2d9607a5a3d" xlink:href="mck-20210630.xsd#mck_VantageandClarusOneSourcingServicesLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_3cc28eb0-ac19-4445-a790-63b55284cbf7" xlink:to="loc_mck_VantageandClarusOneSourcingServicesLLCMember_c2381915-91de-4ea2-bdfb-d2d9607a5a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d4763e08-245e-4ef7-99fe-12d424848f99" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_9be63dcb-b9ca-4193-aa25-c0601afb8067" xlink:to="loc_dei_LegalEntityAxis_d4763e08-245e-4ef7-99fe-12d424848f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_89fb4597-916f-481f-b22f-7b897af7f528" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_d4763e08-245e-4ef7-99fe-12d424848f99" xlink:to="loc_dei_EntityDomain_89fb4597-916f-481f-b22f-7b897af7f528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MckessonEuropeSubsidiaryMember_7267da98-f5e8-4104-9958-714d7eced7fe" xlink:href="mck-20210630.xsd#mck_MckessonEuropeSubsidiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_89fb4597-916f-481f-b22f-7b897af7f528" xlink:to="loc_mck_MckessonEuropeSubsidiaryMember_7267da98-f5e8-4104-9958-714d7eced7fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c9e1daf3-7842-49d6-8ec6-c4df507124b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_9be63dcb-b9ca-4193-aa25-c0601afb8067" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c9e1daf3-7842-49d6-8ec6-c4df507124b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4247ff8c-8648-4a34-bdcf-ce2565a8586c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c9e1daf3-7842-49d6-8ec6-c4df507124b4" xlink:to="loc_us-gaap_EquityComponentDomain_4247ff8c-8648-4a34-bdcf-ce2565a8586c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_e1f16adb-c72f-4268-bf71-2270c485df61" xlink:href="mck-20210630.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4247ff8c-8648-4a34-bdcf-ce2565a8586c" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_e1f16adb-c72f-4268-bf71-2270c485df61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_53fe1856-8afe-4b2f-b4d5-82836387e021" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4247ff8c-8648-4a34-bdcf-ce2565a8586c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_53fe1856-8afe-4b2f-b4d5-82836387e021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_9be63dcb-b9ca-4193-aa25-c0601afb8067" xlink:to="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_8cc78358-2b1b-4b81-89be-39c476ae1c93" xlink:href="mck-20210630.xsd#mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests_8cc78358-2b1b-4b81-89be-39c476ae1c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_32803e48-a451-47f9-9470-ee5c7d859fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_32803e48-a451-47f9-9470-ee5c7d859fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePrice_e8c88808-6f7e-48d4-afda-ee5ca97b07bf" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestsPutRightExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePrice_e8c88808-6f7e-48d4-afda-ee5ca97b07bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PutRightValueInterestRateSpread_10bd6ae1-9e86-4cee-a36f-aa51bd6e2750" xlink:href="mck-20210630.xsd#mck_PutRightValueInterestRateSpread"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_PutRightValueInterestRateSpread_10bd6ae1-9e86-4cee-a36f-aa51bd6e2750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_6340a67e-91dd-4fbe-bee1-e1d4ed6e1bf0" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestsPutRightExercisePriceIncrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_NoncontrollingInterestsPutRightExercisePriceIncrease_6340a67e-91dd-4fbe-bee1-e1d4ed6e1bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_ffcd6226-cc14-4545-80a6-08f9af78b2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest_ffcd6226-cc14-4545-80a6-08f9af78b2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_40df4a01-4cc4-49e6-81a0-7cbeb75147f5" xlink:href="mck-20210630.xsd#mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased_40df4a01-4cc4-49e6-81a0-7cbeb75147f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_f03d04be-9cb8-4d00-9195-722a456d4ffe" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_f03d04be-9cb8-4d00-9195-722a456d4ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_389940a4-e5c2-43f4-a52c-f5b58edbd5bc" xlink:href="mck-20210630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_389940a4-e5c2-43f4-a52c-f5b58edbd5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_1f2185dd-f89d-427a-a66d-d3d6cf9d03ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_1f2185dd-f89d-427a-a66d-d3d6cf9d03ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_57578eef-a2a8-4f5f-aaef-a57e5243ae66" xlink:href="mck-20210630.xsd#mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue_57578eef-a2a8-4f5f-aaef-a57e5243ae66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_27487cd5-9e03-4e2a-bfe8-a38507f4e786" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_27487cd5-9e03-4e2a-bfe8-a38507f4e786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_40768d13-af36-4ff8-bce4-313a68c5d1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_05166d26-0c46-4920-b4b4-61ef1c26fa23" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_40768d13-af36-4ff8-bce4-313a68c5d1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestAbstract_0ccecb5e-0a35-430d-b88d-e67b625e249d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestTable_7c36a2ed-deea-45b3-b774-8674d801d254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestAbstract_0ccecb5e-0a35-430d-b88d-e67b625e249d" xlink:to="loc_us-gaap_MinorityInterestTable_7c36a2ed-deea-45b3-b774-8674d801d254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_05d88dda-6517-413b-a1f1-0f8c438ff65d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_7c36a2ed-deea-45b3-b774-8674d801d254" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_05d88dda-6517-413b-a1f1-0f8c438ff65d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2c52b40c-d66b-4fed-bb1f-f1f703c7262a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_05d88dda-6517-413b-a1f1-0f8c438ff65d" xlink:to="loc_us-gaap_EquityComponentDomain_2c52b40c-d66b-4fed-bb1f-f1f703c7262a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_872131ee-cc75-4235-9ec4-c924a159241f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2c52b40c-d66b-4fed-bb1f-f1f703c7262a" xlink:to="loc_us-gaap_NoncontrollingInterestMember_872131ee-cc75-4235-9ec4-c924a159241f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RedeemableNoncontrollingInterestMember_8f57d551-c8ab-40ac-9535-48a7b1f7c885" xlink:href="mck-20210630.xsd#mck_RedeemableNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2c52b40c-d66b-4fed-bb1f-f1f703c7262a" xlink:to="loc_mck_RedeemableNoncontrollingInterestMember_8f57d551-c8ab-40ac-9535-48a7b1f7c885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestLineItems_3d41b341-ac42-4540-964c-25a66f31387a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestTable_7c36a2ed-deea-45b3-b774-8674d801d254" xlink:to="loc_us-gaap_MinorityInterestLineItems_3d41b341-ac42-4540-964c-25a66f31387a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MovementInMinorityInterestRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3d41b341-ac42-4540-964c-25a66f31387a" xlink:to="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_4e7e8552-0d50-4914-945e-dc34098da07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:to="loc_us-gaap_MinorityInterest_4e7e8552-0d50-4914-945e-dc34098da07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0f82f224-2948-4a92-b6af-4b15e50ccb76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0f82f224-2948-4a92-b6af-4b15e50ccb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2062d99e-5b25-4a00-bc47-a2142e6f95c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_2062d99e-5b25-4a00-bc47-a2142e6f95c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c440392a-12ed-4259-91e5-c3537518b038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_c440392a-12ed-4259-91e5-c3537518b038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_f0cb7401-9fd9-46b6-b883-773c525bce71" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_f0cb7401-9fd9-46b6-b883-773c525bce71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f1db2cac-4e64-4ecd-9b9e-12bc5b27d7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInMinorityInterestRollForward_f31005a0-0928-4e84-b77c-80e8e07c56f8" xlink:to="loc_us-gaap_MinorityInterest_f1db2cac-4e64-4ecd-9b9e-12bc5b27d7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestLineItems_3d41b341-ac42-4540-964c-25a66f31387a" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_afc1e25e-6190-4be3-9843-2b4eb4e57df3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_afc1e25e-6190-4be3-9843-2b4eb4e57df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_8d65a123-c095-453f-bb0c-6d5697bd73a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest_8d65a123-c095-453f-bb0c-6d5697bd73a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_275cd3b7-50ad-4821-9564-77bab3be275c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_275cd3b7-50ad-4821-9564-77bab3be275c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationofTemporaryEquitytoLiability_06a02cf3-d8ea-4b1a-827d-151160315cc7" xlink:href="mck-20210630.xsd#mck_ReclassificationofTemporaryEquitytoLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_mck_ReclassificationofTemporaryEquitytoLiability_06a02cf3-d8ea-4b1a-827d-151160315cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_22d34efc-9af0-4136-a5c4-0e6826f27841" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_22d34efc-9af0-4136-a5c4-0e6826f27841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_9cf387d9-a5eb-425e-a421-1bb63719d8c4" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestDecreaseForExerciseOfPutRight"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight_9cf387d9-a5eb-425e-a421-1bb63719d8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_9456cd45-2e01-40ee-8a11-bbcb3bfeec43" xlink:href="mck-20210630.xsd#mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest_9456cd45-2e01-40ee-8a11-bbcb3bfeec43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_153f1b1d-3ebf-4cca-b749-43725ae1d125" xlink:href="mck-20210630.xsd#mck_NoncontrollingInterestIncreaseDecreaseDuetoOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther_153f1b1d-3ebf-4cca-b749-43725ae1d125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_d1fad93e-3102-49d4-9a04-0c0ace517534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_6be34afe-f063-4fa3-b772-452b06523859" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount_d1fad93e-3102-49d4-9a04-0c0ace517534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="simple" xlink:href="mck-20210630.xsd#EarningsLossPerCommonShare"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a13c976b-6ca8-4c2a-a90f-06719292cc70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_a97c848c-bc48-4e38-9410-f17bdf4a37cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a13c976b-6ca8-4c2a-a90f-06719292cc70" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_a97c848c-bc48-4e38-9410-f17bdf4a37cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="simple" xlink:href="mck-20210630.xsd#EarningsLossPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2782773b-b838-4013-a18e-5f00f9f01a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_32d1d307-80d0-45ed-b3b1-4514f38f0475" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2782773b-b838-4013-a18e-5f00f9f01a46" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_32d1d307-80d0-45ed-b3b1-4514f38f0475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#EarningsLossPerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/EarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2360238c-bcd3-4113-bb4b-f1d1e80fb773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_953a5382-32d9-4967-a42b-2d3847f73622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2360238c-bcd3-4113-bb4b-f1d1e80fb773" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_953a5382-32d9-4967-a42b-2d3847f73622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_82993dda-ddc2-4584-9439-d7e0727f462e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_953a5382-32d9-4967-a42b-2d3847f73622" xlink:to="loc_us-gaap_AwardTypeAxis_82993dda-ddc2-4584-9439-d7e0727f462e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d48ce2d5-861e-41f6-ad78-192e68254a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_82993dda-ddc2-4584-9439-d7e0727f462e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d48ce2d5-861e-41f6-ad78-192e68254a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_19a28b23-024e-407e-acd7-b408d4cb2ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d48ce2d5-861e-41f6-ad78-192e68254a63" xlink:to="loc_us-gaap_EmployeeStockOptionMember_19a28b23-024e-407e-acd7-b408d4cb2ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d6f15929-12f7-4b67-b12f-7c29fb118710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d48ce2d5-861e-41f6-ad78-192e68254a63" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d6f15929-12f7-4b67-b12f-7c29fb118710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_953a5382-32d9-4967-a42b-2d3847f73622" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_734779fe-f5fe-441c-a918-c6cc776bdcd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_734779fe-f5fe-441c-a918-c6cc776bdcd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_34e4dfb9-db4e-4963-b58e-6dc103549332" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_34e4dfb9-db4e-4963-b58e-6dc103549332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_d9d31281-89ce-4494-b8d6-34aec8185cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_d9d31281-89ce-4494-b8d6-34aec8185cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_988aaa76-9923-47c7-9455-960fea523989" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_988aaa76-9923-47c7-9455-960fea523989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_254edab6-9353-475a-8ccc-5bce8fe0c27a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_NetIncomeLoss_254edab6-9353-475a-8ccc-5bce8fe0c27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9a972f1d-9124-4abe-991e-0dc29aed9390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9a972f1d-9124-4abe-991e-0dc29aed9390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_60eb258f-3d9a-451a-88da-550940fc2cda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9a972f1d-9124-4abe-991e-0dc29aed9390" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_60eb258f-3d9a-451a-88da-550940fc2cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_fc19b5e0-0df9-4e72-bf2d-1f42742d66c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9a972f1d-9124-4abe-991e-0dc29aed9390" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_fc19b5e0-0df9-4e72-bf2d-1f42742d66c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_49d2dc3b-2342-4477-811e-4854cef5be65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_fc19b5e0-0df9-4e72-bf2d-1f42742d66c2" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_49d2dc3b-2342-4477-811e-4854cef5be65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06652fa9-8115-4a39-b65b-54ac314ec274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_9a972f1d-9124-4abe-991e-0dc29aed9390" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06652fa9-8115-4a39-b65b-54ac314ec274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cc527933-1649-4f94-8ebd-dae83d701e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cc527933-1649-4f94-8ebd-dae83d701e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_cec4dca7-3083-4c6c-9298-8ceadc9a314c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cc527933-1649-4f94-8ebd-dae83d701e8b" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_cec4dca7-3083-4c6c-9298-8ceadc9a314c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_ba68639a-14ec-4680-9d57-7041d2fd336d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_cec4dca7-3083-4c6c-9298-8ceadc9a314c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_ba68639a-14ec-4680-9d57-7041d2fd336d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_291016de-78bc-4deb-89dd-2b68c5c87639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_cec4dca7-3083-4c6c-9298-8ceadc9a314c" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_291016de-78bc-4deb-89dd-2b68c5c87639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_714faaf0-50d5-496d-bdbc-53d01411e305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_cec4dca7-3083-4c6c-9298-8ceadc9a314c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_714faaf0-50d5-496d-bdbc-53d01411e305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_b262568c-937a-4e9f-a24c-84cbd632d1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_cc527933-1649-4f94-8ebd-dae83d701e8b" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_b262568c-937a-4e9f-a24c-84cbd632d1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_28bf1d31-ccad-4f04-888f-e510ce4a299e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b262568c-937a-4e9f-a24c-84cbd632d1dc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_28bf1d31-ccad-4f04-888f-e510ce4a299e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_b53322dd-63d4-4e2c-96c8-abec189f8aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b262568c-937a-4e9f-a24c-84cbd632d1dc" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_b53322dd-63d4-4e2c-96c8-abec189f8aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6610cb2d-c9d8-497f-b9cc-2b335436f5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b262568c-937a-4e9f-a24c-84cbd632d1dc" xlink:to="loc_us-gaap_EarningsPerShareBasic_6610cb2d-c9d8-497f-b9cc-2b335436f5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_83faa119-c023-4ad0-9952-e601bbaa3e04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_ea808269-d0ad-4a94-8779-1dd87703c002" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_83faa119-c023-4ad0-9952-e601bbaa3e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="simple" xlink:href="mck-20210630.xsd#GoodwillandIntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b95dc7de-d5bf-4faa-b305-11b8aa9521dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_dc3cc6ec-a5b0-4e8b-95f0-99979b28bcf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b95dc7de-d5bf-4faa-b305-11b8aa9521dd" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_dc3cc6ec-a5b0-4e8b-95f0-99979b28bcf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="simple" xlink:href="mck-20210630.xsd#GoodwillandIntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_28075471-913c-4f98-81d0-6113c4375387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_6bfd3a9f-0636-40d8-97e8-a58bed27ae06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_28075471-913c-4f98-81d0-6113c4375387" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_6bfd3a9f-0636-40d8-97e8-a58bed27ae06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_ca52eb75-5f1d-4225-822c-45abec8be09b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_28075471-913c-4f98-81d0-6113c4375387" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_ca52eb75-5f1d-4225-822c-45abec8be09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5a6c179-9c19-4910-a230-9f12913c2745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_691b26f3-1c85-4853-ad1d-b5be58108778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d5a6c179-9c19-4910-a230-9f12913c2745" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_691b26f3-1c85-4853-ad1d-b5be58108778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_65d9a69a-76f9-4a25-bc99-db9ba4aa9fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_691b26f3-1c85-4853-ad1d-b5be58108778" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_65d9a69a-76f9-4a25-bc99-db9ba4aa9fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d25be56-d967-4e4b-bb46-ee1b7cef364d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_65d9a69a-76f9-4a25-bc99-db9ba4aa9fc9" xlink:to="loc_us-gaap_SegmentDomain_0d25be56-d967-4e4b-bb46-ee1b7cef364d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_e78c4c1b-a145-47ef-a6a6-043dad9940f9" xlink:href="mck-20210630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d25be56-d967-4e4b-bb46-ee1b7cef364d" xlink:to="loc_mck_USPharmaceuticalSegmentMember_e78c4c1b-a145-47ef-a6a6-043dad9940f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_1dcd3e04-563c-4ec3-a69b-ea2480fca258" xlink:href="mck-20210630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d25be56-d967-4e4b-bb46-ee1b7cef364d" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_1dcd3e04-563c-4ec3-a69b-ea2480fca258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_5062777c-def5-45a3-be15-1dcdd0fe5cdc" xlink:href="mck-20210630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d25be56-d967-4e4b-bb46-ee1b7cef364d" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_5062777c-def5-45a3-be15-1dcdd0fe5cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_bc4525c9-af18-4bf9-8cb0-52dcd980a832" xlink:href="mck-20210630.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d25be56-d967-4e4b-bb46-ee1b7cef364d" xlink:to="loc_mck_InternationalSegmentMember_bc4525c9-af18-4bf9-8cb0-52dcd980a832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_9b376b93-ce9e-4176-ab5b-fc31b28f68ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_691b26f3-1c85-4853-ad1d-b5be58108778" xlink:to="loc_us-gaap_GoodwillLineItems_9b376b93-ce9e-4176-ab5b-fc31b28f68ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_f598e516-616a-4ffa-a133-a69c17403579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9b376b93-ce9e-4176-ab5b-fc31b28f68ba" xlink:to="loc_us-gaap_GoodwillRollForward_f598e516-616a-4ffa-a133-a69c17403579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_960d9407-cea6-4540-8c86-1146e7ae42b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f598e516-616a-4ffa-a133-a69c17403579" xlink:to="loc_us-gaap_Goodwill_960d9407-cea6-4540-8c86-1146e7ae42b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0b1b162d-a1f5-48a3-8be8-f293063736bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f598e516-616a-4ffa-a133-a69c17403579" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_0b1b162d-a1f5-48a3-8be8-f293063736bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8e5a500c-3ca1-42c2-8167-57beda6b5561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f598e516-616a-4ffa-a133-a69c17403579" xlink:to="loc_us-gaap_Goodwill_8e5a500c-3ca1-42c2-8167-57beda6b5561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3a3d1f71-b8b6-44b0-abbd-820915786d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_47f51b06-6c60-4439-a737-88e4f489cb39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_3a3d1f71-b8b6-44b0-abbd-820915786d36" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_47f51b06-6c60-4439-a737-88e4f489cb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82dbb9eb-f3bb-4e6b-9f77-804dae300ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_47f51b06-6c60-4439-a737-88e4f489cb39" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82dbb9eb-f3bb-4e6b-9f77-804dae300ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_82dbb9eb-f3bb-4e6b-9f77-804dae300ce2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_124ecb48-84b5-4879-ac4b-1ab093b80dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_124ecb48-84b5-4879-ac4b-1ab093b80dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceAgreementsMember_d6a42d7b-4a49-45a6-a9f4-765bba9fb2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:to="loc_us-gaap_ServiceAgreementsMember_d6a42d7b-4a49-45a6-a9f4-765bba9fb2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PharmacyLicensesMember_ae7e09d1-5dfc-46f9-89d7-908b9fecb062" xlink:href="mck-20210630.xsd#mck_PharmacyLicensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:to="loc_mck_PharmacyLicensesMember_ae7e09d1-5dfc-46f9-89d7-908b9fecb062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_4d9214d5-6584-459a-9441-7cb777c816aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_4d9214d5-6584-459a-9441-7cb777c816aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_97c5059a-b021-41a3-81a0-4dbded0663d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_97c5059a-b021-41a3-81a0-4dbded0663d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_352d4235-6ffa-4a8e-856a-4f74cbc160e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32694bd2-ec6e-4f34-9e66-8b5bfc453ff1" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_352d4235-6ffa-4a8e-856a-4f74cbc160e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_044a5243-4a8c-4205-8627-15e68f292427" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_47f51b06-6c60-4439-a737-88e4f489cb39" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_044a5243-4a8c-4205-8627-15e68f292427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_ed693d3f-ae27-4790-9644-48feee340c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_044a5243-4a8c-4205-8627-15e68f292427" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_ed693d3f-ae27-4790-9644-48feee340c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e000e730-04d2-4579-b9ea-07b3db2bcd02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_044a5243-4a8c-4205-8627-15e68f292427" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e000e730-04d2-4579-b9ea-07b3db2bcd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_59e22248-70cb-46a3-9a97-b6a7c20e7a77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_044a5243-4a8c-4205-8627-15e68f292427" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_59e22248-70cb-46a3-9a97-b6a7c20e7a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0c01c9ec-2e93-43fb-98b5-6c0ce81c4ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_044a5243-4a8c-4205-8627-15e68f292427" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0c01c9ec-2e93-43fb-98b5-6c0ce81c4ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5bc34965-4cb5-4418-989b-c122ff9304b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f3e736fc-5450-458e-9e59-ae06c6cf272a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5bc34965-4cb5-4418-989b-c122ff9304b1" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f3e736fc-5450-458e-9e59-ae06c6cf272a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d231786b-2872-48de-9592-a1b1e77d2b88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5bc34965-4cb5-4418-989b-c122ff9304b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d231786b-2872-48de-9592-a1b1e77d2b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_525905f4-4c2c-45c3-9d99-4bbf725f808d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d231786b-2872-48de-9592-a1b1e77d2b88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_525905f4-4c2c-45c3-9d99-4bbf725f808d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f73a1a09-c139-46f8-9b19-9196449eb269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d231786b-2872-48de-9592-a1b1e77d2b88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f73a1a09-c139-46f8-9b19-9196449eb269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fbe2abbb-57c4-4d23-9c5a-29c85952f34e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d231786b-2872-48de-9592-a1b1e77d2b88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fbe2abbb-57c4-4d23-9c5a-29c85952f34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f6de1612-b604-4b60-b0fc-1fd4252361b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d231786b-2872-48de-9592-a1b1e77d2b88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f6de1612-b604-4b60-b0fc-1fd4252361b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_67d53d42-cb6b-425c-9ba2-81d1990eb9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d231786b-2872-48de-9592-a1b1e77d2b88" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_67d53d42-cb6b-425c-9ba2-81d1990eb9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_86aafd30-1de8-41ee-8537-82aa2077b64a" xlink:href="mck-20210630.xsd#mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_d231786b-2872-48de-9592-a1b1e77d2b88" xlink:to="loc_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_86aafd30-1de8-41ee-8537-82aa2077b64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="simple" xlink:href="mck-20210630.xsd#DebtandFinancingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_006ed6be-de1d-4d5b-a9c7-c516994e06ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_4ed2bf21-1084-47e3-9a15-45351c22a1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_006ed6be-de1d-4d5b-a9c7-c516994e06ed" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_4ed2bf21-1084-47e3-9a15-45351c22a1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="simple" xlink:href="mck-20210630.xsd#DebtandFinancingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b2fec6a7-3fc7-4237-9ce4-660f1f186f85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_4b544197-526e-493d-a636-e7749f7a4cc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b2fec6a7-3fc7-4237-9ce4-660f1f186f85" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_4b544197-526e-493d-a636-e7749f7a4cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_3393b0b8-ab18-4ba2-ac0d-1a48b089d171" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2ad55648-d973-435e-8c71-29b1fe1711d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_3393b0b8-ab18-4ba2-ac0d-1a48b089d171" xlink:to="loc_us-gaap_DebtInstrumentTable_2ad55648-d973-435e-8c71-29b1fe1711d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_c8055835-448f-4641-8ccc-d658db8076e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ad55648-d973-435e-8c71-29b1fe1711d0" xlink:to="loc_us-gaap_DebtInstrumentAxis_c8055835-448f-4641-8ccc-d658db8076e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_c8055835-448f-4641-8ccc-d658db8076e6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A270NotesDueDecember152022Member_d898f7dc-2ab9-4cee-b8c3-2ff100552d2a" xlink:href="mck-20210630.xsd#mck_A270NotesDueDecember152022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A270NotesDueDecember152022Member_d898f7dc-2ab9-4cee-b8c3-2ff100552d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_f5778396-bbc1-4b02-b3f9-6081c9d91fb9" xlink:href="mck-20210630.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A285NotesDueMarch152023Member_f5778396-bbc1-4b02-b3f9-6081c9d91fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_7e2a59f6-9ca1-4d98-9473-168fee6323d6" xlink:href="mck-20210630.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A380NotesDueMarch152024Member_7e2a59f6-9ca1-4d98-9473-168fee6323d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A090NotesDueDecember32025Member_220c3959-2261-45b7-a4bf-323431aa8efa" xlink:href="mck-20210630.xsd#mck_A090NotesDueDecember32025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A090NotesDueDecember32025Member_220c3959-2261-45b7-a4bf-323431aa8efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_79e6f206-617b-428c-b584-1c40c9235638" xlink:href="mck-20210630.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_79e6f206-617b-428c-b584-1c40c9235638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_dc7785f1-7990-4714-b456-9fc7e81dcd67" xlink:href="mck-20210630.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A395NotesDueFebruary162028Member_dc7785f1-7990-4714-b456-9fc7e81dcd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_e86980cf-d11e-4cd0-9ccc-976130c38447" xlink:href="mck-20210630.xsd#mck_A475NotesDueMay302029Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A475NotesDueMay302029Member_e86980cf-d11e-4cd0-9ccc-976130c38447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_64eeff6e-d142-4951-8517-bb65da68f4a5" xlink:href="mck-20210630.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A600NotesDueMarch12041Member_64eeff6e-d142-4951-8517-bb65da68f4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_b9a6340c-4019-4dfa-b6bc-d10de502a37c" xlink:href="mck-20210630.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A488NotesDueMarch152044Member_b9a6340c-4019-4dfa-b6bc-d10de502a37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_8ffb2bc9-a09d-4af6-8e5b-a5ddce254daa" xlink:href="mck-20210630.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_8ffb2bc9-a09d-4af6-8e5b-a5ddce254daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A150EuroNotesDueNovember172025Member_ac9c26ee-1829-4051-819a-0b95a2c32451" xlink:href="mck-20210630.xsd#mck_A150EuroNotesDueNovember172025Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A150EuroNotesDueNovember172025Member_ac9c26ee-1829-4051-819a-0b95a2c32451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A163EuroNotesDueOctober302026Member_1740f91c-bbe8-4888-8056-bc622813e64b" xlink:href="mck-20210630.xsd#mck_A163EuroNotesDueOctober302026Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A163EuroNotesDueOctober302026Member_1740f91c-bbe8-4888-8056-bc622813e64b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A313SterlingNotesDueFebruary172029Member_816ef6f2-40be-429f-96fe-4db2ea683517" xlink:href="mck-20210630.xsd#mck_A313SterlingNotesDueFebruary172029Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cc08ccc5-93ba-48a3-a523-80854cdf43b6" xlink:to="loc_mck_A313SterlingNotesDueFebruary172029Member_816ef6f2-40be-429f-96fe-4db2ea683517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0b779fd2-4926-4f27-8e0e-048ae59b0172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ad55648-d973-435e-8c71-29b1fe1711d0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0b779fd2-4926-4f27-8e0e-048ae59b0172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_75b6fd3c-3327-42ca-9818-8442d5c45cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0b779fd2-4926-4f27-8e0e-048ae59b0172" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_75b6fd3c-3327-42ca-9818-8442d5c45cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_85e1c0c5-c438-42b6-8445-f5b33eef8f56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_75b6fd3c-3327-42ca-9818-8442d5c45cfc" xlink:to="loc_us-gaap_LoansPayableMember_85e1c0c5-c438-42b6-8445-f5b33eef8f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2ad55648-d973-435e-8c71-29b1fe1711d0" xlink:to="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_595657b8-48ca-4e91-9e64-93022b60defb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_595657b8-48ca-4e91-9e64-93022b60defb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6adb5bd0-4165-4fb6-b01e-491a8ff7208b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:to="loc_us-gaap_LongTermDebt_6adb5bd0-4165-4fb6-b01e-491a8ff7208b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_72b432af-787a-424b-a23c-b97a6c896dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:to="loc_us-gaap_FinanceLeaseLiability_72b432af-787a-424b-a23c-b97a6c896dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_baf33193-697e-43ca-827b-c7e3735753a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_baf33193-697e-43ca-827b-c7e3735753a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a9b0c0db-2f3e-4e2f-b703-2622c9958453" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a9b0c0db-2f3e-4e2f-b703-2622c9958453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e642f06a-3493-41cd-a967-ba2c4d130faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_22bb007c-6eae-4c71-906f-35ea80990dac" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_e642f06a-3493-41cd-a967-ba2c4d130faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="simple" xlink:href="mck-20210630.xsd#DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#DebtandFinancingActivitiesLongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_738dfed8-e22b-4f2b-bea7-929e27b7be3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e6b84143-34c6-4711-9c5a-eb0c3ee693c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_738dfed8-e22b-4f2b-bea7-929e27b7be3c" xlink:to="loc_us-gaap_DebtInstrumentTable_e6b84143-34c6-4711-9c5a-eb0c3ee693c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4a1fb2de-0d7d-4dc7-a424-9e3f0548d34f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6b84143-34c6-4711-9c5a-eb0c3ee693c7" xlink:to="loc_us-gaap_DebtInstrumentAxis_4a1fb2de-0d7d-4dc7-a424-9e3f0548d34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4a1fb2de-0d7d-4dc7-a424-9e3f0548d34f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A063EuroNotesDueAugust172021Member_6ef7ba6e-3a27-4e8b-9d27-b06520b2ac83" xlink:href="mck-20210630.xsd#mck_A063EuroNotesDueAugust172021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A063EuroNotesDueAugust172021Member_6ef7ba6e-3a27-4e8b-9d27-b06520b2ac83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A285NotesDueMarch152023Member_4260711a-c9a2-4618-9693-18704ba143b0" xlink:href="mck-20210630.xsd#mck_A285NotesDueMarch152023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A285NotesDueMarch152023Member_4260711a-c9a2-4618-9693-18704ba143b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A380NotesDueMarch152024Member_eb198cb1-c42e-44c7-83a2-2e8381e168c6" xlink:href="mck-20210630.xsd#mck_A380NotesDueMarch152024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A380NotesDueMarch152024Member_eb198cb1-c42e-44c7-83a2-2e8381e168c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A765DebenturesDueMarch12027Member_8396730f-4f77-4568-a3ef-8e347b2688a2" xlink:href="mck-20210630.xsd#mck_A765DebenturesDueMarch12027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A765DebenturesDueMarch12027Member_8396730f-4f77-4568-a3ef-8e347b2688a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A395NotesDueFebruary162028Member_dc308933-74f5-444f-9da7-0aa58f79e43e" xlink:href="mck-20210630.xsd#mck_A395NotesDueFebruary162028Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A395NotesDueFebruary162028Member_dc308933-74f5-444f-9da7-0aa58f79e43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A475NotesDueMay302029Member_119c6f56-da41-480d-8859-ad6bb9078b8e" xlink:href="mck-20210630.xsd#mck_A475NotesDueMay302029Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A475NotesDueMay302029Member_119c6f56-da41-480d-8859-ad6bb9078b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A600NotesDueMarch12041Member_9854de8a-2eb2-4943-9964-68557bace7fa" xlink:href="mck-20210630.xsd#mck_A600NotesDueMarch12041Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A600NotesDueMarch12041Member_9854de8a-2eb2-4943-9964-68557bace7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A488NotesDueMarch152044Member_56b259da-1b1e-4cc6-a11f-b2c1bc7887a1" xlink:href="mck-20210630.xsd#mck_A488NotesDueMarch152044Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_A488NotesDueMarch152044Member_56b259da-1b1e-4cc6-a11f-b2c1bc7887a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_TenderOfferNotesMember_bbdd11a3-c867-4ba4-9f6a-86747850528b" xlink:href="mck-20210630.xsd#mck_TenderOfferNotesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0c36dcc2-6947-4a71-ad68-33ad033c5890" xlink:to="loc_mck_TenderOfferNotesMember_bbdd11a3-c867-4ba4-9f6a-86747850528b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_84dad953-3b06-4f08-b462-95f907603876" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6b84143-34c6-4711-9c5a-eb0c3ee693c7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_84dad953-3b06-4f08-b462-95f907603876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f50e4efb-68fc-4a3a-97a6-acbe4a96d156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_84dad953-3b06-4f08-b462-95f907603876" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f50e4efb-68fc-4a3a-97a6-acbe4a96d156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_eda00a71-080f-499e-b0da-1458ff27722a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f50e4efb-68fc-4a3a-97a6-acbe4a96d156" xlink:to="loc_us-gaap_LoansPayableMember_eda00a71-080f-499e-b0da-1458ff27722a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_5400bf10-838a-4423-b49a-590474cfcb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6b84143-34c6-4711-9c5a-eb0c3ee693c7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_5400bf10-838a-4423-b49a-590474cfcb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_aab5f57a-c06c-4b48-8a2f-a7b62ad06483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_5400bf10-838a-4423-b49a-590474cfcb5a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_aab5f57a-c06c-4b48-8a2f-a7b62ad06483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_233080d1-7b0f-4ca4-9c05-33a4aca0e3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_aab5f57a-c06c-4b48-8a2f-a7b62ad06483" xlink:to="loc_us-gaap_SubsequentEventMember_233080d1-7b0f-4ca4-9c05-33a4aca0e3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e6b84143-34c6-4711-9c5a-eb0c3ee693c7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeaseObligations_c285d8f5-0e88-4fde-adee-1deda9e28cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_DebtAndCapitalLeaseObligations_c285d8f5-0e88-4fde-adee-1deda9e28cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_da0c4ec6-a75b-4714-a778-3376dbeee293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_da0c4ec6-a75b-4714-a778-3376dbeee293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c249bc91-c87b-4338-8c1c-112f6529ba74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c249bc91-c87b-4338-8c1c-112f6529ba74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_d61b0662-92ba-4aad-bc61-d1a78dfa3f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_d61b0662-92ba-4aad-bc61-d1a78dfa3f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_dbf6f45d-4413-4b95-ac43-35fb9616d61b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_dbf6f45d-4413-4b95-ac43-35fb9616d61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_740d9017-4d64-4470-a73e-83885b3d67dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_740d9017-4d64-4470-a73e-83885b3d67dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_dbf17d07-4be2-4769-9126-afa6a6240cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a5a31f2-2cc1-4633-8469-0f56f85e41a8" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_dbf17d07-4be2-4769-9126-afa6a6240cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_13bd9d44-f88e-42fd-944f-2aff23985248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_ecd5364d-0cad-455b-8e6d-338d8c0a4980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_13bd9d44-f88e-42fd-944f-2aff23985248" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_ecd5364d-0cad-455b-8e6d-338d8c0a4980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3ce5e35b-7021-4b2b-9cae-59a21eaa7257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ecd5364d-0cad-455b-8e6d-338d8c0a4980" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3ce5e35b-7021-4b2b-9cae-59a21eaa7257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_60ebc12a-c9a3-44b2-99f7-96c7f9c78e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3ce5e35b-7021-4b2b-9cae-59a21eaa7257" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_60ebc12a-c9a3-44b2-99f7-96c7f9c78e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_a4a927aa-9721-40d7-9d22-82c92d001f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_60ebc12a-c9a3-44b2-99f7-96c7f9c78e47" xlink:to="loc_us-gaap_UnsecuredDebtMember_a4a927aa-9721-40d7-9d22-82c92d001f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_013884f7-7d7e-4146-9cc8-ab470272152d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ecd5364d-0cad-455b-8e6d-338d8c0a4980" xlink:to="loc_us-gaap_CreditFacilityAxis_013884f7-7d7e-4146-9cc8-ab470272152d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_002edac8-6b69-4994-887b-79dd56f33280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_013884f7-7d7e-4146-9cc8-ab470272152d" xlink:to="loc_us-gaap_CreditFacilityDomain_002edac8-6b69-4994-887b-79dd56f33280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_66bdfbc2-a998-4145-a027-5a485cdc973f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_002edac8-6b69-4994-887b-79dd56f33280" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_66bdfbc2-a998-4145-a027-5a485cdc973f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_c0c4f439-795f-489d-89b2-c86037619e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_002edac8-6b69-4994-887b-79dd56f33280" xlink:to="loc_us-gaap_LineOfCreditMember_c0c4f439-795f-489d-89b2-c86037619e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6e1f8ff7-980a-4828-b02d-7356f0ddaaac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ecd5364d-0cad-455b-8e6d-338d8c0a4980" xlink:to="loc_us-gaap_DebtInstrumentAxis_6e1f8ff7-980a-4828-b02d-7356f0ddaaac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cd2fda2d-0f2d-464c-9464-629ef36bd665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6e1f8ff7-980a-4828-b02d-7356f0ddaaac" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cd2fda2d-0f2d-464c-9464-629ef36bd665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_d5e14c44-4494-46c9-bfe5-bcbfd5f84800" xlink:href="mck-20210630.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd2fda2d-0f2d-464c-9464-629ef36bd665" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember_d5e14c44-4494-46c9-bfe5-bcbfd5f84800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_a017425d-13a8-4a74-896a-9477d93888aa" xlink:href="mck-20210630.xsd#mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cd2fda2d-0f2d-464c-9464-629ef36bd665" xlink:to="loc_mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember_a017425d-13a8-4a74-896a-9477d93888aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_ecd5364d-0cad-455b-8e6d-338d8c0a4980" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bcfbf509-f163-4df1-98bc-59fb75957849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bcfbf509-f163-4df1-98bc-59fb75957849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_fcda6a90-7d08-4276-8fdf-76843356d455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:to="loc_us-gaap_DebtInstrumentTerm_fcda6a90-7d08-4276-8fdf-76843356d455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_9997bdc3-6c5e-42c8-bc8e-a4c809084e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_9997bdc3-6c5e-42c8-bc8e-a4c809084e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_abe12a66-04e8-446c-9ec1-8fd08c5bd39a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:to="loc_us-gaap_LineOfCredit_abe12a66-04e8-446c-9ec1-8fd08c5bd39a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_0ff60159-7a8a-4a29-96fd-9c17cc84c494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:to="loc_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases_0ff60159-7a8a-4a29-96fd-9c17cc84c494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_53f7427b-7150-4c2e-a9d0-6201ef9f1615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_390b7a5d-59bb-40b8-80dc-168d0bed4f3f" xlink:to="loc_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_53f7427b-7150-4c2e-a9d0-6201ef9f1615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#DebtandFinancingActivitiesCommercialPaperDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c6e3f026-1e89-4bb7-8927-a440caeccab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_05017f30-224a-46c0-90ad-bb6782cfd849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c6e3f026-1e89-4bb7-8927-a440caeccab7" xlink:to="loc_us-gaap_DebtInstrumentTable_05017f30-224a-46c0-90ad-bb6782cfd849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8c78986e-0816-4383-8bde-f2bbb99b437f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_05017f30-224a-46c0-90ad-bb6782cfd849" xlink:to="loc_us-gaap_CreditFacilityAxis_8c78986e-0816-4383-8bde-f2bbb99b437f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1c9b9f62-1981-4ddc-8fb2-e2a31d35e0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_8c78986e-0816-4383-8bde-f2bbb99b437f" xlink:to="loc_us-gaap_CreditFacilityDomain_1c9b9f62-1981-4ddc-8fb2-e2a31d35e0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_8d096cc5-0320-49b6-88fd-23eda09c638f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_1c9b9f62-1981-4ddc-8fb2-e2a31d35e0f1" xlink:to="loc_us-gaap_CommercialPaperMember_8d096cc5-0320-49b6-88fd-23eda09c638f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_0c60871b-d80e-47ed-9820-23e781c0b5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_05017f30-224a-46c0-90ad-bb6782cfd849" xlink:to="loc_us-gaap_DebtInstrumentLineItems_0c60871b-d80e-47ed-9820-23e781c0b5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f1c0b30d-56b3-44bd-90c8-6e9588dba777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c60871b-d80e-47ed-9820-23e781c0b5f1" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f1c0b30d-56b3-44bd-90c8-6e9588dba777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_5f335308-4b7a-4f65-83a7-2be402cf2de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommercialPaper"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c60871b-d80e-47ed-9820-23e781c0b5f1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommercialPaper_5f335308-4b7a-4f65-83a7-2be402cf2de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfCommercialPaper_8365bcfd-632a-4d98-8b16-efdad94951c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfCommercialPaper"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c60871b-d80e-47ed-9820-23e781c0b5f1" xlink:to="loc_us-gaap_RepaymentsOfCommercialPaper_8365bcfd-632a-4d98-8b16-efdad94951c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermCommercialPaperCurrent_0a4329f3-9c5b-4b78-96aa-b4cabcf50f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermCommercialPaperCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_0c60871b-d80e-47ed-9820-23e781c0b5f1" xlink:to="loc_us-gaap_LongTermCommercialPaperCurrent_0a4329f3-9c5b-4b78-96aa-b4cabcf50f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefits" xlink:type="simple" xlink:href="mck-20210630.xsd#PensionBenefits"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cbd47077-38eb-4056-a0f6-6ae5470a5b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_26699c22-38c6-4016-8072-b41d0239e7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cbd47077-38eb-4056-a0f6-6ae5470a5b63" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_26699c22-38c6-4016-8072-b41d0239e7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#PensionBenefitsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/PensionBenefitsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b03504a4-d05b-4f11-92b5-968a6f7c8a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_072b6fcb-6684-4bcb-9456-7326ddc36b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b03504a4-d05b-4f11-92b5-968a6f7c8a7a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_072b6fcb-6684-4bcb-9456-7326ddc36b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b2ac993a-370c-4fa1-aa18-260da7f68959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_072b6fcb-6684-4bcb-9456-7326ddc36b21" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b2ac993a-370c-4fa1-aa18-260da7f68959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_971af3cd-de17-4284-8a55-d15bb9a3e08b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b2ac993a-370c-4fa1-aa18-260da7f68959" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_971af3cd-de17-4284-8a55-d15bb9a3e08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_9f47a247-578d-463f-a970-721fd5a7025c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_971af3cd-de17-4284-8a55-d15bb9a3e08b" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_9f47a247-578d-463f-a970-721fd5a7025c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b0a59e6b-07fa-4066-a459-d1d8e1394047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_072b6fcb-6684-4bcb-9456-7326ddc36b21" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b0a59e6b-07fa-4066-a459-d1d8e1394047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ad8ae12c-7e4e-49fd-9035-0a05fba19075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b0a59e6b-07fa-4066-a459-d1d8e1394047" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_ad8ae12c-7e4e-49fd-9035-0a05fba19075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_576df35a-d1d9-4233-ba5e-6a01c4f9a75e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b0a59e6b-07fa-4066-a459-d1d8e1394047" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_576df35a-d1d9-4233-ba5e-6a01c4f9a75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedPercentage_bf84c66b-444c-49e8-a8e5-b18e1ab580e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b0a59e6b-07fa-4066-a459-d1d8e1394047" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedPercentage_bf84c66b-444c-49e8-a8e5-b18e1ab580e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivities" xlink:type="simple" xlink:href="mck-20210630.xsd#HedgingActivities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_85a12467-98dc-4571-abbc-6115d85145d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_78ff8b23-3c0e-44de-a357-e50f353d1b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_85a12467-98dc-4571-abbc-6115d85145d3" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_78ff8b23-3c0e-44de-a357-e50f353d1b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="simple" xlink:href="mck-20210630.xsd#HedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_aeaf2173-20ac-4e58-823a-d10d60f90a91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_bf69cf62-f701-46b7-b17c-806284babcec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_aeaf2173-20ac-4e58-823a-d10d60f90a91" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_bf69cf62-f701-46b7-b17c-806284babcec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#HedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c3241f2a-f111-485a-937d-6923c7f8bc30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c3241f2a-f111-485a-937d-6923c7f8bc30" xlink:to="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_28c2709d-6f37-46dc-8af9-f6d820131088" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:to="loc_us-gaap_DebtInstrumentAxis_28c2709d-6f37-46dc-8af9-f6d820131088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_576ff542-0e9e-44ba-9006-406dab3a0467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_28c2709d-6f37-46dc-8af9-f6d820131088" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_576ff542-0e9e-44ba-9006-406dab3a0467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_943a89f8-882d-4d79-bc96-765c44e519c6" xlink:href="mck-20210630.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_576ff542-0e9e-44ba-9006-406dab3a0467" xlink:to="loc_mck_EuroDenominatedNotesMember_943a89f8-882d-4d79-bc96-765c44e519c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_993b8e72-e8a2-403f-b785-dcba3b1c4c4d" xlink:href="mck-20210630.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_576ff542-0e9e-44ba-9006-406dab3a0467" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_993b8e72-e8a2-403f-b785-dcba3b1c4c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_A2025NotesMember_931a6585-1673-4e4d-9e99-1f2455a03521" xlink:href="mck-20210630.xsd#mck_A2025NotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_576ff542-0e9e-44ba-9006-406dab3a0467" xlink:to="loc_mck_A2025NotesMember_931a6585-1673-4e4d-9e99-1f2455a03521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6f2e8e49-eeb8-4e70-8c3f-87cf00f52ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6f2e8e49-eeb8-4e70-8c3f-87cf00f52ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c9b99cae-5d5b-447c-930a-d9725685b723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6f2e8e49-eeb8-4e70-8c3f-87cf00f52ec1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c9b99cae-5d5b-447c-930a-d9725685b723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_c89e3db2-8f1f-4bbf-90a4-11711541caf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c9b99cae-5d5b-447c-930a-d9725685b723" xlink:to="loc_us-gaap_LoansPayableMember_c89e3db2-8f1f-4bbf-90a4-11711541caf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1083de15-96f9-4821-8bdb-e5c9850e5c3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1083de15-96f9-4821-8bdb-e5c9850e5c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_f6c20d24-38a7-4ed5-8a1a-2234043bfc2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_1083de15-96f9-4821-8bdb-e5c9850e5c3d" xlink:to="loc_us-gaap_HedgingRelationshipDomain_f6c20d24-38a7-4ed5-8a1a-2234043bfc2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_8e54dbae-db2b-442a-850e-d131b9e576ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f6c20d24-38a7-4ed5-8a1a-2234043bfc2d" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_8e54dbae-db2b-442a-850e-d131b9e576ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_39f90b8f-e98e-4729-8235-5748c8155bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_f6c20d24-38a7-4ed5-8a1a-2234043bfc2d" xlink:to="loc_us-gaap_CashFlowHedgingMember_39f90b8f-e98e-4729-8235-5748c8155bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_31b7e858-a1f9-4402-8b28-f1df1aa3260e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_31b7e858-a1f9-4402-8b28-f1df1aa3260e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2767b2c0-9f59-442a-9bbf-2892c31fa56f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_31b7e858-a1f9-4402-8b28-f1df1aa3260e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2767b2c0-9f59-442a-9bbf-2892c31fa56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_November2018CrossCurrencySwapsMember_f3f57189-46a0-421a-b51d-e02647922536" xlink:href="mck-20210630.xsd#mck_November2018CrossCurrencySwapsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2767b2c0-9f59-442a-9bbf-2892c31fa56f" xlink:to="loc_mck_November2018CrossCurrencySwapsMember_f3f57189-46a0-421a-b51d-e02647922536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_7a9739f1-3021-4308-96e5-909504d76f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2767b2c0-9f59-442a-9bbf-2892c31fa56f" xlink:to="loc_us-gaap_CurrencySwapMember_7a9739f1-3021-4308-96e5-909504d76f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7cf20104-45d1-4677-b94d-cede6d20d9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2767b2c0-9f59-442a-9bbf-2892c31fa56f" xlink:to="loc_us-gaap_InterestRateSwapMember_7cf20104-45d1-4677-b94d-cede6d20d9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_79f786f3-326e-4f0b-9c45-1a5b972756e7" xlink:href="mck-20210630.xsd#mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2767b2c0-9f59-442a-9bbf-2892c31fa56f" xlink:to="loc_mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember_79f786f3-326e-4f0b-9c45-1a5b972756e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0685bb35-d7ba-4835-b268-6926e4ebd71e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:to="loc_us-gaap_HedgingDesignationAxis_0685bb35-d7ba-4835-b268-6926e4ebd71e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_e0c0bdb8-be4c-4537-8f19-3f8f87c65b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_0685bb35-d7ba-4835-b268-6926e4ebd71e" xlink:to="loc_us-gaap_HedgingDesignationDomain_e0c0bdb8-be4c-4537-8f19-3f8f87c65b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_eba05f4b-eff3-4557-becc-1a9f786fde38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_e0c0bdb8-be4c-4537-8f19-3f8f87c65b1d" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_eba05f4b-eff3-4557-becc-1a9f786fde38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_1ab7b0a7-b8ef-43cb-9c20-fa953344bc13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_e0c0bdb8-be4c-4537-8f19-3f8f87c65b1d" xlink:to="loc_us-gaap_NondesignatedMember_1ab7b0a7-b8ef-43cb-9c20-fa953344bc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_fcb74a06-c68f-46f1-883e-8da74987ffc1" xlink:to="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_24b50d7d-3a4d-488c-a2d6-66caeb806eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:to="loc_us-gaap_LongTermDebt_24b50d7d-3a4d-488c-a2d6-66caeb806eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_4210d8ca-52ce-4e74-a43b-8ab86e50b568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_4210d8ca-52ce-4e74-a43b-8ab86e50b568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_23306c6a-56a5-463f-9480-5e95d67fac5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_23306c6a-56a5-463f-9480-5e95d67fac5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_9f01f30a-2b80-4f18-8e5e-bfe6a1538192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_9f01f30a-2b80-4f18-8e5e-bfe6a1538192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_92cc0732-3613-4825-8b38-7cd612871fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:to="loc_us-gaap_DebtInstrumentTerm_92cc0732-3613-4825-8b38-7cd612871fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3ceb0fd6-6017-4724-b64a-f31b5d3563cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_654ec88e-4ad4-4a67-b071-0be360acd5d7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3ceb0fd6-6017-4724-b64a-f31b5d3563cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#HedgingActivitiesDerivativeInstrumentsFairValueDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6c4ca3d7-ca4e-4e04-bb1b-3b67825443e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_001161b4-ac1e-428d-bfc0-3bfb6bb3972c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_6c4ca3d7-ca4e-4e04-bb1b-3b67825443e3" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_001161b4-ac1e-428d-bfc0-3bfb6bb3972c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_a533e9a6-f135-4c18-a253-f13bdc4bbed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_001161b4-ac1e-428d-bfc0-3bfb6bb3972c" xlink:to="loc_us-gaap_HedgingDesignationAxis_a533e9a6-f135-4c18-a253-f13bdc4bbed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_f0d4b603-d779-44ce-b99f-0a0bb892cf3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_a533e9a6-f135-4c18-a253-f13bdc4bbed8" xlink:to="loc_us-gaap_HedgingDesignationDomain_f0d4b603-d779-44ce-b99f-0a0bb892cf3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5258322b-32f9-44f2-8a13-b867e44b897c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f0d4b603-d779-44ce-b99f-0a0bb892cf3f" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_5258322b-32f9-44f2-8a13-b867e44b897c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_5a448f36-924f-4145-acb7-50585fbe8c16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_f0d4b603-d779-44ce-b99f-0a0bb892cf3f" xlink:to="loc_us-gaap_NondesignatedMember_5a448f36-924f-4145-acb7-50585fbe8c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_432e61f5-cc5d-4666-9336-5048e6655b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_001161b4-ac1e-428d-bfc0-3bfb6bb3972c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_432e61f5-cc5d-4666-9336-5048e6655b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1c82f79b-14af-4fa0-bf02-21be0ec0d18d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_432e61f5-cc5d-4666-9336-5048e6655b42" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1c82f79b-14af-4fa0-bf02-21be0ec0d18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrencySwapMember_5d619a9d-1f51-49c3-86ab-c928d80d485f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrencySwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c82f79b-14af-4fa0-bf02-21be0ec0d18d" xlink:to="loc_us-gaap_CurrencySwapMember_5d619a9d-1f51-49c3-86ab-c928d80d485f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ae5c0c65-f1b8-4d4e-b448-cdd074561b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c82f79b-14af-4fa0-bf02-21be0ec0d18d" xlink:to="loc_us-gaap_InterestRateSwapMember_ae5c0c65-f1b8-4d4e-b448-cdd074561b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_e3150c09-1a1f-49e4-ac74-39a359221e14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c82f79b-14af-4fa0-bf02-21be0ec0d18d" xlink:to="loc_us-gaap_ForeignExchangeContractMember_e3150c09-1a1f-49e4-ac74-39a359221e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8f4e5a79-1075-4aee-83b1-c197210536b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_001161b4-ac1e-428d-bfc0-3bfb6bb3972c" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8f4e5a79-1075-4aee-83b1-c197210536b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8f4e5a79-1075-4aee-83b1-c197210536b5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_85fe1d92-b573-467a-ad46-d8661189f536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_85fe1d92-b573-467a-ad46-d8661189f536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_9622be7b-3805-488d-b43d-7ad16807058a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_9622be7b-3805-488d-b43d-7ad16807058a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CurrentAssetLiabilityMember_0e659369-347e-4d16-9de3-dc95f99eb208" xlink:href="mck-20210630.xsd#mck_CurrentAssetLiabilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:to="loc_mck_CurrentAssetLiabilityMember_0e659369-347e-4d16-9de3-dc95f99eb208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_2bcf59f5-02c3-4567-a968-89aaccdd37ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_2bcf59f5-02c3-4567-a968-89aaccdd37ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_bc488615-3b76-49d6-aa93-e8157478f5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_bc488615-3b76-49d6-aa93-e8157478f5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NoncurrentAssetLiabilityMember_f60e39fb-14bb-44cf-8d7c-164ffa59a7da" xlink:href="mck-20210630.xsd#mck_NoncurrentAssetLiabilityMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_eaea349a-472b-4d43-9385-762c8f3a7c34" xlink:to="loc_mck_NoncurrentAssetLiabilityMember_f60e39fb-14bb-44cf-8d7c-164ffa59a7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_6e7f5686-53b9-4495-8d1a-4a99f654618a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_001161b4-ac1e-428d-bfc0-3bfb6bb3972c" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_6e7f5686-53b9-4495-8d1a-4a99f654618a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_96d3ad8a-3c33-4246-a729-332ca629844c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_6e7f5686-53b9-4495-8d1a-4a99f654618a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_96d3ad8a-3c33-4246-a729-332ca629844c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_2e03eb74-18fe-4ec2-b164-b11c547f71e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_6e7f5686-53b9-4495-8d1a-4a99f654618a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_2e03eb74-18fe-4ec2-b164-b11c547f71e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_b5927e69-9011-4306-89ea-23695a517efc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_6e7f5686-53b9-4495-8d1a-4a99f654618a" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_b5927e69-9011-4306-89ea-23695a517efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityNotionalAmount_24d20da1-1262-4a2d-9d29-bd238a7c5fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_6e7f5686-53b9-4495-8d1a-4a99f654618a" xlink:to="loc_us-gaap_DerivativeLiabilityNotionalAmount_24d20da1-1262-4a2d-9d29-bd238a7c5fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="mck-20210630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c9241c6e-b320-4bfa-a94a-ef3b13fa4546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_994d0f86-c5f7-4669-810c-13e15f65c725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c9241c6e-b320-4bfa-a94a-ef3b13fa4546" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_994d0f86-c5f7-4669-810c-13e15f65c725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="mck-20210630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2617c315-b582-4b21-8c41-8e833b79f329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_e7ce6420-1b64-423e-a329-7cad3e21785d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2617c315-b582-4b21-8c41-8e833b79f329" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_e7ce6420-1b64-423e-a329-7cad3e21785d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ce2b5596-d85d-4e86-ac65-171be500debe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_327d5992-b987-490f-aba4-46959e0455ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ce2b5596-d85d-4e86-ac65-171be500debe" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_327d5992-b987-490f-aba4-46959e0455ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_133e1d5d-f98d-453a-bb08-814193841f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_327d5992-b987-490f-aba4-46959e0455ad" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_133e1d5d-f98d-453a-bb08-814193841f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_542d9ae8-66d6-4409-ae3a-db1520e102b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_133e1d5d-f98d-453a-bb08-814193841f96" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_542d9ae8-66d6-4409-ae3a-db1520e102b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_71631aba-1d0b-4522-a0ef-b54cd20424b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_542d9ae8-66d6-4409-ae3a-db1520e102b6" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_71631aba-1d0b-4522-a0ef-b54cd20424b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsNonrecurringMember_f358b8a3-0bd5-4a97-9440-a31dd561c0f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsNonrecurringMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_542d9ae8-66d6-4409-ae3a-db1520e102b6" xlink:to="loc_us-gaap_FairValueMeasurementsNonrecurringMember_f358b8a3-0bd5-4a97-9440-a31dd561c0f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_29f887ce-a564-4e37-904e-a5e6c2c98e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_327d5992-b987-490f-aba4-46959e0455ad" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_29f887ce-a564-4e37-904e-a5e6c2c98e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5de3f82c-2344-4e4f-8f6c-404de7d3f5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_29f887ce-a564-4e37-904e-a5e6c2c98e66" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5de3f82c-2344-4e4f-8f6c-404de7d3f5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fafe064d-fe5e-4f62-9e01-38abcbfac4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5de3f82c-2344-4e4f-8f6c-404de7d3f5c9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fafe064d-fe5e-4f62-9e01-38abcbfac4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_73df711c-08c3-4008-a425-b76886e35721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5de3f82c-2344-4e4f-8f6c-404de7d3f5c9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_73df711c-08c3-4008-a425-b76886e35721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d91462b1-8efc-4b36-8a1c-9b4f7a435c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_327d5992-b987-490f-aba4-46959e0455ad" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d91462b1-8efc-4b36-8a1c-9b4f7a435c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7b138cbe-6310-4ecc-88ae-fa1a9cc8f1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d91462b1-8efc-4b36-8a1c-9b4f7a435c46" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7b138cbe-6310-4ecc-88ae-fa1a9cc8f1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_11849ecd-4fd2-42f7-8ff2-484b422a434b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d91462b1-8efc-4b36-8a1c-9b4f7a435c46" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_11849ecd-4fd2-42f7-8ff2-484b422a434b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4727305c-a603-462c-ac56-ec013fdeca9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d91462b1-8efc-4b36-8a1c-9b4f7a435c46" xlink:to="loc_us-gaap_LongTermDebt_4727305c-a603-462c-ac56-ec013fdeca9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_5c9bb0fe-85fc-4ac6-be49-358243b77745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d91462b1-8efc-4b36-8a1c-9b4f7a435c46" xlink:to="loc_us-gaap_DebtInstrumentFairValue_5c9bb0fe-85fc-4ac6-be49-358243b77745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="simple" xlink:href="mck-20210630.xsd#CommitmentsandContingentLiabilities"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5c96b519-f97b-47c5-9009-f02cb2c47de7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e2a7225e-d95f-428e-a6b9-22c16aa1fa89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5c96b519-f97b-47c5-9009-f02cb2c47de7" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e2a7225e-d95f-428e-a6b9-22c16aa1fa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables" xlink:type="simple" xlink:href="mck-20210630.xsd#CommitmentsandContingentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_44ae8b9b-36fb-4446-ab93-0b6edcc0deb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_54b24dfb-1ba0-45ef-9f53-735cfd4931ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_44ae8b9b-36fb-4446-ab93-0b6edcc0deb1" xlink:to="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_54b24dfb-1ba0-45ef-9f53-735cfd4931ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#CommitmentsandContingentLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_98116a81-1817-413b-aef8-81395cd4cf29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_98116a81-1817-413b-aef8-81395cd4cf29" xlink:to="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_8b7fd866-20da-420e-a6f7-424dc562d7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_us-gaap_LitigationStatusAxis_8b7fd866-20da-420e-a6f7-424dc562d7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_49e7cd73-8ff4-4a1a-ac5a-d3c98a20394b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_8b7fd866-20da-420e-a6f7-424dc562d7dd" xlink:to="loc_us-gaap_LitigationStatusDomain_49e7cd73-8ff4-4a1a-ac5a-d3c98a20394b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_ea04b0f7-9c3a-4f67-b339-90bfe45b98bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_49e7cd73-8ff4-4a1a-ac5a-d3c98a20394b" xlink:to="loc_us-gaap_PendingLitigationMember_ea04b0f7-9c3a-4f67-b339-90bfe45b98bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_410b18bc-6bec-428b-8a97-b35cbb43b7eb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_dei_LegalEntityAxis_410b18bc-6bec-428b-8a97-b35cbb43b7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_15991861-1ad3-46e7-b98e-461564fb7af3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_410b18bc-6bec-428b-8a97-b35cbb43b7eb" xlink:to="loc_dei_EntityDomain_15991861-1ad3-46e7-b98e-461564fb7af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_a6ff4312-d9ff-488f-9082-a1732e604d99" xlink:href="mck-20210630.xsd#mck_ThreeLargestU.S.PharmaceuticalDistributorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_15991861-1ad3-46e7-b98e-461564fb7af3" xlink:to="loc_mck_ThreeLargestU.S.PharmaceuticalDistributorsMember_a6ff4312-d9ff-488f-9082-a1732e604d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_54364607-60ff-4b6a-bb59-3e1a66d3f233" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_srt_StatementGeographicalAxis_54364607-60ff-4b6a-bb59-3e1a66d3f233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1c73ba94-e65e-44a2-94bc-237712b7a27f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_54364607-60ff-4b6a-bb59-3e1a66d3f233" xlink:to="loc_srt_SegmentGeographicalDomain_1c73ba94-e65e-44a2-94bc-237712b7a27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_8a518a2c-c2a6-4ce5-b8ee-aeef32cc8039" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1c73ba94-e65e-44a2-94bc-237712b7a27f" xlink:to="loc_country_CA_8a518a2c-c2a6-4ce5-b8ee-aeef32cc8039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6d45c966-b9e7-498c-b4aa-e8ce94828531" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_srt_LitigationCaseAxis_6d45c966-b9e7-498c-b4aa-e8ce94828531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2e146726-ba46-445c-b09d-75e57975ba2d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_6d45c966-b9e7-498c-b4aa-e8ce94828531" xlink:to="loc_srt_LitigationCaseTypeDomain_2e146726-ba46-445c-b09d-75e57975ba2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_c530b742-ab4e-459b-a42a-813a730c33ce" xlink:href="mck-20210630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_2e146726-ba46-445c-b09d-75e57975ba2d" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_c530b742-ab4e-459b-a42a-813a730c33ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2cbe9821-ae62-4d58-8080-30879ce6e1f7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_srt_RangeAxis_2cbe9821-ae62-4d58-8080-30879ce6e1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_11e99f83-b458-4c26-ade2-3b0201b7eafc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2cbe9821-ae62-4d58-8080-30879ce6e1f7" xlink:to="loc_srt_RangeMember_11e99f83-b458-4c26-ade2-3b0201b7eafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9d2a92f8-f1bc-4dee-b378-924919b4cb73" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_11e99f83-b458-4c26-ade2-3b0201b7eafc" xlink:to="loc_srt_MinimumMember_9d2a92f8-f1bc-4dee-b378-924919b4cb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_71d3f1d7-0b55-415b-b7a1-12c4187fd0c3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_11e99f83-b458-4c26-ade2-3b0201b7eafc" xlink:to="loc_srt_MaximumMember_71d3f1d7-0b55-415b-b7a1-12c4187fd0c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a1765a6f-4566-4aae-aaa6-46a2a0098fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a1765a6f-4566-4aae-aaa6-46a2a0098fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_d30b52a3-9eeb-4db2-b583-177b7304d3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_a1765a6f-4566-4aae-aaa6-46a2a0098fe7" xlink:to="loc_us-gaap_LossContingencyNatureDomain_d30b52a3-9eeb-4db2-b583-177b7304d3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_bd78cba3-e388-4466-8a2e-747513037f36" xlink:href="mck-20210630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_d30b52a3-9eeb-4db2-b583-177b7304d3c4" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_bd78cba3-e388-4466-8a2e-747513037f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOpioidStatutesMember_b78fae6b-16ab-4c4a-ac27-16ebd4e4f6e3" xlink:href="mck-20210630.xsd#mck_StateOpioidStatutesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_d30b52a3-9eeb-4db2-b583-177b7304d3c4" xlink:to="loc_mck_StateOpioidStatutesMember_b78fae6b-16ab-4c4a-ac27-16ebd4e4f6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_afcc5592-421c-4a37-be87-fed7441a4f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_afcc5592-421c-4a37-be87-fed7441a4f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8662acd4-0630-4f50-8d86-2a63a4bf8265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_afcc5592-421c-4a37-be87-fed7441a4f8c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8662acd4-0630-4f50-8d86-2a63a4bf8265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8aae1a68-b358-4d7b-9d47-f2ea2b9746a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8662acd4-0630-4f50-8d86-2a63a4bf8265" xlink:to="loc_us-gaap_SubsequentEventMember_8aae1a68-b358-4d7b-9d47-f2ea2b9746a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_99a468a6-89ed-4a34-9fab-512ce8cdd859" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_srt_StatementScenarioAxis_99a468a6-89ed-4a34-9fab-512ce8cdd859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f3dd82c7-d1b7-4437-95e8-599d575cbce8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_99a468a6-89ed-4a34-9fab-512ce8cdd859" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f3dd82c7-d1b7-4437-95e8-599d575cbce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_31db5c61-9a6b-4e5b-b819-8e43806debac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f3dd82c7-d1b7-4437-95e8-599d575cbce8" xlink:to="loc_srt_ScenarioForecastMember_31db5c61-9a6b-4e5b-b819-8e43806debac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_40d719b0-5a0b-47bd-850c-caa9cba9df91" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_srt_CounterpartyNameAxis_40d719b0-5a0b-47bd-850c-caa9cba9df91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5e422b9-6512-48c5-9d13-a4ae304a8db0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_40d719b0-5a0b-47bd-850c-caa9cba9df91" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5e422b9-6512-48c5-9d13-a4ae304a8db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateOfNewYorkMember_80d45c5e-48ac-465f-a3a3-d198fe7b092c" xlink:href="mck-20210630.xsd#mck_StateOfNewYorkMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5e422b9-6512-48c5-9d13-a4ae304a8db0" xlink:to="loc_mck_StateOfNewYorkMember_80d45c5e-48ac-465f-a3a3-d198fe7b092c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StateAndLocalGovernmentalEntitiesMember_d5230492-aef8-4ec7-89b7-30396036ac13" xlink:href="mck-20210630.xsd#mck_StateAndLocalGovernmentalEntitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5e422b9-6512-48c5-9d13-a4ae304a8db0" xlink:to="loc_mck_StateAndLocalGovernmentalEntitiesMember_d5230492-aef8-4ec7-89b7-30396036ac13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_GovernmentalEntitiesMember_8e0e9872-2950-4778-8078-6d13aa8f9f23" xlink:href="mck-20210630.xsd#mck_GovernmentalEntitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5e422b9-6512-48c5-9d13-a4ae304a8db0" xlink:to="loc_mck_GovernmentalEntitiesMember_8e0e9872-2950-4778-8078-6d13aa8f9f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_IndividualClaimantMember_8babffba-b191-4417-9f2a-5bcec3b895ad" xlink:href="mck-20210630.xsd#mck_IndividualClaimantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d5e422b9-6512-48c5-9d13-a4ae304a8db0" xlink:to="loc_mck_IndividualClaimantMember_8babffba-b191-4417-9f2a-5bcec3b895ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_f0350f69-22b0-404d-a936-570d1886316f" xlink:to="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_8ee13c43-4092-4122-af36-02faca0de473" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_8ee13c43-4092-4122-af36-02faca0de473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_5e9b00ab-b9e5-4bd9-ae93-3433b9e2c193" xlink:href="mck-20210630.xsd#mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts_5e9b00ab-b9e5-4bd9-ae93-3433b9e2c193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStates_211f8d4e-461d-470c-9001-77f07fdea37e" xlink:href="mck-20210630.xsd#mck_LossContingencyNumberofStates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencyNumberofStates_211f8d4e-461d-470c-9001-77f07fdea37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberofStateAttorneyGenerals_a69a9aba-1b0e-48a0-83fa-0d77de6405cd" xlink:href="mck-20210630.xsd#mck_LossContingencyNumberofStateAttorneyGenerals"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencyNumberofStateAttorneyGenerals_a69a9aba-1b0e-48a0-83fa-0d77de6405cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyNumberOfOtherDefendants_1717f187-e476-4ac3-a093-9bebd9a85d44" xlink:href="mck-20210630.xsd#mck_LossContingencyNumberOfOtherDefendants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencyNumberOfOtherDefendants_1717f187-e476-4ac3-a093-9bebd9a85d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfDefendants_9591720d-f248-400a-8ab9-2c5fa784f85f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfDefendants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_us-gaap_LossContingencyNumberOfDefendants_9591720d-f248-400a-8ab9-2c5fa784f85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_cd52e2f3-0a42-4b2b-9fa3-7590ff9947cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_cd52e2f3-0a42-4b2b-9fa3-7590ff9947cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_b9bfe451-7150-492a-a5cb-e0a85003edad" xlink:href="mck-20210630.xsd#mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward_b9bfe451-7150-492a-a5cb-e0a85003edad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_790cf2ee-d043-4ec4-82ee-f0a7bfc65795" xlink:href="mck-20210630.xsd#mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment_790cf2ee-d043-4ec4-82ee-f0a7bfc65795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_4c18711b-ed1f-400d-9a6c-2e38896af06d" xlink:href="mck-20210630.xsd#mck_LossContingencySettlementAgreementAwardPaymentPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencySettlementAgreementAwardPaymentPeriod_4c18711b-ed1f-400d-9a6c-2e38896af06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_0642ae68-19b0-4e21-9e6e-9dbb19a79910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_0642ae68-19b0-4e21-9e6e-9dbb19a79910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a725b7b4-7a14-4dda-87ab-7b57e73637ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_a725b7b4-7a14-4dda-87ab-7b57e73637ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_c77362a4-0b59-4233-9604-e338075e1acc" xlink:href="mck-20210630.xsd#mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax_c77362a4-0b59-4233-9604-e338075e1acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_21b42503-0152-4252-9d6c-9b7c598afa55" xlink:href="mck-20210630.xsd#mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids_21b42503-0152-4252-9d6c-9b7c598afa55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_c39fcc8b-a124-4547-8473-28112541f06e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_c39fcc8b-a124-4547-8473-28112541f06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_LossContingencyAccrualAfterTax_ebb3f4b9-053f-4fc1-8cef-798223194465" xlink:href="mck-20210630.xsd#mck_LossContingencyAccrualAfterTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ac13f32b-aabb-4476-b84c-1e7a440efc65" xlink:to="loc_mck_LossContingencyAccrualAfterTax_ebb3f4b9-053f-4fc1-8cef-798223194465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b83d6a10-0607-4564-a26c-f4a40963adca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d767c119-791b-41a2-9821-8e586696f2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b83d6a10-0607-4564-a26c-f4a40963adca" xlink:to="loc_us-gaap_LossContingenciesTable_d767c119-791b-41a2-9821-8e586696f2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d557f325-1345-4b33-b7ce-31c0ef34fa85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d767c119-791b-41a2-9821-8e586696f2fa" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d557f325-1345-4b33-b7ce-31c0ef34fa85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_faefb52a-9188-49b8-a636-445512fb882c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_d557f325-1345-4b33-b7ce-31c0ef34fa85" xlink:to="loc_us-gaap_LossContingencyNatureDomain_faefb52a-9188-49b8-a636-445512fb882c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_e7ecd868-bcec-4073-b8d2-82abb2e9e24e" xlink:href="mck-20210630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_faefb52a-9188-49b8-a636-445512fb882c" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_e7ecd868-bcec-4073-b8d2-82abb2e9e24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_361f572e-99d3-4c87-8f17-e9094be948f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d767c119-791b-41a2-9821-8e586696f2fa" xlink:to="loc_us-gaap_LossContingenciesLineItems_361f572e-99d3-4c87-8f17-e9094be948f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_d6600a9a-96db-490c-9b2e-dc4e24df13b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_361f572e-99d3-4c87-8f17-e9094be948f4" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueCurrent_d6600a9a-96db-490c-9b2e-dc4e24df13b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_c9b843ee-0bfc-4342-b1a5-012049d26ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValueNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_361f572e-99d3-4c87-8f17-e9094be948f4" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValueNoncurrent_c9b843ee-0bfc-4342-b1a5-012049d26ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7c234973-75c0-4758-a4a3-8c6e02889af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_361f572e-99d3-4c87-8f17-e9094be948f4" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7c234973-75c0-4758-a4a3-8c6e02889af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="simple" xlink:href="mck-20210630.xsd#StockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_9f60219b-3676-46fd-9957-1b579ac50392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2594c21b-3a18-49db-b765-cb764475a6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_9f60219b-3676-46fd-9957-1b579ac50392" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_2594c21b-3a18-49db-b765-cb764475a6a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="simple" xlink:href="mck-20210630.xsd#StockholdersEquityDeficitTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a11a0d47-fced-491f-b459-46c62d340757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_b59f1b93-ef4e-4821-a9e1-74cf0be97616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a11a0d47-fced-491f-b459-46c62d340757" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_b59f1b93-ef4e-4821-a9e1-74cf0be97616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2d989654-95a7-4206-88a7-d7037c0d8361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a11a0d47-fced-491f-b459-46c62d340757" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_2d989654-95a7-4206-88a7-d7037c0d8361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#StockholdersEquityDeficitNarrativeDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2d34bff3-11e0-46b3-b80d-bb48b2256864" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesTable_23a1e721-937e-4b0c-9851-f49654b4a4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2d34bff3-11e0-46b3-b80d-bb48b2256864" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesTable_23a1e721-937e-4b0c-9851-f49654b4a4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_89df3a0a-4132-4fa7-9306-df9c6e608622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_23a1e721-937e-4b0c-9851-f49654b4a4f4" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_89df3a0a-4132-4fa7-9306-df9c6e608622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_9a0d8585-51e6-4c6e-b8f4-0bc1655cfd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_89df3a0a-4132-4fa7-9306-df9c6e608622" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_9a0d8585-51e6-4c6e-b8f4-0bc1655cfd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AcceleratedShareRepurchaseMember_58339447-9fde-4c0d-87ea-d7878c32f2ea" xlink:href="mck-20210630.xsd#mck_AcceleratedShareRepurchaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_9a0d8585-51e6-4c6e-b8f4-0bc1655cfd5d" xlink:to="loc_mck_AcceleratedShareRepurchaseMember_58339447-9fde-4c0d-87ea-d7878c32f2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c1a17678-cac9-430e-9419-1bf1a48fab86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_23a1e721-937e-4b0c-9851-f49654b4a4f4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c1a17678-cac9-430e-9419-1bf1a48fab86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_31582dda-a0c8-46a1-a463-b85fcad55776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c1a17678-cac9-430e-9419-1bf1a48fab86" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_31582dda-a0c8-46a1-a463-b85fcad55776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d59a0a54-0bd3-4d0e-8cdd-0828dfed5296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_31582dda-a0c8-46a1-a463-b85fcad55776" xlink:to="loc_us-gaap_SubsequentEventMember_d59a0a54-0bd3-4d0e-8cdd-0828dfed5296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e270142d-8abd-4126-b2ab-754b20716811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_23a1e721-937e-4b0c-9851-f49654b4a4f4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e270142d-8abd-4126-b2ab-754b20716811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_91b4bd71-4a71-47cb-8c09-6975dcba4371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e270142d-8abd-4126-b2ab-754b20716811" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_91b4bd71-4a71-47cb-8c09-6975dcba4371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_24c59413-d3ba-4106-ae8e-2e1222775d74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_91b4bd71-4a71-47cb-8c09-6975dcba4371" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_24c59413-d3ba-4106-ae8e-2e1222775d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcceleratedShareRepurchasesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesTable_23a1e721-937e-4b0c-9851-f49654b4a4f4" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_158aee70-c617-450d-83c6-bf1dc72aee7e" xlink:href="mck-20210630.xsd#mck_CommonStockVotingRightsNumberofVotesPerCommonShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:to="loc_mck_CommonStockVotingRightsNumberofVotesPerCommonShare_158aee70-c617-450d-83c6-bf1dc72aee7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_f41682a0-3a5f-4600-9883-e693daab8ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_f41682a0-3a5f-4600-9883-e693daab8ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_dc049e77-870e-4f77-bb36-eadf6a797068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_dc049e77-870e-4f77-bb36-eadf6a797068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_e1b1cc31-de2d-4588-9a51-b4559b429c7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_e1b1cc31-de2d-4588-9a51-b4559b429c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_d87eed42-c13a-491f-9b02-f080615f9d10" xlink:href="mck-20210630.xsd#mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:to="loc_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased_d87eed42-c13a-491f-9b02-f080615f9d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f3e94d1c-f201-4833-85ff-12d6efff7afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesLineItems_8b856036-0804-442c-836c-a57d196885b4" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f3e94d1c-f201-4833-85ff-12d6efff7afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2616400f-b146-4435-abe0-0ebeae58654d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2616400f-b146-4435-abe0-0ebeae58654d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_5f74d00c-b5cf-4fd4-98c3-40bab1f77be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:to="loc_us-gaap_HedgingDesignationAxis_5f74d00c-b5cf-4fd4-98c3-40bab1f77be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3a11e8f6-5870-421f-a0c0-e613fff4d7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_5f74d00c-b5cf-4fd4-98c3-40bab1f77be6" xlink:to="loc_us-gaap_HedgingDesignationDomain_3a11e8f6-5870-421f-a0c0-e613fff4d7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_dca5f903-38d3-42e5-aaa7-069e79a01e40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_3a11e8f6-5870-421f-a0c0-e613fff4d7d5" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_dca5f903-38d3-42e5-aaa7-069e79a01e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b4707f5-c0af-4751-ac93-b76a476c4f38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b4707f5-c0af-4751-ac93-b76a476c4f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1455d6f4-a628-4825-8e6a-2481b5a809af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_4b4707f5-c0af-4751-ac93-b76a476c4f38" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1455d6f4-a628-4825-8e6a-2481b5a809af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_49486a4d-9a15-4f81-8d0a-7785baa0e333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1455d6f4-a628-4825-8e6a-2481b5a809af" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_49486a4d-9a15-4f81-8d0a-7785baa0e333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d54b7fd7-7ac3-4d84-9373-367675607978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:to="loc_us-gaap_DebtInstrumentAxis_d54b7fd7-7ac3-4d84-9373-367675607978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1bca2921-e6a2-413a-912c-634dd7426bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d54b7fd7-7ac3-4d84-9373-367675607978" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1bca2921-e6a2-413a-912c-634dd7426bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_EuroDenominatedNotesMember_a57d9ad5-bfab-4821-b70a-e157ee7b004b" xlink:href="mck-20210630.xsd#mck_EuroDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1bca2921-e6a2-413a-912c-634dd7426bed" xlink:to="loc_mck_EuroDenominatedNotesMember_a57d9ad5-bfab-4821-b70a-e157ee7b004b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_BritishPoundSterlingDenominatedNotesMember_cb9de779-aff8-46d8-9a06-c18275367503" xlink:href="mck-20210630.xsd#mck_BritishPoundSterlingDenominatedNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1bca2921-e6a2-413a-912c-634dd7426bed" xlink:to="loc_mck_BritishPoundSterlingDenominatedNotesMember_cb9de779-aff8-46d8-9a06-c18275367503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d1f36a44-c4c2-4b9c-872c-96e0e35b5359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d1f36a44-c4c2-4b9c-872c-96e0e35b5359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_728814ad-a069-4983-9000-2bf08951d269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d1f36a44-c4c2-4b9c-872c-96e0e35b5359" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_728814ad-a069-4983-9000-2bf08951d269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_99fc91b1-5604-404e-9430-0c191c068508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_728814ad-a069-4983-9000-2bf08951d269" xlink:to="loc_us-gaap_LoansPayableMember_99fc91b1-5604-404e-9430-0c191c068508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_a3863f17-2a97-4206-abc7-ee3c2b6fcbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_a3863f17-2a97-4206-abc7-ee3c2b6fcbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_a3863f17-2a97-4206-abc7-ee3c2b6fcbb8" xlink:to="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_188861a0-027f-4240-823c-7f15d7a38506" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_188861a0-027f-4240-823c-7f15d7a38506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_2a845d35-ddc8-49b5-a74c-6d6302d1e4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_2a845d35-ddc8-49b5-a74c-6d6302d1e4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_17226b75-43a2-4406-9f37-0cdc91f6f77f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_17226b75-43a2-4406-9f37-0cdc91f6f77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_d643a7f3-282c-40ea-a201-ffdcdd9d3f7f" xlink:href="mck-20210630.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember_d643a7f3-282c-40ea-a201-ffdcdd9d3f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_d9604c55-6334-4e10-8a43-0a42f579a9a8" xlink:href="mck-20210630.xsd#mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember_d9604c55-6334-4e10-8a43-0a42f579a9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_49b0737f-1be4-49d6-bf7f-e58fc855ce4a" xlink:href="mck-20210630.xsd#mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember_49b0737f-1be4-49d6-bf7f-e58fc855ce4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_cac95cac-6ef0-41ad-8503-2fff2c800819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3547fee4-6eb9-4798-89ca-223ef629325c" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_cac95cac-6ef0-41ad-8503-2fff2c800819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a39b4e7d-dc6f-44e1-9fc2-4eba8cf6f660" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_01f1e237-6901-4190-9fb3-94b8a211e480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_01f1e237-6901-4190-9fb3-94b8a211e480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c629843c-4162-4208-a1da-ad8c6a7c25d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c629843c-4162-4208-a1da-ad8c6a7c25d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4198ef88-df40-4630-99ec-ec382bd081d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4198ef88-df40-4630-99ec-ec382bd081d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_6d8985d7-30aa-4568-987c-d626812c0e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_6d8985d7-30aa-4568-987c-d626812c0e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_0a94b1d0-76d6-421d-afa2-a5fcfa8d5cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax_0a94b1d0-76d6-421d-afa2-a5fcfa8d5cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_8b89e7b0-ba75-4cef-aa74-744972fd4fe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_8b89e7b0-ba75-4cef-aa74-744972fd4fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3a9841dd-2652-4ee2-a14b-c9d4028b564c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_3a9841dd-2652-4ee2-a14b-c9d4028b564c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_f6787aed-cfff-40fc-9d2f-2247e6954d18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_f6787aed-cfff-40fc-9d2f-2247e6954d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_987958c7-de45-408b-b893-a99ada1d46ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect_987958c7-de45-408b-b893-a99ada1d46ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_bf8fef28-6722-404d-b84b-c8fbde4a8ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax_bf8fef28-6722-404d-b84b-c8fbde4a8ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_43814884-afb5-436e-b1c6-63753e047c1d" xlink:href="mck-20210630.xsd#mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax_43814884-afb5-436e-b1c6-63753e047c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_fefba11b-7387-4141-ae64-f03246612465" xlink:href="mck-20210630.xsd#mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest_fefba11b-7387-4141-ae64-f03246612465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_57cec226-7baf-4ebb-adaa-a57cead8b592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_57cec226-7baf-4ebb-adaa-a57cead8b592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_155233ea-4726-4068-9bce-fb3808929926" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_LongTermDebt_155233ea-4726-4068-9bce-fb3808929926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_feba933f-921c-41d7-a524-a64a76368bad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax_feba933f-921c-41d7-a524-a64a76368bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_055b4e91-5bfc-4d85-ac81-2c441a1be561" xlink:href="mck-20210630.xsd#mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_9eb0dd34-8363-40cc-b184-24061b38264b" xlink:to="loc_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax_055b4e91-5bfc-4d85-ac81-2c441a1be561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_90bc2909-96ce-4e02-b9fa-120cbde03c1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e0447bc6-1910-48a9-a944-f1002abb617e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_90bc2909-96ce-4e02-b9fa-120cbde03c1e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e0447bc6-1910-48a9-a944-f1002abb617e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e4cc906d-b022-47d1-8f99-c7709a72e1ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e0447bc6-1910-48a9-a944-f1002abb617e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e4cc906d-b022-47d1-8f99-c7709a72e1ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b7af4b24-3601-4670-960a-35f03ef3e9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e4cc906d-b022-47d1-8f99-c7709a72e1ec" xlink:to="loc_us-gaap_EquityComponentDomain_b7af4b24-3601-4670-960a-35f03ef3e9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_86e3f4f5-f0bc-4367-8e1d-7d0084114ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b7af4b24-3601-4670-960a-35f03ef3e9fb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_86e3f4f5-f0bc-4367-8e1d-7d0084114ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_3b49eb1a-271c-4638-b1d4-9443794dcade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_86e3f4f5-f0bc-4367-8e1d-7d0084114ad0" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_3b49eb1a-271c-4638-b1d4-9443794dcade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_555721fa-6792-4742-9d26-24e0443ada23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_86e3f4f5-f0bc-4367-8e1d-7d0084114ad0" xlink:to="loc_us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember_555721fa-6792-4742-9d26-24e0443ada23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_dd9ac87c-24f6-40b3-834e-a583e1f7ceac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_86e3f4f5-f0bc-4367-8e1d-7d0084114ad0" xlink:to="loc_us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember_dd9ac87c-24f6-40b3-834e-a583e1f7ceac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_51e5a906-e337-4b6c-b11e-015b15a22075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_86e3f4f5-f0bc-4367-8e1d-7d0084114ad0" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember_51e5a906-e337-4b6c-b11e-015b15a22075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02d76650-5ba1-41a6-89c4-6f1e064cd569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_e0447bc6-1910-48a9-a944-f1002abb617e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02d76650-5ba1-41a6-89c4-6f1e064cd569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_02d76650-5ba1-41a6-89c4-6f1e064cd569" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b7f902ce-adae-4845-94cc-cf7bcaaa1ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b7f902ce-adae-4845-94cc-cf7bcaaa1ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9733a5c3-2c0e-4459-a585-dab10174b07d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9733a5c3-2c0e-4459-a585-dab10174b07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1b7ed7e6-450c-4ab7-aa32-a16e6305949a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_1b7ed7e6-450c-4ab7-aa32-a16e6305949a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0fcc514e-8930-427b-940d-49308792df8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0fcc514e-8930-427b-940d-49308792df8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c9e3e768-094d-4446-adcb-80ea9bbae75d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c9e3e768-094d-4446-adcb-80ea9bbae75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a1f24c8d-3350-4a63-a79a-56b5dc96e67c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_a1f24c8d-3350-4a63-a79a-56b5dc96e67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_76a81dcb-9130-49fb-ad3b-f4d7dbc5eebb" xlink:href="mck-20210630.xsd#mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight_76a81dcb-9130-49fb-ad3b-f4d7dbc5eebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_84979dad-f6a3-4a08-9983-136854024f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_276b2a53-2a4d-48b4-a3ca-1d3b3d8413f2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_84979dad-f6a3-4a08-9983-136854024f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="simple" xlink:href="mck-20210630.xsd#SegmentsofBusiness"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d2ed8a40-4044-4d5d-8545-64f83af78615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_0ef2d1a1-8db5-446b-9689-a30dfe31ca19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d2ed8a40-4044-4d5d-8545-64f83af78615" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_0ef2d1a1-8db5-446b-9689-a30dfe31ca19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="simple" xlink:href="mck-20210630.xsd#SegmentsofBusinessTables"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_428ce424-fe2d-41dc-b0de-48702739c674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_665b3981-bd33-49b7-9ac5-5e33ec227fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_428ce424-fe2d-41dc-b0de-48702739c674" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_665b3981-bd33-49b7-9ac5-5e33ec227fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="simple" xlink:href="mck-20210630.xsd#SegmentsofBusinessDetails"/>
  <link:presentationLink xlink:role="http://mckesson123.com/role/SegmentsofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_df909626-58e1-47ee-ad8b-a3067c36e5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_df909626-58e1-47ee-ad8b-a3067c36e5bf" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_81000136-dbae-407c-b9b0-a255acbd5be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_81000136-dbae-407c-b9b0-a255acbd5be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f7585d06-0802-4f87-a9f1-6dfec2d3b6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_81000136-dbae-407c-b9b0-a255acbd5be5" xlink:to="loc_us-gaap_SegmentDomain_f7585d06-0802-4f87-a9f1-6dfec2d3b6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_USPharmaceuticalSegmentMember_0da38026-a3d0-4103-8bbb-c8c1e35b61fb" xlink:href="mck-20210630.xsd#mck_USPharmaceuticalSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f7585d06-0802-4f87-a9f1-6dfec2d3b6d8" xlink:to="loc_mck_USPharmaceuticalSegmentMember_0da38026-a3d0-4103-8bbb-c8c1e35b61fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_PrescriptionTechnologySolutionsMember_7c6d9cca-485b-467c-87dc-7b882f4e7c25" xlink:href="mck-20210630.xsd#mck_PrescriptionTechnologySolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f7585d06-0802-4f87-a9f1-6dfec2d3b6d8" xlink:to="loc_mck_PrescriptionTechnologySolutionsMember_7c6d9cca-485b-467c-87dc-7b882f4e7c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_MedicalSurgicalSolutionsSegmentMember_89ebf3ba-41b3-4588-8d50-20699916289a" xlink:href="mck-20210630.xsd#mck_MedicalSurgicalSolutionsSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f7585d06-0802-4f87-a9f1-6dfec2d3b6d8" xlink:to="loc_mck_MedicalSurgicalSolutionsSegmentMember_89ebf3ba-41b3-4588-8d50-20699916289a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_InternationalSegmentMember_6212a641-f332-448d-8be6-cdf8c86c2488" xlink:href="mck-20210630.xsd#mck_InternationalSegmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f7585d06-0802-4f87-a9f1-6dfec2d3b6d8" xlink:to="loc_mck_InternationalSegmentMember_6212a641-f332-448d-8be6-cdf8c86c2488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_07454d27-fce1-4b1d-8fa9-cec74db36aae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:to="loc_srt_StatementGeographicalAxis_07454d27-fce1-4b1d-8fa9-cec74db36aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6a97d9be-9fa4-40cd-b205-0706010cccd1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_07454d27-fce1-4b1d-8fa9-cec74db36aae" xlink:to="loc_srt_SegmentGeographicalDomain_6a97d9be-9fa4-40cd-b205-0706010cccd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ca753f91-dcb3-47a2-a8cb-d6e8082e14f9" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6a97d9be-9fa4-40cd-b205-0706010cccd1" xlink:to="loc_country_US_ca753f91-dcb3-47a2-a8cb-d6e8082e14f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_4cd20610-0c39-4dca-b967-fbed76ef76d7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6a97d9be-9fa4-40cd-b205-0706010cccd1" xlink:to="loc_srt_EuropeMember_4cd20610-0c39-4dca-b967-fbed76ef76d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_69917e10-580a-4504-a29b-a9cb5064d240" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:to="loc_srt_LitigationCaseAxis_69917e10-580a-4504-a29b-a9cb5064d240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f7cf72d0-1909-4368-b96d-c3f22d333328" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_69917e10-580a-4504-a29b-a9cb5064d240" xlink:to="loc_srt_LitigationCaseTypeDomain_f7cf72d0-1909-4368-b96d-c3f22d333328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_ShareholderDerivativeActionMember_bacdcffa-8c68-4c65-abfd-48b922e8cbf6" xlink:href="mck-20210630.xsd#mck_ShareholderDerivativeActionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_f7cf72d0-1909-4368-b96d-c3f22d333328" xlink:to="loc_mck_ShareholderDerivativeActionMember_bacdcffa-8c68-4c65-abfd-48b922e8cbf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_0542fdeb-9680-4e9b-9fab-4eab4035fa4a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:to="loc_srt_ConsolidationItemsAxis_0542fdeb-9680-4e9b-9fab-4eab4035fa4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_bbec2d78-3bee-4bd0-8f70-48a5c51d68b1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_0542fdeb-9680-4e9b-9fab-4eab4035fa4a" xlink:to="loc_srt_ConsolidationItemsDomain_bbec2d78-3bee-4bd0-8f70-48a5c51d68b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_8cd4a408-2551-4536-9af8-21c95e4d0cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_bbec2d78-3bee-4bd0-8f70-48a5c51d68b1" xlink:to="loc_us-gaap_OperatingSegmentsMember_8cd4a408-2551-4536-9af8-21c95e4d0cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8c7b3ec9-d59f-426e-ad38-d21edb3e15dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8c7b3ec9-d59f-426e-ad38-d21edb3e15dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_c7c8f954-d32b-4b2a-9f77-772a699bdafb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_8c7b3ec9-d59f-426e-ad38-d21edb3e15dd" xlink:to="loc_us-gaap_LossContingencyNatureDomain_c7c8f954-d32b-4b2a-9f77-772a699bdafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NationalPrescriptionOpiateLitigationMember_ceecd7f4-8375-4cad-b623-03c9f223a7bc" xlink:href="mck-20210630.xsd#mck_NationalPrescriptionOpiateLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_c7c8f954-d32b-4b2a-9f77-772a699bdafb" xlink:to="loc_mck_NationalPrescriptionOpiateLitigationMember_ceecd7f4-8375-4cad-b623-03c9f223a7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_43fb2f16-bfa3-4dca-b8b8-4b02a25c18c3" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_4b32f6ad-fb65-4879-98fa-be087373baa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_NumberOfReportableSegments_4b32f6ad-fb65-4879-98fa-be087373baa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_984c4860-cfa8-4c41-8d58-a5e63dcf9289" xlink:href="mck-20210630.xsd#mck_NumberOfNationalBrandMedicalSurgicalProducts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_mck_NumberOfNationalBrandMedicalSurgicalProducts_984c4860-cfa8-4c41-8d58-a5e63dcf9289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_3ac7b2a0-7023-4ca1-9a46-77df96633f31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfCountriesInWhichEntityOperates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_NumberOfCountriesInWhichEntityOperates_3ac7b2a0-7023-4ca1-9a46-77df96633f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_NumberOfBusinessOperations_d18d9652-2e0a-407d-ad3b-9b0e9a14b46f" xlink:href="mck-20210630.xsd#mck_NumberOfBusinessOperations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_mck_NumberOfBusinessOperations_d18d9652-2e0a-407d-ad3b-9b0e9a14b46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_b26dbea1-77ea-4124-98a2-0120260fd351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:to="loc_us-gaap_RevenuesAbstract_b26dbea1-77ea-4124-98a2-0120260fd351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_33555836-bdc8-427a-a755-347f98759e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_b26dbea1-77ea-4124-98a2-0120260fd351" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_33555836-bdc8-427a-a755-347f98759e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossAbstract_62706c61-d66a-42af-9cc3-31b4508dfdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:to="loc_us-gaap_OperatingIncomeLossAbstract_62706c61-d66a-42af-9cc3-31b4508dfdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_61f015cf-3590-473c-8471-91d22d039e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingIncomeLossAbstract_62706c61-d66a-42af-9cc3-31b4508dfdfe" xlink:to="loc_us-gaap_OperatingIncomeLoss_61f015cf-3590-473c-8471-91d22d039e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_356d1244-7257-4d3b-87b0-0cad90a6d2ab" xlink:href="mck-20210630.xsd#mck_CorporateOperatingExpenseandOtherIncomeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:to="loc_mck_CorporateOperatingExpenseandOtherIncomeNet_356d1244-7257-4d3b-87b0-0cad90a6d2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_5acfa984-4a4e-455a-988c-13ff0d5248d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:to="loc_us-gaap_InterestAndDebtExpense_5acfa984-4a4e-455a-988c-13ff0d5248d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8baf576c-0bb4-4e88-9fb6-2e58bbe06330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationProfitLossAbstract_3565840a-c6dc-4e28-8242-e791e1b65197" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8baf576c-0bb4-4e88-9fb6-2e58bbe06330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mck_RevenueDerivedFromServicesPercentage_c17b5061-8bb0-4a27-8916-19539fb94300" xlink:href="mck-20210630.xsd#mck_RevenueDerivedFromServicesPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_mck_RevenueDerivedFromServicesPercentage_c17b5061-8bb0-4a27-8916-19539fb94300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLIFOReservePeriodCharge_74143e0a-4363-47ee-a0a3-db6d85eb4142" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLIFOReservePeriodCharge"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_InventoryLIFOReservePeriodCharge_74143e0a-4363-47ee-a0a3-db6d85eb4142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_9df3dfc7-458e-4fba-b7da-802be7ad2ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_InventoryWriteDown_9df3dfc7-458e-4fba-b7da-802be7ad2ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_5ecc3715-f9e8-44c8-9c0e-636074e4fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease_5ecc3715-f9e8-44c8-9c0e-636074e4fa39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_4af2753e-a77f-425c-9da0-2c381f21422f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e5189133-669e-4e2e-af4b-d64147e5e04e" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_4af2753e-a77f-425c-9da0-2c381f21422f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>mck-20210630_g1.jpg
<TEXT>
begin 644 mck-20210630_g1.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  ^ 9@# 2(  A$! Q$!_\0
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M?$#XA>(?$4S;FU&]DG'7A2QV@>V,5CE& CC:DO:?"C;/,RGE].*I?$S]#O\
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MOK:UCTK71)/(L2EH(P,DX!^_ZFOJ^&430I(O1E##Z&OPG\+C_BIM(_Z^XO\
MT,5^XUUK%GX?\.-J6H7$=K96MOYLTTAPJ*JY)-=>;X"E@W!45N<F1YE6QT9R
MKO8R?B9\2M#^$WA&]\1^(+G[-I]JN<+C?(QZ(@[L3T%?./\ P\N^&W_0)U['
M_7O'_P#%U\@_M:?M)7?Q\\;,EF\EOX4TUBFGVK$CS#G!G<?WF' '8<>N?(O!
MO@_6/'WB2RT'0K*2_P!3O)/+BB3Z\DGL .<GTKU,)DM%4/:8K1_D>/C.(*\L
M1[/!K3\S]1?AC^V_X4^+GB^S\.^'?#VOW-]<')9H(Q'$@ZN[;^%'>O2/CA\=
M-#^ OANVUO7K>[N;6XG%NJV:!FW$$]R..*P?V9_V<])_9]\&1VD82[\07:A]
M1U';S(_]Q?1%S@#OU->3?\%+O^2-Z/\ ]A1/_0&KP(4L/7QL:5)>XV?23KXO
M#X"5>LUSDO\ P\M^&Q_YA.O?^ \?_P 71_P\N^&__0)U[_OQ'_\ %U^97-=%
MIOPY\5:S8Q7MAX<U2]M)AF.>WLY'1L$C(8#U!'X5]=+),%!7EI\SXJ/$.83T
MC9_(_1/_ (>7?#?_ *!.O?\ ?B/_ .+H/_!2[X;_ /0)U[_P'C_^+K\]O^%2
M^-O^A2UK_P  )?\ XFC_ (5+XV_Z%+6O_ "7_P")K/\ LC+_ .;\33^W,S_E
M_ _6SX"_M%>'OVA-/U6[\/VM]:QZ;*L4HO4522P)!&&/I7J]?%__  37\*ZS
MX7\->-$U?2[S2WFO(&C6[@:(L C X!'2O</VI?C<GP(^%5[K<0635KAQ9Z?$
MW1IF!()'HH#-^&*^0Q&&BL6Z%#;H?<X3&2^I+$XC1VU-WXJ?'SP-\&;59/%.
MO6]E<2+NBL4/F7,ONL:_-C_:.!ZD5\U>(O\ @IYX7M;ADT;PEJ6H1 \37$R0
M9_X#\U?GWXD\3:IXQUR[UC6KV;4=2NG,DL\[%F)/;Z = /2K/A;P/XB\;71M
M_#^AZAK4XZI8VSRD?7:/YU]71R/#48<V(E=_@?$U^(L77J..&5E][/N:'_@J
M+8>8OG>!;KRR>2EZN1_X[7HG@W_@HO\ "_Q!)'#JW]I>')6X+W5N9(E_X$F3
M_P".U\#7/[,GQ7M83+)\/]>*CD[+)F/Y ?TKA=<\,ZOX9N&M]7TN\TN=>#'=
MP-$V?H16CRK+JVE-Z^3,UG6:4-:BT\T?MUX/^('AKXA:>;WPUKEAK=MQN>RN
M%DV$] P!RI]C@UT-?'/_  31\&G2?A;K?B&2/:^J7YBC8CGRXU X]LL?RKN?
MVU_VA+CX(_#V.TT698_$VM%H+63J;>,#YY<>HX ]S[5\=4P?^UO#4G?6Q]U2
MQ_\ L2Q==6TN=M\6?VGOAY\&&:#Q!KL;:F!D:99#SKG\5'W?^!$9KYXUK_@I
M_P"'[>X9-,\':A=0YXEN+E(R1_N@'^=?GM?7]SJ=[/>7D\MW=S,9)9IF+.[$
MY)))Y/UK=\)_#7Q9X\8CP[X<U36MIPS65J\JKGU(&!^)KZ^GD>%HP4J\K_@?
M#U>(<;B)\N'C9?>S[AM/^"HFFM,!<^!KM8NA:.]0D?AMKT_P5_P4(^%/BAXX
M=0O+WPW.W!_M"W)BS_OIN'XG%?GK??LU_%33H3+/X UX1C.2ED[X]S@=/K7!
M:IHM_H=P;?4;&XL)U)!CN(F1N.V"*;RG+ZZ_=2L_)B6=YG0:=6.GFC]R_#?B
MK1O&.FIJ.A:K9ZO8/PMQ8SK-'ZXW*2,\C\ZUOYU\Y_L#^"3X/_9UT>:1/+GU
MB>74W]PY"H?^_:)7L7Q/^(FE?"OP3JGB;6)-EG8Q%]H.&D8\*B^Y.!^-?#U:
M/+7=&GKK8_0Z&(Y\-&O5TTN7/&/CO0/A_HLVJ^(]6M=(T^,?--=2!0?8#JQ]
MADFOE[QG_P %*O >BW$D&@Z/J?B$*<>?@6\;>A7=\Q'U KX2^-GQN\1_'3Q=
M/K.N73FW#,+.P5B(;:/)PJKZXQECR:X&WMY;J98;>)YI6^['&NYC[ "OL<+D
M-*,%/$O4^%QG$E:<^3"JR/OR/_@J-9;QO\"7.SOMOE!_]!KU3X<?\% ?AAXX
MNH;+4KFX\*WDA"@ZH@$&2>GF@X ]VVBOS4U#X5^,M)T\7][X5UBULB,_:);&
M54^N=M<MTR,<UU2R7!5D_9[^3.&.?9A1DG4U7FC]Y[6\@O[9+BWE2>"0!DDC
M8,K ]"".U3U^5W['G[6&H_"+Q-8^'/$-[+<^"[V00D2DM]@=C@2+_L9^\H[$
MD5^IL,R7$*2QL'C<!E93D$'H:^+QV"G@JG)+;H?H&6YC3S"ESQW6Z/&/CO\
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M6=^U=\!E^/OPRETJV=(=;L9/M>G3/]WS ""C'L&!(]N#VKP\'..$QL7/9/\
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M1_>4?F,USYKE\<935:C\7YG5DV:2P%7V%;X7^!^P'\J^0?\ @I?_ ,D;T?\
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M/!(K8XW*\B,,^N%4_P# A7=?\$P/"%Q)KGC+Q2T96TB@BTV.0YP[LPD=0?\
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M)?LB,Z_1F!(KNU4*-H  [ "N;$<0RE&U&%KG5A>%XQES8B=_)''?"/X6Z/\
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HTLX+"W2"UACMH%^['$H51WX Z45\G5G[6<I]V?:T:?L*4:6]E8__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>mck-20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mck="http://mckesson123.com/20210630"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mck-20210630.xsd" xlink:type="simple"/>
    <context id="iff44e00c31454749a800ec4298771ea3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie16ea3b369e24068be0eb517c465b38d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0444596583fc42aaa4fcca038aabea7e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1500NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia75568a432454780a30eeca181f10bb8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A1625NotesDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2a9bb91a104c4960a636e6e9340aedff_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mck:A3125NotesDue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie2dde5d2936140a6940741e305619e4e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i507f1cf3441d436a9874220e71af41c3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ide611772c559475e8e24346506419cca_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie70b404c2db04f2ebe83db4787529b8e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4a5a6c3bbe5e44deb764a82396a14df9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i29b18210e4c94b3e9eeea079457c3440_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia04e0037336742a5862b1a73adc63e1f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iedb46ad9eb03415b8c3ef478a437c8d0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i31f3423fd8914bcc953eed5489c40bb9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i15e4d7260c2e41f096bdffa4d471fb63_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i634d779a260d4eab96c467a9cdde3019_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4c03ab80e93f47289af42a50526f49e2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i22d5a4e9af084716946bdd5617413192_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5ebbfc861a6b4540a93bb5855e3d39fd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i26afe17b7028469f99257689fdff7dda_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6a3a202be855424c8713dd4fb041ea5f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8466c6d9312243f598d0a021cf047894_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0259ca22a00146cdafb9ed748adbb334_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icedc97c57c25494bb97ac3ef916d8842_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i72ec1598f96f46b4a2aa09a894edbf4e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id9687fb04dbd469694095f24c00a6c23_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i24796da60e81481facb6d498be5e87ed_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i755d7f41b47e492b8cb1bb239e98220c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ice2df17bcd5c4d70b58287a28e594ce8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iecd424d4030942d9b9c9e99c1603c4a3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7f7de12727134d7896b46445549479aa_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8425fdcd51654e2788cfd296989eaf07_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6ba16cd1fc7244ceb1279fd03c7f3d71_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2843b04f5ade4927b1bcf699ff9e4e7f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i45bcf4e2e2d8477e8b1e8879961cbdf6_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic5ddcf2818a34e28bd1e5fa9f983727c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i725d870b5d0847e5a0034ebf590b23a9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibd2846306c6949939b64d3cbdef8e7c3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5039f65c2af54891b1478714de89353c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7e4d9b8d9f51455cba6575dd2af5893a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i5013134a08dd45ba9c62f3e98630e1ff_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i056b6f4cd57242638814e7e5ff75d938_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if98dc411e46a41db9665e0cdbbd91413_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia3eb01708eee4de88a588b3642d67848_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8c8196204fec46a4b86aba7adf40b724_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id548799f7ab1465c837921be5e020ed5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia1aaf42c089f4e2fa8f947ce43febbf5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i87c849ded324459ca97d3b31b68b0bd6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i468f96b19c9d424ab3c34d92dd9ba0f2_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9b3fb15d56c74664afb9bf5941948b0f_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6e51367df2e54805b65a34b535c3a768_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6a911394561149eeb8e541a9ff705e67_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6d6a811e39f549ae99a6bda061e024e8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i92f41c6f9c3f4caab2c60ad954bef6af_I20210705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-05</instant>
        </period>
    </context>
    <context id="i057cd4a01a544d42941664a044c0ee99_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2b729438362242159879d1e5ae05f931_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mck:EuropeanBusinessesDisposalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i84cf7e31c16f42f68495c67d9cf8d2e2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i57c77c79ca8e4393a2c77738aeb14820_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mck:RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6c075b17e18f4530aaaaa06575761b8a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mck:RestructuringPlanRemoteWorkTransitioningMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9283db20095f427da10212779ff9e45d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i57a8d9571d55442c857cdee195f25036_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i87ee4b68e9ad4be0b0e837451f122185_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2c475719e1e54e988a2716b400ad19c8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i47e37dbe4a284e4dbcd7fb304b436339_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i630193b02c1347faaf81c65e56471d75_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i17d2abc247664f6daa16f853d87054b7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i34e5f5eb8b104181b2273e06b8521cc7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i91e0eb4c78cd4021aa5f951829fd7105_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i035aba39d89d4cbda66c1e89394e2887_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2e6dc977232b4be2a968cd362119be8a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i66234f14da784e5eb4675592aa380d6c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib9f49c85d9c54b139a81fb46d5568528_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id94f3503c3d14315bb499f5363c098fb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic4d2ba414ea445368df49de0797a4169_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7a0d6267ee1a4d7780d02c0f5b857095_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i710aa73bfd1a41c98226e45589abb990_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0bc550c41437490f858d0f9e149d60d0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i992084e24e76444492d6225980031942_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i19168a33968540e783b28d52a160795c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if40e1d1aa4ac42c587f1b983fd883ee3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iac2a35f73ee14590b8a577b32c972839_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie45718b0614548d1830f76b0122b7111_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i191304ad1c25432190397b7fa834d148_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id719933d788f420798852650db76c74f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ied3d3ec15dce44668530b0cfc63e4725_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="idaf31474e16b4981835b7927ff4927eb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i487864b97fe74bb085d985d73639d6db_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i63b54516555043abafd60e6f00353370_I20210412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-04-12</instant>
        </period>
    </context>
    <context id="i5ddf756d852f408fbd54c3f4a61f8d6a_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="i87be9fd9c6fb4f4785e90cb0a3b47104_I20180919">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2018-09-19</instant>
        </period>
    </context>
    <context id="i2334ff340e7e4425bafcfaaf4f20fc95_I20210412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-12</instant>
        </period>
    </context>
    <context id="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2f923212c58c47f88ad486925df58806_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i69a2a49641144b609177a6d98a66f9eb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i508c6f433af04bcd9ab04b4a8838efbd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:MckessonEuropeSubsidiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i59705e8d049944ec81dc730a85f8b9e6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i365faceb5dac4b6c8e146917134e4cd2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mck:VantageandClarusOneSourcingServicesLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i412cde1488dd4d8ab371ad4c8f5faa1d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic01bba4cd87f497d8faba0d38fa0e49b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i30a07bf169524e7ba24b49eb98a91985_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i51575d10eabd476db89a9db186145b8a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:RedeemableNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i9bd869d54ffa406bb2261915a7499d39_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i34ca8e4a850d48e9b2104497582378ad_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3b31c456dd94434c9a3d61732463ebce_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i53500c27297841a0b5752e04f4847019_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id6b9935a1072411f89e91e4985e6c37a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i88f5c5e2af1a4fe4952d7a38df3fb91c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i42674b470461487c889c63f9ddc05423_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if9a99eac4149443cb99bd6701ec37a59_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1c2064f2c8eb49c3849453a95a9c86c4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i82edf712cf2f4662ac55525b3410634f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i032911e077b3421889a6ddae5be68041_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7e598facc678461e9c9bce2f326a6b53_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if9bd1f8e3c8348ac85a0747fd5ead3c3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie633b96d5f6e4594bb149b9a781b4f7f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i340abf5713294118849a48ca0137e899_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2202b302407642afa17e3d40e4f0eba4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9d12ee52b8454b869fd9946a0fa4dea8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i593296998692453094e57c17348b980f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia43438708a6949cd9cf16f70af409bba_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0f7bc8f0af7b4ef4baba244ec29d1ccf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ServiceAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ideb771110e984bc6b277c2585a3c3c6f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4d856a3247a04312a0f97fa937d9eed7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i32a42ebe572b4d43a291732f6cd1090f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mck:PharmacyLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3d3366f7c074412792772c50da23b51d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i035c0f3929ab4099b0ee92a80f3a4278_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0f46fc9ae83e465096134ae813e19eca_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iccbdbd7b3a45463c9d5c7a2b7100baa2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0390e639fcad44a19ceb60da2c72ce2c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7fbde6fe64aa486ab9d6ced83a9cd75c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie584228b8d12471fb55c1f0dfb5e49f9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5f2b8389302f4c9d9c629498687890a4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i17ea7a07b00745c4b4e10ece2a6d1062_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibb31fe16ed0945ccb087b29dc4df346e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8407cd75013b4842b7e8b7b851404c4e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A270NotesDueDecember152022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iebe203936fb34a7a9344c5a6786888f7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i41289baaaa434780a092e5aa64685cf3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id5fef0e85ad14e5a8339aa8bf7f1f834_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9aee8ea463a843d09b2055c2c57299fd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i169a4495697f4cc6a8840fef9d567050_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0a05c4c8a26643e09852e9a58afb81b1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A090NotesDueDecember32025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib19d5790e42d4cf79c39f2cd0f8b3b29_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8f832373d87043299bdd466eea4cdba1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iae5f8b803832412fbac51e8806cb157b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1e6c020b9a784d1892f9c88f64b4176e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifee3165ec08d4e9d94616eacd185bdd9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i88b5e65988454c43b931f14c2f226ef5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7e672708b526455fade2322b90db6797_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic881a7db34944589a71dcb5194c00876_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia66cc0f4490547d7b0e20380ae14d605_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i393368a727ec4afe826cf57617c10f72_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0509dea68b7c4cebaf62b299de6337f9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i918f3ab82fc247afa4f05e53d52b0e43_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1586326f43a34f1ea78093d8355235f0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i15cf8725ddab482688388dd6b20edb40_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A150EuroNotesDueNovember172025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1fb67a2ffa7344a8ac4da91deabca230_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i14953d2fb5684f679ab2a851b343c97b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A163EuroNotesDueOctober302026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifffd02ac34b54a9d83eede3f64ae16e7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i755188d16c194ff880eddc359eea6d40_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A313SterlingNotesDueFebruary172029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i52b40196e15a40109ba391d8c6419991_I20210717">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A063EuroNotesDueAugust172021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-17</instant>
        </period>
    </context>
    <context id="i083ed7e2edf54f4b83be55e6fa4c6f7b_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A285NotesDueMarch152023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i5a40c09a559944b7bada0ac4b7f9ed85_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A380NotesDueMarch152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i2c1f8c6acdf4492e89a70c07d233052b_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A765DebenturesDueMarch12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i8cd03befc3844879a03bf8f5fa13ca89_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A395NotesDueFebruary162028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="if0edf0d51ebc4525bc018b0e3e316674_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A475NotesDueMay302029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i310b2ea151234b239e7d7b390ccb95cb_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A600NotesDueMarch12041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="ibef52b2a142145dab5d69647024ad296_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A488NotesDueMarch152044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i5f3accdb3da74028a9b53d7cbfada305_I20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-23</instant>
        </period>
    </context>
    <context id="i9c2de330c27f48448b2891e90290996d_D20210723-20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:TenderOfferNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="i25b1cae8ddb3438888532104a195d342_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="ia01f828cfc8d4b21a6b8edf6be853a2c_D20190701-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i6e548eee92194bd0ac6aa9274c25b1a9_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i382e8de72c834d1eac88fcfa16537bad_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4601e5b7a09c46ccb58053797c15dbc7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4398603060f24739aba2e6bf31a25415_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3b2b1270b93847d1b81d237136f5a141_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iacf778d3b2e94d20a54cbcb22993e5bf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id40f1c8ac21f4308bf805ca389c79975_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id62cfccb10834659abc7c6a555e79614_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibbabad5c01b74ee69bce61c31d9c74ac_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i87ef7e5959ad4f249be2667fc9962adc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia550dbf4b8264bfb9f5b32e88da36352_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie9cfdb9a5439470287947e0237d40a46_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icc80b14c5bcc4ef59c002900d86c6c35_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic94ceeda5f8d4c34920ab05d68d536f7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7e80ec0a1e2d4560a4bb44c4d5f4a808_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3252989f4e9143d3a010d05024100a86_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0d1c889a01024ed39200b6381c6e96e7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iaad66d5fe7e44e1f84cb3ffe38ed1ab1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i80839eede57645f39c2726f49aa8dd4f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:November2018CrossCurrencySwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie2831786f08a4f11887081ccec157fb0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id92758a2bb7c4cff8bb23c47c0c1232f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie7a08d2dbea84831a38c40ef01c2c6e7_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:BritishPoundSterlingDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i8814cd508cb14d7a92a7f3da4dedb9e8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i956714c5c73546d6bdd695153b63c85a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9ef3d8dbb2ba449ca93f70296442ff7b_I20200427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-27</instant>
        </period>
    </context>
    <context id="i124c1e4e44e4428894d8a3cf36e6b1f8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:A2025NotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ief989ade667c4ef18be6557ba0496c47_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7e159bf48d534941b449647bc4af9899_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iddb83da1863c4b8384938b9fad9620c2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1a3a75a3436b4b3685c3cfc786388204_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mck:ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic2941f5ca10940f394d4dd8bfb64ac58_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id617d1f4a3154d5ead974c1efa393746_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3d7fdeabe846450cbffd7d9cb27d2e5f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0b6587a427294928b598b9dd585bb983_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id5eb3ee735d54234824cb44c72ee37bd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i558eb332169346989d3fd5ae0d6527e4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:CurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if7c97a01f67041b391ae942c70306640_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if46eae73de4e4324a272398b73a63332_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1cb0c057ebf04f36a85edd8c4c2ae13c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3de9a66fbd214a428e97ce8f78d46531_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9fca76452d9740ef9b482b67b89fa4f8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2acd26c3075244feb92ff6dd6d80e75c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">mck:NoncurrentAssetLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CurrencySwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8d2fcd1df20c4538955a00e476ec7c57_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ieb89381a71734f36b7d1abc0599bc5dc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id0d9f4fb8711478cb44177fe5109b6be_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8d0248921e62472a9c05a75192f10e2a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i057bad05c3bc428daef027fdad88ff14_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1c462aabc2274d09a39e632a3b618cce_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic7ab7b1f45b443cba7bfac6496401a9f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i50a5c757907c4088ae0296ac7b7d7d28_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie0f92fdc3cca4ab5a3cf1a1bf925cfd1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i17405e4be62d40c6ab31341f02725dfc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie6b3e479a7ba41eab5874e29f520ca6e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i264ad77616174b4a9fc0c900da89178a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ieb9b9bae1bf74a07b096fa2f28832165_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ida94316064164aa9be5a8557cd06794c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsNonrecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2f1e101a3d9e451eb8389cf243131a05_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia19dcf632c5a4f9b87ae18a87b76e38c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i468d5d79395f4d76980c0de14e2195fe_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i560f2387215143f39820008aab86b0e9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7967e4fff72d493bb8ebc9597e37bc19_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5952f660e44f4b63bfd67ce4efa66744_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icd94e17f05724bf4ba48a2eb22b0163b_I20210721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-21</instant>
        </period>
    </context>
    <context id="i8ca3354c383c4d99b989e74af58a1b0e_I20210720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfNewYorkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-20</instant>
        </period>
    </context>
    <context id="ifa1d16398d7f44208aa02d08c3991ca4_D20210721-20210721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-21</startDate>
            <endDate>2021-07-21</endDate>
        </period>
    </context>
    <context id="ie15c86f3be0f4af2ac4c88a44e20c8ef_D20210721-20210721">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mck:ThreeLargestU.S.PharmaceuticalDistributorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-21</startDate>
            <endDate>2021-07-21</endDate>
        </period>
    </context>
    <context id="i47e3cbf548f448a6aac81a1abd64fb0b_D20210721-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-21</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i909c1a4a44c746a4977ccb484c3c8edf_D20210720-20210720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfNewYorkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-20</startDate>
            <endDate>2021-07-20</endDate>
        </period>
    </context>
    <context id="iadd28ed11a014305be6b12b7cad3adab_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id5cbe1ba860d47aaa8b10c167bd7e101_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia1f6e17a404c4e1692e1e7ec1023c177_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateOfNewYorkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i570f356eb38c49d788e8a9f41b36575c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:StateAndLocalGovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4466b2bd90eb4851915c2314922946d0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib81d4fa67aed495cbee1685f6ef28fcc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if9ed7575e2c84fb79c4efda8cfe8f99c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:GovernmentalEntitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i15595dc6958149c891a687ee33e881b7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">mck:IndividualClaimantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:NationalPrescriptionOpiateLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2a53a7efe6f64eb58432e009a3da7d7d_I20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:StateOpioidStatutesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-30</instant>
        </period>
    </context>
    <context id="ia7c806eed28f452681024ccfb6d0ba58_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mck:StateOpioidStatutesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie4f9f1cff0f944b581c9e22ae2cafe95_D20210722-20210722">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-22</startDate>
            <endDate>2021-07-22</endDate>
        </period>
    </context>
    <context id="i0bb253bd3d3a47dabfafb9011d880dc1_D20210723-20210723">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-23</startDate>
            <endDate>2021-07-23</endDate>
        </period>
    </context>
    <context id="i326582e2cec94f4596b88b8eac101ee1_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i7ee5de63e94947cf8f40df8a36d1d075_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mck:AcceleratedShareRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4eda871b01a9492083d9a7ace055a4bd_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iaeccc89714c54493995d9661c58ae337_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i683faa57c1154143bdcceac4cfc4f4be_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5add2ae2ff484cb1a39c941a288349b2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i78e5d212e61b44749ee2c344ba273205_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic34f3a349fc24b3d947bac4654010cb5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia069814e274d4623bfb7a2f2d90124b4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifeb84bdd46314ab589c286f47e9fbff3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mck:AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7580c94982c04c6db55b6b8d11dd6efe_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0e4d013ff96647e297facf5a8709f13e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7d7a3c97158f4b2295ecfac3630c7dda_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mck:EuroDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7a707105caaf4446872eecd75721360b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i96cab475915a4dbcaae2796d530de73b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i78d13cdfde3141419e99db6a257de4aa_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i541b64e198c948d092258fb4eb641885_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib9a959a0c7b148a38c6b8331c113e2cf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i76038b5bf32948138203a73d85210e1e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i18ebdcc4b1e44eea804b218171e8f605_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i20557e420ca347deb38e35cfe75e2f15_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibf2ebdbafd554d41a758ebc6b7078157_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7bbc1cd6847947c1857128d50574b91f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id5e06f9d71a142728e7dd68ecedc7eb7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia79b569c95894cf8af0a2bce6c0e7a42_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ia6258d106eb74184a1fa0a7767f79b2f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7c68e3755f574f668c6f9e3736c38803_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i207edd1ad0f24086a0af0cd0897714c5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1d84fa2b48714007ba888640e7295e09_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iafaf876b672949d4a457c37fb78dcc15_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i09d8587e16084bb098356d7c27d734c0_D20200701-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic5004bc3d244470f87a0e4366f016d4c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i102de3e4924b431f90a2f289213c9b87_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:InternationalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idba260eba8e74ac5a3c690150d88e82e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:USPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6affa371637042a0beed138683334e5c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:PrescriptionTechnologySolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifcaabd55fcc24731b0b6daa24a824ce3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mck:MedicalSurgicalSolutionsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie40bd4cb78c741a287b7a02340752d2d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if0f85e764ff74422a0b261f62ad59faa_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i49c8bc60131d4dedb5a99976b761279b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927653</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mck:ShareholderDerivativeActionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>mck:segment</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eurPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="gbp">
        <measure>iso4217:GBP</measure>
    </unit>
    <unit id="case">
        <measure>mck:case</measure>
    </unit>
    <unit id="state">
        <measure>mck:state</measure>
    </unit>
    <unit id="stateattorney">
        <measure>mck:stateAttorney</measure>
    </unit>
    <unit id="distributor">
        <measure>mck:distributor</measure>
    </unit>
    <unit id="vote">
        <measure>mck:vote</measure>
    </unit>
    <unit id="product">
        <measure>mck:product</measure>
    </unit>
    <unit id="country">
        <measure>mck:country</measure>
    </unit>
    <unit id="business_operation">
        <measure>mck:business_operation</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80L2ZyYWc6ZDNiYmY0ZGY3MDU5NDhiNmI4OWNlODhlZTYzZTVkNWIvdGFibGU6MTA1YmU1NDZhNWQwNGI3ODlkZmVjZTZiNzFmODBhOTYvdGFibGVyYW5nZToxMDViZTU0NmE1ZDA0Yjc4OWRmZWNlNmI3MWY4MGE5Nl8zLTItMS0xLTA_e64509e7-83de-48f0-8e4e-9ba28101169d">0000927653</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80L2ZyYWc6ZDNiYmY0ZGY3MDU5NDhiNmI4OWNlODhlZTYzZTVkNWIvdGFibGU6MTA1YmU1NDZhNWQwNGI3ODlkZmVjZTZiNzFmODBhOTYvdGFibGVyYW5nZToxMDViZTU0NmE1ZDA0Yjc4OWRmZWNlNmI3MWY4MGE5Nl80LTQtMS0xLTA_220bcd1f-22bb-4cc0-a52c-6f428e15499b">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80L2ZyYWc6ZDNiYmY0ZGY3MDU5NDhiNmI4OWNlODhlZTYzZTVkNWIvdGFibGU6MTA1YmU1NDZhNWQwNGI3ODlkZmVjZTZiNzFmODBhOTYvdGFibGVyYW5nZToxMDViZTU0NmE1ZDA0Yjc4OWRmZWNlNmI3MWY4MGE5Nl8xMS0yLTEtMS0w_d9e0ddf0-b688-48d5-9c74-2943a9864831">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80L2ZyYWc6ZDNiYmY0ZGY3MDU5NDhiNmI4OWNlODhlZTYzZTVkNWIvdGFibGU6MTA1YmU1NDZhNWQwNGI3ODlkZmVjZTZiNzFmODBhOTYvdGFibGVyYW5nZToxMDViZTU0NmE1ZDA0Yjc4OWRmZWNlNmI3MWY4MGE5Nl8xMi0yLTEtMS0w_122d5e3d-6d4c-4d67-b4db-bdd30ce6e3fe">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80L2ZyYWc6ZDNiYmY0ZGY3MDU5NDhiNmI4OWNlODhlZTYzZTVkNWIvdGFibGU6MTA1YmU1NDZhNWQwNGI3ODlkZmVjZTZiNzFmODBhOTYvdGFibGVyYW5nZToxMDViZTU0NmE1ZDA0Yjc4OWRmZWNlNmI3MWY4MGE5Nl8xMy0yLTEtMS0w_5a3de32d-14ab-41fd-bf93-a60d0ceb4336">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTU1_f683d786-0c1b-419d-8693-d7c28fcd2aca">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YTM0NmMwYjkxMmQzNDRmZDhhMmFhYmQ5MmRmN2Q0ODAvdGFibGVyYW5nZTphMzQ2YzBiOTEyZDM0NGZkOGEyYWFiZDkyZGY3ZDQ4MF8wLTAtMS0xLTA_d7b25cb4-f01c-4b02-bce9-a823f03fc5d8">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8xMjQ_f977a8b9-444f-4729-9b33-8be5a4270634">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6OGEwMjVkYjRlOTczNGYyNTk4YjZiYTNlY2Y2ZGEwYmUvdGFibGVyYW5nZTo4YTAyNWRiNGU5NzM0ZjI1OThiNmJhM2VjZjZkYTBiZV8wLTAtMS0xLTA_363efe7b-b88f-4f9a-893a-0b9c27b9e22c">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTU2_7d49082e-f6e7-4d6b-834f-f593fcd6a047">1-13252</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTQ3_31769815-511d-4683-bfe4-c67080f825d0">McKESSON CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6MmUyNWU2YTM0ZTNhNGNjYjg2ZWM3OGYzMzAyZjU2ZTkvdGFibGVyYW5nZToyZTI1ZTZhMzRlM2E0Y2NiODZlYzc4ZjMzMDJmNTZlOV8wLTAtMS0xLTA_f5b65385-36de-4e02-81be-99eb70354d40">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6MmUyNWU2YTM0ZTNhNGNjYjg2ZWM3OGYzMzAyZjU2ZTkvdGFibGVyYW5nZToyZTI1ZTZhMzRlM2E0Y2NiODZlYzc4ZjMzMDJmNTZlOV8wLTItMS0xLTA_5cd7dd29-bb08-44b3-a391-ef32cf27957b">94-3207296</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTQ5_2f80c580-f9ce-434e-9d98-190c2e640a11">6555 State Hwy 161</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTQ4_3f5419e0-79b2-463b-b360-e671aa75940b">Irving</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTUw_e549d583-bc7e-4478-a3b2-048a4fcfd0d0">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTQ0_90467efc-c90c-4e4d-837e-7561c2acba46">75039</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTUx_0f8f8440-54a1-403c-82e4-50659f0acc2a">972</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTUy_924ae003-e16f-48a6-93dc-20e8600c0065">446-4800</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ie16ea3b369e24068be0eb517c465b38d_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl8xLTAtMS0xLTA_81a4fe1a-b756-4d85-b9da-24683ae5358d">Common stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie16ea3b369e24068be0eb517c465b38d_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl8xLTEtMS0xLTA_8ea1bbba-6c5f-474e-b476-383f11f45db3">MCK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie16ea3b369e24068be0eb517c465b38d_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl8xLTItMS0xLTA_afdfe537-6d22-4871-97d8-7034644443d7">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i0444596583fc42aaa4fcca038aabea7e_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl8zLTAtMS0xLTA_f3e43744-01da-4d1b-b79d-6a03cfb1924f">1.500% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0444596583fc42aaa4fcca038aabea7e_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl8zLTEtMS0xLTA_a7301e5a-809b-44ea-b3f0-b84a48723823">MCK25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0444596583fc42aaa4fcca038aabea7e_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl8zLTItMS0xLTA_18dbf48b-66ac-488a-8753-9c7b2de4dc6a">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ia75568a432454780a30eeca181f10bb8_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl80LTAtMS0xLTA_553856d0-4fc4-4b1a-98c8-b10c89f548e9">1.625% Notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia75568a432454780a30eeca181f10bb8_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl80LTEtMS0xLTA_097adef1-4af7-4f67-8692-b7174226bf42">MCK26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia75568a432454780a30eeca181f10bb8_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl80LTItMS0xLTA_2288753a-a699-4c55-a985-a1dbb22e549a">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i2a9bb91a104c4960a636e6e9340aedff_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl81LTAtMS0xLTA_ad0bfce8-7c2d-4168-bbd8-f64a0dc191ea">3.125% Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i2a9bb91a104c4960a636e6e9340aedff_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl81LTEtMS0xLTA_5c5847b1-18c3-4213-9e3a-8083770bba44">MCK29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i2a9bb91a104c4960a636e6e9340aedff_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6YWU3ZWU4OTRlYTAwNDhhZDlmZWY3MDczZDEzMTllNGYvdGFibGVyYW5nZTphZTdlZTg5NGVhMDA0OGFkOWZlZjcwNzNkMTMxOWU0Zl81LTItMS0xLTA_38e5c24d-7484-4e3b-9588-0554b35943af">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTQ1_889df83c-e1bf-453d-a12e-8a47fb2c2c47">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTUz_ff285bda-215b-49a1-9ce0-ff4483addca7">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6NGYyYTU2ZTkzY2JhNGVmYmIzZTQ4OWI2N2QyNTUzMjQvdGFibGVyYW5nZTo0ZjJhNTZlOTNjYmE0ZWZiYjNlNDg5YjY3ZDI1NTMyNF8wLTAtMS0xLTA_7cc1d827-5afd-4b46-979b-49acacba8063">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6NGYyYTU2ZTkzY2JhNGVmYmIzZTQ4OWI2N2QyNTUzMjQvdGFibGVyYW5nZTo0ZjJhNTZlOTNjYmE0ZWZiYjNlNDg5YjY3ZDI1NTMyNF8xLTYtMS0xLTA_381dc5c6-640e-4585-949f-f51a32d98542">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGFibGU6NGYyYTU2ZTkzY2JhNGVmYmIzZTQ4OWI2N2QyNTUzMjQvdGFibGVyYW5nZTo0ZjJhNTZlOTNjYmE0ZWZiYjNlNDg5YjY3ZDI1NTMyNF8yLTYtMS0xLTA_7f285827-ffeb-4d4c-9931-b2c24f30a100">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMTQ2_db6d1715-5bb0-4da1-be4e-4a753a7a19e1">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xL2ZyYWc6MTRmZmVlZGIwNjEzNDY5NTkwYWVjZTgxMTMzOTQ2NTEvdGV4dHJlZ2lvbjoxNGZmZWVkYjA2MTM0Njk1OTBhZWNlODExMzM5NDY1MV8yMDc3_8f88f7d1-7e1b-40d5-a1de-2e628d3f2a0e"
      unitRef="shares">154674571</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMi01LTEtMS0w_b980b16b-76d4-45b3-b2bb-25136597a892"
      unitRef="usd">62674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMi03LTEtMS0w_f89ccb60-abe5-4e8d-838d-8d2938edfbf4"
      unitRef="usd">55679000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMy01LTEtMS0w_89fded92-2190-4a90-8ce1-1c526caa7827"
      unitRef="usd">59642000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMy03LTEtMS0w_7ef19ad1-1489-42c0-9d00-b12a020121e7"
      unitRef="usd">52979000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfNC01LTEtMS0w_6f646fd2-74b3-459a-84dd-f89775cb0bd0"
      unitRef="usd">3032000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfNC03LTEtMS0w_fdd2d3fe-2616-4b99-abb1-dcf36ccb2e79"
      unitRef="usd">2700000000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfNS01LTEtMS0w_86a7e808-f249-41f3-b19a-c6d22caadee6"
      unitRef="usd">2232000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfNS03LTEtMS0w_1d000213-e544-4738-a80f-bda69517c442"
      unitRef="usd">2097000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfNi01LTEtMS0w_0af36516-a1c2-4f86-b4f5-29b961cba49e"
      unitRef="usd">-74000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfNi03LTEtMS0w_fb9f845d-14e3-47d4-aac2-e38d5f130c2b"
      unitRef="usd">131000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfOC01LTEtMS0w_0ac94e57-1374-45c7-8168-9941745e9a6d"
      unitRef="usd">158000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <mck:RestructuringImpairmentandOtherRelatedCharges
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfOC03LTEtMS0w_9d35ba4f-ed37-4a8b-b38b-d98a62f3369c"
      unitRef="usd">56000000</mck:RestructuringImpairmentandOtherRelatedCharges>
    <us-gaap:OperatingExpenses
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTAtNS0xLTEtMA_86d535fe-46db-4437-9d59-6cff84a20e05"
      unitRef="usd">2464000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTAtNy0xLTEtMA_719bc19e-1274-4e37-a208-6027d8a17714"
      unitRef="usd">2022000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTEtNS0xLTEtMA_adf828eb-7ca7-488a-816f-d492a5de8bd0"
      unitRef="usd">568000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTEtNy0xLTEtMA_33504b24-bb6d-4891-a2bd-eb39864e4ca5"
      unitRef="usd">678000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTItNS0xLTEtMA_3574b6bc-8357-4efb-8f2a-a53d3d78ddec"
      unitRef="usd">43000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTItNy0xLTEtMA_5be30c17-0a3c-473b-bc10-8a660c679fde"
      unitRef="usd">27000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTQtNS0xLTEtMA_a68d36b4-433d-48a2-91bc-6b0c6d6f9879"
      unitRef="usd">49000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTQtNy0xLTEtMA_d73fba68-ab21-4840-90d5-4c813605be42"
      unitRef="usd">60000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTUtNS0xLTEtMA_e16b0623-8989-4ea4-81ea-d537180995f4"
      unitRef="usd">562000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTUtNy0xLTEtMA_d32b4cc3-0961-4f51-853a-37e2b5e3d993"
      unitRef="usd">645000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTYtNS0xLTEtMA_7c2d961b-b8c8-48fa-990c-80fdfc360086"
      unitRef="usd">26000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTYtNy0xLTEtMA_0b57e646-e92f-4195-9a0f-8c2d8abd6ab0"
      unitRef="usd">150000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTctNS0xLTEtMA_fe1776d1-2c5f-4c49-b276-10212f46586a"
      unitRef="usd">536000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTctNy0xLTEtMA_41bbb7cf-6434-4118-983f-bb23e5c95881"
      unitRef="usd">495000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTgtNS0xLTEtMA_bc49a88b-c66b-4133-aecf-2f969c16524f"
      unitRef="usd">-3000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTgtNy0xLTEtMA_1dcc1199-6fe1-40d5-b122-cab2129f363a"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTktNS0xLTEtMA_e09efa75-35d2-44b5-89e5-0f233dbd2083"
      unitRef="usd">533000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMTktNy0xLTEtMA_b0a6a5a4-ed82-4459-8387-59912c5f2759"
      unitRef="usd">494000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjAtNS0xLTEtMA_04ca3996-8dbf-4aa6-85d0-4d74e2b831f9"
      unitRef="usd">47000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjAtNy0xLTEtMA_e4660d64-167a-4881-8c28-b506a1628800"
      unitRef="usd">50000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjEtNS0xLTEtMA_f8c99178-374b-4642-b10c-5a40cb85de35"
      unitRef="usd">486000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjEtNy0xLTEtMA_1b20f40b-38c6-4795-8eee-7853657188e5"
      unitRef="usd">444000000</us-gaap:NetIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjUtNS0xLTEtMA_fe42dfc3-2a3b-482a-8434-80d90512fe5e"
      unitRef="usdPerShare">3.09</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjUtNy0xLTEtMA_2eb65c56-b363-404e-85ad-ddf7b4bfb8e4"
      unitRef="usdPerShare">2.72</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjYtNS0xLTEtMA_3e17eb44-8f86-47da-a5fe-44804e05270c"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjYtNy0xLTEtMA_1bc7802b-ca8e-47db-82da-bfbf22f6a115"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjctNS0xLTEtMA_38d1a33b-d5a6-4c3c-9c85-db2d3d0bf5e6"
      unitRef="usdPerShare">3.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjctNy0xLTEtMA_fa7ef808-b863-4a16-98bd-1e1814397cb9"
      unitRef="usdPerShare">2.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjktNS0xLTEtMA_efcc517b-ecc4-4391-8959-7f7a6421cd03"
      unitRef="usdPerShare">3.13</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMjktNy0xLTEtMA_5fd5f0b9-8fc6-45a6-876f-3e6927a63196"
      unitRef="usdPerShare">2.74</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzAtNS0xLTEtMA_c4e69d83-9900-41ed-8e18-8ce5a4cacc1f"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzAtNy0xLTEtMA_f127f6d9-221a-4572-b4b7-a21c218191a8"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzEtNS0xLTEtMA_7ef651a2-17a6-4281-ba9c-ba4f6a80a5fa"
      unitRef="usdPerShare">3.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzEtNy0xLTEtMA_8df360f9-512c-4960-b169-11ab0bda3d4d"
      unitRef="usdPerShare">2.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzQtNS0xLTEtMA_bbab2671-e37d-4e6d-ac00-a9b12dcd5277"
      unitRef="shares">158100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzQtNy0xLTEtMA_aed697f2-95ec-478f-8430-dbb6c046d6a8"
      unitRef="shares">163200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzUtNS0xLTEtMA_2c5b32d7-5df1-4ddf-a641-f630ed1e77fb"
      unitRef="shares">156200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xMy9mcmFnOjBjMzZkZTgwNjk5ZjQxMDNhZDUxZjJiZjEzMGE1NWI3L3RhYmxlOmUzZGRjZjNmMTBiZTQ5ZTk5MDBkZmVlOGU3MjM5Nzk0L3RhYmxlcmFuZ2U6ZTNkZGNmM2YxMGJlNDllOTkwMGRmZWU4ZTcyMzk3OTRfMzUtNy0xLTEtMA_7ab2b84b-2fba-49e0-87c5-68e8e43b0c10"
      unitRef="shares">162000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMi01LTEtMS0w_198ff204-c5d4-4570-b6c2-0cd815dfde82"
      unitRef="usd">533000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMi03LTEtMS0w_d49db17e-0d95-42c8-90ca-7ef72515a1c2"
      unitRef="usd">494000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfNS01LTEtMS0w_6db2bf41-d63a-4040-b76f-9d5ea59899b2"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfNS03LTEtMS0w_b185cfff-28f4-4815-92e0-0c9a0371c80c"
      unitRef="usd">33000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfNi01LTEtMS0w_804df5e5-7118-4988-b1ca-137b3e272093"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfNi03LTEtMS0w_80c46e32-5f38-43ea-8940-98a1dabc0f08"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfNy01LTEtMS0w_0d2e51bf-81ad-459d-9de4-bad14faf5d20"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfNy03LTEtMS0w_dd4b91ed-05d8-43eb-9530-e883267e916a"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfOC01LTEtMS0w_c08e9def-53d7-4d28-9032-4fe113e6f292"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfOC03LTEtMS0w_f5c9a55e-5036-48b2-80e1-faeba7517f20"
      unitRef="usd">29000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMTAtNS0xLTEtMA_9088d221-ba54-4e50-a1cc-7e5359b5f962"
      unitRef="usd">559000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMTAtNy0xLTEtMA_a96dbc1c-fc35-4593-afef-d94aba0762e4"
      unitRef="usd">523000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMTEtNS0xLTEtMA_60ea06b3-57b3-4341-9be0-7323ce12d20c"
      unitRef="usd">50000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMTEtNy0xLTEtMA_ae8e9626-9a7a-416b-be87-93bcdb81aa49"
      unitRef="usd">111000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMTItNS0xLTEtMA_502307a4-17f1-4c21-889e-e3406e398944"
      unitRef="usd">509000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xNi9mcmFnOjA4NTFiMDJlNjg4NjRjMmQ4NmZjYzEwNjM2MzZkMDA2L3RhYmxlOjg2NjRhMGY2ZjM1MzQ1ZDg5MTVkMDliNjU0NTY1YTFhL3RhYmxlcmFuZ2U6ODY2NGEwZjZmMzUzNDVkODkxNWQwOWI2NTQ1NjVhMWFfMTItNy0xLTEtMA_53071544-a222-4487-97c5-dabcc88dc0eb"
      unitRef="usd">412000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMy0xLTEtMS0w_e087cd77-8d50-44c5-b21f-bd420577a19e"
      unitRef="usd">2423000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMy0zLTEtMS0w_8b7d7079-d468-410e-a193-60c92769c4e1"
      unitRef="usd">6278000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNC0xLTEtMS0w_5a154e23-1cda-47be-b13f-2dfa7d07428a"
      unitRef="usd">20198000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNC0zLTEtMS0w_671e5f0c-27cc-44fd-b4ad-8bfb7655d674"
      unitRef="usd">19181000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNS0xLTEtMS0w_e2653b3d-fa3e-4751-a6ca-f05714c7ca78"
      unitRef="usd">20016000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNS0zLTEtMS0w_32247a16-c82c-4420-9232-0d87f994d4f0"
      unitRef="usd">19246000000</us-gaap:InventoryNet>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNi0xLTEtMS0w_3b69f3e7-17b0-4431-ae3d-2e320a7d585f"
      unitRef="usd">7000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNi0zLTEtMS0w_ec97b708-3d9b-4649-9864-c9b30c638999"
      unitRef="usd">12000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNy0xLTEtMS0w_59c23f19-fa89-4f9f-80f8-065e2cf6516d"
      unitRef="usd">706000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNy0zLTEtMS0w_df3c5cd4-c55e-4775-ad1c-54d5aac6086a"
      unitRef="usd">665000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfOC0xLTEtMS0w_ef9147d4-0751-40d6-8885-8439b06f4302"
      unitRef="usd">43350000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfOC0zLTEtMS0w_8bbe8481-d55f-470a-bbbc-3fa3bb08fafd"
      unitRef="usd">45382000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfOS0xLTEtMS0w_e10c33bd-79b0-412f-b00a-54d75dcc99ea"
      unitRef="usd">2549000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfOS0zLTEtMS0w_811d8760-d912-46a7-bde0-88906840d907"
      unitRef="usd">2581000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTAtMS0xLTEtMA_8ef068d5-534f-4cdb-ad77-51fecaae3618"
      unitRef="usd">2071000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTAtMy0xLTEtMA_dd68240c-cc9b-410a-be28-934ad2f6c64c"
      unitRef="usd">2100000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTEtMS0xLTEtMA_a6256960-0925-4ca5-a5c3-18dda2ba50c9"
      unitRef="usd">9520000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTEtMy0xLTEtMA_c6e9dd2d-7bc9-4824-a056-d0aed6b47d6a"
      unitRef="usd">9493000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTItMS0xLTEtMA_ff161f6c-360b-4289-b189-5cb4d5543c49"
      unitRef="usd">2797000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTItMy0xLTEtMA_3396b18a-d7d2-4855-a965-f31927bc926a"
      unitRef="usd">2878000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTQtMS0xLTEtMA_af514c4d-98a5-4c88-be4e-9030695cb264"
      unitRef="usd">2607000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTQtMy0xLTEtMA_416d5de2-b6c0-4a64-a533-0795047d3016"
      unitRef="usd">2581000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTUtMS0xLTEtMA_a0b8df84-b5c2-43f0-86bd-3fca80cd3a0d"
      unitRef="usd">62894000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTUtMy0xLTEtMA_1a0b3cd1-f831-414c-ac77-a72b58b288c3"
      unitRef="usd">65015000000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTktMS0xLTEtMA_a20ca206-251c-406f-80a5-7e41ecd0000d"
      unitRef="usd">38389000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMTktMy0xLTEtMA_bb9bd7fc-fafc-40c4-ab3a-493e4af0e954"
      unitRef="usd">38975000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjEtMS0xLTEtMA_c3d55c7a-cd10-4461-999b-73f4aa3d274b"
      unitRef="usd">752000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjEtMy0xLTEtMA_aae6bc2d-6be2-45bd-9ff5-ceb8ba3599cd"
      unitRef="usd">742000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjItMS0xLTEtMA_51797ce1-c685-4583-a585-e6dd9e6cd522"
      unitRef="usd">392000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjItMy0xLTEtMA_8d7259fc-dcbd-4bb5-a778-7d5b6f24bb15"
      unitRef="usd">390000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjMtMS0xLTEtMA_bbf398e2-ace4-40c0-bafa-20b2a53d9e39"
      unitRef="usd">5000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjMtMy0xLTEtMA_cb77f1c1-2bdd-4d81-9a2e-3d16b08f019d"
      unitRef="usd">9000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjQtMS0xLTEtMA_0175b607-65dd-4fb7-b07f-de9b6e834657"
      unitRef="usd">4297000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjQtMy0xLTEtMA_fdd40058-78da-466b-99be-77de544d81a3"
      unitRef="usd">3987000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjUtMS0xLTEtMA_0f1db60c-fb50-4df4-a2a7-2a37a796bad3"
      unitRef="usd">43835000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjUtMy0xLTEtMA_b45f01c0-b338-4ee0-876c-22d149ffb0cd"
      unitRef="usd">44103000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjYtMS0xLTEtMA_55577be5-0e8a-4b38-91e5-14039dafc2ec"
      unitRef="usd">6424000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjYtMy0xLTEtMA_d609ba09-a96a-4d86-872b-7c024483ccb6"
      unitRef="usd">6406000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjctMS0xLTEtMA_e38f434a-c3f7-441c-9793-692166737e29"
      unitRef="usd">1441000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjctMy0xLTEtMA_5b47b3fd-f993-4220-893a-1138ed2568cd"
      unitRef="usd">1411000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjgtMS0xLTEtMA_db325b72-ee53-4212-8a42-682444fa7e4b"
      unitRef="usd">1888000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjgtMy0xLTEtMA_a159fdf6-b6a3-4c0b-8ea2-38ccf11dc47c"
      unitRef="usd">1867000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjktMS0xLTEtMA_e310ed96-2a03-45b5-9057-3f38a2185d22"
      unitRef="usd">7596000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:LitigationReserveNoncurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMjktMy0xLTEtMA_d9f25fcb-8649-4cf1-b200-b1304483715b"
      unitRef="usd">8067000000</us-gaap:LitigationReserveNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzAtMS0xLTEtMA_6b141827-48d7-4594-9a71-e1e9a1e97ba0"
      unitRef="usd">1748000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzAtMy0xLTEtMA_236c5526-abc0-422e-b86b-a4e3b06e0e08"
      unitRef="usd">1715000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzEtMS0xLTEtMA_0c6a764d-13ea-415e-9686-3820a0439dda"
      unitRef="usd">7000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzEtMy0xLTEtMA_d0e020be-dc36-4bb2-b823-f6b1a2733164"
      unitRef="usd">1271000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzIx_3209eb78-6a4f-42fb-83bf-0f18137b0a98"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzIx_6df10fe1-2479-40c1-a23f-13033dd84b9c"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzM1_31b1ff79-2a3c-429e-af99-2ea699edbf91"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzM1_ccdf6fbc-3040-4369-997e-e050c6313a13"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzU3_4ac150f0-b268-4687-917f-3cd7e1e7a5bc"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzU3_4c29c416-ba40-47b4-9eb0-6447b989d031"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzU3_c469fd00-0cc0-4e62-a6f8-fe2c175c1e35"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOmZlYzVhODFjYjQwYzRlZjk5ZTIyNTYxNjEwNWM0NzU4XzU3_e1821884-6fef-4567-b280-7dd7762133a0"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMS0xLTEtMA_12150b1f-ba94-4754-8e37-d2b70890a488"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzMtMy0xLTEtMA_2d3e3a84-e5b7-48b3-a10d-a41c3f4a2b18"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE3ODU1MGI3NTIzMjQyNzY4ZWRmMzg2MWFkNzMwNGZlXzE4_98abf703-b385-49b6-a93c-c7fbe4e17fbc"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE3ODU1MGI3NTIzMjQyNzY4ZWRmMzg2MWFkNzMwNGZlXzE4_e8d8b7b6-dd4a-4156-a078-50c8e659ce94"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE3ODU1MGI3NTIzMjQyNzY4ZWRmMzg2MWFkNzMwNGZlXzMy_34c258c6-7d77-417c-939e-ae1741c78147"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE3ODU1MGI3NTIzMjQyNzY4ZWRmMzg2MWFkNzMwNGZlXzMy_fa89546a-1c01-4492-8439-21bcdb6091ee"
      unitRef="shares">800000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE3ODU1MGI3NTIzMjQyNzY4ZWRmMzg2MWFkNzMwNGZlXzU3_e6546f37-0019-4c59-b6b6-a4cd987d2ac2"
      unitRef="shares">274000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOmE3ODU1MGI3NTIzMjQyNzY4ZWRmMzg2MWFkNzMwNGZlXzY0_edb2a67a-daec-4b80-b0c7-8da8e66d9d52"
      unitRef="shares">273000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMS0xLTEtMA_8d470b8e-37b4-4cb5-87c7-f930fb8e3f57"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzQtMy0xLTEtMA_aff8fc5b-ed58-454f-a89c-0e9f1e7e9fa0"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzUtMS0xLTEtMA_74beb754-9f08-4af9-bd7e-0a87e5d6c4cd"
      unitRef="usd">7057000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzUtMy0xLTEtMA_d1e144b0-4d80-4cbc-a035-5b2037a84aeb"
      unitRef="usd">6925000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzYtMS0xLTEtMA_de1476db-aef1-4f9d-b9ac-8e3cec7b475a"
      unitRef="usd">8618000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzYtMy0xLTEtMA_88306dfa-0cda-4e3e-badf-a9cd3f533722"
      unitRef="usd">8202000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzctMS0xLTEtMA_6838d41a-2ad8-4b5e-910e-b2b6454af753"
      unitRef="usd">-1627000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzctMy0xLTEtMA_834e7185-a156-44d8-9b2d-39a1cc130997"
      unitRef="usd">-1480000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzktMC0xLTEtMC90ZXh0cmVnaW9uOmQ2ODNlNjIwOWRmODQ4ZTNhZTRmNzU3MDJhODk4Yjk1XzMw_fcb47038-8822-48df-bbba-c98a2e477943"
      unitRef="shares">119000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzktMC0xLTEtMC90ZXh0cmVnaW9uOmQ2ODNlNjIwOWRmODQ4ZTNhZTRmNzU3MDJhODk4Yjk1XzM3_b23f6817-5871-4e1d-a07a-2cfa31da169c"
      unitRef="shares">115000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzktMS0xLTEtMA_588bb790-74f2-4c2d-bf9f-69712d5591e6"
      unitRef="usd">14579000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfMzktMy0xLTEtMA_7cced4ec-f3b4-4f8d-a7c9-e2b96cbaf9a2"
      unitRef="usd">13670000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDAtMS0xLTEtMA_58409ab4-9d92-4605-8d9a-8b04b8b4b687"
      unitRef="usd">-529000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDAtMy0xLTEtMA_0a8bbdc0-7083-4aa8-ade6-d3630cafda90"
      unitRef="usd">-21000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDEtMS0xLTEtMA_d963c42f-4d5e-4c6d-94b2-5bf9113ea310"
      unitRef="usd">484000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDEtMy0xLTEtMA_03cb7a88-71e0-41a7-a925-48df297750d6"
      unitRef="usd">196000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDItMS0xLTEtMA_160aacee-f8db-4acc-9798-995d1dfb5c7d"
      unitRef="usd">-45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDItMy0xLTEtMA_c659e184-c21d-44e0-9349-8fd26d5aa81f"
      unitRef="usd">175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDMtMS0xLTEtMA_bf4586bd-d38e-4dc7-ab94-43817ff05d2f"
      unitRef="usd">62894000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8xOS9mcmFnOmYyYzdmYTM1NTM3MDQzZmFhZDRhNzMwNzVjYmUwZDAxL3RhYmxlOmMwM2QwMjBhNDQ1NzRlMWE4YWNiZWExODZkZjQ3YjQ0L3RhYmxlcmFuZ2U6YzAzZDAyMGE0NDU3NGUxYThhY2JlYTE4NmRmNDdiNDRfNDMtMy0xLTEtMA_fde62c16-0f04-4fe4-b8cd-b3e74617ebde"
      unitRef="usd">65015000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="ide611772c559475e8e24346506419cca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0xLTEtMS0w_454ef79b-27c9-4ab0-bf08-138506b46d44"
      unitRef="shares">273000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ide611772c559475e8e24346506419cca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0zLTEtMS0w_7d2f2e65-f8da-477d-b6e7-7b3ef17cfc75"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie70b404c2db04f2ebe83db4787529b8e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy01LTEtMS0w_6059ea21-58d7-479a-9bcc-6cdc774eeb82"
      unitRef="usd">6925000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a5a6c3bbe5e44deb764a82396a14df9_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy05LTEtMS0w_99362731-7840-43b1-b8f4-b623dadaaf08"
      unitRef="usd">8202000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i29b18210e4c94b3e9eeea079457c3440_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0xMS0xLTEtMA_8ebd49ce-4a96-417b-a86f-ab2293e06f22"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ia04e0037336742a5862b1a73adc63e1f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0xMy0xLTEtMA_03475dd1-3a46-4fab-8bfa-fad470f52559"
      unitRef="shares">115000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia04e0037336742a5862b1a73adc63e1f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0xNS0xLTEtMA_917fd87a-7d6b-480e-a1e4-7f6634ecce38"
      unitRef="usd">-13670000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iedb46ad9eb03415b8c3ef478a437c8d0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0xNy0xLTEtMA_04a33b11-521b-441a-9437-4a9fc434112e"
      unitRef="usd">196000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMy0xOS0xLTEtMA_d94d273d-65f3-436c-a861-bb4e3a4b07b8"
      unitRef="usd">175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i31f3423fd8914bcc953eed5489c40bb9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNC0xLTEtMS0w_3dd41540-4777-43ac-b377-165a999cc347"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i15e4d7260c2e41f096bdffa4d471fb63_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNC01LTEtMS0w_a77619de-bfb0-49c3-9e12-26c2efe6b70c"
      unitRef="usd">71000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i634d779a260d4eab96c467a9cdde3019_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNC0xNS0xLTEtMA_9188ea8c-b0c4-41b9-b89d-5e786d51e4c3"
      unitRef="usd">-59000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNC0xOS0xLTEtMA_cd8b282b-24b1-4502-8353-2c49b4b51d6f"
      unitRef="usd">12000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i15e4d7260c2e41f096bdffa4d471fb63_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNS01LTEtMS0w_e585ba3a-14e3-4647-89a0-9b8016389913"
      unitRef="usd">33000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNS0xOS0xLTEtMA_9d6168c5-308a-4f2e-8e24-8390c2b780de"
      unitRef="usd">33000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNi0xNy0xLTEtMA_177931bd-9be8-47a8-9961-a74050a86ab5"
      unitRef="usd">39000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNi0xOS0xLTEtMA_2a2dfecf-2eca-4eec-95c2-7875299bdc75"
      unitRef="usd">39000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4c03ab80e93f47289af42a50526f49e2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNy0xMS0xLTEtMA_3b7dc93d-f731-45de-a5df-5ab19368954d"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfNy0xOS0xLTEtMA_782ada91-f241-4f59-9701-357996cd688e"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i22d5a4e9af084716946bdd5617413192_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOC05LTEtMS0w_c7c72765-b877-4acc-b1b1-1bfcf59ccaea"
      unitRef="usd">486000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOC0xNy0xLTEtMA_e05aab43-ea36-4f1a-aee5-0944c6b9a3a1"
      unitRef="usd">39000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOC0xOS0xLTEtMA_28146496-5223-4a81-b533-464910e1252d"
      unitRef="usd">525000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i15e4d7260c2e41f096bdffa4d471fb63_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOS01LTEtMS0w_2aa0e0e6-fb43-44dc-b351-5592d65dc94a"
      unitRef="usd">150000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i634d779a260d4eab96c467a9cdde3019_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOS0xMy0xLTEtMA_631b207e-1662-4646-b18c-74ad2f82e36c"
      unitRef="shares">4000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i634d779a260d4eab96c467a9cdde3019_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOS0xNS0xLTEtMA_1a3bbbc5-42fd-403d-a967-e03dcd7ab876"
      unitRef="usd">850000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfOS0xOS0xLTEtMA_63ea98dd-f0e9-4eee-904d-f437f99cac52"
      unitRef="usd">1000000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i15e4d7260c2e41f096bdffa4d471fb63_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTAtNS0xLTEtMA_b6350256-77a1-4a85-9272-8912a60ec639"
      unitRef="usd">178000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i4c03ab80e93f47289af42a50526f49e2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTAtMTEtMS0xLTA_e45a4d19-b13c-4753-b28b-2153cbedac17"
      unitRef="usd">-170000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTAtMTktMS0xLTA_0a3757a2-b9d0-409b-a84c-193844dc762b"
      unitRef="usd">8000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTEtMTctMS0xLTM4NTg_f875cedf-f382-4c97-acf7-1a4271cda84c"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTEtMTktMS0xLTM4NTg_e38534a5-bcb7-4d74-a8f3-92a9d8f9f180"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmVlNWZhYzkzOWZkNjQwNTQ5NjUwY2NjYzI4Y2VjOTdlXzgyNDYzMzcyMDgzNzE_c5dce1f9-319c-4e72-b7a5-e6da04ae843b"
      unitRef="usdPerShare">0.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i22d5a4e9af084716946bdd5617413192_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTEtOS0xLTEtMA_4214e739-38f1-4d85-ab61-4ecace389146"
      unitRef="usd">65000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTEtMTktMS0xLTA_ccfa712f-7cb7-439b-adcc-5a5fc2b2c2be"
      unitRef="usd">65000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i22d5a4e9af084716946bdd5617413192_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTItOS0xLTEtMA_1b5a5fd0-660e-4b0a-be55-6f7b69ee6c37"
      unitRef="usd">5000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTItMTctMS0xLTA_f394ebbf-dcae-4cff-a117-b2d515d52fca"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTItMTktMS0xLTA_4e8bd6be-802b-4822-a342-340e238b7fc7"
      unitRef="usd">4000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i5ebbfc861a6b4540a93bb5855e3d39fd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMS0xLTEtMA_4bd260a0-bdfa-4900-8c62-e84ec054bf05"
      unitRef="shares">274000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ebbfc861a6b4540a93bb5855e3d39fd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMy0xLTEtMA_8fa2e5e7-70b6-4945-85c8-2dc52498f6f3"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i26afe17b7028469f99257689fdff7dda_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtNS0xLTEtMA_e548f632-f920-4565-aab6-019d0364d1b9"
      unitRef="usd">7057000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6a3a202be855424c8713dd4fb041ea5f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtOS0xLTEtMA_57e4f0a0-4a76-40c0-8fc2-266ea22bc04f"
      unitRef="usd">8618000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8466c6d9312243f598d0a021cf047894_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMTEtMS0xLTA_33e16245-e155-4f1b-b778-5aecab1676a0"
      unitRef="usd">-1627000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i0259ca22a00146cdafb9ed748adbb334_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMTMtMS0xLTA_ef6a5c18-7df0-4caa-90f5-016d2119291c"
      unitRef="shares">119000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0259ca22a00146cdafb9ed748adbb334_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMTUtMS0xLTA_fdad7145-cc7b-4dae-a3e6-b0acd9c5a111"
      unitRef="usd">-14579000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icedc97c57c25494bb97ac3ef916d8842_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMTctMS0xLTA_556c8140-d502-4989-98a1-5d9bfbefaace"
      unitRef="usd">484000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOjYxNTYyYzU3OGJiODQ3M2RhNmFlZGYxMmJkODYyYjJhL3RhYmxlcmFuZ2U6NjE1NjJjNTc4YmI4NDczZGE2YWVkZjEyYmQ4NjJiMmFfMTMtMTktMS0xLTA_a87c78fe-078b-41f5-a688-a421f0471c89"
      unitRef="usd">-45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i72ec1598f96f46b4a2aa09a894edbf4e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0xLTEtMS0w_73b83dbf-fdf3-449c-a88e-ef50d24b9270"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i72ec1598f96f46b4a2aa09a894edbf4e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0zLTEtMS0w_ead5b251-acf0-40f6-bf09-107c4d66571c"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id9687fb04dbd469694095f24c00a6c23_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy01LTEtMS0w_fc31ceee-9bdc-4557-804d-b135a3c70789"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i24796da60e81481facb6d498be5e87ed_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy05LTEtMS0w_08b45886-bd23-4863-a4a7-7b8ef884546e"
      unitRef="usd">13022000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i755d7f41b47e492b8cb1bb239e98220c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0xMS0xLTEtMA_cacd71d0-0cd7-4da1-acfa-f0b981a3c3eb"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ice2df17bcd5c4d70b58287a28e594ce8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0xMy0xLTEtMA_0c750754-76d5-40ba-8ecc-6999bf503c81"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice2df17bcd5c4d70b58287a28e594ce8_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0xNS0xLTEtMA_59f4d6c4-4425-4fc0-9c0b-bbaae741f77a"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iecd424d4030942d9b9c9e99c1603c4a3_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0xNy0xLTEtMA_e7f2553a-7963-4567-af66-04256330678e"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f7de12727134d7896b46445549479aa_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMy0xOS0xLTEtMA_819ae5cf-e219-46b3-9f6a-f0746d4091fc"
      unitRef="usd">5309000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8425fdcd51654e2788cfd296989eaf07_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNC05LTEtMS0zNzc0_277354dc-111a-4a34-8d98-387f3ca11030"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6ba16cd1fc7244ceb1279fd03c7f3d71_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNC0xOS0xLTEtMzc3NA_0770c747-dc47-46bd-bcd8-3ac2a61648a0"
      unitRef="usd">-13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i2843b04f5ade4927b1bcf699ff9e4e7f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xLTEtMS0zNzc0_bfacdc75-e5ce-41ee-a477-bcf88d1134d0"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2843b04f5ade4927b1bcf699ff9e4e7f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0zLTEtMS0zNzc0_ae42095e-f987-4c4a-93c2-05205085b3bc"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i45bcf4e2e2d8477e8b1e8879961cbdf6_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS01LTEtMS0zNzc0_c31b847a-274d-4f22-b607-fe5dca62f033"
      unitRef="usd">6663000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5ddcf2818a34e28bd1e5fa9f983727c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS05LTEtMS0zNzc0_ff32da7b-1e5e-4713-ae25-099045d03aa6"
      unitRef="usd">13009000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i725d870b5d0847e5a0034ebf590b23a9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xMS0xLTEtMzc3NA_6a29e4e5-c98f-420f-ba2e-d8f9f3ec50c0"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="ibd2846306c6949939b64d3cbdef8e7c3_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xMy0xLTEtMzc3NA_8bfdf3bc-10f6-4cea-9948-26c8b22620a2"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd2846306c6949939b64d3cbdef8e7c3_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xNS0xLTEtMzc3NA_78724e6d-88b9-4926-a650-5f71eae30623"
      unitRef="usd">-12892000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5039f65c2af54891b1478714de89353c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xNy0xLTEtMzc3NA_7c6a524f-5650-45c9-b3fe-0d2d51e706d8"
      unitRef="usd">217000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7e4d9b8d9f51455cba6575dd2af5893a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xOS0xLTEtMzc3NA_b2533961-5da3-4d79-876c-86a9366eb4eb"
      unitRef="usd">5296000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i5013134a08dd45ba9c62f3e98630e1ff_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNC01LTEtMS0w_85569aff-7905-4503-869a-9d07c7b25392"
      unitRef="usd">21000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i056b6f4cd57242638814e7e5ff75d938_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNC0xNS0xLTEtMA_62437a0b-02a9-4656-9e94-d3d5d7c5e885"
      unitRef="usd">-24000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNC0xOS0xLTEtMA_74cc084e-64c8-49c3-9aa8-700823a949ab"
      unitRef="usd">-3000000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5013134a08dd45ba9c62f3e98630e1ff_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS01LTEtMS0w_70e22101-893b-4dfe-a084-87db7bf80f8d"
      unitRef="usd">23000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNS0xOS0xLTEtMA_49ce8f27-84b8-4bca-a330-bdf4adf50e90"
      unitRef="usd">23000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNi0xNy0xLTEtMA_f8c7ce06-de5b-46f4-8d4d-3b018c6cd853"
      unitRef="usd">43000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNi0xOS0xLTEtMA_7e586669-48fc-480e-be7a-308c908420f8"
      unitRef="usd">43000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if98dc411e46a41db9665e0cdbbd91413_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNy0xMS0xLTEtMA_f7273731-75ce-4027-9bfd-2203757a524d"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfNy0xOS0xLTEtMA_7dff03a5-e195-4417-9419-82e19b3d3a11"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="ia3eb01708eee4de88a588b3642d67848_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfOC05LTEtMS0w_d66c9f5e-4e1a-4d38-8fc7-f705b0b35876"
      unitRef="usd">444000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfOC0xNy0xLTEtMA_bd069ec9-42ec-4bd3-874f-42d5db141471"
      unitRef="usd">39000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfOC0xOS0xLTEtMA_36b53d8b-a7a0-434b-b15e-5a1ca7686962"
      unitRef="usd">483000000</mck:NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i5013134a08dd45ba9c62f3e98630e1ff_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTAtNS0xLTEtMA_d25d266a-9c66-42e4-bff0-fbaef48a087d"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTAtMTktMS0xLTA_d484a516-f221-4646-bb04-795fadf3748c"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOjlhMjEyMjE2MzQ5NDQ0N2VhNDJhMmNlNDgzZWFlMjQ3XzgyNDYzMzcyMDgzNjk_d6d0a8bd-24c0-40e7-af47-8fa79e900a9d"
      unitRef="usdPerShare">0.41</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="ia3eb01708eee4de88a588b3642d67848_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTEtOS0xLTEtMA_aae69b5e-c05d-4837-9387-9ceaa9aa677a"
      unitRef="usd">67000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTEtMTktMS0xLTA_f9240e5e-ac6c-4b55-85b2-ba965719c8eb"
      unitRef="usd">67000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i5013134a08dd45ba9c62f3e98630e1ff_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTItNS0xLTEtMA_24b3fdb7-39e7-44b8-be1f-9837fc6a52e7"
      unitRef="usd">-1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ia3eb01708eee4de88a588b3642d67848_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTItOS0xLTEtMA_57c7b120-7725-4c02-9515-f8e83e43ea3a"
      unitRef="usd">2000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTItMTctMS0xLTA_a583d43f-3ec8-4263-8263-b4dff0850327"
      unitRef="usd">6000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTItMTktMS0xLTA_751ec993-004f-432b-a59f-607c5db540af"
      unitRef="usd">7000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesOutstanding
      contextRef="i8c8196204fec46a4b86aba7adf40b724_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMS0xLTEtMA_a92406d2-4219-4e7e-aa9b-39affc4be79f"
      unitRef="shares">272000000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8c8196204fec46a4b86aba7adf40b724_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMy0xLTEtMA_e9c0a377-533b-4365-91bb-bdddbb4efb99"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id548799f7ab1465c837921be5e020ed5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtNS0xLTEtMA_576b8adf-f541-4b7e-9305-04414962ffd1"
      unitRef="usd">6711000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia1aaf42c089f4e2fa8f947ce43febbf5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtOS0xLTEtMA_9403a188-8f2e-44cb-9e03-6cadd1385543"
      unitRef="usd">13384000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87c849ded324459ca97d3b31b68b0bd6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMTEtMS0xLTA_9fa6554f-e3e6-4702-ae83-f805ee4fa774"
      unitRef="usd">-1735000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i468f96b19c9d424ab3c34d92dd9ba0f2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMTMtMS0xLTA_e4a111ed-2ee0-45c1-beb8-7e2447bdc2ab"
      unitRef="shares">110000000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i468f96b19c9d424ab3c34d92dd9ba0f2_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMTUtMS0xLTA_06203651-61db-4722-ad82-b88ae18898d9"
      unitRef="usd">-12916000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9b3fb15d56c74664afb9bf5941948b0f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMTctMS0xLTA_0f09bcde-b92c-49e7-a10d-dc0abcbe55e0"
      unitRef="usd">207000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6e51367df2e54805b65a34b535c3a768_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yMi9mcmFnOjE2ZjUxYzljZDc3YjQ3MzY5ZDQ2NjczODFiZmE5OWM1L3RhYmxlOmRkOWQwNTIzMzcxMTQwMGNhNzFjYmE3MWYxZWJlYWQ0L3RhYmxlcmFuZ2U6ZGQ5ZDA1MjMzNzExNDAwY2E3MWNiYTcxZjFlYmVhZDRfMTMtMTktMS0xLTA_abef4cbb-a14a-471c-aef3-c353c9c5988b"
      unitRef="usd">5653000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMy0xLTEtMS0w_dcb39c5d-572a-4cb6-bdfe-888c45d90213"
      unitRef="usd">533000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMy0zLTEtMS0w_d0ccb4af-7afb-4910-9a09-84b8f021d3cc"
      unitRef="usd">494000000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNS0xLTEtMS0w_60a4d7ed-edfa-469f-a21a-ebd606f40abb"
      unitRef="usd">80000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNS0zLTEtMS0w_41b20615-13ae-4af2-bb34-c836272b22f0"
      unitRef="usd">75000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNi0xLTEtMS0w_21548671-98d0-43f4-906f-a23b12de239c"
      unitRef="usd">138000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNi0zLTEtMS0w_e484a69f-2c18-492c-825c-d1080a7e8fb4"
      unitRef="usd">142000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AssetImpairmentCharges
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNy0xLTEtMS0w_8ef11776-8041-4673-b4e6-40e903c64b19"
      unitRef="usd">104000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNy0zLTEtMS0w_213c483c-dbc6-40e5-96b0-a863dae79b64"
      unitRef="usd">5000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfOS0xLTEtMS0w_1919f5c6-45a5-4155-936f-592a6a1a8b33"
      unitRef="usd">-36000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfOS0zLTEtMS0w_b91710b9-8c66-44fa-b5c9-72db01519b09"
      unitRef="usd">-28000000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTAtMS0xLTEtMA_de46a8ff-2d30-48af-be95-8fe287a6652e"
      unitRef="usd">-23000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTAtMy0xLTEtMA_a30d9f9c-e1ad-4c03-b921-c0bb8c4feed6"
      unitRef="usd">-52000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:OperatingLeaseExpense
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTEtMS0xLTEtMA_a93395f1-e48a-4110-9d2a-ebb95064dfaa"
      unitRef="usd">90000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTEtMy0xLTEtMA_c5a7e1c3-1fa8-45de-8fdd-05f1ba8c2f96"
      unitRef="usd">83000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTItMS0xLTEtMA_d84bd43e-9fb8-4f2d-a6a6-a3948e09898a"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:GainLossOnSaleOfOtherAssets
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTItMy0xLTEtMA_95ad2aad-50a3-414c-bc15-39588c837b78"
      unitRef="usd">-2000000</us-gaap:GainLossOnSaleOfOtherAssets>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTMtMS0xLTEtMA_5e605f47-f833-4929-8a34-94660fbab6de"
      unitRef="usd">-194000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTMtMy0xLTEtMA_7d6de602-73fd-4737-8f61-78a1e0da8092"
      unitRef="usd">-9000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTUtMS0xLTEtMA_ed02e954-ac90-4927-a15b-121cc5c665dd"
      unitRef="usd">1045000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTUtMy0xLTEtMA_63b066b4-2741-490c-ad26-b00453ca4f43"
      unitRef="usd">-2291000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTYtMS0xLTEtMA_bc75aea5-a385-48a4-bacf-b5774fd3a482"
      unitRef="usd">901000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTYtMy0xLTEtMA_039b362e-87f6-4cd5-899c-6c35ee4bb5b9"
      unitRef="usd">-238000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTctMS0xLTEtMA_81b6bed2-d3d8-4ff5-bca9-f302492ab89d"
      unitRef="usd">-609000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTctMy0xLTEtMA_45e9b4fb-37c1-48c8-b79c-04ca70ac43d9"
      unitRef="usd">-4214000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTgtMS0xLTEtMA_2731bd91-e31c-498d-94f8-c1b31364e72b"
      unitRef="usd">-90000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTgtMy0xLTEtMA_e94b1965-e63a-4617-9208-ad74df0aa3a7"
      unitRef="usd">-89000000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTktMS0xLTEtMA_309d03e4-9a74-4dc9-acea-2575737cb226"
      unitRef="usd">-54000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedTaxesPayable
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMTktMy0xLTEtMA_5c179f20-aa37-4239-96ef-05bebe812295"
      unitRef="usd">76000000</us-gaap:IncreaseDecreaseInAccruedTaxesPayable>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjAtMS0xLTEtMA_5ce30c2c-67b7-4ea5-aafe-11ac877e60d0"
      unitRef="usd">74000000</mck:IncreaseDecreaseInLitigationReserve>
    <mck:IncreaseDecreaseInLitigationReserve
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjAtMy0xLTEtMA_04e666f4-fd4c-495c-bb7d-1a92adac8bbe"
      unitRef="usd">0</mck:IncreaseDecreaseInLitigationReserve>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjEtMS0xLTEtMA_efc8f577-2436-444c-b306-b0ddf2549c5a"
      unitRef="usd">149000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjEtMy0xLTEtMA_21b472f5-28da-417a-b1ef-ca20be64c6ed"
      unitRef="usd">150000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjItMS0xLTEtMA_344887ab-de7d-45c9-bb24-c7ab8f4de7ca"
      unitRef="usd">-1622000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjItMy0xLTEtMA_47b96b45-a48b-4c18-9c9d-6e370e01d9b2"
      unitRef="usd">-1062000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjUtMS0xLTEtMA_23a26243-31d8-4980-aa43-cf66a317f97b"
      unitRef="usd">93000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjUtMy0xLTEtMA_f5880bce-2b3d-4f6b-ab3f-46cd474c4b2e"
      unitRef="usd">72000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjYtMS0xLTEtMA_df38ca52-1c53-4ba9-b34e-bfede7f710f4"
      unitRef="usd">66000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireSoftware
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjYtMy0xLTEtMA_dd396273-f9b7-4065-ab5f-8d76e3d59421"
      unitRef="usd">45000000</us-gaap:PaymentsToAcquireSoftware>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjctMS0xLTEtMA_3cfde963-17c1-4f37-8000-fc41b69a6445"
      unitRef="usd">1000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjctMy0xLTEtMA_02826cbc-2ea8-435b-9d58-00c99a193301"
      unitRef="usd">4000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjgtMS0xLTEtMA_3e633afb-c4eb-4dfb-8efa-f147d8cf820b"
      unitRef="usd">83000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjgtMy0xLTEtMA_f37902a3-6837-48c7-9e24-d77fa7ae82bf"
      unitRef="usd">7000000</us-gaap:ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjktMS0xLTEtMA_1d8ed4b0-ecb8-4a02-a86e-8e497ece4371"
      unitRef="usd">22000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMjktMy0xLTEtMA_7ee5d569-b956-4d83-bf90-771702e7dc24"
      unitRef="usd">16000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzAtMS0xLTEtMA_bd5adb44-fb06-4611-bfa7-4454a9fa8c89"
      unitRef="usd">-99000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzAtMy0xLTEtMA_6d19b42e-19ba-49b0-b7fb-338d1c0ae64f"
      unitRef="usd">-130000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzMtMS0xLTEtMA_2abb23cf-808f-4f8c-bce6-4a9102434247"
      unitRef="usd">0</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzMtMy0xLTEtMA_e28b6824-a0ed-4d93-a24c-2badb4c9e849"
      unitRef="usd">5303000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzQtMS0xLTEtMA_dac74e3d-3104-45c8-a703-ecaaa289916e"
      unitRef="usd">0</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzQtMy0xLTEtMA_e3accc14-0a13-482c-98fa-716d06511e67"
      unitRef="usd">5303000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzYtMS0xLTEtMA_3907cc70-d358-4bb3-9a52-8f17aa90aec3"
      unitRef="usd">2000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzYtMy0xLTEtMA_a0e299b0-1931-4f7b-b258-3f4ee01513cf"
      unitRef="usd">2000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzgtMS0xLTEtMA_49920b0a-d18a-4263-a75a-f1dd293bc387"
      unitRef="usd">71000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzgtMy0xLTEtMA_b1272087-d48f-4f47-88bc-873397537693"
      unitRef="usd">21000000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzktMS0xLTEtMA_8821d24c-fbd6-4b4e-b49f-4ff24b547c37"
      unitRef="usd">1008000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfMzktMy0xLTEtMA_30f90197-adea-4c5c-8f7d-054b165676fd"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDAtMS0xLTEtMA_864a32c0-aaf0-4235-a700-9878532fa8b1"
      unitRef="usd">69000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDAtMy0xLTEtMA_2653d115-4101-492c-a92e-ac079b8185d0"
      unitRef="usd">74000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDEtMS0xLTEtOTY5OA_35ecfd49-b32b-4524-b470-6d857e1f0a87"
      unitRef="usd">1031000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDEtMy0xLTEtOTcwMw_0f65e4a3-8f6d-404f-8c51-65f5290e11d7"
      unitRef="usd">49000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDEtMS0xLTEtMA_9c1cf110-65ef-441d-a399-c15ac24c88e6"
      unitRef="usd">-112000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDEtMy0xLTEtMA_9e1e835d-c6a3-4145-a4cc-04b2630564ca"
      unitRef="usd">165000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDItMS0xLTEtMA_3bc3315a-2164-4bad-bad8-9ae0be3919de"
      unitRef="usd">-2151000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDItMy0xLTEtMA_a62d84d8-0a39-430f-9d7f-b5f402f04ab2"
      unitRef="usd">61000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDMtMS0xLTEtMA_d19ca89c-fc09-4e8c-bdce-ce6c0c31756a"
      unitRef="usd">11000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDMtMy0xLTEtMA_4a2ac52e-1b42-4129-9c8f-0f5667feefb4"
      unitRef="usd">-28000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDQtMS0xLTEtMA_5829429e-c5da-4ff0-8417-173ff0996bfe"
      unitRef="usd">-3861000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDQtMy0xLTEtMA_2f471cd5-f3e7-41a4-bbb5-21747550dad5"
      unitRef="usd">-1159000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDUtMS0xLTEtMA_0d8cc6da-4381-4190-ae0e-960ef2f1cb99"
      unitRef="usd">6396000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7f7de12727134d7896b46445549479aa_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDUtMy0xLTEtMA_41c668e3-d556-4278-bfa1-de9e34dc7cda"
      unitRef="usd">4023000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDYtMS0xLTEtMA_7fe71bdb-7c29-4869-9abe-636512c2ff86"
      unitRef="usd">2535000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6e51367df2e54805b65a34b535c3a768_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDYtMy0xLTEtMA_c50efee5-966e-4f3c-aeb7-4b6e7659fe0b"
      unitRef="usd">2864000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:RestrictedCashCurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDctMS0xLTEtMA_e7f942e1-ed3d-468e-b739-f39c069596c4"
      unitRef="usd">112000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i6e51367df2e54805b65a34b535c3a768_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDctMy0xLTEtMA_d22c780b-24e5-440d-a98d-31933294cec6"
      unitRef="usd">251000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDktMS0xLTEtMA_e43bf605-8d67-4ba2-8434-9fda9b3f0c0f"
      unitRef="usd">2423000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6e51367df2e54805b65a34b535c3a768_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8yNS9mcmFnOjljOTNiZWNlYzE3MTQzODVhOGUwODJjNmNjNWRkMzQ5L3RhYmxlOjQ0MmNiZDY2YzRjNjQ5M2I4NmVhZWZkM2Y5ODViNTY4L3RhYmxlcmFuZ2U6NDQyY2JkNjZjNGM2NDkzYjg2ZWFlZmQzZjk4NWI1NjhfNDktMy0xLTEtMA_27e88eff-e476-45f2-ad15-c0f151934f30"
      unitRef="usd">2613000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMTA3Nzg_d19233f5-1d4b-4c82-a372-8ed7848f0ae2">Significant Accounting Policies&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: McKesson Corporation (&#x201c;McKesson,&#x201d; or the &#x201c;Company,&#x201d;) is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments, and other organizations in healthcare to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#x201c;RxTS&#x201d;), Medical-Surgical Solutions, and International. Refer to Financial Note 14, &#x201c;Segments of Business,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S.&#x201d;) of America (&#x201c;GAAP&#x201d;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) pandemic. As COVID-19 evolves, the Company&#x2019;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations for the three months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, previously filed with the SEC on May 12, 2021 (&#x201c;2021 Annual Report&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, the Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfNjIy_e4c2efc6-9ad5-48c3-a84f-8b00bfd6c4c4"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMTA3NDU_5632848c-3478-4056-84de-0f59cf9016c0">&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#x2019;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#x201c;VIE&#x201d;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;U.S.&#x201d;) of America (&#x201c;GAAP&#x201d;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMTA3NDE_c65ca087-612e-42ba-8be1-f0b0c4869917">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the coronavirus disease 2019 (&#x201c;COVID-19&#x201d;) pandemic. As COVID-19 evolves, the Company&#x2019;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.</us-gaap:UseOfEstimates>
    <us-gaap:ComparabilityOfPriorYearFinancialData
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMzI5ODUzNDkwMzI2Mg_267a94b9-d6d6-40ac-a9a2-a6f0b3d5d179">The results of operations for the three months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, previously filed with the SEC on May 12, 2021 (&#x201c;2021 Annual Report&#x201d;).</us-gaap:ComparabilityOfPriorYearFinancialData>
    <us-gaap:FiscalPeriod
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMTA3NjQ_341f934c-a495-489d-bbaa-2632b352c6d1">The Company&#x2019;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.</us-gaap:FiscalPeriod>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMTA3NTE_3819c879-ebcc-4409-a41a-e67ceaff64b0">Certain prior year amounts have been reclassified to conform to the current year presentation.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl8zMS9mcmFnOjBjYTljODM1MmE4YjRiOTZiMjRhZDdhYmQ1NzZiMjI4L3RleHRyZWdpb246MGNhOWM4MzUyYThiNGI5NmIyNGFkN2FiZDU3NmIyMjhfMTA3Njk_4c9974c7-42a4-49d4-b74b-6374dfa369a1">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, the Company adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#x2019;s condensed consolidated financial statements or disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfNDkxMw_b17488dd-7fbf-4b67-bd62-8f1cf1bc50bf">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Held for Sale&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are reclassified into &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less cost to sell is reported as an adjustment to the carrying value of the disposal group. Assets and liabilities that have met the classification of held for sale were $7 million and $5 million, respectively, at June 30, 2021 and $12&#160;million and $9&#160;million, respectively, at March 31, 2021. Based on its analysis, the Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations and are not considered to be significant disposals based on its quantitative and qualitative evaluation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 5, 2021, the Company entered into an agreement to sell certain of its European businesses (&#x201c;disposal group&#x201d;) to the PHOENIX Group for a purchase price of &#x20ac;1.2&#160;billion (or, approximately $1.5&#160;billion), subject to certain adjustments, including net debt adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#x201c;McKesson Europe&#x201d;) at the divestiture date. The Company concluded that the held for sale criteria were not met in the first quarter of 2022 and continued to classify the assets and liabilities of these businesses as held and used in the condensed consolidated balance sheet. Beginning in the second quarter of 2022, the disposal group will be reflected in the Company&#x2019;s condensed consolidated financial statements as held for sale. The disposal group will be remeasured to the lower of its carrying amount or fair value less costs to sell, which the Company estimates will result in a charge of between $500&#160;million and $700&#160;million, primarily related to the inclusion of the accumulated other comprehensive income balances into the carrying amount of the disposal group and the impairment of internal-use software that will not be completed. While this range reflects the Company&#x2019;s best estimate as of the date of this Quarterly Report on Form 10-Q, actual charges could differ based on operating results, changes in foreign exchange rates, and other factors prior to closing of the transaction. The transaction is anticipated to close during 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals, as applicable.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <mck:HeldForSalePolicyTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfMzI5ODUzNDkwMzM1Nw_a36d7861-f222-46f2-8ce0-0bde1cdc889f">Assets and liabilities to be disposed of by sale (&#x201c;disposal groups&#x201d;) are reclassified into &#x201c;held for sale&#x201d; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less cost to sell is reported as an adjustment to the carrying value of the disposal group.</mck:HeldForSalePolicyTextBlock>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i6a911394561149eeb8e541a9ff705e67_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfMTAxMA_dd42ea86-37ca-434f-bd99-6e3895050e11"
      unitRef="usd">7000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i6a911394561149eeb8e541a9ff705e67_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfMTAxNw_46059afc-961c-48c8-894b-5139d94ac292"
      unitRef="usd">5000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i6d6a811e39f549ae99a6bda061e024e8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfMTA0NQ_51f4dc30-3aa2-4fc2-8c4f-320293693d33"
      unitRef="usd">12000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
      contextRef="i6d6a811e39f549ae99a6bda061e024e8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfMTA1Mg_1cf627de-e5e7-4986-8726-94e8aac3be09"
      unitRef="usd">9000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i92f41c6f9c3f4caab2c60ad954bef6af_I20210705"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfNTQ5NzU1ODE1ODQ0NA_92438649-9e8a-493e-bee2-6c5459a1b153"
      unitRef="eur">1200000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected
      contextRef="i92f41c6f9c3f4caab2c60ad954bef6af_I20210705"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfNTQ5NzU1ODE1ODQ3MA_0c5dddc4-bdce-4eb7-bf5b-0ffd95ea8e4e"
      unitRef="usd">1500000000</mck:DisposalGroupIncludingDiscontinuedOperationConsiderationExpected>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected
      contextRef="i057cd4a01a544d42941664a044c0ee99_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfNTQ5NzU1ODE1ODQ5MA_ac92109e-b7d8-4416-acf9-1f5b1599807c"
      unitRef="usd">500000000</mck:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected>
    <mck:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected
      contextRef="i2b729438362242159879d1e5ae05f931_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80MC9mcmFnOmVhNDVjNTY4MDMzNTQwYmRhNzUyNWY1YWZkZTZiMGU3L3RleHRyZWdpb246ZWE0NWM1NjgwMzM1NDBiZGE3NTI1ZjVhZmRlNmIwZTdfNTQ5NzU1ODE1ODUwOA_20b4f091-96bb-4a16-9b1e-337e02edba8a"
      unitRef="usd">700000000</mck:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNzg3MQ_17ba553d-c57d-4284-8dfe-d0e464a08d8d">Restructuring, Impairment, and Related Charges&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded restructuring, impairment, and related charges of $158 million and $56 million during the three months ended June 30, 2021 and 2020, respectively. These charges are included in &#x201c;Restructuring, impairment, and related charges&#x201d; in the Condensed Consolidated Statements of Operations. In addition, charges related to restructuring initiatives are included in &#x201c;Cost of sales&#x201d; in the Condensed Consolidated Statements of Operations and were not material for the three months ended June 30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restructuring Initiatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily includes the rationalization of the Company&#x2019;s office space in North America. Where it determines to cease using office space, the Company plans to exit the portion of the facility no longer used. It also may retain and repurpose certain other office locations. The Company expects to incur total charges of approximately $180 million&#160;to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments. The Company recorded charges of $95 million in the three months ended June 30, 2021. This initiative is anticipated to be completed in 2022. Charges primarily relate to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#x201c;U.K.&#x201d;), which is included in the Company&#x2019;s International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. The Company expects to incur total charges of approximately $85 million to $90 million, of which $63 million of charges were recorded to date. The Company recorded charges of $6 million and $14 million, respectively, in the three months ended June 30, 2021 and 2020, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. The initiative is anticipated to be substantially complete in 2022 and estimated remaining charges primarily consist of accelerated amortization of long-lived assets, facility and other exit costs, and employee-related costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three months ended June 30, 2021 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Costs primarily relate to the transition to the partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs related to the transition to the partial remote work model and U.K. operating model and cost optimization efforts described above, as well as costs for optimization programs in Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three months ended June 30, 2020 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above, and an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the three months ended June 30, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March 31, 2021, the total reserve balance was $151 million, of which $99 million was recorded in &#x201c;Other accrued liabilities&#x201d; and $52 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of June 30, 2021, the total reserve balance was $177 million, of which $127 million was recorded in &#x201c;Other accrued liabilities&#x201d; and $50 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfODM_93244ae5-120f-417d-ad8a-26bf3a75c001"
      unitRef="usd">158000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringSettlementAndImpairmentProvisions
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMTI2_7015c667-0dd0-460c-b4ed-0f4bf354823a"
      unitRef="usd">56000000</us-gaap:RestructuringSettlementAndImpairmentProvisions>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i84cf7e31c16f42f68495c67d9cf8d2e2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjc0ODc3OTA4MTAxMg_d26d76c7-0a5f-4dbc-baa5-56e8013f037c"
      unitRef="usd">180000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i57c77c79ca8e4393a2c77738aeb14820_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjc0ODc3OTA4MTA0MA_23c093dc-eb65-42d1-a2bc-260af3f2c07c"
      unitRef="usd">280000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringCharges
      contextRef="i6c075b17e18f4530aaaaa06575761b8a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjc0ODc3OTA4MTE4Mg_358cc110-af2a-4f05-9e1f-d778e060c264"
      unitRef="usd">95000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i9283db20095f427da10212779ff9e45d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjkxMA_f1508871-4077-4537-b311-a1dafa76ab84"
      unitRef="usd">85000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i57a8d9571d55442c857cdee195f25036_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjkxNg_fecceb21-9304-41fa-89e6-d6e13ec99892"
      unitRef="usd">90000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i87ee4b68e9ad4be0b0e837451f122185_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjc0ODc3OTA4NTM2Ng_1519b0bb-ee39-4457-a115-bb09fa2a7b8e"
      unitRef="usd">63000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringCharges
      contextRef="i2c475719e1e54e988a2716b400ad19c8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjk1Mg_ef8ae368-75a3-4e45-8aec-2f3d21108d33"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i47e37dbe4a284e4dbcd7fb304b436339_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfMjc0ODc3OTA4MDk1Ng_2c40f0b9-d2e5-4f83-b6df-3e6c08f1e5a8"
      unitRef="usd">14000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNzg2NQ_33803971-cf13-4306-8b27-c9d6a9a95cb0">&lt;div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three months ended June 30, 2021 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.271%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.091%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Costs primarily relate to the transition to the partial remote work model described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs related to the transition to the partial remote work model and U.K. operating model and cost optimization efforts described above, as well as costs for optimization programs in Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restructuring, impairment, and related charges during the three months ended June 30, 2020 consisted of the following: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:5.194%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Severance and employee-related costs, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exit and other-related costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments and accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above, and an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Primarily represents costs associated with an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Exit and other-related costs primarily include project consulting fees.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:SeveranceCosts1
      contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMi0xLTEtMS0w_bef6bcc6-2067-4369-bb9b-98ad22e670bd"
      unitRef="usd">2000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMi0zLTEtMS0w_cdbf3a60-adec-4ad2-87ca-7e27ec04d735"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMi01LTEtMS0w_0330d21d-fa1d-48dc-b4af-998e20462caa"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMi03LTEtMS0w_79e7f816-0985-426a-bb8c-5b0f17746233"
      unitRef="usd">12000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMi05LTEtMS0w_f45f2742-d493-4484-bab3-271513c601eb"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMi0xMS0xLTEtMA_83d5a002-5464-4809-b81e-45f944fb4f66"
      unitRef="usd">14000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMy0xLTEtMS0w_cdcc151f-6640-4812-9645-d9ad80fe1ca5"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMy0zLTEtMS0w_42c9ea8f-7f04-411a-a388-dc7ed34b27b4"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMy01LTEtMS0w_a395fc65-1c73-4e4f-a055-9ecabb6f1a54"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMy03LTEtMS0w_c9bfd892-ab37-4f3b-821b-ebb5c3134663"
      unitRef="usd">14000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMy05LTEtMS0w_383085e7-03bf-4b11-bfd9-c030c9a05f12"
      unitRef="usd">21000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfMy0xMS0xLTEtMA_0e868722-417a-4755-a74b-79570d7e7c45"
      unitRef="usd">40000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNC0xLTEtMS0w_f7e4b4a6-184c-45b0-bdde-59f526e5613d"
      unitRef="usd">8000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNC0zLTEtMS0w_21fb9f8e-7c49-4d1e-bd5b-970b81c9557d"
      unitRef="usd">17000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNC01LTEtMS0w_d5090567-9689-444d-b8d1-79677235fbf3"
      unitRef="usd">4000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNC03LTEtMS0w_a23e0868-7e17-43e4-9251-0c9980dc989b"
      unitRef="usd">34000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNC05LTEtMS0w_37dabf43-a1e6-44a3-bfcb-513496abcc21"
      unitRef="usd">41000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNC0xMS0xLTEtMA_22aed470-c376-48c6-a15b-f8b994d93a34"
      unitRef="usd">104000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNS0xLTEtMS0w_5ac9c91e-0ef3-41e4-bf43-ed5a748e8459"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNS0zLTEtMS0w_086912ed-a5c0-47f7-8d04-93a1a690df53"
      unitRef="usd">18000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNS01LTEtMS0w_d4e65e72-2ba6-4ba6-a2bb-2969d77d0dc4"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNS03LTEtMS0w_6c2b08fa-3aea-4547-870b-2a4178795549"
      unitRef="usd">60000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNS05LTEtMS0w_22c43daa-de8f-4a57-943c-55412dc1f18a"
      unitRef="usd">62000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjI4ODVmMDk5YzMyMzRkZWVhODI1YjQ3NTFjNGUzZGUzL3RhYmxlcmFuZ2U6Mjg4NWYwOTljMzIzNGRlZWE4MjViNDc1MWM0ZTNkZTNfNS0xMS0xLTEtMA_da2b78d4-7b63-42ee-ba04-591acd8332fa"
      unitRef="usd">158000000</us-gaap:RestructuringCharges>
    <us-gaap:SeveranceCosts1
      contextRef="i17d2abc247664f6daa16f853d87054b7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMi0xLTEtMS0w_665eff1e-448f-4285-8219-17464c3bbdee"
      unitRef="usd">1000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i34e5f5eb8b104181b2273e06b8521cc7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMi0zLTEtMS0w_6b297579-c1d3-4bab-b858-5a2158601981"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i91e0eb4c78cd4021aa5f951829fd7105_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMi01LTEtMS0w_acf19cc4-8808-4d0d-8748-0b480886d419"
      unitRef="usd">0</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i035aba39d89d4cbda66c1e89394e2887_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMi03LTEtMS0w_85652ab4-0504-493d-bb72-15fc296fef65"
      unitRef="usd">17000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i2e6dc977232b4be2a968cd362119be8a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMi05LTEtMS0w_9f79736a-9abe-4641-910c-db3ea4d72e94"
      unitRef="usd">20000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMi0xMS0xLTEtMA_3c78d80d-6ccf-4e33-a48f-55e90d6fe74e"
      unitRef="usd">38000000</us-gaap:SeveranceCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i17d2abc247664f6daa16f853d87054b7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMy0xLTEtMS0w_f8db8846-8aa0-442e-a936-900abb201aa1"
      unitRef="usd">1000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i34e5f5eb8b104181b2273e06b8521cc7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMy0zLTEtMS0w_53288326-a579-48a2-aaac-5487cbbc7f8c"
      unitRef="usd">0</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i91e0eb4c78cd4021aa5f951829fd7105_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMy01LTEtMS0w_ce1ac2c4-7d59-42dd-82d9-f28fc6ccadda"
      unitRef="usd">3000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i035aba39d89d4cbda66c1e89394e2887_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMy03LTEtMS0w_94c4d257-18b3-45ee-9bf2-f3ebebcd2b55"
      unitRef="usd">2000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i2e6dc977232b4be2a968cd362119be8a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMy05LTEtMS0w_09cc8b5f-815a-4024-9cb2-4c1f75f47121"
      unitRef="usd">7000000</us-gaap:BusinessExitCosts1>
    <us-gaap:BusinessExitCosts1
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfMy0xMS0xLTEtMA_819df7de-ee2a-4dd3-a6c5-b0a7e0136361"
      unitRef="usd">13000000</us-gaap:BusinessExitCosts1>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i17d2abc247664f6daa16f853d87054b7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNC0xLTEtMS0w_91c634c1-df00-469f-b044-13b36f52080c"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i34e5f5eb8b104181b2273e06b8521cc7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNC0zLTEtMS0w_a15d3550-2a1a-4a7b-a72d-5a0723be7fdc"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i91e0eb4c78cd4021aa5f951829fd7105_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNC01LTEtMS0w_3292f198-a4b3-4ffd-bb26-96e947927af5"
      unitRef="usd">0</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i035aba39d89d4cbda66c1e89394e2887_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNC03LTEtMS0w_dfc461c1-3aed-496b-9567-44222d1b7828"
      unitRef="usd">4000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i2e6dc977232b4be2a968cd362119be8a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNC05LTEtMS0w_137d1157-0ebe-4787-9f2d-348b79948a78"
      unitRef="usd">1000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <mck:AssetImpairmentChargesIncludingAcceleratedDepreciation
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNC0xMS0xLTEtMA_ad76cb34-8e56-40f7-80a7-b3cc623c8a37"
      unitRef="usd">5000000</mck:AssetImpairmentChargesIncludingAcceleratedDepreciation>
    <us-gaap:RestructuringCharges
      contextRef="i17d2abc247664f6daa16f853d87054b7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNS0xLTEtMS0w_1706c985-fbf9-4b39-9b82-5af06fd0ebfc"
      unitRef="usd">2000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i34e5f5eb8b104181b2273e06b8521cc7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNS0zLTEtMS0w_ca61ac77-35bf-4370-a816-918950ce5f0a"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i91e0eb4c78cd4021aa5f951829fd7105_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNS01LTEtMS0w_ada67616-d058-475d-bb57-ec80ebdfe0f3"
      unitRef="usd">3000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i035aba39d89d4cbda66c1e89394e2887_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNS03LTEtMS0w_75df3485-58ac-41c5-8c4f-44ee13950893"
      unitRef="usd">23000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i2e6dc977232b4be2a968cd362119be8a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNS05LTEtMS0w_2b7365a2-5d39-4a8e-86b3-7ff49037fc8a"
      unitRef="usd">28000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjBjYzRlMjAzZWVkZjQ1ZDFhODhjYmUyOGM4MThhZTcwL3RhYmxlcmFuZ2U6MGNjNGUyMDNlZWRmNDVkMWE4OGNiZTI4YzgxOGFlNzBfNS0xMS0xLTEtMA_5c5a8ca0-3662-4697-9af1-f8e8b983196b"
      unitRef="usd">56000000</us-gaap:RestructuringCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNzg2Ng_401c3929-012b-4010-8537-62082fb36554">&lt;div style="margin-bottom:1pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to the restructuring liabilities associated with the Company&#x2019;s restructuring initiatives for the three months ended June 30, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring, impairment, and related charges &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-cash charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of March 31, 2021, the total reserve balance was $151 million, of which $99 million was recorded in &#x201c;Other accrued liabilities&#x201d; and $52 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of June 30, 2021, the total reserve balance was $177 million, of which $127 million was recorded in &#x201c;Other accrued liabilities&#x201d; and $50 million was recorded in &#x201c;Other non-current liabilities&#x201d; in the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i66234f14da784e5eb4675592aa380d6c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMS0xLTEtMS0w_3aba2b18-e43f-4340-a5a4-30063a92bf1a"
      unitRef="usd">19000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ib9f49c85d9c54b139a81fb46d5568528_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMS0zLTEtMS0w_587f3ddb-2b6c-4075-8328-fb41573ed57c"
      unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id94f3503c3d14315bb499f5363c098fb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMS01LTEtMS0w_5f33e157-e455-40c3-87b2-fc1e7df36810"
      unitRef="usd">3000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ic4d2ba414ea445368df49de0797a4169_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMS03LTEtMS0w_7cced684-e031-4f70-9ac5-7aac03a06ea8"
      unitRef="usd">66000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i7a0d6267ee1a4d7780d02c0f5b857095_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMS05LTEtMS0w_06722e31-787d-4eed-a01c-f818d3a5712d"
      unitRef="usd">59000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMS0xMS0xLTEtMA_9160449c-5e61-4a4e-82cc-2af9b239e393"
      unitRef="usd">151000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMi0xLTEtMS0w_c3d5907a-f010-4514-a9a8-7b655cc537ba"
      unitRef="usd">12000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMi0zLTEtMS0w_856be6d3-cae4-4412-9e4d-01105e14e6d3"
      unitRef="usd">18000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMi01LTEtMS0w_7a1e3b57-1b9f-433f-82da-fa6b7eff1e9f"
      unitRef="usd">6000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMi03LTEtMS0w_2c39bb8d-ecb6-42b2-9e59-4133268be788"
      unitRef="usd">60000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMi05LTEtMS0w_e9de0676-173a-4aa3-a9d4-04ebb084cffe"
      unitRef="usd">62000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMi0xMS0xLTEtMA_6e97aad1-4694-49cc-aafa-b71d3259b46f"
      unitRef="usd">158000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMy0xLTEtMS0w_cf44c149-03da-490b-a580-20dd100f8cc5"
      unitRef="usd">8000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMy0zLTEtMS0w_c245b1ae-0a6d-4a8a-a70b-f54e0d1827a4"
      unitRef="usd">17000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMy01LTEtMS0w_6cbd19e9-6a9e-457b-a411-6f4d2881ff7c"
      unitRef="usd">4000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMy03LTEtMS0w_fb49b064-9fb9-45fb-9191-1629909f503c"
      unitRef="usd">34000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMy05LTEtMS0w_53be7b7f-6499-4f8c-81e8-b58c7e0d5a7f"
      unitRef="usd">41000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfMy0xMS0xLTEtMA_fce74f43-a369-4aff-a208-008870e6963a"
      unitRef="usd">104000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:PaymentsForRestructuring
      contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNC0xLTEtMS0w_abc92222-944b-4016-8684-3fd023a5064b"
      unitRef="usd">5000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNC0zLTEtMS0w_b12d7697-9fce-43cf-be23-e84eee3455d4"
      unitRef="usd">1000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNC01LTEtMS0w_784ff923-a6fa-4573-9f3b-8fefc03100a3"
      unitRef="usd">2000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNC03LTEtMS0w_3bc1195f-5728-4b29-8f75-3f527f1d4e7e"
      unitRef="usd">5000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNC05LTEtMS0w_a629c7e0-013d-4204-a011-3b5fa98b7f0e"
      unitRef="usd">8000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNC0xMS0xLTEtMA_85758851-b3cb-455c-8251-3ecba0993214"
      unitRef="usd">21000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i44242fbcd53a4c6cbbfbce47286fea85_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNS0xLTEtMS0w_c190f872-7bd9-4d59-8821-10072a6b58f9"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="ie6b72cc8f64c4aa4be1f5fd3a2c2d345_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNS0zLTEtMS0w_f3753c4b-95f3-41ba-9a3e-b19a38ee2214"
      unitRef="usd">0</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i596d6fa9657a4812b2f7d2716ec1c072_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNS01LTEtMS0w_612233c8-68e8-47e6-9c11-519c0d179f82"
      unitRef="usd">-1000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i7024bd066c404b769d0d51b8934644dc_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNS03LTEtMS0w_efd1aa4b-67ff-4d36-9dce-e827cdb20853"
      unitRef="usd">-3000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="i630193b02c1347faaf81c65e56471d75_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNS05LTEtMS0w_37900182-e569-4b79-b95a-4d95dfa8c8d8"
      unitRef="usd">-3000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserveTranslationAndOtherAdjustment
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNS0xMS0xLTEtMA_ad711504-0bd2-4462-9558-80bf6f80ae2b"
      unitRef="usd">-7000000</us-gaap:RestructuringReserveTranslationAndOtherAdjustment>
    <us-gaap:RestructuringReserve
      contextRef="i710aa73bfd1a41c98226e45589abb990_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNi0xLTEtMS0w_0a1bd5a0-d529-4cb8-a31f-cd784eadf6df"
      unitRef="usd">18000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i0bc550c41437490f858d0f9e149d60d0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNi0zLTEtMS0w_7ae977fe-e1ff-45a4-9410-b8372fe3e034"
      unitRef="usd">4000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i992084e24e76444492d6225980031942_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNi01LTEtMS0w_1c3feba5-7ff0-491a-9485-f36fd2429cc5"
      unitRef="usd">2000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i19168a33968540e783b28d52a160795c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNi03LTEtMS0w_a55373c9-bd1c-4d93-bf81-08eef10e4df1"
      unitRef="usd">84000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="if40e1d1aa4ac42c587f1b983fd883ee3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNi05LTEtMS0w_1f99abf1-9e64-4d70-abe6-5d176bc1eccf"
      unitRef="usd">69000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RhYmxlOjJmNDExYTU1YmRmMDRiZWE5NDQ3OTI3YmE2ZTMxYTRmL3RhYmxlcmFuZ2U6MmY0MTFhNTViZGYwNGJlYTk0NDc5MjdiYTZlMzFhNGZfNi0xMS0xLTEtMA_3ede9e47-0884-4acb-aca5-4dbb908e8ade"
      unitRef="usd">177000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNjIxMg_56fd109d-3b5c-4e65-ad6d-76892a81423d"
      unitRef="usd">151000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="iac2a35f73ee14590b8a577b32c972839_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNjIyNQ_5f6cb324-590c-4005-b7e8-da5176710df5"
      unitRef="usd">99000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie45718b0614548d1830f76b0122b7111_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNjI1MQ_1eb715f7-2e8a-4696-bbe1-83a0515eb0df"
      unitRef="usd">52000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNjMzMA_1a1d1513-bb05-4f33-b9e8-72ac836acb8c"
      unitRef="usd">177000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i191304ad1c25432190397b7fa834d148_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNjM0Mw_8ff0c632-a093-4b08-a335-7501bbe748a2"
      unitRef="usd">127000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="id719933d788f420798852650db76c74f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80My9mcmFnOjYwMmMzNjU2ZmEyNjRmNzc4NmY0Zjg1N2RhYTZjODM3L3RleHRyZWdpb246NjAyYzM2NTZmYTI2NGY3Nzg2ZjRmODU3ZGFhNmM4MzdfNjM2OQ_10524adf-793b-4732-a187-0cc317d32068"
      unitRef="usd">50000000</us-gaap:RestructuringReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfNDM4Nw_45cbb0fe-8782-48e8-9ce4-7c4eb8ad7be0">Income Taxes &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June 30, 2021 and 2020, the Company recorded income tax expense of $26 million and $150 million, respectively. The Company&#x2019;s reported income tax rates were 4.6% and 23.3% for the three months ended June 30, 2021 and 2020, respectively. Fluctuations in the Company&#x2019;s reported income tax rates are primarily due to discrete items recognized in the quarter and changes in the mix of earnings between various taxing jurisdictions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2021, the Company had $1.7 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate if recognized. During the three months ended June 30, 2021, the Company recognized a net discrete tax benefit of $97 million primarily related to statute of limitation expirations in various taxing jurisdictions. During the next twelve months, the Company does not estimate any material reduction in its unrecognized tax benefits. However, this may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. The unrecognized tax benefit may also increase or decrease due to future developments in the Opioid related litigation and claims, as discussed in Financial Note 12, &#x201c;Commitments and Contingent Liabilities.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#x201c;IRS&#x201d;) is currently examining the Company&#x2019;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfMTAw_9f3e9c0a-e97c-48aa-adfd-7a3913cd08cf"
      unitRef="usd">26000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfMTI5_44ef356c-6350-4506-b06b-5fcd233d3503"
      unitRef="usd">150000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfMzA3_52e4af18-e8bc-451c-a60a-1a91333e885a"
      unitRef="number">0.046</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfMzQ0_329462e1-9818-405a-a31b-df4d2b2f9808"
      unitRef="number">0.233</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfMjcxMQ_47b25dca-eb74-47da-8518-9d328f3aeb48"
      unitRef="usd">1700000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfMjc1Mw_47a411f3-8e23-4f21-99e7-69fa39251f29"
      unitRef="usd">1300000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80Ni9mcmFnOjBhZWUwOGJmZTQzNjQ3MTFhNjdhM2NjMjkwYjQxMmIwL3RleHRyZWdpb246MGFlZTA4YmZlNDM2NDcxMWE2N2EzY2MyOTBiNDEyYjBfNTQ5NzU1ODE0NzYyNg_725b80bb-0c21-4967-b8bb-6a2ab1d72a8b"
      unitRef="usd">97000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMzQzMQ_97a47c76-d099-43bf-8a08-42bb980a2bfc">Redeemable Noncontrolling Interests and Noncontrolling Interests&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#x201c;Domination Agreement&#x201d;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#x20ac;0.83 per share. As a result, during the three months ended June 30, 2021 and 2020, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $8 million and $11 million, respectively. All amounts were recorded in &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Company&#x2019;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#x201c;Put Right&#x201d;) their noncontrolling shares at &#x20ac;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#x201c;Put Amount&#x201d;). Subsequent to the Domination Agreement&#x2019;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#x201c;Appraisal Proceedings&#x201d;) with the Stuttgart Regional Court (the &#x201c;Court&#x201d;) to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified currently in the Domination Agreement. On September 19, 2018, the Court ruled that the Put Amount shall be increased by &#x20ac;0.51 resulting in an adjusted Put Amount of &#x20ac;23.50. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp;amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount shall remain &#x20ac;22.99, thereby rejecting the lower court&#x2019;s increase, and the recurring compensation remained at &#x20ac;0.83 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June 30, 2021 and 2020, the Company paid $1.0 billion and $49&#160;million, respectively, to purchase 34.5&#160;million and 1.8&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $983 million and $49 million, respectively, for the three months ended June 30, 2021 and 2020, and the Company recorded the associated effect of the increase in the Company&#x2019;s ownership interest of $178 million and $3 million, respectively, as an increase to McKesson&#x2019;s stockholders additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $287 million, were transferred from &#x201c;Redeemable noncontrolling interests&#x201d; to &#x201c;Noncontrolling interests&#x201d; on the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The redeemable noncontrolling interest was adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. Prior to expiration of the Put Right, the balance of the redeemable noncontrolling interests was reported as the greater of its carrying value or its maximum redemption value at each reporting date. At March 31, 2021, the carrying value of $1.3&#160;billion exceeded the maximum redemption value of $1.2 billion and the Company owned approximately 78% of McKesson Europe&#x2019;s outstanding common shares. At June 30, 2021, the Company owned approximately 95%, of McKesson Europe&#x2019;s outstanding common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity interests in the Company&#x2019;s consolidated entities primarily related to ClarusONE Sourcing Services LLP and Vantage Oncology Holdings, LLC. As of June 30, 2021, noncontrolling interests also represent minority shareholder equity interests in McKesson Europe, as discussed above. During the three months ended June 30, 2021 and 2020, the Company allocated a total of $39 million of net income to noncontrolling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of McKesson Europe redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:-4.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <us-gaap:MinorityInterestDisclosureTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMzQzOA_7677261d-93f2-4db5-889f-49837702ae3d">Redeemable Noncontrolling Interests and Noncontrolling Interests&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#x201c;Domination Agreement&#x201d;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#x20ac;0.83 per share. As a result, during the three months ended June 30, 2021 and 2020, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $8 million and $11 million, respectively. All amounts were recorded in &#x201c;Net income attributable to noncontrolling interests&#x201d; in the Company&#x2019;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in &#x201c;Other accrued liabilities&#x201d; in the Company&#x2019;s Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#x201c;Put Right&#x201d;) their noncontrolling shares at &#x20ac;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#x201c;Put Amount&#x201d;). Subsequent to the Domination Agreement&#x2019;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#x201c;Appraisal Proceedings&#x201d;) with the Stuttgart Regional Court (the &#x201c;Court&#x201d;) to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified currently in the Domination Agreement. On September 19, 2018, the Court ruled that the Put Amount shall be increased by &#x20ac;0.51 resulting in an adjusted Put Amount of &#x20ac;23.50. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp;amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount shall remain &#x20ac;22.99, thereby rejecting the lower court&#x2019;s increase, and the recurring compensation remained at &#x20ac;0.83 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June 30, 2021 and 2020, the Company paid $1.0 billion and $49&#160;million, respectively, to purchase 34.5&#160;million and 1.8&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $983 million and $49 million, respectively, for the three months ended June 30, 2021 and 2020, and the Company recorded the associated effect of the increase in the Company&#x2019;s ownership interest of $178 million and $3 million, respectively, as an increase to McKesson&#x2019;s stockholders additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $287 million, were transferred from &#x201c;Redeemable noncontrolling interests&#x201d; to &#x201c;Noncontrolling interests&#x201d; on the Condensed Consolidated Balance Sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The redeemable noncontrolling interest was adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. Prior to expiration of the Put Right, the balance of the redeemable noncontrolling interests was reported as the greater of its carrying value or its maximum redemption value at each reporting date. At March 31, 2021, the carrying value of $1.3&#160;billion exceeded the maximum redemption value of $1.2 billion and the Company owned approximately 78% of McKesson Europe&#x2019;s outstanding common shares. At June 30, 2021, the Company owned approximately 95%, of McKesson Europe&#x2019;s outstanding common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Noncontrolling interests represent third-party equity interests in the Company&#x2019;s consolidated entities primarily related to ClarusONE Sourcing Services LLP and Vantage Oncology Holdings, LLC. As of June 30, 2021, noncontrolling interests also represent minority shareholder equity interests in McKesson Europe, as discussed above. During the three months ended June 30, 2021 and 2020, the Company allocated a total of $39 million of net income to noncontrolling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of McKesson Europe redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:-4.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MinorityInterestDisclosureTextBlock>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="ied3d3ec15dce44668530b0cfc63e4725_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfNDEw_d655c743-9ca0-44ba-a6ef-dbc3ffca7cba"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="idaf31474e16b4981835b7927ff4927eb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfNTQ5_5c544859-8dc0-448d-95b5-c2eb11421da7"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i487864b97fe74bb085d985d73639d6db_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfNTky_e9066b2e-e0a5-4eca-84a8-b21481ba5fa9"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i63b54516555043abafd60e6f00353370_I20210412"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfOTkx_5f4fb2e0-43f2-41c9-b6e4-46cc7bc4c452"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i5ddf756d852f408fbd54c3f4a61f8d6a_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfOTkx_e3951f7b-6f11-4978-9003-cc17d3b662c6"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:PutRightValueInterestRateSpread
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMTA1NA_951ec250-0e2a-482a-ad83-47fd5c1f79cb"
      unitRef="number">0.05</mck:PutRightValueInterestRateSpread>
    <mck:NoncontrollingInterestsPutRightExercisePriceIncrease
      contextRef="i87be9fd9c6fb4f4785e90cb0a3b47104_I20180919"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3OTU0OQ_b7846977-f91d-4544-90a2-301a0fd4c077"
      unitRef="eurPerShare">0.51</mck:NoncontrollingInterestsPutRightExercisePriceIncrease>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i87be9fd9c6fb4f4785e90cb0a3b47104_I20180919"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3OTU1Nw_744f0d97-e6ac-41fb-a3b7-1734b4408394"
      unitRef="eurPerShare">23.50</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i63b54516555043abafd60e6f00353370_I20210412"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3OTU2Ng_5f4fb2e0-43f2-41c9-b6e4-46cc7bc4c452"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:NoncontrollingInterestsPutRightExercisePrice
      contextRef="i5ddf756d852f408fbd54c3f4a61f8d6a_I20141231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3OTU2Ng_e3951f7b-6f11-4978-9003-cc17d3b662c6"
      unitRef="eurPerShare">22.99</mck:NoncontrollingInterestsPutRightExercisePrice>
    <mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests
      contextRef="i2334ff340e7e4425bafcfaaf4f20fc95_I20210412"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3OTU3NQ_a53910e4-e2bb-49cd-a5d7-5414f1e7dec8"
      unitRef="eurPerShare">0.83</mck:AnnualRecurringCompensationPerSharetoNoncontrollingInterests>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="idaf31474e16b4981835b7927ff4927eb_D20210401-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMTQxOQ_ebecf922-27de-40d7-b2c6-d65fdf932984"
      unitRef="usd">1000000000.0</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
      contextRef="i487864b97fe74bb085d985d73639d6db_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3NTg1Ng_e60f15dd-8eda-45b3-b0da-496192b41cc6"
      unitRef="usd">49000000</us-gaap:PaymentsForRepurchaseOfRedeemableNoncontrollingInterest>
    <mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased
      contextRef="idaf31474e16b4981835b7927ff4927eb_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMTQzNA_9f697c94-4b34-42df-ad3c-c0b2fec12fe0"
      unitRef="shares">34500000</mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased>
    <mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased
      contextRef="i487864b97fe74bb085d985d73639d6db_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3NTg4NQ_88cba683-ba2a-4c07-b39c-c1d1b455dcd9"
      unitRef="shares">1800000</mck:RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3NTkxNA_00d67171-ee25-4d02-a97e-9d2bf3786a7c"
      unitRef="usd">983000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMTYwMw_88a39b3d-89b2-4c04-9ee6-ac645f2283f9"
      unitRef="usd">49000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i15e4d7260c2e41f096bdffa4d471fb63_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA4MDMzOA_b6350256-77a1-4a85-9272-8912a60ec639"
      unitRef="usd">178000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i5013134a08dd45ba9c62f3e98630e1ff_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA4MDMyMg_d25d266a-9c66-42e4-bff0-fbaef48a087d"
      unitRef="usd">3000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfNTQ5NzU1ODE1MTc4Ng_dfdb5bd3-389c-441c-8ac0-888eb16646ec"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i69a2a49641144b609177a6d98a66f9eb_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjU0Mg_049aec3d-223b-4185-a447-5621f2d8a186"
      unitRef="usd">1300000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue
      contextRef="i69a2a49641144b609177a6d98a66f9eb_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjU4Ng_363e0709-541c-4ca9-bc04-c1b61ed6b780"
      unitRef="usd">1200000000</mck:RedeemableNoncontrollingInterestsMaximumRedemptionValue>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i69a2a49641144b609177a6d98a66f9eb_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjY0Mw_f251ef95-2ebd-4c92-84db-4115c09bcaff"
      unitRef="number">0.78</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i508c6f433af04bcd9ab04b4a8838efbd_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMjc0ODc3OTA3NzU4NQ_cb5db1ad-0e6f-40d0-a2c0-a30c1310f818"
      unitRef="number">0.95</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i59705e8d049944ec81dc730a85f8b9e6_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMzA4Mg_1c89016e-61e6-4d99-933a-267e271e8c13"
      unitRef="usd">39000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i365faceb5dac4b6c8e146917134e4cd2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMzA4Mg_ab952915-3ff5-4d11-a809-32d850e6b011"
      unitRef="usd">39000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RleHRyZWdpb246YzYzYmI3YjkwYmZkNDk1ZDgyYWJkZTc0YzE0OTEwYTVfMzQ0MA_ae2c1ba2-bcef-4ed1-919c-9141ddac9a21">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(983)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of McKesson Europe redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:-4.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable Noncontrolling Interests&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification of recurring compensation to other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments to noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercises of Put Right&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock>
    <us-gaap:MinorityInterest
      contextRef="iedb46ad9eb03415b8c3ef478a437c8d0_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfMS0yLTEtMS0w_ed787d5b-eaae-4e59-ab72-509107486ea9"
      unitRef="usd">196000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i412cde1488dd4d8ab371ad4c8f5faa1d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfMS00LTEtMS0w_3131b7c1-1aa6-4c80-b259-2a9517c12027"
      unitRef="usd">1271000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfMi0yLTEtMS0w_74f23443-c090-482d-8023-defe9f11497e"
      unitRef="usd">39000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfMi00LTEtMS0w_1d0d398c-3d98-4350-a527-519676959aba"
      unitRef="usd">8000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfMy0yLTEtMS0w_6bff1d5b-0763-4943-b804-d61addeea19a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfMy00LTEtMS0w_f61610c3-8e98-4f4c-b12f-05a1216a933e"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNC00LTEtMS0w_5b22a0aa-216d-42bc-a450-025a8891586f"
      unitRef="usd">8000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNS0yLTEtMS0w_3d6e6e0a-b039-4f41-a1b8-be14d54a0878"
      unitRef="usd">39000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNS00LTEtMS0w_d7c53c5c-3f7e-4951-be08-a85f01c540f4"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNi00LTEtMS0w_00d67171-ee25-4d02-a97e-9d2bf3786a7c"
      unitRef="usd">983000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNy0yLTEtMS0xMjU0_dfdb5bd3-389c-441c-8ac0-888eb16646ec"
      unitRef="usd">-287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest
      contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNy00LTEtMS0xMjU0_7203dbe0-0937-4112-8140-9c0f48a0d01b"
      unitRef="usd">287000000</mck:ReclassificationOfTemporaryEquityToNoncontrollingInterest>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i8ba09eac65d24ea7990ae1fc213d93ac_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNy0yLTEtMS0w_45e8c61e-d207-4404-9ce1-6b9274e8a49a"
      unitRef="usd">1000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="ie395d70b97ee449f8d89852cdddfe4ce_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfNy00LTEtMS0w_d1cbae21-beaf-4adf-a4e0-25052ccd48e9"
      unitRef="usd">3000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="icedc97c57c25494bb97ac3ef916d8842_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfOC0yLTEtMS0w_d35afa56-d2d9-467c-b021-c415f7c80db1"
      unitRef="usd">484000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="ic01bba4cd87f497d8faba0d38fa0e49b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOmFkYzIzN2NjMWIwMjRhMzBiMzdkZjFhOGRiYzgzZDcwL3RhYmxlcmFuZ2U6YWRjMjM3Y2MxYjAyNGEzMGIzN2RmMWE4ZGJjODNkNzBfOC00LTEtMS0w_8a4f4b04-6c5f-4dce-a67b-f41154704f7f"
      unitRef="usd">7000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:MinorityInterest
      contextRef="iecd424d4030942d9b9c9e99c1603c4a3_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfMS0yLTEtMS0w_ea23ee24-a09a-4a84-bf81-e0238c4b445b"
      unitRef="usd">217000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i30a07bf169524e7ba24b49eb98a91985_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfMS00LTEtMS0w_7be1af68-b940-490e-b634-1af0ae78d805"
      unitRef="usd">1402000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfMi0yLTEtMS0w_a5f4950e-8bfa-4dd6-bffe-4efeed593c67"
      unitRef="usd">39000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest
      contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfMi00LTEtMS0w_fa7cf261-fa9a-44e7-b679-955afeefee8b"
      unitRef="usd">11000000</us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfMy0yLTEtMS0w_816bd4b7-661f-4cb0-8431-7cbd609ce91c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfMy00LTEtMS0w_3423eb4e-4235-4351-858f-e4fb4b223c27"
      unitRef="usd">61000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <mck:ReclassificationofTemporaryEquitytoLiability
      contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfNC00LTEtMS0w_10e5f2e5-b5b9-4ff6-927f-4fca0c3ac6c9"
      unitRef="usd">11000000</mck:ReclassificationofTemporaryEquitytoLiability>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfNS0yLTEtMS0w_8b6c7b57-b564-4502-bfee-afa1baf05e91"
      unitRef="usd">43000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfNS00LTEtMS0w_d4fb1114-52b3-4a7a-a2d5-8feabce43111"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <mck:NoncontrollingInterestDecreaseForExerciseOfPutRight
      contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfNi00LTEtMS0w_88a39b3d-89b2-4c04-9ee6-ac645f2283f9"
      unitRef="usd">49000000</mck:NoncontrollingInterestDecreaseForExerciseOfPutRight>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i39f01c129de8474a9789456e9e35b86d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfNy0yLTEtMS0w_96d968f2-1c92-4108-a491-58fdead74efb"
      unitRef="usd">-6000000</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <mck:NoncontrollingInterestIncreaseDecreaseDuetoOther
      contextRef="i2f923212c58c47f88ad486925df58806_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfNy00LTEtMS0w_254c03ed-106b-43f9-9e35-99ca3078183f"
      unitRef="usd">0</mck:NoncontrollingInterestIncreaseDecreaseDuetoOther>
    <us-gaap:MinorityInterest
      contextRef="i9b3fb15d56c74664afb9bf5941948b0f_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfOC0yLTEtMS0w_2ad906e7-3303-47c5-b442-fe193a72c712"
      unitRef="usd">207000000</us-gaap:MinorityInterest>
    <us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount
      contextRef="i51575d10eabd476db89a9db186145b8a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl80OS9mcmFnOmM2M2JiN2I5MGJmZDQ5NWQ4MmFiZGU3NGMxNDkxMGE1L3RhYmxlOjMxYjVjOTU0MDFmZjQ5OTFiNTUzMDlhNzI4ZGY1Y2JmL3RhYmxlcmFuZ2U6MzFiNWM5NTQwMWZmNDk5MWI1NTMwOWE3MjhkZjVjYmZfOC00LTEtMS0w_a8ce107f-a776-4d14-ac07-ad69131281c1"
      unitRef="usd">1414000000</us-gaap:RedeemableNoncontrollingInterestEquityCommonCarryingAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RleHRyZWdpb246NjcyOTgyMzg4YjE3NDk3YzkzY2JkNGI0ZjIyNTQyNjNfMTE3MQ_9dc6641b-f677-4591-a117-a67a4a84cd8c">Earnings (Loss) Per Common Share&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings (loss) per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately 1&#160;million and 3&#160;million of potentially dilutive securities for the three months ended June 30, 2021 and 2020 were excluded from the computation of diluted net earnings per common share as they were anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes dilutive effect from restricted stock units, performance-based restricted stock units, and performance-based stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RleHRyZWdpb246NjcyOTgyMzg4YjE3NDk3YzkzY2JkNGI0ZjIyNTQyNjNfNTQ5NzU1ODE0MDg4OQ_e53f8861-2575-49a5-b99b-82b567b99a1c"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RleHRyZWdpb246NjcyOTgyMzg4YjE3NDk3YzkzY2JkNGI0ZjIyNTQyNjNfNTQ5NzU1ODE0MDg5Nw_7cbec23b-998b-4186-a3af-6925aa757369"
      unitRef="shares">3000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RleHRyZWdpb246NjcyOTgyMzg4YjE3NDk3YzkzY2JkNGI0ZjIyNTQyNjNfMTE4MA_0930415a-0f28-440e-a35c-2ce1d16e5ff7">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The computations for basic and diluted earnings or loss per common share are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.867%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions, except per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to McKesson Corporation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (loss) per common share attributable to McKesson: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discontinued operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.02)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Includes dilutive effect from restricted stock units, performance-based restricted stock units, and performance-based stock units.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Certain computations may reflect rounding adjustments.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMi01LTEtMS0w_60f33560-d4f2-47e4-bea1-73858c690e04"
      unitRef="usd">536000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMi03LTEtMS0w_6580466b-2c68-4c8a-a154-47c83853a00c"
      unitRef="usd">495000000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMy01LTEtMS0w_04ca3996-8dbf-4aa6-85d0-4d74e2b831f9"
      unitRef="usd">47000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMy03LTEtMS0w_e4660d64-167a-4881-8c28-b506a1628800"
      unitRef="usd">50000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfNC01LTEtMS0w_ac933a5e-c10e-4655-8d22-18258f5f9434"
      unitRef="usd">489000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfNC03LTEtMS0w_230d0e49-aef1-43a9-9d71-804e07c17b3f"
      unitRef="usd">445000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfNS01LTEtMS0w_7ae14a51-595c-4110-9628-d8d7c9d670cb"
      unitRef="usd">-3000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfNS03LTEtMS0w_c3122786-38a3-41f7-a227-163fa4777cc0"
      unitRef="usd">-1000000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfNi01LTEtMS0w_2564379e-4ca7-4235-81cc-6783d0c8bbdc"
      unitRef="usd">486000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfNi03LTEtMS0w_7b3b6d28-a0a4-4e92-939a-10740eb51aec"
      unitRef="usd">444000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfOS01LTEtMS0w_2c5b32d7-5df1-4ddf-a641-f630ed1e77fb"
      unitRef="shares">156200000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfOS03LTEtMS0w_7ab2b84b-2fba-49e0-87c5-68e8e43b0c10"
      unitRef="shares">162000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9bd869d54ffa406bb2261915a7499d39_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTEtNS0xLTEtOTYzOA_877ea216-8579-4f2a-93f4-79f110676bef"
      unitRef="shares">100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i34ca8e4a850d48e9b2104497582378ad_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTEtNy0xLTEtOTY0Mw_d96ce247-46d3-48a6-8bbd-2c1271613a97"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i3b31c456dd94434c9a3d61732463ebce_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTEtNS0xLTEtMA_01874df9-c041-4ac4-a256-8f846e29e712"
      unitRef="shares">1800000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i53500c27297841a0b5752e04f4847019_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTEtNy0xLTEtMA_431de9f3-3edd-48db-b51c-7de5077bc3b7"
      unitRef="shares">1200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTItNS0xLTEtMA_a5d0e1e1-7eee-41b3-858c-4504f45362d4"
      unitRef="shares">158100000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTItNy0xLTEtMA_11147a67-1e01-4ed1-a5e6-9864eed4cbbb"
      unitRef="shares">163200000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTYtNS0xLTEtMA_fe42dfc3-2a3b-482a-8434-80d90512fe5e"
      unitRef="usdPerShare">3.09</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTYtNy0xLTEtMA_2eb65c56-b363-404e-85ad-ddf7b4bfb8e4"
      unitRef="usdPerShare">2.72</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTctNS0xLTEtMA_3e17eb44-8f86-47da-a5fe-44804e05270c"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTctNy0xLTEtMA_1bc7802b-ca8e-47db-82da-bfbf22f6a115"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTgtNS0xLTEtMA_ef914beb-6797-409b-9093-817c30420bc8"
      unitRef="usdPerShare">3.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMTgtNy0xLTEtMA_7ad1b94b-0265-4a44-8298-55412828ec33"
      unitRef="usdPerShare">2.72</us-gaap:EarningsPerShareDiluted>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMjAtNS0xLTEtMA_efcc517b-ecc4-4391-8959-7f7a6421cd03"
      unitRef="usdPerShare">3.13</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMjAtNy0xLTEtMA_5fd5f0b9-8fc6-45a6-876f-3e6927a63196"
      unitRef="usdPerShare">2.74</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMjEtNS0xLTEtMA_c4e69d83-9900-41ed-8e18-8ce5a4cacc1f"
      unitRef="usdPerShare">-0.02</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMjEtNy0xLTEtMA_f127f6d9-221a-4572-b4b7-a21c218191a8"
      unitRef="usdPerShare">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:EarningsPerShareBasic
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMjItNS0xLTEtMA_9f63e469-8262-4c61-b1b4-4ee8339baa78"
      unitRef="usdPerShare">3.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81NS9mcmFnOjY3Mjk4MjM4OGIxNzQ5N2M5M2NiZDRiNGYyMjU0MjYzL3RhYmxlOjVjMjYxNDAyZGRiNjQwNzdhYTY0NDNhYmVmNjkxYTIyL3RhYmxlcmFuZ2U6NWMyNjE0MDJkZGI2NDA3N2FhNjQ0M2FiZWY2OTFhMjJfMjItNy0xLTEtMA_016f4b8d-3b48-4d9b-95fe-d5a77b35de77"
      unitRef="usdPerShare">2.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMjAyMw_a0a3de35-c69f-4c07-8cd5-776704ec3ee0">Goodwill and Intangible Assets, Net &lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense of intangible assets was $98 million and $106 million for the three months ended June 30, 2021 and 2020, respectively. Estimated amortization expense of these assets is as follows: $279 million, $273 million, $261 million, $255 million, and $223 million for the remainder of 2022 and each of the succeeding years through 2026 and $1.5 billion thereafter. All intangible assets were subject to amortization as of June 30, 2021 and March 31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMjAzMQ_83eca281-6e01-4ade-b54f-1f2dd56cb5d9">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the carrying amount of goodwill were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.716%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, March&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance, June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="id6b9935a1072411f89e91e4985e6c37a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfMS0xLTEtMS0w_f19c3f02-d340-42b4-9bff-1130957b32ab"
      unitRef="usd">3963000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i88f5c5e2af1a4fe4952d7a38df3fb91c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfMS0zLTEtMS0w_61d715bd-47d6-48ea-a425-ee2b4f302d42"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i42674b470461487c889c63f9ddc05423_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfMS01LTEtMS0w_54f57acc-1e34-42f5-8b3e-521fc2ad6305"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if9a99eac4149443cb99bd6701ec37a59_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfMS03LTEtMS0w_2aa9972d-f2f6-47c1-b015-be7617c50edc"
      unitRef="usd">1535000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfMS05LTEtMS0w_067b6c4f-f243-44f4-aa61-1f4c1153bd93"
      unitRef="usd">9493000000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i1c2064f2c8eb49c3849453a95a9c86c4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNi0xLTEtMS0w_b9a8aade-7993-4db6-94b9-9e14ee356b29"
      unitRef="usd">7000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i82edf712cf2f4662ac55525b3410634f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNi0zLTEtMS0w_43589d80-a0cd-4a6c-86b9-e09e5bb27dc6"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i032911e077b3421889a6ddae5be68041_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNi01LTEtMS0w_f0d45f65-c947-4244-a4e1-6e9797b842db"
      unitRef="usd">0</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="i2c475719e1e54e988a2716b400ad19c8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNi03LTEtMS0w_da4e4dd2-961a-4922-84f2-52e14037f72e"
      unitRef="usd">20000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNi05LTEtMS0w_e1d3c029-6f02-4fc6-ace9-395d838ce93b"
      unitRef="usd">27000000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="i7e598facc678461e9c9bce2f326a6b53_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNy0xLTEtMS0w_977a3efe-eefd-4a94-b0f0-35cf57de55d3"
      unitRef="usd">3970000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if9bd1f8e3c8348ac85a0747fd5ead3c3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNy0zLTEtMS0w_502e91d5-fc6e-4787-8ec4-770e971f1816"
      unitRef="usd">1542000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie633b96d5f6e4594bb149b9a781b4f7f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNy01LTEtMS0w_8e9a1f56-06d2-41d2-957c-957dbd7ac4c3"
      unitRef="usd">2453000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i87ee4b68e9ad4be0b0e837451f122185_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNy03LTEtMS0w_912fbd5a-a0d4-4949-b9df-f60bedc9e97b"
      unitRef="usd">1555000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjVmYmI1ZTc3ZDNmNzQzMWNhOWVjNGMyNDNhZmM2NGZlL3RhYmxlcmFuZ2U6NWZiYjVlNzdkM2Y3NDMxY2E5ZWM0YzI0M2FmYzY0ZmVfNy05LTEtMS0w_527f632a-6635-4072-8d08-f7b0d6e9d9fa"
      unitRef="usd">9520000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMjAyMA_3652b8b5-fe0b-432f-ac9f-8f6ce300e904">&lt;div style="margin-top:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding intangible assets is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.022%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.110%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Amortization&lt;br/&gt;Period&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,329)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trademarks and trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,880)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i340abf5713294118849a48ca0137e899_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi0xLTEtMS0w_b464357c-b62b-4e6f-b3da-997b4cad33a5">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2202b302407642afa17e3d40e4f0eba4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi0zLTEtMS0w_c503e4d6-6777-4922-a19a-682a647761ea"
      unitRef="usd">3747000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2202b302407642afa17e3d40e4f0eba4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi01LTEtMS0w_19b7e9e8-ac4d-41da-8d2a-f21d99057181"
      unitRef="usd">2329000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2202b302407642afa17e3d40e4f0eba4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi03LTEtMS0w_b0e37e77-3877-4407-90e5-d029b6b16373"
      unitRef="usd">1418000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9d12ee52b8454b869fd9946a0fa4dea8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi05LTEtMS0w_6b3e3b13-5d41-445d-b33b-842082f4e4cc"
      unitRef="usd">3739000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9d12ee52b8454b869fd9946a0fa4dea8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi0xMS0xLTEtMA_bcf72970-5f45-4c40-8b0d-8a1de5addb8a"
      unitRef="usd">2269000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9d12ee52b8454b869fd9946a0fa4dea8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMi0xMy0xLTEtMA_20df4919-4d4a-45e1-b43d-36057343e814"
      unitRef="usd">1470000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i593296998692453094e57c17348b980f_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy0xLTEtMS0w_725f2c5a-f881-4158-b92c-1fe8b7aefdd3">P10Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia43438708a6949cd9cf16f70af409bba_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy0zLTEtMS0w_bdb8b8ca-5833-4acf-a67f-ab4c7d01b189"
      unitRef="usd">1088000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia43438708a6949cd9cf16f70af409bba_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy01LTEtMS0w_93040665-dd5d-4f53-b87d-cd66da5038df"
      unitRef="usd">530000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia43438708a6949cd9cf16f70af409bba_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy03LTEtMS0w_1bdbd678-4ce1-41aa-9dce-fb3e68826f8b"
      unitRef="usd">558000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0f7bc8f0af7b4ef4baba244ec29d1ccf_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy05LTEtMS0w_fe230e5e-143e-4160-9f83-1c9a740fe6b2"
      unitRef="usd">1081000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0f7bc8f0af7b4ef4baba244ec29d1ccf_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy0xMS0xLTEtMA_12cfe6e8-9d0c-4674-9084-e86880876ab7"
      unitRef="usd">513000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0f7bc8f0af7b4ef4baba244ec29d1ccf_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfMy0xMy0xLTEtMA_60560219-a56b-4204-bdeb-92386112fb10"
      unitRef="usd">568000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ideb771110e984bc6b277c2585a3c3c6f_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC0xLTEtMS0w_06845080-86e7-4ba0-b165-6c642581a989">P23Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4d856a3247a04312a0f97fa937d9eed7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC0zLTEtMS0w_9d8cbe02-4d74-4fa6-8777-65c8e59060be"
      unitRef="usd">503000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4d856a3247a04312a0f97fa937d9eed7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC01LTEtMS0w_8ba4c2ec-9a2c-4f09-912b-8e281283e09b"
      unitRef="usd">252000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4d856a3247a04312a0f97fa937d9eed7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC03LTEtMS0w_79aeaf09-e6f3-44a5-8b0c-dc3bc1eb357c"
      unitRef="usd">251000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i32a42ebe572b4d43a291732f6cd1090f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC05LTEtMS0w_2371ef2e-2ea1-4c3f-8cfb-2dfa4d1d98f4"
      unitRef="usd">497000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i32a42ebe572b4d43a291732f6cd1090f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC0xMS0xLTEtMA_da12fe70-e67e-4880-acce-af97a587558d"
      unitRef="usd">244000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i32a42ebe572b4d43a291732f6cd1090f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNC0xMy0xLTEtMA_498460f1-e047-4940-b7cb-0c4877b3a646"
      unitRef="usd">253000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="i3d3366f7c074412792772c50da23b51d_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS0xLTEtMS0w_83042fe4-c174-41fc-81f8-f8d9f02690fb">P12Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i035c0f3929ab4099b0ee92a80f3a4278_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS0zLTEtMS0w_65958685-b95e-4329-a195-7f3c4f3aa842"
      unitRef="usd">934000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i035c0f3929ab4099b0ee92a80f3a4278_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS01LTEtMS0w_c539da4f-77f7-48dd-9fe3-7e839978d497"
      unitRef="usd">412000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i035c0f3929ab4099b0ee92a80f3a4278_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS03LTEtMS0w_a96d50eb-8569-4681-8873-9eccf85f21ae"
      unitRef="usd">522000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0f46fc9ae83e465096134ae813e19eca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS05LTEtMS0w_564d9db9-eb29-4988-b64d-f1a3ee819618"
      unitRef="usd">925000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0f46fc9ae83e465096134ae813e19eca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS0xMS0xLTEtMA_014e46ef-4e0c-40df-8861-2aff6728566b"
      unitRef="usd">394000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0f46fc9ae83e465096134ae813e19eca_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNS0xMy0xLTEtMA_a236331c-acf7-4631-a940-a99db2bbc92e"
      unitRef="usd">531000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="iccbdbd7b3a45463c9d5c7a2b7100baa2_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi0xLTEtMS0w_70c8696c-8e52-41ab-b515-933ded48ec48">P4Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0390e639fcad44a19ceb60da2c72ce2c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi0zLTEtMS0w_729af322-d93a-4d2d-bdfe-c4afabff4f43"
      unitRef="usd">150000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0390e639fcad44a19ceb60da2c72ce2c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi01LTEtMS0w_1301da3a-7e7b-4787-8309-8d7894541f75"
      unitRef="usd">127000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0390e639fcad44a19ceb60da2c72ce2c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi03LTEtMS0w_60c22e22-51d4-4187-925b-3d94e083817b"
      unitRef="usd">23000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7fbde6fe64aa486ab9d6ced83a9cd75c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi05LTEtMS0w_4919dcc5-b437-425f-bbeb-2a532b0f61ef"
      unitRef="usd">150000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7fbde6fe64aa486ab9d6ced83a9cd75c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi0xMS0xLTEtMA_dad07931-a5a2-43ae-b152-55a955dba662"
      unitRef="usd">122000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7fbde6fe64aa486ab9d6ced83a9cd75c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNi0xMy0xLTEtMA_4f81e866-a4ca-4af6-a779-e8391b0a59fc"
      unitRef="usd">28000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
      contextRef="ie584228b8d12471fb55c1f0dfb5e49f9_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy0xLTEtMS0w_830db249-fff6-4050-a000-434334152cef">P6Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5f2b8389302f4c9d9c629498687890a4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy0zLTEtMS0w_3b03c4da-1ee1-4fdc-ac83-969d6f195df9"
      unitRef="usd">255000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5f2b8389302f4c9d9c629498687890a4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy01LTEtMS0w_98f8adff-4521-4891-b128-8044e9f2b057"
      unitRef="usd">230000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5f2b8389302f4c9d9c629498687890a4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy03LTEtMS0w_dd2b6e8c-492c-42be-8874-61bcb9624a12"
      unitRef="usd">25000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i17ea7a07b00745c4b4e10ece2a6d1062_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy05LTEtMS0w_3a28cd0a-378d-4ea8-9df8-6beded1856fb"
      unitRef="usd">254000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i17ea7a07b00745c4b4e10ece2a6d1062_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy0xMS0xLTEtMA_b0b69d23-9224-422f-8497-1304a4bfa306"
      unitRef="usd">226000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i17ea7a07b00745c4b4e10ece2a6d1062_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfNy0xMy0xLTEtMA_8acbdba3-e938-4974-9122-c01a377c82ed"
      unitRef="usd">28000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfOC0zLTEtMS0w_c879ffae-1abb-456a-9e87-2ea6a5237888"
      unitRef="usd">6677000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfOC01LTEtMS0w_ccbcfef2-53d0-4b05-af18-ad2fd3b33822"
      unitRef="usd">3880000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfOC03LTEtMS0w_7e40b803-a341-43c3-aa60-e2716279d8fc"
      unitRef="usd">2797000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfOC05LTEtMS0w_46b1cfea-66cc-4d45-bcd3-00a9b5e07959"
      unitRef="usd">6646000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfOC0xMS0xLTEtMA_640990ed-90bf-4c51-ac0e-ff0d81a69ab4"
      unitRef="usd">3768000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RhYmxlOjQzYmYyZGQ1ZGFmMTQyNmNiMWFlMmRkOWI0ZDU0NWRkL3RhYmxlcmFuZ2U6NDNiZjJkZDVkYWYxNDI2Y2IxYWUyZGQ5YjRkNTQ1ZGRfOC0xMy0xLTEtMA_1ec90775-4411-420d-a564-ed840be9f4ed"
      unitRef="usd">2878000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTY5NQ_f6a0711f-2601-4b6c-86b0-a94232f684ad"
      unitRef="usd">98000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTczOA_0a07d9c7-090d-4e4a-b10d-f006a7fa1386"
      unitRef="usd">106000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTgzOQ_774548f0-d309-42cf-b124-03090d049228"
      unitRef="usd">279000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTg0Mw_90283535-1148-4934-b062-3d868ad3a6f7"
      unitRef="usd">273000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTg0Nw_502d9889-3d66-4cc3-a039-257c7232c632"
      unitRef="usd">261000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTg1MQ_f2cd4cf8-2560-4d7a-a137-7b010849acff"
      unitRef="usd">255000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTg1OQ_d4a98522-8a9c-4298-9160-ba2e5d0e5ab8"
      unitRef="usd">223000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl81OC9mcmFnOjYxOWNlNGI3YTk5ZDRmMTliMGU0MWE5MDk3ZGZlMzllL3RleHRyZWdpb246NjE5Y2U0YjdhOTlkNGYxOWIwZTQxYTkwOTdkZmUzOWVfMTkzNA_41b977a6-bd26-4dd4-b903-e78d7277a27e"
      unitRef="usd">1500000000</mck:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNTIxOA_be952569-b553-4754-aa61-8ea5c2e07165">Debt and Financing Activities&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63% Euro Notes due August 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $7.2 billion and $7.1 billion at June 30, 2021 and March 31, 2021, respectively, of which $752 million and $742 million, respectively, was included under the caption &#x201c;Current portion of long-term debt&#x201d; within the Company&#x2019;s Condensed Consolidated Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 17, 2021, the Company redeemed its 0.63% &#x20ac;600 million (or, approximately $709 million) total principal Euro-denominated notes, originally due on August 17, 2021, prior to maturity. The notes were redeemed at par value using cash on hand.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tender Offer&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) 2.85% Notes due 2023, (ii) 3.80% Notes due 2024, (iii) 7.65% Debentures due 2027, (iv) 3.95% Notes due 2028, (v) 4.75% Notes due 2029, (vi) 6.00% Notes due 2041, and (vii) 4.88% Notes due 2044 (collectively referred to herein as the &#x201c;Tender Offer Notes&#x201d;). In connection with the tender offer, the Company paid an aggregate consideration of $1.1&#160;billion to redeem $922&#160;million principal amount of the notes at a redemption price equal to 100% of the principal amount and premiums of $182&#160;million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment and in the second quarter of 2022 the Company will record a loss on debt extinguishment, consisting of the premiums paid and a portion of the unamortized discounts and debt issuance costs proportional to the principal amount of debt retired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revolving Credit Facilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a Credit Agreement, dated as of September 25, 2019 (the &#x201c;2020 Credit Facility&#x201d;), that provides a syndicated $4.0 billion five-year senior unsecured credit facility with a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#x201c;LIBOR&#x201d;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had no&#160;borrowings during the three months ended June 30, 2021 and 2020 and no amounts outstanding as of June 30, 2021 and March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 31, 2021, the Company entered into Amendment No. 2 to the 2020 Credit Facility, which superseded Amendment No. 1, dated as of February 1, 2021. The 2020 Credit Facility, as amended, contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At June 30, 2021, the Company was in compliance with all covenants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also maintains bilateral credit facilities primarily denominated in Euro with a committed amount of $8 million and an uncommitted amount of $118 million as of June 30, 2021. Borrowings and repayments were not material during the three months ended June 30, 2021 and 2020, and amounts outstanding under these credit lines were not material as of June 30, 2021 and March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. There were no borrowings or repayments during the three months ended June 30, 2021. During the three months ended June 30, 2020, the Company borrowed $5.3 billion and repaid $5.3 billion under the program. At June 30, 2021 and March 31, 2021, there were no commercial paper notes outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNTIwNg_edafe4ca-2267-47d5-b72d-c0046a4a1eb9">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;U.S. Dollar notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.70% Notes due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.85% Notes due March 15, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80% Notes due March 15, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90% Notes due December 3, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.65% Debentures due March 1, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.95% Notes due February 16, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75% Notes due May 30, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.00% Notes due March 1, 2041&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.88% Notes due March 15, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline"&gt;Foreign currency notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.63% Euro Notes due August 17, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50% Euro Notes due November 17, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.63% Euro Notes due October 30, 2026 &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.13% Sterling Notes due February 17, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease and other obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;These notes are unsecured and unsubordinated obligations of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these notes is payable semi-annually.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Interest on these foreign currency notes is payable annually.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibb31fe16ed0945ccb087b29dc4df346e_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNC0wLTEtMS0wL3RleHRyZWdpb246MzM0Y2I3NGI3Mjg2NGEzODkzMjUyNGUyMGU5NGE2MGNfNA_74ae5e8c-ad04-4cdb-91a8-90e3363b745a"
      unitRef="number">0.0270</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ibb31fe16ed0945ccb087b29dc4df346e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNC0xLTEtMS0w_d979501c-4db6-491a-a7bb-b12d367fc2f8"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8407cd75013b4842b7e8b7b851404c4e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNC0zLTEtMS0w_a5552860-1e7f-420c-876a-329fde368d92"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iebe203936fb34a7a9344c5a6786888f7_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNS0wLTEtMS0wL3RleHRyZWdpb246YTIwNGFkNzExYmY1NDZhZmE3MWRlNjBhMmQwNjE4NmVfNA_ef5deaae-3880-4ef9-b550-79e36dfcc1a5"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iebe203936fb34a7a9344c5a6786888f7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNS0xLTEtMS0w_0d2e8a2d-3185-42c0-b86c-4154039fbdf2"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i41289baaaa434780a092e5aa64685cf3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNS0zLTEtMS0w_b992577f-7e05-4481-9c2a-23bb52390f6b"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id5fef0e85ad14e5a8339aa8bf7f1f834_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNi0wLTEtMS0wL3RleHRyZWdpb246ZTNjNmFhM2JmMGFkNDg1MzhkOGQwZGY5YjVjZWQyYWFfNA_a868f6b5-e8ce-402d-88e9-7680400dcd3e"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="id5fef0e85ad14e5a8339aa8bf7f1f834_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNi0xLTEtMS0w_e84bcdec-980c-4cac-9f02-e46972058d92"
      unitRef="usd">1100000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9aee8ea463a843d09b2055c2c57299fd_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNi0zLTEtMS0w_6d5fcd13-5784-475e-a5ba-40017098d6f3"
      unitRef="usd">1100000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i169a4495697f4cc6a8840fef9d567050_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNy0wLTEtMS0wL3RleHRyZWdpb246NzY3NzViYTdiNWI5NDdiYzhjNjY4N2VkMDRhOTJlODNfNA_513f7f2c-3cf9-4991-9939-7022cde725c3"
      unitRef="number">0.0090</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i169a4495697f4cc6a8840fef9d567050_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNy0xLTEtMS0w_37b0c644-4b4c-4ae3-81b2-3236d0ab118b"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0a05c4c8a26643e09852e9a58afb81b1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfNy0zLTEtMS0w_b62d5ab8-e98d-4f86-bc24-fac76ee4f6d1"
      unitRef="usd">500000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib19d5790e42d4cf79c39f2cd0f8b3b29_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfOC0wLTEtMS0wL3RleHRyZWdpb246M2IyNzZlZjUyMmM5NDU5ZDljMTgyZWY3ZmZiODdmMWJfNA_240fd751-3f31-4a83-8560-7551ae67f4c1"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib19d5790e42d4cf79c39f2cd0f8b3b29_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfOC0xLTEtMS0w_c98af1ba-7d34-4bf9-9ebb-3598c8be6216"
      unitRef="usd">167000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i8f832373d87043299bdd466eea4cdba1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfOC0zLTEtMS0w_3bec897c-ef5d-4cc5-8203-4add327d3f75"
      unitRef="usd">167000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iae5f8b803832412fbac51e8806cb157b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfOS0wLTEtMS0wL3RleHRyZWdpb246OTQxZmI4OTk2YzVmNDFiZjg5ZGY2ZjIwM2QzNDg1YzFfNA_3d870748-3135-4f8d-8380-a2cd63561ab3"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="iae5f8b803832412fbac51e8806cb157b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfOS0xLTEtMS0w_f191fcdc-1ff1-4c0c-81b5-e167a6f4d294"
      unitRef="usd">600000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1e6c020b9a784d1892f9c88f64b4176e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfOS0zLTEtMS0w_63146fa3-984f-402d-a0b2-d0d57a51f6b6"
      unitRef="usd">600000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifee3165ec08d4e9d94616eacd185bdd9_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTAtMC0xLTEtMC90ZXh0cmVnaW9uOjdiNTFjMTMzMzQyZDRmMGE5ZDM5MzhjMDMyZjQyNTFhXzQ_fda62bca-962a-48da-8484-e4bcdd9df7b2"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ifee3165ec08d4e9d94616eacd185bdd9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTAtMS0xLTEtMA_3b92e267-a743-4e41-a9fa-0dea55508a51"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i88b5e65988454c43b931f14c2f226ef5_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTAtMy0xLTEtMA_d099c789-cf8e-4792-a559-3d36055f812c"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7e672708b526455fade2322b90db6797_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmYxY2YxMTE0M2ZiMjQ3ODBhMWQ5MjFiZjk1ZWUwMWQ1XzQ_8ba124a6-b621-4f6d-99a3-35f2e1bb5e2d"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i7e672708b526455fade2322b90db6797_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTEtMS0xLTEtMA_c9b3e883-2817-4654-8f4c-025471b3a641"
      unitRef="usd">282000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ic881a7db34944589a71dcb5194c00876_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTEtMy0xLTEtMA_3335c15c-3b5b-4918-9c98-65894ec8b7a1"
      unitRef="usd">282000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia66cc0f4490547d7b0e20380ae14d605_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTItMC0xLTEtMC90ZXh0cmVnaW9uOjU3NWM2OTAwZWFkODQ4N2FhZTE0NWFmMmM3MzliMjgwXzQ_85d2dc74-60bf-4550-b42a-f33683e1e4c5"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ia66cc0f4490547d7b0e20380ae14d605_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTItMS0xLTEtMA_43cfe9d3-ae60-4124-a201-d3c0017c54b6"
      unitRef="usd">411000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i393368a727ec4afe826cf57617c10f72_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTItMy0xLTEtMA_13a8bed4-36ca-4da3-802e-01361352b343"
      unitRef="usd">411000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0509dea68b7c4cebaf62b299de6337f9_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTQtMC0xLTEtMC90ZXh0cmVnaW9uOjE4ZTRlNDlkZTg3YjQ5NDZhYjJiOTMzZTUyZGQ5YThjXzQ_4b1205bb-e5dd-440e-ad31-c6c736f7adf7"
      unitRef="number">0.0063</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i0509dea68b7c4cebaf62b299de6337f9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTQtMS0xLTEtMA_81275a9a-3379-484b-a96f-fcd16826cdec"
      unitRef="usd">711000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i918f3ab82fc247afa4f05e53d52b0e43_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTQtMy0xLTEtMA_7bd57c76-8de2-4d38-a929-70cc95b6c773"
      unitRef="usd">704000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1586326f43a34f1ea78093d8355235f0_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOmIxM2U1ZDFlZWFiNTQwZmE5YzMzZjllZGQzMTcxM2I1XzQ_fb987dc9-ca2b-475c-84dc-3edb9697a629"
      unitRef="number">0.0150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1586326f43a34f1ea78093d8355235f0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTUtMS0xLTEtMA_f43d41ed-54a4-4e26-8951-c61ae954af27"
      unitRef="usd">708000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i15cf8725ddab482688388dd6b20edb40_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTUtMy0xLTEtMA_4fd869da-58e2-43ef-8ed8-320b1e1b30fe"
      unitRef="usd">700000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1fb67a2ffa7344a8ac4da91deabca230_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOjc2NzNmODExNDZjMzQ3NjlhNWMwOGZjNWQzM2Q0MmNjXzQ_fbfb49f0-2994-4b22-8d7d-8db2d4bc5eab"
      unitRef="number">0.0163</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i1fb67a2ffa7344a8ac4da91deabca230_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTYtMS0xLTEtMA_ba946efa-5498-433b-8497-a69ff00b4244"
      unitRef="usd">592000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i14953d2fb5684f679ab2a851b343c97b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTYtMy0xLTEtMA_a3b37d49-5cd4-4857-98f1-6eba041f8766"
      unitRef="usd">587000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifffd02ac34b54a9d83eede3f64ae16e7_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTctMC0xLTEtMC90ZXh0cmVnaW9uOmVmZjdmY2FjODRlOTQ5YjA5NDMzODMyMzlkNGQ0MjFiXzQ_ec36a2c4-33e0-4eab-9250-5e8aea7628fe"
      unitRef="number">0.0313</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ifffd02ac34b54a9d83eede3f64ae16e7_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTctMS0xLTEtMA_89c45a31-b4f0-41de-a91f-df629a89f8a9"
      unitRef="usd">635000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i755188d16c194ff880eddc359eea6d40_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTctMy0xLTEtMA_c78fa87d-9141-40b4-8e46-10e832f3d8f3"
      unitRef="usd">627000000</us-gaap:LongTermDebt>
    <us-gaap:FinanceLeaseLiability
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTktMS0xLTEtMA_e7774703-fd36-40f0-8880-3c7fa89bbbc0"
      unitRef="usd">270000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMTktMy0xLTEtMA_e837330b-ea58-4ef4-9f60-ec1a834055f1"
      unitRef="usd">270000000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMjAtMS0xLTEtMA_d0e8e8f7-5283-43f2-a996-98caa9770da9"
      unitRef="usd">7176000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMjAtMy0xLTEtMA_c4eaf777-f2c3-4a86-b6f7-2584a7a2c94d"
      unitRef="usd">7148000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMjEtMS0xLTEtMA_5cb57bc0-6ef3-4f15-902a-5d1ae248e779"
      unitRef="usd">752000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMjEtMy0xLTEtMA_fcc58642-7128-4b13-9df0-e70d55d6e5a2"
      unitRef="usd">742000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMjItMS0xLTEtMA_31ab5d8b-f314-46eb-8fb8-816a8b0e2396"
      unitRef="usd">6424000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RhYmxlOjdlY2RmNmRhOWQ5MTRlZTc4YWQ2ZTRhNGMzZGM1NDUzL3RhYmxlcmFuZ2U6N2VjZGY2ZGE5ZDkxNGVlNzhhZDZlNGE0YzNkYzU0NTNfMjItMy0xLTEtMA_d048f283-4b63-4376-891f-e9337619ccb1"
      unitRef="usd">6406000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzg0_90ceab7c-dde2-4374-bbb1-c99a551f32c6"
      unitRef="usd">7200000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:DebtAndCapitalLeaseObligations
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzkx_2dfcb4e2-a25c-4c90-9121-b12115e15432"
      unitRef="usd">7100000000</us-gaap:DebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNDMx_85d0aebd-8a0b-4801-acbb-20ebafd427c2"
      unitRef="usd">752000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i507f1cf3441d436a9874220e71af41c3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNDM4_2b2b4de9-aec0-4a0b-b4a3-10d79d65411f"
      unitRef="usd">742000000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i52b40196e15a40109ba391d8c6419991_I20210717"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk2NzE4MA_cf89bcdb-d92f-4f9c-a704-0ee3f60a6950"
      unitRef="number">0.0063</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i52b40196e15a40109ba391d8c6419991_I20210717"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MDc0NQ_b1eece72-423a-4bc9-99a2-b59ee1f38878"
      unitRef="eur">600000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i52b40196e15a40109ba391d8c6419991_I20210717"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MDczOQ_0ba780ac-37c3-40cc-a7e3-4203f427752f"
      unitRef="usd">709000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i083ed7e2edf54f4b83be55e6fa4c6f7b_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzAzMA_4e73f42e-6fee-411e-8248-9576f5647dc9"
      unitRef="number">0.0285</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5a40c09a559944b7bada0ac4b7f9ed85_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzAzNw_c028ac05-5f90-4169-93ea-fb136b3b7da1"
      unitRef="number">0.0380</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2c1f8c6acdf4492e89a70c07d233052b_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzA0NA_ec34ec02-08b6-4f22-a8b6-b86269169bf6"
      unitRef="number">0.0765</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8cd03befc3844879a03bf8f5fa13ca89_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzA1MQ_23484198-e5f7-409d-95b6-f31eac66566a"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if0edf0d51ebc4525bc018b0e3e316674_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzA1OA_77d6ea81-e08c-4480-88b8-b8071f290bce"
      unitRef="number">0.0475</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i310b2ea151234b239e7d7b390ccb95cb_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzA2NQ_6fb228d4-04a7-43de-b251-9862c452db19"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ibef52b2a142145dab5d69647024ad296_I20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzA3Mg_c3117060-7236-47a7-89cd-a55e8b600101"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i5f3accdb3da74028a9b53d7cbfada305_I20210723"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MjQwNg_f82a56be-6477-45c8-bea1-5e431d90852a"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i5f3accdb3da74028a9b53d7cbfada305_I20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MjQyOQ_7e20c257-e487-4607-b5f2-2414481fd66e"
      unitRef="usd">922000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i9c2de330c27f48448b2891e90290996d_D20210723-20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzI5ODUzNDkxMzA3OQ_3ecca617-4c9c-4fd8-be79-4f7285161f99"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i9c2de330c27f48448b2891e90290996d_D20210723-20210723"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MjQ1MQ_bbac30a4-fea1-4df6-b08f-28c37e755e1c"
      unitRef="usd">182000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i25b1cae8ddb3438888532104a195d342_I20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMjgxOQ_b025cb03-544d-45eb-bbb9-90b62cd97543"
      unitRef="usd">4000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ia01f828cfc8d4b21a6b8edf6be853a2c_D20190701-20190930"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNTIwNw_67522d2a-f148-4dab-ad86-177bee1ae4f9">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6e548eee92194bd0ac6aa9274c25b1a9_I20190930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMjk0OQ_64ef72f9-16ef-4b28-b098-99bec1df6f1e"
      unitRef="usd">3600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i382e8de72c834d1eac88fcfa16537bad_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzEwMA_b346caeb-b66e-4f4b-8735-6b6980ac85e6"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i4601e5b7a09c46ccb58053797c15dbc7_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzEwMA_ceaaf7a4-a528-42b2-87b4-17a06867f03c"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i4398603060f24739aba2e6bf31a25415_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzE1OA_198a1f09-154b-4c11-bed4-b818d17ec538"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i3b2b1270b93847d1b81d237136f5a141_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfMzE1OA_91f6d472-a333-4ec2-88c9-cd17829044ce"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases
      contextRef="iacf778d3b2e94d20a54cbcb22993e5bf_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNDQ0MQ_90c0e5d2-48ae-4633-90bb-8f9cf68abf65"
      unitRef="usd">8000000</us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases>
    <us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity
      contextRef="iacf778d3b2e94d20a54cbcb22993e5bf_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNDQ3Mw_bad49bf9-63ee-4115-a5c6-90210bc459e3"
      unitRef="usd">118000000</us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id40f1c8ac21f4308bf805ca389c79975_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNDg2Mg_6c509fc1-9432-4290-984d-80492e98d7cf"
      unitRef="usd">4000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="id62cfccb10834659abc7c6a555e79614_D20210401-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MTIyNw_a3e32221-8793-4b20-9a57-a9992172c4af"
      unitRef="usd">0</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="id62cfccb10834659abc7c6a555e79614_D20210401-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNjA0NzMxMzk4MTIyNw_da787528-72e2-461b-a7df-10af4649d458"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:ProceedsFromIssuanceOfCommercialPaper
      contextRef="ibbabad5c01b74ee69bce61c31d9c74ac_D20200401-20200630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNDk3MA_85d32092-a0e5-40db-b1aa-d7a64dfa78da"
      unitRef="usd">5300000000</us-gaap:ProceedsFromIssuanceOfCommercialPaper>
    <us-gaap:RepaymentsOfCommercialPaper
      contextRef="ibbabad5c01b74ee69bce61c31d9c74ac_D20200401-20200630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNTAwNg_b834d3fb-cfd1-4478-9a10-ce443114b2b6"
      unitRef="usd">5300000000</us-gaap:RepaymentsOfCommercialPaper>
    <us-gaap:LongTermCommercialPaperCurrent
      contextRef="i87ef7e5959ad4f249be2667fc9962adc_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNTE2NA_10a48458-9f84-4d45-bee3-f868a2e03136"
      unitRef="usd">0</us-gaap:LongTermCommercialPaperCurrent>
    <us-gaap:LongTermCommercialPaperCurrent
      contextRef="id40f1c8ac21f4308bf805ca389c79975_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82MS9mcmFnOjgwZGY4MmM4NWIyNDQ2YmU4NDY5YTJkNmViZWNiOTgzL3RleHRyZWdpb246ODBkZjgyYzg1YjI0NDZiZTg0NjlhMmQ2ZWJlY2I5ODNfNTE2NA_8052c964-24e8-4039-8efe-5cf10c01f3fe"
      unitRef="usd">0</us-gaap:LongTermCommercialPaperCurrent>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82NC9mcmFnOmRlNDcyNTI0NDE3NzQ3NjY5M2NhNjBkYTQzM2NiODE0L3RleHRyZWdpb246ZGU0NzI1MjQ0MTc3NDc2NjkzY2E2MGRhNDMzY2I4MTRfMjQ2NQ_7b3a1f6f-24cd-4bc7-8a6a-489f25385d67">Pension Benefits&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net periodic expense for defined benefit pension plans was approximately zero and $7 million for the three months ended June 30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash contributions to these plans were $14 million and $7 million for the three months ended June 30, 2021 and 2020, respectively. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#x2019; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ia550dbf4b8264bfb9f5b32e88da36352_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82NC9mcmFnOmRlNDcyNTI0NDE3NzQ3NjY5M2NhNjBkYTQzM2NiODE0L3RleHRyZWdpb246ZGU0NzI1MjQ0MTc3NDc2NjkzY2E2MGRhNDMzY2I4MTRfNzU_ed54a695-dac0-4d61-b9ff-0e1b588fc087"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie9cfdb9a5439470287947e0237d40a46_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82NC9mcmFnOmRlNDcyNTI0NDE3NzQ3NjY5M2NhNjBkYTQzM2NiODE0L3RleHRyZWdpb246ZGU0NzI1MjQ0MTc3NDc2NjkzY2E2MGRhNDMzY2I4MTRfMTE1_78a5e9ad-943e-4b76-bdab-4d6e89809fe2"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ia550dbf4b8264bfb9f5b32e88da36352_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82NC9mcmFnOmRlNDcyNTI0NDE3NzQ3NjY5M2NhNjBkYTQzM2NiODE0L3RleHRyZWdpb246ZGU0NzI1MjQ0MTc3NDc2NjkzY2E2MGRhNDMzY2I4MTRfMTkx_3c5c9928-1a46-4860-bb9e-dc48e5c80cc9"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ie9cfdb9a5439470287947e0237d40a46_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82NC9mcmFnOmRlNDcyNTI0NDE3NzQ3NjY5M2NhNjBkYTQzM2NiODE0L3RleHRyZWdpb246ZGU0NzI1MjQ0MTc3NDc2NjkzY2E2MGRhNDMzY2I4MTRfMjMx_cc7c2c3c-9ff1-4b51-8786-1ac97113909c"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanFundedPercentage
      contextRef="icc80b14c5bcc4ef59c002900d86c6c35_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82NC9mcmFnOmRlNDcyNTI0NDE3NzQ3NjY5M2NhNjBkYTQzM2NiODE0L3RleHRyZWdpb246ZGU0NzI1MjQ0MTc3NDc2NjkzY2E2MGRhNDMzY2I4MTRfNTc0_ab359394-c402-4f4c-bbd5-8aca90965ce8"
      unitRef="number">0.10</us-gaap:DefinedBenefitPlanFundedPercentage>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMTEyMjE_2558807d-4b1e-40ad-91c1-096b0017e01a">Hedging Activities In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#x2019;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. &lt;div style="margin-bottom:6pt;padding-left:2.25pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Foreign Currency Exchange Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#x2019;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Derivative Instruments Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2021 and March 31, 2021, the Company had &#x20ac;1.7 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#x2019;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments in &#x201c;Accumulated other comprehensive loss&#x201d; in the Condensed Consolidated Statements of Stockholders&#x2019; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Losses from net investment hedges recorded within Other comprehensive income were $22 million and $34 million during the three months ended June 30, 2021 and 2020, respectively. There was no ineffectiveness in non-derivative net investment hedges during the three months ended June 30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2021 and March 31, 2021, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $500 million Canadian dollars. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#x2019;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in &#x201c;Accumulated other comprehensive loss&#x201d; in the Condensed Consolidated Statements of Stockholders&#x2019; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#x2019;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#x2019;s net investment hedges for the three months ended June 30, 2021 and 2020. The remaining cross-currency swaps will mature November 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from the Company&#x2019;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $5 million and $51 million during the three months ended June 30, 2021 and 2020, respectively. There was no ineffectiveness in the Company&#x2019;s cross-currency swap hedges for the three months ended June 30, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#xa3;450 million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#xa3;450 million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At June 30, 2021 and March 31, 2021, the Company had cross-currency swaps with total gross notional amounts of approximately $2.6 billion, which are designated as cash flow hedges. These swaps will mature between August 2021 and January 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $500 million and &#x20ac;600 million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#x201c;EURIBOR&#x201d;) for the &#x20ac;600 million swaps. The $500 million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes. Refer to Financial Note 8, &#x201c;Debt and Financing Activities,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains or losses from cash flow hedges recorded in Other comprehensive income were zero and a loss of $5 million during the three months ended June 30, 2021 and 2020, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations were not material in the three months ended June 30, 2021 and 2020. There was no ineffectiveness in the Company&#x2019;s cash flow hedges for the three months ended June 30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives Not Designated as Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At June 30, 2021 and March 31, 2021, the total gross notional amounts of these contracts were $54 million and $39 million, respectively. These contracts will predominantly mature between July 2021 and December 2021 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations. Changes in the fair values were not material in the three months ended June 30, 2021 and 2020. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.481%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:LongTermDebt
      contextRef="ic94ceeda5f8d4c34920ab05d68d536f7_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMTUwMg_407a223c-78fc-42d0-bbab-a8e24de97d19"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i7e80ec0a1e2d4560a4bb44c4d5f4a808_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMTUwMg_780d4e36-0865-4d10-a8f1-88bd4bed7928"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3252989f4e9143d3a010d05024100a86_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMjcxMQ_25f7c989-fcad-4b32-a385-13e3a71a4cbb"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i0d1c889a01024ed39200b6381c6e96e7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMjc2NA_fe567143-2c50-4387-8af8-f6a3f51841c2"
      unitRef="usd">-34000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iaad66d5fe7e44e1f84cb3ffe38ed1ab1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMzI4OQ_8ef8f095-a4cf-4d90-b310-6fc9dbc722d2"
      unitRef="cad">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i80839eede57645f39c2726f49aa8dd4f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMzI4OQ_f19cfcbc-cd5b-4daa-b1bd-db2932e686b9"
      unitRef="cad">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="ie2831786f08a4f11887081ccec157fb0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfNTQ2OA_43cac93b-262d-4d34-974d-edb381976e3d"
      unitRef="usd">-5000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="id92758a2bb7c4cff8bb23c47c0c1232f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfNTUyMQ_d8da1535-7c9f-4873-b747-a70b3af20449"
      unitRef="usd">-51000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:LongTermDebt
      contextRef="ie7a08d2dbea84831a38c40ef01c2c6e7_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfNTgyMw_de8ce093-e40a-4374-82a8-1a5fea4d6b15"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ie7a08d2dbea84831a38c40ef01c2c6e7_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfNjE3NQ_de8ce093-e40a-4374-82a8-1a5fea4d6b15"
      unitRef="gbp">450000000</us-gaap:LongTermDebt>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8814cd508cb14d7a92a7f3da4dedb9e8_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfNzQzNg_62a6558e-a152-497c-8bcc-ab45d3d47191"
      unitRef="usd">2600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i956714c5c73546d6bdd695153b63c85a_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfNzQzNg_6591078b-2e3d-4d92-886b-2df1798e0e10"
      unitRef="usd">2600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9ef3d8dbb2ba449ca93f70296442ff7b_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODA4MQ_25042617-c77b-44f0-ad3b-619b59f6ba9f"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9ef3d8dbb2ba449ca93f70296442ff7b_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODA4OA_b0b8fc63-9cdb-4155-90e4-c2bc8ef36ed9"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9ef3d8dbb2ba449ca93f70296442ff7b_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODMxNw_25042617-c77b-44f0-ad3b-619b59f6ba9f"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9ef3d8dbb2ba449ca93f70296442ff7b_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODU0Mg_b0b8fc63-9cdb-4155-90e4-c2bc8ef36ed9"
      unitRef="eur">600000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9ef3d8dbb2ba449ca93f70296442ff7b_I20200427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODU1Ng_25042617-c77b-44f0-ad3b-619b59f6ba9f"
      unitRef="usd">500000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DebtInstrumentTerm
      contextRef="i124c1e4e44e4428894d8a3cf36e6b1f8_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMTEyMjM_d30903c9-ab2e-4de6-b8de-43ebfb8db8b7">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ief989ade667c4ef18be6557ba0496c47_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODkzOA_2de0f948-eaaa-47de-bcac-673ce90d783d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i7e159bf48d534941b449647bc4af9899_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfODk5NQ_c8af7c7b-5b90-4b07-92a0-d2dee7a2b576"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iddb83da1863c4b8384938b9fad9620c2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfOTcwMw_758f3c00-f663-45b1-a3b1-fb772823332c"
      unitRef="usd">54000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1a3a75a3436b4b3685c3cfc786388204_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfOTcxMA_6feee010-20ff-479d-8d29-3fe738f7d1db"
      unitRef="usd">39000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RleHRyZWdpb246MTJmOGVkMjRmNDBiNDQ4Zjk1MWYzZTYyMjM0ZDk2MmNfMTEyMTg_7900f410-44fd-41fa-bf63-a8312fa3e316">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding the fair value of derivatives on a gross basis is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.481%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.033%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.817%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.202%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet &lt;br/&gt;Caption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value of &lt;br/&gt;Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. Dollar Notional&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other/Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency swaps (non-current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets/liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward starting interest rate swaps (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated for hedge accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange contracts (current)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic2941f5ca10940f394d4dd8bfb64ac58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNS0yLTEtMS0w_3a25398a-69b1-45b2-9d15-6466c285ee2d"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id617d1f4a3154d5ead974c1efa393746_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNS00LTEtMS0w_de6f6b39-ae07-4e1b-96e7-034e943201bb"
      unitRef="usd">50000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i3d7fdeabe846450cbffd7d9cb27d2e5f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNS01LTEtMS0w_f4150ec9-5ac9-44b6-8aca-fb198f333b71"
      unitRef="usd">895000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i0b6587a427294928b598b9dd585bb983_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNS03LTEtMS0w_53cd49d1-eb78-4982-827f-f7537f4fd252"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id5eb3ee735d54234824cb44c72ee37bd_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNS05LTEtMS0w_011b680b-6fcf-4610-b3cb-4da390d4bfce"
      unitRef="usd">47000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i558eb332169346989d3fd5ae0d6527e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNS0xMC0xLTEtMA_6b1f1ea2-efc3-4340-b523-4225220702cc"
      unitRef="usd">826000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if7c97a01f67041b391ae942c70306640_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNi0yLTEtMS0w_4f6abb76-ed31-404f-b5e5-b8284f887b56"
      unitRef="usd">77000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if46eae73de4e4324a272398b73a63332_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNi00LTEtMS0w_f8599d97-bcb5-473e-a84e-3b60cce47f60"
      unitRef="usd">128000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i1cb0c057ebf04f36a85edd8c4c2ae13c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNi01LTEtMS0w_dcd9c31d-9303-42ed-878e-bddd575800cc"
      unitRef="usd">2594000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3de9a66fbd214a428e97ce8f78d46531_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNi03LTEtMS0w_3d0f47ca-7791-495f-b7d4-d377c171a4a0"
      unitRef="usd">72000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i9fca76452d9740ef9b482b67b89fa4f8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNi05LTEtMS0w_18cf76ea-f31a-4ae4-b8f2-fdbd9560b678"
      unitRef="usd">92000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i2acd26c3075244feb92ff6dd6d80e75c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNi0xMC0xLTEtMA_65fae290-2a78-45b2-9f19-30d9b9a581d7"
      unitRef="usd">2663000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i8d2fcd1df20c4538955a00e476ec7c57_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNy0yLTEtMS0w_743a44f8-1f1a-46e3-b9e0-52ac30b6446c"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i8d2fcd1df20c4538955a00e476ec7c57_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNy00LTEtMS0w_b9225112-5faa-4061-a71a-8596d6816891"
      unitRef="usd">5000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i8d2fcd1df20c4538955a00e476ec7c57_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNy01LTEtMS0w_459fe097-bfcf-4965-ad70-d09d4f3c3832"
      unitRef="usd">711000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ieb89381a71734f36b7d1abc0599bc5dc_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNy03LTEtMS0w_280a0106-ee93-41bc-a3e4-9c52521e5eb4"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ieb89381a71734f36b7d1abc0599bc5dc_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNy05LTEtMS0w_5c8659cd-994b-4d34-92d5-1e064bc01f16"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ieb89381a71734f36b7d1abc0599bc5dc_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfNy0xMC0xLTEtMA_ddab9e96-d147-4645-8533-20f85d0065c2"
      unitRef="usd">704000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id0d9f4fb8711478cb44177fe5109b6be_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfOS0yLTEtMS0w_8b56d704-b5a4-4aaa-a716-b0209c68900b"
      unitRef="usd">81000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id0d9f4fb8711478cb44177fe5109b6be_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfOS00LTEtMS0w_a4e02095-a74f-4345-8ba0-90c22cec5c47"
      unitRef="usd">183000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i8d0248921e62472a9c05a75192f10e2a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfOS03LTEtMS0w_76f28175-d2e1-4a26-8743-8ce09baa818c"
      unitRef="usd">76000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i8d0248921e62472a9c05a75192f10e2a_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfOS05LTEtMS0w_ffaf538b-331e-492f-a4dc-1eec7ebb7fc6"
      unitRef="usd">146000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i057bad05c3bc428daef027fdad88ff14_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTEtMi0xLTEtMA_53d945ce-c283-4dce-861a-e04f4a318ac2"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i057bad05c3bc428daef027fdad88ff14_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTEtNC0xLTEtMA_cfc3d45a-4711-4f1f-a92c-6cc137957d2a"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i057bad05c3bc428daef027fdad88ff14_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTEtNS0xLTEtMA_627d2b1d-b66f-4c3a-a638-d53864f7d6c4"
      unitRef="usd">42000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1c462aabc2274d09a39e632a3b618cce_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTEtNy0xLTEtMA_eabc7dae-b1a0-4bac-afb2-eab55370d427"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i1c462aabc2274d09a39e632a3b618cce_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTEtOS0xLTEtMA_d7f59c9f-f04a-45e6-9907-966c611b99b8"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i1c462aabc2274d09a39e632a3b618cce_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTEtMTAtMS0xLTA_2d524bb1-ee49-4ebc-8c08-fa6bcffc8318"
      unitRef="usd">29000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic7ab7b1f45b443cba7bfac6496401a9f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTItMi0xLTEtMA_017be7f0-2beb-425e-8cb5-5d9e51448c56"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ic7ab7b1f45b443cba7bfac6496401a9f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTItNC0xLTEtMA_eb9f9f6b-269a-483d-b253-213a65830402"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="ic7ab7b1f45b443cba7bfac6496401a9f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTItNS0xLTEtMA_2f3ed6e0-95dc-495c-9b60-1e5dc80ad438"
      unitRef="usd">12000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i50a5c757907c4088ae0296ac7b7d7d28_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTItNy0xLTEtMA_91748879-0afb-4efe-aa5a-4741e9b406ab"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i50a5c757907c4088ae0296ac7b7d7d28_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTItOS0xLTEtMA_bf75039e-80b2-4a5b-9d6f-acb4626ee1fe"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityNotionalAmount
      contextRef="i50a5c757907c4088ae0296ac7b7d7d28_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTItMTAtMS0xLTA_b987e842-35ce-460c-bb30-e2e47753ca43"
      unitRef="usd">10000000</us-gaap:DerivativeLiabilityNotionalAmount>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie0f92fdc3cca4ab5a3cf1a1bf925cfd1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTMtMi0xLTEtMA_3bd1b7b5-4919-4df1-98e8-1f2de6321441"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ie0f92fdc3cca4ab5a3cf1a1bf925cfd1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTMtNC0xLTEtMA_b43dbc36-f3b1-42d2-ae1a-d407beda1612"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i17405e4be62d40c6ab31341f02725dfc_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTMtNy0xLTEtMA_9fef164b-9663-4f2c-92ee-194e7b27f0f4"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i17405e4be62d40c6ab31341f02725dfc_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl82Ny9mcmFnOjEyZjhlZDI0ZjQwYjQ0OGY5NTFmM2U2MjIzNGQ5NjJjL3RhYmxlOjA4MzY3YWVkNmM1MzRhYzhiOGFkOGQzYmI5YTJkYzdkL3RhYmxlcmFuZ2U6MDgzNjdhZWQ2YzUzNGFjOGI4YWQ4ZDNiYjlhMmRjN2RfMTMtOS0xLTEtMA_a0a50455-a812-4d71-914c-ade9daea01f1"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RleHRyZWdpb246MmEzOThhZjdhMjg4NGU1ZmI1OTczNWNjZTZhZDZhM2VfNjkxNw_09a4e881-c165-48a5-bccf-8cde1155d988">Fair Value Measurements&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements and Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 - quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 - significant other observable market-based inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents at June 30, 2021 and March 31, 2021 included investments in money market funds of $521 million and $1.6 billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#x2019;s marketable securities were not material at June 30, 2021 and March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair values of the Company&#x2019;s interest rate swaps, foreign currency forward contracts, and cross-currency swaps were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, &#x201c;Hedging Activities,&#x201d; for fair value and other information on the Company&#x2019;s derivatives including interest rate swaps, forward foreign currency contracts, and cross-currency swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#x2019;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets associated with the Company&#x2019;s restructuring initiatives as discussed in more detail in Financial Note 3, &#x201c;Restructuring, Impairment, and Related Charges.&#x201d; At March 31, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#x2019;s International segment and goodwill of the Company&#x2019;s Europe Retail Pharmacy reporting unit within the International segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no liabilities measured at fair value on a nonrecurring basis at June 30, 2021 and March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Fair Value Disclosures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June 30, 2021 and March 31, 2021, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.903%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of the Company&#x2019;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted cash, included within &#x201c;Prepaid expenses and other&#x201d; on the Company&#x2019;s Condensed Consolidated Balance Sheets as of June 30, 2021 and March 31, 2021, primarily consists of funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. The amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within &#x201c;Other accrued liabilities&#x201d; on the Company&#x2019;s Condensed Consolidated Balance Sheets as of June 30, 2021 and March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a discounted cash flow (&#x201c;DCF&#x201d;) model to determine the fair value of the reporting unit. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.&lt;/span&gt;&lt;/div&gt;The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie6b3e479a7ba41eab5874e29f520ca6e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RleHRyZWdpb246MmEzOThhZjdhMjg4NGU1ZmI1OTczNWNjZTZhZDZhM2VfMTIzNg_5c138f3d-2ed6-45c1-b816-1396fc21fd21"
      unitRef="usd">521000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i264ad77616174b4a9fc0c900da89178a_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RleHRyZWdpb246MmEzOThhZjdhMjg4NGU1ZmI1OTczNWNjZTZhZDZhM2VfMTI0Mw_fa04cd3e-0f47-4adc-96e0-78e1ae07cea8"
      unitRef="usd">1600000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ieb9b9bae1bf74a07b096fa2f28832165_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RleHRyZWdpb246MmEzOThhZjdhMjg4NGU1ZmI1OTczNWNjZTZhZDZhM2VfNTAwNw_659878f7-bb84-408c-9635-b03826d439c6"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ida94316064164aa9be5a8557cd06794c_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RleHRyZWdpb246MmEzOThhZjdhMjg4NGU1ZmI1OTczNWNjZTZhZDZhM2VfNTAwNw_ad888619-3727-4ea0-ab48-0f338f6e25cd"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RleHRyZWdpb246MmEzOThhZjdhMjg4NGU1ZmI1OTczNWNjZTZhZDZhM2VfMzI5ODUzNDkxMzU1NQ_d1abff47-037a-4638-9868-adac1413985d">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#x2019;s long-term debt was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.223%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.903%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, including current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i2f1e101a3d9e451eb8389cf243131a05_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RhYmxlOjllZTUyYWRlZWI5OTQ4MjliYTg2NDhmYTQ1MzEyNTU4L3RhYmxlcmFuZ2U6OWVlNTJhZGVlYjk5NDgyOWJhODY0OGZhNDUzMTI1NThfMi0xLTEtMS02NjA_218d99a3-719a-4439-bf0a-632457096dcb"
      unitRef="usd">7176000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i2f1e101a3d9e451eb8389cf243131a05_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RhYmxlOjllZTUyYWRlZWI5OTQ4MjliYTg2NDhmYTQ1MzEyNTU4L3RhYmxlcmFuZ2U6OWVlNTJhZGVlYjk5NDgyOWJhODY0OGZhNDUzMTI1NThfMi0zLTEtMS02NjM_d1da27ce-e638-42c9-965e-b1148133bb79"
      unitRef="usd">7865000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LongTermDebt
      contextRef="ia19dcf632c5a4f9b87ae18a87b76e38c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RhYmxlOjllZTUyYWRlZWI5OTQ4MjliYTg2NDhmYTQ1MzEyNTU4L3RhYmxlcmFuZ2U6OWVlNTJhZGVlYjk5NDgyOWJhODY0OGZhNDUzMTI1NThfMi01LTEtMS02NTA_c8e54c83-e7e4-49fe-b334-c8792a41c7a5"
      unitRef="usd">7148000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia19dcf632c5a4f9b87ae18a87b76e38c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83MC9mcmFnOjJhMzk4YWY3YTI4ODRlNWZiNTk3MzVjY2U2YWQ2YTNlL3RhYmxlOjllZTUyYWRlZWI5OTQ4MjliYTg2NDhmYTQ1MzEyNTU4L3RhYmxlcmFuZ2U6OWVlNTJhZGVlYjk5NDgyOWJhODY0OGZhNDUzMTI1NThfMi03LTEtMS02NTM_1b424d62-612f-4db9-95f5-88dc05c523b2"
      unitRef="usd">7785000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMTkzMzE_4a11691f-67e8-4261-accc-56457d888144">Commitments and Contingent Liabilities &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765321000039/mck-20210331.htm#i08f9baf810c0412e93ea6effc6d22995_214" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 19 to the Company&#x2019;s 2021 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;I. Litigation and Claims Involving Distribution of Controlled Substances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;), state and federal controlled substances laws, and other statutes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#x201c;MDL&#x201d;) in the United States District Court for the Northern District of Ohio captioned &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re: National Prescription Opiate Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Case No. 17-md-2804. At present, there are approximately 2,900 cases under the jurisdiction of the MDL court. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Three cases involving McKesson that were previously part of the federal MDL have been remanded to other federal courts for discovery and trial. On January 14, 2020, the Judicial Panel on Multidistrict Litigation finalized its Conditional Remand Order, ordering that the cases brought by Cabell County, West Virginia and the City of Huntington, West Virginia be remanded to the U.S. District Court for the Southern District of West Virginia. Trial in that case ended on July 28, 2021 and the outcome is pending. On February 5, 2020, the case brought by the City and County of San Francisco was remanded to the U.S. District Court for the Northern District of California; trial has been set for April 25, 2022. Also on February 5, 2020, the case brought by the Cherokee Nation was remanded by the MDL court to the U.S. District Court for the Eastern District of Oklahoma; trial has been set for September 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is also named in approximately 300 similar state court cases pending in 38 states plus Puerto Rico, along with 3 cases in Canada. These include actions filed by 26 state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state court cases. For example, trials in the cases brought by the Ohio and Washington attorneys general are scheduled for September 2021; the case brought by the Alabama attorney general is scheduled to go to trial in November 2021; the case brought by the Rhode Island attorney general is scheduled for January 2022; and the case brought by Dallas County, Texas, is scheduled for trial in January 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 21, 2021, the Company and the two other national pharmaceutical distributors announced that they had negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. If the proposed settlement agreement and settlement process leads to final settlement, the three distributors would pay up to approximately $21 billion over 18 years, with up to $7.9 billion to be paid by the Company for its 38.1% portion; a minimum of 85% of such payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#x2019; attorneys&#x2019; fees and costs, and would be payable over a shorter time period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The proposed agreement would also establish a clearinghouse that would consolidate controlled-substance distribution data from the three largest U.S. distributors, which will be available to the settling states to use as part of their anti-diversion efforts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Agreement is subject to contingencies and will not become effective unless the Company determines that (1) following a sign-on period of 30 days, a sufficient number of states have agreed to be bound by the proposed agreement; and, subsequently, (2) following a sign-on period of 120 days, that a sufficient number of states and political subdivisions, including those that have not sued, have agreed to be bound by the agreement (or otherwise had their claims foreclosed).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The exact amount that would be due under the proposed agreement depends on several factors, including the participation rate of states and political subdivisions, the extent to which states take action to foreclose opioid lawsuits by political subdivisions, and the extent to which political subdivisions in settling states file additional opioid lawsuits against the Company after the proposed agreement becomes effective. The proposed agreement contemplates that if certain governmental entities do not agree to a settlement under the framework, but the distributors nonetheless conclude that there is sufficient participation to warrant the settlement, there would be a corresponding reduction in the amount due from the Company to account for the unresolved claims of the governmental entities that do not participate. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This settlement process only addresses the claims of U.S. state attorneys general and political subdivisions in participating states. The West Virginia subdivisions and Native American tribes are not part of this settlement process. The proposed agreement provides that the Company will place its first annual payment, estimated to be approximately $482&#160;million, into escrow on or before September 30, 2021, to be disbursed when and if the proposed agreement becomes effective. Subsequent payments would be due on July 15 of each year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 20, 2021, the Company announced that it and the two other national pharmaceutical distributors had agreed to pay up to $1.2&#160;billion, of which the Company&#x2019;s portion would be 38.1%, in a settlement with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that New York and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework, as well as certain attorneys&#x2019; fees and costs. If the broad settlement is finalized, New York and its participating subdivisions will become part of that broader agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that a broad settlement of opioid claims by governmental entities is probable, and that the loss related thereto can be reasonably estimated. The Company recorded a charge of $8.1 billion ($6.8 billion after-tax) in the fiscal year ended March 31, 2021 related to its share of the global settlement as well as claims of West Virginia municipalities and the Native American tribes. In connection with the matters described above, the Company recorded additional charges of $74&#160;million ($61&#160;million after-tax) in the quarter ended June 30, 2021 within &#x201c;Claims and litigation charges, net&#x201d; in the Condensed Consolidated Statements of Operations, including a pre-tax charge of $27&#160;million ($22&#160;million after-tax) related to the settlement with New York and its participating subdivisions, and a pre-tax charge of $47&#160;million ($39&#160;million after-tax) related to the proposed settlement agreement with state and local governmental entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s estimated accrued liability for opioid-related claims of governmental entities, including the $482&#160;million initial payment under the proposed settlement agreement, is as follows as of June 30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current litigation liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;This amount, recorded in &#x201c;Other accrued liabilities&#x201d; on the Condensed Consolidated Balance Sheet, is the amount estimated to be paid prior to June 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If a broad settlement is not reached under the proposed agreement, litigation will continue. The Company continues to prepare for trial in these pending matters, and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as 3 cases brought in Canada (two by governmental entities and one by an individual). These claims, and those of private entities generally, are not included in the settlement framework for governmental entities, or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. One such case brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court seeks to recover for damages allegedly arising from their family members&#x2019; abuse of prescription opioids; trial in that case is scheduled to begin in October 2021. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Poppell v. Cardinal Health, Inc. et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CE19-00472. The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the many uncertainties associated with any potential settlement arrangement or other resolution of all of these opioid-related litigation matters, including the uncertain scope of participation by governmental entities in any potential settlement under the framework described above, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#x2019;s financial position, cash flows or liquidity, or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the Company was served with two qui tam complaints filed by the same two relators alleging violations of the federal False Claims Act, the California False Claims Act, and the California Unfair Business Practices statute based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. Kelley&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19-cv-2233, and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;State of California ex rel. Kelley&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, CGC-19-576931. The complaints seek relief including treble damages, civil penalties, attorney fees, and costs in unspecified amounts. On February 16, 2021, the court in the federal action dismissed the second amended complaint with prejudice, and the relators appealed the dismissal to the U.S. Court of Appeals for the Ninth Circuit. On June 28, 2021, the court in the state action dismissed the complaint with prejudice.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;II. Other Litigation and Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 5, 2018, the Company&#x2019;s subsidiary, RxC Acquisition Company (d/b/a RxCrossroads), was served with a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaint filed in July 2017 in the United States District Court for the Southern District of Illinois by a relator against RxC Acquisition Company, among others, alleging that UCB, Inc. provided illegal &#x201c;kickbacks&#x201d; to providers, including nurse educator services and reimbursement assistance services provided through RxC Acquisition Company, in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;United States ex rel. CIMZNHCA, LLC v. UCB, Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, No. 17-cv-00765. The complaint sought treble damages, civil penalties, and further relief. The United States and the states named in the complaint declined to intervene in the suit. On December 17, 2018, the United States filed a motion to dismiss the complaint in its entirety; this motion was denied on April 15, 2019. On June 7, 2019, the court denied the United States&#x2019; motion for reconsideration. On July 8, 2019, the United States appealed to the United States Court of Appeals for the Seventh Circuit seeking interlocutory review of the denial of its motion for reconsideration of the denial of the motion to dismiss the complaint. On September 3, 2019, the United States District Court for the Southern District of Illinois stayed the district court proceedings pending the appeal. On August 17, 2020, the Seventh Circuit reversed the district court&#x2019;s decision on the United States&#x2019; motion to dismiss and remanded the case with instructions that the district court enter judgment for the defendants on the relator&#x2019;s claims under the False Claims Act. The relator sought a re-hearing en banc at the Seventh Circuit, which was denied. The relator&#x2019;s False Claims Act case was dismissed, with judgment entered in favor of the defendants on September 30, 2020. On February 10, 2021, the relator filed a Petition for Writ of Certiorari at the United States Supreme Court seeking review of the Seventh Circuit&#x2019;s ruling; that petition was denied on June 28, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;III.&#160;Government Subpoenas and Investigations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 19, 2021, the Norwegian Competition Authority carried out an inspection of Norsk Medisinaldepot AS regarding alleged sharing of competitively sensitive information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the United States Department of Justice served a Civil Investigative Demand on the Company seeking documents related to distribution arrangements for ophthalmology products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IV. State Opioid Statutes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legislative, regulatory or industry measures to address the misuse of prescription opioid medications could affect the Company&#x2019;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#x201c;OSA&#x201d;) which required the creation of an aggregate $100&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#x2019;s decision on procedural grounds. The Company has accrued a $50&#160;million pre-tax charge ($37&#160;million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized in &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Consolidated Statement of Operations for the year ended March 31, 2021 and in &#x201c;Other accrued liabilities&#x201d; in the Consolidated Balance Sheet as of March 31, 2021. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing en banc with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. The petition was filed on May 17, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMTkzMzA_7df1dbef-5808-48dd-aacb-5924ad6fbe7b">&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in &lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765321000039/mck-20210331.htm#i08f9baf810c0412e93ea6effc6d22995_214" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial Note 19 to the Company&#x2019;s 2021 Annual Report&lt;/a&gt;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.&lt;/span&gt;Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i468d5d79395f4d76980c0de14e2195fe_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMzgxMA_69694646-a29b-40a8-b49e-7f9e49bf9298"
      unitRef="case">2900</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts
      contextRef="i560f2387215143f39820008aab86b0e9_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMzg2Mg_279bc8a7-5b5e-41d5-89e9-449d9b55ff1c"
      unitRef="case">3</mck:LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i7967e4fff72d493bb8ebc9597e37bc19_I20210630"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNDc5Nw_42ad3c71-6e8b-457e-997c-fb1ba94c057b"
      unitRef="case">300</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofStates
      contextRef="i7967e4fff72d493bb8ebc9597e37bc19_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNDgzNw_323aa495-93c7-4f8c-8bad-54824ff745bb"
      unitRef="state">38</mck:LossContingencyNumberofStates>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i5952f660e44f4b63bfd67ce4efa66744_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNDg3Ng_c9009ede-00a4-4c3c-becc-10e536027278"
      unitRef="case">3</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:LossContingencyNumberofStateAttorneyGenerals
      contextRef="i7967e4fff72d493bb8ebc9597e37bc19_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNDkyNw_abe8bc4b-d67f-4b76-80c7-9fcc210c9d0f"
      unitRef="stateattorney">26</mck:LossContingencyNumberofStateAttorneyGenerals>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="icd94e17f05724bf4ba48a2eb22b0163b_I20210721"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyMDM4Mw_5b9ee651-5a11-475e-8fcf-629cfb5e81b2"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="i8ca3354c383c4d99b989e74af58a1b0e_I20210720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyMDM4Mw_9487d9df-5bcf-4c86-9b4f-11cad846dcfd"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <us-gaap:LossContingencyNumberOfDefendants
      contextRef="ifa1d16398d7f44208aa02d08c3991ca4_D20210721-20210721"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyMDM3NA_af9c2b8b-9689-4894-b87b-9ae47e583db1"
      unitRef="distributor">3</us-gaap:LossContingencyNumberOfDefendants>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ie15c86f3be0f4af2ac4c88a44e20c8ef_D20210721-20210721"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNjA5NQ_31cc8254-16ba-497b-bdd0-bf49f96ad33f"
      unitRef="usd">21000000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LossContingencySettlementAgreementAwardPaymentPeriod
      contextRef="ie15c86f3be0f4af2ac4c88a44e20c8ef_D20210721-20210721"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNjExNQ_8c94d338-c2ff-4f44-94c6-4e6fd67326ce">P18Y</mck:LossContingencySettlementAgreementAwardPaymentPeriod>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ifa1d16398d7f44208aa02d08c3991ca4_D20210721-20210721"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNjE0NA_81a017d4-cbdc-4e09-b99e-d87cd61d83a0"
      unitRef="usd">7900000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="i8ca3354c383c4d99b989e74af58a1b0e_I20210720"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMTczNw_1424e6a1-76eb-4f57-b160-6d52f05dc32b"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="icd94e17f05724bf4ba48a2eb22b0163b_I20210721"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMTczNw_37b1f8e0-79f6-46f7-92e9-6595dcbb8a37"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment
      contextRef="icd94e17f05724bf4ba48a2eb22b0163b_I20210721"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyMDQ4Ng_a9f19a80-20e9-47a4-9890-32e20ba91736"
      unitRef="number">0.85</mck:LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment>
    <us-gaap:LossContingencyNumberOfDefendants
      contextRef="ifa1d16398d7f44208aa02d08c3991ca4_D20210721-20210721"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyMTc2NA_af9c2b8b-9689-4894-b87b-9ae47e583db1"
      unitRef="distributor">3</us-gaap:LossContingencyNumberOfDefendants>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i47e3cbf548f448a6aac81a1abd64fb0b_D20210721-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMzAwMQ_ae0f6f08-5490-4bf0-8485-fbfc588fab30"
      unitRef="usd">482000000</us-gaap:PaymentsForLegalSettlements>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="icd94e17f05724bf4ba48a2eb22b0163b_I20210721"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyNzA3MQ_5b9ee651-5a11-475e-8fcf-629cfb5e81b2"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <mck:LossContingencyNumberOfOtherDefendants
      contextRef="i8ca3354c383c4d99b989e74af58a1b0e_I20210720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyNzA3MQ_9487d9df-5bcf-4c86-9b4f-11cad846dcfd"
      unitRef="distributor">2</mck:LossContingencyNumberOfOtherDefendants>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i909c1a4a44c746a4977ccb484c3c8edf_D20210720-20210720"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyNzA3NQ_e2bd209d-b4fb-427a-9e22-098fd2b2cb7e"
      unitRef="usd">1200000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="i8ca3354c383c4d99b989e74af58a1b0e_I20210720"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMTgxNQ_1424e6a1-76eb-4f57-b160-6d52f05dc32b"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward
      contextRef="icd94e17f05724bf4ba48a2eb22b0163b_I20210721"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMTgxNQ_37b1f8e0-79f6-46f7-92e9-6595dcbb8a37"
      unitRef="number">0.381</mck:LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="iadd28ed11a014305be6b12b7cad3adab_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNzc1MA_492b00af-04ad-4e61-bed9-954f48bda804"
      unitRef="usd">8100000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="iadd28ed11a014305be6b12b7cad3adab_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNzc1NA_e43492cc-b78e-455f-a690-c7a44c5171c5"
      unitRef="usd">6800000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="id5cbe1ba860d47aaa8b10c167bd7e101_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyOTg2OQ_3a4706c5-c219-42f9-98ec-848a062369ce"
      unitRef="usd">74000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="id5cbe1ba860d47aaa8b10c167bd7e101_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIyOTg4Mg_22444da2-35c3-4939-b71e-863819a21bec"
      unitRef="usd">61000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="ia1f6e17a404c4e1692e1e7ec1023c177_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMTg2Mw_2fc60270-86cb-4ce3-9071-38b4dfab6650"
      unitRef="usd">27000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="ia1f6e17a404c4e1692e1e7ec1023c177_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMTkwMA_c18f9341-549a-4dd9-b45f-f2335d9dfd7c"
      unitRef="usd">22000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="i570f356eb38c49d788e8a9f41b36575c_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMjA2MA_f7421756-3d78-4bd0-84c0-d93c429f5db2"
      unitRef="usd">47000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax
      contextRef="i570f356eb38c49d788e8a9f41b36575c_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMjA3Mw_f8720c55-0924-4113-9d61-ff274d7a29ed"
      unitRef="usd">39000000</mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax>
    <us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMzI5ODUzNDk3NzU2NQ_b8ddf9ea-5bf2-41da-93f9-0d3a2a2d0d5d">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company&#x2019;s estimated accrued liability for opioid-related claims of governmental entities, including the $482&#160;million initial payment under the proposed settlement agreement, is as follows as of June 30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:88.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current litigation liabilities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total litigation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;This amount, recorded in &#x201c;Other accrued liabilities&#x201d; on the Condensed Consolidated Balance Sheet, is the amount estimated to be paid prior to June 30, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="i47e3cbf548f448a6aac81a1abd64fb0b_D20210721-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfNTQ5NzU1ODIzMzQxMQ_ae0f6f08-5490-4bf0-8485-fbfc588fab30"
      unitRef="usd">482000000</us-gaap:PaymentsForLegalSettlements>
    <us-gaap:LossContingencyAccrualCarryingValueCurrent
      contextRef="i4466b2bd90eb4851915c2314922946d0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RhYmxlOmUwYTU4MmE3NGJiMzQxNmI5NWViMjc5NTMwODg4OGMyL3RhYmxlcmFuZ2U6ZTBhNTgyYTc0YmIzNDE2Yjk1ZWIyNzk1MzA4ODg4YzJfMS0xLTEtMS0xMjkyMA_8eae0f26-b138-40fb-b626-55107d3a287d"
      unitRef="usd">545000000</us-gaap:LossContingencyAccrualCarryingValueCurrent>
    <us-gaap:LossContingencyAccrualCarryingValueNoncurrent
      contextRef="i4466b2bd90eb4851915c2314922946d0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RhYmxlOmUwYTU4MmE3NGJiMzQxNmI5NWViMjc5NTMwODg4OGMyL3RhYmxlcmFuZ2U6ZTBhNTgyYTc0YmIzNDE2Yjk1ZWIyNzk1MzA4ODg4YzJfMi0xLTEtMS0xMjkyMA_824cfaa2-71d3-4ded-ba56-7bbc2a1e8375"
      unitRef="usd">7596000000</us-gaap:LossContingencyAccrualCarryingValueNoncurrent>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i4466b2bd90eb4851915c2314922946d0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RhYmxlOmUwYTU4MmE3NGJiMzQxNmI5NWViMjc5NTMwODg4OGMyL3RhYmxlcmFuZ2U6ZTBhNTgyYTc0YmIzNDE2Yjk1ZWIyNzk1MzA4ODg4YzJfNC0xLTEtMS0xMjkyMA_af1b9d96-fd59-4c2b-abe8-558e990bec94"
      unitRef="usd">8141000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ib81d4fa67aed495cbee1685f6ef28fcc_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMzI5ODUzNDk3NzU2Nw_bf226e2d-cdc2-4542-9d07-c48cb7b4247d"
      unitRef="case">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if9ed7575e2c84fb79c4efda8cfe8f99c_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMzI5ODUzNDk3NzU4Mg_53f8edda-9bf0-4699-9771-dcc50039767e"
      unitRef="case">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i15595dc6958149c891a687ee33e881b7_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMzI5ODUzNDk3NzU3NA_f19558b0-a042-4744-8814-3519033c0b0a"
      unitRef="case">1</us-gaap:LossContingencyPendingClaimsNumber>
    <mck:OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids
      contextRef="i2a53a7efe6f64eb58432e009a3da7d7d_I20180430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMTc3MTI_be84a43c-c08b-4816-8911-d734196679b4"
      unitRef="usd">100000000</mck:OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="ia7c806eed28f452681024ccfb6d0ba58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMTg1MTg_8f7ac982-38a1-4cee-8f5a-4d8735fabfb2"
      unitRef="usd">50000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <mck:LossContingencyAccrualAfterTax
      contextRef="ia7c806eed28f452681024ccfb6d0ba58_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83My9mcmFnOmI5MTY1YTNmODE0YzRjODk4Y2QzNjgwYTNkYjU4MDcxL3RleHRyZWdpb246YjkxNjVhM2Y4MTRjNGM4OThjZDM2ODBhM2RiNTgwNzFfMTg1Mzc_58e20590-1d2a-46d7-8081-73145b87fa7b"
      unitRef="usd">37000000</mck:LossContingencyAccrualAfterTax>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNTM1Mw_f0fc0953-dd63-469b-8a4b-38baac22acfa">Stockholders' Equity (Deficit) &lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of the Company&#x2019;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 23, 2021, the Company raised its quarterly dividend from $0.42 to $0.47 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#x201c;ASR&#x201d;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#x2019;s stock price, corporate and regulatory requirements, restrictions under the Company&#x2019;s debt obligations, and other market and economic conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#x2019;s common stock. Pursuant to the ASR agreement, the Company paid $1.0&#160;billion to the financial institution and received an initial delivery of 4.3 million shares in May 2021. The transaction will be completed during the second quarter of 2022, at which point the Company expects to receive additional shares. There were no share repurchases during the three months ended June 30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Board approved an increase of $2.0 billion for the authorized share repurchase of McKesson&#x2019;s common stock. The total remaining authorization outstanding for repurchases of the Company&#x2019;s common stock at June 30, 2021 was $1.8 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments arising during period, net of income tax expense of zero and zero &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of zero and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses on net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses on net investment hedges arising during period, net of income tax benefit of $6 and $22 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of zero and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses on cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses on cash flow hedges arising during period, net of income tax benefit of zero and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of zero and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in retirement-related benefit plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial gain and prior service cost arising during the period, net of income tax expense of zero and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial gain (loss), prior service cost and transition obligation, net of income tax benefit expense of zero and zero &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other, net of income tax benefit of zero and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax benefit of $1 and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three months ended June 30, 2021 and 2020 includes net foreign currency translation adjustments of $9 million and $58 million, respectively, attributable to redeemable noncontrolling interests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three months ended June 30, 2021 includes foreign currency losses of $22 million on the net investment hedges from the &#x20ac;1.7 billion&#160;Euro-denominated notes, losses of $5 million on the net investment hedges from cross-currency swaps, and losses on net investment hedges of $6 million attributable to redeemable noncontrolling interests. The three months ended June 30, 2020 include foreign currency losses of $34 million on the net investment hedges from the &#x20ac;1.7 billion Euro-denominated notes and losses of $51 million on the net investment hedges from cross-currency swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three months ended June 30, 2021 and 2020 include net actuarial gains of zero and $3 million, respectively, which are attributable to redeemable noncontrolling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Pre-tax amount was reclassified into &#x201c;Cost of sales&#x201d; and &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into &#x201c;Income tax expense&#x201d; in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss) &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss) by component for the three months ended June 30, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Losses on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of put right by noncontrolling shareholders of McKesson Europe AG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss) by component for the three months ended June 30, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <mck:CommonStockVotingRightsNumberofVotesPerCommonShare
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNzk_0c767056-668f-45e7-88af-5276f1806ea6"
      unitRef="vote">1</mck:CommonStockVotingRightsNumberofVotesPerCommonShare>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ie4f9f1cff0f944b581c9e22ae2cafe95_D20210722-20210722"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzAy_34e2c435-b44e-4492-9981-1ab75496adf0"
      unitRef="usdPerShare">0.42</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i0bb253bd3d3a47dabfafb9011d880dc1_D20210723-20210723"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzA4_f11d1d95-1fb0-4453-8ea8-a3c1851bd661"
      unitRef="usdPerShare">0.47</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i326582e2cec94f4596b88b8eac101ee1_D20210501-20210531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMTA0NDUzNjA0Nzg5MTU_246d0b12-3864-4553-be06-d4171caefb78"
      unitRef="usd">1000000000.0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i326582e2cec94f4596b88b8eac101ee1_D20210501-20210531"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMTA0NDUzNjA0Nzg5ODk_246d0b12-3864-4553-be06-d4171caefb78"
      unitRef="usd">1000000000.0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i7ee5de63e94947cf8f40df8a36d1d075_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMTA0NDUzNjA0NzkwNTg_036f0c46-6266-4ede-a8df-3df8d18bc947"
      unitRef="shares">4300000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNzY5NjU4MTQxMDI4Mw_fd919c41-d545-4722-aef8-fa030c6af557"
      unitRef="shares">0</us-gaap:StockRepurchasedDuringPeriodShares>
    <mck:StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased
      contextRef="i4eda871b01a9492083d9a7ace055a4bd_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMTA0NDUzNjA0NzgzMjk_75ffe220-f29c-43a7-a284-e07ae00a38e6"
      unitRef="usd">2000000000.0</mck:StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ie2dde5d2936140a6940741e305619e4e_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMTA0NDUzNjA0Nzg0MTI_73f0aff2-cdde-47f0-bfc1-01a3d2925547"
      unitRef="usd">1800000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNTM1OQ_65da3b62-1ea6-4f14-ac9d-e1038efd38ff">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.163%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#160;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments arising during period, net of income tax expense of zero and zero &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of zero and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses on net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses on net investment hedges arising during period, net of income tax benefit of $6 and $22 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of zero and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses on cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized losses on cash flow hedges arising during period, net of income tax benefit of zero and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax expense of zero and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in retirement-related benefit plans &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net actuarial gain and prior service cost arising during the period, net of income tax expense of zero and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of actuarial gain (loss), prior service cost and transition obligation, net of income tax benefit expense of zero and zero &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation adjustments and other, net of income tax benefit of zero and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to income statement, net of income tax benefit of $1 and zero&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#x2019;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#x2019;s reporting currency, U.S. dollars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three months ended June 30, 2021 and 2020 includes net foreign currency translation adjustments of $9 million and $58 million, respectively, attributable to redeemable noncontrolling interests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three months ended June 30, 2021 includes foreign currency losses of $22 million on the net investment hedges from the &#x20ac;1.7 billion&#160;Euro-denominated notes, losses of $5 million on the net investment hedges from cross-currency swaps, and losses on net investment hedges of $6 million attributable to redeemable noncontrolling interests. The three months ended June 30, 2020 include foreign currency losses of $34 million on the net investment hedges from the &#x20ac;1.7 billion Euro-denominated notes and losses of $51 million on the net investment hedges from cross-currency swaps. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The three months ended June 30, 2021 and 2020 include net actuarial gains of zero and $3 million, respectively, which are attributable to redeemable noncontrolling interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Pre-tax amount was reclassified into &#x201c;Cost of sales&#x201d; and &#x201c;Selling, distribution, general, and administrative expenses&#x201d; in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into &#x201c;Income tax expense&#x201d; in the Condensed Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMy0wLTEtMS0wL3RleHRyZWdpb246ZDk3MDYxNWQzZGQ3NGUyZjk1MDEyM2E1MDJjYzY5ZjdfOTc_0e61fa54-1c8a-4073-a3d1-d8f01728b409"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMy0wLTEtMS0wL3RleHRyZWdpb246ZDk3MDYxNWQzZGQ3NGUyZjk1MDEyM2E1MDJjYzY5ZjdfMTAx_fa3f08fe-aacf-46ce-8246-f44f0d3ad5f1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMy01LTEtMS0w_c66a428b-bc51-4222-8887-48058e451fd6"
      unitRef="usd">34000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMy03LTEtMS0w_6c8278f5-9f7e-45f0-a626-4305ef5db83f"
      unitRef="usd">96000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNC0wLTEtMS0wL3RleHRyZWdpb246MDUzZWFiMGRiYzM5NDU2ZmI3OGI1NzMyMzJmZjNkZWZfNjc_35058cbb-6d8f-4b12-9b90-bb62d0457eb9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNC0wLTEtMS0wL3RleHRyZWdpb246MDUzZWFiMGRiYzM5NDU2ZmI3OGI1NzMyMzJmZjNkZWZfNzE_9fc7905b-670a-479a-95c0-081acedc2f08"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNC01LTEtMS0w_738974cb-3e8d-4ed2-800f-c78370e3fa69"
      unitRef="usd">-17000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNC03LTEtMS0w_2f366f34-79e5-4496-b84e-37b6cfead65f"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNS01LTEtMS0w_3caaf5ce-2244-49aa-ada9-8993ce29f088"
      unitRef="usd">51000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNS03LTEtMS0w_251668a2-ac31-457d-afc7-f94d61d965e4"
      unitRef="usd">96000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNy0wLTEtMS0wL3RleHRyZWdpb246ZWIxYjlmYWY0OThmNDBlNDhkMjEzZTcxNWI4ZGFmZDFfOTk_8bfcf0da-1ae9-4cff-ae6c-21d87dd12f39"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNy0wLTEtMS0wL3RleHRyZWdpb246ZWIxYjlmYWY0OThmNDBlNDhkMjEzZTcxNWI4ZGFmZDFfMTAz_86c7a0bc-7b2d-4faa-9872-49509e90a5c3"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNy01LTEtMS0w_a1a800db-c088-4edc-804d-22f77ab31f1f"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfNy03LTEtMS0w_c229bde4-9bf2-4cb8-8a70-d911a6cbaf71"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfOC0wLTEtMS0wL3RleHRyZWdpb246ZmYxZTE3ODMzN2VlNDIzYmIxMjdmY2FhMzg4MTQyMjJfNjc_d2d8677c-d9ff-4044-a8a4-ba449c727c81"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfOC0wLTEtMS0wL3RleHRyZWdpb246ZmYxZTE3ODMzN2VlNDIzYmIxMjdmY2FhMzg4MTQyMjJfNzE_e24b5eaf-8fa2-4e7b-85bf-6ed35537261a"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfOC01LTEtMS0w_9d44c605-82bc-47f8-bbae-3c49c6c28047"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfOC03LTEtMS0w_48810358-e55a-442f-9c53-9f66a6dd75cb"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfOS01LTEtMS0w_75289773-4486-4717-b487-591feeef6686"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfOS03LTEtMS0w_6b8628b3-3b2d-4f5b-8bb8-aff5f919e118"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmQzMWMzMTQ3ZGVkYjQ5YWJhZDRjOWUzNjg3YjYzNjE3XzExMg_7068d8c7-e46c-464c-9154-fe525d301507"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTEtMC0xLTEtMC90ZXh0cmVnaW9uOmQzMWMzMTQ3ZGVkYjQ5YWJhZDRjOWUzNjg3YjYzNjE3XzExNg_4f19f6c0-216e-4129-ae71-647b53f552e2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTEtNS0xLTEtMA_d6c0b4d6-29f9-4faf-b16d-f7b50c290cb1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTEtNy0xLTEtMA_60944f49-1904-4d78-93ad-43dc3e8918c5"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmY2NTcxNzBiYTAyMzRkMWVhNmNiOTk3NTJmODhlMWY0XzY3_b2a1e38d-3b34-41ee-b6ca-b2eb856015b4"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTItMC0xLTEtMC90ZXh0cmVnaW9uOmY2NTcxNzBiYTAyMzRkMWVhNmNiOTk3NTJmODhlMWY0Xzcy_16acfe77-f92e-4c10-9ef8-207bd97e8867"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTItNS0xLTEtMA_7594d702-ae83-4c19-8e28-1b9a0e5e84e0"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTItNy0xLTEtMA_6e156fce-94f6-4750-8106-4abf1cd98644"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTMtNS0xLTEtMA_1825dfdb-a4f9-4e43-96b2-fc975590a073"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTMtNy0xLTEtMA_38000b67-0d45-4851-ba46-367f9c8074b8"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjkzMTQ1YWQwNzgxYzQ3NWQ4ZTdmZDMzZTgzNTEyMGJiXzEwMg_5574ae9f-1e76-4470-b158-6f3192c7672b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTUtMC0xLTEtMC90ZXh0cmVnaW9uOjkzMTQ1YWQwNzgxYzQ3NWQ4ZTdmZDMzZTgzNTEyMGJiXzEwNg_5767e066-5b5d-4efa-8dc8-9153e44af620"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i683faa57c1154143bdcceac4cfc4f4be_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTUtNS0xLTEtMA_cdeeaed3-a626-4214-8f71-ba5aa890049a"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5add2ae2ff484cb1a39c941a288349b2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTUtNy0xLTEtMA_fb033b33-4d00-46d3-8d8e-cdc0557f5901"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOmNhNjhjMGE2YzBlMjRkMjY4ODMzYzcxYWUxNGE0NzNlXzExMQ_5f7f7ae0-a3f5-4ca6-92f9-53d2c13ff727"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTYtMC0xLTEtMC90ZXh0cmVnaW9uOmNhNjhjMGE2YzBlMjRkMjY4ODMzYzcxYWUxNGE0NzNlXzExNQ_d52bd485-cda1-4b79-9387-8b9432c7feff"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i78e5d212e61b44749ee2c344ba273205_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTYtNS0xLTEtMA_6ab0a528-7cc5-41b5-988e-3137565f729e"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic34f3a349fc24b3d947bac4654010cb5_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTYtNy0xLTEtMA_ae9ee35a-220f-4483-b41c-34f753e85a2f"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjRiZGU5Yjk1NTE3NTQxMTNiMjliYTEzZWFiMTgxYjQ1Xzg1_b54a12cf-b0db-4768-ac0d-e692844efec9"
      unitRef="usd">0</mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax>
    <mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTctMC0xLTEtMC90ZXh0cmVnaW9uOjRiZGU5Yjk1NTE3NTQxMTNiMjliYTEzZWFiMTgxYjQ1Xzg5_18b62431-d85f-44e6-89d5-6b0679f5a062"
      unitRef="usd">0</mck:OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia069814e274d4623bfb7a2f2d90124b4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTctNS0xLTEtMA_bb66c669-cc3b-43f0-998e-c04a6808ca44"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ifeb84bdd46314ab589c286f47e9fbff3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTctNy0xLTEtMA_fe7f4a53-5eae-4e30-9a49-80d936b4ad3c"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i7580c94982c04c6db55b6b8d11dd6efe_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjU2NTQxZDkxZDMwZjRjY2Q4NzBlODZiMDEyMmM5YTY4XzY3_d073e2c4-221e-455a-9d49-cec70b52f2bb"
      unitRef="usd">-1000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i0e4d013ff96647e297facf5a8709f13e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTgtMC0xLTEtMC90ZXh0cmVnaW9uOjU2NTQxZDkxZDMwZjRjY2Q4NzBlODZiMDEyMmM5YTY4Xzcx_284b1dda-2ea8-47aa-a6bb-d1a26bdf64a1"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7580c94982c04c6db55b6b8d11dd6efe_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTgtNS0xLTEtMA_a7bd7011-7b6f-449b-b9d3-6e205266cf2c"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0e4d013ff96647e297facf5a8709f13e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTgtNy0xLTEtMA_4f382d37-4564-4ea6-8cbc-856de169ece9"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7580c94982c04c6db55b6b8d11dd6efe_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTktNS0xLTEtMA_c419eadb-9a4a-4388-be62-7af9dd19164f"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0e4d013ff96647e297facf5a8709f13e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMTktNy0xLTEtMA_276c05eb-0e26-43f6-bfa2-91a5e2718939"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMjEtNS0xLTEtMA_e8834b00-946d-4d13-8214-4c92acc0d794"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmZhYTUyOTQ0M2ViZTQxYWNiOWJiNWNkN2VkNTgzMWIyL3RhYmxlcmFuZ2U6ZmFhNTI5NDQzZWJlNDFhY2I5YmI1Y2Q3ZWQ1ODMxYjJfMjEtNy0xLTEtMA_0c494576-fcdc-4213-9713-dcc5cc2a0dc1"
      unitRef="usd">29000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest
      contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMjk5Mw_7d1d26cd-7429-46c7-ad96-d9649fdaa29b"
      unitRef="usd">9000000</mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest>
    <mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest
      contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzA4Ng_f78ff415-8b7f-40e9-9418-361ff87f2e83"
      unitRef="usd">58000000</mck:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i3252989f4e9143d3a010d05024100a86_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzcyNA_25f7c989-fcad-4b32-a385-13e3a71a4cbb"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:LongTermDebt
      contextRef="ic94ceeda5f8d4c34920ab05d68d536f7_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzc4Nw_407a223c-78fc-42d0-bbab-a8e24de97d19"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i7e80ec0a1e2d4560a4bb44c4d5f4a808_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzc4Nw_780d4e36-0865-4d10-a8f1-88bd4bed7928"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="ie2831786f08a4f11887081ccec157fb0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzg3Mg_43cac93b-262d-4d34-974d-edb381976e3d"
      unitRef="usd">-5000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfMzk5Mg_026c46e6-d6b3-4531-9ee1-f5618123a437"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i0d1c889a01024ed39200b6381c6e96e7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNDExMg_fe567143-2c50-4387-8af8-f6a3f51841c2"
      unitRef="usd">-34000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:LongTermDebt
      contextRef="i7d7a3c97158f4b2295ecfac3630c7dda_I20200630"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNDE4NA_ac546bc5-5f2a-4290-a3e8-312fa3ecc7c4"
      unitRef="eur">1700000000</us-gaap:LongTermDebt>
    <us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
      contextRef="id92758a2bb7c4cff8bb23c47c0c1232f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNDI3Mg_d8da1535-7c9f-4873-b747-a70b3af20449"
      unitRef="usd">-51000000</us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax>
    <mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNDM5Mg_e31f9d11-7a2b-4be0-a617-d86350a9387a"
      unitRef="usd">0</mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax>
    <mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNTQ5NzU1ODE1NDQ2NQ_b5164b36-09b3-4197-ad5c-b79d0bb929be"
      unitRef="usd">3000000</mck:OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RleHRyZWdpb246ZDg3MmIzYmFiYTlkNDRmY2I2MGMxOTYwZWM0MDBiODVfNTM1Mg_9ad8d806-647a-4c5e-a44c-bf67969fc650">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss) by component for the three months ended June 30, 2021 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Losses on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(96)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of put right by noncontrolling shareholders of McKesson Europe AG&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,627)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information regarding changes in the Company&#x2019;s Accumulated other comprehensive income (loss) by component for the three months ended June 30, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation Adjustments, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Net Investment Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains (Losses) on Cash Flow Hedges, &lt;br/&gt;Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,703)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to earnings and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: amounts attributable to noncontrolling and redeemable noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) attributable to McKesson&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a707105caaf4446872eecd75721360b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMi0xLTEtMS0w_1b7b32dd-c1f7-4ae7-9ea8-7417db727833"
      unitRef="usd">-1361000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i96cab475915a4dbcaae2796d530de73b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMi0zLTEtMS0w_49a847ee-1c3d-46d8-9b62-4631ef5ff19d"
      unitRef="usd">-36000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i78d13cdfde3141419e99db6a257de4aa_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMi01LTEtMS0w_bd6d96f0-b355-4f94-966f-306fdcec48de"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i541b64e198c948d092258fb4eb641885_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMi03LTEtMS0w_e565d99b-0df4-467b-9842-40e936b4be41"
      unitRef="usd">-96000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i29b18210e4c94b3e9eeea079457c3440_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMi05LTEtMS0w_c5f5514d-8415-4a18-9bdd-6ae90b990e9d"
      unitRef="usd">-1480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMy0xLTEtMS0w_d9d70446-4047-4917-a5be-945774604032"
      unitRef="usd">34000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMy0zLTEtMS0w_4ebc2a3e-a512-4b9d-9d6c-6c4a61ebd1a0"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMy01LTEtMS0w_764ecf38-9a43-4167-bb44-30e431540edf"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMy03LTEtMS0w_e4d8d199-e58e-48a2-8bd3-0349681770d0"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfMy05LTEtMS0w_c4693b25-251c-454b-b1c8-7706f1e08386"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNC0xLTEtMS0w_b2937426-ad8d-456c-b88d-ece077c34b6f"
      unitRef="usd">-17000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNC0zLTEtMS0w_db1cc371-5d08-46ce-879b-83a4015b4436"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNC01LTEtMS0w_2ba15a13-b338-4cbe-a4d2-fb546604e1fa"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNC03LTEtMS0w_0fdccbf9-0086-449d-bbe3-e73daa47b907"
      unitRef="usd">3000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNC05LTEtMS0w_a72d9672-4695-4dce-8a7b-f894f573f163"
      unitRef="usd">-14000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNS0xLTEtMS0w_f36cfab7-f888-4432-806c-e26468252b1c"
      unitRef="usd">51000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNS0zLTEtMS0w_d60d1813-c2e4-4e66-bd66-aed4022ba448"
      unitRef="usd">-27000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNS01LTEtMS0w_32490bb6-0cab-49a7-9263-c20419bb0e68"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNS03LTEtMS0w_97c7f5ee-a455-4865-98c6-a5e6e2d40eab"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNS05LTEtMS0w_3ed239d9-6de1-4cf9-be2c-ad911a6212e5"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNi0xLTEtMS0w_5ac354bd-80fb-4fd2-88c9-648417725868"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNi0zLTEtMS0w_7e12559a-d985-4a2c-ad7c-b18aabc45ad5"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNi01LTEtMS0w_d283ee41-b247-43c5-939a-1d488faa8542"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNi03LTEtMS0w_63812d1e-7509-4dfc-99ee-46df700bad16"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNi05LTEtMS0w_4e26f1e5-149f-4019-83b1-3005c9c5334e"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNy0xLTEtMS0w_13ca6ec7-d06f-477d-bcee-5a2514586bdd"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNy0zLTEtMS0w_c2ca58ee-b3d9-47c6-a1ba-3e9caf7c140c"
      unitRef="usd">-21000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNy01LTEtMS0w_9bc8c1d8-7f5c-4592-af8d-c373b5ff916d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNy03LTEtMS0w_7278cbb9-f37e-4c31-b7cd-7c2ed13c5e04"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfNy05LTEtMS0w_ed8f6d1b-4f84-4675-97db-bb7aa85295cb"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i7b5803b2ab2b412eaf66768b069a4431_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC0xLTEtMS0xMDg5Mg_e29bfadc-53b8-4371-9512-f2995e00bc5e"
      unitRef="usd">-158000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i277c2608d34f43df9126f92b763e36a5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC0zLTEtMS0xMDg5NQ_545a8be7-1f23-44d9-a9db-49e09eff6928"
      unitRef="usd">0</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="iaeccc89714c54493995d9661c58ae337_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC01LTEtMS0xMDg5OA_d1256b91-270f-48ac-90ed-f45a5090e754"
      unitRef="usd">0</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i431eb2c6117c4dae8bdb28b6c0d41d8a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC03LTEtMS0xMDkwOA_e8841d27-5411-485a-99a4-cf48bcb16c14"
      unitRef="usd">-12000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight
      contextRef="i4c03ab80e93f47289af42a50526f49e2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC05LTEtMS0xMDkxMA_f264acae-f056-4f31-99a2-2a27c5262a96"
      unitRef="usd">-170000000</mck:AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib9a959a0c7b148a38c6b8331c113e2cf_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC0xLTEtMS0w_8951256d-96e6-46b1-85ea-26faf44ee96d"
      unitRef="usd">-1477000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i76038b5bf32948138203a73d85210e1e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC0zLTEtMS0w_c482c1a5-eb17-4aa4-a9a5-53ca2c230085"
      unitRef="usd">-57000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i18ebdcc4b1e44eea804b218171e8f605_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC01LTEtMS0w_c44b9f3e-452f-4f09-9a98-f9f1d594df82"
      unitRef="usd">13000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i20557e420ca347deb38e35cfe75e2f15_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC03LTEtMS0w_dd90959b-b4d5-4761-a3f5-24b17e8482d5"
      unitRef="usd">-106000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8466c6d9312243f598d0a021cf047894_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmE3M2Y2YjJiZDEyNjQ4OGU4ODM1ZTM4OGFlNDc4MWJjL3RhYmxlcmFuZ2U6YTczZjZiMmJkMTI2NDg4ZTg4MzVlMzg4YWU0NzgxYmNfOC05LTEtMS0w_e4558b42-bf05-4ffa-a5de-ecb280b817db"
      unitRef="usd">-1627000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf2ebdbafd554d41a758ebc6b7078157_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMi0xLTEtMS0w_e7a22dc2-aa83-4994-a5fe-2073cfc6340c"
      unitRef="usd">-1780000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7bbc1cd6847947c1857128d50574b91f_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMi0zLTEtMS0w_426acfbd-1d94-42ea-af25-46053e05c214"
      unitRef="usd">138000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id5e06f9d71a142728e7dd68ecedc7eb7_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMi01LTEtMS0w_aa75eb3e-4048-461b-a2b1-1b93e193d932"
      unitRef="usd">49000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia79b569c95894cf8af0a2bce6c0e7a42_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMi03LTEtMS0w_c5c59a7b-6ca4-4ea7-b4e0-dd12515fa656"
      unitRef="usd">-110000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i755d7f41b47e492b8cb1bb239e98220c_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMi05LTEtMS0w_522d69ac-5782-49b7-9480-06b8898fa65a"
      unitRef="usd">-1703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMy0xLTEtMS0w_ede8f8b3-601c-4d7f-8173-30e606f58411"
      unitRef="usd">96000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMy0zLTEtMS0w_a8ce6aab-e899-4c5c-859a-9b8b9a5eb38a"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMy01LTEtMS0w_46273a19-4ade-48e4-853c-de84ab3dc3b0"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ia6258d106eb74184a1fa0a7767f79b2f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMy03LTEtMS0w_94422eff-c573-4589-9530-493b0f52f35e"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfMy05LTEtMS0w_9e8cfde9-9900-4c6b-9945-91997b5160df"
      unitRef="usd">27000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNC0xLTEtMS0w_ffd17850-0bd3-4b16-b3eb-dab0ccfbfd5d"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNC0zLTEtMS0w_17579710-1c66-4cbf-b756-d873fab1fd87"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNC01LTEtMS0w_76a4f8c1-8e6c-4374-81e5-3e2b032a4820"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ia6258d106eb74184a1fa0a7767f79b2f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNC03LTEtMS0w_23ebcb65-7c64-4e92-8afe-a6c7c43f1bdb"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNC05LTEtMS0w_659f6f4f-2d27-4863-a481-e1d5d327e4f4"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNS0xLTEtMS0w_c01470d9-08cf-4ccd-a807-aba9c66031a7"
      unitRef="usd">96000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNS0zLTEtMS0w_ab56f417-c4f5-4046-ad43-7d49f6004657"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNS01LTEtMS0w_97be3ec3-2f95-41b8-adc3-7140823477ff"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia6258d106eb74184a1fa0a7767f79b2f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNS03LTEtMS0w_5a888a23-4b55-4d34-b59e-c10f7064d8b9"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNS05LTEtMS0w_3381c8e1-4d3a-4ba7-992b-ce47910b9ca7"
      unitRef="usd">29000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNi0xLTEtMS0w_3bb24f2b-c108-419f-a2cd-e41323776e28"
      unitRef="usd">58000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNi0zLTEtMS0w_a8505aeb-2202-430b-89dc-d285a5d96539"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNi01LTEtMS0w_b9c6fd58-e57c-4db6-b330-ae6cf97f2cc5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ia6258d106eb74184a1fa0a7767f79b2f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNi03LTEtMS0w_7762746e-9d28-4381-89f3-a4fccd86fa9a"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNi05LTEtMS0w_b48643c6-f38c-4650-a1e6-80c7a29e5169"
      unitRef="usd">61000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i2ebdee667ff248acb25504c9e8d2db78_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNy0xLTEtMS0w_cf4055bc-a1e1-46f4-a0b6-03757ba2d8a1"
      unitRef="usd">38000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i45497ff724624a93843d07243c9eb3a6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNy0zLTEtMS0w_423ebc36-90db-4ff8-a61a-ce5a2e38ef53"
      unitRef="usd">-63000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie9b330a99b6d4938bc7cd97623b08918_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNy01LTEtMS0w_a5476ea7-7933-461a-8947-59ca917b3232"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia6258d106eb74184a1fa0a7767f79b2f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNy03LTEtMS0w_27981dce-fb35-4c15-b78d-8b5dadc4f6a1"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfNy05LTEtMS0w_276ae825-1555-42d2-92dc-b0e33f16e139"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7c68e3755f574f668c6f9e3736c38803_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfOC0xLTEtMS0w_5d194d0a-78d9-402c-ba17-e7354e8bfc32"
      unitRef="usd">-1742000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i207edd1ad0f24086a0af0cd0897714c5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfOC0zLTEtMS0w_6943764b-7d2b-409f-8db2-2dc0d934077c"
      unitRef="usd">75000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1d84fa2b48714007ba888640e7295e09_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfOC01LTEtMS0w_a82015b0-8bd8-41ae-944e-7133d027e0da"
      unitRef="usd">44000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iafaf876b672949d4a457c37fb78dcc15_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfOC03LTEtMS0w_14403d3b-1a66-48ae-967a-a5a3ba618e76"
      unitRef="usd">-112000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87c849ded324459ca97d3b31b68b0bd6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl83OS9mcmFnOmQ4NzJiM2JhYmE5ZDQ0ZmNiNjBjMTk2MGVjNDAwYjg1L3RhYmxlOmIzOWYwYTk2YjUyNzQwMjQ5NDJlMGY0ZWFhNjljMzNhL3RhYmxlcmFuZ2U6YjM5ZjBhOTZiNTI3NDAyNDk0MmUwZjRlYWE2OWMzM2FfOC05LTEtMS0w_6d41cf9b-0ff9-40e8-97a7-ab3699f43f0b"
      unitRef="usd">-1735000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfODAwMw_309f7dc7-f48a-4839-9f27-09d1802b467f">Segments of Business&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commencing with the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. All prior segment information has been recast to reflect the Company&#x2019;s new segment structure and current period presentation. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The RxTS segment unifies the solutions and services of CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation to serve biopharma and life sciences partners and patients. By combining automation and expert navigation of the healthcare ecosystem, RxTS connects pharmacies, providers, payers, and biopharma to address patients&#x2019; medication access, adherence, and affordability challenges to help people get the medicine they need to live healthier lives. RxCrossroads was previously included in the former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and McKesson Prescription Automation were previously included in Other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 275,000 national brand medical-surgical products as well as McKesson&#x2019;s own line of products through a network of distribution centers within the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The International segment includes the Company&#x2019;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#x2019;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 12 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#x2019;s Canada operations deliver vital medicines, supplies, and information technology services throughout Canada and includes Rexall Health retail pharmacies. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other. In the second quarter of 2022, the Company entered into an agreement to sell certain of its Europe businesses, primarily located in France, Italy, Ireland, Portugal, Belgium, and Slovenia. The sale also includes the Company&#x2019;s German headquarters and wound-care business, business center in Lithuania, and an ownership stake in its joint venture in the Netherlands. Refer to Financial Note 2, &#x201c;Held for Sale,&#x201d; for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, approximately 35% of the RxTS segment&#x2019;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and approximately 7% of the International segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#x2019;s reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for the three months ended June 30, 2021 and 2020 includes $23 million and $52 million, respectively, of credits related to the last-in, first-out (&#x201c;LIFO&#x201d;) method of accounting for inventories. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for the three months ended June 30, 2021 includes inventory charges totaling $164 million on certain personal protective equipment and other related products.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net for the three months ended June 30, 2021 includes charges of $74&#160;million related to the Company&#x2019;s estimated liability for opioid-related claims, as discussed in more detail in Financial &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Note 12&lt;/span&gt;, &#x201c;Commitments and Contingent Liabilities." Corporate expenses, net for the three months ended June 30, 2020 includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i09d8587e16084bb098356d7c27d734c0_D20200701-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1MTc2Ng_318febcf-bcb7-43f9-a5cb-6b6118ef182a"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <mck:NumberOfNationalBrandMedicalSurgicalProducts
      contextRef="ic5004bc3d244470f87a0e4366f016d4c_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMzI5ODUzNDkwMjkxMQ_d845094b-ecea-40dc-8f30-1c572f3d8863"
      unitRef="product">275000</mck:NumberOfNationalBrandMedicalSurgicalProducts>
    <us-gaap:NumberOfCountriesInWhichEntityOperates
      contextRef="i102de3e4924b431f90a2f289213c9b87_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1MTc2Mg_2a994c98-0117-4162-a9ba-d8a6eeeb04cd"
      unitRef="country">12</us-gaap:NumberOfCountriesInWhichEntityOperates>
    <mck:NumberOfBusinessOperations
      contextRef="i102de3e4924b431f90a2f289213c9b87_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMzI5ODUzNDkwMjkwNw_ccad910e-e54c-426b-9397-418ca3333f17"
      unitRef="business_operation">2</mck:NumberOfBusinessOperations>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfODAwNQ_d814627c-fffd-434e-99c7-18655b371cea">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial information relating to the Company&#x2019;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating profit &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Pharmaceutical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prescription Technology Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical-Surgical Solutions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate expenses, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from continuing operations before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#x2019;s total revenues, approximately 35% of the RxTS segment&#x2019;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#x2019;s total revenues, and approximately 7% of the International segment&#x2019;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Segment operating profit includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#x2019;s reportable segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s U.S. Pharmaceutical segment&#x2019;s operating profit for the three months ended June 30, 2021 and 2020 includes $23 million and $52 million, respectively, of credits related to the last-in, first-out (&#x201c;LIFO&#x201d;) method of accounting for inventories. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The Company&#x2019;s Medical-Surgical Solutions segment&#x2019;s operating profit for the three months ended June 30, 2021 includes inventory charges totaling $164 million on certain personal protective equipment and other related products.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Corporate expenses, net for the three months ended June 30, 2021 includes charges of $74&#160;million related to the Company&#x2019;s estimated liability for opioid-related claims, as discussed in more detail in Financial &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Note 12&lt;/span&gt;, &#x201c;Commitments and Contingent Liabilities." Corporate expenses, net for the three months ended June 30, 2020 includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#x2019;s controlled substances monitoring program.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c2064f2c8eb49c3849453a95a9c86c4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMy0xLTEtMS0w_03d9030d-5b64-4997-b52a-e10c538bd696"
      unitRef="usd">50019000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idba260eba8e74ac5a3c690150d88e82e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMy0zLTEtMS0w_ac8fd5d8-e472-4d29-8e55-aa751ad9dadc"
      unitRef="usd">44670000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82edf712cf2f4662ac55525b3410634f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfNC0xLTEtMS0yNTE2_f44be8a8-f2a5-4b17-a920-96be1eb60a41"
      unitRef="usd">881000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6affa371637042a0beed138683334e5c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfNC0zLTEtMS0yNTE2_78a77e35-358a-4660-ac36-6f0b12cd689e"
      unitRef="usd">656000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i032911e077b3421889a6ddae5be68041_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfNS0xLTEtMS0w_8bb28e8d-24cc-4f6a-ba3d-56b4c0828727"
      unitRef="usd">2528000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifcaabd55fcc24731b0b6daa24a824ce3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfNS0zLTEtMS0w_cc4fcdef-63d0-4888-a73f-519b86215672"
      unitRef="usd">1801000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c475719e1e54e988a2716b400ad19c8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfNi0xLTEtMS0w_1562028f-0fe6-479e-bc94-8f356f348691"
      unitRef="usd">9246000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i47e37dbe4a284e4dbcd7fb304b436339_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfNi0zLTEtMS0w_7f2b6d56-935e-4f02-866e-fd0a6fb190c5"
      unitRef="usd">8552000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfOC0xLTEtMS0w_0652d326-146b-4129-939e-df5fcaeb98a0"
      unitRef="usd">62674000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfOC0zLTEtMS0w_c75a18ff-a2b9-42c1-a4f8-ddae9a68ec95"
      unitRef="usd">55679000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1c2064f2c8eb49c3849453a95a9c86c4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTEtMS0xLTEtMA_b3bf2db3-17ff-4024-bbe0-7d5d0ddd2c58"
      unitRef="usd">682000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idba260eba8e74ac5a3c690150d88e82e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTEtMy0xLTEtMA_26ccfdbe-c056-42fe-b42f-3225fdfc8ecc"
      unitRef="usd">613000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i82edf712cf2f4662ac55525b3410634f_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTItMS0xLTEtMjUyOQ_a3e03b23-4dea-44d4-b7bb-bc93d658e380"
      unitRef="usd">104000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6affa371637042a0beed138683334e5c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTItMy0xLTEtMjUyOQ_6cd1c295-2963-4aa4-9c64-890431152aeb"
      unitRef="usd">68000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i032911e077b3421889a6ddae5be68041_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTMtMS0xLTEtMA_544352d5-7c03-4173-9780-e53a6e17b387"
      unitRef="usd">75000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifcaabd55fcc24731b0b6daa24a824ce3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTMtMy0xLTEtMA_4b68cd29-e7ea-4f87-97b0-e567b431f25d"
      unitRef="usd">89000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2c475719e1e54e988a2716b400ad19c8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTQtMS0xLTEtMA_700b5bfe-0b54-45fb-9ce4-a14f82bea29a"
      unitRef="usd">53000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i47e37dbe4a284e4dbcd7fb304b436339_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTQtMy0xLTEtMA_b6433cc1-dd77-453c-8472-83f2fa28896d"
      unitRef="usd">3000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie40bd4cb78c741a287b7a02340752d2d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTYtMS0xLTEtMA_d557dbc7-756f-4281-9156-e4e0dbf577bf"
      unitRef="usd">914000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if0f85e764ff74422a0b261f62ad59faa_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTYtMy0xLTEtMA_c81b951b-dcfe-4c93-adeb-55099fecff30"
      unitRef="usd">773000000</us-gaap:OperatingIncomeLoss>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTctMS0xLTEtMA_4bacd687-6f28-42a0-8e86-15f1d907f7fc"
      unitRef="usd">303000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <mck:CorporateOperatingExpenseandOtherIncomeNet
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTctMy0xLTEtMA_cfa629e1-ef64-4113-944e-00e54a8785f4"
      unitRef="usd">68000000</mck:CorporateOperatingExpenseandOtherIncomeNet>
    <us-gaap:InterestAndDebtExpense
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTgtMS0xLTEtMA_75d4b7a5-15f1-40d3-a869-6a62d369e714"
      unitRef="usd">49000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTgtMy0xLTEtMA_3d04b349-9c35-4b8b-81cd-2c5316e5ff23"
      unitRef="usd">60000000</us-gaap:InterestAndDebtExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iff44e00c31454749a800ec4298771ea3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTktMS0xLTEtMA_d7276f3c-fd6e-4196-9ceb-5c7e71a3fa28"
      unitRef="usd">562000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i73cb480f74ee4b2187c3fc0e2a0a8cbf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RhYmxlOmRiYWM0MTcyZGY2YzRmNTI4MTY2MmQxN2Q2YWEwZTNjL3RhYmxlcmFuZ2U6ZGJhYzQxNzJkZjZjNGY1MjgxNjYyZDE3ZDZhYTBlM2NfMTktMy0xLTEtMA_3a87d50e-7900-446b-af2b-e8ebdf649635"
      unitRef="usd">645000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i1c2064f2c8eb49c3849453a95a9c86c4_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1MzI3Ng_91e34103-9912-4352-a2d1-c59738aa9c94"
      unitRef="number">0.01</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i82edf712cf2f4662ac55525b3410634f_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1MzMwNQ_8c93786a-8a59-4ff0-a795-6e786e41dd5f"
      unitRef="number">0.35</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i032911e077b3421889a6ddae5be68041_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1MzI4NA_11855d46-e39e-4dfb-9fba-d5ce77d00180"
      unitRef="number">0.02</mck:RevenueDerivedFromServicesPercentage>
    <mck:RevenueDerivedFromServicesPercentage
      contextRef="i2c475719e1e54e988a2716b400ad19c8_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1MzQwOQ_18512bc7-bbae-4d08-bf36-e65de27415b9"
      unitRef="number">0.07</mck:RevenueDerivedFromServicesPercentage>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="i1c2064f2c8eb49c3849453a95a9c86c4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1Mzg0NQ_2e818a88-ad57-4fc9-9e20-f669c196563f"
      unitRef="usd">-23000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryLIFOReservePeriodCharge
      contextRef="idba260eba8e74ac5a3c690150d88e82e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1Mzg0OQ_6f3d34d3-f955-4843-ae64-ec17b707d02a"
      unitRef="usd">-52000000</us-gaap:InventoryLIFOReservePeriodCharge>
    <us-gaap:InventoryWriteDown
      contextRef="i032911e077b3421889a6ddae5be68041_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1NDA2OQ_49d82941-cebc-4691-86e9-3489a8613567"
      unitRef="usd">164000000</us-gaap:InventoryWriteDown>
    <us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease
      contextRef="id5cbe1ba860d47aaa8b10c167bd7e101_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMzI5ODUzNDkyNDkzNA_4f66f5b6-7574-45c5-b2ad-8f801cd0b689"
      unitRef="usd">74000000</us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i49c8bc60131d4dedb5a99976b761279b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmE5YjY2NGRkMDg2ZjQ3MjQ5MjRlMzc0NTE5NTFiMTU2L3NlYzphOWI2NjRkZDA4NmY0NzI0OTI0ZTM3NDUxOTUxYjE1Nl84Mi9mcmFnOmRlOWMyYmNjOTlkZTQxZjQ4YzljYTllYWU5MmE2MzQ3L3RleHRyZWdpb246ZGU5YzJiY2M5OWRlNDFmNDhjOWNhOWVhZTkyYTYzNDdfMTY0OTI2NzQ1NjcwNQ_6d42b095-f9c3-4370-988f-9c7056784134"
      unitRef="usd">131000000</us-gaap:GainLossRelatedToLitigationSettlement>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321664491736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-13252<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">McKESSON CORPORATION<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">94-3207296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6555 State Hwy 161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Irving<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">446-4800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">154,674,571<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member', window );">1.500% Notes Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.500% Notes due 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member', window );">1.625% Notes Due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.625% Notes due 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member', window );">3.125% Notes Due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Notes due 2029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCK29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1500NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A1625NotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mck_A3125NotesDue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321661910104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 62,674<span></span>
</td>
<td class="nump">$ 55,679<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="num">(59,642)<span></span>
</td>
<td class="num">(52,979)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,032<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, distribution, general, and administrative expenses</a></td>
<td class="num">(2,232)<span></span>
</td>
<td class="num">(2,097)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Claims and litigation charges, net</a></td>
<td class="num">(74)<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RestructuringImpairmentandOtherRelatedCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="num">(158)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="num">(2,464)<span></span>
</td>
<td class="num">(2,022)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">568<span></span>
</td>
<td class="nump">678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Interest expense</a></td>
<td class="num">(49)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from continuing operations before income taxes</a></td>
<td class="nump">562<span></span>
</td>
<td class="nump">645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">536<span></span>
</td>
<td class="nump">495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">533<span></span>
</td>
<td class="nump">494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to McKesson Corporation</a></td>
<td class="nump">$ 486<span></span>
</td>
<td class="nump">$ 444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 3.09<span></span>
</td>
<td class="nump">$ 2.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.02)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">3.07<span></span>
</td>
<td class="nump">2.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">3.13<span></span>
</td>
<td class="nump">2.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.02)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 3.11<span></span>
</td>
<td class="nump">$ 2.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">158.1<span></span>
</td>
<td class="nump">163.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">156.2<span></span>
</td>
<td class="nump">162.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RestructuringImpairmentandOtherRelatedCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring, Impairment and Other Related Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RestructuringImpairmentandOtherRelatedCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321664402024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 533<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Unrealized losses on cash flow hedges</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Changes in retirement-related benefit plans</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">559<span></span>
</td>
<td class="nump">523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(111)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to McKesson Corporation</a></td>
<td class="nump">$ 509<span></span>
</td>
<td class="nump">$ 412<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321661943016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,423<span></span>
</td>
<td class="nump">$ 6,278<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net</a></td>
<td class="nump">20,198<span></span>
</td>
<td class="nump">19,181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">20,016<span></span>
</td>
<td class="nump">19,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">706<span></span>
</td>
<td class="nump">665<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">43,350<span></span>
</td>
<td class="nump">45,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant, and equipment, net</a></td>
<td class="nump">2,549<span></span>
</td>
<td class="nump">2,581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">2,071<span></span>
</td>
<td class="nump">2,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,520<span></span>
</td>
<td class="nump">9,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">2,797<span></span>
</td>
<td class="nump">2,878<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">2,607<span></span>
</td>
<td class="nump">2,581<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">62,894<span></span>
</td>
<td class="nump">65,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Drafts and accounts payable</a></td>
<td class="nump">38,389<span></span>
</td>
<td class="nump">38,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">752<span></span>
</td>
<td class="nump">742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">4,297<span></span>
</td>
<td class="nump">3,987<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">43,835<span></span>
</td>
<td class="nump">44,103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">6,424<span></span>
</td>
<td class="nump">6,406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Long-term deferred tax liabilities</a></td>
<td class="nump">1,441<span></span>
</td>
<td class="nump">1,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">1,888<span></span>
</td>
<td class="nump">1,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserveNoncurrent', window );">Long-term litigation liabilities</a></td>
<td class="nump">7,596<span></span>
</td>
<td class="nump">8,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,748<span></span>
</td>
<td class="nump">1,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Redeemable noncontrolling interests</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value, 800 shares authorized and 274 and 273 shares issued at June 30, 2021 and March 31, 2021, respectively</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">7,057<span></span>
</td>
<td class="nump">6,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">8,618<span></span>
</td>
<td class="nump">8,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,627)<span></span>
</td>
<td class="num">(1,480)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury shares, at cost, 119 and 115 shares at June 30, 2021 and March 31, 2021, respectively</a></td>
<td class="num">(14,579)<span></span>
</td>
<td class="num">(13,670)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total McKesson Corporation stockholders&#8217; deficit</a></td>
<td class="num">(529)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">484<span></span>
</td>
<td class="nump">196<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity (deficit)</a></td>
<td class="num">(45)<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable noncontrolling interests, and equity (deficit)</a></td>
<td class="nump">$ 62,894<span></span>
</td>
<td class="nump">$ 65,015<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321768697912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>McKesson Corporation stockholders&#8217; deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">800,000,000<span></span>
</td>
<td class="nump">800,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">274,000,000<span></span>
</td>
<td class="nump">273,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares (in shares)</a></td>
<td class="nump">119,000,000<span></span>
</td>
<td class="nump">115,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321660603896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
<th class="th"><div>Opening retained earnings adjustment: adoption of new accounting standard</div></th>
<th class="th">
<div>Opening retained earnings adjustment: adoption of new accounting standard </div>
<div>Retained Earnings</div>
</th>
<th class="th"><div>Adjusted balance, April 1</div></th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Additional Paid-in Capital</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Retained Earnings</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Accumulated Other Comprehensive Loss</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Treasury</div>
</th>
<th class="th">
<div>Adjusted balance, April 1 </div>
<div>Noncontrolling Interests</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">$ 5,309<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,663<span></span>
</td>
<td class="nump">$ 13,022<span></span>
</td>
<td class="num">$ (1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="nump">$ 5,296<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 6,663<span></span>
</td>
<td class="nump">$ 13,009<span></span>
</td>
<td class="num">$ (1,703)<span></span>
</td>
<td class="num">$ (12,892)<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">$ 483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">272,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">$ 5,653<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,711<span></span>
</td>
<td class="nump">13,384<span></span>
</td>
<td class="num">(1,735)<span></span>
</td>
<td class="num">$ (12,916)<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance (shares) at Mar. 31, 2021</a></td>
<td class="num">(115,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(115,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">6,925<span></span>
</td>
<td class="nump">8,202<span></span>
</td>
<td class="num">(1,480)<span></span>
</td>
<td class="num">$ (13,670)<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares under employee plans (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares under employee plans</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Repurchase of common stock (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (850)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">$ (4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance (shares) at Jun. 30, 2021</a></td>
<td class="num">(119,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(119,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="num">$ (45)<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 7,057<span></span>
</td>
<td class="nump">$ 8,618<span></span>
</td>
<td class="num">$ (1,627)<span></span>
</td>
<td class="num">$ (14,579)<span></span>
</td>
<td class="nump">$ 484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321658536344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share)</a></td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321664392408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 533<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">80<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Long-lived asset impairment charges</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Credits associated with last-in, first-out inventory method</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Loss from sales of businesses and investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash items</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>Changes in assets and liabilities, net of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="num">(1,045)<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(901)<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Drafts and accounts payable</a></td>
<td class="num">(609)<span></span>
</td>
<td class="num">(4,214)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable', window );">Taxes</a></td>
<td class="num">(54)<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_IncreaseDecreaseInLitigationReserve', window );">Litigation liabilities</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="num">(149)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(1,622)<span></span>
</td>
<td class="num">(1,062)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payments for property, plant, and equipment</a></td>
<td class="num">(93)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireSoftware', window );">Capitalized software expenditures</a></td>
<td class="num">(66)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash, cash equivalents, and restricted cash acquired</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates', window );">Proceeds from sales of businesses and investments, net</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(99)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments of short-term borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5,303)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract', window );"><strong>Common stock transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Issuances</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Share repurchases</a></td>
<td class="num">(1,008)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(69)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="num">(1,031)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(112)<span></span>
</td>
<td class="nump">165<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(2,151)<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">11<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(3,861)<span></span>
</td>
<td class="num">(1,159)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of period</a></td>
<td class="nump">6,396<span></span>
</td>
<td class="nump">4,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of period</a></td>
<td class="nump">2,535<span></span>
</td>
<td class="nump">2,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Less: Restricted cash at end of period included in Prepaid expenses and other</a></td>
<td class="num">(112)<span></span>
</td>
<td class="num">(251)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 2,423<span></span>
</td>
<td class="nump">$ 2,613<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_IncreaseDecreaseInLitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Litigation Reserve</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_IncreaseDecreaseInLitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321656679464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nature of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: McKesson Corporation (&#8220;McKesson,&#8221; or the &#8220;Company,&#8221;) is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments, and other organizations in healthcare to help provide the right medicines, medical products, and healthcare services to the right patients at the right time, safely, and cost-effectively. The Company reports its financial results in four reportable segments: U.S. Pharmaceutical, Prescription Technology Solutions (&#8220;RxTS&#8221;), Medical-Surgical Solutions, and International. Refer to Financial Note 14, &#8220;Segments of Business,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic. As COVID-19 evolves, the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations for the three months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, previously filed with the SEC on May 12, 2021 (&#8220;2021 Annual Report&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321658673784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Held for Sale</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Held for Sale</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are reclassified into &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less cost to sell is reported as an adjustment to the carrying value of the disposal group. Assets and liabilities that have met the classification of held for sale were $7 million and $5 million, respectively, at June 30, 2021 and $12&#160;million and $9&#160;million, respectively, at March 31, 2021. Based on its analysis, the Company determined that the disposal groups classified as held for sale do not meet the criteria for classification as discontinued operations and are not considered to be significant disposals based on its quantitative and qualitative evaluation.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2021, the Company entered into an agreement to sell certain of its European businesses (&#8220;disposal group&#8221;) to the PHOENIX Group for a purchase price of &#8364;1.2&#160;billion (or, approximately $1.5&#160;billion), subject to certain adjustments, including net debt adjustments, and reduced by the value of the noncontrolling interest held by minority shareholders of McKesson Europe AG (&#8220;McKesson Europe&#8221;) at the divestiture date. The Company concluded that the held for sale criteria were not met in the first quarter of 2022 and continued to classify the assets and liabilities of these businesses as held and used in the condensed consolidated balance sheet. Beginning in the second quarter of 2022, the disposal group will be reflected in the Company&#8217;s condensed consolidated financial statements as held for sale. The disposal group will be remeasured to the lower of its carrying amount or fair value less costs to sell, which the Company estimates will result in a charge of between $500&#160;million and $700&#160;million, primarily related to the inclusion of the accumulated other comprehensive income balances into the carrying amount of the disposal group and the impairment of internal-use software that will not be completed. While this range reflects the Company&#8217;s best estimate as of the date of this Quarterly Report on Form 10-Q, actual charges could differ based on operating results, changes in foreign exchange rates, and other factors prior to closing of the transaction. The transaction is anticipated to close during 2023, pursuant to the satisfaction of customary closing conditions, including receipt of regulatory approvals, as applicable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321753994712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring, Impairment, and Related Charges</a></td>
<td class="text">Restructuring, Impairment, and Related Charges<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded restructuring, impairment, and related charges of $158 million and $56 million during the three months ended June 30, 2021 and 2020, respectively. These charges are included in &#8220;Restructuring, impairment, and related charges&#8221; in the Condensed Consolidated Statements of Operations. In addition, charges related to restructuring initiatives are included in &#8220;Cost of sales&#8221; in the Condensed Consolidated Statements of Operations and were not material for the three months ended June 30, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restructuring Initiatives</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, the Company approved an initiative to increase operational efficiencies and flexibility by transitioning to a partial remote work model for certain employees. This initiative primarily includes the rationalization of the Company&#8217;s office space in North America. Where it determines to cease using office space, the Company plans to exit the portion of the facility no longer used. It also may retain and repurpose certain other office locations. The Company expects to incur total charges of approximately $180 million&#160;to $280 million for this initiative, consisting primarily of exit related costs, accelerated depreciation and amortization of long-lived assets, and asset impairments. The Company recorded charges of $95 million in the three months ended June 30, 2021. This initiative is anticipated to be completed in 2022. Charges primarily relate to lease right-of-use and other long-lived asset impairments, lease exit costs, and accelerated depreciation and amortization.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the first quarter of 2021, the Company committed to an initiative within the United Kingdom (&#8220;U.K.&#8221;), which is included in the Company&#8217;s International segment, to further drive operational changes in technologies and business processes, efficiencies, and cost savings. The initiative includes reducing the number of retail pharmacy stores, decommissioning obsolete technologies and processes, reorganizing and consolidating certain business operations, and related headcount reductions. The Company expects to incur total charges of approximately $85 million to $90 million, of which $63 million of charges were recorded to date. The Company recorded charges of $6 million and $14 million, respectively, in the three months ended June 30, 2021 and 2020, primarily related to asset impairments and accelerated depreciation expense as well as employee severance and other employee-related costs. The initiative is anticipated to be substantially complete in 2022 and estimated remaining charges primarily consist of accelerated amortization of long-lived assets, facility and other exit costs, and employee-related costs.</span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three months ended June 30, 2021 consisted of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:20.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.271%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.091%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.249%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Costs primarily relate to the transition to the partial remote work model described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs related to the transition to the partial remote work model and U.K. operating model and cost optimization efforts described above, as well as costs for optimization programs in Canada.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three months ended June 30, 2020 consisted of the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.194%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above, and an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><div style="margin-bottom:1pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the three months ended June 30, 2021: </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2021, the total reserve balance was $151 million, of which $99 million was recorded in &#8220;Other accrued liabilities&#8221; and $52 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of June 30, 2021, the total reserve balance was $177 million, of which $127 million was recorded in &#8220;Other accrued liabilities&#8221; and $50 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321656321304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2021 and 2020, the Company recorded income tax expense of $26 million and $150 million, respectively. The Company&#8217;s reported income tax rates were 4.6% and 23.3% for the three months ended June 30, 2021 and 2020, respectively. Fluctuations in the Company&#8217;s reported income tax rates are primarily due to discrete items recognized in the quarter and changes in the mix of earnings between various taxing jurisdictions. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2021, the Company had $1.7 billion of unrecognized tax benefits, of which $1.3 billion would reduce income tax expense and the effective tax rate if recognized. During the three months ended June 30, 2021, the Company recognized a net discrete tax benefit of $97 million primarily related to statute of limitation expirations in various taxing jurisdictions. During the next twelve months, the Company does not estimate any material reduction in its unrecognized tax benefits. However, this may change as the Company continues to have ongoing negotiations with various taxing authorities throughout the year. The unrecognized tax benefit may also increase or decrease due to future developments in the Opioid related litigation and claims, as discussed in Financial Note 12, &#8220;Commitments and Contingent Liabilities.&#8221;</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal jurisdiction, various U.S. state jurisdictions, and various foreign jurisdictions. The Internal Revenue Service (&#8220;IRS&#8221;) is currently examining the Company&#8217;s U.S. corporation income tax returns for 2018 and 2019. The Company is generally subject to audit by taxing authorities in various U.S. states and in foreign jurisdictions for fiscal years 2013 through the current fiscal year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321658178328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDisclosureTextBlock', window );">Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text">Redeemable Noncontrolling Interests and Noncontrolling Interests<div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redeemable Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s redeemable noncontrolling interests primarily related to its consolidated subsidiary, McKesson Europe. Under the December 2014 domination and profit and loss transfer agreement (the &#8220;Domination Agreement&#8221;), the noncontrolling shareholders of McKesson Europe are entitled to receive an annual recurring compensation amount of &#8364;0.83 per share. As a result, during the three months ended June 30, 2021 and 2020, the Company recorded a total attribution of net income to the noncontrolling shareholders of McKesson Europe of $8 million and $11 million, respectively. All amounts were recorded in &#8220;Net income attributable to noncontrolling interests&#8221; in the Company&#8217;s Condensed Consolidated Statements of Operations and the corresponding liability balance was recorded in &#8220;Other accrued liabilities&#8221; in the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Domination Agreement, the noncontrolling shareholders of McKesson Europe had a right to put (&#8220;Put Right&#8221;) their noncontrolling shares at &#8364;22.99 per share, increased annually for interest in the amount of five percentage points above a base rate published by the German Bundesbank semi-annually, less any compensation amount or guaranteed dividend already paid by McKesson with respect to the relevant time period (&#8220;Put Amount&#8221;). Subsequent to the Domination Agreement&#8217;s registration, certain noncontrolling shareholders of McKesson Europe initiated appraisal proceedings (&#8220;Appraisal Proceedings&#8221;) with the Stuttgart Regional Court (the &#8220;Court&#8221;) to challenge the adequacy of the Put Amount, annual recurring compensation amount, and/or the guaranteed dividend. During the pendency of the Appraisal Proceedings, such amount was paid as specified currently in the Domination Agreement. On September 19, 2018, the Court ruled that the Put Amount shall be increased by &#8364;0.51 resulting in an adjusted Put Amount of &#8364;23.50. The annual recurring compensation amount and/or the guaranteed dividend remained unadjusted. Noncontrolling shareholders of McKesson Europe appealed this decision. McKesson Europe Holdings GmbH &amp; Co. KGaA also appealed the decision. On April 12, 2021, the Company received notice that the Stuttgart Court of Appeals ruled that the Put Amount shall remain &#8364;22.99, thereby rejecting the lower court&#8217;s increase, and the recurring compensation remained at &#8364;0.83 per share.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2021 and 2020, the Company paid $1.0 billion and $49&#160;million, respectively, to purchase 34.5&#160;million and 1.8&#160;million shares, respectively, of McKesson Europe through exercises of the Put Right by the noncontrolling shareholders. This decreased the carrying value of the noncontrolling interests by $983 million and $49 million, respectively, for the three months ended June 30, 2021 and 2020, and the Company recorded the associated effect of the increase in the Company&#8217;s ownership interest of $178 million and $3 million, respectively, as an increase to McKesson&#8217;s stockholders additional paid-in capital. The Put Right expired on June 15, 2021, at which point the remaining shares owned by the minority shareholders, with a carrying value of $287 million, were transferred from &#8220;Redeemable noncontrolling interests&#8221; to &#8220;Noncontrolling interests&#8221; on the Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The redeemable noncontrolling interest was adjusted each period for the proportion of other comprehensive income, primarily due to changes in foreign currency exchange rates, attributable to the noncontrolling shareholders. Prior to expiration of the Put Right, the balance of the redeemable noncontrolling interests was reported as the greater of its carrying value or its maximum redemption value at each reporting date. At March 31, 2021, the carrying value of $1.3&#160;billion exceeded the maximum redemption value of $1.2 billion and the Company owned approximately 78% of McKesson Europe&#8217;s outstanding common shares. At June 30, 2021, the Company owned approximately 95%, of McKesson Europe&#8217;s outstanding common shares.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Noncontrolling interests represent third-party equity interests in the Company&#8217;s consolidated entities primarily related to ClarusONE Sourcing Services LLP and Vantage Oncology Holdings, LLC. As of June 30, 2021, noncontrolling interests also represent minority shareholder equity interests in McKesson Europe, as discussed above. During the three months ended June 30, 2021 and 2020, the Company allocated a total of $39 million of net income to noncontrolling interests.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2021 were as follows:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2020 were as follows:</span></div><div style="text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321657981352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) Per Common Share</a></td>
<td class="text">Earnings (Loss) Per Common Share<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per common share are computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. The computation of diluted earnings (loss) per common share is similar to that of basic earnings (loss) per common share, except that the former reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive securities include outstanding stock options, restricted stock units, and performance-based and other restricted stock units. Approximately 1&#160;million and 3&#160;million of potentially dilutive securities for the three months ended June 30, 2021 and 2020 were excluded from the computation of diluted net earnings per common share as they were anti-dilutive.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.239%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to McKesson Corporation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.07&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units, performance-based restricted stock units, and performance-based stock units.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321656407848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets, Net</a></td>
<td class="text">Goodwill and Intangible Assets, Net <div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:26.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.716%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March&#160;31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,555&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,520&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,329)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,880)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,797&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,768)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets was $98 million and $106 million for the three months ended June 30, 2021 and 2020, respectively. Estimated amortization expense of these assets is as follows: $279 million, $273 million, $261 million, $255 million, and $223 million for the remainder of 2022 and each of the succeeding years through 2026 and $1.5 billion thereafter. All intangible assets were subject to amortization as of June 30, 2021 and March 31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321661506472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt and Financing Activities</a></td>
<td class="text">Debt and Financing Activities<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,424&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt includes both U.S. dollar and foreign currency-denominated borrowings. Debt outstanding totaled $7.2 billion and $7.1 billion at June 30, 2021 and March 31, 2021, respectively, of which $752 million and $742 million, respectively, was included under the caption &#8220;Current portion of long-term debt&#8221; within the Company&#8217;s Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 17, 2021, the Company redeemed its 0.63% &#8364;600 million (or, approximately $709 million) total principal Euro-denominated notes, originally due on August 17, 2021, prior to maturity. The notes were redeemed at par value using cash on hand.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tender Offer</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company completed a cash tender offer for a portion of its existing outstanding (i) 2.85% Notes due 2023, (ii) 3.80% Notes due 2024, (iii) 7.65% Debentures due 2027, (iv) 3.95% Notes due 2028, (v) 4.75% Notes due 2029, (vi) 6.00% Notes due 2041, and (vii) 4.88% Notes due 2044 (collectively referred to herein as the &#8220;Tender Offer Notes&#8221;). In connection with the tender offer, the Company paid an aggregate consideration of $1.1&#160;billion to redeem $922&#160;million principal amount of the notes at a redemption price equal to 100% of the principal amount and premiums of $182&#160;million. The redemption of the Tender Offer Notes was accounted for as a debt extinguishment and in the second quarter of 2022 the Company will record a loss on debt extinguishment, consisting of the premiums paid and a portion of the unamortized discounts and debt issuance costs proportional to the principal amount of debt retired.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facilities </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Credit Agreement, dated as of September 25, 2019 (the &#8220;2020 Credit Facility&#8221;), that provides a syndicated $4.0 billion five-year senior unsecured credit facility with a $3.6 billion aggregate sublimit of availability in Canadian dollars, British pound sterling, and Euro. Borrowings under the 2020 Credit Facility bear interest based upon the London Interbank Offered Rate (&#8220;LIBOR&#8221;), Canadian Dealer Offered Rate for credit extensions denominated in Canadian dollars, a prime rate, or alternative overnight rates as applicable, plus agreed margins. The 2020 Credit Facility matures in September 2024 and had no&#160;borrowings during the three months ended June 30, 2021 and 2020 and no amounts outstanding as of June 30, 2021 and March 31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 31, 2021, the Company entered into Amendment No. 2 to the 2020 Credit Facility, which superseded Amendment No. 1, dated as of February 1, 2021. The 2020 Credit Facility, as amended, contains various customary investment grade covenants, including a financial covenant which obligates the Company to maintain a maximum Total Debt to Consolidated EBITDA ratio, as defined in the amended credit agreement. If the Company does not comply with these covenants, its ability to use the 2020 Credit Facility may be suspended and repayment of any outstanding balances under the 2020 Credit Facility may be required. At June 30, 2021, the Company was in compliance with all covenants. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains bilateral credit facilities primarily denominated in Euro with a committed amount of $8 million and an uncommitted amount of $118 million as of June 30, 2021. Borrowings and repayments were not material during the three months ended June 30, 2021 and 2020, and amounts outstanding under these credit lines were not material as of June 30, 2021 and March 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a commercial paper program to support its working capital requirements and for other general corporate purposes. Under the program, the Company can issue up to $4.0 billion in outstanding commercial paper notes. There were no borrowings or repayments during the three months ended June 30, 2021. During the three months ended June 30, 2020, the Company borrowed $5.3 billion and repaid $5.3 billion under the program. At June 30, 2021 and March 31, 2021, there were no commercial paper notes outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321656354440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pension Benefits</a></td>
<td class="text">Pension Benefits<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net periodic expense for defined benefit pension plans was approximately zero and $7 million for the three months ended June 30, 2021 and 2020, respectively.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash contributions to these plans were $14 million and $7 million for the three months ended June 30, 2021 and 2020, respectively. The projected unit credit method is utilized in measuring net periodic pension expense over the employees&#8217; service life for the pension plans. Unrecognized actuarial losses exceeding 10% of the greater of the projected benefit obligation or the market value of assets are amortized on a straight-line basis over the average remaining future service periods and expected life expectancy.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321658554568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Hedging Activities</a></td>
<td class="text">Hedging Activities In the normal course of business, the Company is exposed to interest rate and foreign currency exchange rate fluctuations. At times, the Company limits these risks through the use of derivatives such as cross-currency swaps, foreign currency forward contracts, and interest rate swaps. In accordance with the Company&#8217;s policy, derivatives are only used for hedging purposes. It does not use derivatives for trading or speculative purposes. <div style="margin-bottom:6pt;padding-left:2.25pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company conducts its business worldwide in U.S. dollars and the functional currencies of its foreign subsidiaries, including Euro, British pound sterling, and Canadian dollars. Changes in foreign currency exchange rates could have a material adverse impact on the Company&#8217;s financial results that are reported in U.S. dollars. The Company is also exposed to foreign currency exchange rate risk related to its foreign subsidiaries, including intercompany loans denominated in non-functional currencies. The Company has certain foreign currency exchange rate risk programs that use foreign currency forward contracts and cross-currency swaps. These forward contracts and cross-currency swaps are generally used to offset the potential income statement effects from intercompany loans and other obligations denominated in non-functional currencies. These programs reduce but do not entirely eliminate foreign currency exchange rate risk.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Derivative Instruments Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2021 and March 31, 2021, the Company had &#8364;1.7 billion of Euro-denominated notes designated as non-derivative net investment hedges. These hedges are utilized to hedge portions of the Company&#8217;s net investments in non-U.S. subsidiaries against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. For all notes that are designated as net investment hedges and meet effectiveness requirements, the changes in carrying value of the notes attributable to the change in spot rates are recorded in foreign currency translation adjustments in &#8220;Accumulated other comprehensive loss&#8221; in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments.&#160;To the extent foreign currency denominated notes designated as net investment hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Losses from net investment hedges recorded within Other comprehensive income were $22 million and $34 million during the three months ended June 30, 2021 and 2020, respectively. There was no ineffectiveness in non-derivative net investment hedges during the three months ended June 30, 2021 and 2020.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2021 and March 31, 2021, the Company had cross-currency swaps designated as net investment hedges with a total gross notional amount of $500 million Canadian dollars. Under the terms of the cross-currency swap contracts, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These swaps are utilized to hedge portions of the Company&#8217;s net investments denominated in Canadian dollars against the effect of exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The changes in the fair value of these derivatives attributable to the changes in spot currency exchange rates and differences between spot and forward interest rates are recorded in &#8220;Accumulated other comprehensive loss&#8221; in the Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) where they offset foreign currency translation gains and losses recorded on the Company&#8217;s net investments denominated in Canadian dollars. To the extent cross-currency swaps designated as hedges are ineffective, changes in carrying value attributable to the change in spot rates are recorded in earnings. There was no ineffectiveness in the Company&#8217;s net investment hedges for the three months ended June 30, 2021 and 2020. The remaining cross-currency swaps will mature November 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from the Company&#8217;s cross-currency swaps designated as net investment hedges recorded in Other comprehensive income were losses of $5 million and $51 million during the three months ended June 30, 2021 and 2020, respectively. There was no ineffectiveness in the Company&#8217;s cross-currency swap hedges for the three months ended June 30, 2021 and 2020. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 30, 2019, the Company entered into a number of cross-currency swaps designated as fair value hedges with total notional amounts of &#163;450 million British pound sterling. Under the terms of the cross-currency swap contracts, the Company agreed with third parties to exchange fixed interest payments in British pound sterling for floating interest payments in U.S. dollars based on three-month LIBOR plus a spread. These swaps are utilized to hedge the changes in the fair value of the underlying &#163;450 million British pound sterling notes resulting from changes in benchmark interest rates and foreign exchange rates. The changes in the fair value of these derivatives, which are designated as fair value hedges, and the offsetting changes in the fair value of the hedged notes are recorded in earnings. Gains from these fair value hedges recorded in earnings were largely offset by the losses recorded in earnings related to these notes. The swaps will mature in February 2023.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company also enters into cross-currency swaps to hedge intercompany loans denominated in non-functional currencies. For cross-currency swap transactions, the Company agrees with third parties to exchange fixed interest payments in one currency for fixed interest payments in another currency at specified intervals and to exchange principal in one currency for principal in another currency, calculated by reference to agreed-upon notional amounts. These cross-currency swaps are designed to reduce the income statement effects arising from fluctuations in foreign exchange rates and have been designated as cash flow hedges. At June 30, 2021 and March 31, 2021, the Company had cross-currency swaps with total gross notional amounts of approximately $2.6 billion, which are designated as cash flow hedges. These swaps will mature between August 2021 and January 2024.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For forward contracts and cross-currency swaps that are designated as cash flow hedges, the effective portion of changes in the fair value&#160;of the hedges is recorded in Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings. Changes in fair values representing hedge ineffectiveness are recognized in current earnings. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 27, 2020, the Company entered into forward starting interest rate swaps designated as cash flow hedges, with combined notional amounts of $500 million and &#8364;600 million, to hedge the variability of future benchmark interest rates on planned bond issuances. Under the terms of the forward interest rate swap contracts, the Company agreed with third parties to pay fixed interest payments for the $500 million swaps for floating interest payments in U.S. dollars based on three-month LIBOR and to pay fixed interest payments for floating interest payments in Euros based on six-month Euro Interbank Offered Rate (&#8220;EURIBOR&#8221;) for the &#8364;600 million swaps. The $500 million swaps were terminated upon the issuance of the 2025 Notes in November 2020. The settlement loss on the swaps was not material and will be amortized on a straight-line basis as interest expense over the five-year life of the 2025 Notes. Refer to Financial Note 8, &#8220;Debt and Financing Activities,&#8221; for more information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains or losses from cash flow hedges recorded in Other comprehensive income were zero and a loss of $5 million during the three months ended June 30, 2021 and 2020, respectively. Gains or losses reclassified from Accumulated other comprehensive income and recorded in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations were not material in the three months ended June 30, 2021 and 2020. There was no ineffectiveness in the Company&#8217;s cash flow hedges for the three months ended June 30, 2021 and 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives Not Designated as Hedges</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative instruments not designated as hedges are marked-to-market at the end of each accounting period with the change in fair value included in earnings.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a number of forward contracts to hedge the Euro against cash flows denominated in British pound sterling and other European currencies. At June 30, 2021 and March 31, 2021, the total gross notional amounts of these contracts were $54 million and $39 million, respectively. These contracts will predominantly mature between July 2021 and December 2021 and none of these contracts were designated for hedge accounting. Changes in the fair values for contracts not designated as hedges are recorded directly into earnings in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. Changes in the fair values were not material in the three months ended June 30, 2021 and 2020. Gains or losses from these contracts are largely offset by changes in the value of the underlying intercompany obligations.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.672%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.817%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.206%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div>Refer to Financial Note 11, "Fair Value Measurements," for more information on these recurring fair value measurements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321656440360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:12pt;text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain assets and liabilities at fair value in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements and Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The fair value hierarchy consists of three levels of inputs that may be used to measure fair value as follows:</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 - quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 - significant other observable market-based inputs.</span></div><div style="margin-bottom:12pt;padding-left:58.5pt;text-align:justify;text-indent:-40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 - significant unobservable inputs for which little or no market data exists and requires considerable assumptions that are significant to the fair value measurement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents at June 30, 2021 and March 31, 2021 included investments in money market funds of $521 million and $1.6 billion, respectively, which are reported at fair value. The fair value of money market funds was determined using quoted prices for identical investments in active markets, which are considered to be Level 1 inputs under the fair value measurements and disclosure guidance. The carrying value of all other cash equivalents approximates their fair value due to their relatively short-term nature. Fair values for the Company&#8217;s marketable securities were not material at June 30, 2021 and March 31, 2021.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair values of the Company&#8217;s interest rate swaps, foreign currency forward contracts, and cross-currency swaps were determined using observable inputs from available market information, including quoted interest rates, foreign currency exchange rates, and other observable inputs from available market information.&#160;These inputs are considered Level 2 under the fair value measurements and disclosure guidance, and may not be representative of actual values that could have been realized or that will be realized in the future. Refer to Financial Note 10, &#8220;Hedging Activities,&#8221; for fair value and other information on the Company&#8217;s derivatives including interest rate swaps, forward foreign currency contracts, and cross-currency swaps.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to assets and liabilities that are measured at fair value on a recurring basis, the Company&#8217;s assets and liabilities are also subject to nonrecurring fair value measurements. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets associated with the Company&#8217;s restructuring initiatives as discussed in more detail in Financial Note 3, &#8220;Restructuring, Impairment, and Related Charges.&#8221; At March 31, 2021, assets measured at fair value on a nonrecurring basis included long-lived assets of the Company&#8217;s International segment and goodwill of the Company&#8217;s Europe Retail Pharmacy reporting unit within the International segment.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no liabilities measured at fair value on a nonrecurring basis at June 30, 2021 and March 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Fair Value Disclosures</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June 30, 2021 and March 31, 2021, the carrying amounts of cash, certain cash equivalents, restricted cash, marketable securities, receivables, drafts and accounts payable, short-term borrowings, and other current liabilities approximated their estimated fair values because of the short maturity of these financial instruments. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of commercial paper using quoted prices in active markets for identical instruments, which are considered Level 1 inputs under the fair value measurements and disclosure guidance.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.903%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,176&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of the Company&#8217;s long-term debt was determined using quoted market prices in a less active market and other observable inputs from available market information, which are considered to be Level 2 inputs, and may not be representative of actual values that could have been realized or that will be realized in the future.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Cash</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash, included within &#8220;Prepaid expenses and other&#8221; on the Company&#8217;s Condensed Consolidated Balance Sheets as of June 30, 2021 and March 31, 2021, primarily consists of funds temporarily held on behalf of unaffiliated medical practice groups related to their COVID-19 business continuity borrowings. The amounts have been designated as restricted cash due to contractual provisions requiring their segregation from all other funds until utilized by the medical practices for a limited list of qualified activities. Corresponding deposit liabilities associated with these funds have been recorded by the Company within &#8220;Other accrued liabilities&#8221; on the Company&#8217;s Condensed Consolidated Balance Sheets as of June 30, 2021 and March 31, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value assessments of the reporting unit and the reporting unit's net assets, which are performed for goodwill impairment tests, are considered a Level 3 measurement due to the significance of unobservable inputs developed using company-specific information. The Company considered a market approach as well as an income approach using a discounted cash flow (&#8220;DCF&#8221;) model to determine the fair value of the reporting unit. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-lived Assets</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain long-lived and intangible assets at fair value on a nonrecurring basis when events occur that indicate an asset group may not be recoverable. If the carrying amount of an asset group is not recoverable, an impairment charge is recorded to reduce the carrying amount by the excess over its fair value.</span></div>The Company utilizes multiple approaches including the DCF model and market approaches for estimating the fair value of intangible assets. The future cash flows used in the analysis are based on internal cash flow projections from its long-range plans and include significant assumptions by management. Accordingly, the fair value assessment of the long-lived assets is considered a Level 3 fair value measurement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321656381480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingent Liabilities</a></td>
<td class="text">Commitments and Contingent Liabilities <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765321000039/mck-20210331.htm#i08f9baf810c0412e93ea6effc6d22995_214" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 19 to the Company&#8217;s 2021 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">I. Litigation and Claims Involving Distribution of Controlled Substances</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and its affiliates are defendants in many cases asserting claims related to distribution of controlled substances. They are named as defendants along with other pharmaceutical wholesale distributors, pharmaceutical manufacturers, and retail pharmacy chains. The plaintiffs in these actions include state attorneys general, county and municipal governments, tribal nations, hospitals, health and welfare funds, third-party payors, and individuals. These actions have been filed in state and federal courts throughout the U.S., and in Puerto Rico and Canada. They seek monetary damages and other forms of relief based on a variety of causes of action, including negligence, public nuisance, unjust enrichment, and civil conspiracy, as well as alleging violations of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), state and federal controlled substances laws, and other statutes.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since December 5, 2017, nearly all such cases pending in federal district courts have been transferred for consolidated pre-trial proceedings to a multi-district litigation (&#8220;MDL&#8221;) in the United States District Court for the Northern District of Ohio captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re: National Prescription Opiate Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. 17-md-2804. At present, there are approximately 2,900 cases under the jurisdiction of the MDL court. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three cases involving McKesson that were previously part of the federal MDL have been remanded to other federal courts for discovery and trial. On January 14, 2020, the Judicial Panel on Multidistrict Litigation finalized its Conditional Remand Order, ordering that the cases brought by Cabell County, West Virginia and the City of Huntington, West Virginia be remanded to the U.S. District Court for the Southern District of West Virginia. Trial in that case ended on July 28, 2021 and the outcome is pending. On February 5, 2020, the case brought by the City and County of San Francisco was remanded to the U.S. District Court for the Northern District of California; trial has been set for April 25, 2022. Also on February 5, 2020, the case brought by the Cherokee Nation was remanded by the MDL court to the U.S. District Court for the Eastern District of Oklahoma; trial has been set for September 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also named in approximately 300 similar state court cases pending in 38 states plus Puerto Rico, along with 3 cases in Canada. These include actions filed by 26 state attorneys general, and some by or on behalf of individuals, including wrongful death lawsuits, and putative class action lawsuits brought on behalf of children with neonatal abstinence syndrome due to alleged exposure to opioids in utero. Trial dates have been set in several of these state court cases. For example, trials in the cases brought by the Ohio and Washington attorneys general are scheduled for September 2021; the case brought by the Alabama attorney general is scheduled to go to trial in November 2021; the case brought by the Rhode Island attorney general is scheduled for January 2022; and the case brought by Dallas County, Texas, is scheduled for trial in January 2022.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 21, 2021, the Company and the two other national pharmaceutical distributors announced that they had negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities. If the proposed settlement agreement and settlement process leads to final settlement, the three distributors would pay up to approximately $21 billion over 18 years, with up to $7.9 billion to be paid by the Company for its 38.1% portion; a minimum of 85% of such payments must be used by state and local governmental entities to remediate the opioid epidemic. Most of the remaining percentage relates to plaintiffs&#8217; attorneys&#8217; fees and costs, and would be payable over a shorter time period.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposed agreement would also establish a clearinghouse that would consolidate controlled-substance distribution data from the three largest U.S. distributors, which will be available to the settling states to use as part of their anti-diversion efforts.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Agreement is subject to contingencies and will not become effective unless the Company determines that (1) following a sign-on period of 30 days, a sufficient number of states have agreed to be bound by the proposed agreement; and, subsequently, (2) following a sign-on period of 120 days, that a sufficient number of states and political subdivisions, including those that have not sued, have agreed to be bound by the agreement (or otherwise had their claims foreclosed).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exact amount that would be due under the proposed agreement depends on several factors, including the participation rate of states and political subdivisions, the extent to which states take action to foreclose opioid lawsuits by political subdivisions, and the extent to which political subdivisions in settling states file additional opioid lawsuits against the Company after the proposed agreement becomes effective. The proposed agreement contemplates that if certain governmental entities do not agree to a settlement under the framework, but the distributors nonetheless conclude that there is sufficient participation to warrant the settlement, there would be a corresponding reduction in the amount due from the Company to account for the unresolved claims of the governmental entities that do not participate. Those non-participating governmental entities would be entitled to pursue their claims against the Company and other defendants. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This settlement process only addresses the claims of U.S. state attorneys general and political subdivisions in participating states. The West Virginia subdivisions and Native American tribes are not part of this settlement process. The proposed agreement provides that the Company will place its first annual payment, estimated to be approximately $482&#160;million, into escrow on or before September 30, 2021, to be disbursed when and if the proposed agreement becomes effective. Subsequent payments would be due on July 15 of each year. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 20, 2021, the Company announced that it and the two other national pharmaceutical distributors had agreed to pay up to $1.2&#160;billion, of which the Company&#8217;s portion would be 38.1%, in a settlement with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, to resolve opioid-related claims. This settlement was negotiated in connection with the broad proposed settlement described above, but provides assurance that New York and its participating subdivisions will receive a settlement amount consistent with their allocations under the broad settlement framework, as well as certain attorneys&#8217; fees and costs. If the broad settlement is finalized, New York and its participating subdivisions will become part of that broader agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that a broad settlement of opioid claims by governmental entities is probable, and that the loss related thereto can be reasonably estimated. The Company recorded a charge of $8.1 billion ($6.8 billion after-tax) in the fiscal year ended March 31, 2021 related to its share of the global settlement as well as claims of West Virginia municipalities and the Native American tribes. In connection with the matters described above, the Company recorded additional charges of $74&#160;million ($61&#160;million after-tax) in the quarter ended June 30, 2021 within &#8220;Claims and litigation charges, net&#8221; in the Condensed Consolidated Statements of Operations, including a pre-tax charge of $27&#160;million ($22&#160;million after-tax) related to the settlement with New York and its participating subdivisions, and a pre-tax charge of $47&#160;million ($39&#160;million after-tax) related to the proposed settlement agreement with state and local governmental entities.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s estimated accrued liability for opioid-related claims of governmental entities, including the $482&#160;million initial payment under the proposed settlement agreement, is as follows as of June 30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,141&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This amount, recorded in &#8220;Other accrued liabilities&#8221; on the Condensed Consolidated Balance Sheet, is the amount estimated to be paid prior to June 30, 2022.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a broad settlement is not reached under the proposed agreement, litigation will continue. The Company continues to prepare for trial in these pending matters, and believes that it has valid defenses to the claims pending against it, and it intends to vigorously defend against all such claims if acceptable settlement terms are not achieved.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the vast majority of opioid claims have been brought by governmental entities in the U.S., the Company is also a defendant in cases brought in the U.S. by private plaintiffs, such as hospitals, health and welfare funds, third-party payors, and individuals, as well as 3 cases brought in Canada (two by governmental entities and one by an individual). These claims, and those of private entities generally, are not included in the settlement framework for governmental entities, or in the charges recorded by the Company, described above. The Company believes it has valid legal defenses in these matters and intends to mount a vigorous defense. One such case brought by a group of individual plaintiffs in Glynn County, Georgia Superior Court seeks to recover for damages allegedly arising from their family members&#8217; abuse of prescription opioids; trial in that case is scheduled to begin in October 2021. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Poppell v. Cardinal Health, Inc. et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CE19-00472. The Company has not concluded a loss is probable in any of these matters; nor is the amount of any loss reasonably estimable.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the many uncertainties associated with any potential settlement arrangement or other resolution of all of these opioid-related litigation matters, including the uncertain scope of participation by governmental entities in any potential settlement under the framework described above, the Company is not able to reasonably estimate the upper or lower ends of the range of ultimate possible loss for all opioid-related litigation matters. An adverse judgment or negotiated resolution in any of these matters could have a material adverse impact on the Company&#8217;s financial position, cash flows or liquidity, or results of operations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the Company was served with two qui tam complaints filed by the same two relators alleging violations of the federal False Claims Act, the California False Claims Act, and the California Unfair Business Practices statute based on alleged predicate violations of the Controlled Substances Act and its implementing regulations, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19-cv-2233, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State of California ex rel. Kelley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, CGC-19-576931. The complaints seek relief including treble damages, civil penalties, attorney fees, and costs in unspecified amounts. On February 16, 2021, the court in the federal action dismissed the second amended complaint with prejudice, and the relators appealed the dismissal to the U.S. Court of Appeals for the Ninth Circuit. On June 28, 2021, the court in the state action dismissed the complaint with prejudice.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">II. Other Litigation and Claims</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 5, 2018, the Company&#8217;s subsidiary, RxC Acquisition Company (d/b/a RxCrossroads), was served with a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaint filed in July 2017 in the United States District Court for the Southern District of Illinois by a relator against RxC Acquisition Company, among others, alleging that UCB, Inc. provided illegal &#8220;kickbacks&#8221; to providers, including nurse educator services and reimbursement assistance services provided through RxC Acquisition Company, in violation of the Anti-Kickback Statute, the False Claims Act, and various state false claims statutes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States ex rel. CIMZNHCA, LLC v. UCB, Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, No. 17-cv-00765. The complaint sought treble damages, civil penalties, and further relief. The United States and the states named in the complaint declined to intervene in the suit. On December 17, 2018, the United States filed a motion to dismiss the complaint in its entirety; this motion was denied on April 15, 2019. On June 7, 2019, the court denied the United States&#8217; motion for reconsideration. On July 8, 2019, the United States appealed to the United States Court of Appeals for the Seventh Circuit seeking interlocutory review of the denial of its motion for reconsideration of the denial of the motion to dismiss the complaint. On September 3, 2019, the United States District Court for the Southern District of Illinois stayed the district court proceedings pending the appeal. On August 17, 2020, the Seventh Circuit reversed the district court&#8217;s decision on the United States&#8217; motion to dismiss and remanded the case with instructions that the district court enter judgment for the defendants on the relator&#8217;s claims under the False Claims Act. The relator sought a re-hearing en banc at the Seventh Circuit, which was denied. The relator&#8217;s False Claims Act case was dismissed, with judgment entered in favor of the defendants on September 30, 2020. On February 10, 2021, the relator filed a Petition for Writ of Certiorari at the United States Supreme Court seeking review of the Seventh Circuit&#8217;s ruling; that petition was denied on June 28, 2021.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">III.&#160;Government Subpoenas and Investigations</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company receives subpoenas or requests for information from various government agencies. The Company generally responds to such subpoenas and requests in a cooperative, thorough and timely manner. These responses sometimes require time and effort and can result in considerable costs being incurred by the Company. Such subpoenas and requests can lead to the assertion of claims or the commencement of civil or criminal legal proceedings against the Company and other members of the health care industry, as well as to settlements of claims against the Company. The Company responds to these requests in the ordinary course of business. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 19, 2021, the Norwegian Competition Authority carried out an inspection of Norsk Medisinaldepot AS regarding alleged sharing of competitively sensitive information.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the United States Department of Justice served a Civil Investigative Demand on the Company seeking documents related to distribution arrangements for ophthalmology products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IV. State Opioid Statutes</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative, regulatory or industry measures to address the misuse of prescription opioid medications could affect the Company&#8217;s business in ways that it may not be able to predict. For example, in April 2018, the State of New York adopted the Opioid Stewardship Act (the &#8220;OSA&#8221;) which required the creation of an aggregate $100&#160;million annual surcharge on all manufacturers and distributors licensed to sell or distribute opioids in New York. The initial surcharge payment would have been due on January 1, 2019 for opioids sold or distributed during calendar year 2017. On July 6, 2018, the Healthcare Distribution Alliance filed a lawsuit challenging the constitutionality of the law and seeking an injunction against its enforcement. On December 19, 2018, the U.S. District Court for the Southern District of New York found the law unconstitutional and issued an injunction preventing the State of New York from enforcing the law. The State appealed that decision. On September 14, 2020, a panel of the U.S. Court of Appeals for the Second Circuit reversed the district court&#8217;s decision on procedural grounds. The Company has accrued a $50&#160;million pre-tax charge ($37&#160;million after-tax) as its estimated share of the OSA surcharge for calendar years 2017 and 2018. This OSA provision was recognized in &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Consolidated Statement of Operations for the year ended March 31, 2021 and in &#8220;Other accrued liabilities&#8221; in the Consolidated Balance Sheet as of March 31, 2021. The State of New York adopted an excise tax on sales of opioids in the State, which became effective July 1, 2019. The law adopting the excise tax made clear that the OSA does not apply to sales or distributions occurring after December 31, 2018. The Healthcare Distribution Alliance filed a petition for panel rehearing, or, in the alternative, for rehearing en banc with the U.S. Court of Appeals for the Second Circuit; that petition was denied on December 18, 2020. On February 12, 2021, the Court of Appeals for the Second Circuit granted a motion by the Healthcare Distribution Alliance to stay its mandate pending the filing and disposition of a petition for writ of certiorari before the U.S. Supreme Court. The petition was filed on May 17, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321656674152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity (Deficit)</a></td>
<td class="text">Stockholders' Equity (Deficit) <div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of the Company&#8217;s outstanding common stock is permitted one vote on proposals presented to stockholders and is entitled to share equally in any dividends declared by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;). </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 23, 2021, the Company raised its quarterly dividend from $0.42 to $0.47 per common share for dividends declared on or after such date by the Board. The Company anticipates that it will continue to pay quarterly cash dividends in the future.&#160;However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon the Company's future earnings, financial condition, capital requirements, and other factors.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Plans</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock repurchases may be made from time to time in open market transactions, privately negotiated transactions, through accelerated share repurchase (&#8220;ASR&#8221;) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company&#8217;s stock price, corporate and regulatory requirements, restrictions under the Company&#8217;s debt obligations, and other market and economic conditions.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, the Company entered into an ASR program with a third-party financial institution to repurchase $1.0&#160;billion of the Company&#8217;s common stock. Pursuant to the ASR agreement, the Company paid $1.0&#160;billion to the financial institution and received an initial delivery of 4.3 million shares in May 2021. The transaction will be completed during the second quarter of 2022, at which point the Company expects to receive additional shares. There were no share repurchases during the three months ended June 30, 2020.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Board approved an increase of $2.0 billion for the authorized share repurchase of McKesson&#8217;s common stock. The total remaining authorization outstanding for repurchases of the Company&#8217;s common stock at June 30, 2021 was $1.8 billion.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Comprehensive Income (Loss)</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.163%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.258%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments arising during period, net of income tax expense of zero and zero </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of zero and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on net investment hedges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on net investment hedges arising during period, net of income tax benefit of $6 and $22 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of zero and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on cash flow hedges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on cash flow hedges arising during period, net of income tax benefit of zero and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of zero and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain and prior service cost arising during the period, net of income tax expense of zero and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain (loss), prior service cost and transition obligation, net of income tax benefit expense of zero and zero </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other, net of income tax benefit of zero and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax benefit of $1 and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three months ended June 30, 2021 and 2020 includes net foreign currency translation adjustments of $9 million and $58 million, respectively, attributable to redeemable noncontrolling interests. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three months ended June 30, 2021 includes foreign currency losses of $22 million on the net investment hedges from the &#8364;1.7 billion&#160;Euro-denominated notes, losses of $5 million on the net investment hedges from cross-currency swaps, and losses on net investment hedges of $6 million attributable to redeemable noncontrolling interests. The three months ended June 30, 2020 include foreign currency losses of $34 million on the net investment hedges from the &#8364;1.7 billion Euro-denominated notes and losses of $51 million on the net investment hedges from cross-currency swaps. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three months ended June 30, 2021 and 2020 include net actuarial gains of zero and $3 million, respectively, which are attributable to redeemable noncontrolling interests.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Pre-tax amount was reclassified into &#8220;Cost of sales&#8221; and &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into &#8220;Income tax expense&#8221; in the Condensed Consolidated Statements of Operations.</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accumulated Other Comprehensive Income (Loss) </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three months ended June 30, 2021 are as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Losses on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,477)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,627)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three months ended June 30, 2020 are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,742)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,735)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321658082520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments of Business</a></td>
<td class="text">Segments of Business<div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing with the second quarter of 2021, the Company implemented a new segment reporting structure which resulted in four reportable segments: U.S. Pharmaceutical, RxTS, Medical-Surgical Solutions, and International. All prior segment information has been recast to reflect the Company&#8217;s new segment structure and current period presentation. The organizational structure also includes Corporate, which consists of income and expenses associated with administrative functions and projects, and the results of certain investments. The factors for determining the reportable segments included the manner in which management evaluates the performance of the Company combined with the nature of the individual business activities. The Company evaluates the performance of its operating segments on a number of measures, including revenues and operating profit before interest expense and income taxes. Assets by operating segment are not reviewed by management for the purpose of assessing performance or allocating resources.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. In addition, the segment sells financial, operational, and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing, technological, and other services.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RxTS segment unifies the solutions and services of CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation to serve biopharma and life sciences partners and patients. By combining automation and expert navigation of the healthcare ecosystem, RxTS connects pharmacies, providers, payers, and biopharma to address patients&#8217; medication access, adherence, and affordability challenges to help people get the medicine they need to live healthier lives. RxCrossroads was previously included in the former U.S. Pharmaceutical and Specialty Solutions reportable segment and CoverMyMeds, RelayHealth, and McKesson Prescription Automation were previously included in Other.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. This segment offers more than 275,000 national brand medical-surgical products as well as McKesson&#8217;s own line of products through a network of distribution centers within the United States.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International segment includes the Company&#8217;s operations in Europe and Canada, bringing together non-U.S.-based drug distribution services, specialty pharmacy, retail, and infusion care services. The Company&#8217;s operations in Europe provide distribution and services to wholesale, institutional, and retail customers in 12 European countries where it owns, partners, or franchises with retail pharmacies and operates through two businesses: Pharmaceutical Distribution and Retail Pharmacy. The Company&#8217;s Canada operations deliver vital medicines, supplies, and information technology services throughout Canada and includes Rexall Health retail pharmacies. McKesson Europe was previously reflected as the European Pharmaceutical Solutions reportable segment and McKesson Canada was previously included in Other. In the second quarter of 2022, the Company entered into an agreement to sell certain of its Europe businesses, primarily located in France, Italy, Ireland, Portugal, Belgium, and Slovenia. The sale also includes the Company&#8217;s German headquarters and wound-care business, business center in Lithuania, and an ownership stake in its joint venture in the Netherlands. Refer to Financial Note 2, &#8220;Held for Sale,&#8221; for more information.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, approximately 35% of the RxTS segment&#8217;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#8217;s total revenues, and approximately 7% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#8217;s reportable segments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three months ended June 30, 2021 and 2020 includes $23 million and $52 million, respectively, of credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the three months ended June 30, 2021 includes inventory charges totaling $164 million on certain personal protective equipment and other related products.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the three months ended June 30, 2021 includes charges of $74&#160;million related to the Company&#8217;s estimated liability for opioid-related claims, as discussed in more detail in Financial </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12</span>, &#8220;Commitments and Contingent Liabilities." Corporate expenses, net for the three months ended June 30, 2020 includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321659691608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements of McKesson include the financial statements of all wholly-owned subsidiaries and majority-owned or controlled companies. For those consolidated subsidiaries where the Company&#8217;s ownership is less than 100%, the portion of the net income or loss allocable to the noncontrolling interests is reported as &#8220;Net income attributable to noncontrolling interests&#8221; in the Condensed Consolidated Statements of Operations. All significant intercompany balances and transactions have been eliminated in consolidation including the intercompany portion of transactions with equity method investees. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers itself to control an entity if it is the majority owner of or has voting control over such entity. The Company also assesses control through means other than voting rights and determines which business entity is the primary beneficiary of the variable interest entity (&#8220;VIE&#8221;). The Company consolidates VIEs when it is determined that it is the primary beneficiary of the VIE. Investments in business entities in which the Company does not have control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. </span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;U.S.&#8221;) of America (&#8220;GAAP&#8221;) for interim financial reporting and the rules and regulations of the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and therefore do not include all information and disclosures normally included in the annual consolidated financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">To prepare the financial statements in conformity with GAAP, management must make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of these financial statements and income and expenses during the reporting period. Actual amounts may differ from these estimated amounts. The Company continues to evaluate the ongoing impacts, including the economic consequences, of the coronavirus disease 2019 (&#8220;COVID-19&#8221;) pandemic. As COVID-19 evolves, the Company&#8217;s accounting estimates and assumptions may change over time and may change materially in future periods. In the opinion of management, the unaudited condensed consolidated financial statements include all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows of McKesson for the interim periods presented.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComparabilityOfPriorYearFinancialData', window );">Results of Operations</a></td>
<td class="text">The results of operations for the three months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the entire year. These interim financial statements should be read in conjunction with the annual audited financial statements, accounting policies, and financial notes included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, previously filed with the SEC on May 12, 2021 (&#8220;2021 Annual Report&#8221;).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Period</a></td>
<td class="text">The Company&#8217;s fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text">Certain prior year amounts have been reclassified to conform to the current year presentation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, the Company adopted Accounting Standards Update (&#8220;ASU&#8221;) 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies and clarifies certain other aspects of accounting for income taxes.&#160;The adoption of this amended guidance did not have a material impact on the Company&#8217;s condensed consolidated financial statements or disclosures.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_HeldForSalePolicyTextBlock', window );">Held for Sale</a></td>
<td class="text">Assets and liabilities to be disposed of by sale (&#8220;disposal groups&#8221;) are reclassified into &#8220;held for sale&#8221; if their carrying amounts are principally expected to be recovered through a sale transaction rather than through continuing use. The reclassification occurs when the disposal group is available for immediate sale and the sale is highly probable. These criteria are generally met when an agreement to sell exists, or management has committed to a plan to sell the assets within one year. Disposal groups are measured at the lower of carrying amount or fair value less costs to sell and are not depreciated or amortized. The fair value of a disposal group, less any costs to sell, is assessed each reporting period it remains classified as held for sale and any remeasurement to the lower of carrying value or fair value less cost to sell is reported as an adjustment to the carrying value of the disposal group.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to commitments and obligations incurred in the ordinary course of business, the Company is subject to a variety of claims and legal proceedings, including claims from customers and vendors, pending and potential legal actions for damages, governmental investigations, and other matters. The Company and its affiliates are parties to the legal claims and proceedings described below and in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/927653/000092765321000039/mck-20210331.htm#i08f9baf810c0412e93ea6effc6d22995_214" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Financial Note 19 to the Company&#8217;s 2021 Annual Report</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which disclosure is incorporated in this footnote by this reference. The Company is vigorously defending itself against those claims and in those proceedings. Significant developments in those matters are described below. If the Company is unsuccessful in defending, or if it determines to settle, any of these matters, it may be required to pay substantial sums, be subject to injunction and/or be forced to change how it operates its business, which could have a material adverse impact on its financial position or results of operations.</span>Unless otherwise stated, the Company is unable to reasonably estimate the loss or a range of possible loss for the matters described below. Often, the Company is unable to determine that a loss is probable, or to reasonably estimate the amount of loss or a range of loss, for a claim because of the limited information available and the potential effects of future events and decisions by third parties, such as courts and regulators, that will determine the ultimate resolution of the claim. Many of the matters described are at preliminary stages, raise novel theories of liability or seek an indeterminate amount of damages. It is not uncommon for claims to remain unresolved over many years. The Company reviews loss contingencies at least quarterly to determine whether the likelihood of loss has changed and whether it can make a reasonable estimate of the loss or range of loss. When the Company determines that a loss from a claim is probable and reasonably estimable, it records a liability for an estimated amount. The Company also provides disclosure when it is reasonably possible that a loss may be incurred or when it is reasonably possible that the amount of a loss will exceed its recorded liability.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_HeldForSalePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Held for Sale</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_HeldForSalePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123368208&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComparabilityOfPriorYearFinancialData">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reporting any exceptions to the  comparability of prior year financial data with data shown for the most recent accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124429468&amp;loc=d3e288-107754<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComparabilityOfPriorYearFinancialData</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321657982936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring, Impairment, and Related Costs</a></td>
<td class="text"><div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three months ended June 30, 2021 consisted of the following: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:20.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.271%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.091%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.699%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.249%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Costs primarily relate to the transition to the partial remote work model described above.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs related to the transition to the partial remote work model and U.K. operating model and cost optimization efforts described above, as well as costs for optimization programs in Canada.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily consist of accruals for costs to be incurred without future economic benefits, project consulting fees, and other exit costs expensed as incurred.</span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring, impairment, and related charges during the three months ended June 30, 2020 consisted of the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.194%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance and employee-related costs, net </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exit and other-related costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments and accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with the U.K. operating model and cost optimization efforts described above, and an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Primarily represents costs associated with an operating model and cost optimization initiative which was substantially completed in the year ended March 31, 2021.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Exit and other-related costs primarily include project consulting fees.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring and Asset Impairment Charges</a></td>
<td class="text"><div style="margin-bottom:1pt;margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to the restructuring liabilities associated with the Company&#8217;s restructuring initiatives for the three months ended June 30, 2021: </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.263%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring, impairment, and related charges </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of March 31, 2021, the total reserve balance was $151 million, of which $99 million was recorded in &#8220;Other accrued liabilities&#8221; and $52 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet. </span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of June 30, 2021, the total reserve balance was $177 million, of which $127 million was recorded in &#8220;Other accrued liabilities&#8221; and $50 million was recorded in &#8220;Other non-current liabilities&#8221; in the Condensed Consolidated Balance Sheet.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321658128712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestAbstract', window );"><strong>Noncontrolling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock', window );">Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2021 were as follows:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of McKesson Europe redeemable noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in redeemable noncontrolling interests and noncontrolling interests for the three months ended June 30, 2020 were as follows:</span></div><div style="text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable Noncontrolling Interests</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of recurring compensation to other accrued liabilities</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercises of Put Right</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2020</span></td><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,414&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4M<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591554-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321656545512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of computations for basic and diluted earnings per common share</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The computations for basic and diluted earnings or loss per common share are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.239%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions, except per share amounts)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations attributable to McKesson Corporation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to McKesson Corporation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (loss) per common share attributable to McKesson: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.07&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Continuing operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discontinued operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Includes dilutive effect from restricted stock units, performance-based restricted stock units, and performance-based stock units.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Certain computations may reflect rounding adjustments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321660141960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of changes in the carrying amount of goodwill</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the carrying amount of goodwill were as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:26.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.523%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.716%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.129%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Pharmaceutical</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prescription Technology Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, March&#160;31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,493&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance, June 30, 2021</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,970&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,555&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,520&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of information regarding intangible assets</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding intangible assets is as follows:</span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.022%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.119%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Amortization<br/>Period<br/>(Years)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,747&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,329)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(530)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,880)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,797&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,646&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,768)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,878&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321658132616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Long-Term Debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consisted of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">U.S. Dollar notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.70% Notes due December 15, 2022</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85% Notes due March 15, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80% Notes due March 15, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90% Notes due December 3, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.65% Debentures due March 1, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.95% Notes due February 16, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75% Notes due May 30, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.00% Notes due March 1, 2041</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.88% Notes due March 15, 2044</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Foreign currency notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.63% Euro Notes due August 17, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50% Euro Notes due November 17, 2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63% Euro Notes due October 30, 2026 </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.13% Sterling Notes due February 17, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease and other obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,424&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,406&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">These notes are unsecured and unsubordinated obligations of the Company.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these notes is payable semi-annually.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Interest on these foreign currency notes is payable annually.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321660759224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of information regarding the fair value of derivatives on a gross basis</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding the fair value of derivatives on a gross basis is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.481%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.033%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.672%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.817%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.206%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet <br/>Caption</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value of <br/>Derivative</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. Dollar Notional</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated for hedge accounting</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other/Other accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swaps (non-current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets/liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swaps (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated for hedge accounting</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts (current)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321655450136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s long-term debt is recorded at amortized cost. The carrying value and fair value of the Company&#8217;s long-term debt was as follows:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:55.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.752%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.903%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Carrying Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, including current maturities</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,176&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,148&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,785&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321660376968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock', window );">Schedule of Estimated Accrual Liability</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company&#8217;s estimated accrued liability for opioid-related claims of governmental entities, including the $482&#160;million initial payment under the proposed settlement agreement, is as follows as of June 30, 2021:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current litigation liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term litigation liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total litigation liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,141&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">This amount, recorded in &#8220;Other accrued liabilities&#8221; on the Condensed Consolidated Balance Sheet, is the amount estimated to be paid prior to June 30, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14472-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14453-108349<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14394-108349<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12053-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321755692376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of information regarding other comprehensive income (loss) including noncontrolling and redeemable noncontrolling interests, net of tax, by component</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding Other comprehensive income (loss) including noncontrolling interests and redeemable noncontrolling interests, net of tax, by component is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.163%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.258%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#160;(In millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments arising during period, net of income tax expense of zero and zero </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of zero and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on net investment hedges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on net investment hedges arising during period, net of income tax benefit of $6 and $22 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of zero and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on cash flow hedges</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized losses on cash flow hedges arising during period, net of income tax benefit of zero and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax expense of zero and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in retirement-related benefit plans </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net actuarial gain and prior service cost arising during the period, net of income tax expense of zero and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of actuarial gain (loss), prior service cost and transition obligation, net of income tax benefit expense of zero and zero </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments and other, net of income tax benefit of zero and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to income statement, net of income tax benefit of $1 and zero</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-18pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of tax</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Foreign currency translation adjustments primarily result from the conversion of non-U.S. dollar financial statements of the Company&#8217;s foreign subsidiary, McKesson Europe, and its operations in Canada into the Company&#8217;s reporting currency, U.S. dollars.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three months ended June 30, 2021 and 2020 includes net foreign currency translation adjustments of $9 million and $58 million, respectively, attributable to redeemable noncontrolling interests. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three months ended June 30, 2021 includes foreign currency losses of $22 million on the net investment hedges from the &#8364;1.7 billion&#160;Euro-denominated notes, losses of $5 million on the net investment hedges from cross-currency swaps, and losses on net investment hedges of $6 million attributable to redeemable noncontrolling interests. The three months ended June 30, 2020 include foreign currency losses of $34 million on the net investment hedges from the &#8364;1.7 billion Euro-denominated notes and losses of $51 million on the net investment hedges from cross-currency swaps. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The three months ended June 30, 2021 and 2020 include net actuarial gains of zero and $3 million, respectively, which are attributable to redeemable noncontrolling interests.</span></div><div style="margin-bottom:12pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Pre-tax amount was reclassified into &#8220;Cost of sales&#8221; and &#8220;Selling, distribution, general, and administrative expenses&#8221; in the Condensed Consolidated Statements of Operations. The related tax expense was reclassified into &#8220;Income tax expense&#8221; in the Condensed Consolidated Statements of Operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three months ended June 30, 2021 are as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Losses on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,480)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,477)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,627)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding changes in the Company&#8217;s Accumulated other comprehensive income (loss) by component for the three months ended June 30, 2020 are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.087%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Foreign Currency Translation Adjustments, Net of Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Net Investment Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains (Losses) on Cash Flow Hedges, <br/>Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,780)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to earnings and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) attributable to McKesson</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at June 30, 2020</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,742)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,735)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321658221992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial information relating to the Company&#8217;s reportable operating segments and reconciliations to the condensed consolidated totals is as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:77.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.843%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30, </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,801&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,674&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,679&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Pharmaceutical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">682&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Technology Solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical-Surgical Solutions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate expenses, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from continuing operations before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Revenues from services on a disaggregated basis represent less than 1% of the U.S. Pharmaceutical segment&#8217;s total revenues, approximately 35% of the RxTS segment&#8217;s total revenues, less than 2% of the Medical-Surgical Solutions segment&#8217;s total revenues, and approximately 7% of the International segment&#8217;s total revenues. The International segment reflects foreign revenues. Revenues for the remaining three reportable segments are domestic.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Segment operating profit includes gross profit, net of total operating expenses, as well as other income, net, for the Company&#8217;s reportable segments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s U.S. Pharmaceutical segment&#8217;s operating profit for the three months ended June 30, 2021 and 2020 includes $23 million and $52 million, respectively, of credits related to the last-in, first-out (&#8220;LIFO&#8221;) method of accounting for inventories. </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The Company&#8217;s Medical-Surgical Solutions segment&#8217;s operating profit for the three months ended June 30, 2021 includes inventory charges totaling $164 million on certain personal protective equipment and other related products.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Corporate expenses, net for the three months ended June 30, 2021 includes charges of $74&#160;million related to the Company&#8217;s estimated liability for opioid-related claims, as discussed in more detail in Financial </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 12</span>, &#8220;Commitments and Contingent Liabilities." Corporate expenses, net for the three months ended June 30, 2020 includes a net gain of $131 million recorded in connection with insurance proceeds received during the first quarter of 2021 from the settlement of the shareholder derivative action related to the Company&#8217;s controlled substances monitoring program.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321661465432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies - Narrative (Details) - segment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321659668200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held for Sale - Narrative (Details)<br> $ in Millions, &#8364; in Billions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 05, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 05, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Held-for-sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Assets held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember', window );">European Businesses (Disposal Group) | Held-for-sale | Expected | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected', window );">Charge to remeasure to lower of carrying amount or fair value less costs to sell</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember', window );">European Businesses (Disposal Group) | Held-for-sale | Expected | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected', window );">Charge to remeasure to lower of carrying amount or fair value less costs to sell</a></td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember', window );">European Businesses (Disposal Group) | Held-for-sale | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected', window );">Purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">&#8364; 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Expected</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down, Expected</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2473-110228<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mck_EuropeanBusinessesDisposalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321659251080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringSettlementAndImpairmentProvisions', window );">Restructuring, impairment, and related charges recognized</a></td>
<td class="nump">$ 158<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Net restructuring, impairment, and related charges recognized</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Net restructuring, impairment, and related charges recognized</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Pre-tax charges recorded to-date</a></td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember', window );">Restructuring Plan - Remote Work Transitioning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Net restructuring, impairment, and related charges recognized</a></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember', window );">Restructuring Plan - Remote Work Transitioning | Minimum | Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember', window );">Restructuring Plan - Remote Work Transitioning | Maximum | Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected total pre-tax charges</a></td>
<td class="nump">$ 280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringSettlementAndImpairmentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restructuring charges, remediation cost, and asset impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringSettlementAndImpairmentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mck_RestructuringPlanRemoteWorkTransitioningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321663064264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">104<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance and employee-related costs, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessExitCosts1', window );">Exit and other-related costs</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation', window );">Asset impairments and accelerated depreciation</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Total</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AssetImpairmentChargesIncludingAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Asset Impairment Charges, Including Accelerated Depreciation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AssetImpairmentChargesIncludingAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessExitCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessExitCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321756332488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring, impairment, and related charges</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Non-cash charges</a></td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Cash payments</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment', window );">Other</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning balance</a></td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending balance</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAndOtherAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAndOtherAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321661352872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense (benefit) related to continuing operations</a></td>
<td class="nump">$ 26<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Reported income tax expense (benefit) rates (percent)</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="nump">23.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would reduce income tax expense and the effective tax rate</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Discrete tax benefit recognized</a></td>
<td class="nump">$ 97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321660163784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 12, 2021 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 19, 2018 </div>
<div>&#8364; / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePrice', window );">Put right redemption price per share (in euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 23.50<span></span>
</td>
<td class="nump">&#8364; 22.99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_PutRightValueInterestRateSpread', window );">Put right value, interest rate spread (as a percent)</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestsPutRightExercisePriceIncrease', window );">Increase in Put Amount (in Euros per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments for purchase shares of McKesson Europe</a></td>
<td class="nump">$ 1,031,000,000<span></span>
</td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Associated increase in Company's ownership interest on its equity</a></td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying value of redeemable noncontrolling interests</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,271,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">47,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Decrease in noncontrolling interest</a></td>
<td class="nump">983,000,000<span></span>
</td>
<td class="nump">49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying value of redeemable noncontrolling interests</a></td>
<td class="nump">7,000,000<span></span>
</td>
<td class="nump">1,414,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,271,000,000<span></span>
</td>
<td class="nump">$ 1,402,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional Paid-in Capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Associated increase in Company's ownership interest on its equity</a></td>
<td class="nump">178,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests', window );">Annual recurring dividend (in euro per share) | &#8364; / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0.83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember', window );">McKesson Europe Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest', window );">Payments for purchase shares of McKesson Europe</a></td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="nump">$ 49,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased', window );">Shares purchased (shares) | shares</a></td>
<td class="nump">34.5<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Carrying value of redeemable noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue', window );">Maximum redemption value of redeemable noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership percentage (as a percent)</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember', window );">Vantage and ClarusOne Sourcing Services LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestLineItems', window );"><strong>Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Recurring Compensation Per Share to Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestsPutRightExercisePriceIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests, Put Right, Exercise Price Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestsPutRightExercisePriceIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_PutRightValueInterestRateSpread">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Put Right Value, Interest Rate Spread</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_PutRightValueInterestRateSpread</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable Noncontrolling Interests, Maximum Redemption Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period for redemption of redeemable noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_MckessonEuropeSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mck_VantageandClarusOneSourcingServicesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321664636600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Beginning balance</a></td>
<td class="nump">1,271<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ending balance</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Beginning balance</a></td>
<td class="nump">196<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Ending balance</a></td>
<td class="nump">484<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="nump">287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember', window );">Redeemable Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInMinorityInterestRollForward', window );"><strong>Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Noncontrolling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Beginning balance</a></td>
<td class="nump">1,271<span></span>
</td>
<td class="nump">1,402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other comprehensive income (loss)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationofTemporaryEquitytoLiability', window );">Reclassification of recurring compensation to other accrued liabilities</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Payments to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight', window );">Exercises of Put Right</a></td>
<td class="num">(983)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest', window );">Reclassification of McKesson Europe redeemable noncontrolling interests</a></td>
<td class="num">(287)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther', window );">Other</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount', window );">Ending balance</a></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 1,414<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestDecreaseForExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease for Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestDecreaseForExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NoncontrollingInterestIncreaseDecreaseDuetoOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase (Decrease) Due to Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NoncontrollingInterestIncreaseDecreaseDuetoOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_ReclassificationofTemporaryEquitytoLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification of Temporary Equity to Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_ReclassificationofTemporaryEquitytoLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInMinorityInterestRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInMinorityInterestRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_RedeemableNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321661337368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Common Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedLineItems', window );"><strong>Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income from continuing operations</a></td>
<td class="nump">$ 536<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Income from continuing operations attributable to McKesson Corporation</a></td>
<td class="nump">489<span></span>
</td>
<td class="nump">445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations, net of tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to McKesson Corporation</a></td>
<td class="nump">$ 486<span></span>
</td>
<td class="nump">$ 444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">156.2<span></span>
</td>
<td class="nump">162.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">158.1<span></span>
</td>
<td class="nump">163.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>Diluted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">$ 3.09<span></span>
</td>
<td class="nump">$ 2.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.02)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Total (in dollars per share)</a></td>
<td class="nump">3.07<span></span>
</td>
<td class="nump">2.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Basic</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Continuing operations (in dollars per share)</a></td>
<td class="nump">3.13<span></span>
</td>
<td class="nump">2.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Discontinued operations (in dollars per share)</a></td>
<td class="num">(0.02)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Total (in dollars per share)</a></td>
<td class="nump">$ 3.11<span></span>
</td>
<td class="nump">$ 2.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities (shares)</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Restricted stock units (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Restricted stock units (in shares)</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321664494712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 9,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">9,520<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">3,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">3,970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">1,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">1,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">1,535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation adjustments, net</a></td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 1,555<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321664645240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 6,677<span></span>
</td>
<td class="nump">$ 6,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(3,880)<span></span>
</td>
<td class="num">(3,768)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 2,797<span></span>
</td>
<td class="nump">2,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 3,747<span></span>
</td>
<td class="nump">3,739<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,329)<span></span>
</td>
<td class="num">(2,269)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,418<span></span>
</td>
<td class="nump">1,470<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember', window );">Service agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,088<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(530)<span></span>
</td>
<td class="num">(513)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 558<span></span>
</td>
<td class="nump">568<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember', window );">Pharmacy licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">23 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(252)<span></span>
</td>
<td class="num">(244)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 251<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 934<span></span>
</td>
<td class="nump">925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(412)<span></span>
</td>
<td class="num">(394)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 522<span></span>
</td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(127)<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted- Average Remaining Amortization Period (Years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 255<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(230)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ServiceAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mck_PharmacyLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321664629880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of intangible assets</a></td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Estimated annual amortization expense, remainder of 2022</a></td>
<td class="nump">279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated annual amortization expense, 2023</a></td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated annual amortization expense, 2024</a></td>
<td class="nump">261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated annual amortization expense, 2025</a></td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated annual amortization expense, 2026</a></td>
<td class="nump">223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Estimated annual amortization expense, thereafter</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321662069864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Financing Activities - Schedule of Long-Term Debt (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Lease and other obligations</a></td>
<td class="nump">$ 270<span></span>
</td>
<td class="nump">$ 270<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Total debt</a></td>
<td class="nump">7,176<span></span>
</td>
<td class="nump">7,148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less: Current portion</a></td>
<td class="nump">752<span></span>
</td>
<td class="nump">742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">$ 6,424<span></span>
</td>
<td class="nump">6,406<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member', window );">2.70% Notes due December 15, 2022 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member', window );">2.85% Notes due March 15, 2023 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member', window );">3.80% Notes due March 15, 2024 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member', window );">0.90% Notes due December 3, 2025 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member', window );">7.65% Debentures due March 1, 2027 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member', window );">3.95% Notes due February 16, 2028 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member', window );">4.75% Notes due May 30, 2029 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member', window );">6.00% Notes due March 1, 2041 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 282<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member', window );">4.88% Notes due March 15, 2044 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 411<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member', window );">0.63% Euro Notes due August 17, 2021 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 711<span></span>
</td>
<td class="nump">704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member', window );">1.50% Euro Notes due November 17, 2025 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 708<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member', window );">1.63% Euro Notes due October 30, 2026 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">1.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 592<span></span>
</td>
<td class="nump">587<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member', window );">3.13% Sterling Notes due February 17, 2029 | Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding</a></td>
<td class="nump">$ 635<span></span>
</td>
<td class="nump">$ 627<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A270NotesDueDecember152022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A090NotesDueDecember32025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A150EuroNotesDueNovember172025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A163EuroNotesDueOctober302026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A313SterlingNotesDueFebruary172029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321658748648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Financing Activities - Long-Term Debt Narrative (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>Jul. 23, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 17, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 17, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,176<span></span>
</td>
<td class="nump">$ 7,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 752<span></span>
</td>
<td class="nump">$ 742<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member', window );">0.63% Euro Notes due August 17, 2021 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member', window );">0.63% Euro Notes due August 17, 2021 | Term Loan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="nump">0.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt principal redeemed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 709<span></span>
</td>
<td class="nump">&#8364; 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member', window );">2.85% Notes due March 15, 2023 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member', window );">2.85% Notes due March 15, 2023 | Term Loan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member', window );">3.80% Notes due March 15, 2024 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member', window );">3.80% Notes due March 15, 2024 | Term Loan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member', window );">7.65% Debentures due March 1, 2027 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member', window );">7.65% Debentures due March 1, 2027 | Term Loan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">7.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member', window );">3.95% Notes due February 16, 2028 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member', window );">3.95% Notes due February 16, 2028 | Term Loan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member', window );">4.75% Notes due May 30, 2029 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member', window );">4.75% Notes due May 30, 2029 | Term Loan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member', window );">6.00% Notes due March 1, 2041 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member', window );">6.00% Notes due March 1, 2041 | Term Loan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member', window );">4.88% Notes due March 15, 2044 | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member', window );">4.88% Notes due March 15, 2044 | Term Loan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on debt instrument (percent)</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember', window );">Tender Offer Notes | Term Loan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt principal redeemed</a></td>
<td class="nump">$ 922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Aggregate consideration of debt redeemed</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price percentage of principal (percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Premiums</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.13,16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A063EuroNotesDueAugust172021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A285NotesDueMarch152023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A380NotesDueMarch152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A765DebenturesDueMarch12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A395NotesDueFebruary162028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A475NotesDueMay302029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A600NotesDueMarch12041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A488NotesDueMarch152044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_TenderOfferNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321754430808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Revolving Credit Facilities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases', window );">Committed balance</a></td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity', window );">Uncommitted balance</a></td>
<td class="nump">118,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revolving Credit Facility | The 2020 Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Syndicated senior unsecured revolving credit facility term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings under facility</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amounts outstanding under facility</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Revolving Credit Facility | Canadian Dollar, British Pound Sterling, and Euros Sublimit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Syndicated senior unsecured revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321660903064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Financing Activities - Commercial Paper (Details) - Commercial Paper - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Outstanding notes (up to)</a></td>
<td class="nump">$ 4,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper', window );">Proceeds from issuance of commercial paper</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 5,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfCommercialPaper', window );">Repayments of commercial paper</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 5,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermCommercialPaperCurrent', window );">Commercial paper</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermCommercialPaperCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the current portion of long-term unsecured obligations issued by corporations and other borrowers to investors (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermCommercialPaperCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowing by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow due to repaying amounts borrowed by issuing commercial paper.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321660884584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pension Benefits - Narrative (Details) - Pension Plan - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic pension expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Cash contributions to the plans</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedPercentage', window );">Percentage threshold of greater of projected benefit obligation or market value of assets (percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of plan assets to benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321754780536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Hedging Activities - Narrative (Details)<br> &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="3"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Apr. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 27, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>GBP (&#163;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains (losses) from cash flow hedges recorded within other comprehensive income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (5,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) from net investment hedges recorded within other comprehensive income</a></td>
<td class="num">(22,000,000)<span></span>
</td>
<td class="num">(34,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember', window );">Forward contracts to hedge Euro against British Pound cash flows | Derivatives not designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="nump">54,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Derivatives used in net investment hedge, gains (losses) gross</a></td>
<td class="num">(5,000,000)<span></span>
</td>
<td class="num">(51,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | November 2018 cross currency swaps | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Gains (losses) from cash flow hedges recorded within other comprehensive income</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">$ (5,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency swap | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward starting interest rate swaps | Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional values of financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="nump">&#8364; 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Term Loan | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember', window );">British Pound Sterling Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_A2025NotesMember', window );">2025 Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mck_November2018CrossCurrencySwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mck_November2018CrossCurrencySwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_A2025NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_A2025NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321659479176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Hedging Activities - Derivative Instruments Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Prepaid expenses and other/Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">895<span></span>
</td>
<td class="nump">826<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Cross currency swap | Non-current Asset / Liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">2,594<span></span>
</td>
<td class="nump">2,663<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Forward starting interest rate swaps | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">711<span></span>
</td>
<td class="nump">704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting | Foreign Exchange Contract | Prepaid expenses and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">U.S. Dollar notional amount, asset</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated for hedge accounting | Foreign Exchange Contract | Other accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesFairValueLineItems', window );"><strong>Derivatives, Fair Value [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Fair value of derivative, asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Fair value of derivative, liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityNotionalAmount', window );">U.S. Dollar, notional amount, liability</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesFairValueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesFairValueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_CurrentAssetLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=mck_NoncurrentAssetLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=mck_NoncurrentAssetLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321659724088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Fair value, inputs, level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Investments in money market funds</a></td>
<td class="nump">$ 521,000,000<span></span>
</td>
<td class="nump">$ 1,600,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Fair value, inputs, level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying amount of liabilities</a></td>
<td class="nump">7,176,000,000<span></span>
</td>
<td class="nump">7,148,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Estimated fair values of liabilities</a></td>
<td class="nump">7,865,000,000<span></span>
</td>
<td class="nump">7,785,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember', window );">Nonrecurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities measured at fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsNonrecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321665194632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 21, 2021 </div>
<div>USD ($) </div>
<div>distributor</div>
</th>
<th class="th">
<div>Jul. 20, 2021 </div>
<div>USD ($) </div>
<div>distributor</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>case </div>
<div>state </div>
<div>stateAttorney</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,000,000<span></span>
</td>
<td class="nump">$ 8,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax', window );">After-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,000,000<span></span>
</td>
<td class="nump">$ 6,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Total litigation liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,141,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | State of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax', window );">After-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation | State and local governmental entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax', window );">After-tax expenses related to estimated litigation liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_StateOpioidStatutesMember', window );">State Opioid Statutes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids', window );">Aggregate annual surcharge on licensed manufacturers and distributors of opioids</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Total litigation liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyAccrualAfterTax', window );">After-tax accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opioid Litigation | Governmental entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada | National Prescription Opioid Litigation | An individual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStates', window );">Number of states in which court cases are pending | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofStateAttorneyGenerals', window );">Number of attorney generals that have filed claims | stateAttorney</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts', window );">Number of cases selected for remand to other federal courts | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | National Prescription Opioid Litigation | Expected</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Expected settlement payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 482,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | National Prescription Opioid Litigation | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfOtherDefendants', window );">Number of other national distributors named in suit | distributor</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfDefendants', window );">Number of distributors | distributor</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="nump">$ 7,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company</a></td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment', window );">Portion of settlement award to be used by state and local government for remediation (percent)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | National Prescription Opioid Litigation | Subsequent Event | State of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencyNumberOfOtherDefendants', window );">Number of other national distributors named in suit | distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward', window );">Portion of settlement to be paid by the Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Complaints filed against the entity | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending | Three Largest U.S. Pharmaceutical Distributors | National Prescription Opioid Litigation | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Award payable under proposed framework</a></td>
<td class="nump">$ 21,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod', window );">Period over which award would be payable under proposed framework</a></td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Award Amount To Be Used by State and Local Government</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, After Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Accrual, Period Increase (Decrease), Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberOfOtherDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Other Defendants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberOfOtherDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStateAttorneyGenerals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of State Attorney Generals</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStateAttorneyGenerals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencyNumberofStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencyNumberofStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_LossContingencySettlementAgreementAwardPaymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Settlement Agreement, Award Payment Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_LossContingencySettlementAgreementAwardPaymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of defendants named in a legal action.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateOfNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateOfNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_StateAndLocalGovernmentalEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_StateAndLocalGovernmentalEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_StateOpioidStatutesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_StateOpioidStatutesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_GovernmentalEntitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_GovernmentalEntitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=mck_IndividualClaimantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=mck_IndividualClaimantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mck_ThreeLargestU.S.PharmaceuticalDistributorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321768727720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingent Liabilities - Estimated Accrual Liability (Details) - National Prescription Opioid Litigation<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueCurrent', window );">Current litigation liabilities</a></td>
<td class="nump">$ 545<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent', window );">Long-term litigation liabilities</a></td>
<td class="nump">7,596<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Total litigation liabilities</a></td>
<td class="nump">$ 8,141<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321661279720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 23, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jul. 22, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare', window );">Number of votes per share of common stock permitted on proposals presented to stockholders (vote) | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Share repurchases (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased', window );">Approved increase to the authorized share repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Authorized amount available for future repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember', window );">Accelerated Share Repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesLineItems', window );"><strong>Accelerated Share Repurchases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Shares repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Share repurchases (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CommonStockVotingRightsNumberofVotesPerCommonShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number of Votes Per Common Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CommonStockVotingRightsNumberofVotesPerCommonShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Additional Amount Authorized to be Repurchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mck_AcceleratedShareRepurchaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321659172984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)<br> &#8364; in Millions, &#163; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>GBP (&#163;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax', window );">Foreign currency translation adjustments, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax', window );">Reclassified to income statement, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Unrealized gains (loss) on cash flow hedges arising during period, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect', window );">Net actuarial loss and prior service cost arising during the period, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax', window );">Amortization of actuarial (gain) loss and prior service costs, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax', window );">Foreign currency translation adjustments and other, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax', window );">Net actuarial gain (losses) attributable to redeemable noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest', window );">Translation gain (loss) attributable to redeemable noncontrolling interest</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Losses on Net Investment Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Unrealized gains (losses) on net investment hedges arising during period, tax</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassified to income statement, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) from net investment hedges recorded within other comprehensive income</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassified to income statement, tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember', window );">Net actuarial loss and prior servicecost arising during the period, net of income tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember', window );">Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember', window );">Foreign currency translation adjustments and other, net of income tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Changes in retirement-related benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassified to income statement, net of income tax expense</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Reclassified to income statement, tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember', window );">Euro Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember', window );">British Pound Sterling Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#163;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#163; 450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember', window );">Net Investment Hedging | Euro Denominated Notes | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt outstanding | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,700<span></span>
</td>
<td class="nump">&#8364; 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Gain (loss) from net investment hedges recorded within other comprehensive income</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivatives designated for hedge accounting | Net Investment Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax', window );">Derivatives used in net investment hedge, gains (losses) gross</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="num">$ (51)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income Translation Impact On Pension Plans, Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_EuroDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mck_BritishPoundSterlingDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321660670088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">$ 175<span></span>
</td>
<td class="nump">$ 5,309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">14<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(45)<span></span>
</td>
<td class="nump">5,653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,480)<span></span>
</td>
<td class="num">(1,703)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">23<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="num">(170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,627)<span></span>
</td>
<td class="num">(1,735)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign Currency Translation Adjustments, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,361)<span></span>
</td>
<td class="num">(1,780)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">34<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="num">(158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(1,477)<span></span>
</td>
<td class="num">(1,742)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Losses on Net Investment Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">(57)<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember', window );">Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember', window );">Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>AOCI Attributable to Parent, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(96)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to earnings and other</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Less: amounts attributable to noncontrolling and redeemable noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) attributable to McKesson</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight', window );">Exercise of put right by noncontrolling shareholders of McKesson Europe AG</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance</a></td>
<td class="num">$ (106)<span></span>
</td>
<td class="num">$ (112)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Exercise of Put Right</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140321756331432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business (Details)<br> product in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>segment </div>
<div>product </div>
<div>business_operation </div>
<div>country</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>product </div>
<div>segment </div>
<div>business_operation </div>
<div>country</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 62,674.0<span></span>
</td>
<td class="nump">$ 55,679.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit</a></td>
<td class="nump">568.0<span></span>
</td>
<td class="nump">678.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_CorporateOperatingExpenseandOtherIncomeNet', window );">Corporate income (expenses), net</a></td>
<td class="num">(303.0)<span></span>
</td>
<td class="num">(68.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Interest expense</a></td>
<td class="num">(49.0)<span></span>
</td>
<td class="num">(60.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income from continuing operations before income taxes</a></td>
<td class="nump">562.0<span></span>
</td>
<td class="nump">645.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Pre-tax credits related to LIFO accounting</a></td>
<td class="nump">23.0<span></span>
</td>
<td class="nump">52.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Net gain on settlement proceeds</a></td>
<td class="num">(74.0)<span></span>
</td>
<td class="nump">131.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember', window );">National Prescription Opioid Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease', window );">Pre-tax expenses related to estimated litigation liability</a></td>
<td class="nump">74.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,100.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit</a></td>
<td class="nump">914.0<span></span>
</td>
<td class="nump">773.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=mck_ShareholderDerivativeActionMember', window );">Shareholder derivative action</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Net gain on settlement proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember', window );">U.S. Pharmaceutical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">50,019.0<span></span>
</td>
<td class="nump">44,670.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit</a></td>
<td class="nump">$ 682.0<span></span>
</td>
<td class="nump">613.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLIFOReservePeriodCharge', window );">Pre-tax credits related to LIFO accounting</a></td>
<td class="nump">$ 23.0<span></span>
</td>
<td class="nump">52.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember', window );">Prescription Technology Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">881.0<span></span>
</td>
<td class="nump">656.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit</a></td>
<td class="nump">$ 104.0<span></span>
</td>
<td class="nump">68.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 2,528.0<span></span>
</td>
<td class="nump">1,801.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit</a></td>
<td class="nump">$ 75.0<span></span>
</td>
<td class="nump">89.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory impairments and excess inventory</a></td>
<td class="nump">$ 164.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember', window );">Medical-Surgical Solutions | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfNationalBrandMedicalSurgicalProducts', window );">Number of national brand medical-surgical products offered (more than) | product</a></td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Segment revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 9,246.0<span></span>
</td>
<td class="nump">8,552.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLossAbstract', window );"><strong>Segment operating profit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating profit</a></td>
<td class="nump">$ 53.0<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_RevenueDerivedFromServicesPercentage', window );">Revenue derived from services, percentage (less than)</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember', window );">International | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfCountriesInWhichEntityOperates', window );">Number of countries in which entity segment operates | country</a></td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_mck_NumberOfBusinessOperations', window );">Number of business operations | business_operation</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_CorporateOperatingExpenseandOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corporate Operating Expense and Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_CorporateOperatingExpenseandOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfBusinessOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Business Operations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfBusinessOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_NumberOfNationalBrandMedicalSurgicalProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of National Brand Medical-Surgical Products</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_NumberOfNationalBrandMedicalSurgicalProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mck_RevenueDerivedFromServicesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue Derived From Services, Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mck_RevenueDerivedFromServicesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mck_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLIFOReservePeriodCharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e99989-122729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLIFOReservePeriodCharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfCountriesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of countries in which the entity operates as of balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfCountriesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mck_ShareholderDerivativeActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mck_ShareholderDerivativeActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_PrescriptionTechnologySolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_MedicalSurgicalSolutionsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mck_InternationalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>71
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MEL5R7+&CQ"I? GL02HDXWUQR%G"I+X#S<P%]N=W1-R@718?_ U!+ P04
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M0E-O8H<)M8\HC0!]7PFAWR;&0=F0#O\%4$L#!!0    ( (*-!%.4J[M[N@8
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M$<6=H9@HGIEC]Y$K.,3-,(9[%A': /9GG*O51)_DU<UM^ ]02P,$%     @
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M?<.S9?E"RV/&>;8H+^<L$(>[!(C?G[*,;V[D.S+;-_K._@102P,$%     @
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M\/-5GY"+WO-Q&&R;9)P<;#Z ZA] ]8.^3K+_PDJ%Y%854@*R.Q5ERG.F;TH
MG-)J@W85R_22 0:25/'RJ4EAKCBKS@.1&1Q #(*1N6; 8RFGFAU<L6E&]X_\
M'D6MT-@FP[X[,L,#J&$0U*004O%_O:"&UA-C,FJA<M@DV UK=( U"L*Z$>53
M-P?^S!"M*KVDBBWE4K]!E&ZH?&+.C![92**DA=:V\81P?, Z/O%>UTQ*0*KH
MJQO6V'HD&;10V29XY(851X8YHR"P*8#BL.(A@D*O.X#XPM4&Y;1275Z>H367
M< 7:"<O^&4(KY!LJF-J(S$F7D86QB]O)ZS+J>Q9#?*0!<9A41-FM<]3D9LY
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M297N;'KOMZ^IC^>"]17>1OE7;?/9BXN)*KJ8?-,+PX/&N/Q7?^SS<"#P;/&
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MR;=RU5S[A/#D9TT:],T'\+WR/@T/;&#\OX?KOP!02P,$%     @ @HT$4Q!
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M"6JGMU9LPY-J33$NF65*)V?>Y_-SK^?&;Q_:T0I[V[#)(; 90&06YO @.:*
M[=C17%S4FQ :5N]3-B\ @S^^Q>)^HSJKEX'AS>KP,#T9A9S:)?9N.W2]_&*Q
M#!I[HF\+@65"+%I!?#T4B...4$3#\V\4B\%?'HM=WP#ZC4\PJ4!]TX<FHF#L
MF\/7F/IN_2WK)GS"V0P/'\)0:PL)("LQA^B@=S[IA'<\U873N?^@,]/.Z=2?
MTAY=&!J YW.-969Y01/47_BN_P=02P,$%     @ @HT$4]<X'D&G!   , L
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M>F#")!H>G*[]]#?5CF9)?[N@X1T-&]#[F2:A;A]X@^[?@;-_ 5!+ P04
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MMOL[E 1^7;N(7>\]KHD-5<3)O-R?L8_U)([RPP:5EN]DVU*ZH0_3%MVT_::
MG";]$$E-ND9_!XKM%%X;V_6^%O@S7A&\>:Y(3U@QW_LR<51R3.7Q,46)/% ^
M#L:21W%H= ^(FE)/ELE?YD614_$'5^C54%6(OH>VZ%J 0E=#TSKI?)>@:0;+
M'; [1N0KFBU36-!8>R+';M"98?F1D@)6/<P#!4MV'Z?R83].G[H39D>7,;57
MXY\<!BHW:<.]?-@]O&H6X3*_%P]/(K+6=#0C!:Y(-9H6V0AT>&8$PJJUO]J7
MRE(O^]^67F:HG0#Q5TK9/>$,'-YZ%_\ 4$L#!!0    ( (*-!%.DI(PY9 D
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M^W?7G[[LP.OBO55HT7:XAA@?H $M_7,V)*C7,PZ>6!)[2M083*B?"%D@)"Q
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ML03L6O(67TW&'3^,G^^WXV[%E/^/QIM+-AI6RFG;?7,U8FT?HPZB;X"7 N
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M9[T_ZD;Q[&CK#BKVY+BSE9 /4I<]QL#+V&4Q:&,&]$ UL':?H>HQ*Z19JG8
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MV33[8ZVK@9RG]BB1;?9M01P30?<R<2#EK $@S6H8]\+1)/%\6*ZK2%_AS^7
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MM"U1DA^)XQD[N]EXN]GU6$G[H=,/$ F)V"4)!@ MJ[^^YP(@2-FR-VF_2'P
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MLB%-K4 /:GF1GT(BVZZ)[CZ<,2H ]WN0K))RB^L:SJF$A<H#NHDN$%-#-$-
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M.EDEZ#H(2IX0U&5OM')SRUZK'/)=^@XJ76N>K#6_3@XR_+E4;=:-6BR)DO@
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M*#;BBN>\[:-U,)P;;U:5076!H3,EET%&V(=V3@ Y9Z4Q2+P4;H[G))N66*3
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M4."&U<(^J/UOV-KSUO'E2A@_PKZY.QX%D-?&JJH%DP85E\T_>VK]< 281#V
MI 4D7N]&D-?R%V;98J;5'K2[36QNXDWU:%*.2Q>4CU;3*2><73Q@@13FM4!X
MKV2NI-5*T*4MW$F+&HTUP&31?SCXY,!F. LMJ>-(P[P5O6Q$)SVB4[@GQM+
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M)LY>KH3Q*QQZV2B O#56U;TR(:BY[+[LOL_#2Q227B'QN#M''N6&6;:<:W4
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M)6A9@-ZO#.'<;_B [F_.Y3]02P,$%     @ @HT$4PX302DN @  /@4  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S0N>&ULG51-C],P$/TK5DX@09TFW8)6
M::2V"P*D755; 0?$P4DFB;6.'>Q)L_OOL9TT%-3VP"7QC.>]^?),TBO]9&H
M),^-D&85U(CM+:4FKZ%A9J9:D/:F5+IA:$5=4=-J8(4'-8)&8;BD#>,R2!.O
MV^DT41T*+F&GB>F:ANF7#0C5KX)Y<%0\\JI&IZ!ITK(*]H!?VYVV$IU8"MZ
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ME.M- >/W%63EMR.H30B+39<@O6M@]ZYA+<@;B/)M\'B^X<O\X%65B#7U<?\
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M4'8!SJ=2FD/'!JAK^>P/4$L#!!0    ( (*-!%/.6&RSQ04  %,:   9
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M(>':0/U^QYC<7N@$U7NDV=]02P,$%     @ @HT$4PELOIU#!0  ,AP  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#$N>&ULO5G;;N,V$/T5PMB'!&ABD91O
M@6-@XZ3H;I%MD&#;9UJB;6$ET26I./OWI2X1;?'BK!/WQ=9E.#PSFCDS)*=;
MQG^(-:42O&1I+JY[:RDW5_V^B-8T(^*2;6BNWBP9SXA4MWS5%QM.25P-RM(^
M"H)A/R-)WIM-JV</?#9EA4R3G#YP((HL(_SG#4W9]KH'>Z\/'I/56I8/^K/I
MAJSH$Y7?-P]<W?5;+7&2T5PD+ ><+J][G^'5/$3E@$KB[X1NQ<XU*$U9,/:C
MO/D27_>"$A%-:21+%43]/=,Y3=-2D\+Q;Z.TU\Y9#MR]?M7^>V6\,F9!!)VS
M])\DENOKWK@'8KHD12H?V?8/VA@T*/5%+!75+]@VLD$/1(60+&L&*P19DM?_
MY*5QQ,X I<<^ #4#4'= Z!B FP&X,K1&5IEU2R2933G; EY**VWE1>6;:K2R
M)LG+S_@DN7J;J'%R]DACJ@)CD5+PC>41RR5GJ1):@2^YI)P**0#)8_?+"_"D
M0BLNE *V!/,UR5=4@"0'[]9\=DLE25)QKN;X_G0+SCZ=@T^EYOM$B;)<3/M2
M>:"THQ\UUM[4UB*'M1C<JZG6 MSE,8WWQ_>5YUKWH5?WW2"OPJ]%?@EP\!M
M 8(6//.W#P\\<'#[-7&E#SOTN7SI41VVJL-*=>A0?4-729Z76A<D)7E$;=ZO
M50PK%26!/,_@9#CM/UOF';3S#KSS?E-4EBBK,@J(E#Q9%+***<E OF]M8K>V
M1E9/,MA!%HY:8/6G&AC@!X$=^[#%/O1B_TNN*0<*NV+8=4E]S_35EK.4"7%N
M0SHTD.(.4%-B".U 1RW0D1?H _FIJ%GEW"]Z=60@N<"3#EJ+3(CM<,<MW+$7
MKLK> X$X-C_W.+1/.FDGG7ASZPU\YDDS&&A"#MZ?:(V.70,A&CFB .X4 _CQ
M =OH]$6L1<05LA!IL.@D0=NH]4>M3<@5ME#3,\1>R(\T2HD0R3*)2-7%J))Y
M'_U)A5#7=P57W9GJC=HX^R6KL $8C4<.P)KTH9_U#V=:HV!W7M>LFO+A <X_
M(K\T)\/A1]=(J'D4^HGT;<EK4N)NF6P"T!1"T.5939S0SYP?5$VAR:]F!GEE
M]O%K#H:3$Q#4Q$ 2=,'Z1/8[0TWDR$_DQ_(3,KG=Y">;D(N?D.9_] ;^MV(R
M"1QV$9DB%X[>#VF.1WZ./\P_R"3JW5+?8#.%4.!()J39'/F[[?=U!$B3,/*3
M\%%!CTQ>[@:]5V0?JZ9NY*?NHX/>;- M06\1<@:]+@C(WZ6?L"@CLU5W%F6D
MBPSR%QEWEEH*2]>%EG;<E:6ZJB!_57EG(FCV1_X6_ CE6-,U]M/U45F&31KN
M]KX6$5?OBS518S]1'YMFV"3I+BMX1?;A:AK'?AIW1BPVB=GPGRGBPK.S37)*
MYL::N?$';)I@DX;WUG*-&RQ288 <GM!\C?^7[15L,O.X:X I EUYH+D;GV"'
M!1_>8K&(.)-6\S;V\[:MT' :%9R7_BV-4!;4;Y3[664:B2)>T!BD"5DD:2(3
M:O>_A=:-#V"1<7X!S?W8S_U',Y&Y/#"8R">R#U>7$.Q?0-R]4!XE@HK2^0^%
M!-7!A16@N22XF(R-0+%(A8YE3JAK4>BO12=L24++PL'9DX2Z((5'KAS"P[M#
M%A''=PYUQ0G?NW!H%.SN]W9WA"TB,(3=?<3^SNE+1OFJ.I02*I^+7-8G">W3
M]N#K<W7<TWE^ Z_F]?&55E.?IMT3K@J) "E=*I7!Y4CYBM<'5/6-9)OJC&?!
MI&19=;FF)*:\%%#OEXS)UYMR@O:8</8?4$L#!!0    ( (*-!%,#)0G0Q@0
M  ,3   9    >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;+5874_C.!3]*U;%
M TC0Q$X_4:DTE%DMN\,*P;#SL-H'D[BM16)W;8?"O]_K)"0A=<W':%[:V+GW
M^MSCVW-=S[92/>@U8P8]9:G09[VU,9O3(-#QFF54]^6&"7BSE"JC!H9J%>B-
M8C0IG+(T(&$X"C+*16\^*^:NU7PF<Y-RP:X5TGF64?5\SE*Y/>OAWLO$#5^M
MC9T(YK,-7;%;9NXVUPI&01TEX1D3FDN!%%N>];[@TP496X?"XF_.MKKUC&PJ
M]U(^V,%E<M8++2*6LMC8$!2^'MF"I:F-!#C^JX+VZC6M8_OY)?IO1?*0S#W5
M;"'3'SPQZ[/>I(<2MJ1Y:F[D]G=6)32T\6*9ZN(3;2O;L(?B7!N95<Z (..B
M_*9/%1$M!XCC=B"5 ^DZ#/8X1)5#5"1:(BO2NJ"&SF=*;I&RUA#-/A3<%-Z0
M#1=V&V^-@K<<_,S\*U6"BY5&A]^DUD?HFBFTD%D&#-^NJ6+H\((9RE-X=8+N
M;B_0X<$1.D !TO:M1ER@.\&-/FY-7/$TA2V"N8/V<!88 &R7#>(*W'D)CNP!
M%Z$K*<Q:HZ\B8<EK_P 2K;,E+]F>$V_ /W+11U%XC$A(L //XOWNH0=.5),?
M%?&BM\BWK!=T'Z,+GN:&)<?H_OEE(Q8IU4#FI8C3/ %[]'TKRTETQ<Q:)NB?
M;Q 971J6Z7\]N 8UKD&!:[ '%ZPD,X:62F8HAAW@(K?+@G8H:O9M91ER5(2T
MXO$X'T:C6?#8IG?79C =UC:OL YKK$,OUK] ZGB)EQJC^'UNZ'W*D)%(2&'1
M*PGU!_"Y, PJU#C1EXL,6\A.!N,.>H?-,'2C']7H1S_']$Y25_&?3&M;%5)M
M9&GE2FBT W8PF782<M@,]FS'N$YH[$W(JDB93L)UE1%+6@D=(P$[)I?(T"<7
M[O$NR5$'ML,$NU%/:M23SQ;1>_F>[);VI%O^#IO!P(U\6B.?>B7D1]&G6')"
M'X'A%8,J*C2C4F-HW-I0857CU",,.&S:1>AEZIQJ'J-#_K+"D5/5RQC35J)X
M..J3#AV567LC\8BX^<"MAH;]HKI<PA'!5EABI10."4BS.%?<<*:]))!F">(E
MH=+H-VD@#AHF?=REP6$VBOK[B&B:"_9WEPJE+^.F(6!_1U@XM<GFGX"Z4J41
MS)9<N*DHPX];.4;]L*M'#BO2'^\CHND0V-\B+MQ*]!'XY0*3MN2$_7"GH'<[
MQ)[^@)L&@?T=XKLT-/T(U-$.5&"ZV\H<5AZF&_''8V_)%>K@*[A&D+%?D7^Z
MX"8.&G"WDSBL@(8]DHP;3<;37UUPT_<5W/2]!4<:A2=^A?]HP57A7O^T<5?D
M'%;[F2:-V!/L!7LM#0.B:9H^N^0>'7KDN0K]JOUT4>^:1'L@-\V#^)O'K9'Q
M U2%XR#].F(C].2-OQ&?[7BDT7_BU_\;.#<K'MNFIPO\N?W3]U8#K(*V.UNX
MT_XJH_?4<*/XQ*_X;K@^)AH])J-?1':CHL1_AOXDV>/=8T1_TB7;9=25_:!U
MG9 QM2IN632<+'-ARO_:]6Q]D_.EN+_HS)_CTT5Y'].$*:^'KJA:<5#$E"TA
M9-@?PWZJ\L:E'!BY*2XM[J4Q,BL>UXPF3%D#>+^4\,NO!G:!^MYK_C]02P,$
M%     @ @HT$4_V/+"6: P  H@X  !D   !X;"]W;W)K<VAE971S+W-H965T
M-#,N>&ULM9==;]LV%(;_"B'TH@5:2Z0M.RYL W'2;1V0P8B7[:+H!2T=2VPI
MTB.IN/GW(RE%<F9+'6#GQI(HGO=\Z.BQSFPOU7>= QCTH^!"SX/<F-W',-1)
M#@75 [D#8>]LI2JHL9<J"_5. 4V]4<%#$D7CL*!,!(N97UNIQ4R6AC,!*X5T
M6114/2V!R_T\P,'SPCW+<N,6PL5L1S-8@WG8K92]"AN5E!4@-),"*=C.@VO\
M<4G&SL#O^(O!7A^<(Y?*1LKO[N)S.@\B%Q%P2(R3H/;P"#? N5.R<?Q3BP:-
M3V=X>/ZL_HM/WB:SH1IN)/^;I2:?!U<!2F%+2V[NY?XWJ!.*G5XBN?:_:%_O
MC0*4E-K(HC:V$11,5$?ZHR[$@0'!'0:D-B ^[LJ1C_*6&KJ8*;E'RNVV:N[$
MI^JM;7!,N*>R-LK>9=;.+'Z5,MTSSA$5*?HL#!49VW! UUJ#T>_1'[8Q/J"U
M;8:TM,MRBVYRNP<T8@*9'- -5>J)B0Q=%[(4QNUH--_>@J&,ZW?HC=M^9]?L
MD]"ST-C(G?\PJ:-<5E&2CBB'Z$X*DVOT2:20OK0/;<9-VN0Y[27I%?R]% ,T
MC-XC$A'\L+Y%;]^\ZY$=-M4<>MGASZKYY5[:7]LW>ZK2KSW*HT9YY)5''<I+
MR)@0KLX;RJE(X%01*XFQEW"OX^-B.IH.9^'C"<=QXSCN=6QSL)TM;"\J!2)Y
M0D91H3FMWJGTFVU1^Y*Z5A%@3@55R<<'09')Z9#&34CCWI!L$_RD$.,CG].8
M1*>]3AJODUZO#X/U *UR:E&00&E80GG/<[UJ5*\NW#'31GEZ?L=,CPHUG(X[
M.@9'+5.BU^V96O\PKHZ>P0>@PV=V32WPLAJ3CK;!I'5,>AVO%.A$L9W/_D](
M<B&YS)[06O+2'//PI9>6//C2Z,$M>_ %X%-K'%8/QR/24;T6/_B5^8./ =3U
M2%L X7,)A(\1U%.-ED&X'T)WD#KP?%B7*G,G_Z^)6ACA2],(MSC"%^ 1/@82
M&<4=0"(MD,@K XD< ZFCB4@+)'(ND,@QD'JJT0*)] /)?N:!$C[YWO\PTL*'
M7!H^I(4/N0!\R"GX#...2K7P(:\,'W+BZZ>K<5KZD'/I4PN,7Y0C_F\YPH.Q
MH0"5^>%(H\1]QU<31+/:#&#7U=C1;J^FMSMJ>20TXK"UIM%@8C-6U4!471BY
M\T/(1AH[TOC3W Z1H-P&>W\KI7F^< Z:L73Q+U!+ P04    " ""C013N51?
MG5$%   +&P  &0   'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6R]65UOXC@4
M_2L6FH=6FC;Q1P*,*!*E.[L=37>K=F9'J]4^N,1 U"1F;5.F^^O7"6D,<6*H
M%/'2DG#O];%]S_'E>K3AXEDN&5/@9YID\JJW5&KUR?/D;,E2*B_YBF7ZFSD7
M*57Z42P\N1*,1H53FGC(]T,OI7'6&X^*=_=B/.)KE<09NQ= KM.4BM=KEO#-
M50_VWEX\Q(NERE]XX]&*+M@C4]]7]T(_>564*$Y9)F.> <'F5[T)_#0E*'<H
M+/Z,V4;N? ;Y5)XX?\X?;J.KGI\C8@F;J3P$U?]>V)0E21Y)X_BW#-JKQLP=
M=S^_1?]<3%Y/YHE*-N7)CSA2RZO>H <B-J?K1#WPS6^LG%"0QYOQ1!9_P::T
M]7M@MI:*IZ6S1I#&V?8__5DNQ(Z#CM/L@$H'5'<@+0ZX=,#%1+?(BFG=4$7'
M(\$W0.36.EK^H5B;PEO/)L[R;7Q40G\;:S\U_I7S:!,G":!9!&XS1;-%_)0P
M,)&2*?D1_*XSZ0(\ZNR)UOHUGVNC;?+DF_# %E1$<;:P7<'9#5,T3N2Y]O_^
M> /./IR##R#.P)T>3CO+D:?T!'(8WJP$>[T%BUK 8G#',[64X)<L8M&^OZ<G
M7LT>O<W^&CD#?EEGEP#['P'R$6S ,W6[WU&AW6&3^QX<7&T&+N+AEGB?XRQ6
M[.*K3NR&S0!_?]7VX%:Q5/[C&(U4HY%B--*V]8)+":94B-=\!R<I7V>J:5.V
M8<(B3"X++^,P[/='WLON2C49D; RVD,85 @#)\+);+9.UPE5>CDT/*'B_XJ\
M:P*YC13LC'^!!P._AK+)JA\.FF&&%<S0"3/GR!'+&%HKA/K#^C*&%D TZ+?@
MZU?X^DY\TT)&F-"RFQ3K)Y?Q2CHR:% %'IP@7X?5:$/G-'X4DLRB"S!Y84*?
M,5I^\H.J7/4J.\ ]$S&/P-E?C IYWK05[H$@ J^YJP,S](V^^MVPK(RSFQ^X
M3^KY45H%>U9XV)P@<.<4@)TQK0RU1R*$T;".M,D,A6U0D8&*NF!;&65W.2&!
M@SI(9(&$I.^W8#0Z#K$3XR,3+_&, ;H0C.FB1SESR0@V)"?@&S3R"]WZVR'C
M#HP$_<.4,W(,W7I\/.5L28;^P,H16Y.U%6S)$2/*T*W*[Z)<W^92@.N'6Z,5
MQ"U C<C#02>$&UB+&0366@XLB$';\0O-P0#=@GV_I+HBG;V"1),ND\R51L@H
M-_)/P#9D-!BY-;A#MAT8">&#;$-&CY%;CX]F&[(5.?!Q+4&0+<ADITC:QVCT
M&+GU^#U<*T/MGUL!JN-LLB*D!:A1>.2NR8_D&K*K;13 .D1BUY)!BQH@<R8@
MMU)_$S32:2F>9?&34>6/(*.IFW1&NU%X"M(9%49N%>Z2=.Z1CJ@JD=%DY-;D
MXTEGJ_(0DWJFV*H\1$%+IAA51FY5?A?IAC:="+1(UV"%ARVDPT;HL;M$/Y)T
MV"[0 U2'B.WZ/, MM0(V1P-V"_8W-EMF/.&+5U>7P4@V1B<@&=YI:[CEMT.2
M'1B)'.08-EJ,.^J/8%N-85 OSK"MQKM&^QB-&N/N.B2XH?D!4?T'9K,5:@%J
M=!UWTB/!#4V2>HF FWHD+?C,.8#=ZOR'6C+A2ALCS?@431%L9!:?K"UR8*3P
M(+F(T5S245N$V*J+@J"6$L16712TG O$J"[IKBE"&ILB=1%HM$(M75)B])QT
MTA(A=@&.K)5LL*F3R]NY;DB96!2W,!+,\G&W-P_5V^JF9U+<;WC&?'M-=$?%
M(LXD2-A<N_J7?;TT8GOSLGU0?%5<7CQQI7A:?%PR77**W$!_/^=<O3WD U3W
M7^/_ 5!+ P04    " ""C013+63J  @#  !\"0  &0   'AL+W=O<FMS:&5E
M=',O<VAE970T-2YX;6RMEEE/&S$0@/^*M>(!)&"OG"B)E -:J@8A(MJ'J@].
M=I*U\-JI[2707]^Q-UD"V42HRDO6QQS?C)T9=U92/>D4P)"7C O=]5)CEE>^
MKV<I9%1?RB4(W)E+E5&#4[7P]5(!39Q2QOTH"!I^1IGP>AVW=J]Z'9D;S@3<
M*Z+S+*/J=0!<KKI>Z&T6'M@B-7;![W66= $3,(_+>X4SO[22L R$9E(0!?.N
MUP^OAJ%3<!(_&*STUIC84*92/MG);=+U DL$'&;&FJ#X>88A<&XM(<>?M5&O
M]&D5M\<;ZS<N> QF2C4,)?_)$I-VO99'$IC3G)L'N?H*ZX#JUMY,<NU^R6HM
M&WADEFLCL[4R$F1,%%_ZLD[$E@+:J5:(U@K11X7:'H5XK1"[0 LR%]:(&MKK
M*+DBRDJC-3MPN7':& T3]A@G1N$N0SW3^R)ELF*<$RH2<BL,%0LVY4#Z6H/1
MY^0.;](%N:-*49MO'.\(D=,1&,JX/L/=Q\F(G)Z<D1/"!!FC83PKW?$-HEJ'
M_FR--2BPHCU8,1E+85)-KD4"R7M]'T,LXXPV<0ZB@P:_Y>*2Q,$YB8(HK. 9
M?EX].( 3EVF/G;WXO]).1DS/N-2Y O*K/]5&X6W_?<!MK71;<VYK>]SV,ZD,
M^TO=/PA>L!9H('*.9U424$=0=6*%Z88S;:O#<Z_=ZOC/VTG<%0F#1BGS#KE>
M(M</9NJ&"6;@XCM>OLH+^BZDZR*D<S*F)E?,O)()UKTDYY_,8Z.$:AS,X[4V
M#$L($E$A<HK'6)'8<RQSMI FH&R.\>9$56DM/-6W<A8UV]4Y:Y9XS6/@(5%<
M1=2L((JKB5HE4>M(1+4JHM8N42.L)FJ71.TC$=6KB-J[1/5Z-5$8O-7BX$A,
MC<J2&NQ"17L.+MQJ$.$QH$P*^(R8&U"5:.%N9:@'P0<V?ZN/9: 6KKUK,I.Y
M,$6I+U?+)T3?-<X/ZP/[M'#]\<U,\2X94[5@0A,.<S097#8Q6ZIH]<7$R*7K
MEE-IL/>Z88K/(U!6 /?G4IK-Q#HH'UR]?U!+ P04    " ""C013]&*U/M8%
M  !@(@  &0   'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6RU6EUOFT@4_2LC
MJY52:6LS7T BQU*;;+59M=VJ:7<?5ON [8F-"HQW&))&VA^_PY@PV -#4,Q+
M N;>RYG+F<-A8/[ Q8]\RY@$/],DRR\G6REW%[-9OMJR-,JG?,<R=>2.BS22
M:E=L9OE.L&BMD])DACS/GZ51G$T6<_W;%[&8\T(F<<:^") 7:1J)Q_<LX0^7
M$SAY^N%KO-G*\H?98KZ+-NR6R>^[+T+MS>HJZSAE61[S# AV=SEY!R^N:%@F
MZ(@_8_:0-[9!.90EYS_*G9OUY<0K$;&$K619(E+_[MD52Y*RDL+Q;U5T4I^S
M3&QN/U7_H >O!K.,<G;%D[_BM=Q>3L()6+.[J$CD5_[P&ZL&1,MZ*Y[D^B]X
MJ&*]"5@5N>1IE:P0I'&V_Q_]K!K12("D(P%5">BY";A*P'J@>V1Z6->1C!9S
MP1^ **-5M7)#]T9GJ]'$67D9;Z501V.5)Q?7;"E!E*W!ASB+LE6<;<"[LK.Q
MC%D.WH);Q9MUD3# [\!'GFW>?F,B!3KK[)K)*$[R-RKL^^TU.'OU!KP"<08^
MQ4FB+E$^GTF%L#S/;%6A>;]'@SK0_%YD4X"]7P#R$&Q)OW*G?XJ$2H=MZ3/5
ME[HYJ&X.TO6PJSDW62Y%H9@KP=\?50"XD2S-_W&4QW5YK,N3CO(?F>*?;CZ7
M6R8 7R;Q)I)=K=L7\W6Q<G;>+U#@S6?WS?ZX8PY0DAHE<:+\QF64J)FQE&V@
M]KFT<<( !OX1JK8@$K;#HC4LVM.\/+\ 5X40Y979<5'VK0TAM4].T1' EAB"
MVO'Y-3[_&6U+RBDCRRG3U4#?NF(^0>0(GV_A\XGGMP,,:H"!$R":!MYK\)E+
M-<_7!5-S>L72I:(AI'H"(?!?=707/4;+A#D8'];G#,>84.=U^7/GD&XRU6J6
M2R BJ10KTTU7BE2?[VS'Q$IMO&F[$N[:NET.C- SBNNYF7O ":#NK;E4(J"D
MMU4P/8L@Q#N>]E40[0@Z!-JX-<">(8>TR1 EKZOM$SWP 'I ([AP%,6%1G*A
M6W-?1I&>XKIA+IA&<Z%;= =RA#R'([8*=W/$J#!TRS">AEXG1\@0CAAAA?XH
M'#'""-W*^$*.N(OKAKE@&BV%X2DY$EH<@= F26B1Y"#J$*K19>@63V]ZWGZO
MP9HG= !/D-%9Y(W!$V3T$;GU\64\Z2FN6^:"V3"QZ(0\J8HU>4(MFE1!M"/H
M$*C19N26SV#JJ_N-NFRJ984X%!3-DV (3XS6(C(*3XQ&(K=&OI G[N*Z:2Z8
M1E>1V[$.Y(EM7*$?'//$-J[-H$.@1I]1GX2>'_B2#VPIBD@\ NAKFH1#:&+D
M%HWB79$1232F>^TIKGOF>F8ULHI/:5^Q;5]]2TZP;5_]+CG!1IZQ6T')-#BR
MKX]/:POG QB"C=#B<98+&NL%8YK7GN*Z72Z81E#Q*<TK?HYYQ0/,*S;"C-W:
MZ4^]-O-:4H3 (10Q&HM'\:[8:",>T[OV%-?]<L$T8HI/Z5VQ[5U1>+R&@VWK
MV@PZ!&I$&;MUDTS#L.OYA@QYOB%&8,DHOI48821C^M:>XKIA+IA&3LDI?2NQ
M?2N!\'@ATO:MS:!#H$:6B5LYO:F/7X-?"\$;1'E7; K58ACL5Z.',*6Q,CN*
M<R5&(,F8SK6GN&Z;"Z9157)*YTILYQK83+&=:^"1#J88=29N 853ZEE,^<SO
MJX778/#3,#&*2T:QK\0H)1G3OO84UXUSP*1&7>DI[2NU[6O@A<=O#VS[&G29
M$VI4FKJ%%+:IRA\KR?6ZR=['^@.H0HWPTE%\+#6"2<?TL3W%88^L4".O])0^
MEMH^EIY;+YIL'TO#C@=BVG@5UK<("Q55;A74I'R!V_9D' Q^[J%&?NDHII8:
MV:1CFMJ>XKIY+IA&8NDI32VU3:V/Z3%?6H+0,5]FC=?_Y;<7RJ-N5'- PNY4
MEJ>>ZR9 [#]GV.](OM-?!"RYE#S5FUL6K9DH ]3Q.ZXX4NV4'QG4'Y4L_@=0
M2P,$%     @ @HT$4Q^.\?Z>!0  L"(  !D   !X;"]W;W)K<VAE971S+W-H
M965T-#<N>&ULM9I;;]LV%,>_"N&U0PJTEDB1LMTY!G+%,J1=D+3;P[ 'V:9M
MH;JX%!4WP#[\2%H1Y40FY7E\L26;YZ_#<_F9E#S>Y.Q;L:*4@Q]IDA6GO17G
MZX^>5\Q6-(V*?KZFF?AFD;,TXN*4+;UBS6@T5T9IXB'?#[TTBK/>9*P^NV.3
M<5[R),[H'0-%F:81>SJG2;XY[<'>\P?W\7+%Y0?>9+R.EO2!\J_K.R;.O%IE
M'J<T*^(\ XPN3GMG\.,U&4D#->*/F&Z*QC&04YGF^3=Y<C,_[?G2(YK0&9<2
MD7A[I!<T2:22\.-[)=JKKRD-F\?/ZM=J\F(RTZB@%WGR9SSGJ]/>L ?F=!&5
M";_/-[_2:D)$ZLWRI%"O8%.-]7M@5A8\3RMCX4$:9]OWZ$<5B(8!@GL,4&6
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MVI)J>;.@_PJ@<Z#S7&N[6[@$W9\J^0M02P,$%     @ @HT$4Q0RB^+ !0
MY1L  !D   !X;"]W;W)K<VAE971S+W-H965T-3$N>&ULQ5G;;MLX$/T5PBV*
M%&AJD;)\21T#B9TT29,@:+:[#XM]8&S:%BJ)+DG'+; ?OT.)%F5'IN56Q?:A
MD6C.T0P/Y\R(ZJ^X^"KGC"GT/8X2>=J8*[4X:3;E>,YB*M_S!4O@ERD7,55P
M*V9-N1",3E*C.&H2SVLW8QHFC4$_'7L0@SY?JBA,V(- <AG'5/PX9Q%?G39P
M8SWP.9S-E1YH#OH+.F./3'U9/ BX:^8HDS!FB0QY@@2;GC;.\,FMW]$&Z8P_
M0[:2A6ND0WGB_*N^N9Z<-CSM$8O86&D("G^>V9!%D48"/[X9T$;^3&U8O%ZC
M7Z;!0S!/5+(AC_X*)VI^VN@VT(1-Z3)2G_GJBIF  HTWYI%,_T<K,]=KH/%2
M*AX;8_ @#I/L+_UN%J)@0/ . V(,2%4#WQCX50U:QJ!5U2 P!D%5@[8Q:%<U
MZ!B#3E6#KC'H5C7H&8->50/LK9GS*IOD9%=F&Z_IQBG?S6QCI;MR1!4=] 5?
M(:'G YZ^2+=V:@^;,4QT%CXJ ;^&8*<&5VPR"Y,9.M/9$*J0272,[JD05&<'
M.AHQ1<-(OD5O7N&V_P&%";H+HP@22+Y#KXNW_:8"?S1J<VR>?9X]F^QXMH_N
M>*+F$ETD$S;9M&]"''DP9!W,.7$"WBR3]\CWWB'B$?SE<82.7K\M<6M8'<7;
MC3(ZP)>++Y_1T9M77;_=^E"&=7$ UO!LET>7;I0[*@ %[UN=CP>@[(OKZ@"L
MW7%='\#7/H]NW%AG"_"(=/9Q_^D E'T>W;JQ'MEB'1WN?3Q_T%@Z$]\Z\L7/
MD]]/L?T=V",FPN<LT?^^A=_0M6*Q_,>!W,J16RER:P?R1ZC_$AU%7$H&XC$5
M/$9C*N=H"F4?S4%T0&@$&W,!F0^BI^:@)%S-F4!C'D,_,=>%'OP*$[AG9=J2
M.=!.'="]QO/ ZS>?BVG^<L9QX*7_\HD;P05Y<($S.+ML$@J^#&<)51 %M$19
M9-!:C/DR4:"KCJ5LYT]KUTQ2)T?N["4IX\@PE$#7%R80EH(^2]5#4^9"4"2!
MD"T6,KI*9OHM%U_=/,ZN,TYHUU943,#E1 EH^R12W#!UL10<T9G>K0J="RB
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MC$Z8T!/@]RF'#6!N] /R+WN#_P!02P,$%     @ @HT$4X ]$.CI!   O1L
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M!R%^VI/KQ44OM(AH3.?:AB#F[Y'.:!S;2 ;'OUG07CZF=2P>'Z)_2B=O)O-
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M9CGV8H\DD-*<FSNY^0IE0GW+-Y=<NW^R*6,#C\QS;616@E%!QD1QI<]E(6J
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M8'T"[:^,P:? SUQ_8^:_ %!+ P04    " ""C013Y^/I7+H#  !+#0  &0
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M-_=RH$5N+XX;H?$::A\3_-JATFS ]:W UV4U,'?1^OMI\0]02P,$%     @
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M"QM+"E6R/"RCJHJX!_6HL"94;";47'UPG60Y51FH!' 5/Y(T(Z!/27FP8E[
MFOBP]?9Y 6NJPF:JVFQ>P%4JZN+RAJH3\AH2.]:,A<V,M>',@-OIR2A21*'I
M":_91+8EADQ_BP=JA!H]H!D.F[O'^B*;I&6VLIKJS?2J6AM7N\5R:U8C@ALZ
M2JRY$YNY\]6=#JY28"6(3")%>S5)8C-)7N;R\IBSJ&'Q84<S'@"D)RJG,((U
MQEXMMBHM=AO8!6M>Q&9>S(7091I"USJ$!JI3^Z@ZM9>E8LUM^/#M4[&M2<@V
MD]!F4['=WL?5B'3=>A?:FL]L<R.WX3QLMW=P1I$B"DV+]IJTV):'[?:^K4:D
M<?ES)Z#KTF"3P>V$9Q0IVJL)SS83WBI'&6TG&=6 &I*8C*DT;4M-:_86&C=;
MDX_]EHV;7:4;M^SEE1G)UHQDFQFI^71'0=BK/;F"*$B.36@Z:!C223)^Y012
MM%5SD'VP!7]K$K+-#=:&_5WMEKKE/K%&IJ%D<C27.68N>\T)V&O<ZFA><K;0
M9SF:4)RW[+.<=G:I$<EYOHA"LXMC9I?!U(]5Z4C5'05)>4(I74[29<VR+IJ%
M?MGLXGRYG]2<+3A-IW[G37\/<ZK-2;?RHUY5IB'[.II"G/_Y-S&GYA>OLMU5
MD:9HTZSAK'O8UV1OS;%>V=Z53_4<S1R.N7NYF'.&SDG,(AHG(?L[D[!9?J#/
MA$?HFOFQ*2HU0SA;:%-<G=I=<VJ_9O&D*Q6B@ PA:N82'!('JBC[L;@&4G?%
M(%-KX<)A:[]AU5V=V%USPW'&H4* SO"6S8%+[L&RY)CQM7YP=4IW\1;\H'.Q
M:\[%+7Y0=RKJ;F=D6BT[YP;';?*"SM1N>QU?.BQ-+5EK4[BYFPM;J-)=G6)=
M<XI]Y:8XS]0V;XKTJD^K6-%LG6%=<X8]AP[JT5<W!048+J!B2Q80"I'TD @*
M]1%L*PDX3,ND,Z2[A=K:U9G3-=?6;W(PYM:4W+A,EW5"N5_0BE=?=&KVS*GY
M!>Z$L*S?LH:%]G1.]K90;'LZ,WOF8CN_#G,!-M#Z ^B]\D'UA,.'VEM!N'+9
MJEMNG&MERD50+W>/,R)\DES1%2AQ2WII<?EV>0WX-+G\6GI_9GT8I)=YM9KT
M;O&-SR<*54C&H++_?A^BC*?7==,'R6;);=$ADY)%R<<I\0/"E0!\/V:0HK,'
M-<'RTO3)?U!+ P04    " ""C013-8X,F]X&  "2*0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970U."YX;6S-FEMOVS84Q[\*80Q8"S2UQ8LO01+ <6_9FC5H
MVNUAV ,CT;96B4Q%.I=]^I&28MHBJ;AP[/0EL>0_C\XY/.2/M'AT*XIO<LZ8
M G=YQN5Q9Z[4]6&W*^,YRZE\+:X9U]],19%3I2^+65=>%XPF9:,\Z\)>K]_-
M:<H[)T?EO8OBY$@L5)9R=E$ N<AS6MR?LDS<'G>BSL.-S^ELKLR-[LG1-9VQ
M2Z:^7E\4^JJ[M)*D.>,R%1P4;'K<&4>'$S(P#4K%GRF[E2N?@0GE2HAOYN(L
M.>[TC$<L8[$R)JC^=\,F+,N,)>W']]IH9_E,TW#U\X/U=V7P.I@K*ME$9'^E
MB9H?=X8=D+ I763JL[C]P.J B+$7BTR6?\%MK>UU0+R02N1U8^U!GO+J/[VK
M$['20-OQ-X!U ]AL@ ,-4-T E8%6GI5AO:&*GAP5XA841JVMF0]E;LK6.IJ4
MFVZ\5(7^-M7MU,FE$O&WN<@25LA?P=OOBU3=@Q=OV#2-4_42'(!+73C)(F-
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MUA41'O::G>&3#7JAWK PB[:EV8\,X\C#JN8X]FC" ]D2+6I'VHX'L@LTD_V
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M.:.Z+XQ ?S\50CU<F <LCV&>_ ]02P,$%     @ @HT$4Q?!^]P>!P  PB$
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( (*-!%/)0(OFG@0  (8G   /
M>&PO=V]R:V)O;VLN>&ULQ9I?;]HZ&(>_BL7-Z:3N0/YU6S4FT4)7I(ZB4O5V
M,HD!JXG-L4V[LT]_G"!T[(W^M)M77(4X(7EB.WY>O_'G5VV>EUH_LQ]-K>RP
MMW%N>]GOVW(C&F[_UENA_)&5-@UW?M>L^W9K!*_L1@C7U/UT,+CH-URJWI?/
MAVO-33_<T4Z43FKE"]N")RE>[?_'VUWV(JU<REJZ?X>][G<M>JR12C;RIZB&
MO4&/V8U^O=5&_M3*\7I1&EW7PUZR/_ DC)/E;\6+%O*1+VU7XOCR@7N08>]B
MX"^XDL:Z[HSN^MPSO@A_\GYOY_2-K)TP8^[$5Z-W6ZG6[67\4_2#Q^CJX;#=
M5^*E^9-JU*N5+,58E[M&*+>O1R/J%E#9C=S:'E.\$</>M7X1ALWY6K0/Y>\R
MK?8/Z#Q94%WF4OH#9EIUC(0\][/Q9+:8C)G_M;B_FXY'CWYG\>@WWR:S #(%
MD.D)(;^G 60&(+.30%Z-[D:SZPD+(', F9\0,JK) D 6IVSN+("\ ) 7IX3,
M \@/ /+#*2&+ /(C@/Q("[F0:R7]N5PY-BI+O5/.C\YLKFM92F$#R$\ \A,M
MY*VH*^;_R1:\CH;N 1J[![10#\(ZLRO=SO@*.V?39LNE:?]SSKBJPB$G@8HA
M=LQ4E;H1[)'_B%HS049)B)7R("KA+^)ORF;:\RG7QAIMOYLJ'R>$F,@I";%4
M)MPH#V79V9VV]AV;^^#A6C>-5FRQX1$FLDI"K)6O6E>OLJZ[;N<KD*MU2\!&
MUOIXZCS$1%Y)B,4R%DO7(=Y(Q579MO:H#12EB\>9!'DE(1;+7"CKR]B54&(E
M7<2%5)(0N^165.NW:PSY(R$6R(T?]=@3KW>"?1/<[HQH_Q#A(7,DQ.IHWU?I
M.J2N\UWK3G!^G]U)O@Q#;"23E%@F"Z?+YXVN*V'L7VSRS\[/W]C9V/?!4KIW
M(25R24KLDH58[VM2K]C5SDHE;-C0*9RE$#L%!C)1<)TBIZ3$3H%10XR)G)(2
M.P4:.L9$3DF)G0(-'6,BJZ3$5H&&CC&19%)BR4!#L[,0$QDG)3;.[RYD9X]M
M5[710(FLDQ);YPTI'CC#G FR3D9L'2C'.+6#M)-1:P?*,9QI9<A &;6!CMCQ
M6,_,8)Z,V#]8DV%Z)T/^R8C]$\WXV7LVX\;P-JO<MKOC(2;R3T;L'VSSJ#:1
M?S)B_V#,,%V6(?]DQ/[!F&'"+$/^R8C]$V94]MU1UO$+CM23$:L'1VYAE\R1
M>G+R[!G"#+MDCM23$ZL'!YA1;2+UY,3JP0%FA(GDDQ/+!V-&C0X_TYPRH1:-
M0SF23W[*A!I['V(B^>3$\H&849"9(_GDIYS\Q*\0DD].+!^,&;U"R$(YL85^
MS:/^$L*%GSJ1A0IB"QV92H:@(2:R4$%LH:.88V'D2\<98B(+%<06>G/6NX^1
M0DQDH8)ZK0"<]89O>H$L5%"O%H"8X9M>P.4"Q!:"D_-X40.R4$%L(8P9-3JR
M4$%L(8P9-3JR4$&]:N!HJN/(5*A $BHZ"?4/Z[XJ_Y1*5#-_!^O+2UZ7<\/:
MS?Z#=5ZT7Y)6N[J^]F7WZD[SZK",[+ $[LM_4$L#!!0    ( (*-!%-9=@'X
M]0$  #@C   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-VKM.ZT 4
MA>%7B?P 3/8MP!&AHJ%%O( 5)A>1Q)8]"'A[HE"$95&<!LVJK+'E[;_Z9(U]
M]Y3W;=EUQW&[Z\?9QV%_')?-MI3^7TKC:IL/[7C5]?EXNK+NAD-;3LMAD_IV
M]=IN<M+Y?)&&GS.:^[N?,V?/GWW^GXG=>KU;Y8=N]7;(Q_++X/3>#:_C-N?2
MS)[;89/+LDD?^\OI,9T/<G6:W,P>7Y;-\/@B3:H=I!"D]8,,@JQ^D$.0UP\*
M"(KZ00L(6M0/NH:@Z_I!-Q!T4S_H%H)NZP?)'&6<$R1-L";06I!K(?!:$&PA
M$%N0;"$P6Q!M(5!;D&TA<%L0;B&06Y!N(;!;$&\AT%M1;R706U%O)=!;)R_;
M!'HKZJT$>BOJK01Z*^JM!'HKZJT$>BOJK01Z*^JM!'HKZJT$>AOJ;01Z&^IM
M!'H;ZFT$>MMDLX1 ;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V-0&]#O8U ;T>]
MG4!O1[V=0&]'O9U ;T>]G4!OGVQV$^CMJ+<3Z.VHMQ/H[:BW$^CMJ+<3Z.VH
MMQ/H':AW$.@=J'<0Z!VH=Q#H':AW$.@=J'<0Z!V3CY4$>@?J'01Z!^H=!'H'
MZAT$>@?J'7^I]U@^]WF\]'RO\3OW7U)=3O?FR^//R^^3B//BC'."'V7NOP!0
M2P,$%     @ @HT$4Q?(S!O; 0  T2(  !,   !;0V]N=&5N=%]4>7!E<UTN
M>&ULS=I=3X,P% ;@O[)P:T;7K_D1YXUZJU[X!RJ<#3*@3=O-^>\M3$TT2EQF
MXGL#@;;G/;3)<\7EXXNC,-FU31<6616CNV L%!6U)N3649=&EM:W)J9'OV+.
M%&NS(B9FLSDK;!>IB]/8U\BN+F]H:39-G-SNTNM0VVZ1>6I"-KG>3^RS%IEQ
MKJD+$],XVW;EEY3I6T*>5@YS0E6[<)(F9.S;A'[DYX"W=?=;\KXN:?)@?+PS
M;9K%=@T+\:6AD(^7^*9'NUS6!96VV+1I21Z<)U.&BBBV3;XO>C*>'-,.T_[*
MC\X?RHP%IID/WKJ03LS3X7'O1]*OGKI4B'RLQS_Q(S&5/OK[J#_MDLI?9J?M
M?;9^/9Q'8,/M^#W^?,8?]0_L0X#T(4'Z4"!]:) ^YB!]G(+T<0;2QSE('WR&
MT@B*J!R%5(YB*D=!E:.HRE%8Y2BN<A18.8JL D56@2*K0)%5H,@J4&05*+(*
M%%D%BJP"15:!(JM$D56BR"I19)4HLDH4626*K!)%5HDBJT215:+(JE!D52BR
M*A19%8JL"D56A2*K0I%5H<BJ4&15*+)J%%DUBJP:15:-(JM&D56CR*I19-4H
MLFH46?5_ROID[?JO?[+H[WEKZNX]GPU_LER] E!+ 0(4 Q0    ( (*-!%,'
M04UB@0   +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL
M4$L! A0#%     @ @HT$4R R\U?N    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ @HT$4YE<G",0!@  G"<
M !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " ""C013JHR2>/(%   @'0  &               @($-"   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ @HT$4R#5/#J?!0  E18
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M965T-BYX;6Q02P$"% ,4    " ""C013.B[.O8$"  !G!0  &
M    @('Y*0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @
M@HT$4V)]J\/(!P  J"   !@              ("!L"P  'AL+W=O<FMS:&5E
M=',O<VAE970X+GAM;%!+ 0(4 Q0    ( (*-!%/Z57MRD D  ,L7   8
M          " @:XT  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
M    " ""C013O\4.^>$&  "'$   &0              @(%T/@  >&PO=V]R
M:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( (*-!%,00'0WB@@  .T;
M   9              " @8Q%  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL
M4$L! A0#%     @ @HT$4]<X'D&G!   , L  !D              ("!34X
M 'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " ""C0131%QY
MA^P(  !%'   &0              @($K4P  >&PO=V]R:W-H965T<R]S:&5E
M=#$S+GAM;%!+ 0(4 Q0    ( (*-!%.\.W[KJ 0  !H,   9
M  " @4Y<  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @
M@HT$4_T2*L)[!   ]PD  !D              ("!+6$  'AL+W=O<FMS:&5E
M=',O<VAE970Q-2YX;6Q02P$"% ,4    " ""C013I*2,.60)  !/&   &0
M            @('?90  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4
M Q0    ( (*-!%.MG/;$%P,  /T&   9              " @7IO  !X;"]W
M;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ @HT$4P_].EAA#
M;BX  !D              ("!R'(  'AL+W=O<FMS:&5E=',O<VAE970Q."YX
M;6Q02P$"% ,4    " ""C013ZM@#>3$)  "<&P  &0              @(%@
M?P  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( (*-!%.2
M2:1?41L  #)0   9              " @<B(  !X;"]W;W)K<VAE971S+W-H
M965T,C N>&UL4$L! A0#%     @ @HT$4]/AQ(MU"@  [2$  !D
M     ("!4*0  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (*-!%/9U353P@,  -T(   9              "
M@47/  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ @HT$
M4XI)<VS_ P  [P@  !D              ("!/M,  'AL+W=O<FMS:&5E=',O
M<VAE970R-RYX;6Q02P$"% ,4    " ""C013YZEH<\ #  !9"   &0
M        @(%TUP  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0
M   ( (*-!%-KJ!QA> ,  & (   9              " @6O;  !X;"]W;W)K
M<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ @HT$4T6?I3>9 @  M 4
M !D              ("!&M\  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q0
M2P$"% ,4    " ""C013W%8K(1(#  "B!@  &0              @('JX0
M>&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( (*-!%/27_^B
M-0<  &T:   9              " @3/E  !X;"]W;W)K<VAE971S+W-H965T
M,S(N>&UL4$L! A0#%     @ @HT$4_,'[@X;!0  \@P  !D
M ("!G^P  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " ""
MC013#A-!*2X"   ^!0  &0              @('Q\0  >&PO=V]R:W-H965T
M<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( (*-!%/< -LI_0,  -H/   9
M          " @5;T  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#
M%     @ @HT$4\7AR*O- P  %A   !D              ("!BO@  'AL+W=O
M<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " ""C013-A;>A@X%   B
M&@  &0              @(&._   >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM
M;%!+ 0(4 Q0    ( (*-!%/CP9O0S 4  -8?   9              " @=,!
M 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ @HT$4_.&
MYK;8 @  UP<  !D              ("!U@<! 'AL+W=O<FMS:&5E=',O<VAE
M970S.2YX;6Q02P$"% ,4    " ""C013SEALL\4%  !3&@  &0
M    @('E"@$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    (
M (*-!%,);+Z=0P4  #(<   9              " @>$0 0!X;"]W;W)K<VAE
M971S+W-H965T-#$N>&UL4$L! A0#%     @ @HT$4P,E"=#&!    Q,  !D
M             ("!6Q8! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"
M% ,4    " ""C013_8\L)9H#  "B#@  &0              @(%8&P$ >&PO
M=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( (*-!%.Y5%^=404
M  L;   9              " @2D? 0!X;"]W;W)K<VAE971S+W-H965T-#0N
M>&UL4$L! A0#%     @ @HT$4RUDZ@ ( P  ? D  !D              ("!
ML20! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4    " ""C013
M]&*U/M8%  !@(@  &0              @('P)P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0V+GAM;%!+ 0(4 Q0    ( (*-!%,?CO'^G@4  + B   9
M      " @?TM 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%
M  @ @HT$4SA>DU1[ P  #0P  !D              ("!TC,! 'AL+W=O<FMS
M:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " ""C013!(^]S; "  !]!P
M&0              @(&$-P$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+
M 0(4 Q0    ( (*-!%.M.38_O@(  +4&   9              " @6LZ 0!X
M;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ @HT$4Q0RB^+
M!0  Y1L  !D              ("!8#T! 'AL+W=O<FMS:&5E=',O<VAE970U
M,2YX;6Q02P$"% ,4    " ""C013@#T0Z.D$  "]&P  &0
M@(%70P$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( (*-
M!%/0V!5XW0(  #4)   9              " @7=( 0!X;"]W;W)K<VAE971S
M+W-H965T-3,N>&UL4$L! A0#%     @ @HT$4V?@_+\F!P  Q24  !D
M         ("!BTL! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4
M    " ""C013KBJE-4\"   ]!0  &0              @('H4@$ >&PO=V]R
M:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( (*-!%/GX^E<N@,  $L-
M   9              " @6Y5 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL
M4$L! A0#%     @ @HT$4P$RO'3P!P  0"T  !D              ("!7UD!
M 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " ""C013-8X,
MF]X&  "2*0  &0              @(&&80$ >&PO=V]R:W-H965T<R]S:&5E
M=#4X+GAM;%!+ 0(4 Q0    ( (*-!%,7P?O<'@<  ,(A   9
M  " @9MH 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @
M@HT$4RQ=GK]9 P  #!4   T              ( !\&\! 'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " ""C013EXJ[',     3 @  "P              @ %T
M<P$ 7W)E;',O+G)E;'-02P$"% ,4    " ""C013R4"+YIX$  "&)P  #P
M            @ %== $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ @HT$
M4UEV ?CU 0  .",  !H              ( !*'D! 'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ @HT$4Q?(S!O; 0  T2(  !,
M         ( !57L! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $, 0P!,
)$@  87T!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>303</ContextCount>
  <ElementCount>367</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>104</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>17</UnitCount>
  <MyReports>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Held for Sale</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSale</Role>
      <ShortName>Held for Sale</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Restructuring, Impairment, and Related Charges</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</Role>
      <ShortName>Restructuring, Impairment, and Related Charges</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2113105 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2117106 - Disclosure - Earnings (Loss) Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShare</Role>
      <ShortName>Earnings (Loss) Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2120107 - Disclosure - Goodwill and Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</Role>
      <ShortName>Goodwill and Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2125108 - Disclosure - Debt and Financing Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivities</Role>
      <ShortName>Debt and Financing Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2131109 - Disclosure - Pension Benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefits</Role>
      <ShortName>Pension Benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2133110 - Disclosure - Hedging Activities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivities</Role>
      <ShortName>Hedging Activities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2137111 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2140112 - Disclosure - Commitments and Contingent Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilities</Role>
      <ShortName>Commitments and Contingent Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2144113 - Disclosure - Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficit</Role>
      <ShortName>Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2149114 - Disclosure - Segments of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusiness</Role>
      <ShortName>Segments of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables</Role>
      <ShortName>Restructuring, Impairment, and Related Charges (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2314302 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - Earnings (Loss) Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareTables</Role>
      <ShortName>Earnings (Loss) Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShare</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2321304 - Disclosure - Goodwill and Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables</Role>
      <ShortName>Goodwill and Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/GoodwillandIntangibleAssetsNet</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2326305 - Disclosure - Debt and Financing Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesTables</Role>
      <ShortName>Debt and Financing Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/DebtandFinancingActivities</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2334306 - Disclosure - Hedging Activities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesTables</Role>
      <ShortName>Hedging Activities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/HedgingActivities</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2338307 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/FairValueMeasurements</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2341308 - Disclosure - Commitments and Contingent Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables</Role>
      <ShortName>Commitments and Contingent Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/CommitmentsandContingentLiabilities</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2345309 - Disclosure - Stockholders' Equity (Deficit) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitTables</Role>
      <ShortName>Stockholders' Equity (Deficit) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficit</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2350310 - Disclosure - Segments of Business (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessTables</Role>
      <ShortName>Segments of Business (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SegmentsofBusiness</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Held for Sale - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HeldforSaleNarrativeDetails</Role>
      <ShortName>Held for Sale - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails</Role>
      <ShortName>Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/IncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails</Role>
      <ShortName>Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Earnings (Loss) Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/EarningsLossPerCommonShareDetails</Role>
      <ShortName>Earnings (Loss) Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/EarningsLossPerCommonShareTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2422410 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2424412 - Disclosure - Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2427413 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails</Role>
      <ShortName>Debt and Financing Activities - Schedule of Long-Term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2428414 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails</Role>
      <ShortName>Debt and Financing Activities - Long-Term Debt Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2429415 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails</Role>
      <ShortName>Debt and Financing Activities - Revolving Credit Facilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2430416 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails</Role>
      <ShortName>Debt and Financing Activities - Commercial Paper (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2432417 - Disclosure - Pension Benefits - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/PensionBenefitsNarrativeDetails</Role>
      <ShortName>Pension Benefits - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2435418 - Disclosure - Hedging Activities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesNarrativeDetails</Role>
      <ShortName>Hedging Activities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2436419 - Disclosure - Hedging Activities - Derivative Instruments Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails</Role>
      <ShortName>Hedging Activities - Derivative Instruments Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2439420 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2442421 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails</Role>
      <ShortName>Commitments and Contingent Liabilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2443422 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails</Role>
      <ShortName>Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2446423 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2447424 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2448425 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails</Role>
      <ShortName>Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/StockholdersEquityDeficitTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="mck-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2451426 - Disclosure - Segments of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://mckesson123.com/role/SegmentsofBusinessDetails</Role>
      <ShortName>Segments of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://mckesson123.com/role/SegmentsofBusinessTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="mck-20210630.htm">mck-20210630.htm</File>
    <File>mck-20210630.xsd</File>
    <File>mck-20210630_cal.xml</File>
    <File>mck-20210630_def.xml</File>
    <File>mck-20210630_lab.xml</File>
    <File>mck-20210630_pre.xml</File>
    <File>mck_exhibit311x06302021.htm</File>
    <File>mck_exhibit312x06302021.htm</File>
    <File>mck_exhibit32x06302021.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mck-20210630_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>77
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mck-20210630.htm": {
   "axisCustom": 0,
   "axisStandard": 32,
   "contextCount": 303,
   "dts": {
    "calculationLink": {
     "local": [
      "mck-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mck-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mck-20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mck-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mck-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "mck-20210630.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd"
     ]
    }
   },
   "elementCount": 548,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 5
   },
   "keyCustom": 38,
   "keyStandard": 329,
   "memberCustom": 49,
   "memberStandard": 52,
   "nsprefix": "mck",
   "nsuri": "http://mckesson123.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://mckesson123.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Held for Sale",
     "role": "http://mckesson123.com/role/HeldforSale",
     "shortName": "Held for Sale",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Restructuring, Impairment, and Related Charges",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges",
     "shortName": "Restructuring, Impairment, and Related Charges",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - Income Taxes",
     "role": "http://mckesson123.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113105 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterestDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117106 - Disclosure - Earnings (Loss) Per Common Share",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShare",
     "shortName": "Earnings (Loss) Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120107 - Disclosure - Goodwill and Intangible Assets, Net",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet",
     "shortName": "Goodwill and Intangible Assets, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125108 - Disclosure - Debt and Financing Activities",
     "role": "http://mckesson123.com/role/DebtandFinancingActivities",
     "shortName": "Debt and Financing Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131109 - Disclosure - Pension Benefits",
     "role": "http://mckesson123.com/role/PensionBenefits",
     "shortName": "Pension Benefits",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133110 - Disclosure - Hedging Activities",
     "role": "http://mckesson123.com/role/HedgingActivities",
     "shortName": "Hedging Activities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137111 - Disclosure - Fair Value Measurements",
     "role": "http://mckesson123.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140112 - Disclosure - Commitments and Contingent Liabilities",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilities",
     "shortName": "Commitments and Contingent Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144113 - Disclosure - Stockholders' Equity (Deficit)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficit",
     "shortName": "Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149114 - Disclosure - Segments of Business",
     "role": "http://mckesson123.com/role/SegmentsofBusiness",
     "shortName": "Segments of Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307301 - Disclosure - Restructuring, Impairment, and Related Charges (Tables)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables",
     "shortName": "Restructuring, Impairment, and Related Charges (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314302 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - Earnings (Loss) Per Common Share (Tables)",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareTables",
     "shortName": "Earnings (Loss) Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321304 - Disclosure - Goodwill and Intangible Assets, Net (Tables)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables",
     "shortName": "Goodwill and Intangible Assets, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326305 - Disclosure - Debt and Financing Activities (Tables)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesTables",
     "shortName": "Debt and Financing Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334306 - Disclosure - Hedging Activities (Tables)",
     "role": "http://mckesson123.com/role/HedgingActivitiesTables",
     "shortName": "Hedging Activities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338307 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341308 - Disclosure - Commitments and Contingent Liabilities (Tables)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables",
     "shortName": "Commitments and Contingent Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345309 - Disclosure - Stockholders' Equity (Deficit) (Tables)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitTables",
     "shortName": "Stockholders' Equity (Deficit) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2350310 - Disclosure - Segments of Business (Tables)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessTables",
     "shortName": "Segments of Business (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Significant Accounting Policies - Narrative (Details)",
     "role": "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ie2dde5d2936140a6940741e305619e4e_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Held for Sale - Narrative (Details)",
     "role": "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
     "shortName": "Held for Sale - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i6a911394561149eeb8e541a9ff705e67_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Restructuring, Impairment, and Related Charges - Narrative (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringSettlementAndImpairmentProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Summary of Restructuring Charges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i507f1cf3441d436a9874220e71af41c3_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410405 - Disclosure - Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)",
     "role": "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
     "shortName": "Restructuring, Impairment, and Related Charges - Summary of Restructuring Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i507f1cf3441d436a9874220e71af41c3_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Income Taxes (Details)",
     "role": "http://mckesson123.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ie2dde5d2936140a6940741e305619e4e_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i507f1cf3441d436a9874220e71af41c3_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i63b54516555043abafd60e6f00353370_I20210412",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i63b54516555043abafd60e6f00353370_I20210412",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:NoncontrollingInterestsPutRightExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eurPerShare",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i507f1cf3441d436a9874220e71af41c3_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)",
     "role": "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
     "shortName": "Redeemable Noncontrolling Interests and Noncontrolling Interests - Schedule of Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iedb46ad9eb03415b8c3ef478a437c8d0_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:MinorityInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Earnings (Loss) Per Common Share (Details)",
     "role": "http://mckesson123.com/role/EarningsLossPerCommonShareDetails",
     "shortName": "Earnings (Loss) Per Common Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i507f1cf3441d436a9874220e71af41c3_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422410 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Amount of Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ie2dde5d2936140a6940741e305619e4e_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Schedule of Information Regarding Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ie2dde5d2936140a6940741e305619e4e_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424412 - Disclosure - Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)",
     "role": "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails",
     "shortName": "Goodwill and Intangible Assets, Net - Narrative - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ie2dde5d2936140a6940741e305619e4e_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427413 - Disclosure - Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
     "shortName": "Debt and Financing Activities - Schedule of Long-Term Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ie2dde5d2936140a6940741e305619e4e_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ie2dde5d2936140a6940741e305619e4e_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeaseObligations",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428414 - Disclosure - Debt and Financing Activities - Long-Term Debt Narrative (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
     "shortName": "Debt and Financing Activities - Long-Term Debt Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i52b40196e15a40109ba391d8c6419991_I20210717",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRepurchasedFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iacf778d3b2e94d20a54cbcb22993e5bf_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429415 - Disclosure - Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
     "shortName": "Debt and Financing Activities - Revolving Credit Facilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iacf778d3b2e94d20a54cbcb22993e5bf_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "id40f1c8ac21f4308bf805ca389c79975_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430416 - Disclosure - Debt and Financing Activities - Commercial Paper (Details)",
     "role": "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
     "shortName": "Debt and Financing Activities - Commercial Paper (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "id40f1c8ac21f4308bf805ca389c79975_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ie2dde5d2936140a6940741e305619e4e_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ie2dde5d2936140a6940741e305619e4e_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ia550dbf4b8264bfb9f5b32e88da36352_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432417 - Disclosure - Pension Benefits - Narrative (Details)",
     "role": "http://mckesson123.com/role/PensionBenefitsNarrativeDetails",
     "shortName": "Pension Benefits - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ia550dbf4b8264bfb9f5b32e88da36352_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435418 - Disclosure - Hedging Activities - Narrative (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
     "shortName": "Hedging Activities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iddb83da1863c4b8384938b9fad9620c2_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "id0d9f4fb8711478cb44177fe5109b6be_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436419 - Disclosure - Hedging Activities - Derivative Instruments Fair Value (Details)",
     "role": "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
     "shortName": "Hedging Activities - Derivative Instruments Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "id0d9f4fb8711478cb44177fe5109b6be_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ie6b3e479a7ba41eab5874e29f520ca6e_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439420 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://mckesson123.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ie6b3e479a7ba41eab5874e29f520ca6e_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "id5cbe1ba860d47aaa8b10c167bd7e101_D20210401-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValuePeriodIncreaseDecrease",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442421 - Disclosure - Commitments and Contingent Liabilities - Narrative (Details)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
     "shortName": "Commitments and Contingent Liabilities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "id5cbe1ba860d47aaa8b10c167bd7e101_D20210401-20210630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "mck:LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i4466b2bd90eb4851915c2314922946d0_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443422 - Disclosure - Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)",
     "role": "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
     "shortName": "Commitments and Contingent Liabilities - Estimated Accrual Liability (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i4466b2bd90eb4851915c2314922946d0_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualCarryingValueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ie2dde5d2936140a6940741e305619e4e_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:CommonStockVotingRightsNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446423 - Disclosure - Stockholders' Equity (Deficit) - Narrative (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails",
     "shortName": "Stockholders' Equity (Deficit) - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "ie2dde5d2936140a6940741e305619e4e_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mck:CommonStockVotingRightsNumberofVotesPerCommonShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "vote",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447424 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails",
     "shortName": "Stockholders' Equity (Deficit) - Schedule of Other Comprehensive Income (Loss), Net of Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i507f1cf3441d436a9874220e71af41c3_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448425 - Disclosure - Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)",
     "role": "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
     "shortName": "Stockholders' Equity (Deficit) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) by Component (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i7a707105caaf4446872eecd75721360b_I20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451426 - Disclosure - Segments of Business (Details)",
     "role": "http://mckesson123.com/role/SegmentsofBusinessDetails",
     "shortName": "Segments of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mck:CorporateOperatingExpenseandOtherIncomeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i72ec1598f96f46b4a2aa09a894edbf4e_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "i72ec1598f96f46b4a2aa09a894edbf4e_I20200331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Significant Accounting Policies",
     "role": "http://mckesson123.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mck-20210630.htm",
      "contextRef": "iff44e00c31454749a800ec4298771ea3_D20210401-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 104,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mck_A063EuroNotesDueAugust172021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.63% Euro Notes Due August 17, 2021",
        "label": "0.63% Euro Notes Due August 17, 2021 [Member]",
        "terseLabel": "0.63% Euro Notes due August 17, 2021"
       }
      }
     },
     "localname": "A063EuroNotesDueAugust172021Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A090NotesDueDecember32025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.90% Notes Due December 3, 2025",
        "label": "0.90% Notes Due December 3, 2025 [Member]",
        "terseLabel": "0.90% Notes due December 3, 2025"
       }
      }
     },
     "localname": "A090NotesDueDecember32025Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1500NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.500% Notes Due 2025",
        "label": "1.500% Notes Due 2025 [Member]",
        "terseLabel": "1.500% Notes Due 2025"
       }
      }
     },
     "localname": "A1500NotesDue2025Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A150EuroNotesDueNovember172025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.50% Euro Notes Due November 17, 2025",
        "label": "1.50% Euro Notes Due November 17, 2025 [Member]",
        "terseLabel": "1.50% Euro Notes due November 17, 2025"
       }
      }
     },
     "localname": "A150EuroNotesDueNovember172025Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A1625NotesDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.625% Notes Due 2026",
        "label": "1.625% Notes Due 2026 [Member]",
        "terseLabel": "1.625% Notes Due 2026"
       }
      }
     },
     "localname": "A1625NotesDue2026Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A163EuroNotesDueOctober302026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.63% Euro Notes Due October 30, 2026",
        "label": "1.63% Euro Notes Due October 30, 2026 [Member]",
        "terseLabel": "1.63% Euro Notes due October 30, 2026"
       }
      }
     },
     "localname": "A163EuroNotesDueOctober302026Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A2025NotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Notes",
        "label": "2025 Notes [Member]",
        "terseLabel": "2025 Notes"
       }
      }
     },
     "localname": "A2025NotesMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A270NotesDueDecember152022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.70% Notes Due December 15, 2022",
        "label": "2.70% Notes Due December 15, 2022 [Member]",
        "terseLabel": "2.70% Notes due December 15, 2022"
       }
      }
     },
     "localname": "A270NotesDueDecember152022Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A285NotesDueMarch152023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.85% Notes Due March 15, 2023",
        "label": "2.85% Notes Due March 15, 2023 [Member]",
        "terseLabel": "2.85% Notes due March 15, 2023"
       }
      }
     },
     "localname": "A285NotesDueMarch152023Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A3125NotesDue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.125% Notes Due 2029",
        "label": "3.125% Notes Due 2029 [Member]",
        "terseLabel": "3.125% Notes Due 2029"
       }
      }
     },
     "localname": "A3125NotesDue2029Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A313SterlingNotesDueFebruary172029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.13% Sterling Notes Due February 17, 2029",
        "label": "3.13% Sterling Notes Due February 17, 2029 [Member]",
        "terseLabel": "3.13% Sterling Notes due February 17, 2029"
       }
      }
     },
     "localname": "A313SterlingNotesDueFebruary172029Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A380NotesDueMarch152024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.80% Notes Due March 15, 2024",
        "label": "3.80% Notes Due March 15, 2024 [Member]",
        "terseLabel": "3.80% Notes due March 15, 2024"
       }
      }
     },
     "localname": "A380NotesDueMarch152024Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A395NotesDueFebruary162028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.95% Notes Due February 16, 2028",
        "label": "3.95% Notes Due February 16, 2028 [Member]",
        "terseLabel": "3.95% Notes due February 16, 2028"
       }
      }
     },
     "localname": "A395NotesDueFebruary162028Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A475NotesDueMay302029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.75% Notes Due May 30, 2029",
        "label": "4.75% Notes Due May 30, 2029 [Member]",
        "terseLabel": "4.75% Notes due May 30, 2029"
       }
      }
     },
     "localname": "A475NotesDueMay302029Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A488NotesDueMarch152044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.88% Notes Due March 15, 2044",
        "label": "4.88% Notes Due March 15, 2044 [Member]",
        "terseLabel": "4.88% Notes due March 15, 2044"
       }
      }
     },
     "localname": "A488NotesDueMarch152044Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A600NotesDueMarch12041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "6.00% Notes Due March 1, 2041",
        "label": "6.00% Notes Due March 1, 2041 [Member]",
        "terseLabel": "6.00% Notes due March 1, 2041"
       }
      }
     },
     "localname": "A600NotesDueMarch12041Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_A765DebenturesDueMarch12027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "7.65% Debentures Due March 1, 2027",
        "label": "7.65% Debentures Due March 1, 2027 [Member]",
        "terseLabel": "7.65% Debentures due March 1, 2027"
       }
      }
     },
     "localname": "A765DebenturesDueMarch12027Member",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AcceleratedShareRepurchaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchase [Member]",
        "label": "Accelerated Share Repurchase [Member]",
        "terseLabel": "Accelerated Share Repurchase"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]",
        "label": "Accumulated Defined Benefit Plans Adjustment, Amortization of Actuarial Loss, Prior Service Cost and Transition Obligation, Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Amortization of actuarial loss, prior service cost and transition obligation, net of income tax expense"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentAmortizationofActuarialLossPriorServiceCostandTransitionObligationIncludingPortionAttributabletoNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service and Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Net actuarial loss and prior servicecost arising during the period, net of income tax benefit"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceandNetGainLossIncludingPortionAttributabletoNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "label": "Accumulated Defined Benefit Plans, Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments and other, net of income tax expense"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansForeignCurrencyAdjustmentIncludingPortionAttributabletoNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "label": "Adjustments to Additional Paid in Capital, Exercise of Put Right",
        "terseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe AG",
        "verboseLabel": "Associated increase in Company's ownership interest on its equity"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_AnnualRecurringCompensationPerSharetoNoncontrollingInterests": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "label": "Annual Recurring Compensation Per Share to Noncontrolling Interests",
        "terseLabel": "Annual recurring dividend (in euro per share)"
       }
      }
     },
     "localname": "AnnualRecurringCompensationPerSharetoNoncontrollingInterests",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_AssetImpairmentChargesIncludingAcceleratedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Impairment Charges, Including Accelerated Depreciation",
        "label": "Asset Impairment Charges, Including Accelerated Depreciation",
        "terseLabel": "Asset impairments and accelerated depreciation"
       }
      }
     },
     "localname": "AssetImpairmentChargesIncludingAcceleratedDepreciation",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_BritishPoundSterlingDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "British Pound Sterling Denominated Notes [Member]",
        "label": "British Pound Sterling Denominated Notes [Member]",
        "terseLabel": "British Pound Sterling Denominated Notes"
       }
      }
     },
     "localname": "BritishPoundSterlingDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_CommonStockVotingRightsNumberofVotesPerCommonShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "label": "Common Stock, Voting Rights, Number of Votes Per Common Share",
        "terseLabel": "Number of votes per share of common stock permitted on proposals presented to stockholders (vote)"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberofVotesPerCommonShare",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_CorporateOperatingExpenseandOtherIncomeNet": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/SegmentsofBusinessDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Operating Expense and Other Income, Net",
        "label": "Corporate Operating Expense and Other Income, Net",
        "negatedTerseLabel": "Corporate income (expenses), net"
       }
      }
     },
     "localname": "CorporateOperatingExpenseandOtherIncomeNet",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_CurrentAssetLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Asset / Liability [Member]",
        "label": "Current Asset / Liability [Member]",
        "terseLabel": "Prepaid expenses and other/Other accrued liabilities"
       }
      }
     },
     "localname": "CurrentAssetLiabilityMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_DisposalGroupIncludingDiscontinuedOperationConsiderationExpected": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Expected",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Expected",
        "terseLabel": "Purchase price"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationExpected",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down, Expected",
        "label": "Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down, Expected",
        "terseLabel": "Charge to remeasure to lower of carrying amount or fair value less costs to sell"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationLossGainOnWriteDownExpected",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_EuroDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Denominated Notes [Member]",
        "label": "Euro Denominated Notes [Member]",
        "terseLabel": "Euro Denominated Notes"
       }
      }
     },
     "localname": "EuroDenominatedNotesMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_EuropeanBusinessesDisposalGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "European Businesses (Disposal Group)",
        "label": "European Businesses (Disposal Group) [Member]",
        "terseLabel": "European Businesses (Disposal Group)"
       }
      }
     },
     "localname": "EuropeanBusinessesDisposalGroupMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Four",
        "terseLabel": "Estimated annual amortization expense, thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]",
        "label": "Forward Contracts to Hedge Euro Against British Pound Cash Flows [Member]",
        "terseLabel": "Forward contracts to hedge Euro against British Pound cash flows"
       }
      }
     },
     "localname": "ForwardContractstoHedgeEuroAgainstBritishPoundCashFlowsMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_GovernmentalEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Governmental Entities",
        "label": "Governmental Entities [Member]",
        "terseLabel": "Governmental entities"
       }
      }
     },
     "localname": "GovernmentalEntitiesMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_HeldForSalePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Held for Sale",
        "label": "Held for Sale [Policy Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "HeldForSalePolicyTextBlock",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mck_IncreaseDecreaseInLitigationReserve": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Litigation Reserve",
        "label": "Increase (Decrease) in Litigation Reserve",
        "terseLabel": "Litigation liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInLitigationReserve",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_IndividualClaimantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Claimant",
        "label": "Individual Claimant [Member]",
        "terseLabel": "An individual"
       }
      }
     },
     "localname": "IndividualClaimantMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_InternationalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment",
        "label": "International Segment [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalSegmentMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award",
        "label": "Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement Award",
        "terseLabel": "Portion of settlement to be paid by the Company"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementAward",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Award Amount To Be Used by State and Local Government",
        "label": "Litigation Settlement, Award Amount To Be Used by State and Local Government",
        "terseLabel": "Portion of settlement award to be used by state and local government for remediation (percent)"
       }
      }
     },
     "localname": "LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_LossContingencyAccrualAfterTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Accrual, After Tax",
        "label": "Loss Contingency Accrual, After Tax",
        "terseLabel": "After-tax accrual"
       }
      }
     },
     "localname": "LossContingencyAccrualAfterTax",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Accrual, Period Increase (Decrease), Net of Tax",
        "label": "Loss Contingency Accrual, Period Increase (Decrease), Net of Tax",
        "terseLabel": "After-tax expenses related to estimated litigation liability"
       }
      }
     },
     "localname": "LossContingencyAccrualPeriodIncreaseDecreaseNetOfTax",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_LossContingencyNumberOfOtherDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Other Defendants",
        "label": "Loss Contingency, Number of Other Defendants",
        "terseLabel": "Number of other national distributors named in suit"
       }
      }
     },
     "localname": "LossContingencyNumberOfOtherDefendants",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts",
        "label": "Loss Contingency, Number of Cases Selected For Remand to Other Federal Courts",
        "terseLabel": "Number of cases selected for remand to other federal courts"
       }
      }
     },
     "localname": "LossContingencyNumberofCasesSelectedForRemandtoOtherFederalCourts",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStateAttorneyGenerals": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of State Attorney Generals",
        "label": "Loss Contingency, Number of State Attorney Generals",
        "terseLabel": "Number of attorney generals that have filed claims"
       }
      }
     },
     "localname": "LossContingencyNumberofStateAttorneyGenerals",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencyNumberofStates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States",
        "label": "Loss Contingency, Number of States",
        "terseLabel": "Number of states in which court cases are pending"
       }
      }
     },
     "localname": "LossContingencyNumberofStates",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_LossContingencySettlementAgreementAwardPaymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "label": "Loss Contingency, Settlement Agreement, Award Payment Period",
        "terseLabel": "Period over which award would be payable under proposed framework"
       }
      }
     },
     "localname": "LossContingencySettlementAgreementAwardPaymentPeriod",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mck_MckessonEuropeSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mckesson Europe Subsidiary [Member]",
        "label": "Mckesson Europe Subsidiary [Member]",
        "terseLabel": "McKesson Europe Subsidiary"
       }
      }
     },
     "localname": "MckessonEuropeSubsidiaryMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_MedicalSurgicalSolutionsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical-Surgical Solutions Segment [Member]",
        "label": "Medical-Surgical Solutions Segment [Member]",
        "terseLabel": "Medical-Surgical Solutions"
       }
      }
     },
     "localname": "MedicalSurgicalSolutionsSegmentMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NationalPrescriptionOpiateLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In re: National Prescription Opiate Litigation [Member]",
        "label": "National Prescription Opiate Litigation [Member]",
        "terseLabel": "National Prescription Opioid Litigation"
       }
      }
     },
     "localname": "NationalPrescriptionOpiateLitigationMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestDecreaseForExerciseOfPutRight": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "label": "Noncontrolling Interest, Decrease for Exercise of Put Right",
        "negatedTerseLabel": "Exercises of Put Right",
        "terseLabel": "Decrease in noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseForExerciseOfPutRight",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestIncreaseDecreaseDuetoOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "label": "Noncontrolling Interest, Increase (Decrease) Due to Other",
        "terseLabel": "Other",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDecreaseDuetoOther",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price",
        "label": "Noncontrolling Interests, Put Right, Exercise Price",
        "terseLabel": "Put right redemption price per share (in euros per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePrice",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NoncontrollingInterestsPutRightExercisePriceIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests, Put Right, Exercise Price Increase",
        "label": "Noncontrolling Interests, Put Right, Exercise Price Increase",
        "terseLabel": "Increase in Put Amount (in Euros per share)"
       }
      }
     },
     "localname": "NoncontrollingInterestsPutRightExercisePriceIncrease",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mck_NoncurrentAssetLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-current Asset / Liability [Member]",
        "label": "Non-current Asset / Liability [Member]",
        "terseLabel": "Non-current Asset / Liability"
       }
      }
     },
     "localname": "NoncurrentAssetLiabilityMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_November2018CrossCurrencySwapsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2018 Cross Currency Swaps [Member]",
        "label": "November 2018 Cross Currency Swaps [Member]",
        "terseLabel": "November 2018 cross currency swaps"
       }
      }
     },
     "localname": "November2018CrossCurrencySwapsMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_NumberOfBusinessOperations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Business Operations",
        "label": "Number of Business Operations",
        "terseLabel": "Number of business operations"
       }
      }
     },
     "localname": "NumberOfBusinessOperations",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_NumberOfNationalBrandMedicalSurgicalProducts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of National Brand Medical-Surgical Products",
        "label": "Number of National Brand Medical-Surgical Products",
        "terseLabel": "Number of national brand medical-surgical products offered (more than)"
       }
      }
     },
     "localname": "NumberOfNationalBrandMedicalSurgicalProducts",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mck_OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids",
        "label": "Opioid Stewardship Act, Annual Surcharge on Licensed Manufacturers and Distributors of Opioids",
        "terseLabel": "Aggregate annual surcharge on licensed manufacturers and distributors of opioids"
       }
      }
     },
     "localname": "OpioidStewardshipActAnnualSurchargeOnLicensedManufacturersAndDistributorsOfOpioids",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax",
        "label": "Other Comprehensive Income (Loss) Defined Benefit Plans Net Unamortized Gain Loss Attributable to Redeemable Noncontrolling Interest Arising During Period Net Of Tax",
        "terseLabel": "Net actuarial gain (losses) attributable to redeemable noncontrolling interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlansNetUnamortizedGainLossAttributabletoRedeemableNoncontrollingInterestArisingDuringPeriodNetOfTax",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest",
        "label": "Other Comprehensive Income (Loss) Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Redeemable Noncontrolling Interest",
        "terseLabel": "Translation gain (loss) attributable to redeemable noncontrolling interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income Translation Impact On Pension Plans, Tax",
        "label": "Other Comprehensive Income Translation Impact On Pension Plans, Tax",
        "terseLabel": "Foreign currency translation adjustments and other, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeTranslationImpactOnPensionPlansTax",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_PharmacyLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy licenses [Member]",
        "label": "Pharmacy Licenses [Member]",
        "terseLabel": "Pharmacy licenses"
       }
      }
     },
     "localname": "PharmacyLicensesMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PrescriptionTechnologySolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Segment [Member]",
        "label": "Prescription Technology Solutions [Member]",
        "terseLabel": "Prescription Technology Solutions"
       }
      }
     },
     "localname": "PrescriptionTechnologySolutionsMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_PutRightValueInterestRateSpread": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Put Right Value, Interest Rate Spread",
        "label": "Put Right Value, Interest Rate Spread",
        "terseLabel": "Put right value, interest rate spread (as a percent)"
       }
      }
     },
     "localname": "PutRightValueInterestRateSpread",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_ReclassificationOfTemporaryEquityToNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Noncontrolling Interest",
        "label": "Reclassification of Temporary Equity to Noncontrolling Interest",
        "negatedLabel": "Reclassification of McKesson Europe redeemable noncontrolling interests",
        "negatedTerseLabel": "Reclassification of McKesson Europe redeemable noncontrolling interests"
       }
      }
     },
     "localname": "ReclassificationOfTemporaryEquityToNoncontrollingInterest",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_ReclassificationofTemporaryEquitytoLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification of Temporary Equity to Liability",
        "label": "Reclassification of Temporary Equity to Liability",
        "negatedTerseLabel": "Reclassification of recurring compensation to other accrued liabilities"
       }
      }
     },
     "localname": "ReclassificationofTemporaryEquitytoLiability",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RedeemableNoncontrollingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interest [Member]",
        "label": "Redeemable Noncontrolling Interest [Member]",
        "terseLabel": "Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RedeemableNoncontrollingInterestsMaximumRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interests, Maximum Redemption Value",
        "label": "Redeemable Noncontrolling Interests, Maximum Redemption Value",
        "terseLabel": "Maximum redemption value of redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestsMaximumRedemptionValue",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "label": "Repurchase of Redeemable Noncontrolling Interest, Shares Repurchased",
        "terseLabel": "Shares purchased (shares)"
       }
      }
     },
     "localname": "RepurchaseOfRedeemableNoncontrollingInterestSharesRepurchased",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mck_RestructuringImpairmentandOtherRelatedCharges": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring, Impairment and Other Related Charges",
        "label": "Restructuring, Impairment and Other Related Charges",
        "negatedTerseLabel": "Restructuring, impairment, and related charges"
       }
      }
     },
     "localname": "RestructuringImpairmentandOtherRelatedCharges",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_RestructuringPlanRemoteWorkTransitioningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Plan, Remote Work Transitioning",
        "label": "Restructuring Plan, Remote Work Transitioning [Member]",
        "terseLabel": "Restructuring Plan - Remote Work Transitioning"
       }
      }
     },
     "localname": "RestructuringPlanRemoteWorkTransitioningMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments",
        "label": "Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments [Member]",
        "terseLabel": "Restructuring Type, Exit Related Costs, Accelerated Depreciation, Amortization and Asset Impairments"
       }
      }
     },
     "localname": "RestructuringTypeExitRelatedCostsAcceleratedDepreciationAmortizationAndAssetImpairmentsMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_RevenueDerivedFromServicesPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Derived From Services, Percentage",
        "label": "Revenue Derived From Services, Percentage",
        "terseLabel": "Revenue derived from services, percentage (less than)"
       }
      }
     },
     "localname": "RevenueDerivedFromServicesPercentage",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility), Canadian Dollar, British Pound Sterling, and Euros Sublimit [Member]",
        "terseLabel": "Canadian Dollar, British Pound Sterling, and Euros Sublimit"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityCanadianDollarBritishPoundSterlingandEurosSublimitMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "label": "Senior Unsecured Credit Facility (the 2020 Credit Facility) [Member]",
        "terseLabel": "The 2020 Credit Facility"
       }
      }
     },
     "localname": "SeniorUnsecuredCreditFacilitythe2020CreditFacilityMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ShareholderDerivativeActionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shareholder Derivative Action",
        "label": "Shareholder Derivative Action [Member]",
        "terseLabel": "Shareholder derivative action"
       }
      }
     },
     "localname": "ShareholderDerivativeActionMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateAndLocalGovernmentalEntitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State and Local Governmental Entities",
        "label": "State and Local Governmental Entities [Member]",
        "terseLabel": "State and local governmental entities"
       }
      }
     },
     "localname": "StateAndLocalGovernmentalEntitiesMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOfNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State of New York",
        "label": "State of New York [Member]",
        "terseLabel": "State of New York"
       }
      }
     },
     "localname": "StateOfNewYorkMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StateOpioidStatutesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "State Opioid Statutes",
        "label": "State Opioid Statutes [Member]",
        "terseLabel": "State Opioid Statutes"
       }
      }
     },
     "localname": "StateOpioidStatutesMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Additional Amount Authorized to be Repurchased",
        "label": "Stock Repurchase Program, Additional Amount Authorized to be Repurchased",
        "terseLabel": "Approved increase to the authorized share repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAdditionalAmountAuthorizedToBeRepurchased",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mck_TenderOfferNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tender Offer Notes",
        "label": "Tender Offer Notes [Member]",
        "terseLabel": "Tender Offer Notes"
       }
      }
     },
     "localname": "TenderOfferNotesMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_ThreeLargestU.S.PharmaceuticalDistributorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "label": "Three Largest U.S. Pharmaceutical Distributors [Member]",
        "terseLabel": "Three Largest U.S. Pharmaceutical Distributors"
       }
      }
     },
     "localname": "ThreeLargestU.S.PharmaceuticalDistributorsMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_USPharmaceuticalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Pharmaceutical Segment [Member]",
        "label": "U.S. Pharmaceutical Segment [Member]",
        "terseLabel": "U.S. Pharmaceutical"
       }
      }
     },
     "localname": "USPharmaceuticalSegmentMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mck_VantageandClarusOneSourcingServicesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "label": "Vantage and ClarusOne Sourcing Services LLC [Member]",
        "terseLabel": "Vantage and ClarusOne Sourcing Services LLC"
       }
      }
     },
     "localname": "VantageandClarusOneSourcingServicesLLCMember",
     "nsuri": "http://mckesson123.com/20210630",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r147",
      "r198",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r218",
      "r222",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r302",
      "r304",
      "r306",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r147",
      "r198",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r218",
      "r222",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r301",
      "r302",
      "r304",
      "r306",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r69",
      "r71",
      "r145",
      "r146",
      "r313",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r0",
      "r152",
      "r157",
      "r233",
      "r471",
      "r472",
      "r473",
      "r488",
      "r489",
      "r553",
      "r555",
      "r556",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Adjusted balance, April 1"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r0",
      "r152",
      "r157",
      "r163",
      "r233",
      "r471",
      "r472",
      "r473",
      "r488",
      "r489",
      "r553",
      "r554",
      "r555",
      "r556",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Opening retained earnings adjustment: adoption of new accounting standard"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r0",
      "r152",
      "r157",
      "r163",
      "r233",
      "r471",
      "r472",
      "r473",
      "r488",
      "r489",
      "r553",
      "r554",
      "r555",
      "r556",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r0",
      "r152",
      "r157",
      "r163",
      "r233",
      "r471",
      "r472",
      "r473",
      "r488",
      "r489",
      "r553",
      "r554",
      "r555",
      "r556",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r312",
      "r349",
      "r455",
      "r461",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r609",
      "r655",
      "r657",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r312",
      "r349",
      "r455",
      "r461",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r609",
      "r655",
      "r657",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r312",
      "r349",
      "r399",
      "r455",
      "r461",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r609",
      "r655",
      "r657",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r312",
      "r349",
      "r399",
      "r455",
      "r461",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r609",
      "r655",
      "r657",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r70",
      "r71",
      "r145",
      "r146",
      "r313",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r158",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Expected"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r158",
      "r163",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r226",
      "r227",
      "r373",
      "r374",
      "r656",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r226",
      "r227",
      "r373",
      "r374",
      "r656",
      "r665",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r158",
      "r163",
      "r281",
      "r456",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accelerated Share Repurchases [Line Items]",
        "terseLabel": "Accelerated Share Repurchases [Line Items]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesTable": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table reflecting activity in an accelerated share repurchase (ASR) program.",
        "label": "Accelerated Share Repurchases [Table]",
        "terseLabel": "Accelerated Share Repurchases [Table]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r51",
      "r596"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r81",
      "r87",
      "r95",
      "r96",
      "r97",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Changes in retirement-related benefit plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r80",
      "r87",
      "r95",
      "r96",
      "r97",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Net Gains (Losses) and Other Components of Benefit Plans, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r75",
      "r87",
      "r95",
      "r96",
      "r97",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign Currency Translation Adjustments, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember": {
     "auth_ref": [
      "r87",
      "r95",
      "r96",
      "r97",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, including portion attributable to noncontrolling interest.",
        "label": "Accumulated Gain (Loss), Cash Flow Hedge, Including Noncontrolling Interest [Member]",
        "terseLabel": "Unrealized Gains (Losses) on Cash Flow Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r87",
      "r95",
      "r96",
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Including Noncontrolling Interest [Member]",
        "verboseLabel": "Unrealized Losses on Net Investment Hedges, Net of Tax"
       }
      }
     },
     "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r42",
      "r84",
      "r86",
      "r87",
      "r637",
      "r662",
      "r663"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r95",
      "r96",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r83",
      "r87",
      "r95",
      "r96",
      "r97",
      "r149",
      "r150",
      "r151",
      "r516",
      "r658",
      "r659",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Total Accumulated Other Comprehensive Loss",
        "verboseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r40",
      "r474",
      "r596"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r471",
      "r472",
      "r473",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r133",
      "r246"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r463",
      "r465",
      "r475",
      "r476"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r133",
      "r241",
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive securities (shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r133",
      "r251"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Long-lived asset impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r142",
      "r206",
      "r213",
      "r220",
      "r232",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r509",
      "r519",
      "r570",
      "r594",
      "r596",
      "r615",
      "r635"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r28",
      "r29",
      "r67",
      "r142",
      "r232",
      "r294",
      "r295",
      "r296",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r509",
      "r519",
      "r570",
      "r594",
      "r596"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r252",
      "r255"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Current",
        "terseLabel": "Assets held for sale"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r466",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r536",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "verboseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessExitCosts1": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Business Exit Costs",
        "terseLabel": "Exit and other-related costs"
       }
      }
     },
     "localname": "BusinessExitCosts1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r26",
      "r49",
      "r135"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents at end of period"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Investments in money market funds"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r129",
      "r135",
      "r136"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r129",
      "r574"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r139",
      "r142",
      "r166",
      "r170",
      "r171",
      "r173",
      "r175",
      "r183",
      "r184",
      "r185",
      "r232",
      "r294",
      "r299",
      "r300",
      "r301",
      "r307",
      "r308",
      "r347",
      "r348",
      "r352",
      "r356",
      "r570",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r288",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingent Liabilities"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r291",
      "r667"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends declared per common share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICITParenthetical",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r149",
      "r150",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r38",
      "r596"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value, 800 shares authorized and 274 and 273 shares issued at June 30, 2021 and March 31, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComparabilityOfPriorYearFinancialData": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reporting any exceptions to the  comparability of prior year financial data with data shown for the most recent accounting period.",
        "label": "Comparability of Prior Year Financial Data, Policy [Policy Text Block]",
        "terseLabel": "Results of Operations"
       }
      }
     },
     "localname": "ComparabilityOfPriorYearFinancialData",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r91",
      "r93",
      "r94",
      "r106",
      "r628",
      "r650"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to McKesson Corporation"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r91",
      "r93",
      "r105",
      "r507",
      "r508",
      "r523",
      "r627",
      "r649"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r91",
      "r93",
      "r104",
      "r506",
      "r523",
      "r626",
      "r648"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock": {
     "auth_ref": [
      "r517",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.",
        "label": "Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block]",
        "terseLabel": "Changes in Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r137",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r222",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r111",
      "r610"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrencySwapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Swap involving the exchange of principal and interest in one currency for another currency.",
        "label": "Currency Swap [Member]",
        "terseLabel": "Cross currency swap"
       }
      }
     },
     "localname": "CurrencySwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r620",
      "r643"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term and long-term debt and lease obligation.",
        "label": "Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r138",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r326",
      "r333",
      "r334",
      "r336",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt and Financing Activities"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r33",
      "r34",
      "r35",
      "r141",
      "r147",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r338",
      "r339",
      "r340",
      "r341",
      "r587",
      "r616",
      "r617",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r324",
      "r338",
      "r339",
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Estimated fair values of liabilities"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r56",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on debt instrument (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r57",
      "r141",
      "r147",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r338",
      "r339",
      "r340",
      "r341",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price percentage of principal (percent)"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Aggregate consideration of debt redeemed"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt principal redeemed"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r57",
      "r141",
      "r147",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r335",
      "r338",
      "r339",
      "r340",
      "r341",
      "r363",
      "r364",
      "r365",
      "r366",
      "r585",
      "r586",
      "r587",
      "r588",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Syndicated senior unsecured revolving credit facility term",
        "verboseLabel": "Debt instrument term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r478",
      "r479"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Long-term deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r392",
      "r400",
      "r402",
      "r443",
      "r445",
      "r446"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Cash contributions to the plans"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of plan assets to benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Funded Percentage",
        "terseLabel": "Percentage threshold of greater of projected benefit obligation or market value of assets (percent)"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r411",
      "r435",
      "r445",
      "r446"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "terseLabel": "Net periodic pension expense"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r133",
      "r253"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r528",
      "r529",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "U.S. Dollar notional amount, asset"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative, Name [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r68",
      "r71",
      "r72",
      "r538",
      "r608"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Fair value of derivative, asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r68",
      "r71",
      "r72",
      "r538",
      "r608"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Fair value of derivative, liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r71",
      "r537",
      "r539",
      "r542",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative, by Nature [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r552",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Hedging Activities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r534",
      "r537",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilityNotionalAmount": {
     "auth_ref": [
      "r528",
      "r529",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative liability.",
        "label": "Derivative Liability, Notional Amount",
        "terseLabel": "U.S. Dollar, notional amount, liability"
       }
      }
     },
     "localname": "DerivativeLiabilityNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r529",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional values of financial instruments"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r527",
      "r530",
      "r531",
      "r534",
      "r535",
      "r541",
      "r542",
      "r548",
      "r549",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives designated for hedge accounting"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r20",
      "r250",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Held-for-sale"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r25",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Held for Sale"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSale"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r451",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson Corporation"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r107",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r164",
      "r166",
      "r173",
      "r174",
      "r175",
      "r179",
      "r180",
      "r556",
      "r557",
      "r629",
      "r651"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings (loss) per common share attributable to McKesson:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r107",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r166",
      "r173",
      "r174",
      "r175",
      "r179",
      "r180",
      "r556",
      "r557",
      "r629",
      "r651"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "totalLabel": "Total (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "terseLabel": "Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r176",
      "r177",
      "r178",
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (Loss) Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r574"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Reported income tax expense (benefit) rates (percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r95",
      "r96",
      "r97",
      "r149",
      "r150",
      "r151",
      "r154",
      "r160",
      "r162",
      "r182",
      "r233",
      "r362",
      "r367",
      "r471",
      "r472",
      "r473",
      "r488",
      "r489",
      "r555",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r582",
      "r658",
      "r659",
      "r660",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r559",
      "r560",
      "r561",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r559",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of information regarding the fair value of derivatives on a gross basis"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r324",
      "r338",
      "r339",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r445",
      "r560",
      "r599",
      "r600",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r559",
      "r560",
      "r562",
      "r563",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r324",
      "r400",
      "r402",
      "r407",
      "r445",
      "r560",
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair value, inputs, level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r324",
      "r338",
      "r339",
      "r400",
      "r402",
      "r407",
      "r445",
      "r560",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair value, inputs, level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r324",
      "r338",
      "r339",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r445",
      "r599",
      "r600",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsNonrecurringMember": {
     "auth_ref": [
      "r559",
      "r560",
      "r562",
      "r563",
      "r564",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.",
        "label": "Fair Value, Nonrecurring [Member]",
        "terseLabel": "Nonrecurring"
       }
      }
     },
     "localname": "FairValueMeasurementsNonrecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r565",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r536",
      "r541",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r590",
      "r593"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Lease and other obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r245"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Estimated annual amortization expense, 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Estimated annual amortization expense, remainder of 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Estimated annual amortization expense, 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Estimated annual amortization expense, 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r247"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Estimated annual amortization expense, 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r242",
      "r243",
      "r245",
      "r248",
      "r611",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetNarrativeIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r245",
      "r612"
     ],
     "calculation": {
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r242",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r245",
      "r611"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "terseLabel": "Weighted- Average Remaining Amortization Period (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Period"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r71",
      "r400",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "verboseLabel": "Foreign Exchange Contract"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfOtherAssets": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of other assets.",
        "label": "Gain (Loss) on Disposition of Other Assets",
        "negatedTerseLabel": "Loss from sales of businesses and investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "terseLabel": "Net gain on settlement proceeds",
        "verboseLabel": "Claims and litigation charges, net"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r236",
      "r237",
      "r596",
      "r614"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets, Net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r238"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation adjustments, net"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r108",
      "r142",
      "r206",
      "r212",
      "r216",
      "r219",
      "r222",
      "r232",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r570"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r534",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r109",
      "r134",
      "r155",
      "r156",
      "r157",
      "r158",
      "r172",
      "r175",
      "r505"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "totalLabel": "Income from continuing operations attributable to McKesson Corporation"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r100",
      "r206",
      "r212",
      "r216",
      "r219",
      "r222",
      "r613",
      "r622",
      "r630",
      "r652"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/SegmentsofBusinessDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income from continuing operations before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r142",
      "r153",
      "r206",
      "r212",
      "r216",
      "r219",
      "r222",
      "r232",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r506",
      "r557",
      "r570"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Income from continuing operations",
        "totalLabel": "Income from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r99",
      "r107",
      "r153",
      "r155",
      "r156",
      "r157",
      "r158",
      "r166",
      "r173",
      "r174",
      "r557",
      "r621",
      "r623",
      "r629",
      "r644"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Continuing operations (in dollars per share)",
        "verboseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r99",
      "r107",
      "r153",
      "r155",
      "r156",
      "r157",
      "r158",
      "r166",
      "r173",
      "r174",
      "r175",
      "r557",
      "r629",
      "r644",
      "r647",
      "r651"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Continuing operations (in dollars per share)",
        "verboseLabel": "Continuing operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r21",
      "r24",
      "r494",
      "r645"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Loss from discontinued operations, net of tax",
        "verboseLabel": "Loss from discontinued operations, net of tax"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r101",
      "r107",
      "r170",
      "r173",
      "r174",
      "r629",
      "r645",
      "r647",
      "r651"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Discontinued operations (in dollars per share)",
        "verboseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r170",
      "r173",
      "r174",
      "r525"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_EarningsPerShareDiluted",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Discontinued operations (in dollars per share)",
        "verboseLabel": "Discontinued operations (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r451",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r5",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r19",
      "r22",
      "r23",
      "r24",
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r143",
      "r482",
      "r486",
      "r487",
      "r490",
      "r492",
      "r495",
      "r496",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r144",
      "r161",
      "r162",
      "r204",
      "r480",
      "r491",
      "r493",
      "r653"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax expense",
        "terseLabel": "Income tax expense (benefit) related to continuing operations"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Drafts and accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.",
        "label": "Increase (Decrease) in Accrued Taxes Payable",
        "terseLabel": "Taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Assets [Abstract]",
        "terseLabel": "Changes in assets and liabilities, net of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r132",
      "r592"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Noncontrolling Interests"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r175"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Restricted stock units (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestAndDebtExpense": {
     "auth_ref": [
      "r584"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      },
      "http://mckesson123.com/role/SegmentsofBusinessDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.",
        "label": "Interest and Debt Expense",
        "negatedLabel": "Interest expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestAndDebtExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Forward starting interest rate swaps"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryLIFOReservePeriodCharge": {
     "auth_ref": [
      "r64",
      "r65",
      "r66",
      "r235"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods, which change has been reflected in the statement of income during the period.",
        "label": "Inventory, LIFO Reserve, Period Charge",
        "negatedLabel": "Pre-tax credits related to LIFO accounting",
        "terseLabel": "Credits associated with last-in, first-out inventory method"
       }
      }
     },
     "localname": "InventoryLIFOReservePeriodCharge",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r27",
      "r63",
      "r596"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory impairments and excess inventory"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r45",
      "r142",
      "r232",
      "r570",
      "r596",
      "r619",
      "r640"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable noncontrolling interests, and equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS, AND EQUITY (DEFICIT)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r55",
      "r142",
      "r232",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r510",
      "r519",
      "r520",
      "r570",
      "r594",
      "r595",
      "r596"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r559"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Liabilities measured at fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r18",
      "r20",
      "r24",
      "r252",
      "r255"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current",
        "terseLabel": "Liabilities held for sale"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r35",
      "r617",
      "r634"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Amounts outstanding under facility"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum amount of borrowing capacity under a line of credit that is available as of the balance sheet date for a specific purpose other than for financing goods acquired for inventory or imminent delivery to a customer.",
        "label": "Line of Credit Facility, Capacity Available for Specific Purpose Other than for Trade Purchases",
        "terseLabel": "Committed balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityCapacityAvailableForSpecificPurposeOtherThanForTradePurchases",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "terseLabel": "Uncommitted balance"
       }
      }
     },
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "netLabel": "Outstanding notes (up to)",
        "terseLabel": "Syndicated senior unsecured revolving credit facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r52",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationReserveNoncurrent": {
     "auth_ref": [
      "r59",
      "r280"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer.",
        "label": "Estimated Litigation Liability, Noncurrent",
        "terseLabel": "Long-term litigation liabilities"
       }
      }
     },
     "localname": "LitigationReserveNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Award payable under proposed framework"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term Loan",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermCommercialPaperCurrent": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the current portion of long-term unsecured obligations issued by corporations and other borrowers to investors (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Long-term Commercial Paper, Current",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "LongTermCommercialPaperCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r35",
      "r323",
      "r337",
      "r338",
      "r339",
      "r617",
      "r636"
     ],
     "calculation": {
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt outstanding",
        "verboseLabel": "Carrying amount of liabilities"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/FairValueMeasurementsDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "terseLabel": "Total long-term debt",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-term Debt and Lease Obligation, Current",
        "terseLabel": "Less: Current portion",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r57",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesScheduleofLongTermDebtDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r284",
      "r285",
      "r286",
      "r287",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r284",
      "r285",
      "r286",
      "r287",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Total litigation liabilities",
        "totalLabel": "Total litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueCurrent": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LossContingencyAccrualAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Current",
        "verboseLabel": "Current litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValueNoncurrent": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LossContingencyAccrualAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.",
        "label": "Loss Contingency, Accrual, Noncurrent",
        "verboseLabel": "Long-term litigation liabilities"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualCarryingValuePeriodIncreaseDecrease": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in loss contingency liability.",
        "label": "Loss Contingency Accrual, Period Increase (Decrease)",
        "terseLabel": "Pre-tax expenses related to estimated litigation liability"
       }
      }
     },
     "localname": "LossContingencyAccrualCarryingValuePeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r284",
      "r285",
      "r286",
      "r287",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesEstimatedAccrualLiabilityDetails",
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNumberOfDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of defendants named in a legal action.",
        "label": "Loss Contingency, Number of Defendants",
        "terseLabel": "Number of distributors"
       }
      }
     },
     "localname": "LossContingencyNumberOfDefendants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Complaints filed against the entity"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r62",
      "r142",
      "r232",
      "r294",
      "r299",
      "r300",
      "r301",
      "r307",
      "r308",
      "r570",
      "r618",
      "r639"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Payments to noncontrolling interests",
        "negatedTerseLabel": "Payments to noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "Redeemable Noncontrolling Interests and Noncontrolling Interests"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterests"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Noncontrolling Interest [Line Items]",
        "terseLabel": "Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "MinorityInterestLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Ownership percentage (as a percent)"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterestTable": {
     "auth_ref": [
      "r62",
      "r110",
      "r504",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest [Table]",
        "terseLabel": "Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "MinorityInterestTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MovementInMinorityInterestRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "MovementInMinorityInterestRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r129",
      "r131",
      "r134"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r24",
      "r89",
      "r92",
      "r97",
      "r102",
      "r134",
      "r142",
      "r153",
      "r155",
      "r156",
      "r157",
      "r158",
      "r161",
      "r162",
      "r172",
      "r206",
      "r212",
      "r216",
      "r219",
      "r222",
      "r232",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r557",
      "r570",
      "r624",
      "r646"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to McKesson Corporation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r89",
      "r92",
      "r97",
      "r161",
      "r162",
      "r513",
      "r522"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperations",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net income attributable to noncontrolling interests",
        "negatedTerseLabel": "Net income attributable to noncontrolling interests",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r110"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest",
        "verboseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]",
        "terseLabel": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r367",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated for hedge accounting"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfCountriesInWhichEntityOperates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of countries in which the entity operates as of balance sheet date.",
        "label": "Number of Countries in which Entity Operates",
        "terseLabel": "Number of countries in which entity segment operates"
       }
      }
     },
     "localname": "NumberOfCountriesInWhichEntityOperates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails",
      "http://mckesson123.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "negatedTotalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r206",
      "r212",
      "r216",
      "r219",
      "r222"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/SegmentsofBusinessDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Total operating profit",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss) [Abstract]",
        "terseLabel": "Segment operating profit"
       }
      }
     },
     "localname": "OperatingIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r591"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Non-cash operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r590"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r590"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r589"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r74",
      "r85",
      "r571",
      "r573",
      "r581"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "OCI, Foreign Currency Transaction and Translation Gain (Loss), Arising During Period, Tax",
        "terseLabel": "Foreign currency translation adjustments, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, Tax",
        "negatedTerseLabel": "Amortization of actuarial (gain) loss and prior service costs, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r87",
      "r95",
      "r96",
      "r98",
      "r575",
      "r577",
      "r582"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r85",
      "r95"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "verboseLabel": "Unrealized gains (losses) on net investment hedges arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r76",
      "r84"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Gains (losses) from cash flow hedges recorded within other comprehensive income",
        "verboseLabel": "Unrealized losses on cash flow hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Unrealized gains (loss) on cash flow hedges arising during period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "verboseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax": {
     "auth_ref": [
      "r85",
      "r573",
      "r581"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Tax",
        "terseLabel": "Reclassified to income statement, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "verboseLabel": "Gain (loss) from net investment hedges recorded within other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r90",
      "r93",
      "r95",
      "r96",
      "r98",
      "r103",
      "r362",
      "r575",
      "r580",
      "r582",
      "r625",
      "r647"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r90",
      "r93",
      "r506",
      "r507",
      "r515"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Less: amounts attributable to noncontrolling and redeemable noncontrolling interests",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r90",
      "r93",
      "r506",
      "r507",
      "r515"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Other comprehensive income (loss) attributable to McKesson"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r82",
      "r84"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Changes in retirement-related benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect": {
     "auth_ref": [
      "r85",
      "r506"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Tax",
        "terseLabel": "Net actuarial loss and prior service cost arising during the period, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r134"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other noncurrent assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "verboseLabel": "Other noncurrent liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Expected settlement payment"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r116",
      "r119"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Share repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfRedeemableNoncontrollingInterest": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period for redemption of redeemable noncontrolling interests.",
        "label": "Payments for Repurchase of Redeemable Noncontrolling Interest",
        "negatedTerseLabel": "Exercise of put right by noncontrolling shareholders of McKesson Europe AG",
        "terseLabel": "Payments for purchase shares of McKesson Europe"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfRedeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r127",
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedLabel": "Cash payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash, cash equivalents, and restricted cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Payments for property, plant, and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireSoftware": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition from vendors of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Acquire Software",
        "negatedLabel": "Capitalized software expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireSoftware",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r399",
      "r401",
      "r407",
      "r424",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r445",
      "r447",
      "r448",
      "r449",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Pension Benefits"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefits"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r375",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r425",
      "r428",
      "r432",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r449",
      "r450",
      "r457",
      "r458",
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension Plan"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r37",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r37",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r37",
      "r596"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value, 100 shares authorized, no shares issued or outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r28",
      "r47",
      "r48"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesDerivativeInstrumentsFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a business segment or subsidiary or sale of an entity that is related to it but not strictly controlled during the period (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).",
        "label": "Proceeds from Divestiture of Businesses and Interests in Affiliates",
        "terseLabel": "Proceeds from sales of businesses and investments, net"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommercialPaper": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from borrowing by issuing commercial paper.",
        "label": "Proceeds from Issuance of Commercial Paper",
        "terseLabel": "Proceeds from issuance of commercial paper"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r120",
      "r470"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Issuances"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised [Abstract]",
        "terseLabel": "Common stock transactions:"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r121",
      "r141"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowings under facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r122",
      "r126"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "terseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r24",
      "r89",
      "r92",
      "r97",
      "r128",
      "r142",
      "r153",
      "r161",
      "r162",
      "r206",
      "r212",
      "r216",
      "r219",
      "r222",
      "r232",
      "r294",
      "r295",
      "r296",
      "r299",
      "r300",
      "r301",
      "r303",
      "r305",
      "r307",
      "r308",
      "r506",
      "r512",
      "r514",
      "r522",
      "r523",
      "r557",
      "r570",
      "r630"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r31",
      "r32",
      "r254",
      "r596",
      "r631",
      "r642"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant, and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r39",
      "r46",
      "r596",
      "r641",
      "r664"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables, net"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r87",
      "r95",
      "r96",
      "r98",
      "r575",
      "r579",
      "r582"
     ],
     "calculation": {
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedLabel": "Reclassified to income statement, net of income tax expense",
        "negatedTerseLabel": "Amounts reclassified to earnings and other"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r85",
      "r88",
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "negatedTerseLabel": "Reclassified to income statement, tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCommonCarryingAmount": {
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the carrying amount of noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. The noncontrolling interest holder's ownership (or holders' ownership) may be in the form of common shares (regardless of class), limited partnership units (regardless of class), non-preferential membership interests, or any other form of common equity regardless of investee entity legal form.",
        "label": "Redeemable Noncontrolling Interest, Equity, Common, Carrying Amount",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Redeemable noncontrolling interests",
        "verboseLabel": "Carrying value of redeemable noncontrolling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCommonCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow due to repaying amounts borrowed by issuing commercial paper.",
        "label": "Repayments of Commercial Paper",
        "terseLabel": "Repayments of commercial paper"
       }
      }
     },
     "localname": "RepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesCommercialPaperDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedLabel": "Repayments of short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r26",
      "r30",
      "r136"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "negatedTerseLabel": "Less: Restricted cash at end of period included in Prepaid expenses and other"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r261",
      "r263",
      "r266",
      "r275",
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring, Impairment, and Related Charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedCharges"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r262",
      "r265",
      "r272",
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Pre-tax charges recorded to-date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r262",
      "r265",
      "r272",
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Expected total pre-tax charges"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r133",
      "r260",
      "r269",
      "r272"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring, impairment, and related charges",
        "totalLabel": "Total",
        "verboseLabel": "Net restructuring, impairment, and related charges recognized"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r262",
      "r263",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r263",
      "r270"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r263",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Non-cash charges"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAndOtherAdjustment": {
     "auth_ref": [
      "r263",
      "r270"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the restructuring reserve related to foreign currency translation (gain) loss and other increases (decreases).",
        "label": "Restructuring Reserve, Translation and Other Adjustment",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAndOtherAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringSettlementAndImpairmentProvisions": {
     "auth_ref": [
      "r112"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restructuring charges, remediation cost, and asset impairment loss.",
        "label": "Restructuring, Settlement and Impairment Provisions",
        "terseLabel": "Restructuring, impairment, and related charges recognized"
       }
      }
     },
     "localname": "RestructuringSettlementAndImpairmentProvisions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r41",
      "r367",
      "r474",
      "r596",
      "r638",
      "r661",
      "r663"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r149",
      "r150",
      "r151",
      "r154",
      "r160",
      "r162",
      "r233",
      "r471",
      "r472",
      "r473",
      "r488",
      "r489",
      "r555",
      "r658",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r425",
      "r428",
      "r432",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r457",
      "r458",
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r425",
      "r428",
      "r432",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r457",
      "r458",
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r197",
      "r198",
      "r211",
      "r217",
      "r218",
      "r225",
      "r226",
      "r229",
      "r372",
      "r373",
      "r610"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenues",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Segment revenues"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r87",
      "r580",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of information regarding changes in accumulated other comprehensive income (loss), net of tax, by component"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of information regarding other comprehensive income (loss) including noncontrolling and redeemable noncontrolling interests, net of tax, by component"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r431",
      "r432",
      "r433",
      "r434",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/PensionBenefitsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of computations for basic and diluted earnings per common share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r166",
      "r170",
      "r173",
      "r175",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r242",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of information regarding intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r239",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r239",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of changes in the carrying amount of goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r284",
      "r285",
      "r286",
      "r287",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.",
        "label": "Schedule of Loss Contingencies by Contingency [Table Text Block]",
        "terseLabel": "Schedule of Estimated Accrual Liability"
       }
      }
     },
     "localname": "ScheduleOfLossContingenciesByContingencyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r265",
      "r272",
      "r273",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r267",
      "r268",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring, Impairment, and Related Costs"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r263",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring and Asset Impairment Charges"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r206",
      "r209",
      "r215",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r206",
      "r209",
      "r215",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of financial information relating to reportable operating segments and reconciliations to the condensed consolidated totals"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r193",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r229",
      "r265",
      "r274",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r193",
      "r195",
      "r196",
      "r206",
      "r210",
      "r216",
      "r220",
      "r221",
      "r222",
      "r223",
      "r225",
      "r228",
      "r229",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segments of Business"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information, Profit (Loss) [Abstract]",
        "terseLabel": "Segment Reporting Information, Profit (Loss) [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "negatedTerseLabel": "Selling, distribution, general, and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ServiceAgreementsMember": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.",
        "label": "Service Agreements [Member]",
        "terseLabel": "Service agreements"
       }
      }
     },
     "localname": "ServiceAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance and employee-related costs, net"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r464",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (shares)",
        "periodStartLabel": "Beginning balance (shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r11",
      "r193",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r211",
      "r212",
      "r213",
      "r214",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r229",
      "r239",
      "r256",
      "r265",
      "r274",
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Business Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofChangesintheCarryingAmountofGoodwillDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringActivityDetails",
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesSummaryofRestructuringChargesDetails",
      "http://mckesson123.com/role/SegmentsofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r36",
      "r37",
      "r38",
      "r139",
      "r142",
      "r166",
      "r170",
      "r171",
      "r173",
      "r175",
      "r183",
      "r184",
      "r185",
      "r232",
      "r294",
      "r299",
      "r300",
      "r301",
      "r307",
      "r308",
      "r347",
      "r348",
      "r352",
      "r356",
      "r362",
      "r570",
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r61",
      "r95",
      "r96",
      "r97",
      "r149",
      "r150",
      "r151",
      "r154",
      "r160",
      "r162",
      "r182",
      "r233",
      "r362",
      "r367",
      "r471",
      "r472",
      "r473",
      "r488",
      "r489",
      "r555",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r582",
      "r658",
      "r659",
      "r660",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsNarrativeDetails",
      "http://mckesson123.com/role/RedeemableNoncontrollingInterestsandNoncontrollingInterestsScheduleofChangesinRedeemableNoncontrollingInterestsandNoncontrollingInterestsDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r182",
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r37",
      "r38",
      "r362",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of shares under employee plans (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r37",
      "r38",
      "r362",
      "r367"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of shares under employee plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Authorized amount available for future repurchases"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r37",
      "r38",
      "r362",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock (shares)",
        "terseLabel": "Share repurchases (shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r37",
      "r38",
      "r362",
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Repurchase of common stock",
        "terseLabel": "Shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r38",
      "r43",
      "r44",
      "r142",
      "r231",
      "r232",
      "r570",
      "r596"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total McKesson Corporation stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "McKesson Corporation stockholders\u2019 deficit"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r96",
      "r142",
      "r149",
      "r150",
      "r151",
      "r154",
      "r160",
      "r232",
      "r233",
      "r367",
      "r471",
      "r472",
      "r473",
      "r488",
      "r489",
      "r503",
      "r504",
      "r521",
      "r555",
      "r570",
      "r575",
      "r576",
      "r582",
      "r659",
      "r660",
      "r687"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofChangesinAccumulatedOtherComprehensiveIncomeLossbyComponentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r140",
      "r348",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r367",
      "r371"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity (Deficit)"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/StockholdersEquityDeficit"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r583",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r583",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r583",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CommitmentsandContingentLiabilitiesNarrativeDetails",
      "http://mckesson123.com/role/DebtandFinancingActivitiesLongTermDebtNarrativeDetails",
      "http://mckesson123.com/role/HeldforSaleNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Trademarks and trade names"
       }
      }
     },
     "localname": "TrademarksAndTradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/GoodwillandIntangibleAssetsNetScheduleofInformationRegardingIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax": {
     "auth_ref": [
      "r572",
      "r577"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) in the cumulative translation adjustment from gain (loss) on foreign currency derivatives that are designated as, and are effective as, economic hedges of a net investment in a foreign entity.",
        "label": "Derivatives used in Net Investment Hedge, Increase (Decrease), Gross of Tax",
        "verboseLabel": "Derivatives used in net investment hedge, gains (losses) gross"
       }
      }
     },
     "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/HedgingActivitiesNarrativeDetails",
      "http://mckesson123.com/role/StockholdersEquityDeficitScheduleofOtherComprehensiveIncomeLossNetofTaxDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r60",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r60",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Ending balance (shares)",
        "negatedPeriodStartLabel": "Beginning balance (shares)",
        "terseLabel": "Treasury stock, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r60",
      "r369",
      "r370"
     ],
     "calculation": {
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury shares, at cost, 119 and 115 shares at June 30, 2021 and March 31, 2021, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r262",
      "r263",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/RestructuringImpairmentandRelatedChargesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r477",
      "r483"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "verboseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "terseLabel": "Discrete tax benefit recognized"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "verboseLabel": "Unrecognized tax benefits that would reduce income tax expense and the effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/DebtandFinancingActivitiesRevolvingCreditFacilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r165",
      "r175"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average common shares outstanding",
        "verboseLabel": "Weighted-average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r164",
      "r175"
     ],
     "calculation": {
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://mckesson123.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://mckesson123.com/role/EarningsLossPerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 17
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429468&loc=d3e288-107754"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.L)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e99989-122729"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2599-110228"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2473-110228"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123368208&loc=d3e12565-110249"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=d3e5291-111683"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613673-111683"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4M",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591554-111686"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13,16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r679": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r680": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r681": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r682": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r683": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r684": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r685": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e526-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868656-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>78
<FILENAME>0000927653-21-000065-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927653-21-000065-xbrl.zip
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MM,I<$J==1'$J##$&B2RQ!,$*M-HRJ0H:!%(N98'$J>45<88%$>=QKS.1Y?
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MBJ(I#C%3/L?_"PD]@0X:%7]VVB-%"5Z)9B%YNE9EB>0F(=DFX4R4CJ0O8+3
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M0PJ+1"@L&Z.R0^UST24&.<>;\YNS%69*H@)E'?MP3@"[!;4$N0_)ZA)R3L*
MT@LAJL78FES8?PN$=5M;Y22)U6#,ENT75;5G&A#H/C=9KF\G@CHI8:&HY"E"
M2-JSF(S&8# D;Q,TB#+.DX6:/7WTBG)Q4J6B"EBK,!ECE(D:JA"A+)9@[V$Z
M9Z%5D))$W38$2K(-1';\D$PDZP7(Q1+P?<RL3";X@BE9=@"MI) "^_"J:&71
M1C/'>_?F42/?SO9*)C/LS)%.7H/'Y T*!ZYD0YAU6@P1+<;V>;):QV"S*37;
M1H 8F9'&@,[+",4U8"/2/&K)VUFP X&Q&"=UK9/.E@T"@D\HI';D0Y,6%IYU
M>IT1O>R\I\Q. O;V.[%+XRJ0P]].UO%M?S NJ?S9MN;CX:A_2(-Q?<DJOH/.
MT4)2&,5WBUHH$,Z"PH+2D<X@"(J@B##_8W*>Y7L[64BR5$1&10\&HK<UH#^
M15$0,N$<IRILGLBFM:8>6(_:$&K4<ZW>&H",2](Q8XG!BR9Y@C\DN].PL97]
M 8W-YT*J4@0-VCOAT08(J99+E[8X@05$B!$75)7>@6QO)]E7<3'YPN)Q$:A
MQ!J6!)04*]B4RH*JT3L7U[02L%)T->F'H. A)AN5<TD9=O?8R4MV857HV/V;
M^.<G+UEPO>%MY#28O?:$[(U%K<"A "T5TYG@"@;M<B#*;L&TY]V(]79\0X6@
M*#*#41$R:%2A!K@4F[(402R:XIR%I*:D,W76VC(%2<(!2%4S+SB5C,BH=#0R
M+ZK./+MH9X"9#G'P;KC2R^,/&WBXF.I3:)-$T4$%C$PW0Q1$02'[%II'JVM
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M2#%%I4+03!C*_ /TK]#RLM.CS3(YHR$"R2"*3!Z3D@6T\+$P4TNH?4@N!->
M=!5_)9"G_<-#&J0.=E\A=TI39&)5*DR:I6"GT!JF&<DEB\88<L%*:)!3.%/A
MS-X/BK5&>S9)R.B R(:8R,JD9>;A!9@:Y ?-CR1G0OV]H^+(!!Z-&9C]ATC*
M6E=2"%9A;D!1OCG2D]-*M62,R+%N'U$68HFAF*@5>9]16VV:5-ATBT:= =6+
M7G6Q]R7Q?36YH!X<KE)AGI%_HQ[_<0L\8_9JDT(J.08FASK4("CO^!\2[,DP
M74&P#5*;<RO8F6C1E+R($I*)*0$5$Y*H41XB>YMLT@U@F_,DS]M)9!@@$64T
MQ6=(&@([:5&8;'TVVC:CKM:@\QY'G?=TX5H/GV.G][(_'/YV\B_*^^S0;U&7
MS^GWA@>=HZLBW"#VR=_3<%0O/#W[MAW^NE*W2KW^8:?'0RLO3+#.[>QL)R\H
M"92D,AC+%B%&@ 39%$ O_/QSL25$YQ6BTYJ(548%'PI0D*"S1B%%%D8HD$*@
MMPVBIJ?P6J5A9[\WQN-5Z9P=H+PR/#WW CZ+R$Y%ELG[4$6J@+)F"RFBU5XF
M2Z%F6VD..YUGV=X503WN=2:"39C/Y71(.#P>T)/.L ]*NL=/5U;/+C\[=/:Y
M7G^]>XK9VEJ2T!$ R>(A15T*:4]98C.J3<VSF?JR;5N=X;L+@W667$X)Z9\.
MN,5/CP<#ZJ63[0]X-#73-6=#Z%:L&7,J'6I**>,LF*)#4JXFK*S%-7.&!JS:
M+)'<<"1/R74@Y;5TWA;A$8J4WCO!ACM1DL:5*!K$R^89TG,&I=ESQLSR-QY5
M'&< +\7'J'0"ET222JO2(,ZXQ%U#^.Q^//HJGWW^VZOOYK/D4/BL<B3TP&H4
MM4\@J B95#K-,MG,\/OKPN<7>ZICBB'LWDM(V0B?HH3L,"AT16>$3#D&N@>S
M<4]Q>/"LV_]PI[SP_.&7J.""JM%;\6F"L:ZN1"6G#=AL8\XV&&ETM#IY@XOO
MTRQAVT ')A#K5I^9/L9:UCYAT,4)%2R *F>9,YE(JKE-X-IHV+Y@40R8NVXQ
MBNX'=,>T54TCZ:M4D"1!G0QEL'H?('O4J6A+-LKB&^5[?RT+JU!F8>CB[-UF
M*L$'S&2MJ_$BTD>RQKB( H)E][E1D)E+M3=GBF?VD',D38@%:K@+!)"1K:P%
M%VL)/P9CN$<S-?<0<C.)BLLY>G:8I6?/H^9"]Q"TCZ%@#E:)I.;?%?F62#?Z
MO7PNU;M;-WG6'WS 07[*G3W -!J.^K6A5"-95O:Q4IG+,S]G</^6[9X75T"B
M1F=0@[81HK;>)&93R3&,O%<"YG_B90F;&4Q\),56K9B$4@0013,-AYQ]+-$"
M)N/G7]O\AEWL)=H^(!J][*=K@/-J0$?8R6L?C_A:&J[T\N;H@ :328?1RG!(
MHZDQ].5\QVTJN6RER[( :FD@&V*;Z*H;65 '[<#./UIGAX]OCY/+H^)E!V/=
M&M29GO-Z'P"JLRNU$"-YL&!$BJ5DET.*RF5%IJ&Q,;,&:#7#E[7U&3BGMO/^
M/D!31&N\0U".37Y0/IK ;D7.QIL8@V] G>FEI6\ 6J?$2]FX1TWDM,D&E :O
M(-5M'4X1:1?S_*-U'A7ITM)/KW:B\8Q0K:0-&FSP(>N2#9+(UBA'#?"WYQ&@
M]]O23ZL L$O!U:R_U@F040>)%$ E5Y.566A$@?!%M*W35N ;_5[Z#F8S+T2T
M@"5DRY[KZJ]6@,Q(-7-1I]%JUJA+>$X1&??-ND]K-CU%D81Q%(N HBUZ0SG[
M!$DA29V6&&VL"IULH;FB.6_*,N8%G:PZ UI;8E82V*/W%%PB7YS/P#!JZ%["
M)3IG;>"G%4Q;$M:M@:K.S@LJ(;+['JV+/A2$TM 8\*6!GPL#/R6,*DQ9V:2%
M,PJ@4 RJ%)NSS5Z0,PW(X+94H7-HX*>UQ3JKDK+,18D$1OM@# I!X"PEETQ#
MTR[=70#U<@;T+G9/LSW77J*33E<?*;J:R(*]IA!B,DU(@KD$Z?R"=%KK2"*'
M B5Z)R4X7]>0I'.%C!0AVDCSKTGG6DI34B4^"P4^*$E6@5,86(N@,Y))F12D
M</Y5R5Q+:4IC2=2]%EF8I&,"Y3-2$<J5C-G[4B3,_UAJ8@3!L_Z &#IK'],!
M]O;I+ [UKHS ]T3=SHLZD0FL0N8B2CG((J .9+5"':WT*='\JY,E4.<;J-.*
MOG88790%#/,2G2*Z6##9NL=(2 P+$R[8(&C,G+[/BQ(U DURQ@7A$@COD>K&
M<DR._3R7U<+,XBZQ>8?8G)+>)%'8-<A)IX2 T=2-XQ)EY&]-*KD!E<WFRII-
MBW8Y$(8@LA.7022+44L-LCH)RN32@ FAN9+*M,:*C9K !>86"))XM'@'I$(Q
M2B2T#9@!>8:=P1_8/:;?3L[__!??$0?IX.0EO:?N9QK][*07O:/CT7!\AIR6
M:KW4F/5)KK3Z-L\&]._CNL[RE99<.G6X5<OX#;Z]A7I>AK6R@-DY*RT/\ A,
M2Y-(M4P'^B"=;\#DS!) L]5 ,?!_2&R?':!P401;4!7E?8V?;D"=EY^7&5N.
M0</&?<8 6EIA0;(&P!#)H#?&I2RL"]  <]XLL4TKLJ%(DD*BSH' 2*HI)$(J
MBF6I)8I[,=INJB'OU(*HAHQ[E"&G8K5*!J&$Z!VK;H^>'7]+VM^+<7\_ ?3C
M&NA2V8PA?9%GN$;DU -G%]\XR3#4.F/9!1U,@>QL\"*)3)+]%\E?S;'O,AR,
M'K_LC#K[8R_R*;_\I>"D\7?8?36@81ITCNJGS:,.^Y075S1$5Q@KBM+>*6DD
MZ**#5]R-'C%Z&P6%>RN@&RN&BSMNCW!T//RB@&!F+=0X7+A@'4$IQ:D,0<?H
M*:9@@JN;=Y.<8UPLG%S.53-?-+I>-X^/?+=R-L&H8JT@@ +1ZEBR=8F "EKK
M8([# >K8KU(=V_KGU-\?X-%!)^&I#4[]X]YH</+XZ<IR>'\%1C@:]0<].ODZ
MG%9.S[@)K,[OG3O#T: 3C_G2:^]\Z?AWPS7E "1=$<8IJ'6B$3PJBDI%(1F]
MIW!E4S:/<)T'4[5]'(=C"CU:>\^_ODQ ^]D)"VHB75M-)<8[H=8&DO8Z00XA
M!A_( 1;C43)W.L?C7*K/^XC'^MY/JVV@P1$.1B<;>'CIS<<&9;-LT(?=_N#=
MXF)_*EO 46;6N<%G5P!4=1B$RL(G'8),"*>9G%D7MY=*>;X&P=P \_/DT)?5
M\C>20U\^]6?RD4N3O"TZDBBLMQ4F2-XC "F1/)4EBN<6Q9DZCU_2/G;7QG*X
M>.F=@P'12QSLTW#T^N'VPU<'.#C$1,>CZA^L7O#/Z>7T7PXD<*13+ 8\6P./
M%C%YB1)CME"BB)\/I#DL*C;K@73%I=U.U$/N_4D3QH=.OZG!;@F'2RL@KU8\
M^PGP!A&21,":G XL0G NI0B>F3T;@7QA!41[2>CGRPK<2T)_S8@1-U?WTQ@Q
MF+.J5<\E"@E:F%@K_JCH$F:-&>/5HAISO=)8:V?4B&&6&?52AX:_,8A&QP/&
MS<77)[->^OG1HA:?+0G^3%$+DR+)B-Z*# X1?90B2>MB=C5:H4&E>QHH\IF4
MSD%9+$F'(" !21L427*4I% Z2=>D:DTS$/E=VJY&PLLX4;2Q%&O=X9"=]^0Q
ME)KOTIJ:P&7^X74#$:[T<MV_T7W>?T^#7KWOJ<LZQ30 2X5V0R\5K(TJYB"(
MZ;V109JDM(2@5 ";&Y!6M1F2OI6 A.AEAH+6(64(E8VP2?*&3511OJ0&)'2<
M5R/T<POI\X*/$B@[MANDDH<27:@5)C/Z5,B7$);XN 62<AM&;7$0*8T))B<;
MC&<;DWR0:+TCTIJ\EW&.<X#]M=1?]'+G?2<?8_=I%SN'.,4EJ3D= 8N!1X5&
MHZ-"MEB@:#QH1:(FU\A8=X17/$HO8/[P^*/XF#A11YU^)X_GZKY=R/FG9"5]
M9;73">%WR0M+E)G;@%'6L],-*97(-#5B$ZKZS;FLIA1+][[_E8C,>N#LXAM'
MN!&44&0J190 P"-4ID!*(7,:+!3,^4J$.EN)4/,J_BFO!$QGFES=?)I<73SB
MA_U-$:,R.F:=-8++& N6&(24V7N1DSP7ISX3IUZ*\SO$J6\N3CT%<6IEC5<\
M%BD%8*T<;/0^>L(DA61O]%2<YFS"RLSOJL?V 0YHBXZ.!^D A_1J4&G-X84R
M7DF)NC2H21(^._7V!6MN/B]DIK.VP9S<9+*: @1PJ;#)%;EXU#;++)QIP$QD
M$P0[@PD_RNB=C#45%P0EO,X!'282QB"<UZ"3MS]0OYN;R.GL)79,(H2."J.*
M(!5AL=99'X4-"*";M&QW[H2M_?N8V_6T?WC4[_''SQ;@&>''A\?=BO#3Q%!G
M&=17\MOCX:C>X44O=8_K,OVK_F"<(V8T"0K#V*6=?DT]7G-(];O=<9+/2?+@
M11P?BF(F8D24HL!C8KIB!##G]%GEZ/S5=7RQ1,>LT/$=2_YB>NAP+BDK?-;,
M=G0N02I;@HJ.+:6VV"BS^-WHV"#&P7N:(.(Y=GK5GYU#9,S&KAH(KFX-!:L
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MI<S94ED@?^P:I_POK=<<SMW-1)T(@BRD+B58RSI$!5<P%8/>B5"DIL51)PN
MD-GHD.Q0I^"D\06B4L%08HQH1D)R.4\*"<PU,%8ICBYJ"5T8E[7C07^5>OW#
MSK@RR$;_V^&'-W[FRWYOGS%Q6)_]9>#4RSY#[16>5"S=:L"CF%YN4'3"26$2
M8@$ ZYTB2G7WA9+:BCC_^:47;K7X5A+1!YLP@C-!&H0<6=SLEP2;C1:9G%Y(
M.<_QZMZMR-@Q ]0IETSL0_!_@4+(T:(R+A-@ VK#-'6)YE;$:4!&"R2#9Z[O
M,W>W8EL=@?A;Z;U91'%^:];\'HQBT)*B2E9*ER C^9BC\M$FD4%FC_?7N9L[
M^<_>SXL!@PG(E#U*\*A]LM&S1DB2G3R5&E"S=L'IV[1HNA7:1Q.+5FP+I/9*
M:'0Z>\/2)3G'M3?N 7V;UAYC3S6P J(D "+T@OURZ:63Y(MM0JVHQ:!OT]JB
M*XQQ!+6NIP8FX%%[TB85JGD-BEQ(<3;+?-].;I-2(_$CEFP,,&-#9VJY%1N=
M<%X:=SJOME"LO3D664S/V8XQR92M!U<WFDEOG%0^&V$<Q"#+(LJY&19Y>C+.
MAH0M(3N)$I13GEQFB5.BG!S%A1S+<V>1IR=.="$:&U(P/D J'HM %1.Q:TT.
M02VB.!MKD:<H=JN,S\RT>,2"]("RH$#GK"L,"%7N[UKHW,E_#I9%$^MW[8PI
M;,>+M3ZQ > OM$W:>Z'G?UETP>G;U+PS1SE+S*(H$-ZR1B@B9>&#&V]X6D0Y
M-X:^36M")7LH;.'!LTB%<!&]]Q;8V-=H!Q$64<;S2-^F50J[8/'.1LOB@Y !
MP;BD78G.YY3D0@[99IGO6Q&["-D;[TA:X2%&$;PV-KND7'8:DCBE;^X.U\-^
M@,FXNU@:.D]E=C3HY^,TNC:;V>FQLUO<O&2G88X<D\X* )S@H8B"0%M;A+09
MYC@IZPW3/K[>_NI8^/X1_MOQD ?N<+@]:>6EV.=URO79V\>#_?&__>YQ';%G
M9\[O-.=%6?E)AUU?67YR[+O1)87*I E"W1FA90FB;I7P04F=0O1SG&#U.T0_
MUKR]TT2G-Y/WSX*['JX!D4>W&Y X'6#%TYY[P\T=C+OI6HQ]>=IWPRU'5%80
M,\):Y349U,D&(8W(M72!:F1\]-=Q]WK[:N6\6U,UL_??+9:"VDFKG0"%(A)E
MJ;WU6FN@TTH4"R/8R\F2=R@=]/K=_O[)N4E91 &7A!BS,24E!4[+**+-B K0
M*TC4R(U2<T069B]@ A&93K)7E]PX48"+S#25!N&,RBHW(/YMDG.]-^QW.WFR
M)9;E_)F3MSFQ7;W],Z$O8GA:83?!D+-0B@-051\K*XM5F$THB T8K/,HRYF,
MRUKV("9;,VQFR)2CP1""L]%9J5R(#9'EUTIKCE.H'O2[F0:KW"GO^93WM)+F
MJP;@#TKS4>?C8V8*_>-!HN'DXP%A'C<^=]X_^95_G<ZQA6@MY"S&>X]5=<=(
M.S R&!FEL6_JTNC%-</129>E=]CIM0^HLW\P>@SJH3-'HU\^=/+HX+$4XG\]
M&)_ZY-?A$?;.+DC,4P:/_[-*MY1?"K>S7?"PTSUY_']V6%S#U@9]:&WU#['W
M?_XQQ-ZP/>0W.SUQV/E$?&-^QOCCA\ESG1"_=-F(GK5#*O&_?JEOW\Z4^A,O
M@=T!?N=Z%K<)YZ8MK8,!E7\^^,]O=[Y[\&2GSNBU^J7UM J75<VOCY E4COW
MJUW,S;FMUWKPY'__I[3BE_GYW?KJ@8N?J3WKK.,G(^*+<3&6.78[^[W'B:KO
MS[@;3\F>G1#[ T9!FV75Q:,A/3[[XY?<&1YU\80=Z7&/CR_ZY1"9!?;:L3\:
M]0\?UU'VG@9CA^[T(>/G30Y?#,"'8C((1SS:1_GLR:>''XX//1KE+X\%_S"(
MKQ\6#^7YL4?C>P_.3CC%!S?PP?@Z?JO:3?]\H!]\]N*GKZ*.1JVQ@6V=X?4(
M<YW-?BQ:<GR7B\<\&O?%#3M[N@,";C0@7F^\V%E;;6WOK.RL;5\%R!RV=GOM
MZ>NM%SLOUK9;*QNKK;7_>?JOE8WG:ZVGF^OK+[:W7VQNS/ 5U(U>X4\<'C!6
M1OW>/UJK#Y\^;"EA(,Q]SS_;W%IO_<JFN-?O;1P?\DU2Z]1B;U5[T"D%@(1(
M6H*IZ:_0"T$)5/#.24)]G2/4ZF&E4YDZCU?[:;PQNFY3?G ZZZ7_.(FK_?<O
MU=;[7;U^G-^NO=]['MYN'JZ9W;>[:N/YUKOUU7VU]_9WO?[V=[/^=JN[_BF)
MC9TUL['SK+.^\UJ]U!O=W4]'!YM_OE ;;[?>[:VNP,;AKMCX]$)L[KP0>SOK
M>F/U]<?-G=<?=]^NR8VN__A2[9WL_IGL^L[6X=[A']V]YR\^;+Q=^[2QNLOW
M??=A]\\_WN[M[']<WUG_M+GSN^+GO<_/_X#\K__J[JGN^_BV_W'C^=[AWI]_
MO-M]NZ+X/+'Q]IW<W/GM8._/C>[FZMK']4_KAN\GU__P)]Q.^:98K[/SMBV2
MC&V0(;>]#;I=EXY\25EAP@=/I&C_/B9$%U)XTOHN[-RM0@_AH3?Z1_0Y,#&S
M-U+GWV4E]$,!\#U6XFLFX4SEJZ./5>G_<JFONU2^[)K^T<T'[DI-8=5ZW>ND
M?J;6^O9-%0Y\/G(G!G':@[;T!X<XXJOYC=G]>1S[_6[$;K<_BOV/UXWIWX_9
M1V#Z>+)%1_W!J)'#^UDG/G]M=^M0/ES_L/OVW<?UP]_Y&K['ZL'!^N&S@]U#
M;N/AUN&&^EULKJZ<7O,'/\OT]G:.#M8__:YV/_W6V=Q9.]E;Y?L\WWNW^7R-
MCS_K[*V^.]E[OJOW5G^']6?^P\N=E='ZMOC(_[[)+BJ3(K2+D*D-4:AV3!3:
MZ)4N0I=DLJ_$-CBPOWRN',YUPRG<[QC)-S-!X5L6:(SCWU^O;.VL;;W<;6VM
MO=K<VFF]>KVU_7IE8Z>UL]EB8K##UK\E=6MSJR7-W_+?6YO/6CO_6FM=X@SG
M?&'EZ4X]+(.&*SWTUYSM5 %R#SS^K*-NR33?S*=YUA^T1@?4^O?9,&M-/.L6
M.]R4IV^T+XW_Q[G."?,=#S*>G! .J'>= G@U;L_:Q/]OY/#_8>O^D=O^I@3G
MT,?0!H#29F<YM&NBZK:/9!"4XWZ%!T_^Z[A'+2W^T:I=?7,K?PF5]BNH7!K]
MI=&_:Z-_D6NS\5:?K?2'];=UN&]U-W?2IXWGNR=\#>R^W>OL[G!;U*[:XW-V
M#U]_9O7[L+NS<K+QYU9GX_EKL_%I7>R]?<&JXJ"S<?A?!^N*G_EV[]WNSF^=
MO3^N6GUM-15RL1V]9Y51 K9]T-@6,23E8BW.F$ZM/BRRU=_96MG8?C&V[4NS
M?ZW9'YT/M#.[7P;]P]E-LO[5//:TIC)G.87<&O7O1^?^"-.8A4">]@\/.\.Z
M9M9ZUF&>PUHPTN#Q;<Y6K8U7R^K3)@]KI''[J1DK]<9E",(K:A=+K@W9QK;7
M3&^+">R49HL"W(,GLBVU,NKG)JTZA_NMX2 Q M.[<WF\V9</WQ[M/VAA=_25
M(U=G^%4X^OA#JQ+!'GU\\&@FD[,W&P&WCO0MVN\,JZ$9;?"1>X?VW_4;+5W-
MCV[:1LK<!NMU.Q:"=K).>%&\,ED\>+*>_GMM>YL)R=/-+28K*SOC%8F?@?XL
MX/2WM8^81F,0U+7;P;GP6SAL#8\HU8"&W.KT6IW1L)4.QM,.?Y_O:6ACY0]Y
MI.*A%7KJ+JFLGFZ8^FU!/M3:W[*G.Y'A'3@(WT;KW;BZPQKX>#3HOZ\#XNH$
MUT0[ON@Q'3LZ963C,,FGDWT%3]F5;Z2RG/B]ZX>OV7=]K>JL]][.QL'&\XVW
MNV^YC7^NZ\WGNY_6/ZV<[+U]K?9VWGWN]Y[L[;R0>SM[!^N?^#W4FN W[&RN
M[G'[$^R]9?6Z^E^'&SM[W<W/_-YBHC7:F[:VF=HL/-7V,E([!(I.Z)JDAO7L
M*G7Q P[H)QS?*VOURT'P+0:P@Q]?G,:RI3'.&TQ\[QK=+\[1;5)V.:O0CE'X
M-D#4;=1!MJEHE8IRP;CXX$F ME;"J6#_$M_35N$3DSEM /L;X?=O8[79Z@]:
M_=$!#5IOCP>=8>Z, QI_C8-'3YB'="ZKV?&I@WWLG1;_^?N,A_Y,.^_%PZV'
MVP];:X='W?X)#<8==G6TMC;Z#__^'7->\T)%;UVOK>0\H.'P])^7W #92)WV
M4^Z->:.*%\EXT2XAL=G5P!8W!]^6021%%@1*^>")-<:T)B/U7Q].6M)^L4SU
MC_GW;NX*4D_YS\W!3O]#[_X!"M[H8FI*=]&N28O87]:Q';45;;).(K+S X(M
MW8O!>]:RUX#HCF0TQO+FX!63>[8NS>3J/S6-]^$-&0C9U.F,Y'CD@_-,25AD
M CQ"226+.K&Q\S]?3F/<D8Q>U=I]W;W.46.]J9\:2N)-$& =E=1.K(S9)8+<
M]IIEY8R526&*"/;!$V>$#G,TU_1-ZC*9:CH5<IUG.AKP&.P<8;=%'RD=UQTM
M_#4S&!K^HY*_2<J0UJ?.4:NND7_?A--,YM%N<8A4Z[(R(+R7@^+UQS>B^.(!
M1-L RC8(G=I>$;2-L"84@8E'!GM2[HN5A[_?IN)ZV6>/X-5!OW=OUX5.W@0%
MR%VHVR1M:;,5L>V@<^+^(F^Y:P5+Z,$3 ,O'A/CN.*?3>5]]%PN0-]1A%ZLC
M__L_O9+NEV%K1%TZJCAH]<9 N*S D(=M0S38-NOA06?4X3M.5@%H0+EU=#P8
M'M?E@%&_Q6>,_4NI_A;_7K5X#4E82:/'-PI8.]UTLUP,6*S%@-N9#+G [/B.
MCSM,"SOI)O,C.YW19!LB83IHI2X.A]\S7]3<]Q[@6.-LGQS&?O=>O/+&Z:+E
M6-+T,1U@;Y^_Z+4^''3XFPLM=LUL6(-&P \O!K!19AK#KG@@!<+Z2(*BJ<6;
MK(G:7YNOXA+!.34()U+%\:!J),$YW<OQYVN]]^=KV-S9ZN[NK'S86#TXV%OM
M,MGA-UA-G_96USZM[W2[&\]WO]C+L;>3NWQ?L_'\CX/UU16Q^?S9N\T_][I[
M;].'C4\;[_AY'S?_?"WV:ALOK6YYR3XU26Q'=M[:D+UIQY"QK6I  9+1QN=)
M0%._HJ:?WOVC]?^+AT*VCG#0>H_=XY]9\KHQ>@\[.7=I\=![J@\GZG )W1M
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MW^FWOOHK)V;8-'R]UHE^33?4!OI[5=V:$E_9F.T9"RK)=:V1]W60P^*G#G)
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M]0@[G)*:V>W"L/>EV3P?&9J!\ZRX 2Z2VV0#? X#G.Q8(7WT1SA06FA $3?
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M,9'&FSBFYLG)$?ZK?=3<C>,^.&OLN%9CYR#4KR*>Z=*2AU)8)P20CD% J67
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MU:KT[9G.C(NB6/B/+*522VD&5HJ8ITY@#BWV% 6HN'$A:.JH0,%P,B^D+;I
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MRA939+6,0!ZX4=%'SA38-K<*?"X^B=55W3OS2135O2/5G>F-&*,(0AKDC)!
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M8L8JYPQW6E@CL, Y9Q4+0278&Q%,CY.,##VP0S9G!-"82J Q%L&808]6Q3G
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M4D*,B]H6@+M?@)LFEYFDC&+2(F-=1%QR@@S!'@7'HN5!T6AR7\Y;9^D6@"L
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M-=FI)+X:CO7W=)!R9W7."MZU.&[M;'[[9+-(-E!'DM4!A=$Y@HHM$NT$LL^
M^%_"C5S-5V6+<A8M@@=#LX:4P'/4FT'D0!-WU)G@<[/D=+SDM"[Y4I?\C?R$
M$I>%5($H(2D!217Q5'DB<X@<R22^*HIK<SY]>59,V<,4RJ&^[LEZ:V<"#DW1
M)/U;83>'O?[@+$CTD:$<M;ZE?FK-W3"XGC[UEPL3XOR^>)7S</2G&^0M#NW%
M4 T@.FX?IGZC#8Y.MPKA3VVO_-@4GR1/X#(S)!F/\"!9($XA6C"'Z"!$0GO#
M%7)U$1_^NP&&Q9;YAM!0E_E:R_PW_22X!<43(];@6@.5KARY\R263KB>9VLH
M&C1<K%\LWO#?!8T791-GX>./;K$OAPLQL6ZN"B<.T>2PCUN@CURI%8^+MZT5
MD6SWTR"U.H.T/S2U/A\@28KCZ__?L</+]9LQA3UW\#F=WGJ_\[W0F.3Z![A'
MCEH^#;ZE=-#Z#]ZA=WQ4;ET(U!?D44>QT\S"T6).U]4EAW,]F&/NM^<6C%9<
MSV=I%E#R[P\FRXLB/M+Q$Y&V3TVBO^![?W\"[;F, 9F=UT! 1T>,1.FV47"3
MA4L(M:CFUV>XL?R(VN%6.)Z:W$;H_&AZK^G3O ,?]IS]L+/G!A]ZQ]WX!G=R
M&)SJAI%6>,K;A6VA5:Y+[_,LB"GMGB!S5 8V::)L1E. 2Y:Y+=OEH@8XW2[?
MRNPBUL;CD&;9A@5K"Y:D\=2?HGBKDZ<P>KVU@(UZT30=;5;7.DB#B2*8VKNK
M;*3.V;QORZ0VFN9M.CKN(G_Y_$>_M_^G.SQ*VWGS\+#;"27_Y]W #8X'^-*?
MG?W.X!RW>6K63GOG;]G^\9YMOWR%X]H]:7_^I+GTAGI/:, -#E9IX@W^J1QW
MGD7-G?%K&_8GKOT)U6C*FA14[*&6;J:];*SNZ<27?=_I3VC-S_G#U)8_P)W7
M0L[1_<]XXY_=Y+&'"O^@-V@EY [[17S*J^67?J<),X[V2KDI[IWY&+[>^F?O
M6_I/ZI?K=X[P$B<C,M1R1V=N.?;&'96GW7,XL-[!YUX9\$'ZW!MT1D_YK3/8
M._^<[GBPU^LW'NPBS+WCSZ5+;W/U$^180^MQWA";(:$4]0J>]),K'J9^D:WA
M[R.VEX\'Q\@"(SY*MW?8=&(8D[GMPTZO$T_7JGC2/P]7IV%^7=?9Q]G%IRU
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MG..-(;#3VXRQ2>%UW;_0GGUS\,(=EF-O=>?.PC38>KE5SI'Z4JN12T6T=HR
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M;'W[A(1'Q"0D"<IFM%ZH)B9$2;16FD(*(B4Z)$^-RW.S.$N38,K+8*+@&G@
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M5@$)'DV6PL_Z.9SO:;.Z_1W>' S):-FD_?39]9L609U);Q/7;(I6Y^@!MW9
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M1G,F'F.2D5NA&-#29QHU*$N"2L5L@C3?=U2[U]Z'6MV>;ML3C+8YNT28\YZ
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MCVNE2+1LI@ET!3Q6:6;KIZ$,)?S3[O:J$JJ,(OZ,IS$U>]V-9M>WVMU^)^[
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M:;@/UCIX=OAF%R#&L/E?"0NS"ZX"!]>>>')';,BJ:+3U@WZ&Z][W3_H5^*O
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MT3$=/NMK6J*8K,.*KA'FVZN$-S8]!Q$Q#W8:\#&P,SDHE6&)LG"- X[0WN.
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MH(*Q]V9P>HHFSI=-T'I#&X:C_BM831NMG;[9;#DTBS=_\**O7.+&_=JQ'WV
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MO&I^2\[K+>BGAO(>">69\P.:*^-=@6@0##Q30Q,BG1=P]H4&LG!"Y*O")K^
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MNX U'1[X0GC/:4:$+CSAB9/@6E-!TIQZ+PK/G$B?/,W$2B+;0-5[Z@QBLO1
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M2S>-K@&BL 96V8._])KD<J>-P')]RS/BK^[TJSCAZ!*<YK(V[37P:AX)-VS
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M7CT^T74+$< 588-%"?5R.#BY!J!";$T;/RYLM)\JU#K/:[%!S61:<)83Q&<
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M]Q>V1]J<OJU"F3<C>U#N0?G!-[L\PPXB-XIM*W0"TPXLL,]]FP4N0#$W^2U
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M+/.LSZ?<\D#E.X)9X3W6K8-UW;:.-'8,UXTH(IP)6!<[.C' 83%LW_4C8K&
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M;X;Q'0'+,R8B*0-E"2C8XVD*4)!DP$H)HK+B4T0U.9!V>-V!*&*!/&H_%QR
M!JX>YN4XJ<1]J01M>$]2\5]JL)($00@$D )FA;=-*L&NXH^&*%(_=*;$B\MD
MMU@:E5^S"+"B<:(@K*4RSK^>N8P7 ,<>3T%A E2]!Q:<_B%8$C7IJR(ORR(G
M3.F"NO>(]@[P@!;)6*C'PPE01VI*6$)\-D>QD&LI[DN3&(8 RYKA2\=@)H(@
M*64#-THE\EL-X:(A<_O,6I$5%0#Z97(AOU6@WHJ/!D9H.2TK/I(V #)$AFJL
MPU2#FET*_$BFXK]"+)KAP@R I0L4D7IH2K$#HC-U\"/H#9@(WLN D7!6\C$D
M!OAD)$I2D"6-#@% >7;!!6L/>3H&@,W!# 8@D9:#>"(L)/XQ!;L!M6$.U+JL
M)Y8 F^*?0)[N:FA7!!$ $#Z?E.FTU:6@0/&Y".)PYS* PV&>-;+<6$5+5+2X
M=#5WW(H?KH ZJP8J*J!V2/96FYP-11NP&JEKR_I:!&F@3Z-V!*(B9L$T:;D,
MM21/-=S?8>S6WA@/IR4P&$%QB?$F4%WP1EX <XH8$WR130JA^X=@7Y0MVJ*%
M*UE;2TFD1H#7J)=JXJV@>3*JK*>.JH*WH7R/T)RIAN0:[TWINCGOC;J&X434
M9I;C.+X1!SXQ.'C<7FR8'G.HV&=;<-IT^Q;;:R/ZM7'73I1&^@T5O%J^>O7>
M*27\?!VX[T?NZ>L/\/GKU?&7K]^.__K, L<U0B?2.>5$=PQ&]2"V#=VDKF_%
M-@L"S]X[L'QW -*VZ,/5[I8TJ!9EH+9[P" %X "/#/Y;(TSC7.57F8;RAPJ@
MN:$:%OGD8B@""Q7XZ%_QUZXLU>PN? ,%DA^ !P&)SBJT\W<(AV9<VXX_JWS'
M91YK8YVA6Z:]F13PA81_,"X9 2NW (@0WEP.N@MA"%961_VB+$8T:V<I7N/4
MH&LZ2ET$UFEMW$G?)@:K%!<)(:6QRKH.V?4C5=@W^_X9.P>P\FJ8I[P$44:
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M<EQN.?F=T=-WJO#L]?1&ZNF9H](-S[68;7FZZ7B1[IA6B,U2N,YB-Z:$1V%
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M.,,:R&,-*LW'"U5I5;-#76\KMB69[_XX?7-R]/]IX/Q.QL( (2WF@P:7]5E
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M3P9RM/'G!?J(!Q6\0G-^M>4>-);[:[P>1Z"N@,D=-FU--LF27Y(;?KO6OB:
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M) 56,JB"T;IS%5*V-H"Q_QS:.R-9"0INF!C?I)S?WEB2'-HNG'Q3:S)W3X'
MF(BN%D_D%\K:6G$PJ S'-2>JU.UP"U$Y)A8=H '=;D)5\/+//+O0@7-&LLY4
MJJ%2)9Z.1MB]3B2>85,M]>- /+,.W8I4*KF[4'.4R$Z05<6QZ#(NQM$)?8G@
M<1.7A%]D>9:<0Z+:34YF&ITM8<W#:HE<*=-8UC<G8M] T@<+MW"&Z%=F1.;&
M9B+ DG!,N%4A;9'AU*[E#.]S+H\QF7U.$^(4F-@GP]P[&<;IDV$V8"Q],DR?
M#-,GP_RPZ-Y[<)&DFGTKZ]?T/_-<V&5';>');IC&YTM38="G9TE93,8B/MZ>
MZR.S.I0-^8V .1<)QVFVNCK)Q 'HHJJS[C\(*OW+A%W4E2]H493E1'8-*<&>
M: -KZ&"!?5))PPIN!^L@QF2#Y0G+G9?4]HB*@ZBB&OE'Y\R#^0I1Y3 M*11=
M<3;>TG3PN2/S'J.@N]F]>B&G/2G:GL/E&$,R39$!-CIX.9>B09LCD\0NL71)
ME]TVSG$"H@Z2$W%8DSJ("'['>-&D$LI^YLH,^!.K?4FGU ',>9 ,W.R0SQ7V
M7--+94GMC:ICX6S0]5+8H-T5PS\$,S7YT)S-/WAY88*J95#Y2YT'RMLEOV!@
M3[#$JM*@&8IV"R^[G:-7$K;N8+GPL@HNKIHR$=F.@DMNODS81/2)?*W*G;AP
M1C7TGY@LOY-GG KJ1Q@,F^O3N2#O@T: D!_P5!#);4T.5V='1SC1C9<E=@O*
MJC;*58]1[)>L7 AQ&D2:<C&D^?W-JSJP@3%9T4]4%/[*Z'J%TXA4GU09!DO1
M'TJ32Y&/5J(KA$Y@I_VG&(XH5A5^7^T>XG(D!9V,8*2JT:AP/_ELLU'9315#
M*JI'J-KH0B+N:__ATQG($A!8@QON54VJFF[B04WPN3,^''59RG6EV#\7F^RW
M9\D3L6:J>EY)?S<SKBUT;T1J25^1QH$7(YQ?PG;??KX^OBDFE[@INZAVT?BX
MCF)TW.ZOUU(%YUCO'J@>2OD7.=W& Q4KU12OJRUO>0) (4F+M9_2*6TWMCI$
M[1PW4H<7%AE%^LR3E+40)1BN;H>K5F[QL?,-3\Q#3=?00-#>*GAN6I3<V*%D
MMCD)!F(;C.^(:"V>VU]8O=R*/)4'O-3U^7_*Z'2MMU[)\UYVP[I2L2PB4DDS
M1J1)-)L(8@\LP]!2?B&/0*2<,W$:"#*NK*E41^#,H?A\8DBGB+&<1#72_2R/
MTRE_$4S.F5 5PCZH9->X25$U]:H(86T)M$HO?C>!8>3 \C2?R\3,2SXSXKJK
MQNS\K$$(\ZM?344[>Z&Q9ZD UW2&I*Y;.2[Y\S6CVPW^:;H#FITH6J.%K^J"
MT;8&=45.M[0BLWPB M)JFUILC&3\(L?*6MEK<*8[M^B!)Y+.>56E7(5^Z];P
MPI05.],8O6M[7@N&+V% 99R@<78E0+<%6MGRKWF@.'E#\:NP&[OG7$K>U5)R
M54[09(N35"I*R2G+JNK11U$U=?O:AZ81?#.79@*#SG; #)WD@#%./!F+"/=L
MVI;5.0("4RF(,F%PO&8@]G%PNP7#FDOO]_?#[GDHD3HG!28U*9NN+':P;_ZS
MZ6VH:,R!0X5!U!0-BGQP&7V?VSU=/N=F,>0^Y'("S!L<KV2;E('H1H"F7IJ4
MHK(]Y2)%!*2SE!78RQ%H!J<8J8BRU_-Q-;]YJH.<\J+L' .W,ST*&DDV9B1Y
M7B3O*-MBBQ-7F=5[')+W?C+WK9K;!M)>3U1+B)JY)$L &PJ>&\BC 3H"VA01
MGU6JPRQ2Y!/VNA *HNJRH2Q\C=!)*>?+.DY H9&)N.EL$L=Y^A58:Z)JCF5_
M#M%!;^GY;RKQOSLN4G;!2WI<F3K8K!ET5.2$+46RSCXHIIG)K$#,C$^8J)X%
M*XW(GG"P,FM,N?:!*$<,G2&E\DA58],N<9,")3RO=\3: RSD^#O/B$$H..X2
M#KJF?',*!HA"D?%I4\01<U[;OL*$/XJ7/Q;S6]$SE[[VVM.-N-@.Q\ND8P(T
M$^_HGG$DPCF=H^2;Y(WF* IL.!MTSMBI-];%YKC<K)5-$VVS3OP$ L*\ZZY$
MZJQ $8=IK$IER(N3R^HF4,HU>]7=_#^K>SS-)X//M5J0Q^XH_VO9TBSR5M?K
M$E*]@LGKVHVVX$N2<CISD*+8JF^.3^NV[9)379:&&!'Z%4_-R)BN("_F^/]?
M/EI^(BZNY2\[#7*.CD(HUF%!V0FXPT/.RM?<8-/@FV]I6ZB:LR=-^2RPOVA9
M)FAI:3^YCMNR2%[+Q*G@-T)I@;F+]5&;[4&4C9"UYW&JK7.1?* $+,^X*D2I
M-90,[^!:M,=W)N5,1I8:0;N+W1'*)0-I95+U8IN1SM_D(3':V1!W>HEP]^>R
MT'_CHH5K+9HBACH;*@9BY50J#+GQ#%=T@YLM3[1]-# \46>0U;VF6N.T$>%V
M;O,&5#N$:8,:%.O:1)9"P]6YR" <IV*L<:P:4B\?7Y/MA8&J^@C(0L9FL0*I
M.?1'O'^,^0%YH?+.98A9->X6)_UBJ^Q4W0#2(3?Y1>=N$;9(T]5SQ<R62M1@
M'N&:XN%YZM&=60\6XK'3]H7B/9TTICI5)IVV!03J5L7$UYB$_3;^+;?QW7X;
M?P/&TF_C]]OX6[2-O^$N]DE>H5+'N$.C>T480>;>B3ZT9,'U:5NR=M/)9.LW
M&=:H9.9FIK*,<8]69%C7FN\C;Q+5VLC:I=@%2IB,_'8.2%3!W/HIY (WR<3V
M+PP;S*NHE(T21,+=6.;O=T<KL]3Q:9?)15Y(5TJ&EYN'H<H6N=ZU7W&(L2$,
MK?!F$UYFG#;^<\>V47:'U.,EKR>JMD_$U$B;T5H_M\VHEAG^];9YK5,'<SL^
MS4:YJ'Y<NJ.^^D -LST+[U735% Z J_$*E[@#/]L;<PGZ?Z+[S3"ERL.V-C^
M^NKEZ"+C1'*31_C4$]S$VXTHWI_\(BE3U8>R/;UQ(+<PU;9KM_2",";A!_V1
MI%3>R4S1I IR=S.BI:01=9QY=X\64XS!!&N IK-97;L!8\PBII6PR _'19+B
MD=3!8%4,#^.P*L>G63..6(F-*O%PFJ9+XNG98=,E<:Y*26U,*U&7-CY&-T7#
M2W'ZJW#-,X%,,_GFL\D7&,L$+I/"6-=+Y44G.T.12U"BGH0XG+CICXHG<[0S
M%E71LG4S3.65V%NJ/=ZS?()^7=;^WJ5,C,$2<5U*KM"=@94!YW_2:>FKNJJ*
M&JTO<$4E(]>R6[;20(LD%VZ-;-M=7P1OD/E"2Q8(O#>2MA$,,2$Y#SSM2_S:
MEJ"<R<.47F&V0U*M>B:F=Y6==D$-%Q!1E9:4HK(%UTL64S7>;I-/+9Y95Y5$
MX'>/.DDLZL0TL0RA' .24+RDGG'G-2/"N-Q-D&PM6/'L4$6FB3QR /LB8OQ-
MLJ@:5H:\H2IRFO67L4$SD"_NO(<TK9/DL]K6%Z*"4A[5H0X(KDE5QSLF92-J
M<D#(G++0K,[CG]GGJ!L =1Z%MS2?FW*&'=K?. -S18F@4U>\X\D!&4_KH, Z
MS"O*U8M2H0NK151L#S<MA<&M$D% 3%Y)1(:FK(Y4+"0WDD2[)G5J<,94$?L?
M;3?QF<[NAZFJ3)";C;B]5TE4$PVDQ&QPCY3(4P=R$8&5-D6JVAB@<I"UP^HR
M#:M#X:'MOL0ZA'@IQ:(9ASQ9*$MDM5>+>X$DND##MSPJ)ICQAI:2W&]:F_X7
M!<GDOO HK\-3U6THA[)1@;1@V!8K?T1<B;=&.5"VTRMD1FO,4ANK(^NTG@3<
MYR*II;V9S-D$3X7C<E)@Z,X^H',C4DTN:;NCU;U7GL@T[1R<^"%+:]6-()RF
M37;"(OOAT4; K9CXAALH#80UQWNC74[JFE@*R %DD55_6%=O^H(:"%O:S[@1
M)77Z5!10B3P+<>4O ^DD=,X_%WFBJC.)S"&I\^UDIVPQ ED\(S<&1<D147Y%
M=R=C05U+ML"7XVZD&,!,;??2@_OJBNZZO3').H'E-E*,47IW[KCQF@V1<.TH
MVI/6;[#,<R6%33):JTUN7#Y!)>$X=GR.G?$T^G#I?<.EWNIPZ>U/1@PLQ[-M
M'Q;*"[V]/MS:AUO[<&L?;EW;XG^B6;Q_<_;AS_,S[?2M=OKNC>2LL]O(PZ:=
MY8I-(V2903R[PZQ: 2Z>Z7KP+V4NU?H/V\YB&D5*QB5_47]XB<9L2J8ODDR\
M5=ST<G9-4<[03A3=:"1]!*GDSRV8[QL2T*L"_L?J-ZN?]\5/OU9L\3?/VS==
M<^7/QO[JWZY[K+_O^7=[ZG6_6?M6X#[KL7K[AF<_^%/-_=!W;OM4X%YD]_^W
M9^_5U]5\G.5"@3_[*W\54MC8:0I-+$<$6^8>4^17\K/5/%*=^_["&G_3S%E(
MQZ/@Y_% 0L%#PV6X?BFL0*"?C[(ZJ:@<B!908PQ%U%EPF,_;:K5YLH:WH8'4
MS8]#A9MUG2&+8C$I^E@VB7DSVR1FY63MA<D:.-7KV6TC>.-F+TA017KK#SO_
MS1/V^\*"Z2Z#A5G301QY/Q8'(R9,JU=NNV0$8SVWX(5;S?@6C+);E#,>0HJ\
MECB+R;WB_VT985Z):I!;D&;SL. 'XLM*B5A8=$HYAT6_JZ@L4SCPD"?2-N]5
ML^)Y=GBPV1O:-BC=GW[<_+OS+O"5&S5QSQIXOK/<YGA("=#6I,5U.NI>XYG'
M^9[1GP>CNRXP>OB,&;UY@?6 NFTITV_>XIOV,UKX;8"A?_;FYX\W5)=[)U)B
MPTTV2G\7)R;(LS]6,LIU,*9FOFLP9@\,VUH3R=8EQ8]&LCFFO).6VM'EM0;@
ML/?+NPRWMF0%S3M*YR:NT":KPBU3Q,IZVZ2@T)K[4UV-K,F]]CLIYB64V!S1
M7I,FSGYPQ\#)$W@.&^8<K$GJU>[",V(VMV>VGMD>A0(_FPO)!CV7/3"-HW$?
M NE#("O9XWS%$7'W\2QV;8=BV12?'&JO!U9KX'C.[<%U\]S#GM^VC-\,R]IF
M?MOQ@)&U?0&C;9#I?GOIR:):JVVK;@F]CC7TFQSP6F5_R2,,X6M,[".RJU^Q
M(H?JV?F-]GYXQXWVWGWL0Q(WL);7LU;/6C^$M=;=<^T9JP]Y;:Y9MH7FNFR>
M+0][%_WC^RC7-D<=G'4U]=,[M7V8:YL9SO*WGN%V/,[EKIMY__0KM U"W<>Y
MGF?VUK5,<805I[RLZIC5[CEXU^]Y..$V92_<ITQG&U?',_K5V=S5,8.=6)U-
MUC];IOVV-H/F2(039.-H=>:$.$V].?>@;G(KXP[8N_J.6S@[6H[B>GVMT<XN
MKN>LFTZ\PXN[A>OWLVGO1%K/)NO*+=/4V^>GUGKWN7JJEK<3UO:.KH[I]J[J
M!B]/L(8"W.#5V605M&4*\)ZNZI.R\XW>:N^9=CQ3V^N=EUU=7"?L/=-M]DR#
MK=OI[75S7RRP!H/_B:TPA*(&RM2G&;..JA8I;.*\+_+MN;FTNV&4[^CB;%59
M_S-;'&OMUE\;O$2;K+JV3'%N[?[K">A N;7:NZY=U_6.R=&[Z-WLVN(ZX;H-
MP79X<;=P_7K7]1E<^9Q=UU8G:Z221XJ+(Q>K7 ,2H2];Y*DX-3Q12<0[6-1^
M0_:PWSM)F[LZ_9;L)J_.;J0S;++RVC+5N0/.ZX*B/*;_X6699]JKO!BKT\]_
MF+V_H[6ENW*HD!/L^$9TS\C/A)&=/G*QS9&+OKRZ+Z_>C"OO<ESS YCJ*Y_1
M 2@;.)SE$[3C[G(T<C_*1W[&YC'W1HC6CW._-CAR^3I))Q5G&B=%!G,IM9_3
MO"Q_P4Z<0(O1"/RQ<DB*N[EK/RCRWC^CW\W8.$Q8=S=C8Q#@U6VRXN\=5=TX
M&W3M YNWR.NT]XT[GLB\07'CGN6VB>6L?7_=K@:;QW([OH]D]L?J]=&,S;CR
M^>QXO5Y>RW"?W,TMA)Z?C7VC/R]G<]?G__X16*;U<NNBW?TR;?<R;;*.VC(-
M>8VQ9ON;K"'%D4#KVJ3/=H-\[?EO-J+9^\:Z3<;7I<"&QS%Z3MX-3KY[!&1;
M.'G7PR/]05A]>&0SKGR09(\'W$C\@6D4SVZ4_<;N)HC673.)))0"\-Y&3V];
M,LA'\0=G.H$AX2&L3&6'=#-!2BV?5&5%,ISN?:K8UJ'HMI@0;K!OWLL(7(N_
M?K"5<=LAW<=.W$4F\.S]^WD"/1.T[]A&#KA#MZ9;DV##EKWW0';S2F$F_2JR
M/>&_++D\^!?\4]\Q(L5%DM7< <;V2_4-VM[>+#M\F915$D\?>NW#FY;>PJ4_
M3-/NH?)T2+(+>+B:,5@V),HON78U3.A0PS37+*^T$2>8"QM/4O%5Y^)2^\Z+
MO'[B?L-7U]/'M&8)9&\0@:*QIFL1*9-2&^=)UNE+</V<FD56EBP:LC].O,43
MEQV(["^=U'M^R;,)O&&=!5I<D4><X+5KU$PGR6C!20F<&.>%5@TY_*_@7 /;
MO!J6&H>1,NW?DXQKMC'0+,,RT7(? Q,S3-G&&THRXMJX2.#^*2<%LG*2,_P&
M2 )#U]A$I'?#7U]YI8%NN*J&\&(P^@OMP_[9OO8.G( 1H7PB\%TK^<4(94%K
M1GG%,5T\+7,M)I=Y(1+&Q;M TM1;U4MP0 6G^/T4^SJ.9Q\-@B=SSA/P/2[S
M=((T%0TB\<;.)!*8(Q6=(5^=_O?HM6Z&&J$%MI/$44>3$DA:EKS<UX[GID73
M"8.'XM^8 ,N*R84&[TN3[R)-8X!OH;PA?#G0P._1,GX%E$K))*-#CL3+V816
M\".0NDI(FN)LXA)>%$W5$QB/4_%( )$RIPE!M^HJ@4%$!1'K!O2XX!DL!Y7#
MH'D&="GAEOW;\O%RY-U<.?U=K-&[(H^3:D=D54YI+*=T!WE-8;*\%4/!Z,@?
MHX0.%+\BH\Y+SE*!4,)2R\1 *R>HY83Z*R9C>5@7W,QR6N5%*9(+_)?(NLBQ
MW;ZKP+V\0!2!%U"249ZF6#.2<EHEE_CFG'(V*5 ^TASD'VX8H:#@M&>%6DD0
M#ASD!.: DH-B >.(<U"^54'P_0@YZLZD%CN<9 LIHJN.0@<U4Y3V!@$N":6P
M/.+.@J="X&#H20HDG@(IQF,@\U=8I1F8@:E<%&0$4'$^!)UX!=1:)M0)R&8&
M1)NB25&@20'W4K!Y"8S[W;LW<I+B^/7ZW35*[&LS/()OF '+J5H]N 5>A">I
M 9MK= +TS^A4X]^D$:/%*3QMHHY<NS5_X;@FV?)WX0.Z5,4U09+^SF$9LGET
MOAKF*2\)K$0-L,BP1/N"9H2&Y &&D!#WD:07,"X8YV^PQ*4&5EF"7*3]C#QG
M&2\__G8H/IDO?T%"G@![C"*@G2E&;:PVM)3L.2X(YS@O$QSV"T%QX,N75PFK
MALH)Z-ZEH,1H;R$1N#>3:O4M'<1!TX\7"E\._A45OQZL'-^JVQX;EFQ_=HC=
M?X?-/L,8;&0] LCZJI,8!ON"I%=D6N[].HO' ,;JX3Z"\3S)5LXPCA]DALMT
MB81_!H@H,>L%>+2\P*M@3&1CQJ*!>,;_;^\?"0DCSW,8,P(O=GS+"2V'V[[C
MFJ%K1J;K??;W#LX%S*%1 R_DPC0GF\1IRW7Z,?W/F[.STQ, XO?O3M\?GA^=
MGMRDVM$I<F?5^I/.X>W1R>')JZ/#/[7W;_Y[].:C]O.KTY/SHY,/;U[_<D<S
MY4GG\_.'D\,/KX_.%X:_W;;6GZ3$80RT."G@4SZI&H7RY]';TT:C=)0UV!M)
MI5R4GRQ;@U&EPB@'M?B3:S5_KZ5/444-0,^78VD/I=-]#0?0O ZC"-(N NM
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M![I)&TD^!;ZM.)6NIZ1$FHR01O+GVI9L.1JKM=&Q/91T5P?^X<#1/;C(0)S
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MU0!9X<%/2$ZC'%9Z$?E7A^0Q"408.H(?40JS5!$4$CM\$D1#3&*S2(#;:'V
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M?3KE/1UC#;6CQ*=3YONG%'?:NI'MN9979;KN+&\B&-,1H2AM-\*:WU2/N:%
M$$Q$V,0'0_/G#COB%O(/EBXY8'=-<>?67VX!U^VM6SJW08G\/M7ZFI#?!B'W
M.NLF<E:,D _<A7!D'(;[K<Q:T0MJ6NJ1$G<P3_/S-F]X.[-\Y3'*1]PE-DW*
MX&Y;$VZ(,6>+P)7M0/K68]0WVOZ3OXP3O=4MN<F0UW;WC;G(#;V];@!K_\Z^
M*IBCB]$B#I:0^C4AU82T W.X2G&'*E#0<%HCU[Q6=*1,YUXCU\SB8NDGS</)
MUCG00VJNKTC4A_3:A]0YH*+-,M]7I;@#*V[E%^@&_38TZY8^J)Z)]L;2KCKZ
M8,,JO/J,7L]"'?2K9*/6-]^6UI^,6<J6@:W5Q9!5N!;S&Y!OH+\6WIV*L'=3
M[VYH@*Q-)R^L^A::SS:FR^$=_:;@MO715_SH-\6).JR#+_/M_6(:P:_4&/BW
M5:VDVT!'J;[,O2Q%OU 3YL$JXJ6.RZ>.HTV%C\W6S'NA6=3A+-#DBL5(,X?>
MH]">'FSK03-]H;E>J$V$Z0(QC".'/DH]'&C_$;ZG1M0+MMJ>V9_V[M%IBVW&
M<*H=:T,SL -MZMG4KWW#^2M^6=IV>[X@8C_+3L7-7OWMV8WJZ]T6[L+"="C;
MM9QH!.\&"18$\E.&#?#&&J'RI'Z4X H 83X)('7XKQ<^"%_6<= O&]K8\S4O
M\C5?3#U?-@CG&02Z]D9HH%4V&KB>/7MU2DL@I.6IT:-PS/#_V&YXXE&[89%M
M-XQM0!-ZLMU'^*'G/Z,(]%$$$C'AZ]\9O8[JE:K!_UEPYYJVJWW]>D%]Z9F@
M"# "QH?)CB(K1-JT@1Y@J[21;\/@VO"9Y@1RA4A[K,&N@<RE":-4#3V8/]"H
M&E_\M 30.+XFF1V^T':#4)@CD+N^L( GZ*<X;9MIU_/O03[_APN7-I?!U:+?
M=MGH=Q&\24QRBM" $M[U$PHK3+N*XN#PD2T$G,>$/G!L<V@[=OC,+#.U/7MT
MK)ZV'-.>!$1')LWG'FD-YV"TC74GT81)6*@V(E%BX9P+!(F_?[+#!Z33R#==
M2R!3@(XY"O!Q <PPXDH[?$,@PM!A)D )CI_ OH@'SP%E5(/_MQ\)B$4S>>29
M56.QGN\Y#GP21,,@Q-<%.&$;V$4*CWO?G*PCQR4%__;7H?_K;PM_)@F@@]Z:
M>=B8)WL4/D@#(?TK^99F\A-S&*#\6OR3N9ZXQ>:WZ&>O:!X19W;:,]@XJ?]]
MB&L@IB )CX>^,'\<FV.8[ ?3>3*?@U]^S1X5G),<O ],-K=E"U<X'K],\C9R
M/VWT"/F ).X'L*R$S\! ?S5+,Q<-.'G\MU_^GVT.AKU>9S1JGO3&G7ZK,VAU
M1+O?Z1J#KC$TNKW_Z__RVQW?(V/MS*/;"A1ALTR4EK?V7W[[8OUQ<7M[?:6=
M7=]\O;XYO;N\OEK%]7C7S?A;][J&3Y=7IU=GEZ>?M9N+?UY>?->.SJZO[BZO
MOEV<OR\HP8Q6B=9S].WJ]-OYY=W<]%<L(M]&SF@;+]O%A$;\8*,.:!58Y[+^
MJ"5?Z3+-9HELNR/5X NK!A<Y^LDC&$^9CO'KD6VI-B+'' $]#JZK '494I;L
M#<P/L$&GH.R0-D.JCSE!9<F&WS\+TT<_BNV-TJ9$)-2SI/G80[)\6)U"?>CL
M^I^7Y\?&0'LT+0L6@<Z9Y#&I#)'V!Q;T$REI6C 5EFTZH"].,P0,"BO,+H2O
MX,W>> RJ&AHQ)FAEO'3\\>?+3]<:_#FR0U9E6X-8BV1C16V3Y07P".X-S AT
M.##>DDF +D2*$]!,KN&7V=\G,.-A>IXV-A^!,O&NHNWR'H7<N-0^H88*G^,*
M8,!47N,CJ%U((+$JFMIX&\[%(HU4;6AA!7+O_+RFY"J>ZUGR===R;",Y-L==
MLX+M!>58\BK%C&0XNK!4E!WB)P@OG*H%>^A-A,]VZRZYNBK$79RIC5:QS+62
M+[CFYMUPL[JK7X6;9WVHA;VENG:'D\:+/4_ED/<\.[70706:#K\>WH4AJ&$4
MP-X$DNV!SWV0#N3 Q\>GL$6X%_3HHQV@JH(J!$PCB)R094B\/"5L-,OQ@LC'
M:!BO3PF-3#@A7Q7[88=T*KCBC 8&KS)="_0CG'H03:>.+5@IFM7<6-8]P&'#
M5 +384]A_%0H EX<3F!L^T&H_3N"K8.'X3$XQ]8!RK;6XO2CDJ^Q%F=E5TX<
M%%F),,N(G,76!:L;B3I"W!\SJ1)5V4+QC$! )O<%B$A'/?8<2S.4 18%.ME3
MSEM *I 'TLO!1WS0DM!%UZ!G9F7-G%!IS$B0!@T'PGF%!)9R""%A?1#8$?G6
ME9CG,$-H3V302=F9))_.3-<<F8<JC)(HST4<Y;D2X6&PXY(0UFOI%$MB5,AS
M]RXL!ZY8IL=%5Z%1_NC4=\$>C3B>MB ZN%70;\4VM=(:QV).I_.&G>/X%1^2
M%!GPJXD'Y/+D^3]@F2/AT"_BB/9DZGC/0N0%I>W1WWY9'9LPFLU?BG%5RK^_
M@,OVY!''84XMRXM<NNB^^IX+_[986ST,N8'#F,D2IYDE OV8(:C/VH/Y2!<G
M? C\;H[@!N$4LD2U]@+!C].S0R'<Y =V$$3P/-QUE#WQ#&)"C0'W5110:IH,
MME-X^I/MHNH-5'J%-&HT-&Q/V&I^O(4MM,=P-0.7IT_&@RL M/,&/69\5*(+
M5P;"S'TFQO!PM]F]Z5*^)#'<.'X7,'T86R+)9$BI^9/9#Q9S0YE':"]]\OR)
M9C2/_]R"1]I5YY$D"G9V?75^B8&\AO;Y\L]OE_#'_S:TTZMS[>STZ^4=Q<EN
MK[_=G%W<%G70EIQYOO-MBWXJ$/#F(VB&Y.&VS.!!NQ<N:LCJBDKA$Y-M#3\(
M'H"0CH&J)F2/!R%=7DA=8Z!.#]1$[UZ0#4ZW(%TBRLT6P%\6WSF._>_('M%U
MHD(+[.0'Q=C">\:6!BKP MC*1.I3$Z:CKK0&C ]L/(0;,QJ/D9%<RE,:1_,3
MQ7$<S[WGORQSBNH7ZQSP1C3!&W2E$,/QMXV4,X%VQA<P85_(I+WO*%DF>.>@
M,#F6/R)=@98-/(S> IA/SD+?=?2F-HPO7%#Q'^G-F?4_Z]IIF%5R&BC5G@2)
M'5)XX$Y&_8+?")LQ$L-00T,!A(-2O8?"L05FV$J!2!)&WN28UN41&#7I0A,A
MF"BRX\1.@ BW:K&B72>L%$Q8Z=0)*R682YVP4B>LE#IAI23ZPAV*?K QO2>R
M[3A[/9J@&?T?P9XC-*&YLH-N)K@N&WQIXIWY:#HBOHW(ZK,MLAGQ 67OL7D>
MX*7]Y'Y82],J0+=RTNK"H3(DV#['G ;B@_K'1U6%8[NT"?2CC]D7YG3IH_?Q
MUXGTU9LL@65%KWRS_%JGKV:JN/B[WD '2V#AUTU]\7?+ANWKK79[HU&7?=?2
MC?;@S<^U6VC4%?7=*ZO?!G./YI0N,KWOJ78Q'W=X67RA /3;&E6!N8\6W/:]
M0N4-5GJ&%V ]G*/@\DD]E]Z[8 [[(:\^<XW>"B6G+C2*=K7B(G#-![5SS9?A
MOVJL_XRTE<P.; G!L395E YVXPJU.%3*,+G!'K&?\R@*R*'X_L,V&/$[X\#Z
M!:_X@IW"L94=DC1)#<!0VR,Y(+=!4CJTUE1Y2RPW;L:1T>BU6E6&PZKIK6+T
MUNS5]%:J,SEH>NONJ4WQFX(JOZ0@YW*]8!UTJ@H"4!T-UFA67F(XY0,]':.]
MAABHC^>5CZ=M[ ^/_$T9<#+]:GM!76'XWU;#Z%:J2<T;PV?NK2L,ZA-Z?19J
M&?LQXEY<K9Z#TBK5SE^,QX*+9\5/F4Q I0$*,M);*[/@C:GHQAZUC%H/+"98
M3FHMO;2GTQY43TM?!]^YU)K[U:;I8^O>TDMW;&%\["VX/7>Q,^7F\*-VXZ2W
MOFVT@XUY)85](WCUFF-JCED2SS*Z:WA^:XZI.>:-<TRKT6^N[SS8(\>LT#W+
MUQ9C#\VWRC?A>A/J3:@WH33M=ZJ&*9.D.I[.1\HJ7=N>E\2I408S^1,(X47O
MQ;77Z%* #XSX@Q2 R4K$&?PQIM$WT"N!]?3VHW">X_+HG.6/QR^\?&W)RU]\
M[\^HGL_QGH(Y[  +9H.%^@D.!N)K$%@F9YF/X5^>'VA!A%V@ @VAGN <X+P(
M,F<:RC%CG,Y&"@Q0/<(NHJGY+&% / V>&,&PNG8*FA+CN3G/<Z7^FIUNIF(B
M@H"E\*T8%X_&C7SK 3&))0!H=@8)-@#/@M^L)J,A[D &>3A%GH4ACJCRWZ0H
M">\:[*I"2D+'&:,+H<0*)*4W,Y0^\W@R?7RXJ0_4PPT-F/TA!Q2:#R6#X0-#
M1&++E35S5I:!@![YYCB4+448/@4QQ)Y52?:[CMZ*%YHZR"#P+)NP+ @@(37]
M5&,<^'VR$0ZLQPG2$#'9B<SN<$MOY[Q8;A=P0G:+"$L"[IACDD5V*"9K''[<
MU2498.<=A22:W.K^1X<*MI;D^AW:Q9B7Q3AS,0ZRN.KOC'8S_F ']Z*6.X7"
M]*]&31CAG=&=G;'15Q]D7][@N,(\[ N]'^@?I%<(3X$6B$"'! T-$GTZ$>K/
M-,!+X(W#)],7!XO8GF12'1H;Y.6(S;!!*W69K$OV<>%</%K/V("'FKJ6.]'U
M+XN,#@#SX?(^TV9@18(:Q*:$4K6!K4!T%%043F]OXF8.5+U)18"$P:Q],9_I
M-=O.<HZE7T=[S:?YO:K.[WJQ)'NS>T 2/ 5$.4>M('. M]Q1,'NQ9)7[\6YI
M,K$G\E3J=QV9-[#@V@&&B>T&XC8:YHOUAP#EU-4N(KQZ<%9>=/\ -Q,"G07\
MD F_##5RX1+VK4<-'D'[4YB?!*B6@(42Q+F8_Q%<=S9R+_R3EFITU5)A6R*?
M-,$1]3<8"D(+\YZV8^S4WDG@-&G!9:PSW,UN2GUF>10CM@T]WR? &>P1$VO6
MLUAPND9&9Z208EFOS:4 !K9#S.%X=O) @LCW<16^@ILU?Y+!@-NJ#(:T43ES
M!#9)QR",-?QM"+#)(*WQ%&?A<FP7#>PT2"O"W<&TQ 2!=&F3'H1#IST4#Z8S
MQHV.7+"M;(=MH0EK]["K.#U+8(N<:%JXC6?5=)E;NN-NXCM.^PHZWH%H,]=@
MK/WNF?X(#_F<FK6B$^4("4U"C]+7$E_TO?: %FT4 IN1(LM]3N*=24DF_(71
M_Q@0QWFX,,_Z(5&+8072&T V,0@P%PQJ_X<(&;67D8J9;Q^!Y( D77'OA4Q^
MV4=2:@;\!3PR)"8?VJ[T'*$+!GU"$P&S'I%SA?P5W"]\8B(0*P(LBV/3]S&#
MB-Y ?(O*O 2#I2;B MU/S#0$=,BK3QPW..Q-Y("$; Z[Q\:1]5Y!,M\*"W0W
MXN,+E9IZRJFJQJ#=8<&;N*QPBFFE2K64@55'P'AN-!DR)+(40,FS(\:T' FT
M4)"'3>T1F%J$M&;I)&M(\4!O0YQ+.AO8;$LT8/,4HC:G2]U'("GF751*KM >
ML](7XSYZ0Z!U4QY0XBV01TRV$<@_;V);!$YK<Q?@Q;90#0M9$!:R6\-"EF N
M-2QD#0NYA_5LVL>TY"K*9>(N(/3BC"]AQL_ ,,:(7.Z/CA'P_SD%<XX]Z>TP
M4AT!4FH+&F5LA*4<'7C?GC&*>JXNHVM?(S^(3,:,QJ=Q)N8]:.?L](.YDN4Y
M/[I\/G]J?.O*+@\4<+&I;\%(.+9J)]<!LT=9N5(%R'A5[E3_ U-UDV"<:T)\
M%F&V'46 E_%HMM$"7-RAU)&FGNT2'+X$_:;-HPEJ9FPXRWG0NWV),>UZ.0ZB
M=9Q8AZ%DTVE@8$4"?I-A)W5H;D;C12%VWB"%#.V\]'X5($5JB0-D=I)X%F9P
MOPL[FDN^E=]%C$9.:CFJG PJKH+%%)258>1&BL7,(! JM&J1O1ZF(-:59Y^^
M91!UUE;G=.6DX>,LUKR$D[]'OHB"693T&!D],>Y=ZNBB['KXKPB$('5 XJ1K
M__">8*D^-4[RA0J" UO!:F1G&+9.LG'91P]58WHS>;T"/V)/CH1AOW>\(2QV
M\:)Y)=BS D/L-JOV"0P]#!J_CGO(!&S\Q#Z7/'HKVAJB]TLA%\)L9PB9RWB,
M6:Y$HJ_:*V)=GX)P.%+]!38QDDZ]S_$&XXF<R=.Y$;+G01']*M^W LM^7?SB
MP4 _Z;8W@2_N=O56[V3G,+M&7^]U%G^]\;#ZH-^ITF2+[6R->5MU<-+,Y?^6
M45J_F*!':6UCNYUX\\"N9R]04;GN'AU:3<O:ZR]WY4JKT6UW-RN!7H=-7J."
M?2,@W9K.WP:=]QKM0>^MTOF.X,!*3=G?L[G=;PT K'/2K>&_2GL\1J/57Q=H
MI&2'M".0JL(R9%FP\D7/ZAQCX2GG(@4*7R9#KJ=W"TPI)WB.LO^XK>=X=89F
M(#BT>F3,!I3>!J+/24_O5PX3JPHW[%_>&+3:25NO'KA:]0CI)5"PMG'4[.WB
MN1%AY%/95IPG3'%"F>8K8XC:2&#3X["*-U)KFQMI@V.OB* Y:ADG^F[10U[;
M-'UAGMR_E*JI],CHM/3UC<R:2E_[+BT(7M'.1N-[!8/Q\V#"+Q8C7)I3DC)O
M7OWMV8WJZ]T6[L+=@QU(:U'5U00RV=SAM.H'>\II&Q+9&!/?9.UU;&VJO &.
MTMB4,C2-,$QCRD)OSM;FJB@JFJ=TL&A".4?) _CS(HI$0^:+B9])H7FZSH6#
M12,A)I2,L*@*1E7I1Y.(:U0X>QQG[XL'X0:88.-X0>&"D]D>S^VJ$6BK; 1Z
M0[0Y0U+8PMN&(YT([0B/Y[UFAB'0;L2Y)Z&7$-&9K#%095M(=XX9A/ '4+#,
M1 3"39&FJ8WAW(]5EJ()HM.\SU2<Y)(F1BO#9^U(DNC['='H@60FGLT%='EW
M.&?3'''%G$O7E#S#'Z[WY&KFA#$T9(EE@WYAF;YO(RU@5ISM:S!H)&2!7>HE
M]&Q2D6=343\E]&JGIZ?'/O'\-_U6U^X]>+-+(!L3SQ7/JH*$*]:HL 0?H%K%
MD2!3@D5A?FIMH&OG!9Z:F1^<D3?!:B*>(DUL)'-(5%V.PGO!I#K*+;1L3NFB
MA#_/ASV'LXV&@3VRL1HGDU6()9P-[7<L#\)B550S@ ZHEN"^(5/!7#@+( _Y
M7EW[+K0)/'^/93IT,=C!#_6^5 TD[RUM(/!;. ;EQ$-FDIM%Z::TE[0=F'7*
MO+IH8Q#XQ'/MT*,47GKIU/?&MD*X2;TO"/$@[^4^S!_?@7#0-=VX<&X,\3!#
MZ4/3H21-DS9AODXXFYVBBC:!@Z:PK3^! K'V[<W6<[\S4D *5"N=1LM1U=U4
MK HT3:2?8C%*JH;;0R50(^/.UGWCZ3&G/Y-L![JU*1\XPO39_R!OV;(&&:\I
MQ<DI7"K\F+)O\8(!S@#) 8OUJ)X2ZQMU[=0)'Z@V&R?QB)?<Q/P7,!!7Y"5+
M4--5<\69F(^F[3!'<E:X"1<JO1GN1H_*MST0T!'\');^+TS.CVC^:J;I*N30
M_"G9- A1;LB[FC[6V3WY">0+Y>]JPC6M4,$;X91:3:.OW9D_M;-(JFC_[0T#
M+&)LJ"K0>'+QPF2A@UI.4D'M(K@1:*Y4*QTO< P7KT]"1\T,:]]!5(EEU8&5
MDA<SP>7,/9@N><\3)XTT>E0C%KB(X$17"BI@L/-+L*X:BPKD548\WA+R /%\
M^$$T M)UG#"J'X&4<FS.;[<)FPI8:1@%L. @H(I4*A8EC@Q--^2[1-T.E'TY
MBZ$6U]D&46")::QQ. A-156LDN=2%23/PO099 L8.W)FP+CB A\@35B)O,$"
M809T58] R<.;B'"%9GXA"^^?B0OS\-S4]VDPK*0^]E#(]0SV&ST:C($V<V *
MUVPT5VY"=H'I<ZGTS"4WAW*6!4A;?)GF - MI,>&AM5?-LD:;SP.@#.6H]VE
MF>EY,7S;$M[BJJM"L\O"!2IL/!*B%IA! 2$<*GI[U^UTXV(OJI]/.#/TT@RM
M+"E6SK,%6S!)QK>8VIX].E;P#_ Z>Y*X#]R$HV;U%5V[%>*EU8'BN=Q$G1*A
MX [!-_A0OKD2J ZW68(6[%.%X=L3COM3K%'?B$<;!L?9)A]>>7 A&ZV& ETX
M\R:@WT]BNL?B8& ]%-&?4U0N5ZC(!TF2JL2(2SV4'@1,E6;B1+4G+4!)8ZEX
M4H$03/=/-K.!.F\$W@D82_KD 8T937QG<_#Q3[ZQ)?R+[<)?$Z+9Q8I]7<9?
ML(R_5Y?QEV N=1E_=<OXSSY_.Z_+^,ND25XK<)BYA#BE,HV*8ZS-ZY!9S:Y0
MVL/(AVN'(-&V1#',5S93[G"U+NF\9F,I<L?F(T@=E!O^7,)&7.>]; 4%W4I8
M'9[:L7C9.$-TU,?S(]V/]SL[A/(+QS8J[ Q=.L=HH\=XPHPBS*B5J6+T%-88
M55 #74[H Z42+U%-&[C(D1U841"P?E*KH+4**E700_$A(ZXBK+/5;B0P)[YI
MX\:EXF'(NQ+ DNW =TV]T\*-QW_TT?$8HT*00,M 7J(9ZY@2QA&=ELB^C(R&
MIZ*BOX3V1O$%=-I8]I0C#":9DX0*8!$=L-A%JS*9'<F Y(42;" /RR!&M2=#
MFLU5A"=C)(=D",;+4.8I_A!% 4C+%$8+P]?A0&GDLVCJN6ET")!L+KNZ$NJ+
ML<<:J:#Y+ R_!(1DX+3J0QSF4^!-$O&\RD8\+U7$\T!8+?(+I2 DU^7,Y941
M9'&XX;DQB\BJ:Z?AW"6*Y(I!4A*.%!U5R"WM+$ 043-<I$_N;#!(ZY_\)0<
M-E87TD@R:6$0Z' QH4Z#<SCG@":^Z33!*\)OEH##YL'./I@C=+U2 ): :D/M
M2%X?7^'?-_A%#!T)X]N^@BL"@0)?M'N=CZV6/AB0\**O&BE]T'3=B+2J,2&.
M\.$HN9(2&Y@0 @.@VHXY 817!*\8>HA0I&':*/<!GT9#QPX>\.3$Q#Z.AY>R
M[^_"!P+3?D?E+QB:[H^&YB ^#*(QXJT&5QEOFGJUK]V#\ -!*1!12<EFT\'0
M^3.#/\'0\::EM^:4AE![HVOG&\'CIR&F-D85;G?T;N9A&L'03[(?\L'-#E04
MBQ@7%I.$VO EU*8T3F#6R)) HRJ:*N/<1=(TM /QP]]EMF\1(/,<9A?[E!7F
ME(*/)JDBCP $ <<BLYM/PHG\^N]:)_T94B)L+X(7&PN?,(]1&RDB5I=B'Y_.
M!!$:BT3@H+NA"#P,6ICI1"0H9B8A5_FB0K4,+322;QA4B'Q?[D8BQ& 'I01N
MZB=M$L"SG,QJ9!H,^"P]0E:&*0M@S2LD6GHK<5 EYZT80H&%>?<NX1"#> ?*
M>TZ'!H%F0/DA>I0;P9%Y'C+O9=K(HX0PQ6 -;0@L1ZA8SXB[A4$6F0AD,F\1
MQB[#]8Y!,85WD D-O'4/MP&FDX&%+3#F']@_I4A71KPY>B1I!N^SK>*=0$I.
MG#=BC,?IS1J6W=BN+*!KT@6TZ,N]6)S''.Y(P1VF(AX:^3@*7$9K6 \E13-;
M$"5F\+C52&7EI=OOE,3']O9LG#L#\9U8!I0SMR1<G<20<Y,N9(L[M"EFD01Y
MP)E.!2#Q$&W40E7^$R7MN0+A"S%WB4-Q;#RCCQ7H4L&-FW)1,HF:VRFDC=PD
M$9'$&(^2="M TU_*OXDY$LN<>:$$_4[Y]= 5>)+JCKC,S^>K>#6/CB]D3VH"
MN8BSEUI@T$AP'F>[!3;F4!HSJ?!J*_AT<X#G=>US)ODEAD7,/9<8*-)+99/)
M%W(FE(19)(_+DDF;C&+IJO0".%R5 Q,1$6&>UQ,>L46)8EX,8/G@!4+- Y-<
M0]-V2+ E,LH7]Z8?HUC&>?VYK2;LK'"<$>4GL2@_5Z/DM7O:DYRN8>2WCS_W
M%\>?UP'R'/Q21ZWKJ/4^HM9K%@09K5?0._+7<G;Z#:=_>O._VM7UW>79A7;Z
M^_6W.^W3]<WWTYOSX\_7UW]<7OU=N[T[O;OX<G%U=WL8=L+=2D&>UDSD??,E
M;KH:&_OG'!I47JM34,V? YONW>3:.E..?GKFAC)%Z9'K^/95EQ7<,9=P\6@M
M_/HK3$^[C -H/DVR01$0T^;D[R>X5(\=SR.%,75II4(6$V&ZLJ_+K> TTE;_
M-*<S3-(0IDT3C9\V+@KWD;G%>#,_C W#D@E)[&AT40(=V(D'*.*^/6S<PNG?
M/\<]E.6V2\3MY$:7G[.V-O=Q$CB:^PH4R=F/,&@S^QFK.G.?"O%C_F5IS]#L
MEY32/YK[#?SB7WD3IW8_<XN4"F[RA0R6N^*>%(=DM\%N4&5)<<6BR0'^U.ZR
M_V&4T"UYL!6IAC[WIY/E,[*C*(7!@V@RE9JB=(>[G ^-ZGFZZ=<2NM2!^DUR
MQ4AU$KT=\ :+'#$1J?<V.UG=)<,H[VPPA8L<'J5>R8I&*9Q())3F!_09CFV?
MRA]&0D?R%=.X=0(()73 2,N$:-,QG\B[15=;:/X@W/.DLQ!IQ5-Z%Y5&/-H2
MC'S9XC\M9EC;??2<1ZZDXD.,TH%\-H2XU,(RHR#NQ>1+:0+3&=GC,=D#<-J<
M#<+MKD@[ET0G1HU49'7$1SF9 H.-4J4B-OFWZ&R\Q B8HBUC4=Q!LC&>N\-[
MO6#>%-:)BPO8HV52:X80S+2)S<96(VZ?GO3QD]+K!HN\/JEO$ZI5@M(XS4I*
M/(*)%X2474U=VL=DBYRR#VY>T/^Q!5:\T<K#BE_@.U&%O.U>?.NM4,AS;M3,
MV-U.@;IA?&A/R@4=4%O?7P%9=KM:';U)FM:?V#4%;&(2GTBR\(&C_L8;W?$8
M%-\<>A&%4=%"1TH\$!=^IHT%2D9LJS<48/J#C%/R0Q;WJY[J<-O2KE#[%6;V
MF?;T8R="F<27@NTF$5,R]&5%F*Q/1:^*'!\OFD"E6<'.,^_C*RG:F&'<;7BU
M6Q)>+0MC=LK'F&?LM^9[Y*OO66(4^8=3?(?9'V</MAB#]@&*-(F;Z_'8MBC7
MD_VD_'UB.\CO&\QBG+ODR_M;:F^RNZ' IHP+^_5,8MNE =P.+Q888V57*BI
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M':/7(^%=KE*U4ER!!U58*38WOLBF:%MMB5Y"$9PL"O:80DEHTUF)]N.Y/G@
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M&GLZ]TX6_>!5C%T\Q:Z-W*)SS1[RGSRA[,=EU[N#D19.AP4!5C&J:K!W*Y<
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MJ?)O']HK*?X=Z(W2WV^6L_3G^]F$B+XX_I^S\?++R+E(3O.J%%A@;4FIP)?
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M\R%UTJ&W0AI2B-5>R3000^^,\CFF;'PJ@1>01M4SQ3$!1?H*.#=HBT<;.AT
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MH&]'Z+TVD=PVT)@LU"O=@(QZ N5MM)Y%%7*?\&,+<$-*K+3C16NI-':3=@K
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M('2!!Y-S*.J@%9([]E9X% 6YAV5S)Q(\Q 'UX&U)G$R_X:J>T"3[[[!6O\7
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M/A*029I'9/1='%4%[Q'CIJ=WQ_SM62QC@?G%K$?$MY_=*][Q)0S[%/"M1_>
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M+[V93])'DNF;"QA-!SQ;)/LUD1OI'=-2 $T@2J80E8RI.I:[$MP[JN;A@'\
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M&FR]N/P$PTFU*F"4W^*B/LC3CS#Y@-,>4NR/'JI[_GT_LUQ+SH\B)<>UCUP
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MBG5CC*N'OQU?7/PVGOP!DSS@Q&S*)3/CZI5@$,BB(ML<K+#T:NND;)L3SCN
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M .JV2*V>]MU-#U$Y&X-B"4-]=QR].]%$5I(24?IB?6R3OW$+2M<%>/7 &XU
M3/!HA&566&"Z%& @E&)@0Q).<V5<F_B-#6!.O]AV8WM]I>PJWP9[[@K2(%B>
M VWY-"^PRV*#/GG+A- 6':"6L<WVND)P?^0>3<<6>@^290-[?(6#YH3##Z.G
M\\D$1^GK>[(0IA<+:^&O))Y%!B:/(@HK<ZWSM:C&HYB/Z%F10=%>Y92-;4(
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M73*68>)"E8P)0I^T@[LH?FJN'*J-+OEM=\?>W<CHPJ00(R_(O*GK@V1K'XW
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M 3,B(9X:"C,R'_81>0<>W-DF[Q4(WE8AT&YY>9UKCO2V0L#MN=5K@RF\]U8
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MLO Y6".91 X4BKB\RJ@(D6, H:.V0QJ(['["&2F\H2@[1'6/+)NV,/+8E^/
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M1YN]P4C_W*<)U5/(SH@L7931L-KU ;[_FDT6^,OTGU<7(1>52R*_S7A:;HG
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M/6V.S"RL;.P<M!LJ>0%Z.@8&>D:&O[.F70VG70<8^9A.G#I_A9G?\BZ+M+^
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MC204]CT"=!];+,.0KV?=4@I$.FW+CE)L7AF=_:*8AM+H_XW\?5PLBAKUQM>
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M5^7QDDWN\QX96W3K5NCK#K%7\.*AS]MRKO/OA(9T-A^TCCD>W7(T$O>9W7P
MS![/XCX@!B$,&I (?6T?Q4>[GIJ>!\G:A#C^:U/\Y"4%%KS>>@0>2TJJ,R(C
MKM)Z+T8T4@9@]!7;*!C[I&'-/RB;R//Z[T*,>CE;0I:)1?I6>CREF)(NUZ8"
MYW<4X5K"I2"G_0T].TB\0]>270LV<6*F!2IA'X+ZY]56<J3C1-FILW<5_B0W
MHOP,Z#"_+**I@, %6"*%;9ADEMO_9V(*TR\*U57C]$WNNL=&,6I$*(:@VJHI
M_#B_/1_;W\4:XJ+9;'/^D44%C.%*.*0;;(+&AK,\R1F?GBK@F][_E,I[P*;S
MM/FUT>%+A*M&?_82H?.6S6<2[/5H^H.T9IL#P29A$%(*Z?YO*A7_+RIEL!NM
MXZYWG?<1Z[<9/NO:4%H?[QX9\N9QW;GO)W'=,+P5%3B2"8628_BIP!4O<*I2
M(^D3.F!;W?.,BZ+&+U(?IHD*N,-^!<S-=$"C],4(YN5G2^LR\SA^G*NJMT9)
M&UE6/-2:,T(Z@">P)E@W[,2;.>0S"@-H88"#V_L4K%4%;95/5JBE17=O,!OP
M#:3$-DUJYT@+Y&VHANU!];[?C7WW-/S!6/4M;XID-3Z/$K9.!4 )-,DWG2)9
M^;_7Z[=!'XM(FG_J.2!G=6DATA?UGPU-T,D'3DL@.F ?GE=A<0//$_F7;*6X
MAQHT\D7?F ^?Y+WL"PG8A$QKB4)CGCAY)X)^A*A6B+"*WUE=N>)K16T/UB4V
M!7QS16,O'[T,DBQD.7@!-LPP(OC7FA1B3F4?GTAUN*H?]$/I',#+JM5I(17;
M,&J>;_(V.:SG(+Q8T3K\ V+>R&B!"D13>,'\ C*J0YLIIXQ7Q#8'.JU05W.4
MA9=N<B8<DO@U6T.+TBSF]! TA0?]$*IV<3+@<1&9:S[.+.Z/@>$M+>A#JJ9/
MZ]I)- F,U.EHO_:)7Y ]MQBXI32]-Y,"Y0E\XZ]1D%S!ENZ[@?1H%^&QXKB/
MT%CI6"A5S7!"&*7+9?ZQ_!.$?'WTA:!YP$-CK:VAL/4P4^0)3WQRKWQF^W<6
M*_@WS4=ZZC!MM8Q[(KQ&3!8LJPGD"#"9Z )7 9&?^F5S%,K'?"/3)7,R%*<J
MXDJ[T_)H&W4Y^%V,:H+NG>)U8V_)-"^[8:?B"EC0*=DD(DOI;U1KT\\S'??\
MSQ!#5J= Y666Z%83J.V[[8'C?@I;.4&1"IB"R5] ->-L,U7+2N^:>=]_'G=>
ME@VWID1BC4,P/3R@/!6(\=WW2\9E#YU5WNO5OI9!(%F=8\?F:ASX;=XE&I@2
M]4 E\U%E'Q?LR+9JFLBF+QL[(:DB3B:WDP79^%;L*&D"5=E%U%;<1-]-NZ>7
MXK2I! V41+>C(Q#,8+778$A>6V9VTJO6J=DN;62]](NV74R6[E,JP-@UL-4P
MW@"93VR\]*-[8NVY/"JG942);I\1]X%T_N^/EW -0L6YCJ*I'W-FUYYQ">YD
M)OHO+*6&=(VP'X3!DI$\VSYF[?H7\:07GZ?ZR07<PNN[_B!.ULL5K[9D9_1P
M=>EU]%.T$G8:X01W("?KRY)DRFI&,!=6]I.E.5^K7NA28[0DW?CHRS C..>:
MGDV^!XX3'\#5\;"8?1UOLP>X]N./ [J6MU=[Y T?6#$O0TY+[/8B;DZ9'23&
M/_A5MOV8:/?^1Q]PT!O>9)?0?L]E6OIBV=&6?W3KG)=<; 85N$I+_* \K/WG
M.A%R I3:"<J9:)?/=2D*6%(Z;W\S].QFG%31=.42!&^EPFVFN;!?3+BUZ"6F
M>T+)-;E[1X;S>,Z:"C3'!,/P-WA8'8U+0GYVJ(C>N?X^T2SEZEN=<C9)6K2Y
MK^A.)CB_H<5N8= (FM0D_BL$8_'L9]C<JN@G]DM$W5<\1[P%NQB6B>&V/UN3
MZBN-R8ZVANFCQ8CKI'E\"BVELN(2*IQ<F;#EVRYU$XWF/P0)X#SV<863.5>
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M=_CX084GD=TROS$#11W_'U!+ P04    " ""C013CF/BT_,' 0!EO H %
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MOQ@W[1<Y+XO5)]!\ CV_\2O^QTEAO^P-^&6^LH3F_,1H-%?\PC/M,3V7\-7
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MV;CJ._E9(U5"$XW:(%T KNV[J/X%<F/F1554,%^C4%W@YBZ,_"VQI.?)COW
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MI69/7U[1DGY8YE6&/E6"^33$,"1)"%$<^Y!Q'$.I2(P0]2(5*[?N%8<%38T
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MC_JK.4,Q56&(/<B1DGJ."$Q;6!5HQSY&7D(01X%3F$0W-:8V,U\79?ID]CP
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M:S UUZY#/7YWU+NS1F]8O@6E7+SJ/&1B<.MJ_1L+AB4=*_ &9Z1V+=Z<KJQ
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M';N_FPISE<Z75?)OW?;61')45T)FK 2-F6#;SIX;4O6">?^=JLY3:_P65KW
M>+"W53]/[L;9OV:9^)[.YY_3A?Q4RJ=B)GQ,_##&D!*D*5A(I5="B)@>5WXH
M_21!L5.2\IZ$J3'J2D'PAU$15#HZ[IWLHVC'B6=A,S#%N<'B3$U'3>^5:?:E
MC$H<1XW<Y8'C%_9_F/9>JLR<WKW>L=V$02M.$B'U:Q_)*(%(VPUQ%$@8D3 F
MS(M)9!?0T(,N4Z.*FP-QZ6ES\%(?G;'*()#O6M3?(=FIX3O_6*S'07G[@[!F
M0/:L&2:^O0=81SOE.J7/9,ZU+(%S.<FR?63'MCBE7DP;[ZS:L+Y1589DM6N:
MQ'H!BQB#A*@8(B(89)(:#\M'*/)#[F$G;CTJ:6K,6>E7+7ZJ16N7 ZKCJ-I1
M7B]8#4QH;C"Y]W4Y!4&__5V.2ANWS\LIH_?ZO9R\P?VTZ4.=CJ-)J-X'J/?=
M;M2ER*JR=9?B/Y9%*443N=[$[OD!$1Z.$X@33B&2A$#,PQ@2K'S?"R1)L&=[
M*M5)@ZG1R$K)54.H"W#YG*=SX-L?8W4;B=/'78/C.S3UK/5OMJHN5GONFHY6
M1FB\5R.P2IKI+\KR;!3//F[K)GVT8[FSP-D^OCOO0>['?->+,BU?OLJ'U!2/
M7I1?]/=P%H3(DXPF,$PP@LC7ZTSJ11X,_ !'DI,H$-SVE.^0@*EQ5ZTCV"@)
MC);V1WP'03Q]PG<N- /3CB,J3L=[;:9W.MT[^,#1#O?:S-D^VVN]KMN*YCZ7
MM%CF+Y4K5.]1SV)"0\R%#S'3KRY"5#LG$?$A\V@<R0@C8G=*WR)C:J_P2L55
MF:>F7E/GP[=#L&)IFGT&(30M 2$280@I51SZ!!$O$B$77KAJY'/KVDBU*\:O
M6_?LBAT.\+XZJAX"6GB<A.9X(XBH#Y$G.*0QU9 S/PF\1'+%O-= 6[=6[1/F
M_R8]5@\A;+<N/_.]'WA^6K_R356Q6L'^EN0MUO>Z&#\D9]1E>(NANPOPMDO=
M,SCO-8YZ8C#]O\K??[[[^58_\$D/]K),.9U?F4G2G+5F>=&L]0)%8\T!>DX3
MC$%$?09IP 44L9\DA#+JAU:%>;H(G]R,9_0'C0' 6 !>FP"V;;!/6W0>E'8N
M&1KJH4G&">4.6:+.<-MGC0X)^TA9I'W#[Y17VA6_ECQ3YT>.EG?:U=CM/-3.
MSSBOI^_'+-]DO)I"X.V=269$D2B,*88)#:1>'N$84E,/ET:8)4(0%5+1H2%G
M1W4ZN)]C-.B\_B%SGA95@:/G90GR].&Q-"5Y=CI652ZI*76I=3+7KLM[7R_S
M[%F"RU^[]1)V'51&*&8(Q3 6(37QJ5PO=_T$RL@DG3')D'**3QUR-,<L2KIJ
M5JRR'*SS[YO5\?YPC3-6=JN/$49@8.?A%?A;Y0^JWA&G^F#UWSJZ(Y"#])1V
MU>5-FDUW!.Q8%^JNCQLMT,P$*26>\CP6>) QD^$3)QAJ]HRASV02T 1%D8IF
MWV3.L@&CS!QCF;;5&>YM/ER30=95&1:RK"IK%645-#YB:8:6L;3CV>''9V":
M/1EKUA)J]M8Q9A,*+_OO$%G6;U#9^?%DOZ6++$_+EQ5G?UZ'F3,54R0PAQH8
ML\@@,=3?8P*9Y%P0D= D5"[^Z%%)4_,XC[@S9\3P'P?9CN!Z@6Y@#CL+-6>B
M.HE(KUQT7-JH='/2Z%U&.7U#QWV+7#[35%S_>-8\)2\7=2'HRZK7PX=E;AHT
MS0(4T5AB"?TP5A"%OOS_R'O;)K=Q+&OPKR!BH_=Q123J(0B0 &<_I=.N&N_C
MLAVVNR<FZH,"KYF:5DHYE.1RSJ]?@*3>4A(%4""3'1O3X[(S1>+> _'P KCW
M7,@S(B'+558@(5$B@NC#8\RQ$4EC,M"US;6(::4_'[A*]8#;<T4:%\2^5Y\-
M?HVY%7QUJ%1;? ,:FR.N-/T!BKNJ]!AWV!6D/Q!'J\6 2SMW!'L9)&W2ZV^%
M2TR1JPDWF<&<9S Q+AW>[9$6)L<NFN&2Y5BE,HA_/,8<&_]<+"FZJ59]"Q.^
MGO.9 3]*BHQKSY3DV=7B7-M"\.?&IXBQ4 ""L1N)71QWZ-YBOD"<:#?F?>G5
M70S?37],E9ZKY1==5BD([]RZKM1JDG"6X4Q(J)AAD%@&@R)3"42*Y9F=!5$H
M+ZFHD$''QEI;0X%J+'3;3H[&JB:(E1*ORXI3=J7!RV7UR^JG@5E%7A/BS6%1
M8>Z?Q/9Z&6XMKI+RZR0D^]/&[%Z:&UX$J:^&A^<'?JTFB!>A:&F,>/G:SMW&
MRK56'Z=<3&?3U51O5QF2Y(0E+($YDG91IXH,\IP22#$WKF.B2&50C\2S(XV-
ME.I0BM?F@MG.WN"V86>0]2.:*'CUS"Z-C6#/R!X6:A>1B-W7Z\QH0W?P:G?Z
M1*^N"Q=T8XBO^H>>K_6FX;,+C_YCNGJX6R]7-G(JW_^4L[5+_'6+/OL_56D_
MX$)RQ124>>)RHG,#N:(IS*5E%?NJ3Q'!8>=R':P8WZ%<XT0@D729@(PS4[ \
MA82FRN6>$EC@-(%%H@W7DKOY"2'OGN$?) 5UX52VRL&FP(_E>P:V9_YOK >.
MOL#&?O"7=0!L/+@!6Q_ QHFX!YE70!CUQ='%CD%?*5< ]?)E<\VMPE/OJTKZ
MST_3Q=15"ZW6*[W)+];<Y,8)83!!-+1_26&1X@+F1"/[E4T0*W+?'/NSHXR-
MR2I#06TIV)CJG\1]'LUVRHJ&4<^D=!*>#LGNYW'RSVJ/@M= Z>MA7ZN@Y/2+
M,+1DH9^_=K!T\XOF[^>57_[P%;*X?.D6_M5_/\P_/[DV2@W+KI;;S?B$(JTS
MJBP+VA<5T22'PF!AHV^2IE0B@XH@=2#OD<=&E'</3M_2=9$$O#*T.E:<[2]6
MFT,1+O][/5U.JT2;?^N@?.LU+WX182]H]TRY&YO!FXW5OSC0MX8WA[B]'(D$
MXQ5?@]9K].&E9D- .:DH&W2#;JSV_O%IMGC6NMKD_%RIAC0OV4QPQ83,H:0Z
ML^M889>P'"4PY0IG3%*#BZ#./&='&AMKU9I=M8)*X#KU/)I^W!,%H[[#NW;9
MZQM0VQVQO,X;G:C,<GZT09GDHM,OF>/R!1V9PKZA5\^[((=CE">,06*(#7)2
MD4"&M(2%C6\*F29$Y$$[7(>W'QLGU-;YO#]]L/,D@\Z(],P _F"$/^(G?8[[
M7!\.,>S#?-*]HR?X]*>Z/;:_\6GY#SY;Z[?/V[_^^]2&$J5\>/ZH?UA_G?:F
M3A+$*&40TT1"0B2&'*<$,DZ%453:?P1E0_@-.[;'W)D**EO!UMAJS?+I]A^=
MQ$X]T?<CA/B8]DP4U\ 93!UAZ$2E%,^A!Z6:,#A>4E#@U1V$5&ULO9A-5;6G
M5N7)OUL\\NE\HE-5<(XDI$KGD$B:0YYE!<28($Q(FK+"NX/?N4'&1CL'=M;U
M&^#/VM2 QGYG(6UGEUA ]<PEG3 *TRR] ,+ULJ3G!AA.>?2"BP?BHI<^&T&'
MPT8X:[FJZETG:8X388B$O)#,=0LTD!640I1H:AD@U5*SC="&7PQR;BBO;_6A
MB$;?!.#:?#\UYEXAJ["/IU],<15&KR*,L&=D3ZH')V#H3]9@?[#7TRTXX7*K
M,,&IS\=7'OBD5Q^V9?('W<I/U^C>SJO,#\VQ-EFA()6,0U(4*2PRBJ&3W$RI
M9I1D.IXJ03<C0YZO89*CG-6;]C=5/LEIE8)22S>]JLHRL5<LSA:^Q%,MZ/@]
M\&/ UYW;GKG3H[..JZ39.0DJ+V] _6UH;[Y3+>4&TT2X;BX&TTOH:.9HM!2N
M@SE$9^'*D:XN#6I.9HP6!*=VK9D832!)<PYYGA!8)!@A0P7#/"C/_FB$\:TV
M=R4IG<MX@HZUKH*D]W7E#HT>SJS.NMY7V<UKG%&==;*EH";*F=0W?>_(XZM^
M6I3N:/S=="EM!+,N]7?]<_76VOC/B5(*$U)DD IEGV]6Y% D*;$HRIS0%"F1
M>Z4H!HPYMB>^,;G2\'N[7D[G>AFXRO0!VH\+(L/7]V%W;2W8F@MV]H(_G<6@
M,CEF<R]_@.*V^?(8=]B&7_Y '+7^"K@T/!WZ5LJZ\8Y6[[2Q3Y-ZJ^?V+ZLO
M]KNSK)ONN.%M@/.EG"[*;[K\,97:1LOV)YL8Q\9!=8KV%V>BC6[VBMA7B],B
M?\U+%Q?"+FIQ!G.:.+F7I(!,$0USN\I%&29")UYR"R/P96Q,Z19#7*[6O)SR
M&7"+X6J1\^1<!\O:=[E8KEZ*]=DP=RO8UZ0T-NH/*_[3KI\J2/U3GU_[&]9.
MY2.P<$2OB#TD0 ,%:+  %1A@AT:]VJX  0TB]7FH_>G>BAML@0$-,D<:%V<E
MP(+3[%_[N^:?S/\O])T;J&3@7^R[%U2S,)+9;JF,>&T+!ZN_>&U'7T1Y8S*I
MXZ'')I=[MQLV(933A"@.:2(+UX=-0$YR#*DL-&9<)'F:3E:NB-;SS.)XC*!H
M:SM2C[O3V_J$3B<&)T#$1F:LX!CFB+JZ:ZDA5W;9+Q!3"<X8R9E7,\I8( Y6
M5[W80OE4+KQCS38H/4]/K@.H[^./+2H'AQX1#RS.NQ_WQ.'$.,,>&9QW]&C/
MO^6C5]+E1U<*LU'8>-XJY>@T3W*I8*JR#!)D,"Q4HF&B,IYJ@G-C1*>'_N1P
M8WO^&[/ 4Q.MV:7GC@QF55589PV="\ '4L35< [&%I6E-UM9G><>1'7\4.F'
M1$X/^3I\TNK^66IIOZJ73)1*H/!$H/C]3* XD87,)4XSF OM!+RPC448Y]#^
M7#+7$)8D2=0TE% +QY>#<E%%-6I.2?",8JTR1!F&&=&I:W6.H'"=9S,[NBPP
M440$U3R]XGP.\6;ZJ)?+?P/\<;%V9T_\Q2["B]9@;BNBW/4Y>O';:>-BZ/LK
M\A<@2D91G],ZCG2BC3!OX ;28'E$76=@R"2B8!O'E$'4%># ]*'.PW0LI9O.
MIRL;=?S0RM[1/A=3.U93C?_HK/B?:KNW$6/_3\W+[W\M)@G*"V.TA(CB!!)&
M[4M#4P,+DF4H99E$+.BET<F*L;T:WB]7T\=JVYK/YVL^<V^)K>F;)@XWP#XZ
M)+#@KM,<^?%Z[\CWS-ZU_;!R .P\J,5!;JK6#])-R;XS-\#Y :PC$2OUKL$Q
M;N%>)TN&K>.[!JRCLKZK;M:--5UFITO!T,OI_;Q.Y'0EKYD4F4 DA=I5^I"<
M4"B*U-$B*TR*)>(F":'%T\.,C?<:*\&>F9WJBL^ ZL=CUT/5,U%U0"F8A-I!
MB,HR9X8:E$;:W7W)$Q<^'4M K4H$;=I!UZ('7VW ]MNB_(N7:H*424E"&*2(
M8[O:Y@06-,F@D9F@+%<D44';NH'CCXTZSFA\[?OPO\!&FL/Y 1I' JDE=)K\
M.*='\'LFHQYPCZ"QYH5>STIK[3:\LMZ:%T"75=?\;M-5V7VOC/)VKK[J*I_A
M5JZF/ZK#FE-9UHDH<F:$@303&A+N0B9!.<PQ1EA*BE78<K*+$6.CQ@,?;L"'
MQR<^+>N<)[>MV+@$[AYX>1\N/=YADOPXL6_H>R;& _,/@-YYT'^Z_#4@1I8?
M[V#(P/KCW:$Z%B"_XEX=6^5\OOMPN,M7-WK;; 0>Q(X"XS1+4RAY5D!B(T8H
MA)0P(:3 >8&3A.B@YCG^8X^-')WI9UKD[>_67Q4SADR-'S?V!'C/E!@9Z_!.
M/>&HQ>W=$S#^L-U\PH$YZN_3X18=B4ZI2@F;S[[PJ?HPO^-/TQ6?;:I_C%!"
M, P3S0@D@@K(!2F@)L84,A$4H3!J:QMM=&2V-18X:Z%=B#7V!A)6*\2>%!4+
MN+Y)Z2QF/=0[>X$2EW-:1QR697R</^(5KXLZJAWPY8,-SMQ_W.+U!Y^Y,N#;
MU1TORV<;N%6Z?A.:9"9S_5LPHQ(2A!"TWZ04IAG)"UT(K;.@K7BO4<?&+)4$
MEUO$2/<7O;,[4"+!"W&9I1QG"84)5G81+Q,-6<8-S#+#D6*8ZY2%I89%QWR8
MA*^SJ .^ MK^W 9,=5UE']/@Q_/1H>V9[[>85G_9,_G&@;JQNM9EC2AT$8)2
M7/$+KY&'%<0( >-()"/HXFXOAG?ZJ=1R6M=<*BD2BO,4XC3%D+"40V9R"A%/
M<BY,EC.$0_A__^9CH_E]V\(HY0 R/^;H"D3/!.&%03 !G'(VZG-^,,"@C_,I
MUUX^M2<_T^WA_*[EPWPQ6]P_OW5=-EYF:FQTJVR<((R4T!2IB]IH"IFRCZXN
M<J(I4M30(,5VKU'']CCOC Y[F/T@]GO*HP/7\^._LQ=6!A^E@GDTZPMFAR"0
MHM*&W\B#\DD0&"^))NSBCKI:\D&K]4Q_-K>N,5NIU?G,L;?/?_#_6I1W3JOO
MN]L8FS#&-=9V%8DI*R#),P49L40EC#%"I5CF(F@]>94U8V.LC3-N9;-Q![1F
M9@+Q#"JG0.45^+/R*W"'_KH9]2/"P>:I9X+L?XK"1<%B0!M7+NPJBX85$HL!
MWI'$6)2;=J/GCXOYO>6JQW=:K+[;6S1]'GB")-:40,>S;AW';$2H$*0)%I1A
M@Y)"A?#NZ6'&1JC.2NC,!,[.&^ L#>R><0%7/_:['JV>::T;4,%4U8Y#5 XZ
M,]2@Y-+N[DO6N/#I6(FU[[319>EXR%5+?><_]7*",48ISBA$1>:Z$J<Y+&2!
M(692B02A1",1UE_#:URO!V#09AL;(YTT7V@VF!_4?H01#[Y7383=PMD4@GYO
M135"ZFL+2CTGO)X:^9737%O N)S<VG9QQZTK=^=U^;RO$>X.M#"6&<2)IJYJ
M/H4%(APJPG"A!$4)"=NH.AYC;#')QL3 3:D3X'EN05T'2=\;3HUUO8FLM[@?
M=ROIQ#C#;AR==_1HFZCEHQT[=Y4+J;5:_F;-^N@TQ#^;.TL>T]5$9L;D@F,H
M:)9"DBN7DI1+F%*%>4H$3U503OK9D<;VG+]=E.7BK^G\?@G6<XLD,%Q6BC2!
M/;S.(NOW^$?!JV<2V-A8]Q:JK'3[*[6=$1MY78(B;B>OLZ,-V\KKDM-'O;PN
M7M Q<]'M=NS*+YJ"BTE!D,2T0# KL(*$H11R@G.8IA11S).4\S0H9?'D,&,C
MAVJ]/:OV"WFU23C=6@QDEU*4,^CZ<<3UF/5,$/5&ZL["B^4ZX;F)K1#$34H\
M/=2PV8BM[AZE(;9_NFN:23G]P5?V&?BTJ',<;RLUJ G&J5*:Y= @54!"+1FP
M5.00V;\2+>VO1!:6<G)ZH+%QPL8Z\,,E\51O0#.=\[ET[0:F<U=3TZ$'Z%F8
M_:@A!G@]D\/.Q!NPQ;"V,F8&2SL.D;-9S@PV<&9+N\O'62X7/G^%].*GQ7QQ
M*!W;Z)!,<J:PYH;9@,$)O&:*0T$2 1&37*O4T#R,+=J'&QMGU*)KM0QBU5VD
M@P;>>6S]*"(>8CT310W6OJ5;@;K&V)CJSUZHQ%>-.S_D\")P%]T_J>EV^:JK
MNXOOKW&J,>MFDZY<=5ND.N$BDZ@P!,K4K4R,1% ("SQ#"=*<$X%RWKGIN(\%
MXSL>J2SMW(/<"W7/78T>D'R%CN5O#G8^?@$U0VT=V"N6[Z6=>0AT?74Y][+A
MM9J?AP#4TA,]Z#;7D=OW19-R8L>T)+IZ=CU/5K=SY<H%GMQ')IG,,L$9ABC'
MU*ZO$@49)QSB0N)<B@+)-.W&:Y<''Q^E'3R/3XW=-^#)65Y+A.B-\=V(SV-&
MPC@O$LH#T]UJL<F7 U^V*'_9H?S^(LJ=F<X?L%Y(SF/X5^$W?UC.45O '3IT
MTLR3Q"XD]?+=6O]AKWQ :4)0<_0I->'*_K]+8A.0)+F&C*D$:DMITOU,)E[G
MQI<&&MMZ+_\U2?X&*FN!6FM0V0N04\,E**"O7QNV[6P4$[&>N6<?K'<OP>K2
M#;$-M8!6A9'0&ZB/8"N*D=KY>2#2UFNO[?+A&N%Y.''0I<[G\UVWUE]VO;MS
M@N=.G<1^599OG]\_/LT6S_9;FRK%JC.W),E3N\9E#')%":2%!9GFS# 3E'_C
M/?+8B+6JAY;[MKJ(I6K=ZYH&ANZY^^+ONPG? ZJ][\H?MQRM [ZFD.P&'#CA
MRB0V;L3<M@]$+O(^ON_H V_L!X)RO-,?>H,P'EN6J\D?_.?T<?VXR1/$PJ12
M93 3A8:$*0H%(=C25I'2A!N."/'AJ:,[CXV'&N/\^.88IW8^N<K[GOFBL2MB
M!N!9;]N><7O1WO-M__7RV3Z^ZR#/[EEG-L_F^0^$/7M*3R?OYZOIZOG#W"S*
MQRJZ_&@?]P\K_;B<((*8D$+##&42$E4P6.B4PH+F-).*V1C&Z[BM?9BQ/96U
MI6#/5/"G,Q94UGHN(2X@V_[HQL.KY^>X*U3>C[4?$B>>\:66O]XO?OQO>X/Z
M$;=_J9[NZKF^<-M!'G(_US9/O.>GPW=>OCWP4M>ZUKLS?;=3O9@WKQF6<,HU
M+2#*G485YP;RJKA0J#P7C%$FO:JXO48;&QGL&0S4UF+ I;]NC!_*ES=BHF+7
M,S'LP[8S%M36=MB-N8R?_Y9,5!P'VI=IQ3/.OHPW+"V;,Y?O,=@.C;<[^]LT
M_A=UK==>+MWJ:3J_UW/Y_(FOUN6FN)C*%!DD&:0FR2#!J80L201D6@IE$D-I
M%B2^U3+6V$C6F0KV;+T!M;6=J[?/H^RW!Q,)NYY)MCML'6JY+P(2N:#[_'@#
M5W5?=/RXM/OR)>%QVE<MG6K$U$QE]:Y9F._Z\6E1\O*Y;D>R6FS;8$^0290A
MQ$"E<P-)FF!8,)5"EA&L-4:Z2/#FU/^[7^06,GZ'@__O ]#,2Q=<TG6IY;JL
M^E:X9M-ZOJQ_LUJ 196>PZ4LUUJ!6>-;6W;.=7-V.0",/@5#M0<YAGUK^*9A
MD@5\:WM/ /M'B'T!/5"P& _PH "R"VHML630[08+*[LXN1]A=KH^?%/OHV75
M6;U?4/6#)':E3FB10VV_/)"PK("%X,3ML'..>5&(S*LP]\2]1Q=,.O- LS,5
MTE+S%&Z7]^FN0*/O\#  B* -N3,N=]J%>WFOP;;>SCBQO]]V[B/7)6U^-D[S
MY_U/%Q^NI\N'JLANL5PM)UPF,D%$VU@M59"XKA[V3A2*G%):$)DD.JC/Y<41
MQ_;H?BGUXW3]&'@ ?QE8OT5?5+AZ?K8;6ZL\5F<M.#07;'YL$7UJ/NI<B)]N
M>1&L7K(LSX_Z*LF5%T$XEU-Y^<)80F V[M#3'TYR<#E!2IO,K@"AL2$!) KE
MD&EA>2;EV*(@\T21:P7 ]L;KL!KL?R&X,>Y:U:]]7/UHYGJL7E7ERP>["-I>
M)S#I6=-K?\17UO(ZX?QE#:]3%W5CC_/ZI<O;QT6YFOY/M71I"O4^Z9^K[W_I
MV0_]QV*^>EA.#"&,Y%A R54.26:)AKN-;)Z9#"&3I1('I1E>9\[88ISWR]7T
ML6J.RN?SM0W0^9X/0-=.N'S;%(=QTY6SYD=>P\U%S^S6JN)\ YP#LNI@N^?5
M#?A/S4OP>1ZQ6TX<0*-2XY4F#<J=<>![2:Z1[MI1.LDUCG22L-4&A,*%X8H)
M2!,;H1%#74LV)%SR14IED=$"T2#%I/V[CXT;*^,:.>* C9O3R/D16F<\>N8G
M?RC"U8].N1Q7].A@A&&UCDXY=R1Q=/)#W1[73WKER@F^E(L?4Z75V^>_5[TX
M?JO%?/:+?F_%<E5RN9I0DS#$B()"9]@&2-+ PI 4RE06]HM!%4)!*FCA)HSM
MP?_MPZ?;3W<?/OT.;N^^?_C'A^\?WG\+>_8[3(,?0?0+;L\LXCI-5\4N&_-=
MX<4;YX%=ROT"MD[L:0]8NFG\B$@YW4&,RDL=S!B4O+K#])+AKKA3>/7&W6*^
M7,RFJ@J*JGS4Z@6<B\04"6+08)1!0K"&1:&%ZP/$4X:(4<2K"\7Y(<9&8P=6
MUCG008%,"YCM9!4'HI[)J ,Z0>4?[0!<70=RYO:#%82TN[=?&7+ADQT[@3GY
MZ#HU<EF?5$\DY2E-F8&($ 9):A]PQ@F&(E>I3KG60N23U6+%9WYQS/$000_X
M=J#^OL+?W1C@#_E_]')IO\-WB](=W5??Y^6>\?_W_\521/\?H+29RA918U^@
M_2*5Z^#K^>'?-^Y_;7)0;E=U':';M'0)*5]X&543Y#PB<3M@'0\S;%NKLVX>
M]:HZ_\ENK'"W>'Q<S*O;5KG3RP_+Y5JK"7?-@Q7)(#),0I(H#850"*)<%MB(
MU!TZ!762/SW.^ ( 9V;-!3=@65D*II6IX,UTWOSDO/!@$,9^K! !N=[C@@JT
M;S5HM9$WH#8S8EOR=ASB-B(_,]:PK<?;'3YJ-G[AXUU;132=98Z_OD3+7!&F
M(9<402*1@CR53J,L$SG1N! I"^L5<6ZHL;'$UM+(1-$"MA]7Q(&P9[K8H7?
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M3 JNC41A:VRO<<>W7+Z;\>ECW9A[MC5X<R1_ ^;Z_'[X%?"C3.=(4 FY)#8
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MH/+L!FRMWY0S;.WOEC\<;SH##\J'G*2>F3#2_'0_8(^%93_'\%=;]SJ'];%
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M&AG6@<Y2_>"-=&(: %';^:C/;88[#0UPZN#L,^2Z&#T1ZN4=9\0D2!:0$YU
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M*=9,$ B\LYMQO%\*WENQJWR$C1WD\Z.N$CM=_>"RF'@9WS"3G&F1RA0PC!E
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ME <<_18=;!EOW%*#EQ4_*C#H<4LWQCA**=K'.G!K."&M#4A@2@'BQEI0AFI
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MLW\I6:!D@+9GCO+1>RBU_<Y]+NWFA#5Z%/_&\T69],J+[^_GR[_^H=6]WCF
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M*!,RTA'U4!,3=&Q]-: M9]G=GSW: ??5ZC=/O:]_V#4]M2I;IU$.I3XUR:A
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M=?F&+F<DKJ:17&]6;H_CX9'GJW([K>XZ^J4RJ-]\YZM[7<QBK"1AEC42DFJ
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MKI(IY'LXE&S 3Z-<^$I[0N]EW1;F/#(XA+[/%RY.:F]VA-D3UTTKBB%2J=
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MGXR3>%2*%6V;*#H6V;3$RW?#^6HJ#\;NA;FXE'<4>GV&S%C\6 TZ%8)[!D$
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M<')E+GAM;-R]67>;.9(F?-^_(J?F=J(2^]*GN^<XO53YC#/ML5U=T]\-#Y:
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M*)L+_Z>+\_EZ^?7I(N,D<^EL3 Q\89ID8Q.$0@:/E<@HQB;'6@SP@KJ=B)U
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MDUAXT4D9"%SIVD)-UR[-!IA'IR*3C"*<4Y[0XV: MX3;$!KH,&[X):RFZ5I
M,DA5LLB0%*-]X66"&&F;6)V(,919^6U='X:#TRVR^K)A3=R]P]7P6)R]#8<7
MUI>":2-]]%#O"D%94V@;2@/:>L%2T3ZHEN^G.Q/:EZ-W!$0.<?,.U%<7I^6>
MKL%-5NDH\,87D)%EVMB16,U& '?11>8R3^84T-R#Y+Z,8RN0MM)A%W"]5X@3
MR1@OFZ:%FXS6%'05G@>)-?<PQ*BWM@L=^"SNR[$;#F;'R[X#I^[O./WPL3JZ
MA,KPX7)JP^OR75NR:XEQV@2L3HSR403:(KXF$'A+6T1G7E 8%DP3;.U+Z4C=
MC5M>'C=55@?>X /\W8R_;[7*0QNY]"3+%&M" 7/D9UCF(=ML-#D>/&*;[.0]
M"1W7&VR+FMT@.H@*^T7H=WQ=G 4E,I&,D!"9K[V$*;8/C(X&01_, SIFL4VQ
MZEYDCNL&]H#. =3W6/L?/7W]ZYNWS_]*/_/RWY^__(W^^/S5ZW=-FB$]M-1)
M.B/MQ.= ;9*N#_W7Y<(+>#+/M3_P$C_B?#7]?)D ?XWH&$6*C@N0I;Z$%!D@
M9(>0BL0HO# 8M@V5.:*/PGZ$#IA.YWR1OC*:ZK678E& -U8!0V39^\AX2EVD
MT[4R>RTQLB7+;A^Y=W#<WB.1J\#]VWG@50[!"F#9V/H@PR'H3 &78D;9*(LI
M;:"T W'C'JVGQ-C0FNH ?)L"SWOXVEPL+9;D2LPO6B>FK^^78;ZJ4V=(L?.\
M^=/L0LWY/\]7ZZJ#ZRSHJ*4GKS9"5I[7'KTU6XS'VL09T3!32J-676WX&=>,
M#@Z[^XI\Q\5 %_>,V^3P-*P^OI@M?O\KY@]XU2_F25G7UAYI%E:K:9FF<"47
MXMZ:$*64"F2J\V&5(U^>N":+H[UD2J)F;:Z0AN1B7-,^)NZ;ZKM[M+^IW]BP
MMOFI.OEZB>OI<G/07M8:OIG1YK]GVWOI)(O<@64B@LI,U.(K#4:&(C39 Y/:
ME-XU8FC<F_TQ]\"I4-!/9<$V:5RSALYS=.0R*L4-*)XEN.+)H;2A3ME3S*I&
M38]VH&[<?H!CHO4@_73P.+5%9@=5P*K$70A9@9"UZ7U($8(U&GB@3>A91!5/
M'BHVJWEN9G<["2N;(Z#O#; 3NY'\KL@9V1);R/.*6H&W]"5Q;@U9@A0;/=8>
M2?BXIKH3@ ^NX7Z<B2U<3WB2RA3:G4)+65OY"?!9U DUUECZ3RJV31[5%J+&
M[>O:"1[WTLQ@QO,$[V&_/'GUY+>GS]_]]?GS]X.]?-W^T&9O7%MH'_XUZ\5T
M'N9I&F84[TPWZ+^"',L)A4<&QM3>(LYK"(H\5Z>9Q)RS2JE-_XU=J#O66M6A
M$>O5-:]D6HO-6$"K0/$;#[2]A/1@O8GH!4-R+9KP>IN.;MZOAD'%74-TA- [
M>#NXH/YRLM(U$XX)FVS(8(,2H-"[6CLD04LC<V2%\48M(.XE9UP ':/?>Z%R
MC+ [0$R]5:WG.OWR_+_.IY_#C)A9/5D_#<OE5_+X_CW,SG'B/4,;Q2:+GG94
M,;%VQQ8@(DG,V)1Y:&-G=R*O!T0=!8.[SM#@.ND :&\Q(;%"046]%[H4UX0I
MGX3B!;+T-0_/&'"1(1AIA4C.)=FH[?2]Y(S[N#(\D(Z7>0? >3G_3%0OEE^)
MA0G9Y%B,HC# U/8XG,E:P4;G>Q(6O57>-4K@N4G%N/=@P\/D8 EW@(X+:=1,
MW]6GQ2K,_K)<G'^ZOJ.[MPCG:A\DJ=%(X:#D5%\%+9W]Q!S$'!P%JSHSW2;_
M[7":Q[V@&AYY)])>!SA]L\1/89HOF\->/>#=DNC$,-INK@C@LAA0%A,X&02D
M[%+PA6?9J!'2#L2->Q4U//*&UD<'$+M-O$1DJ:@,3*"OCWH%/!<(,F#FR()T
MNDV^U_ZP:=;2KY7!.D3&'3SKO%G6H1'KKS5#H#;^K\'%I\L<@8E5+GI>!R"I
M1&#7C$QI=0UE<)B*9Y[Q9JG1#U+5@T,^R%W!8*+OP,Y<#[-YA6&%;VMIR^OR
M-S*B55P3HWQ(M"U FU#[*Z&%8"(YD5H)RWT,KM';WU:R>G#9!P'2<,+O $EU
MINWOT]EL(C!EPP3)P=C:KT$3R793%!UML#*3'6V3H79%00^.]2#X.$BD'4#A
MQ70^7>.KZ6?,+^N0O@_3.+L =;VZF#BC8_;$0XX:R=N/$7Q)$9)G#J/R4=DV
MI]-VNGKPB@>!S8#B[P!,-WSYFK]PZ:T%P3E3UH/T@8,2#B&6@F"\0X6N9-WH
M&>1><GKPC(<YD8X6=@>(N:!_DHU!'E158FW$DJ*"Z)TD.03BQ01-WVH8-(T[
M,G/PI[&]Q-E!?/1J&N)T-EU/<44N^KOU(OWCXV)&0E]5=WW]]5HT7F2/EELH
MG(R@,IGBONIF9<ZB]DQD]FUVT: PV97";@H VSS2-U%4!U;H!E]W+RUR374*
MF8&6CC@1FD,4%H%;3[M4!A99<\AU]9#?!@,/ ^T8A70 K2<I+<[GZ]6;\+6^
M!U[=8!5I48D2 4L=>^W)3$=D");YFK/G$BN-DHKNI:<;2!VE[;N'X?&B[P!
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M=RD9.]6L"6*.$G<'<'F2\R;;+LS>A&E^.;^\Z)M$G9(69'JM2,2&<P&BJUW
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M>&#)EZA;V[/OJ#JZU!O7]3/?+!=UA^1?OOYMA?GE_#4=\Z2]^8<G:4U[9S/
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MOR"%I&VGG 6C,PD2?8!@DJO#-:*++B273MJ99 NMX_JJI[XQ&DII/9SH-TZ
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M(339)R O=W/,GI-7[,$HI-V<4P':9XYDQ="2,^YMHZ>T!TD:U_X-HO ?@^@
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M"XB<I&+>Y<!L/(FA&AE"PRO[!_9J+\EW,PM^_]MJ"D9$$4*!\)MB2B\@FE!
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M"74ZE&99UZ?Z##$30UIFQA5%:)*UB<=W$-3E6_8@8!M" ]W&'1L!16&$I@,
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M*]"Z_'M)HGY;A[)>I818*SG?DJ##Y?_!,%_<3@L1DEMG(@AGR5]VF<2AO8#
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M1L:37;\8N7<I<DA*4*A/L3XX0CL(=-)QY,:EOVL;]='(&$R@8R/CV6[..BG
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MLKCB;#(Z\J:Y[D<4=9&"/$G;SP+H"-%W *$- YA?+:YYNHUHKVTIQCJ'047
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MQ-PF375" 4$SE/:"EOUJ$0Y179< W/1HL*RB81*RM;7^)U'(Z'VIP_UCK#5
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ME]"C;Q:,P^NH/G_T]AOEMX#;XN]_^3]02P,$%     @ @HT$4S;)(8A1"
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MY^^V&M6C=F9.9H*923>HU_]9<J)GIY%,#>93&.]_>C6;RJ@:0]](&B.3;M"
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MF-EC8<$57,\#2#PAL]CJ),,P5S8F*Z5@35\BM4&+?<0%+3J$BN*) SG8$(X
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M\<8'+L[CO]'R=U99<ZH_$3PB@SL>YO;1&[GRA]Y-9-0<Z]K"_-9(96?A[H)
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M!8V)9AE77KJY)*,FS<[E$#)$1IJIFX?<X9V M<_\?2+S9M/!WU!+ 0(4 Q0
M   ( (*-!%-@D0<8 (," ,:5'  0              "  0    !M8VLM,C R
M,3 V,S N:'1M4$L! A0#%     @ @HT$4T_W/:27$P  K<\  !
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M,C$N:'1M4$L! A0#%     @ @HT$4QOS"9LZ!@  -"4  !H
M ( !4B@% &UC:U]E>&AI8FET,S)X,#8S,#(P,C$N:'1M4$L%!@     *  H
*GP(  ,0N!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
